NA	CHEMICAL	GENE-N	13	9	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T4	T13	23639586
NA	CHEMICAL	GENE-Y	13	34	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T4	T14	23639586
NA	CHEMICAL	GENE-Y	13	48	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T4	T16	23639586
NA	CHEMICAL	GENE-N	40	9	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T5	T13	23639586
NA	CHEMICAL	GENE-Y	40	34	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T5	T14	23639586
NA	CHEMICAL	GENE-Y	40	48	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T5	T16	23639586
NA	CHEMICAL	GENE-N	42	9	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T6	T13	23639586
NA	CHEMICAL	GENE-Y	42	34	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T6	T14	23639586
NA	CHEMICAL	GENE-Y	42	48	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T6	T16	23639586
NA	CHEMICAL	GENE-N	42	9	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T7	T13	23639586
NA	CHEMICAL	GENE-Y	42	34	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T7	T14	23639586
NA	CHEMICAL	GENE-Y	42	48	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T7	T16	23639586
NA	CHEMICAL	GENE-N	45	9	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T8	T13	23639586
NA	CHEMICAL	GENE-Y	45	34	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T8	T14	23639586
NA	CHEMICAL	GENE-Y	45	48	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T8	T16	23639586
NA	CHEMICAL	GENE-N	47	9	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T9	T13	23639586
NA	CHEMICAL	GENE-Y	47	34	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T9	T14	23639586
NA	CHEMICAL	GENE-Y	47	48	Analyses of these genes identified over-represented functions associated with gene signaling pathway , chemical metabolism , cell cycle , oxidative stress and apoptosis , which were consistent with the results of significant increase of gene activity and reduction of serum chemical , chemical/chemical ratio , chemical-6-phosphatase and chemical carboxykinase activities , liver glycogen .	T9	T16	23639586
NA	CHEMICAL	GENE-Y	0	3	chemical effects on gene activity studied by its simultaneous and time-separated administration with chemical and chemical .	T19	T27	23334403
NA	CHEMICAL	GENE-Y	13	3	chemical effects on gene activity studied by its simultaneous and time-separated administration with chemical and chemical .	T20	T27	23334403
NA	CHEMICAL	GENE-Y	15	3	chemical effects on gene activity studied by its simultaneous and time-separated administration with chemical and chemical .	T21	T27	23334403
NA	CHEMICAL	GENE-Y	18	8	PURPOSE : To characterise further the previously observed gene ( gene ) interaction of the dual gene antagonist chemical .	T5	T25	23334403
NA	CHEMICAL	GENE-Y	18	10	PURPOSE : To characterise further the previously observed gene ( gene ) interaction of the dual gene antagonist chemical .	T5	T26	23334403
CPR:6	CHEMICAL	GENE-N	18	16	PURPOSE : To characterise further the previously observed gene ( gene ) interaction of the dual gene antagonist chemical .	T5	T22	23334403
CPR:3	CHEMICAL	GENE-N	0	5	chemical upregulates the expression of gene in mouse aortic endothelial cells .	T11	T29	23603059
CPR:3	CHEMICAL	GENE-N	20	13	Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 gene subtypes , gene and gene following chemical ( SA ) treatment .	T6	T21	23603059
CPR:3	CHEMICAL	GENE-Y	20	16	Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 gene subtypes , gene and gene following chemical ( SA ) treatment .	T6	T22	23603059
CPR:3	CHEMICAL	GENE-Y	20	18	Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 gene subtypes , gene and gene following chemical ( SA ) treatment .	T6	T23	23603059
NA	CHEMICAL	GENE-N	13	15	In addition , western blot analysis revealed that SA enhances the phosphorylations of gene ( JchemicalK ) and gene ( gene ) .	T8	T25	23603059
NA	CHEMICAL	GENE-Y	13	18	In addition , western blot analysis revealed that SA enhances the phosphorylations of gene ( JchemicalK ) and gene ( gene ) .	T8	T26	23603059
NA	CHEMICAL	GENE-Y	13	20	In addition , western blot analysis revealed that SA enhances the phosphorylations of gene ( JchemicalK ) and gene ( gene ) .	T8	T27	23603059
CPR:4	CHEMICAL	GENE-N	15	3	Finally , SA-induced gene expression was found to be prevented both by NAC and specific gene inhibitor , chemical , strongly indicating that gene upregulation is a result of the ROS-mediated activation of the gene signaling pathway .	T1	T28	23603059
CPR:4	CHEMICAL	GENE-N	15	15	Finally , SA-induced gene expression was found to be prevented both by NAC and specific gene inhibitor , chemical , strongly indicating that gene upregulation is a result of the ROS-mediated activation of the gene signaling pathway .	T1	T12	23603059
NA	CHEMICAL	GENE-N	15	23	Finally , SA-induced gene expression was found to be prevented both by NAC and specific gene inhibitor , chemical , strongly indicating that gene upregulation is a result of the ROS-mediated activation of the gene signaling pathway .	T1	T13	23603059
NA	CHEMICAL	GENE-N	15	34	Finally , SA-induced gene expression was found to be prevented both by NAC and specific gene inhibitor , chemical , strongly indicating that gene upregulation is a result of the ROS-mediated activation of the gene signaling pathway .	T1	T14	23603059
NA	CHEMICAL	GENE-Y	0	2	chemical-resistant acid phosphatase ( gene ) staining revealed increased osteoclast numbers in tibias of 2-month-old gene-gene mice , and increased numbers of osteoclasts co-cultured with gene-gene osteoblasts .	T1	T3	23044709
NA	CHEMICAL	GENE-Y	0	4	chemical-resistant acid phosphatase ( gene ) staining revealed increased osteoclast numbers in tibias of 2-month-old gene-gene mice , and increased numbers of osteoclasts co-cultured with gene-gene osteoblasts .	T1	T4	23044709
NA	CHEMICAL	GENE-Y	0	15	chemical-resistant acid phosphatase ( gene ) staining revealed increased osteoclast numbers in tibias of 2-month-old gene-gene mice , and increased numbers of osteoclasts co-cultured with gene-gene osteoblasts .	T1	T5	23044709
NA	CHEMICAL	GENE-Y	0	15	chemical-resistant acid phosphatase ( gene ) staining revealed increased osteoclast numbers in tibias of 2-month-old gene-gene mice , and increased numbers of osteoclasts co-cultured with gene-gene osteoblasts .	T1	T6	23044709
NA	CHEMICAL	GENE-Y	0	25	chemical-resistant acid phosphatase ( gene ) staining revealed increased osteoclast numbers in tibias of 2-month-old gene-gene mice , and increased numbers of osteoclasts co-cultured with gene-gene osteoblasts .	T1	T7	23044709
NA	CHEMICAL	GENE-Y	0	25	chemical-resistant acid phosphatase ( gene ) staining revealed increased osteoclast numbers in tibias of 2-month-old gene-gene mice , and increased numbers of osteoclasts co-cultured with gene-gene osteoblasts .	T1	T8	23044709
NA	CHEMICAL	GENE-N	0	15	chemical and chemical intake exert opposite effects on circulating chemical and chemical and differentially regulate gene in the ovaries , oviducts , and uteri of adult rats .	T30	T53	23591044
NA	CHEMICAL	GENE-N	2	15	chemical and chemical intake exert opposite effects on circulating chemical and chemical and differentially regulate gene in the ovaries , oviducts , and uteri of adult rats .	T32	T53	23591044
NA	CHEMICAL	GENE-N	9	15	chemical and chemical intake exert opposite effects on circulating chemical and chemical and differentially regulate gene in the ovaries , oviducts , and uteri of adult rats .	T33	T53	23591044
NA	CHEMICAL	GENE-N	7	15	chemical and chemical intake exert opposite effects on circulating chemical and chemical and differentially regulate gene in the ovaries , oviducts , and uteri of adult rats .	T34	T53	23591044
NA	CHEMICAL	GENE-N	5	21	We report the effects of chemical intake and chemical treatment ( at doses of 100μg/100gBW/day ) on sex hormones and chemical receptors in the ovaries , oviducts and uteri of chemical-preferring rats .	T9	T38	23591044
NA	CHEMICAL	GENE-N	8	21	We report the effects of chemical intake and chemical treatment ( at doses of 100μg/100gBW/day ) on sex hormones and chemical receptors in the ovaries , oviducts and uteri of chemical-preferring rats .	T10	T38	23591044
NA	CHEMICAL	GENE-N	20	21	We report the effects of chemical intake and chemical treatment ( at doses of 100μg/100gBW/day ) on sex hormones and chemical receptors in the ovaries , oviducts and uteri of chemical-preferring rats .	T11	T38	23591044
NA	CHEMICAL	GENE-N	30	21	We report the effects of chemical intake and chemical treatment ( at doses of 100μg/100gBW/day ) on sex hormones and chemical receptors in the ovaries , oviducts and uteri of chemical-preferring rats .	T12	T38	23591044
NA	CHEMICAL	GENE-N	10	15	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T39	23591044
NA	CHEMICAL	GENE-Y	10	27	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T40	23591044
NA	CHEMICAL	GENE-Y	10	29	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T41	23591044
NA	CHEMICAL	GENE-Y	10	31	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T42	23591044
NA	CHEMICAL	GENE-Y	10	33	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T43	23591044
NA	CHEMICAL	GENE-Y	10	35	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T44	23591044
NA	CHEMICAL	GENE-Y	10	37	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T13	T45	23591044
NA	CHEMICAL	GENE-N	19	15	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T39	23591044
NA	CHEMICAL	GENE-Y	19	27	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T40	23591044
NA	CHEMICAL	GENE-Y	19	29	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T41	23591044
NA	CHEMICAL	GENE-Y	19	31	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T42	23591044
NA	CHEMICAL	GENE-Y	19	33	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T43	23591044
NA	CHEMICAL	GENE-Y	19	35	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T44	23591044
NA	CHEMICAL	GENE-Y	19	37	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T14	T45	23591044
NA	CHEMICAL	GENE-N	21	15	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T39	23591044
NA	CHEMICAL	GENE-Y	21	27	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T40	23591044
NA	CHEMICAL	GENE-Y	21	29	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T41	23591044
NA	CHEMICAL	GENE-Y	21	31	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T42	23591044
NA	CHEMICAL	GENE-Y	21	33	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T43	23591044
NA	CHEMICAL	GENE-Y	21	35	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T44	23591044
NA	CHEMICAL	GENE-Y	21	37	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T15	T45	23591044
NA	CHEMICAL	GENE-N	15	15	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T39	23591044
NA	CHEMICAL	GENE-Y	15	27	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T40	23591044
NA	CHEMICAL	GENE-Y	15	29	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T41	23591044
NA	CHEMICAL	GENE-Y	15	31	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T42	23591044
NA	CHEMICAL	GENE-Y	15	33	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T43	23591044
NA	CHEMICAL	GENE-Y	15	35	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T44	23591044
NA	CHEMICAL	GENE-Y	15	37	After 150 days of treatment , animals were euthanized , and tissue samples were harvested to evaluate chemical , chemical , chemical and chemical receptor subunits ( gene , gene and gene , gene , gene and gene , respectively ) .	T16	T45	23591044
NA	CHEMICAL	GENE-Y	15	1	Ovarian gene was not influenced by either treatment , and oviduct gene was reduced after chemical-chemical combination .	T25	T46	23591044
CPR:4	CHEMICAL	GENE-Y	15	11	Ovarian gene was not influenced by either treatment , and oviduct gene was reduced after chemical-chemical combination .	T25	T47	23591044
NA	CHEMICAL	GENE-Y	15	1	Ovarian gene was not influenced by either treatment , and oviduct gene was reduced after chemical-chemical combination .	T26	T46	23591044
CPR:4	CHEMICAL	GENE-Y	15	11	Ovarian gene was not influenced by either treatment , and oviduct gene was reduced after chemical-chemical combination .	T26	T47	23591044
CPR:4	CHEMICAL	GENE-Y	11	1	Oviduct gene , gene and uterine gene were down-regulated by either chemical or chemical .	T27	T48	23591044
CPR:4	CHEMICAL	GENE-Y	11	3	Oviduct gene , gene and uterine gene were down-regulated by either chemical or chemical .	T27	T49	23591044
CPR:4	CHEMICAL	GENE-Y	11	6	Oviduct gene , gene and uterine gene were down-regulated by either chemical or chemical .	T27	T50	23591044
CPR:4	CHEMICAL	GENE-Y	13	1	Oviduct gene , gene and uterine gene were down-regulated by either chemical or chemical .	T28	T48	23591044
CPR:4	CHEMICAL	GENE-Y	13	3	Oviduct gene , gene and uterine gene were down-regulated by either chemical or chemical .	T28	T49	23591044
CPR:4	CHEMICAL	GENE-Y	13	6	Oviduct gene , gene and uterine gene were down-regulated by either chemical or chemical .	T28	T50	23591044
NA	CHEMICAL	GENE-Y	10	3	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T1	T51	23591044
NA	CHEMICAL	GENE-Y	10	5	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T1	T52	23591044
NA	CHEMICAL	GENE-Y	10	16	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T1	T35	23591044
NA	CHEMICAL	GENE-Y	12	3	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T2	T51	23591044
NA	CHEMICAL	GENE-Y	12	5	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T2	T52	23591044
NA	CHEMICAL	GENE-Y	12	16	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T2	T35	23591044
NA	CHEMICAL	GENE-Y	12	3	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T3	T51	23591044
NA	CHEMICAL	GENE-Y	12	5	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T3	T52	23591044
NA	CHEMICAL	GENE-Y	12	16	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T3	T35	23591044
NA	CHEMICAL	GENE-Y	25	3	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T4	T51	23591044
NA	CHEMICAL	GENE-Y	25	5	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T4	T52	23591044
CPR:4	CHEMICAL	GENE-Y	25	16	Conversely , ovarian gene and gene were positively regulated by chemical and chemical-chemical combination , whereas gene was down-regulated in the uterus and oviduct after chemical consumption .	T4	T35	23591044
CPR:3	CHEMICAL	GENE-Y	3	0	gene was increased in ovaries and uteri of chemical-treated rats .	T5	T36	23591044
NA	CHEMICAL	GENE-Y	7	19	Female C57BL/6 mice were exposed to dextran chemical ( DSS ) and treated by intrarectal administration with either CD.siRNA gene or a control solution .	T1	T17	23500058
NA	CHEMICAL	GENE-N	0	3	chemical and chemical receptor mediated excitotoxicity in cerebral cortex of chemical induced diabetic rat : ameliorating effects of chemical .	T15	T28	23267840
NA	CHEMICAL	GENE-N	2	3	chemical and chemical receptor mediated excitotoxicity in cerebral cortex of chemical induced diabetic rat : ameliorating effects of chemical .	T18	T28	23267840
NA	CHEMICAL	GENE-N	6	3	chemical and chemical receptor mediated excitotoxicity in cerebral cortex of chemical induced diabetic rat : ameliorating effects of chemical .	T17	T28	23267840
NA	CHEMICAL	GENE-N	6	3	chemical and chemical receptor mediated excitotoxicity in cerebral cortex of chemical induced diabetic rat : ameliorating effects of chemical .	T16	T28	23267840
NA	CHEMICAL	GENE-Y	7	7	Gene expression studies in diabetic rats showed a down regulation of chemical decarboxylase mRNA leading to accumulation of chemical .	T6	T21	23267840
NA	CHEMICAL	GENE-Y	7	7	Gene expression studies in diabetic rats showed a down regulation of chemical decarboxylase mRNA leading to accumulation of chemical .	T7	T21	23267840
NA	CHEMICAL	GENE-N	4	11	Radioreceptor binding assays showed a significant increase in chemical and chemical receptors density which was confirmed by immunohistochemical studies .	T8	T22	23267840
NA	CHEMICAL	GENE-N	4	11	Radioreceptor binding assays showed a significant increase in chemical and chemical receptors density which was confirmed by immunohistochemical studies .	T9	T22	23267840
NA	CHEMICAL	GENE-N	1	2	Decreased chemical peroxidases gene expression indicates enhanced oxidative stress in diabetic rats .	T10	T23	23267840
NA	CHEMICAL	GENE-Y	6	8	This leads to decreased expression of chemical chemical transporter , which in turn reduces chemical transport .	T11	T24	23267840
NA	CHEMICAL	GENE-Y	7	8	This leads to decreased expression of chemical chemical transporter , which in turn reduces chemical transport .	T12	T24	23267840
CPR:9	CHEMICAL	GENE-Y	14	8	This leads to decreased expression of chemical chemical transporter , which in turn reduces chemical transport .	T13	T24	23267840
NA	CHEMICAL	GENE-Y	0	2	chemical and gene treatment reversed these altered parameters to near control .	T14	T19	23267840
NA	CHEMICAL	GENE-N	2	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T5	T19	15646028
NA	CHEMICAL	GENE-N	2	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T5	T20	15646028
NA	CHEMICAL	GENE-N	2	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T5	T21	15646028
NA	CHEMICAL	GENE-N	2	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T5	T22	15646028
NA	CHEMICAL	GENE-N	2	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T5	T23	15646028
NA	CHEMICAL	GENE-N	2	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T5	T24	15646028
NA	CHEMICAL	GENE-N	5	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T6	T19	15646028
NA	CHEMICAL	GENE-N	5	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T6	T20	15646028
NA	CHEMICAL	GENE-N	5	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T6	T21	15646028
NA	CHEMICAL	GENE-N	5	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T6	T22	15646028
NA	CHEMICAL	GENE-N	5	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T6	T23	15646028
NA	CHEMICAL	GENE-N	5	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T6	T24	15646028
NA	CHEMICAL	GENE-N	11	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T7	T19	15646028
NA	CHEMICAL	GENE-N	11	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T7	T20	15646028
NA	CHEMICAL	GENE-N	11	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T7	T21	15646028
NA	CHEMICAL	GENE-N	11	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T7	T22	15646028
NA	CHEMICAL	GENE-N	11	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T7	T23	15646028
NA	CHEMICAL	GENE-N	11	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T7	T24	15646028
NA	CHEMICAL	GENE-N	13	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T8	T19	15646028
NA	CHEMICAL	GENE-N	13	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T8	T20	15646028
NA	CHEMICAL	GENE-N	13	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T8	T21	15646028
NA	CHEMICAL	GENE-N	13	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T8	T22	15646028
NA	CHEMICAL	GENE-N	13	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T8	T23	15646028
NA	CHEMICAL	GENE-N	13	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T8	T24	15646028
NA	CHEMICAL	GENE-N	15	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T9	T19	15646028
NA	CHEMICAL	GENE-N	15	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T9	T20	15646028
NA	CHEMICAL	GENE-N	15	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T9	T21	15646028
NA	CHEMICAL	GENE-N	15	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T9	T22	15646028
NA	CHEMICAL	GENE-N	15	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T9	T23	15646028
NA	CHEMICAL	GENE-N	15	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T9	T24	15646028
NA	CHEMICAL	GENE-N	18	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T10	T19	15646028
NA	CHEMICAL	GENE-N	18	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T10	T20	15646028
NA	CHEMICAL	GENE-N	18	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T10	T21	15646028
NA	CHEMICAL	GENE-N	18	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T10	T22	15646028
NA	CHEMICAL	GENE-N	18	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T10	T23	15646028
NA	CHEMICAL	GENE-N	18	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T10	T24	15646028
NA	CHEMICAL	GENE-N	31	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T11	T19	15646028
NA	CHEMICAL	GENE-N	31	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T11	T20	15646028
NA	CHEMICAL	GENE-N	31	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T11	T21	15646028
NA	CHEMICAL	GENE-N	31	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T11	T22	15646028
NA	CHEMICAL	GENE-N	31	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T11	T23	15646028
NA	CHEMICAL	GENE-N	31	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T11	T24	15646028
NA	CHEMICAL	GENE-N	33	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T12	T19	15646028
NA	CHEMICAL	GENE-N	33	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T12	T20	15646028
NA	CHEMICAL	GENE-N	33	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T12	T21	15646028
NA	CHEMICAL	GENE-N	33	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T12	T22	15646028
NA	CHEMICAL	GENE-N	33	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T12	T23	15646028
NA	CHEMICAL	GENE-N	33	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T12	T24	15646028
NA	CHEMICAL	GENE-N	39	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T13	T19	15646028
NA	CHEMICAL	GENE-N	39	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T13	T20	15646028
NA	CHEMICAL	GENE-N	39	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T13	T21	15646028
NA	CHEMICAL	GENE-N	39	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T13	T22	15646028
NA	CHEMICAL	GENE-N	39	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T13	T23	15646028
NA	CHEMICAL	GENE-N	39	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T13	T24	15646028
NA	CHEMICAL	GENE-N	40	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T14	T19	15646028
NA	CHEMICAL	GENE-N	40	36	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T14	T20	15646028
NA	CHEMICAL	GENE-N	40	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T14	T21	15646028
NA	CHEMICAL	GENE-N	40	43	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T14	T22	15646028
NA	CHEMICAL	GENE-N	40	9	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T14	T23	15646028
NA	CHEMICAL	GENE-N	40	50	Levels of chemical anion ( chemical ) , reduced or oxidized chemical ( chemical or chemical ) , chemical reactive substance ( TBARS ) , protein carbonyl ( PC ) , chemical , chemical-ubiquinone oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) , chemical-cytochrome c oxidoreductase ( gene ) and mitochondrial membrane potential ( MMP ) were studied in mitochondria isolated from liver of mice belonging to various treatment groups .	T14	T24	15646028
CPR:3	CHEMICAL	GENE-N	7	11	Pre-irradiation administration of RP-1 enhanced levels of chemical induced increase in gene ( upto 16 h ) , gene ( 4 h ) gene activity ( upto 24 h ; p < 0.01 ) and inhibited the radiation-induced decrease in MMP significantly ( 24 h ; p < 0.01 ) .	T3	T16	15646028
CPR:3	CHEMICAL	GENE-N	7	18	Pre-irradiation administration of RP-1 enhanced levels of chemical induced increase in gene ( upto 16 h ) , gene ( 4 h ) gene activity ( upto 24 h ; p < 0.01 ) and inhibited the radiation-induced decrease in MMP significantly ( 24 h ; p < 0.01 ) .	T3	T17	15646028
CPR:3	CHEMICAL	GENE-N	7	23	Pre-irradiation administration of RP-1 enhanced levels of chemical induced increase in gene ( upto 16 h ) , gene ( 4 h ) gene activity ( upto 24 h ; p < 0.01 ) and inhibited the radiation-induced decrease in MMP significantly ( 24 h ; p < 0.01 ) .	T3	T18	15646028
CPR:4	CHEMICAL	GENE-Y	6	10	Discovery of a series of novel chemical , as potent gene gene inhibitors .	T3	T10	23541670
CPR:4	CHEMICAL	GENE-N	6	2	Discovery of a series of novel chemical , as potent gene gene inhibitors .	T3	T11	23541670
NA	CHEMICAL	GENE-Y	9	10	We report the discovery of a novel series of chemical-competitive gene ( gene ) inhibitors based on the chemical scaffold .	T2	T8	23541670
NA	CHEMICAL	GENE-Y	9	12	We report the discovery of a novel series of chemical-competitive gene ( gene ) inhibitors based on the chemical scaffold .	T2	T9	23541670
CPR:4	CHEMICAL	GENE-Y	5	10	We report the discovery of a novel series of chemical-competitive gene ( gene ) inhibitors based on the chemical scaffold .	T1	T8	23541670
CPR:4	CHEMICAL	GENE-Y	5	12	We report the discovery of a novel series of chemical-competitive gene ( gene ) inhibitors based on the chemical scaffold .	T1	T9	23541670
NA	CHEMICAL	GENE-Y	0	2	chemical binds to the gene .	T31	T43	1526623
NA	CHEMICAL	GENE-Y	1	8	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T17	T38	1526623
NA	CHEMICAL	GENE-Y	1	32	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T17	T39	1526623
NA	CHEMICAL	GENE-Y	1	22	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T17	T40	1526623
NA	CHEMICAL	GENE-Y	1	42	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T17	T41	1526623
NA	CHEMICAL	GENE-Y	27	8	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T18	T38	1526623
NA	CHEMICAL	GENE-Y	27	32	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T18	T39	1526623
NA	CHEMICAL	GENE-Y	27	22	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T18	T40	1526623
NA	CHEMICAL	GENE-Y	27	42	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T18	T41	1526623
NA	CHEMICAL	GENE-Y	1	8	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T20	T38	1526623
NA	CHEMICAL	GENE-Y	1	32	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T20	T39	1526623
NA	CHEMICAL	GENE-Y	1	22	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T20	T40	1526623
NA	CHEMICAL	GENE-Y	1	42	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T20	T41	1526623
NA	CHEMICAL	GENE-Y	26	8	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T21	T38	1526623
NA	CHEMICAL	GENE-Y	26	32	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T21	T39	1526623
NA	CHEMICAL	GENE-Y	26	22	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T21	T40	1526623
NA	CHEMICAL	GENE-Y	26	42	Based on these potent effects on gonadal function in vivo as well as previous work in vitro demonstrating affinity of chemical for receptor proteins for glucocorticoids and chemical and for gene ( gene ) , the binding of chemical to gene ( gene ) in vitro was also examined .	T21	T41	1526623
NA	CHEMICAL	GENE-Y	0	32	chemical competition with chemical ( chemical ) for chemical binding sites in dispersed , intact cultured human skin fibroblasts was determined at 22 degrees C. Fifty percent displacement of chemical binding to gene was achieved by 6.4 +/- 1.8 ( SE ) x 10 ( -5 ) M chemical .	T22	T42	1526623
NA	CHEMICAL	GENE-Y	3	32	chemical competition with chemical ( chemical ) for chemical binding sites in dispersed , intact cultured human skin fibroblasts was determined at 22 degrees C. Fifty percent displacement of chemical binding to gene was achieved by 6.4 +/- 1.8 ( SE ) x 10 ( -5 ) M chemical .	T23	T42	1526623
NA	CHEMICAL	GENE-Y	5	32	chemical competition with chemical ( chemical ) for chemical binding sites in dispersed , intact cultured human skin fibroblasts was determined at 22 degrees C. Fifty percent displacement of chemical binding to gene was achieved by 6.4 +/- 1.8 ( SE ) x 10 ( -5 ) M chemical .	T24	T42	1526623
NA	CHEMICAL	GENE-Y	8	32	chemical competition with chemical ( chemical ) for chemical binding sites in dispersed , intact cultured human skin fibroblasts was determined at 22 degrees C. Fifty percent displacement of chemical binding to gene was achieved by 6.4 +/- 1.8 ( SE ) x 10 ( -5 ) M chemical .	T25	T42	1526623
NA	CHEMICAL	GENE-Y	29	32	chemical competition with chemical ( chemical ) for chemical binding sites in dispersed , intact cultured human skin fibroblasts was determined at 22 degrees C. Fifty percent displacement of chemical binding to gene was achieved by 6.4 +/- 1.8 ( SE ) x 10 ( -5 ) M chemical .	T27	T42	1526623
NA	CHEMICAL	GENE-Y	31	32	chemical competition with chemical ( chemical ) for chemical binding sites in dispersed , intact cultured human skin fibroblasts was determined at 22 degrees C. Fifty percent displacement of chemical binding to gene was achieved by 6.4 +/- 1.8 ( SE ) x 10 ( -5 ) M chemical .	T28	T42	1526623
NA	CHEMICAL	GENE-Y	5	21	Additional binding studies performed with chemical in the presence of increasing amounts of chemical showed that the interaction of chemical with gene was competitive when the data were analyzed by the Scatchard method .	T29	T33	1526623
NA	CHEMICAL	GENE-Y	13	21	Additional binding studies performed with chemical in the presence of increasing amounts of chemical showed that the interaction of chemical with gene was competitive when the data were analyzed by the Scatchard method .	T30	T33	1526623
NA	CHEMICAL	GENE-Y	5	21	Additional binding studies performed with chemical in the presence of increasing amounts of chemical showed that the interaction of chemical with gene was competitive when the data were analyzed by the Scatchard method .	T2	T33	1526623
NA	CHEMICAL	GENE-Y	11	20	It should be noted , however , that the dose of chemical required for 50 % occupancy of the chemical receptor is not likely to be achieved in vivo , at least in plasma .	T3	T34	1526623
NA	CHEMICAL	GENE-Y	19	20	It should be noted , however , that the dose of chemical required for 50 % occupancy of the chemical receptor is not likely to be achieved in vivo , at least in plasma .	T4	T34	1526623
NA	CHEMICAL	GENE-Y	2	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T5	T35	1526623
NA	CHEMICAL	GENE-Y	8	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T6	T35	1526623
NA	CHEMICAL	GENE-Y	12	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T7	T35	1526623
NA	CHEMICAL	GENE-Y	14	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T8	T35	1526623
NA	CHEMICAL	GENE-Y	17	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T9	T35	1526623
NA	CHEMICAL	GENE-Y	27	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T10	T35	1526623
NA	CHEMICAL	GENE-Y	16	29	Finally , chemical binding studies performed with other chemical , such as chemical , chemical , and chemical , revealed that in this class of compounds only chemical appears to interact with the chemical receptor .	T11	T35	1526623
CPR:4	CHEMICAL	GENE-N	4	10	Inhibitory effect of synthetic chemical , chemical and chemical on gene activity .	T18	T28	2268554
CPR:4	CHEMICAL	GENE-N	6	10	Inhibitory effect of synthetic chemical , chemical and chemical on gene activity .	T19	T28	2268554
CPR:4	CHEMICAL	GENE-N	8	10	Inhibitory effect of synthetic chemical , chemical and chemical on gene activity .	T20	T28	2268554
CPR:9	CHEMICAL	GENE-N	11	0	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T1	T22	2268554
CPR:9	CHEMICAL	GENE-N	11	2	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T1	T26	2268554
CPR:9	CHEMICAL	GENE-N	0	0	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T2	T22	2268554
CPR:9	CHEMICAL	GENE-N	0	2	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T2	T26	2268554
CPR:9	CHEMICAL	GENE-N	12	0	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T4	T22	2268554
CPR:9	CHEMICAL	GENE-N	12	2	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T4	T26	2268554
CPR:9	CHEMICAL	GENE-N	22	0	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T5	T22	2268554
CPR:9	CHEMICAL	GENE-N	22	2	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T5	T26	2268554
CPR:9	CHEMICAL	GENE-N	24	0	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T6	T22	2268554
CPR:9	CHEMICAL	GENE-N	24	2	gene ( gene ) purified from human placenta transforms C-21 ( chemical and chemical ) as well as C-19 ( chemical and chemical ) steroids into the corresponding chemical and is thus involved in the biosynthesis of all classes of hormonal steroids .	T6	T26	2268554
CPR:4	CHEMICAL	GENE-N	0	9	chemical , chemical and chemical are potent inhibitors of gene with Ki values of approximately 50 nM .	T7	T23	2268554
CPR:4	CHEMICAL	GENE-N	2	9	chemical , chemical and chemical are potent inhibitors of gene with Ki values of approximately 50 nM .	T8	T23	2268554
CPR:4	CHEMICAL	GENE-N	4	9	chemical , chemical and chemical are potent inhibitors of gene with Ki values of approximately 50 nM .	T9	T23	2268554
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a well known gene inhibitor , is also a potent inhibitor of gene with a Ki value of 56 nM .	T10	T24	2268554
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a well known gene inhibitor , is also a potent inhibitor of gene with a Ki value of 56 nM .	T10	T25	2268554
NA	CHEMICAL	GENE-N	5	2	Activation of gene potentiates heteromeric chemical receptors .	T19	T50	23066089
NA	CHEMICAL	GENE-N	5	6	Activation of gene potentiates heteromeric chemical receptors .	T19	T51	23066089
NA	CHEMICAL	GENE-N	0	1	chemical receptors ( gene ) , a family of gene , are widely expressed in the central nervous system and are critically involved in synaptic transmission .	T1	T20	23066089
NA	CHEMICAL	GENE-N	0	3	chemical receptors ( gene ) , a family of gene , are widely expressed in the central nervous system and are critically involved in synaptic transmission .	T1	T35	23066089
NA	CHEMICAL	GENE-N	0	1	chemical receptors ( gene ) , a family of gene , are widely expressed in the central nervous system and are critically involved in synaptic transmission .	T1	T40	23066089
NA	CHEMICAL	GENE-N	6	1	chemical receptors ( gene ) , a family of gene , are widely expressed in the central nervous system and are critically involved in synaptic transmission .	T15	T20	23066089
NA	CHEMICAL	GENE-N	6	3	chemical receptors ( gene ) , a family of gene , are widely expressed in the central nervous system and are critically involved in synaptic transmission .	T15	T35	23066089
NA	CHEMICAL	GENE-N	6	1	chemical receptors ( gene ) , a family of gene , are widely expressed in the central nervous system and are critically involved in synaptic transmission .	T15	T40	23066089
NA	CHEMICAL	GENE-N	7	14	In hippocampal and cortical cultures , the chemical signal caused by activation of native gene was potentiated by activation of gene .	T16	T43	23066089
NA	CHEMICAL	GENE-N	7	20	In hippocampal and cortical cultures , the chemical signal caused by activation of native gene was potentiated by activation of gene .	T16	T44	23066089
NA	CHEMICAL	GENE-N	21	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T47	23066089
NA	CHEMICAL	GENE-Y	21	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T48	23066089
NA	CHEMICAL	GENE-N	21	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T49	23066089
NA	CHEMICAL	GENE-N	21	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T21	23066089
NA	CHEMICAL	GENE-N	21	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T22	23066089
NA	CHEMICAL	GENE-N	21	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T23	23066089
NA	CHEMICAL	GENE-N	21	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T24	23066089
NA	CHEMICAL	GENE-Y	21	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T25	23066089
NA	CHEMICAL	GENE-Y	21	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T26	23066089
NA	CHEMICAL	GENE-Y	21	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T27	23066089
NA	CHEMICAL	GENE-N	21	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T28	23066089
NA	CHEMICAL	GENE-Y	21	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T29	23066089
NA	CHEMICAL	GENE-Y	21	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T17	T30	23066089
CPR:4	CHEMICAL	GENE-N	23	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T47	23066089
CPR:4	CHEMICAL	GENE-Y	23	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T48	23066089
NA	CHEMICAL	GENE-N	23	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T49	23066089
NA	CHEMICAL	GENE-N	23	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T21	23066089
NA	CHEMICAL	GENE-N	23	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T22	23066089
NA	CHEMICAL	GENE-N	23	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T23	23066089
NA	CHEMICAL	GENE-N	23	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T24	23066089
NA	CHEMICAL	GENE-Y	23	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T25	23066089
NA	CHEMICAL	GENE-Y	23	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T26	23066089
NA	CHEMICAL	GENE-Y	23	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T27	23066089
NA	CHEMICAL	GENE-N	23	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T28	23066089
NA	CHEMICAL	GENE-Y	23	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T29	23066089
NA	CHEMICAL	GENE-Y	23	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T2	T30	23066089
CPR:4	CHEMICAL	GENE-N	25	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T47	23066089
CPR:4	CHEMICAL	GENE-Y	25	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T48	23066089
NA	CHEMICAL	GENE-N	25	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T49	23066089
NA	CHEMICAL	GENE-N	25	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T21	23066089
NA	CHEMICAL	GENE-N	25	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T22	23066089
NA	CHEMICAL	GENE-N	25	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T23	23066089
NA	CHEMICAL	GENE-N	25	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T24	23066089
NA	CHEMICAL	GENE-Y	25	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T25	23066089
NA	CHEMICAL	GENE-Y	25	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T26	23066089
NA	CHEMICAL	GENE-Y	25	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T27	23066089
NA	CHEMICAL	GENE-N	25	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T28	23066089
NA	CHEMICAL	GENE-Y	25	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T29	23066089
NA	CHEMICAL	GENE-Y	25	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T3	T30	23066089
CPR:4	CHEMICAL	GENE-N	4	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T47	23066089
CPR:4	CHEMICAL	GENE-Y	4	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T48	23066089
NA	CHEMICAL	GENE-N	4	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T49	23066089
CPR:4	CHEMICAL	GENE-N	4	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T21	23066089
NA	CHEMICAL	GENE-N	4	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T22	23066089
NA	CHEMICAL	GENE-N	4	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T23	23066089
NA	CHEMICAL	GENE-N	4	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T24	23066089
NA	CHEMICAL	GENE-Y	4	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T25	23066089
NA	CHEMICAL	GENE-Y	4	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T26	23066089
NA	CHEMICAL	GENE-Y	4	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T27	23066089
NA	CHEMICAL	GENE-N	4	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T28	23066089
NA	CHEMICAL	GENE-Y	4	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T29	23066089
NA	CHEMICAL	GENE-Y	4	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T4	T30	23066089
NA	CHEMICAL	GENE-N	39	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T47	23066089
NA	CHEMICAL	GENE-Y	39	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T48	23066089
NA	CHEMICAL	GENE-N	39	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T49	23066089
NA	CHEMICAL	GENE-N	39	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T21	23066089
NA	CHEMICAL	GENE-N	39	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T22	23066089
NA	CHEMICAL	GENE-N	39	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T23	23066089
NA	CHEMICAL	GENE-N	39	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T24	23066089
NA	CHEMICAL	GENE-Y	39	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T25	23066089
NA	CHEMICAL	GENE-Y	39	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T26	23066089
NA	CHEMICAL	GENE-Y	39	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T27	23066089
NA	CHEMICAL	GENE-N	39	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T28	23066089
NA	CHEMICAL	GENE-Y	39	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T29	23066089
NA	CHEMICAL	GENE-Y	39	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T5	T30	23066089
CPR:4	CHEMICAL	GENE-N	42	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T47	23066089
CPR:4	CHEMICAL	GENE-Y	42	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T48	23066089
NA	CHEMICAL	GENE-N	42	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T49	23066089
NA	CHEMICAL	GENE-N	42	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T21	23066089
CPR:4	CHEMICAL	GENE-N	42	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T22	23066089
NA	CHEMICAL	GENE-N	42	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T23	23066089
NA	CHEMICAL	GENE-N	42	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T24	23066089
NA	CHEMICAL	GENE-Y	42	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T25	23066089
NA	CHEMICAL	GENE-Y	42	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T26	23066089
NA	CHEMICAL	GENE-Y	42	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T27	23066089
NA	CHEMICAL	GENE-N	42	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T28	23066089
NA	CHEMICAL	GENE-Y	42	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T29	23066089
NA	CHEMICAL	GENE-Y	42	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T6	T30	23066089
NA	CHEMICAL	GENE-N	12	4	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T47	23066089
NA	CHEMICAL	GENE-Y	12	6	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T48	23066089
NA	CHEMICAL	GENE-N	12	18	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T49	23066089
NA	CHEMICAL	GENE-N	12	31	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T21	23066089
NA	CHEMICAL	GENE-N	12	40	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T22	23066089
NA	CHEMICAL	GENE-N	12	44	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T23	23066089
NA	CHEMICAL	GENE-N	12	46	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T24	23066089
NA	CHEMICAL	GENE-Y	12	53	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T25	23066089
NA	CHEMICAL	GENE-Y	12	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T26	23066089
NA	CHEMICAL	GENE-Y	12	55	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T27	23066089
CPR:3	CHEMICAL	GENE-N	12	63	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T28	23066089
CPR:3	CHEMICAL	GENE-Y	12	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T29	23066089
CPR:3	CHEMICAL	GENE-Y	12	67	The potentiation of heteromeric gene by gene activation was attenuated by GDPβS , blocked by an inhibitor of gene or the chemical chelator chemical ( chemical ) , prolonged by the gene inhibitor chemical , but unaffected by the chemical kinase inhibitor chemical . gene ( gene ) inhibition reduced the potentiation by gene of gene/gene , and conversely , direct activation of gene by chemical potentiated gene/gene .	T7	T30	23066089
NA	CHEMICAL	GENE-Y	7	23	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T8	T31	23066089
NA	CHEMICAL	GENE-Y	7	34	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T8	T32	23066089
NA	CHEMICAL	GENE-N	7	37	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T8	T33	23066089
NA	CHEMICAL	GENE-Y	9	23	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T9	T31	23066089
NA	CHEMICAL	GENE-Y	9	34	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T9	T32	23066089
NA	CHEMICAL	GENE-N	9	37	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T9	T33	23066089
NA	CHEMICAL	GENE-Y	11	23	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T10	T31	23066089
NA	CHEMICAL	GENE-Y	11	34	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T10	T32	23066089
NA	CHEMICAL	GENE-N	11	37	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T10	T33	23066089
NA	CHEMICAL	GENE-Y	14	23	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T11	T31	23066089
NA	CHEMICAL	GENE-Y	14	34	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T11	T32	23066089
NA	CHEMICAL	GENE-N	14	37	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T11	T33	23066089
NA	CHEMICAL	GENE-Y	24	23	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T12	T31	23066089
NA	CHEMICAL	GENE-Y	24	34	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T12	T32	23066089
NA	CHEMICAL	GENE-N	24	37	Using site-directed mutagenesis , we identified three chemical ( chemical833 , chemical836 , and chemical840 ) within the membrane proximal region of the gene chemical-terminal domain that , in combination , are required for gene-mediated potentiation of gene .	T12	T33	23066089
CPR:3	CHEMICAL	GENE-Y	0	2	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T17	T31	8566141
NA	CHEMICAL	GENE-Y	0	10	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T17	T32	8566141
NA	CHEMICAL	GENE-N	0	13	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T17	T33	8566141
NA	CHEMICAL	GENE-Y	3	2	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T18	T31	8566141
NA	CHEMICAL	GENE-Y	3	10	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T18	T32	8566141
NA	CHEMICAL	GENE-N	3	13	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T18	T33	8566141
NA	CHEMICAL	GENE-Y	12	2	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T19	T31	8566141
NA	CHEMICAL	GENE-Y	12	10	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T19	T32	8566141
NA	CHEMICAL	GENE-N	12	13	chemical induces gene in rat striatum : reversal with chemical D1 and chemical receptor antagonists .	T19	T33	8566141
CPR:3	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) induced gene expression in the central , dorsal-medial and ventral-medial part of the striatum .	T1	T24	8566141
CPR:3	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) induced gene expression in the central , dorsal-medial and ventral-medial part of the striatum .	T2	T24	8566141
CPR:3	CHEMICAL	GENE-Y	7	4	The distribution pattern of gene induced by chemical was more similar to those seen with dopaminomimetics than with chemical ( chemical ) receptor antagonists .	T3	T20	8566141
NA	CHEMICAL	GENE-N	7	11	The distribution pattern of gene induced by chemical was more similar to those seen with dopaminomimetics than with chemical ( chemical ) receptor antagonists .	T3	T21	8566141
NA	CHEMICAL	GENE-Y	18	4	The distribution pattern of gene induced by chemical was more similar to those seen with dopaminomimetics than with chemical ( chemical ) receptor antagonists .	T4	T20	8566141
NA	CHEMICAL	GENE-N	18	11	The distribution pattern of gene induced by chemical was more similar to those seen with dopaminomimetics than with chemical ( chemical ) receptor antagonists .	T4	T21	8566141
NA	CHEMICAL	GENE-Y	20	4	The distribution pattern of gene induced by chemical was more similar to those seen with dopaminomimetics than with chemical ( chemical ) receptor antagonists .	T5	T20	8566141
NA	CHEMICAL	GENE-N	20	11	The distribution pattern of gene induced by chemical was more similar to those seen with dopaminomimetics than with chemical ( chemical ) receptor antagonists .	T5	T21	8566141
NA	CHEMICAL	GENE-Y	3	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T6	T22	8566141
NA	CHEMICAL	GENE-N	3	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T6	T23	8566141
NA	CHEMICAL	GENE-Y	3	22	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T6	T25	8566141
CPR:6	CHEMICAL	GENE-Y	8	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T7	T22	8566141
NA	CHEMICAL	GENE-N	8	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T7	T23	8566141
CPR:4	CHEMICAL	GENE-Y	8	22	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T7	T25	8566141
NA	CHEMICAL	GENE-Y	12	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T8	T22	8566141
NA	CHEMICAL	GENE-N	12	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T8	T23	8566141
NA	CHEMICAL	GENE-Y	12	22	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T8	T25	8566141
NA	CHEMICAL	GENE-Y	16	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T9	T22	8566141
CPR:6	CHEMICAL	GENE-N	16	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T9	T23	8566141
CPR:4	CHEMICAL	GENE-Y	16	22	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T9	T25	8566141
NA	CHEMICAL	GENE-Y	19	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T10	T22	8566141
NA	CHEMICAL	GENE-N	19	5	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T10	T23	8566141
CPR:3	CHEMICAL	GENE-Y	19	22	Pretreatment with the chemical D1 receptor antagonist , chemical , and the chemical receptor antagonist , chemical , blocked chemical induction of gene in the striatum .	T10	T25	8566141
CPR:3	CHEMICAL	GENE-Y	2	5	However , chemical induction of gene in the striatum was unaffected by the chemical D2 receptor antagonist , chemical .	T11	T26	8566141
NA	CHEMICAL	GENE-Y	2	15	However , chemical induction of gene in the striatum was unaffected by the chemical D2 receptor antagonist , chemical .	T11	T27	8566141
NA	CHEMICAL	GENE-Y	6	5	However , chemical induction of gene in the striatum was unaffected by the chemical D2 receptor antagonist , chemical .	T12	T26	8566141
NA	CHEMICAL	GENE-Y	6	15	However , chemical induction of gene in the striatum was unaffected by the chemical D2 receptor antagonist , chemical .	T12	T27	8566141
NA	CHEMICAL	GENE-Y	18	5	However , chemical induction of gene in the striatum was unaffected by the chemical D2 receptor antagonist , chemical .	T13	T26	8566141
CPR:6	CHEMICAL	GENE-Y	18	15	However , chemical induction of gene in the striatum was unaffected by the chemical D2 receptor antagonist , chemical .	T13	T27	8566141
NA	CHEMICAL	GENE-N	0	14	chemical , a dimeric inhibitor of PSD-95 , reduces inflammatory pain without disrupting cognitive or motor performance : comparison with the chemical receptor antagonist chemical .	T16	T40	23178182
NA	CHEMICAL	GENE-N	21	14	chemical , a dimeric inhibitor of PSD-95 , reduces inflammatory pain without disrupting cognitive or motor performance : comparison with the chemical receptor antagonist chemical .	T17	T40	23178182
CPR:6	CHEMICAL	GENE-N	24	14	chemical , a dimeric inhibitor of PSD-95 , reduces inflammatory pain without disrupting cognitive or motor performance : comparison with the chemical receptor antagonist chemical .	T18	T40	23178182
NA	CHEMICAL	GENE-N	1	2	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T2	T19	23178182
NA	CHEMICAL	GENE-N	1	4	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T2	T30	23178182
NA	CHEMICAL	GENE-Y	1	15	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T2	T22	23178182
NA	CHEMICAL	GENE-Y	1	31	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T2	T23	23178182
NA	CHEMICAL	GENE-N	9	2	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T12	T19	23178182
NA	CHEMICAL	GENE-N	9	4	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T12	T30	23178182
NA	CHEMICAL	GENE-Y	9	15	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T12	T22	23178182
NA	CHEMICAL	GENE-Y	9	31	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T12	T23	23178182
NA	CHEMICAL	GENE-N	11	2	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T15	T19	23178182
NA	CHEMICAL	GENE-N	11	4	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T15	T30	23178182
NA	CHEMICAL	GENE-Y	11	15	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T15	T22	23178182
NA	CHEMICAL	GENE-Y	11	31	Excessive chemical receptor ( gene ) -dependent production of chemical ( chemical ) is involved in the development and maintenance of chronic pain states , and is mediated by gene ( gene ) .	T15	T23	23178182
NA	CHEMICAL	GENE-N	9	5	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T9	T24	23178182
NA	CHEMICAL	GENE-Y	9	7	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T9	T25	23178182
NA	CHEMICAL	GENE-Y	9	12	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T9	T27	23178182
NA	CHEMICAL	GENE-N	9	18	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T9	T28	23178182
NA	CHEMICAL	GENE-N	21	5	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T10	T24	23178182
NA	CHEMICAL	GENE-Y	21	7	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T10	T25	23178182
NA	CHEMICAL	GENE-Y	21	12	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T10	T27	23178182
NA	CHEMICAL	GENE-N	21	18	By binding to both the gene and gene ( nchemicalS ) , gene mediates a specific coupling between gene activation and chemical production .	T10	T28	23178182
NA	CHEMICAL	GENE-N	20	6	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T31	23178182
NA	CHEMICAL	GENE-N	20	12	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T32	23178182
NA	CHEMICAL	GENE-Y	20	12	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T33	23178182
NA	CHEMICAL	GENE-Y	20	12	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T34	23178182
NA	CHEMICAL	GENE-N	20	16	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T35	23178182
NA	CHEMICAL	GENE-N	20	26	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T36	23178182
NA	CHEMICAL	GENE-N	20	27	An alternative approach to modulate the gene-related activity is to perturb the gene/gene/gene complex by targeting gene , thereby decreasing chemical production without interfering with the gene gene function .	T11	T37	23178182
CPR:4	CHEMICAL	GENE-Y	12	9	Here , we compared the effects of a dimeric gene inhibitor , chemical , and the gene antagonist , chemical , on mechanical hypersensitivity in the complete Freund 's adjuvant ( CFA ) model of inflammatory pain .	T13	T38	23178182
NA	CHEMICAL	GENE-N	12	16	Here , we compared the effects of a dimeric gene inhibitor , chemical , and the gene antagonist , chemical , on mechanical hypersensitivity in the complete Freund 's adjuvant ( CFA ) model of inflammatory pain .	T13	T39	23178182
NA	CHEMICAL	GENE-Y	19	9	Here , we compared the effects of a dimeric gene inhibitor , chemical , and the gene antagonist , chemical , on mechanical hypersensitivity in the complete Freund 's adjuvant ( CFA ) model of inflammatory pain .	T14	T38	23178182
CPR:6	CHEMICAL	GENE-N	19	16	Here , we compared the effects of a dimeric gene inhibitor , chemical , and the gene antagonist , chemical , on mechanical hypersensitivity in the complete Freund 's adjuvant ( CFA ) model of inflammatory pain .	T14	T39	23178182
CPR:3	CHEMICAL	GENE-Y	3	16	We found that chemical markedly induced endoplasmic reticulum ( ER ) stress-related genes , such as gene , gene ( gene ) and/or the gene ( gene ) .	T6	T17	23123298
CPR:3	CHEMICAL	GENE-Y	3	18	We found that chemical markedly induced endoplasmic reticulum ( ER ) stress-related genes , such as gene , gene ( gene ) and/or the gene ( gene ) .	T6	T18	23123298
CPR:3	CHEMICAL	GENE-Y	3	20	We found that chemical markedly induced endoplasmic reticulum ( ER ) stress-related genes , such as gene , gene ( gene ) and/or the gene ( gene ) .	T6	T19	23123298
CPR:3	CHEMICAL	GENE-Y	3	24	We found that chemical markedly induced endoplasmic reticulum ( ER ) stress-related genes , such as gene , gene ( gene ) and/or the gene ( gene ) .	T6	T20	23123298
CPR:3	CHEMICAL	GENE-Y	3	26	We found that chemical markedly induced endoplasmic reticulum ( ER ) stress-related genes , such as gene , gene ( gene ) and/or the gene ( gene ) .	T6	T21	23123298
NA	CHEMICAL	GENE-Y	14	4	However , down-regulation of gene and/or gene expression by siRNA had no effect on chemical-induced apoptosis in Caki and HCT116 cells .	T7	T22	23123298
NA	CHEMICAL	GENE-Y	14	6	However , down-regulation of gene and/or gene expression by siRNA had no effect on chemical-induced apoptosis in Caki and HCT116 cells .	T7	T23	23123298
NA	CHEMICAL	GENE-N	5	6	Antihypertensive drugs of the `` chemical channel blocker '' or `` chemical antagonist '' class have been used to establish the physiological role of gene in vascular smooth muscle .	T6	T22	18974361
NA	CHEMICAL	GENE-N	5	6	Antihypertensive drugs of the `` chemical channel blocker '' or `` chemical antagonist '' class have been used to establish the physiological role of gene in vascular smooth muscle .	T6	T19	18974361
NA	CHEMICAL	GENE-N	11	6	Antihypertensive drugs of the `` chemical channel blocker '' or `` chemical antagonist '' class have been used to establish the physiological role of gene in vascular smooth muscle .	T8	T22	18974361
NA	CHEMICAL	GENE-N	11	6	Antihypertensive drugs of the `` chemical channel blocker '' or `` chemical antagonist '' class have been used to establish the physiological role of gene in vascular smooth muscle .	T8	T19	18974361
NA	CHEMICAL	GENE-N	2	0	gene play a role in cardiac pacemaking , chemical secretion , and renal hemodynamics , leading to the hypothesis that mixed T- and L-type blockers may have therapeutic advantages over selective L-type blockers .	T7	T21	18974361
NA	CHEMICAL	GENE-Y	25	12	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T9	T23	18974361
NA	CHEMICAL	GENE-N	25	13	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T9	T24	18974361
NA	CHEMICAL	GENE-Y	29	12	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T10	T23	18974361
NA	CHEMICAL	GENE-N	29	13	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T10	T24	18974361
NA	CHEMICAL	GENE-Y	32	12	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T11	T23	18974361
NA	CHEMICAL	GENE-N	32	13	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T11	T24	18974361
NA	CHEMICAL	GENE-Y	19	12	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T12	T23	18974361
NA	CHEMICAL	GENE-N	19	13	The goal of this study was to identify compounds that block the gene gene with high affinity , focusing on two classes of compounds : chemical ( e.g. , chemical ) and chemical ( e.g. , chemical ) .	T12	T24	18974361
NA	CHEMICAL	GENE-Y	4	4	Compounds were tested using a validated chemical influx assay into a cell line expressing recombinant gene channels .	T13	T25	18974361
CPR:4	CHEMICAL	GENE-N	9	20	This study identified four clinically approved antihypertensive drugs ( chemical , chemical , chemical , and chemical ) as potent gene blockers ( IC ( 50 ) < 3 microM ) .	T14	T26	18974361
CPR:4	CHEMICAL	GENE-N	11	20	This study identified four clinically approved antihypertensive drugs ( chemical , chemical , chemical , and chemical ) as potent gene blockers ( IC ( 50 ) < 3 microM ) .	T15	T26	18974361
CPR:4	CHEMICAL	GENE-N	13	20	This study identified four clinically approved antihypertensive drugs ( chemical , chemical , chemical , and chemical ) as potent gene blockers ( IC ( 50 ) < 3 microM ) .	T16	T26	18974361
CPR:4	CHEMICAL	GENE-N	16	20	This study identified four clinically approved antihypertensive drugs ( chemical , chemical , chemical , and chemical ) as potent gene blockers ( IC ( 50 ) < 3 microM ) .	T17	T26	18974361
NA	CHEMICAL	GENE-Y	7	18	Following a 2-h control period during which chemical infusion was stopped , there was a 2-h experimental period in which the response to hyperglycemia plus either 4× basal gene ( gene ) or portal vein chemical infusion ( PoG ) was measured .	T3	T7	22923473
NA	CHEMICAL	GENE-Y	7	30	Following a 2-h control period during which chemical infusion was stopped , there was a 2-h experimental period in which the response to hyperglycemia plus either 4× basal gene ( gene ) or portal vein chemical infusion ( PoG ) was measured .	T3	T8	22923473
NA	CHEMICAL	GENE-Y	35	18	Following a 2-h control period during which chemical infusion was stopped , there was a 2-h experimental period in which the response to hyperglycemia plus either 4× basal gene ( gene ) or portal vein chemical infusion ( PoG ) was measured .	T4	T7	22923473
NA	CHEMICAL	GENE-Y	35	30	Following a 2-h control period during which chemical infusion was stopped , there was a 2-h experimental period in which the response to hyperglycemia plus either 4× basal gene ( gene ) or portal vein chemical infusion ( PoG ) was measured .	T4	T8	22923473
NA	CHEMICAL	GENE-Y	5	6	Structure and kinetics of monofunctional chemical dehydrogenase from Thermus thermophilus .	T11	T33	17344208
NA	CHEMICAL	GENE-Y	0	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T1	T12	17344208
NA	CHEMICAL	GENE-Y	0	3	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T1	T19	17344208
NA	CHEMICAL	GENE-Y	0	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T1	T22	17344208
NA	CHEMICAL	GENE-Y	0	9	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T1	T29	17344208
NA	CHEMICAL	GENE-Y	2	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T9	T12	17344208
NA	CHEMICAL	GENE-Y	2	3	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T9	T19	17344208
NA	CHEMICAL	GENE-Y	2	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T9	T22	17344208
NA	CHEMICAL	GENE-Y	2	9	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T9	T29	17344208
CPR:9	CHEMICAL	GENE-Y	9	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T2	T12	17344208
CPR:9	CHEMICAL	GENE-Y	9	3	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T2	T19	17344208
CPR:9	CHEMICAL	GENE-Y	9	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T2	T22	17344208
CPR:9	CHEMICAL	GENE-Y	9	9	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T2	T29	17344208
CPR:9	CHEMICAL	GENE-Y	18	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T4	T12	17344208
CPR:9	CHEMICAL	GENE-Y	18	3	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T4	T19	17344208
CPR:9	CHEMICAL	GENE-Y	18	1	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T4	T22	17344208
CPR:9	CHEMICAL	GENE-Y	18	9	chemical dehydrogenase ( gene ) and chemical dehydrogenase ( gene ) catalyze the two-step oxidation of chemical to chemical .	T4	T29	17344208
NA	CHEMICAL	GENE-Y	7	5	The 2.0-A resolution structure of gene reveals a distorted gene and a gene located above the chemical-terminal ends of the strands of the barrel .	T10	T24	17344208
NA	CHEMICAL	GENE-N	7	7	The 2.0-A resolution structure of gene reveals a distorted gene and a gene located above the chemical-terminal ends of the strands of the barrel .	T10	T25	17344208
NA	CHEMICAL	GENE-N	7	7	The 2.0-A resolution structure of gene reveals a distorted gene and a gene located above the chemical-terminal ends of the strands of the barrel .	T10	T26	17344208
CPR:9	CHEMICAL	GENE-Y	8	5	Finally , we demonstrate that gene reacts with chemical producing chemical .	T6	T15	17344208
CPR:9	CHEMICAL	GENE-Y	10	5	Finally , we demonstrate that gene reacts with chemical producing chemical .	T7	T15	17344208
NA	CHEMICAL	GENE-Y	0	1	chemical synthase ( gene ) , the pivotal enzyme for the biosynthesis of chemical ( ref .	T17	T39	17632548
NA	CHEMICAL	GENE-Y	0	3	chemical synthase ( gene ) , the pivotal enzyme for the biosynthesis of chemical ( ref .	T17	T40	17632548
CPR:9	CHEMICAL	GENE-Y	13	1	chemical synthase ( gene ) , the pivotal enzyme for the biosynthesis of chemical ( ref .	T18	T39	17632548
CPR:9	CHEMICAL	GENE-Y	13	3	chemical synthase ( gene ) , the pivotal enzyme for the biosynthesis of chemical ( ref .	T18	T40	17632548
NA	CHEMICAL	GENE-Y	4	9	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T21	T41	17632548
CPR:9	CHEMICAL	GENE-N	4	4	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T21	T42	17632548
CPR:9	CHEMICAL	GENE-Y	4	33	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T21	T44	17632548
NA	CHEMICAL	GENE-Y	13	9	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T22	T41	17632548
CPR:9	CHEMICAL	GENE-N	13	4	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T22	T42	17632548
CPR:9	CHEMICAL	GENE-Y	13	33	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T22	T44	17632548
NA	CHEMICAL	GENE-Y	13	9	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T23	T41	17632548
NA	CHEMICAL	GENE-N	13	4	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T23	T42	17632548
NA	CHEMICAL	GENE-Y	13	33	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T23	T44	17632548
NA	CHEMICAL	GENE-Y	29	9	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T24	T41	17632548
NA	CHEMICAL	GENE-N	29	4	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T24	T42	17632548
NA	CHEMICAL	GENE-Y	29	33	10 ) , is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in chemical and chemical metabolism that includes gene , gene ( MGchemicalTs ) , and gene ( ref .	T24	T44	17632548
NA	CHEMICAL	GENE-Y	2	0	gene conjugates chemical to chemical , the endogenous substrate derived from chemical through the gene pathway .	T26	T45	17632548
NA	CHEMICAL	GENE-Y	2	14	gene conjugates chemical to chemical , the endogenous substrate derived from chemical through the gene pathway .	T26	T46	17632548
NA	CHEMICAL	GENE-Y	4	0	gene conjugates chemical to chemical , the endogenous substrate derived from chemical through the gene pathway .	T27	T45	17632548
NA	CHEMICAL	GENE-Y	4	14	gene conjugates chemical to chemical , the endogenous substrate derived from chemical through the gene pathway .	T27	T46	17632548
NA	CHEMICAL	GENE-Y	11	0	gene conjugates chemical to chemical , the endogenous substrate derived from chemical through the gene pathway .	T28	T45	17632548
NA	CHEMICAL	GENE-Y	11	14	gene conjugates chemical to chemical , the endogenous substrate derived from chemical through the gene pathway .	T28	T46	17632548
NA	CHEMICAL	GENE-Y	17	3	In contrast with gene and gene ( refs 15 , 16 ) , gene does not conjugate chemical to xenobiotics .	T31	T47	17632548
NA	CHEMICAL	GENE-Y	17	5	In contrast with gene and gene ( refs 15 , 16 ) , gene does not conjugate chemical to xenobiotics .	T31	T48	17632548
NA	CHEMICAL	GENE-Y	17	13	In contrast with gene and gene ( refs 15 , 16 ) , gene does not conjugate chemical to xenobiotics .	T31	T49	17632548
NA	CHEMICAL	GENE-Y	9	7	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T32	T50	17632548
NA	CHEMICAL	GENE-Y	9	34	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T32	T34	17632548
NA	CHEMICAL	GENE-N	9	37	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T32	T35	17632548
NA	CHEMICAL	GENE-Y	9	7	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T1	T50	17632548
NA	CHEMICAL	GENE-Y	9	34	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T1	T34	17632548
NA	CHEMICAL	GENE-N	9	37	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T1	T35	17632548
NA	CHEMICAL	GENE-Y	15	7	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T2	T50	17632548
NA	CHEMICAL	GENE-Y	15	34	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T2	T34	17632548
NA	CHEMICAL	GENE-N	15	37	Here we show the atomic structure of gene in a complex with chemical at 3.3 A resolution by X-ray crystallography and provide insights into the high substrate specificity for chemical and chemical that distinguishes gene from other gene .	T2	T35	17632548
NA	CHEMICAL	GENE-N	23	11	Nerve fibers immunoreactive for not only sensory neuromarkers , such as gene ( gene ) , but also sympathetic neuromarkers , such as chemical hydroxylase ( gene ) and gene ( gene ) were increased in the periodontal ligament during ETM .	T7	T13	23000507
NA	CHEMICAL	GENE-N	23	13	Nerve fibers immunoreactive for not only sensory neuromarkers , such as gene ( gene ) , but also sympathetic neuromarkers , such as chemical hydroxylase ( gene ) and gene ( gene ) were increased in the periodontal ligament during ETM .	T7	T14	23000507
NA	CHEMICAL	GENE-Y	23	10	Nerve fibers immunoreactive for not only sensory neuromarkers , such as gene ( gene ) , but also sympathetic neuromarkers , such as chemical hydroxylase ( gene ) and gene ( gene ) were increased in the periodontal ligament during ETM .	T7	T15	23000507
NA	CHEMICAL	GENE-Y	23	26	Nerve fibers immunoreactive for not only sensory neuromarkers , such as gene ( gene ) , but also sympathetic neuromarkers , such as chemical hydroxylase ( gene ) and gene ( gene ) were increased in the periodontal ligament during ETM .	T7	T16	23000507
NA	CHEMICAL	GENE-Y	23	29	Nerve fibers immunoreactive for not only sensory neuromarkers , such as gene ( gene ) , but also sympathetic neuromarkers , such as chemical hydroxylase ( gene ) and gene ( gene ) were increased in the periodontal ligament during ETM .	T7	T17	23000507
NA	CHEMICAL	GENE-Y	23	31	Nerve fibers immunoreactive for not only sensory neuromarkers , such as gene ( gene ) , but also sympathetic neuromarkers , such as chemical hydroxylase ( gene ) and gene ( gene ) were increased in the periodontal ligament during ETM .	T7	T18	23000507
NA	CHEMICAL	GENE-Y	3	5	Pharmacological activators of chemical-activated protein kinase have different effects on chemical transport processes across human lung epithelial cells .	T47	T61	17603555
NA	CHEMICAL	GENE-Y	10	5	Pharmacological activators of chemical-activated protein kinase have different effects on chemical transport processes across human lung epithelial cells .	T48	T61	17603555
NA	CHEMICAL	GENE-Y	4	6	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T30	T55	17603555
NA	CHEMICAL	GENE-Y	4	8	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T30	T57	17603555
CPR:3	CHEMICAL	GENE-Y	13	6	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T40	T55	17603555
CPR:3	CHEMICAL	GENE-Y	13	8	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T40	T57	17603555
CPR:3	CHEMICAL	GENE-Y	15	6	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T42	T55	17603555
CPR:3	CHEMICAL	GENE-Y	15	8	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T42	T57	17603555
NA	CHEMICAL	GENE-Y	4	6	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T3	T55	17603555
NA	CHEMICAL	GENE-Y	4	8	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T3	T57	17603555
CPR:3	CHEMICAL	GENE-Y	22	6	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T8	T55	17603555
CPR:3	CHEMICAL	GENE-Y	22	8	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T8	T57	17603555
CPR:3	CHEMICAL	GENE-Y	24	6	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T27	T55	17603555
CPR:3	CHEMICAL	GENE-Y	24	8	BACKGROUND AND PURPOSE : chemical-activated protein kinase ( gene ) is activated by chemical , chemical , and the chemical mimetic , chemical ( chemical ) .	T27	T57	17603555
NA	CHEMICAL	GENE-Y	17	14	We have completed an extensive study of the pharmacological effects of these drugs on gene activation , chemical concentration , transepithelial chemical-sensitive ( I ( chemical ) ) and chemical-sensitive basolateral ( I ( chemical ) ) short circuit current in H441 lung epithelial cells .	T31	T56	17603555
NA	CHEMICAL	GENE-Y	21	14	We have completed an extensive study of the pharmacological effects of these drugs on gene activation , chemical concentration , transepithelial chemical-sensitive ( I ( chemical ) ) and chemical-sensitive basolateral ( I ( chemical ) ) short circuit current in H441 lung epithelial cells .	T32	T56	17603555
NA	CHEMICAL	GENE-Y	25	14	We have completed an extensive study of the pharmacological effects of these drugs on gene activation , chemical concentration , transepithelial chemical-sensitive ( I ( chemical ) ) and chemical-sensitive basolateral ( I ( chemical ) ) short circuit current in H441 lung epithelial cells .	T33	T56	17603555
NA	CHEMICAL	GENE-Y	29	14	We have completed an extensive study of the pharmacological effects of these drugs on gene activation , chemical concentration , transepithelial chemical-sensitive ( I ( chemical ) ) and chemical-sensitive basolateral ( I ( chemical ) ) short circuit current in H441 lung epithelial cells .	T34	T56	17603555
NA	CHEMICAL	GENE-Y	34	14	We have completed an extensive study of the pharmacological effects of these drugs on gene activation , chemical concentration , transepithelial chemical-sensitive ( I ( chemical ) ) and chemical-sensitive basolateral ( I ( chemical ) ) short circuit current in H441 lung epithelial cells .	T35	T56	17603555
NA	CHEMICAL	GENE-Y	9	0	gene activity was measured as the amount of radiolabelled chemical transferred to the SAMS peptide .	T38	T58	17603555
CPR:3	CHEMICAL	GENE-Y	3	9	KEY RESULTS : chemical , chemical and chemical increased gene activity and decreased I ( chemical ) .	T43	T59	17603555
CPR:3	CHEMICAL	GENE-Y	5	9	KEY RESULTS : chemical , chemical and chemical increased gene activity and decreased I ( chemical ) .	T44	T59	17603555
CPR:3	CHEMICAL	GENE-Y	7	9	KEY RESULTS : chemical , chemical and chemical increased gene activity and decreased I ( chemical ) .	T45	T59	17603555
NA	CHEMICAL	GENE-Y	15	9	KEY RESULTS : chemical , chemical and chemical increased gene activity and decreased I ( chemical ) .	T46	T59	17603555
NA	CHEMICAL	GENE-Y	9	1	The gene inhibitor Compound C prevented the action of chemical and chemical but not chemical .	T1	T60	17603555
NA	CHEMICAL	GENE-Y	4	1	The gene inhibitor Compound C prevented the action of chemical and chemical but not chemical .	T2	T60	17603555
CPR:3	CHEMICAL	GENE-Y	14	1	The gene inhibitor Compound C prevented the action of chemical and chemical but not chemical .	T4	T60	17603555
NA	CHEMICAL	GENE-Y	13	6	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T20	T49	17603555
NA	CHEMICAL	GENE-N	13	15	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T20	T50	17603555
NA	CHEMICAL	GENE-N	13	17	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T20	T51	17603555
NA	CHEMICAL	GENE-Y	14	6	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T21	T49	17603555
NA	CHEMICAL	GENE-N	14	15	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T21	T50	17603555
NA	CHEMICAL	GENE-N	14	17	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T21	T51	17603555
NA	CHEMICAL	GENE-Y	24	6	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T22	T49	17603555
NA	CHEMICAL	GENE-N	24	15	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T22	T50	17603555
NA	CHEMICAL	GENE-N	24	17	CONCLUSIONS AND IMPLICATIONS : Activation of gene is associated with inhibition of apical chemical-sensitive chemical channels ( gene ) , which has important implications for the clinical use of chemical .	T22	T51	17603555
NA	CHEMICAL	GENE-Y	6	6	We also analyzed the formation of chemical-gene -inhibitor complexes by chemical chemical gel electrophoresis ( SDS-PAGE ) .	T8	T27	6725552
NA	CHEMICAL	GENE-Y	10	6	We also analyzed the formation of chemical-gene -inhibitor complexes by chemical chemical gel electrophoresis ( SDS-PAGE ) .	T9	T27	6725552
NA	CHEMICAL	GENE-Y	11	6	We also analyzed the formation of chemical-gene -inhibitor complexes by chemical chemical gel electrophoresis ( SDS-PAGE ) .	T10	T27	6725552
NA	CHEMICAL	GENE-Y	14	12	In purified systems , the bimolecular rate constants for the reactions of gene with chemical-1-inhibitor , gene , and gene were 18.5 , 0.91 , and 0.32 X 10 ( 4 ) M-1 min-1 , respectively .	T11	T28	6725552
NA	CHEMICAL	GENE-Y	14	16	In purified systems , the bimolecular rate constants for the reactions of gene with chemical-1-inhibitor , gene , and gene were 18.5 , 0.91 , and 0.32 X 10 ( 4 ) M-1 min-1 , respectively .	T11	T30	6725552
NA	CHEMICAL	GENE-Y	14	19	In purified systems , the bimolecular rate constants for the reactions of gene with chemical-1-inhibitor , gene , and gene were 18.5 , 0.91 , and 0.32 X 10 ( 4 ) M-1 min-1 , respectively .	T11	T31	6725552
NA	CHEMICAL	GENE-Y	12	12	Furthermore , SDS-PAGE analysis revealed that 1:1 stoichiometric complexes were formed between chemical-gene and each of these three inhibitors .	T12	T32	6725552
NA	CHEMICAL	GENE-Y	13	6	This constant was reduced to 1.8 X 10 ( -2 ) min-1 when gene was inactivated by gene-deficient plasma that had been immunodepleted ( less than 5 % ) of chemical-1-inhibitor .	T1	T14	6725552
NA	CHEMICAL	GENE-Y	13	17	This constant was reduced to 1.8 X 10 ( -2 ) min-1 when gene was inactivated by gene-deficient plasma that had been immunodepleted ( less than 5 % ) of chemical-1-inhibitor .	T1	T15	6725552
NA	CHEMICAL	GENE-Y	13	4	This constant was reduced to 1.8 X 10 ( -2 ) min-1 when gene was inactivated by gene-deficient plasma that had been immunodepleted ( less than 5 % ) of chemical-1-inhibitor .	T1	T16	6725552
NA	CHEMICAL	GENE-Y	14	14	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T2	T17	6725552
NA	CHEMICAL	GENE-Y	14	5	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T2	T18	6725552
NA	CHEMICAL	GENE-Y	14	5	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T2	T19	6725552
NA	CHEMICAL	GENE-Y	14	35	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T2	T20	6725552
NA	CHEMICAL	GENE-Y	22	14	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T3	T17	6725552
NA	CHEMICAL	GENE-Y	22	5	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T3	T18	6725552
NA	CHEMICAL	GENE-Y	22	5	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T3	T19	6725552
NA	CHEMICAL	GENE-Y	22	35	In addition , after inactivation in normal plasma , 74 % of the active chemical-gene was found to form a complex with chemical-1-inhibitor , whereas 26 % of the enzyme formed complexes with gene and gene .	T3	T20	6725552
NA	CHEMICAL	GENE-Y	12	17	Furthermore , 42 % of the labeled enzyme was still complexed with chemical-1-inhibitor when chemical-gene was inactivated in hereditary angioedema plasma that contained 32 % of functional gene .	T4	T21	6725552
NA	CHEMICAL	GENE-Y	12	14	Furthermore , 42 % of the labeled enzyme was still complexed with chemical-1-inhibitor when chemical-gene was inactivated in hereditary angioedema plasma that contained 32 % of functional gene .	T4	T22	6725552
NA	CHEMICAL	GENE-Y	12	17	Furthermore , 42 % of the labeled enzyme was still complexed with chemical-1-inhibitor when chemical-gene was inactivated in hereditary angioedema plasma that contained 32 % of functional gene .	T4	T23	6725552
NA	CHEMICAL	GENE-Y	14	17	Furthermore , 42 % of the labeled enzyme was still complexed with chemical-1-inhibitor when chemical-gene was inactivated in hereditary angioedema plasma that contained 32 % of functional gene .	T5	T21	6725552
NA	CHEMICAL	GENE-Y	14	14	Furthermore , 42 % of the labeled enzyme was still complexed with chemical-1-inhibitor when chemical-gene was inactivated in hereditary angioedema plasma that contained 32 % of functional gene .	T5	T22	6725552
NA	CHEMICAL	GENE-Y	14	17	Furthermore , 42 % of the labeled enzyme was still complexed with chemical-1-inhibitor when chemical-gene was inactivated in hereditary angioedema plasma that contained 32 % of functional gene .	T5	T23	6725552
NA	CHEMICAL	GENE-Y	3	5	While studies of chemical , gene , opiates , and mood stabilizers generally find no effect , mixed results suggest more research is needed on antidepressants and atypical antipsychotics .	T1	T3	23504356
CPR:3	CHEMICAL	GENE-Y	0	5	chemical induces the expression of gene in 5L rat hepatoma cells : a cautionary tale of the use of this cell line in studies on chemical toxicity .	T16	T36	23639626
NA	CHEMICAL	GENE-Y	6	5	chemical induces the expression of gene in 5L rat hepatoma cells : a cautionary tale of the use of this cell line in studies on chemical toxicity .	T17	T36	23639626
NA	CHEMICAL	GENE-Y	0	10	chemical treatment of the cells largely prevented the activation of gene , a regulator of translation initiation and substrate of the gene ( gene ) .	T9	T26	23639626
NA	CHEMICAL	GENE-Y	0	12	chemical treatment of the cells largely prevented the activation of gene , a regulator of translation initiation and substrate of the gene ( gene ) .	T9	T27	23639626
NA	CHEMICAL	GENE-Y	0	23	chemical treatment of the cells largely prevented the activation of gene , a regulator of translation initiation and substrate of the gene ( gene ) .	T9	T28	23639626
NA	CHEMICAL	GENE-Y	12	10	chemical treatment of the cells largely prevented the activation of gene , a regulator of translation initiation and substrate of the gene ( gene ) .	T11	T26	23639626
NA	CHEMICAL	GENE-Y	12	12	chemical treatment of the cells largely prevented the activation of gene , a regulator of translation initiation and substrate of the gene ( gene ) .	T11	T27	23639626
NA	CHEMICAL	GENE-Y	12	23	chemical treatment of the cells largely prevented the activation of gene , a regulator of translation initiation and substrate of the gene ( gene ) .	T11	T28	23639626
NA	CHEMICAL	GENE-Y	11	6	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T12	T29	23639626
CPR:4	CHEMICAL	GENE-Y	11	15	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T12	T30	23639626
CPR:4	CHEMICAL	GENE-N	11	16	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T12	T31	23639626
CPR:4	CHEMICAL	GENE-N	11	18	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T12	T32	23639626
NA	CHEMICAL	GENE-Y	11	26	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T12	T33	23639626
NA	CHEMICAL	GENE-Y	23	6	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T13	T29	23639626
NA	CHEMICAL	GENE-Y	23	15	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T13	T30	23639626
NA	CHEMICAL	GENE-N	23	16	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T13	T31	23639626
NA	CHEMICAL	GENE-N	23	18	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T13	T32	23639626
NA	CHEMICAL	GENE-Y	23	26	By `` working upwards '' from gene , we observed that chemical inhibited endogenous and gene-induced gene and gene activation by interfering with chemical phosphorylation of gene .	T13	T33	23639626
CPR:3	CHEMICAL	GENE-Y	6	13	This inhibition was mediated by a chemical-induced secreted factor which was identified as gene ( gene ) .	T14	T34	23639626
CPR:3	CHEMICAL	GENE-Y	6	15	This inhibition was mediated by a chemical-induced secreted factor which was identified as gene ( gene ) .	T14	T35	23639626
NA	CHEMICAL	GENE-Y	3	3	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T1	T18	23639626
NA	CHEMICAL	GENE-Y	3	11	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T1	T19	23639626
NA	CHEMICAL	GENE-Y	3	23	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T1	T20	23639626
NA	CHEMICAL	GENE-Y	3	27	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T1	T21	23639626
NA	CHEMICAL	GENE-Y	23	3	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T2	T18	23639626
NA	CHEMICAL	GENE-Y	23	11	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T2	T19	23639626
CPR:4	CHEMICAL	GENE-Y	23	23	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T2	T20	23639626
NA	CHEMICAL	GENE-Y	23	27	The induction of gene protein was dependent on a functional chemical receptor and was preceded by a rapid increase in the level of gene mRNA indicating that gene is a previously unknown transcriptional target of chemical in 5L cells .	T2	T21	23639626
NA	CHEMICAL	GENE-Y	5	0	gene was not induced by chemical in the parental cell line of 5L cells , Fao , and in various closely related rat hepatoma cell lines as well as in other unrelated cell types .	T3	T22	23639626
NA	CHEMICAL	GENE-Y	4	8	The observations suggest that in 5L cells the gene gene may have got under the control of a promoter containing chemical responsive element ( s ) leading to the induction of gene by chemical .	T4	T23	23639626
NA	CHEMICAL	GENE-N	4	22	The observations suggest that in 5L cells the gene gene may have got under the control of a promoter containing chemical responsive element ( s ) leading to the induction of gene by chemical .	T4	T24	23639626
NA	CHEMICAL	GENE-Y	4	31	The observations suggest that in 5L cells the gene gene may have got under the control of a promoter containing chemical responsive element ( s ) leading to the induction of gene by chemical .	T4	T25	23639626
NA	CHEMICAL	GENE-Y	33	8	The observations suggest that in 5L cells the gene gene may have got under the control of a promoter containing chemical responsive element ( s ) leading to the induction of gene by chemical .	T5	T23	23639626
NA	CHEMICAL	GENE-N	33	22	The observations suggest that in 5L cells the gene gene may have got under the control of a promoter containing chemical responsive element ( s ) leading to the induction of gene by chemical .	T5	T24	23639626
CPR:3	CHEMICAL	GENE-Y	33	31	The observations suggest that in 5L cells the gene gene may have got under the control of a promoter containing chemical responsive element ( s ) leading to the induction of gene by chemical .	T5	T25	23639626
NA	CHEMICAL	GENE-N	3	9	Inhibitory effect of chemical on excretion of chemical via gene in rats .	T20	T28	23201003
NA	CHEMICAL	GENE-N	7	9	Inhibitory effect of chemical on excretion of chemical via gene in rats .	T21	T28	23201003
NA	CHEMICAL	GENE-N	4	22	Quantitative polymerase chain reaction , western blotting , immunohistochemical analysis and immunofluorescence were used to determine the changes in the expression of gene gene and gene in rat kidney in response to chemical treatment .	T13	T25	23201003
NA	CHEMICAL	GENE-Y	4	23	Quantitative polymerase chain reaction , western blotting , immunohistochemical analysis and immunofluorescence were used to determine the changes in the expression of gene gene and gene in rat kidney in response to chemical treatment .	T13	T26	23201003
NA	CHEMICAL	GENE-Y	4	25	Quantitative polymerase chain reaction , western blotting , immunohistochemical analysis and immunofluorescence were used to determine the changes in the expression of gene gene and gene in rat kidney in response to chemical treatment .	T13	T27	23201003
CPR:4	CHEMICAL	GENE-Y	1	6	Moreover , chemical decreased expression of gene and gene in rat kidney .	T2	T22	23201003
CPR:4	CHEMICAL	GENE-Y	1	8	Moreover , chemical decreased expression of gene and gene in rat kidney .	T2	T23	23201003
NA	CHEMICAL	GENE-Y	2	4	Regions on chemical cyclase VII required for selective regulation by the gene pathway .	T6	T25	23229509
NA	CHEMICAL	GENE-Y	2	11	Regions on chemical cyclase VII required for selective regulation by the gene pathway .	T6	T26	23229509
NA	CHEMICAL	GENE-N	3	4	Regulation of multiple chemical cyclases ( gene ) provides unique inputs to mediate the synthesis of chemical , a ubiquitous second messenger that controls many aspects of cellular function .	T1	T10	23229509
NA	CHEMICAL	GENE-N	3	6	Regulation of multiple chemical cyclases ( gene ) provides unique inputs to mediate the synthesis of chemical , a ubiquitous second messenger that controls many aspects of cellular function .	T1	T13	23229509
CPR:9	CHEMICAL	GENE-N	16	4	Regulation of multiple chemical cyclases ( gene ) provides unique inputs to mediate the synthesis of chemical , a ubiquitous second messenger that controls many aspects of cellular function .	T5	T10	23229509
CPR:9	CHEMICAL	GENE-N	16	6	Regulation of multiple chemical cyclases ( gene ) provides unique inputs to mediate the synthesis of chemical , a ubiquitous second messenger that controls many aspects of cellular function .	T5	T13	23229509
NA	CHEMICAL	GENE-N	23	3	On stimulation by gene , the activities of gene can be further selectively modulated by other pathways to ensure precise control of intracellular chemical responses to specific stimuli .	T2	T8	23229509
CPR:9	CHEMICAL	GENE-N	23	8	On stimulation by gene , the activities of gene can be further selectively modulated by other pathways to ensure precise control of intracellular chemical responses to specific stimuli .	T2	T9	23229509
NA	CHEMICAL	GENE-N	8	10	Although both enzymes could fully restore regulation of chemical by gene , activation of the gene pathway preferentially synergized with gene .	T3	T18	23229509
NA	CHEMICAL	GENE-Y	8	15	Although both enzymes could fully restore regulation of chemical by gene , activation of the gene pathway preferentially synergized with gene .	T3	T19	23229509
NA	CHEMICAL	GENE-Y	8	20	Although both enzymes could fully restore regulation of chemical by gene , activation of the gene pathway preferentially synergized with gene .	T3	T20	23229509
NA	CHEMICAL	GENE-N	10	16	Exchange of domains between the two isoforms indicates that the gene and the chemical-terminus of the gene are important for directing selective regulation of gene by the gene pathway .	T4	T22	23229509
NA	CHEMICAL	GENE-Y	10	24	Exchange of domains between the two isoforms indicates that the gene and the chemical-terminus of the gene are important for directing selective regulation of gene by the gene pathway .	T4	T23	23229509
NA	CHEMICAL	GENE-Y	10	27	Exchange of domains between the two isoforms indicates that the gene and the chemical-terminus of the gene are important for directing selective regulation of gene by the gene pathway .	T4	T24	23229509
NA	CHEMICAL	GENE-Y	5	3	Pharmacokinetic study of gene-Releasing Peptide 6 ( chemical ) in nine male healthy volunteers .	T8	T11	23099431
NA	CHEMICAL	GENE-Y	5	3	Pharmacokinetic study of gene-Releasing Peptide 6 ( chemical ) in nine male healthy volunteers .	T9	T11	23099431
CPR:3	CHEMICAL	GENE-Y	0	3	chemical is a gene secretagogue that also enhances tissue viability in different organs .	T1	T10	23099431
CPR:4	CHEMICAL	GENE-Y	5	7	Western blot assay demonstrated that chemical decreased gene level and induced gene translocation to cause gene release .	T6	T12	23567243
CPR:3	CHEMICAL	GENE-Y	5	11	Western blot assay demonstrated that chemical decreased gene level and induced gene translocation to cause gene release .	T6	T13	23567243
CPR:3	CHEMICAL	GENE-Y	5	15	Western blot assay demonstrated that chemical decreased gene level and induced gene translocation to cause gene release .	T6	T14	23567243
NA	CHEMICAL	GENE-N	17	5	Meanwhile , the alterations of gene , gene and gene levels were also observed in response to chemical treatment .	T7	T17	23567243
NA	CHEMICAL	GENE-Y	17	7	Meanwhile , the alterations of gene , gene and gene levels were also observed in response to chemical treatment .	T7	T18	23567243
NA	CHEMICAL	GENE-Y	17	9	Meanwhile , the alterations of gene , gene and gene levels were also observed in response to chemical treatment .	T7	T19	23567243
NA	CHEMICAL	GENE-Y	13	5	Autophagy takes place in mutated gene neuroblastoma cells in response to hypoxia mimetic chemical .	T5	T21	23380477
CPR:3	CHEMICAL	GENE-Y	4	12	Today , we used chemical , a hypoxia mimetic that inhibits proteasomal gene degradation and generates reactive chemical species ( ROS ) .	T1	T15	23380477
NA	CHEMICAL	GENE-Y	17	12	Today , we used chemical , a hypoxia mimetic that inhibits proteasomal gene degradation and generates reactive chemical species ( ROS ) .	T2	T15	23380477
NA	CHEMICAL	GENE-Y	3	10	We focused on chemical-induced cell death in a DNA-binding mutated gene neuroblastoma cell line ( SKNBE ( 2c ) ) .	T3	T16	23380477
NA	CHEMICAL	GENE-Y	25	9	An autophagic signaling was evidenced by an increase of gene , gene , and gene expression whereas the gene ( mut ) presence decreased with chemical time exposure .	T4	T17	23380477
NA	CHEMICAL	GENE-N	25	11	An autophagic signaling was evidenced by an increase of gene , gene , and gene expression whereas the gene ( mut ) presence decreased with chemical time exposure .	T4	T18	23380477
NA	CHEMICAL	GENE-Y	25	14	An autophagic signaling was evidenced by an increase of gene , gene , and gene expression whereas the gene ( mut ) presence decreased with chemical time exposure .	T4	T19	23380477
CPR:4	CHEMICAL	GENE-Y	25	18	An autophagic signaling was evidenced by an increase of gene , gene , and gene expression whereas the gene ( mut ) presence decreased with chemical time exposure .	T4	T20	23380477
NA	CHEMICAL	GENE-Y	8	10	Endocrine therapy is first-line therapy for patients with chemical receptor-positive or chemical receptor-positive metastatic breast cancer .	T12	T22	12080538
NA	CHEMICAL	GENE-Y	8	10	Endocrine therapy is first-line therapy for patients with chemical receptor-positive or chemical receptor-positive metastatic breast cancer .	T12	T25	12080538
NA	CHEMICAL	GENE-Y	11	10	Endocrine therapy is first-line therapy for patients with chemical receptor-positive or chemical receptor-positive metastatic breast cancer .	T17	T22	12080538
NA	CHEMICAL	GENE-Y	11	10	Endocrine therapy is first-line therapy for patients with chemical receptor-positive or chemical receptor-positive metastatic breast cancer .	T17	T25	12080538
NA	CHEMICAL	GENE-Y	5	10	Commonly used endocrine therapies are chemical , chemical , and gene inhibitors .	T6	T20	12080538
NA	CHEMICAL	GENE-Y	7	10	Commonly used endocrine therapies are chemical , chemical , and gene inhibitors .	T7	T20	12080538
NA	CHEMICAL	GENE-Y	10	1	The gene inhibitors are currently used as second-line therapy after chemical failure .	T13	T21	12080538
CPR:4	CHEMICAL	GENE-Y	5	8	A recent study showed that chemical , an gene inhibitor , is as effective or even superior to chemical when used as a first-line therapy .	T14	T23	12080538
NA	CHEMICAL	GENE-Y	18	8	A recent study showed that chemical , an gene inhibitor , is as effective or even superior to chemical when used as a first-line therapy .	T15	T23	12080538
NA	CHEMICAL	GENE-Y	7	8	A new class of drug , the chemical receptor downregulators , has been developed .	T16	T24	12080538
CPR:4	CHEMICAL	GENE-Y	0	18	chemical , the first agent in this new class , not only induces the degradation of the chemical receptor but also is an chemical antagonist ; further , its lack of agonist activity provides a better safety profile .	T18	T19	12080538
NA	CHEMICAL	GENE-Y	0	18	chemical , the first agent in this new class , not only induces the degradation of the chemical receptor but also is an chemical antagonist ; further , its lack of agonist activity provides a better safety profile .	T1	T19	12080538
NA	CHEMICAL	GENE-Y	23	18	chemical , the first agent in this new class , not only induces the degradation of the chemical receptor but also is an chemical antagonist ; further , its lack of agonist activity provides a better safety profile .	T2	T19	12080538
NA	CHEMICAL	GENE-Y	0	10	chemical Modulate Pro-Oxidant-Antioxidant Balance but not the Immune Response to gene and gene in Obese Individuals .	T6	T16	23494802
NA	CHEMICAL	GENE-N	0	12	chemical Modulate Pro-Oxidant-Antioxidant Balance but not the Immune Response to gene and gene in Obese Individuals .	T6	T15	23494802
NA	CHEMICAL	GENE-Y	12	25	In this randomized double-blind placebo-controlled cross-over trial , the effects of a chemical supplement on serum pro-oxidant-antioxidant balance ( PAB ) and antibody titres to gene ( anti-gene ) and gene ( anti-gene ) were investigated .	T3	T7	23494802
NA	CHEMICAL	GENE-Y	12	27	In this randomized double-blind placebo-controlled cross-over trial , the effects of a chemical supplement on serum pro-oxidant-antioxidant balance ( PAB ) and antibody titres to gene ( anti-gene ) and gene ( anti-gene ) were investigated .	T3	T8	23494802
NA	CHEMICAL	GENE-N	12	30	In this randomized double-blind placebo-controlled cross-over trial , the effects of a chemical supplement on serum pro-oxidant-antioxidant balance ( PAB ) and antibody titres to gene ( anti-gene ) and gene ( anti-gene ) were investigated .	T3	T9	23494802
NA	CHEMICAL	GENE-N	12	32	In this randomized double-blind placebo-controlled cross-over trial , the effects of a chemical supplement on serum pro-oxidant-antioxidant balance ( PAB ) and antibody titres to gene ( anti-gene ) and gene ( anti-gene ) were investigated .	T3	T10	23494802
CPR:9	CHEMICAL	GENE-Y	10	18	The progress of the enzymatic reaction of the hydrolysis of chemical at pH 8 in the presence of gene and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product chemical ( TCh ) .	T4	T11	19472276
NA	CHEMICAL	GENE-Y	14	18	The progress of the enzymatic reaction of the hydrolysis of chemical at pH 8 in the presence of gene and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product chemical ( TCh ) .	T5	T11	19472276
NA	CHEMICAL	GENE-Y	12	32	In the method employed the capillary was first filled with 30 mM chemical-chemical buffer ( pH 8.0 ) and subsequently , plugs of : ( i ) water , ( ii ) gene solution , ( iii ) substrate solution with or without inhibitor , ( iv ) gene solution , and ( v ) water , were hydrodynamically injected into the capillary , and were allowed to stand ( and react ) during a waiting period of 2 min .	T6	T12	19472276
NA	CHEMICAL	GENE-Y	12	48	In the method employed the capillary was first filled with 30 mM chemical-chemical buffer ( pH 8.0 ) and subsequently , plugs of : ( i ) water , ( ii ) gene solution , ( iii ) substrate solution with or without inhibitor , ( iv ) gene solution , and ( v ) water , were hydrodynamically injected into the capillary , and were allowed to stand ( and react ) during a waiting period of 2 min .	T6	T13	19472276
NA	CHEMICAL	GENE-Y	12	32	In the method employed the capillary was first filled with 30 mM chemical-chemical buffer ( pH 8.0 ) and subsequently , plugs of : ( i ) water , ( ii ) gene solution , ( iii ) substrate solution with or without inhibitor , ( iv ) gene solution , and ( v ) water , were hydrodynamically injected into the capillary , and were allowed to stand ( and react ) during a waiting period of 2 min .	T7	T12	19472276
NA	CHEMICAL	GENE-Y	12	48	In the method employed the capillary was first filled with 30 mM chemical-chemical buffer ( pH 8.0 ) and subsequently , plugs of : ( i ) water , ( ii ) gene solution , ( iii ) substrate solution with or without inhibitor , ( iv ) gene solution , and ( v ) water , were hydrodynamically injected into the capillary , and were allowed to stand ( and react ) during a waiting period of 2 min .	T7	T13	19472276
NA	CHEMICAL	GENE-N	4	0	gene regulation of spinal chemical release .	T21	T37	12170059
NA	CHEMICAL	GENE-N	9	2	BACKGROUND : gene ( gene ) agonists produce antinociception in animals .	T12	T24	12170059
NA	CHEMICAL	GENE-N	9	4	BACKGROUND : gene ( gene ) agonists produce antinociception in animals .	T12	T32	12170059
NA	CHEMICAL	GENE-N	12	4	This study tested whether gene agonists stimulate spinal release of the neurotransmitter chemical either by direct actions on noradrenergic terminals or indirectly by stimulating release of other neurotransmitters to induce chemical release .	T13	T31	12170059
NA	CHEMICAL	GENE-N	20	4	This study tested whether gene agonists stimulate spinal release of the neurotransmitter chemical either by direct actions on noradrenergic terminals or indirectly by stimulating release of other neurotransmitters to induce chemical release .	T14	T31	12170059
CPR:5	CHEMICAL	GENE-Y	14	12	Probes were perfused with artificial cerebrospinal fluid containing chemical , the specific gene agonist chemical , or nicotine plus gene antagonists and chemical measured in the microdialysates .	T15	T33	12170059
NA	CHEMICAL	GENE-N	14	19	Probes were perfused with artificial cerebrospinal fluid containing chemical , the specific gene agonist chemical , or nicotine plus gene antagonists and chemical measured in the microdialysates .	T15	T34	12170059
CPR:5	CHEMICAL	GENE-Y	8	12	Probes were perfused with artificial cerebrospinal fluid containing chemical , the specific gene agonist chemical , or nicotine plus gene antagonists and chemical measured in the microdialysates .	T16	T33	12170059
NA	CHEMICAL	GENE-N	8	19	Probes were perfused with artificial cerebrospinal fluid containing chemical , the specific gene agonist chemical , or nicotine plus gene antagonists and chemical measured in the microdialysates .	T16	T34	12170059
NA	CHEMICAL	GENE-Y	16	12	Probes were perfused with artificial cerebrospinal fluid containing chemical , the specific gene agonist chemical , or nicotine plus gene antagonists and chemical measured in the microdialysates .	T17	T33	12170059
NA	CHEMICAL	GENE-N	16	19	Probes were perfused with artificial cerebrospinal fluid containing chemical , the specific gene agonist chemical , or nicotine plus gene antagonists and chemical measured in the microdialysates .	T17	T34	12170059
NA	CHEMICAL	GENE-N	4	5	The effects of specific chemical receptor antagonists and chemical synthase inhibitors were also examined .	T18	T35	12170059
NA	CHEMICAL	GENE-N	4	9	The effects of specific chemical receptor antagonists and chemical synthase inhibitors were also examined .	T18	T36	12170059
NA	CHEMICAL	GENE-N	8	5	The effects of specific chemical receptor antagonists and chemical synthase inhibitors were also examined .	T19	T35	12170059
NA	CHEMICAL	GENE-N	8	9	The effects of specific chemical receptor antagonists and chemical synthase inhibitors were also examined .	T19	T36	12170059
NA	CHEMICAL	GENE-N	3	25	RESULTS : Both chemical and chemical induced chemical release in spinal microdialsyates , an effect reduced by nicotinic antagonists but not chemical antagonists or chemical synthase inhibitors .	T1	T25	12170059
NA	CHEMICAL	GENE-N	5	25	RESULTS : Both chemical and chemical induced chemical release in spinal microdialsyates , an effect reduced by nicotinic antagonists but not chemical antagonists or chemical synthase inhibitors .	T2	T25	12170059
NA	CHEMICAL	GENE-N	7	25	RESULTS : Both chemical and chemical induced chemical release in spinal microdialsyates , an effect reduced by nicotinic antagonists but not chemical antagonists or chemical synthase inhibitors .	T3	T25	12170059
NA	CHEMICAL	GENE-N	21	25	RESULTS : Both chemical and chemical induced chemical release in spinal microdialsyates , an effect reduced by nicotinic antagonists but not chemical antagonists or chemical synthase inhibitors .	T4	T25	12170059
NA	CHEMICAL	GENE-N	24	25	RESULTS : Both chemical and chemical induced chemical release in spinal microdialsyates , an effect reduced by nicotinic antagonists but not chemical antagonists or chemical synthase inhibitors .	T5	T25	12170059
NA	CHEMICAL	GENE-Y	6	22	Both of the nicotinic agonists stimulated chemical release in synaptosomes , and the effect of chemical was blocked at lower concentrations of gene- than gene-preferring gene antagonists .	T6	T26	12170059
NA	CHEMICAL	GENE-Y	6	24	Both of the nicotinic agonists stimulated chemical release in synaptosomes , and the effect of chemical was blocked at lower concentrations of gene- than gene-preferring gene antagonists .	T6	T27	12170059
NA	CHEMICAL	GENE-N	6	25	Both of the nicotinic agonists stimulated chemical release in synaptosomes , and the effect of chemical was blocked at lower concentrations of gene- than gene-preferring gene antagonists .	T6	T28	12170059
NA	CHEMICAL	GENE-Y	8	22	Both of the nicotinic agonists stimulated chemical release in synaptosomes , and the effect of chemical was blocked at lower concentrations of gene- than gene-preferring gene antagonists .	T7	T26	12170059
NA	CHEMICAL	GENE-Y	8	24	Both of the nicotinic agonists stimulated chemical release in synaptosomes , and the effect of chemical was blocked at lower concentrations of gene- than gene-preferring gene antagonists .	T7	T27	12170059
NA	CHEMICAL	GENE-N	8	25	Both of the nicotinic agonists stimulated chemical release in synaptosomes , and the effect of chemical was blocked at lower concentrations of gene- than gene-preferring gene antagonists .	T7	T28	12170059
NA	CHEMICAL	GENE-N	19	10	CONCLUSION : These results suggest that one mechanism by which gene agonists act for analgesia is to stimulate spinal chemical release .	T8	T29	12170059
NA	CHEMICAL	GENE-Y	3	30	The responses to chemical , with respect to both toxicity and efficacy , vary among racial groups , potentially because of variability in the activity levels of the enzyme chemical dehydrogenase ( gene , encoded by the gene gene ) .	T3	T7	23588312
NA	CHEMICAL	GENE-Y	3	32	The responses to chemical , with respect to both toxicity and efficacy , vary among racial groups , potentially because of variability in the activity levels of the enzyme chemical dehydrogenase ( gene , encoded by the gene gene ) .	T3	T8	23588312
NA	CHEMICAL	GENE-Y	3	37	The responses to chemical , with respect to both toxicity and efficacy , vary among racial groups , potentially because of variability in the activity levels of the enzyme chemical dehydrogenase ( gene , encoded by the gene gene ) .	T3	T9	23588312
NA	CHEMICAL	GENE-Y	22	30	The responses to chemical , with respect to both toxicity and efficacy , vary among racial groups , potentially because of variability in the activity levels of the enzyme chemical dehydrogenase ( gene , encoded by the gene gene ) .	T5	T7	23588312
NA	CHEMICAL	GENE-Y	22	32	The responses to chemical , with respect to both toxicity and efficacy , vary among racial groups , potentially because of variability in the activity levels of the enzyme chemical dehydrogenase ( gene , encoded by the gene gene ) .	T5	T8	23588312
NA	CHEMICAL	GENE-Y	22	37	The responses to chemical , with respect to both toxicity and efficacy , vary among racial groups , potentially because of variability in the activity levels of the enzyme chemical dehydrogenase ( gene , encoded by the gene gene ) .	T5	T9	23588312
NA	CHEMICAL	GENE-Y	16	6	Peripheral blood mononuclear cells express mutated gene mRNA in Gitelman 's syndrome : evidence for abnormal chemical-sensitive chemical cotransport .	T13	T28	9596079
NA	CHEMICAL	GENE-Y	17	6	Peripheral blood mononuclear cells express mutated gene mRNA in Gitelman 's syndrome : evidence for abnormal chemical-sensitive chemical cotransport .	T14	T28	9596079
NA	CHEMICAL	GENE-Y	12	8	Genetic analysis has demonstrated complete linkage between the gene gene ( gene or gene ) and Gitelman 's syndrome ( GS ) .	T12	T25	9596079
NA	CHEMICAL	GENE-Y	12	11	Genetic analysis has demonstrated complete linkage between the gene gene ( gene or gene ) and Gitelman 's syndrome ( GS ) .	T12	T17	9596079
NA	CHEMICAL	GENE-Y	12	13	Genetic analysis has demonstrated complete linkage between the gene gene ( gene or gene ) and Gitelman 's syndrome ( GS ) .	T12	T18	9596079
NA	CHEMICAL	GENE-Y	21	15	This study was performed to determine whether peripheral blood mononuclear cells ( PBMC ) express gene mRNA and whether defective PBMC chemical cotransport could be demonstrated in GS .	T9	T22	9596079
CPR:4	CHEMICAL	GENE-Y	2	6	Molecular determinants of chemical block of gene chemical channels .	T16	T40	9486667
CPR:4	CHEMICAL	GENE-N	2	8	Molecular determinants of chemical block of gene chemical channels .	T16	T41	9486667
NA	CHEMICAL	GENE-Y	7	6	Molecular determinants of chemical block of gene chemical channels .	T17	T40	9486667
NA	CHEMICAL	GENE-N	7	8	Molecular determinants of chemical block of gene chemical channels .	T17	T41	9486667
NA	CHEMICAL	GENE-Y	7	1	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T13	T30	9486667
NA	CHEMICAL	GENE-Y	7	3	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T13	T29	9486667
NA	CHEMICAL	GENE-N	7	6	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T13	T33	9486667
NA	CHEMICAL	GENE-N	7	16	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T13	T19	9486667
NA	CHEMICAL	GENE-N	7	18	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T13	T25	9486667
NA	CHEMICAL	GENE-Y	1	1	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T3	T30	9486667
NA	CHEMICAL	GENE-Y	1	3	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T3	T29	9486667
NA	CHEMICAL	GENE-N	1	6	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T3	T33	9486667
NA	CHEMICAL	GENE-N	1	16	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T3	T19	9486667
NA	CHEMICAL	GENE-N	1	18	The gene ( gene ) encodes a chemical channel with biophysical properties nearly identical to the gene ( gene ) .	T3	T25	9486667
CPR:4	CHEMICAL	GENE-Y	3	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T8	T26	9486667
CPR:4	CHEMICAL	GENE-N	3	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T8	T28	9486667
CPR:4	CHEMICAL	GENE-Y	10	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T9	T26	9486667
CPR:4	CHEMICAL	GENE-N	10	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T9	T28	9486667
CPR:4	CHEMICAL	GENE-Y	27	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T10	T26	9486667
CPR:4	CHEMICAL	GENE-N	27	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T10	T28	9486667
CPR:4	CHEMICAL	GENE-Y	30	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T11	T26	9486667
CPR:4	CHEMICAL	GENE-N	30	0	gene/gene channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic chemical drugs , such as chemical , chemical , and chemical , at submicromolar concentrations .	T11	T28	9486667
NA	CHEMICAL	GENE-Y	15	6	By contrast , the closely related gene ( gene ) is 100-fold less sensitive to chemical .	T12	T31	9486667
NA	CHEMICAL	GENE-Y	15	8	By contrast , the closely related gene ( gene ) is 100-fold less sensitive to chemical .	T12	T32	9486667
NA	CHEMICAL	GENE-Y	6	14	To identify the molecular determinants for chemical block , we first engineered chimeras between gene and gene and then used site-directed mutagenesis to localize single chemical residues responsible for block .	T14	T34	9486667
NA	CHEMICAL	GENE-Y	6	16	To identify the molecular determinants for chemical block , we first engineered chimeras between gene and gene and then used site-directed mutagenesis to localize single chemical residues responsible for block .	T14	T35	9486667
NA	CHEMICAL	GENE-Y	25	14	To identify the molecular determinants for chemical block , we first engineered chimeras between gene and gene and then used site-directed mutagenesis to localize single chemical residues responsible for block .	T15	T34	9486667
NA	CHEMICAL	GENE-Y	25	16	To identify the molecular determinants for chemical block , we first engineered chimeras between gene and gene and then used site-directed mutagenesis to localize single chemical residues responsible for block .	T15	T35	9486667
NA	CHEMICAL	GENE-Y	8	18	Thus , our results indicate that important determinants of chemical binding are localized to the pore region of gene .	T1	T18	9486667
NA	CHEMICAL	GENE-Y	12	5	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T4	T21	9486667
NA	CHEMICAL	GENE-N	12	6	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T4	T22	9486667
NA	CHEMICAL	GENE-Y	12	11	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T4	T23	9486667
NA	CHEMICAL	GENE-N	12	13	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T4	T24	9486667
NA	CHEMICAL	GENE-Y	10	5	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T5	T21	9486667
NA	CHEMICAL	GENE-N	10	6	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T5	T22	9486667
NA	CHEMICAL	GENE-Y	10	11	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T5	T23	9486667
NA	CHEMICAL	GENE-N	10	13	Moreover , the reverse mutation gene gene increased the affinity of gene chemical channels for chemical , whereas C-type inactivation could not be recovered .	T5	T24	9486667
CPR:4	CHEMICAL	GENE-N	0	14	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T1	T36	19119014
CPR:4	CHEMICAL	GENE-N	0	16	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T1	T24	19119014
CPR:4	CHEMICAL	GENE-Y	0	18	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T1	T26	19119014
CPR:4	CHEMICAL	GENE-N	21	14	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T7	T36	19119014
CPR:4	CHEMICAL	GENE-N	21	16	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T7	T24	19119014
CPR:4	CHEMICAL	GENE-Y	21	18	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T7	T26	19119014
CPR:4	CHEMICAL	GENE-N	21	14	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T8	T36	19119014
CPR:4	CHEMICAL	GENE-N	21	16	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T8	T24	19119014
CPR:4	CHEMICAL	GENE-Y	21	18	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T8	T26	19119014
CPR:4	CHEMICAL	GENE-N	21	14	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T9	T36	19119014
CPR:4	CHEMICAL	GENE-N	21	16	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T9	T24	19119014
CPR:4	CHEMICAL	GENE-Y	21	18	chemical and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of gene ( gene , gene ) with a very different profile as compared to classical inhibitors , such as chemical , chemical , and chemical .	T9	T26	19119014
NA	CHEMICAL	GENE-Y	7	15	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T10	T29	19119014
CPR:4	CHEMICAL	GENE-Y	7	28	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T10	T30	19119014
NA	CHEMICAL	GENE-Y	7	15	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T11	T29	19119014
CPR:4	CHEMICAL	GENE-Y	7	28	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T11	T30	19119014
NA	CHEMICAL	GENE-Y	23	15	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T12	T29	19119014
CPR:4	CHEMICAL	GENE-Y	23	28	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T12	T30	19119014
NA	CHEMICAL	GENE-Y	7	15	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T13	T29	19119014
CPR:4	CHEMICAL	GENE-Y	7	28	Some of these structurally related compounds have a very different behavior against the widespread isozyme gene , with chemical , chemical , and chemical being efficient inhibitors against gene ( K ( I ) s of 65-138 nM ) , whereas chemical is a much weaker one ( K ( I ) of 2520 nM ) .	T13	T30	19119014
NA	CHEMICAL	GENE-N	21	23	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T14	T31	19119014
NA	CHEMICAL	GENE-N	21	27	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T14	T32	19119014
NA	CHEMICAL	GENE-N	21	31	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T14	T33	19119014
NA	CHEMICAL	GENE-N	21	36	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T14	T34	19119014
NA	CHEMICAL	GENE-N	25	23	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T15	T31	19119014
NA	CHEMICAL	GENE-N	25	27	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T15	T32	19119014
NA	CHEMICAL	GENE-N	25	31	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T15	T33	19119014
NA	CHEMICAL	GENE-N	25	36	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T15	T34	19119014
NA	CHEMICAL	GENE-N	29	23	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T16	T31	19119014
NA	CHEMICAL	GENE-N	29	27	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T16	T32	19119014
NA	CHEMICAL	GENE-N	29	31	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T16	T33	19119014
NA	CHEMICAL	GENE-N	29	36	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T16	T34	19119014
NA	CHEMICAL	GENE-N	34	23	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T17	T31	19119014
NA	CHEMICAL	GENE-N	34	27	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T17	T32	19119014
NA	CHEMICAL	GENE-N	34	31	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T17	T33	19119014
NA	CHEMICAL	GENE-N	34	36	Furthermore , some of these diuretics are quite efficient ( low nanomolar ) inhibitors of other isoforms , for example , chemical against gene ; chemical against gene , chemical against gene , and chemical against gene .	T17	T34	19119014
NA	CHEMICAL	GENE-Y	24	8	Examining the four X-ray crystal structures of their gene adducts , we observed several ( 2-3 ) active site water molecules interacting with the chemical , chemical , and chemical scaffolds which may be responsible for this important difference of activity .	T18	T35	19119014
NA	CHEMICAL	GENE-Y	26	8	Examining the four X-ray crystal structures of their gene adducts , we observed several ( 2-3 ) active site water molecules interacting with the chemical , chemical , and chemical scaffolds which may be responsible for this important difference of activity .	T19	T35	19119014
NA	CHEMICAL	GENE-Y	29	8	Examining the four X-ray crystal structures of their gene adducts , we observed several ( 2-3 ) active site water molecules interacting with the chemical , chemical , and chemical scaffolds which may be responsible for this important difference of activity .	T2	T35	19119014
NA	CHEMICAL	GENE-Y	2	5	Indeed , chemical bound to gene has no interactions with active site water molecules .	T3	T25	19119014
NA	CHEMICAL	GENE-Y	0	4	chemical bound within the gene active site is in an enolic ( lactimic ) tautomeric form , with the enolic chemical also participating in two strong chemical bonds with Asn67 and a water molecule .	T4	T27	19119014
NA	CHEMICAL	GENE-Y	20	4	chemical bound within the gene active site is in an enolic ( lactimic ) tautomeric form , with the enolic chemical also participating in two strong chemical bonds with Asn67 and a water molecule .	T5	T27	19119014
NA	CHEMICAL	GENE-Y	26	4	chemical bound within the gene active site is in an enolic ( lactimic ) tautomeric form , with the enolic chemical also participating in two strong chemical bonds with Asn67 and a water molecule .	T6	T27	19119014
NA	CHEMICAL	GENE-Y	0	3	chemical-dependent chemical-induced currents in chemical-transporter-transfected HEK-293 cells blocked by chemical and antidepressants .	T24	T38	7500004
CPR:3	CHEMICAL	GENE-Y	1	3	chemical-dependent chemical-induced currents in chemical-transporter-transfected HEK-293 cells blocked by chemical and antidepressants .	T26	T38	7500004
NA	CHEMICAL	GENE-Y	3	3	chemical-dependent chemical-induced currents in chemical-transporter-transfected HEK-293 cells blocked by chemical and antidepressants .	T27	T38	7500004
CPR:4	CHEMICAL	GENE-Y	3	3	chemical-dependent chemical-induced currents in chemical-transporter-transfected HEK-293 cells blocked by chemical and antidepressants .	T25	T38	7500004
NA	CHEMICAL	GENE-Y	5	6	To explore the relationship between chemical transport and ion permeation through the chemical transporter , we established a gene ( gene ) cell line suitable for biochemical analysis and patch-clamp recording .	T13	T32	7500004
NA	CHEMICAL	GENE-Y	5	6	To explore the relationship between chemical transport and ion permeation through the chemical transporter , we established a gene ( gene ) cell line suitable for biochemical analysis and patch-clamp recording .	T13	T33	7500004
NA	CHEMICAL	GENE-Y	5	20	To explore the relationship between chemical transport and ion permeation through the chemical transporter , we established a gene ( gene ) cell line suitable for biochemical analysis and patch-clamp recording .	T13	T34	7500004
NA	CHEMICAL	GENE-Y	12	6	To explore the relationship between chemical transport and ion permeation through the chemical transporter , we established a gene ( gene ) cell line suitable for biochemical analysis and patch-clamp recording .	T15	T32	7500004
NA	CHEMICAL	GENE-Y	12	6	To explore the relationship between chemical transport and ion permeation through the chemical transporter , we established a gene ( gene ) cell line suitable for biochemical analysis and patch-clamp recording .	T15	T33	7500004
NA	CHEMICAL	GENE-Y	12	20	To explore the relationship between chemical transport and ion permeation through the chemical transporter , we established a gene ( gene ) cell line suitable for biochemical analysis and patch-clamp recording .	T15	T34	7500004
NA	CHEMICAL	GENE-Y	7	3	Stable transfection of gene cDNA into HEK-293 ( human embryonic kidney ) cells results in lines exhibiting ( 1 ) a high number of transporter copies per cell ( 10 ( 6 ) ) , as detected by radioligand binding and gene-specific antibodies , ( 2 ) high-affinity , chemical-dependent transport of chemical , and ( 3 ) inhibitor sensitivities similar to those of native membranes .	T18	T35	7500004
NA	CHEMICAL	GENE-Y	7	41	Stable transfection of gene cDNA into HEK-293 ( human embryonic kidney ) cells results in lines exhibiting ( 1 ) a high number of transporter copies per cell ( 10 ( 6 ) ) , as detected by radioligand binding and gene-specific antibodies , ( 2 ) high-affinity , chemical-dependent transport of chemical , and ( 3 ) inhibitor sensitivities similar to those of native membranes .	T18	T36	7500004
NA	CHEMICAL	GENE-Y	52	3	Stable transfection of gene cDNA into HEK-293 ( human embryonic kidney ) cells results in lines exhibiting ( 1 ) a high number of transporter copies per cell ( 10 ( 6 ) ) , as detected by radioligand binding and gene-specific antibodies , ( 2 ) high-affinity , chemical-dependent transport of chemical , and ( 3 ) inhibitor sensitivities similar to those of native membranes .	T19	T35	7500004
NA	CHEMICAL	GENE-Y	52	41	Stable transfection of gene cDNA into HEK-293 ( human embryonic kidney ) cells results in lines exhibiting ( 1 ) a high number of transporter copies per cell ( 10 ( 6 ) ) , as detected by radioligand binding and gene-specific antibodies , ( 2 ) high-affinity , chemical-dependent transport of chemical , and ( 3 ) inhibitor sensitivities similar to those of native membranes .	T19	T36	7500004
CPR:3	CHEMICAL	GENE-Y	6	3	Whole-cell voltage-clamp of gene-293 cells reveals chemical-induced , chemical-dependent currents blocked by antidepressants and chemical that are absent in parental cells .	T20	T37	7500004
NA	CHEMICAL	GENE-Y	8	3	Whole-cell voltage-clamp of gene-293 cells reveals chemical-induced , chemical-dependent currents blocked by antidepressants and chemical that are absent in parental cells .	T21	T37	7500004
CPR:4	CHEMICAL	GENE-Y	14	3	Whole-cell voltage-clamp of gene-293 cells reveals chemical-induced , chemical-dependent currents blocked by antidepressants and chemical that are absent in parental cells .	T22	T37	7500004
NA	CHEMICAL	GENE-Y	3	17	In addition to chemical-dependent currents , transfected cells posses an chemical-independent mode of charge movement mediated by gene .	T23	T28	7500004
NA	CHEMICAL	GENE-Y	10	17	In addition to chemical-dependent currents , transfected cells posses an chemical-independent mode of charge movement mediated by gene .	T1	T28	7500004
NA	CHEMICAL	GENE-Y	0	0	gene antagonists without effect in non-transfected cells abolish both chemical-dependent and chemical-independent modes of charge movement in transfected cells .	T2	T29	7500004
NA	CHEMICAL	GENE-Y	11	0	gene antagonists without effect in non-transfected cells abolish both chemical-dependent and chemical-independent modes of charge movement in transfected cells .	T3	T29	7500004
CPR:9	CHEMICAL	GENE-Y	20	8	To explain our observations , we propose that gene function as gene with an indefinite stoichiometry relating ion flux to chemical transport .	T6	T30	7500004
NA	CHEMICAL	GENE-N	20	11	To explain our observations , we propose that gene function as gene with an indefinite stoichiometry relating ion flux to chemical transport .	T6	T31	7500004
NA	CHEMICAL	GENE-Y	0	12	chemical-sensitive spontaneous cholinergic neurotransmission was blocked > 80 % by 1 pM gene despite cleaving < 20 % of the gene .	T2	T14	23485402
NA	CHEMICAL	GENE-Y	0	20	chemical-sensitive spontaneous cholinergic neurotransmission was blocked > 80 % by 1 pM gene despite cleaving < 20 % of the gene .	T2	T15	23485402
NA	CHEMICAL	GENE-N	5	10	Moreover , limited cleavage of gene was conferred onto the gene from gene when fused to the chemical-terminus of gene .	T1	T8	23485402
NA	CHEMICAL	GENE-Y	5	12	Moreover , limited cleavage of gene was conferred onto the gene from gene when fused to the chemical-terminus of gene .	T1	T9	23485402
NA	CHEMICAL	GENE-Y	5	19	Moreover , limited cleavage of gene was conferred onto the gene from gene when fused to the chemical-terminus of gene .	T1	T10	23485402
CPR:3	CHEMICAL	GENE-Y	15	4	Degradation of submandibular gland gene by parasympathetic denervation of chorda tympani and its recovery by chemical , an gene agonist .	T5	T20	18450949
CPR:5	CHEMICAL	GENE-Y	15	18	Degradation of submandibular gland gene by parasympathetic denervation of chorda tympani and its recovery by chemical , an gene agonist .	T5	T19	18450949
CPR:5	CHEMICAL	GENE-Y	2	5	Administration of chemical , an gene agonist ( 10 mg/kg for 7 days po ) , but not chemical ( 0.3 mg/kg for 7 days po ) , recovered the gene protein level reduced by CTD and increased the gene protein level above the control one .	T1	T10	18450949
CPR:3	CHEMICAL	GENE-Y	2	30	Administration of chemical , an gene agonist ( 10 mg/kg for 7 days po ) , but not chemical ( 0.3 mg/kg for 7 days po ) , recovered the gene protein level reduced by CTD and increased the gene protein level above the control one .	T1	T11	18450949
CPR:3	CHEMICAL	GENE-Y	2	39	Administration of chemical , an gene agonist ( 10 mg/kg for 7 days po ) , but not chemical ( 0.3 mg/kg for 7 days po ) , recovered the gene protein level reduced by CTD and increased the gene protein level above the control one .	T1	T12	18450949
NA	CHEMICAL	GENE-Y	18	5	Administration of chemical , an gene agonist ( 10 mg/kg for 7 days po ) , but not chemical ( 0.3 mg/kg for 7 days po ) , recovered the gene protein level reduced by CTD and increased the gene protein level above the control one .	T2	T10	18450949
NA	CHEMICAL	GENE-Y	18	30	Administration of chemical , an gene agonist ( 10 mg/kg for 7 days po ) , but not chemical ( 0.3 mg/kg for 7 days po ) , recovered the gene protein level reduced by CTD and increased the gene protein level above the control one .	T2	T11	18450949
NA	CHEMICAL	GENE-Y	18	39	Administration of chemical , an gene agonist ( 10 mg/kg for 7 days po ) , but not chemical ( 0.3 mg/kg for 7 days po ) , recovered the gene protein level reduced by CTD and increased the gene protein level above the control one .	T2	T12	18450949
NA	CHEMICAL	GENE-Y	11	4	The mRNA level of gene was scarcely affected by CTD and chemical administration .	T3	T14	18450949
CPR:3	CHEMICAL	GENE-Y	2	19	Administration of chemical ( 50 mg/kg for 7 days po ) , a denaturant of lysosomes , increased the gene protein level reduced by CTD .	T4	T16	18450949
CPR:4	CHEMICAL	GENE-N	0	2	chemical represses gene microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating gene in endometrial carcinoma cell lines .	T15	T31	23295740
CPR:3	CHEMICAL	GENE-Y	0	10	chemical represses gene microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating gene in endometrial carcinoma cell lines .	T15	T30	23295740
NA	CHEMICAL	GENE-Y	1	9	Although chemical ( chemical ) , a selective chemical receptor modulator , has been widely used in the treatment of hormone-responsive breast cancer , its chemical-like effect increases the risk of endometrial cancer .	T14	T22	23295740
NA	CHEMICAL	GENE-Y	3	9	Although chemical ( chemical ) , a selective chemical receptor modulator , has been widely used in the treatment of hormone-responsive breast cancer , its chemical-like effect increases the risk of endometrial cancer .	T7	T22	23295740
NA	CHEMICAL	GENE-Y	8	9	Although chemical ( chemical ) , a selective chemical receptor modulator , has been widely used in the treatment of hormone-responsive breast cancer , its chemical-like effect increases the risk of endometrial cancer .	T10	T22	23295740
NA	CHEMICAL	GENE-Y	25	9	Although chemical ( chemical ) , a selective chemical receptor modulator , has been widely used in the treatment of hormone-responsive breast cancer , its chemical-like effect increases the risk of endometrial cancer .	T5	T22	23295740
NA	CHEMICAL	GENE-N	14	30	In this report , we explored the role of microRNAs ( miRNAs ) in chemical-induced epithelial-mesenchymal transition ( EMT ) in ECC-1 and Ishikawa endometrial cancer cell lines and found gene is involved in this process via the regulation of gene .	T9	T23	23295740
NA	CHEMICAL	GENE-Y	14	40	In this report , we explored the role of microRNAs ( miRNAs ) in chemical-induced epithelial-mesenchymal transition ( EMT ) in ECC-1 and Ishikawa endometrial cancer cell lines and found gene is involved in this process via the regulation of gene .	T9	T24	23295740
CPR:4	CHEMICAL	GENE-N	22	0	gene , a miRNA family with tumor suppressive functions in a wide range of cancers , was found reduced in response to chemical treatment .	T12	T25	23295740
NA	CHEMICAL	GENE-Y	2	7	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T13	T26	23295740
NA	CHEMICAL	GENE-Y	2	7	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T13	T27	23295740
NA	CHEMICAL	GENE-Y	2	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T13	T28	23295740
NA	CHEMICAL	GENE-Y	2	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T13	T29	23295740
NA	CHEMICAL	GENE-Y	2	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T13	T16	23295740
NA	CHEMICAL	GENE-Y	2	7	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T1	T26	23295740
NA	CHEMICAL	GENE-Y	2	7	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T1	T27	23295740
CPR:3	CHEMICAL	GENE-Y	2	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T1	T28	23295740
CPR:3	CHEMICAL	GENE-Y	2	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T1	T29	23295740
CPR:4	CHEMICAL	GENE-Y	2	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T1	T16	23295740
NA	CHEMICAL	GENE-Y	17	7	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T2	T26	23295740
NA	CHEMICAL	GENE-Y	17	7	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T2	T27	23295740
NA	CHEMICAL	GENE-Y	17	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T2	T28	23295740
NA	CHEMICAL	GENE-Y	17	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T2	T29	23295740
NA	CHEMICAL	GENE-Y	17	13	Consistent with chemical finger E-box binding homeobox 2 , which was confirmed as a direct target of gene in endometrial cancer cell lines , some other key factors of EMT such as gene and gene increased , whereas gene decreased in the chemical-treated cells , contributing to chemical-induced EMT in these endometrial cancer cells .	T2	T16	23295740
NA	CHEMICAL	GENE-Y	22	6	In addition , we showed that gene directly binds to and represses the promoter of gene miRNAs , and its up-regulation in chemical-treated endometrial cancer cells leads to the down-regulation of gene and eventually to EMT .	T3	T17	23295740
NA	CHEMICAL	GENE-N	22	15	In addition , we showed that gene directly binds to and represses the promoter of gene miRNAs , and its up-regulation in chemical-treated endometrial cancer cells leads to the down-regulation of gene and eventually to EMT .	T3	T18	23295740
CPR:4	CHEMICAL	GENE-N	22	31	In addition , we showed that gene directly binds to and represses the promoter of gene miRNAs , and its up-regulation in chemical-treated endometrial cancer cells leads to the down-regulation of gene and eventually to EMT .	T3	T19	23295740
CPR:4	CHEMICAL	GENE-N	6	10	Collectively , our data suggest that chemical can repress the gene family and induce EMT via the up-regulation of gene in endometrial cancer cells .	T4	T20	23295740
CPR:3	CHEMICAL	GENE-Y	6	19	Collectively , our data suggest that chemical can repress the gene family and induce EMT via the up-regulation of gene in endometrial cancer cells .	T4	T21	23295740
NA	CHEMICAL	GENE-Y	6	14	Similar concentrations of these compounds blocked chemical-induced growth of MCF-7 cells , but chemical receptor ( gene ) interactions do not seem to be involved .	T25	T46	2386945
NA	CHEMICAL	GENE-Y	6	16	Similar concentrations of these compounds blocked chemical-induced growth of MCF-7 cells , but chemical receptor ( gene ) interactions do not seem to be involved .	T25	T47	2386945
NA	CHEMICAL	GENE-Y	13	14	Similar concentrations of these compounds blocked chemical-induced growth of MCF-7 cells , but chemical receptor ( gene ) interactions do not seem to be involved .	T26	T46	2386945
NA	CHEMICAL	GENE-Y	13	16	Similar concentrations of these compounds blocked chemical-induced growth of MCF-7 cells , but chemical receptor ( gene ) interactions do not seem to be involved .	T26	T47	2386945
NA	CHEMICAL	GENE-Y	0	14	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T27	T48	2386945
NA	CHEMICAL	GENE-Y	0	25	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T27	T49	2386945
NA	CHEMICAL	GENE-Y	2	14	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T28	T48	2386945
NA	CHEMICAL	GENE-Y	2	25	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T28	T49	2386945
NA	CHEMICAL	GENE-Y	8	14	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T29	T48	2386945
NA	CHEMICAL	GENE-Y	8	25	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T29	T49	2386945
NA	CHEMICAL	GENE-Y	18	14	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T30	T48	2386945
NA	CHEMICAL	GENE-Y	18	25	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T30	T49	2386945
NA	CHEMICAL	GENE-Y	6	14	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T31	T48	2386945
NA	CHEMICAL	GENE-Y	6	25	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T31	T49	2386945
NA	CHEMICAL	GENE-Y	27	14	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T1	T48	2386945
NA	CHEMICAL	GENE-Y	27	25	chemical and chemical had no effect on the chemical binding properties of the MCF-7 gene , nor did chemical interfere with the induction of chemical receptors by chemical .	T1	T49	2386945
NA	CHEMICAL	GENE-N	2	13	Furthermore , chemical also inhibited incorporation of chemical into MCF-7 cells stimulated by gene in serum-free medium .	T2	T34	2386945
NA	CHEMICAL	GENE-N	7	13	Furthermore , chemical also inhibited incorporation of chemical into MCF-7 cells stimulated by gene in serum-free medium .	T3	T34	2386945
NA	CHEMICAL	GENE-Y	3	4	The Ki for chemical in serum-free medium alone , 0.46 microM , was similar to that determined in the presence of gene ( 0.42 microM ) , gene ( 0.54 microM ) , and gene ( 0.43 microM ) .	T4	T35	2386945
NA	CHEMICAL	GENE-Y	3	27	The Ki for chemical in serum-free medium alone , 0.46 microM , was similar to that determined in the presence of gene ( 0.42 microM ) , gene ( 0.54 microM ) , and gene ( 0.43 microM ) .	T4	T36	2386945
NA	CHEMICAL	GENE-Y	3	14	The Ki for chemical in serum-free medium alone , 0.46 microM , was similar to that determined in the presence of gene ( 0.42 microM ) , gene ( 0.54 microM ) , and gene ( 0.43 microM ) .	T4	T37	2386945
NA	CHEMICAL	GENE-Y	0	10	chemical also blocked cell growth and chemical incorporation into the gene-positive T47D and ZR75-1B human breast cancer cell lines and the gene-negative human breast cancer cell line , MDA-MB-231 .	T6	T38	2386945
NA	CHEMICAL	GENE-Y	0	21	chemical also blocked cell growth and chemical incorporation into the gene-positive T47D and ZR75-1B human breast cancer cell lines and the gene-negative human breast cancer cell line , MDA-MB-231 .	T6	T39	2386945
NA	CHEMICAL	GENE-Y	6	10	chemical also blocked cell growth and chemical incorporation into the gene-positive T47D and ZR75-1B human breast cancer cell lines and the gene-negative human breast cancer cell line , MDA-MB-231 .	T7	T38	2386945
NA	CHEMICAL	GENE-Y	6	21	chemical also blocked cell growth and chemical incorporation into the gene-positive T47D and ZR75-1B human breast cancer cell lines and the gene-negative human breast cancer cell line , MDA-MB-231 .	T7	T39	2386945
CPR:6	CHEMICAL	GENE-Y	6	16	Although numerous mechanisms of action of chemical and chemical have been identified , both drugs are gene antagonists at drug concentrations that inhibit breast cancer cell growth in vitro .	T8	T40	2386945
CPR:6	CHEMICAL	GENE-Y	8	16	Although numerous mechanisms of action of chemical and chemical have been identified , both drugs are gene antagonists at drug concentrations that inhibit breast cancer cell growth in vitro .	T9	T40	2386945
CPR:6	CHEMICAL	GENE-Y	10	8	Inhibition of MCF-7 cell growth by the selective gene antagonists chemical and chemical is consistent with a role for gene antagonism in the broad growth-inhibitory properties of chemical .	T12	T41	2386945
NA	CHEMICAL	GENE-Y	10	16	Inhibition of MCF-7 cell growth by the selective gene antagonists chemical and chemical is consistent with a role for gene antagonism in the broad growth-inhibitory properties of chemical .	T12	T42	2386945
CPR:6	CHEMICAL	GENE-Y	12	8	Inhibition of MCF-7 cell growth by the selective gene antagonists chemical and chemical is consistent with a role for gene antagonism in the broad growth-inhibitory properties of chemical .	T13	T41	2386945
NA	CHEMICAL	GENE-Y	12	16	Inhibition of MCF-7 cell growth by the selective gene antagonists chemical and chemical is consistent with a role for gene antagonism in the broad growth-inhibitory properties of chemical .	T13	T42	2386945
NA	CHEMICAL	GENE-Y	27	8	Inhibition of MCF-7 cell growth by the selective gene antagonists chemical and chemical is consistent with a role for gene antagonism in the broad growth-inhibitory properties of chemical .	T15	T41	2386945
CPR:4	CHEMICAL	GENE-Y	27	16	Inhibition of MCF-7 cell growth by the selective gene antagonists chemical and chemical is consistent with a role for gene antagonism in the broad growth-inhibitory properties of chemical .	T15	T42	2386945
NA	CHEMICAL	GENE-Y	0	3	chemical improves cardiomyopathy in gene-deficient mice through gene protein-mediated modulation of gene protein .	T7	T26	23297412
NA	CHEMICAL	GENE-Y	0	7	chemical improves cardiomyopathy in gene-deficient mice through gene protein-mediated modulation of gene protein .	T7	T27	23297412
NA	CHEMICAL	GENE-Y	0	11	chemical improves cardiomyopathy in gene-deficient mice through gene protein-mediated modulation of gene protein .	T7	T25	23297412
CPR:3	CHEMICAL	GENE-Y	8	19	Here , we show that oral administration of chemical , which leads to activation of an chemical-dependent protein deacetylase SIRT1 , suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in gene-deficient mdx mice .	T1	T10	23297412
NA	CHEMICAL	GENE-Y	8	31	Here , we show that oral administration of chemical , which leads to activation of an chemical-dependent protein deacetylase SIRT1 , suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in gene-deficient mdx mice .	T1	T11	23297412
NA	CHEMICAL	GENE-Y	16	19	Here , we show that oral administration of chemical , which leads to activation of an chemical-dependent protein deacetylase SIRT1 , suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in gene-deficient mdx mice .	T2	T10	23297412
NA	CHEMICAL	GENE-Y	16	31	Here , we show that oral administration of chemical , which leads to activation of an chemical-dependent protein deacetylase SIRT1 , suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in gene-deficient mdx mice .	T2	T11	23297412
NA	CHEMICAL	GENE-Y	17	3	The pro-hypertrophic co-activator gene protein but not gene mRNA was up-regulated in the mdx heart , and chemical administration down-regulated the gene protein level .	T3	T12	23297412
NA	CHEMICAL	GENE-Y	17	7	The pro-hypertrophic co-activator gene protein but not gene mRNA was up-regulated in the mdx heart , and chemical administration down-regulated the gene protein level .	T3	T13	23297412
CPR:4	CHEMICAL	GENE-Y	17	21	The pro-hypertrophic co-activator gene protein but not gene mRNA was up-regulated in the mdx heart , and chemical administration down-regulated the gene protein level .	T3	T14	23297412
NA	CHEMICAL	GENE-Y	14	11	In cultured cardiomyocytes , cardiomyocyte hypertrophy induced by the α ( 1 ) -agonist chemical was inhibited by the overexpression of gene as well as chemical , both of which down-regulated gene protein levels but not gene mRNA levels .	T4	T15	23297412
NA	CHEMICAL	GENE-Y	14	31	In cultured cardiomyocytes , cardiomyocyte hypertrophy induced by the α ( 1 ) -agonist chemical was inhibited by the overexpression of gene as well as chemical , both of which down-regulated gene protein levels but not gene mRNA levels .	T4	T16	23297412
NA	CHEMICAL	GENE-Y	14	36	In cultured cardiomyocytes , cardiomyocyte hypertrophy induced by the α ( 1 ) -agonist chemical was inhibited by the overexpression of gene as well as chemical , both of which down-regulated gene protein levels but not gene mRNA levels .	T4	T17	23297412
NA	CHEMICAL	GENE-Y	25	11	In cultured cardiomyocytes , cardiomyocyte hypertrophy induced by the α ( 1 ) -agonist chemical was inhibited by the overexpression of gene as well as chemical , both of which down-regulated gene protein levels but not gene mRNA levels .	T5	T15	23297412
CPR:4	CHEMICAL	GENE-Y	25	31	In cultured cardiomyocytes , cardiomyocyte hypertrophy induced by the α ( 1 ) -agonist chemical was inhibited by the overexpression of gene as well as chemical , both of which down-regulated gene protein levels but not gene mRNA levels .	T5	T16	23297412
NA	CHEMICAL	GENE-Y	25	36	In cultured cardiomyocytes , cardiomyocyte hypertrophy induced by the α ( 1 ) -agonist chemical was inhibited by the overexpression of gene as well as chemical , both of which down-regulated gene protein levels but not gene mRNA levels .	T5	T17	23297412
NA	CHEMICAL	GENE-Y	14	3	We found that gene induced gene down-regulation via the gene-gene pathway by deacetylation of chemical residues for ubiquitination .	T6	T21	23297412
NA	CHEMICAL	GENE-Y	14	5	We found that gene induced gene down-regulation via the gene-gene pathway by deacetylation of chemical residues for ubiquitination .	T6	T22	23297412
NA	CHEMICAL	GENE-N	14	9	We found that gene induced gene down-regulation via the gene-gene pathway by deacetylation of chemical residues for ubiquitination .	T6	T23	23297412
NA	CHEMICAL	GENE-N	14	9	We found that gene induced gene down-regulation via the gene-gene pathway by deacetylation of chemical residues for ubiquitination .	T6	T24	23297412
CPR:4	CHEMICAL	GENE-Y	0	10	chemical inhibits chemical-induced vascular permeability through suppressing the phosphorylation of gene .	T14	T25	23246481
CPR:3	CHEMICAL	GENE-Y	2	10	chemical inhibits chemical-induced vascular permeability through suppressing the phosphorylation of gene .	T15	T25	23246481
CPR:4	CHEMICAL	GENE-N	3	8	We found that chemical can suppress the chemical-stimulated gene remodeling and gene uptake of HUVECs , as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231 .	T6	T16	23246481
CPR:4	CHEMICAL	GENE-Y	3	11	We found that chemical can suppress the chemical-stimulated gene remodeling and gene uptake of HUVECs , as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231 .	T6	T17	23246481
CPR:3	CHEMICAL	GENE-N	7	8	We found that chemical can suppress the chemical-stimulated gene remodeling and gene uptake of HUVECs , as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231 .	T7	T16	23246481
CPR:3	CHEMICAL	GENE-Y	7	11	We found that chemical can suppress the chemical-stimulated gene remodeling and gene uptake of HUVECs , as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231 .	T7	T17	23246481
CPR:4	CHEMICAL	GENE-Y	4	9	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T8	T18	23246481
CPR:4	CHEMICAL	GENE-Y	4	11	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T8	T19	23246481
CPR:4	CHEMICAL	GENE-Y	4	20	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T8	T20	23246481
CPR:4	CHEMICAL	GENE-Y	4	22	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T8	T21	23246481
CPR:3	CHEMICAL	GENE-Y	6	9	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T9	T18	23246481
CPR:3	CHEMICAL	GENE-Y	6	11	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T9	T19	23246481
NA	CHEMICAL	GENE-Y	6	20	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T9	T20	23246481
NA	CHEMICAL	GENE-Y	6	22	The mechanism revealed that chemical inhibited chemical-induced phosphorylation of gene ( gene ) associating with the suppression of stabilization of gene and gene .	T9	T21	23246481
CPR:4	CHEMICAL	GENE-N	2	7	Moreover , chemical repressed chemical-induced phosphorylation of gene , gene and vascular permeability .	T10	T22	23246481
CPR:4	CHEMICAL	GENE-Y	2	9	Moreover , chemical repressed chemical-induced phosphorylation of gene , gene and vascular permeability .	T10	T23	23246481
CPR:3	CHEMICAL	GENE-N	4	7	Moreover , chemical repressed chemical-induced phosphorylation of gene , gene and vascular permeability .	T11	T22	23246481
CPR:3	CHEMICAL	GENE-Y	4	9	Moreover , chemical repressed chemical-induced phosphorylation of gene , gene and vascular permeability .	T11	T23	23246481
CPR:4	CHEMICAL	GENE-N	0	14	chemical Suppresses Proliferation and Survival of TW2.6 Human Oral Cancer Cells via Inhibition of gene Signaling .	T18	T39	23615471
CPR:4	CHEMICAL	GENE-N	2	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T19	23615471
CPR:4	CHEMICAL	GENE-Y	2	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T20	23615471
CPR:4	CHEMICAL	GENE-Y	2	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T21	23615471
CPR:4	CHEMICAL	GENE-Y	2	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T22	23615471
CPR:4	CHEMICAL	GENE-N	2	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T23	23615471
CPR:4	CHEMICAL	GENE-Y	2	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T25	23615471
CPR:4	CHEMICAL	GENE-Y	2	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T26	23615471
CPR:4	CHEMICAL	GENE-Y	2	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T27	23615471
CPR:4	CHEMICAL	GENE-N	2	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T30	23615471
CPR:4	CHEMICAL	GENE-Y	2	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T32	23615471
CPR:4	CHEMICAL	GENE-Y	2	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T34	23615471
CPR:4	CHEMICAL	GENE-Y	2	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T35	23615471
CPR:3	CHEMICAL	GENE-Y	2	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T6	T36	23615471
NA	CHEMICAL	GENE-N	15	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T19	23615471
NA	CHEMICAL	GENE-Y	15	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T20	23615471
NA	CHEMICAL	GENE-Y	15	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T21	23615471
NA	CHEMICAL	GENE-Y	15	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T22	23615471
NA	CHEMICAL	GENE-N	15	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T23	23615471
NA	CHEMICAL	GENE-Y	15	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T25	23615471
NA	CHEMICAL	GENE-Y	15	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T26	23615471
NA	CHEMICAL	GENE-Y	15	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T27	23615471
NA	CHEMICAL	GENE-N	15	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T30	23615471
NA	CHEMICAL	GENE-Y	15	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T32	23615471
NA	CHEMICAL	GENE-Y	15	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T34	23615471
NA	CHEMICAL	GENE-Y	15	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T35	23615471
NA	CHEMICAL	GENE-Y	15	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T7	T36	23615471
NA	CHEMICAL	GENE-N	16	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T19	23615471
NA	CHEMICAL	GENE-Y	16	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T20	23615471
NA	CHEMICAL	GENE-Y	16	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T21	23615471
NA	CHEMICAL	GENE-Y	16	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T22	23615471
NA	CHEMICAL	GENE-N	16	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T23	23615471
NA	CHEMICAL	GENE-Y	16	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T25	23615471
NA	CHEMICAL	GENE-Y	16	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T26	23615471
NA	CHEMICAL	GENE-Y	16	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T27	23615471
NA	CHEMICAL	GENE-N	16	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T30	23615471
NA	CHEMICAL	GENE-Y	16	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T32	23615471
NA	CHEMICAL	GENE-Y	16	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T34	23615471
NA	CHEMICAL	GENE-Y	16	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T35	23615471
NA	CHEMICAL	GENE-Y	16	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T8	T36	23615471
NA	CHEMICAL	GENE-N	28	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T19	23615471
NA	CHEMICAL	GENE-Y	28	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T20	23615471
NA	CHEMICAL	GENE-Y	28	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T21	23615471
NA	CHEMICAL	GENE-Y	28	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T22	23615471
NA	CHEMICAL	GENE-N	28	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T23	23615471
NA	CHEMICAL	GENE-Y	28	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T25	23615471
NA	CHEMICAL	GENE-Y	28	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T26	23615471
NA	CHEMICAL	GENE-Y	28	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T27	23615471
NA	CHEMICAL	GENE-N	28	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T30	23615471
NA	CHEMICAL	GENE-Y	28	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T32	23615471
NA	CHEMICAL	GENE-Y	28	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T34	23615471
NA	CHEMICAL	GENE-Y	28	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T35	23615471
NA	CHEMICAL	GENE-Y	28	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T9	T36	23615471
NA	CHEMICAL	GENE-N	31	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T19	23615471
NA	CHEMICAL	GENE-Y	31	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T20	23615471
NA	CHEMICAL	GENE-Y	31	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T21	23615471
NA	CHEMICAL	GENE-Y	31	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T22	23615471
NA	CHEMICAL	GENE-N	31	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T23	23615471
NA	CHEMICAL	GENE-Y	31	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T25	23615471
NA	CHEMICAL	GENE-Y	31	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T26	23615471
NA	CHEMICAL	GENE-Y	31	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T27	23615471
NA	CHEMICAL	GENE-N	31	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T30	23615471
NA	CHEMICAL	GENE-Y	31	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T32	23615471
NA	CHEMICAL	GENE-Y	31	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T34	23615471
NA	CHEMICAL	GENE-Y	31	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T35	23615471
NA	CHEMICAL	GENE-Y	31	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T10	T36	23615471
NA	CHEMICAL	GENE-N	36	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T19	23615471
NA	CHEMICAL	GENE-Y	36	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T20	23615471
NA	CHEMICAL	GENE-Y	36	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T21	23615471
NA	CHEMICAL	GENE-Y	36	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T22	23615471
NA	CHEMICAL	GENE-N	36	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T23	23615471
NA	CHEMICAL	GENE-Y	36	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T25	23615471
NA	CHEMICAL	GENE-Y	36	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T26	23615471
NA	CHEMICAL	GENE-Y	36	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T27	23615471
NA	CHEMICAL	GENE-N	36	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T30	23615471
NA	CHEMICAL	GENE-Y	36	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T32	23615471
NA	CHEMICAL	GENE-Y	36	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T34	23615471
NA	CHEMICAL	GENE-Y	36	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T35	23615471
NA	CHEMICAL	GENE-Y	36	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T11	T36	23615471
NA	CHEMICAL	GENE-N	41	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T19	23615471
NA	CHEMICAL	GENE-Y	41	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T20	23615471
NA	CHEMICAL	GENE-Y	41	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T21	23615471
NA	CHEMICAL	GENE-Y	41	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T22	23615471
NA	CHEMICAL	GENE-N	41	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T23	23615471
NA	CHEMICAL	GENE-Y	41	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T25	23615471
NA	CHEMICAL	GENE-Y	41	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T26	23615471
NA	CHEMICAL	GENE-Y	41	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T27	23615471
NA	CHEMICAL	GENE-N	41	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T30	23615471
NA	CHEMICAL	GENE-Y	41	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T32	23615471
NA	CHEMICAL	GENE-Y	41	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T34	23615471
NA	CHEMICAL	GENE-Y	41	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T35	23615471
NA	CHEMICAL	GENE-Y	41	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T12	T36	23615471
NA	CHEMICAL	GENE-N	37	7	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T19	23615471
NA	CHEMICAL	GENE-Y	37	9	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T20	23615471
NA	CHEMICAL	GENE-Y	37	11	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T21	23615471
NA	CHEMICAL	GENE-Y	37	13	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T22	23615471
NA	CHEMICAL	GENE-N	37	18	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T23	23615471
NA	CHEMICAL	GENE-Y	37	22	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T25	23615471
NA	CHEMICAL	GENE-Y	37	24	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T26	23615471
NA	CHEMICAL	GENE-Y	37	26	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T27	23615471
NA	CHEMICAL	GENE-N	37	34	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T30	23615471
NA	CHEMICAL	GENE-Y	37	39	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T32	23615471
NA	CHEMICAL	GENE-Y	37	44	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T34	23615471
NA	CHEMICAL	GENE-Y	37	47	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T35	23615471
NA	CHEMICAL	GENE-Y	37	54	Treatment with chemical decreased protein abundance of gene , gene , gene , gene , chemical-Akt chemical473 , gene Thr 308 , gene , gene , gene , chemical-FOXO1 Thr24 , chemical-FoxO3a Thr32 , gene , chemical-NF-κB chemical536 , gene , chemical-Rb Ser807/811 , gene , and gene , but increased cell cycle inhibitor gene .	T14	T36	23615471
NA	CHEMICAL	GENE-Y	13	2	Overexpression of gene or gene in TW2.6 cells rescued growth inhibition caused by chemical treatment .	T15	T37	23615471
NA	CHEMICAL	GENE-Y	13	4	Overexpression of gene or gene in TW2.6 cells rescued growth inhibition caused by chemical treatment .	T15	T38	23615471
NA	CHEMICAL	GENE-N	6	0	gene interactions modulate mutagenic bypass of a templating chemical lesion .	T22	T32	23267011
NA	CHEMICAL	GENE-Y	15	8	During base excision repair of this mispair , gene is confronted with gap filling opposite chemical .	T14	T27	23267011
NA	CHEMICAL	GENE-Y	6	3	To determine how gene discriminates between chemical , we introduced a point mutation ( gene ) to alter insertion specificity .	T16	T28	23267011
NA	CHEMICAL	GENE-N	6	14	To determine how gene discriminates between chemical , we introduced a point mutation ( gene ) to alter insertion specificity .	T16	T29	23267011
NA	CHEMICAL	GENE-N	12	3	Structural studies with gene gene show that the binary DNA complex has chemical in equilibrium between anti- and syn-forms .	T18	T30	23267011
NA	CHEMICAL	GENE-Y	12	4	Structural studies with gene gene show that the binary DNA complex has chemical in equilibrium between anti- and syn-forms .	T18	T31	23267011
NA	CHEMICAL	GENE-Y	4	4	In contrast to wild-type gene , the ternary complex of the gene mutant with an incoming chemical-analogue and templating chemical resembles a G-A mismatched structure with chemical adopting an anti-conformation .	T2	T23	23267011
NA	CHEMICAL	GENE-N	4	11	In contrast to wild-type gene , the ternary complex of the gene mutant with an incoming chemical-analogue and templating chemical resembles a G-A mismatched structure with chemical adopting an anti-conformation .	T2	T24	23267011
NA	CHEMICAL	GENE-Y	19	4	In contrast to wild-type gene , the ternary complex of the gene mutant with an incoming chemical-analogue and templating chemical resembles a G-A mismatched structure with chemical adopting an anti-conformation .	T3	T23	23267011
NA	CHEMICAL	GENE-N	19	11	In contrast to wild-type gene , the ternary complex of the gene mutant with an incoming chemical-analogue and templating chemical resembles a G-A mismatched structure with chemical adopting an anti-conformation .	T3	T24	23267011
NA	CHEMICAL	GENE-Y	26	4	In contrast to wild-type gene , the ternary complex of the gene mutant with an incoming chemical-analogue and templating chemical resembles a G-A mismatched structure with chemical adopting an anti-conformation .	T4	T23	23267011
NA	CHEMICAL	GENE-N	26	11	In contrast to wild-type gene , the ternary complex of the gene mutant with an incoming chemical-analogue and templating chemical resembles a G-A mismatched structure with chemical adopting an anti-conformation .	T4	T24	23267011
NA	CHEMICAL	GENE-N	3	5	Chronic effect of chemical on gene .	T17	T27	1665782
NA	CHEMICAL	GENE-N	9	10	In previous studies , we have demonstrated that chronic chemical or chemical ( chemical ) treatment of rats results in the reduction of gene binding activities as tolerance develops .	T10	T20	1665782
NA	CHEMICAL	GENE-N	3	10	In previous studies , we have demonstrated that chronic chemical or chemical ( chemical ) treatment of rats results in the reduction of gene binding activities as tolerance develops .	T13	T20	1665782
NA	CHEMICAL	GENE-N	13	10	In previous studies , we have demonstrated that chronic chemical or chemical ( chemical ) treatment of rats results in the reduction of gene binding activities as tolerance develops .	T16	T20	1665782
NA	CHEMICAL	GENE-N	2	14	As both chemical and chemical are relatively non-specific opioid ligands , interacting with both gene , these studies could not determine whether down-regulation of a specific receptor type occurs .	T7	T24	1665782
NA	CHEMICAL	GENE-N	4	14	As both chemical and chemical are relatively non-specific opioid ligands , interacting with both gene , these studies could not determine whether down-regulation of a specific receptor type occurs .	T8	T24	1665782
CPR:5	CHEMICAL	GENE-Y	1	11	Therefore , in the present studies , animals were rendered tolerant to the gene-selective agonist chemical ( chemical ) , and receptor binding activities were measured .	T9	T25	1665782
CPR:5	CHEMICAL	GENE-Y	17	11	Therefore , in the present studies , animals were rendered tolerant to the gene-selective agonist chemical ( chemical ) , and receptor binding activities were measured .	T11	T25	1665782
NA	CHEMICAL	GENE-Y	7	1	When gene binding was determined by using chemical , a 40-50 % decrease in binding in the midbrain and cortex , and 25-35 % decrease in binding in the striatum were observed after 3 or 4 days of chemical treatment .	T15	T26	1665782
NA	CHEMICAL	GENE-Y	7	1	When gene binding was determined by using chemical , a 40-50 % decrease in binding in the midbrain and cortex , and 25-35 % decrease in binding in the striatum were observed after 3 or 4 days of chemical treatment .	T1	T26	1665782
NA	CHEMICAL	GENE-Y	11	5	To our surprise , when gene binding was determined by using chemical ( chemical ) , a 10-15 % decrease in binding was also observed in the midbrain and cortex after 4 days of chemical treatment .	T3	T18	1665782
NA	CHEMICAL	GENE-Y	13	5	To our surprise , when gene binding was determined by using chemical ( chemical ) , a 10-15 % decrease in binding was also observed in the midbrain and cortex after 4 days of chemical treatment .	T4	T18	1665782
NA	CHEMICAL	GENE-Y	34	5	To our surprise , when gene binding was determined by using chemical ( chemical ) , a 10-15 % decrease in binding was also observed in the midbrain and cortex after 4 days of chemical treatment .	T5	T18	1665782
CPR:4	CHEMICAL	GENE-Y	5	9	Our conclusion is that chronic chemical treatment preferentially reduces gene binding activity .	T6	T19	1665782
NA	CHEMICAL	GENE-N	4	3	Enzyme activities such as chemical dismutase , chemical , gene and lipid peroxidation were also determined in the stomach tissues .	T16	T23	23608239
NA	CHEMICAL	GENE-Y	4	3	Enzyme activities such as chemical dismutase , chemical , gene and lipid peroxidation were also determined in the stomach tissues .	T16	T24	23608239
NA	CHEMICAL	GENE-N	7	3	Enzyme activities such as chemical dismutase , chemical , gene and lipid peroxidation were also determined in the stomach tissues .	T17	T23	23608239
NA	CHEMICAL	GENE-Y	7	3	Enzyme activities such as chemical dismutase , chemical , gene and lipid peroxidation were also determined in the stomach tissues .	T17	T24	23608239
NA	CHEMICAL	GENE-N	14	10	Consequently significant changes were observed in enzyme activities such as gene , gene , chemical and LPO in the stomach tissues when compared with chemical control group .	T7	T21	23608239
NA	CHEMICAL	GENE-Y	14	12	Consequently significant changes were observed in enzyme activities such as gene , gene , chemical and LPO in the stomach tissues when compared with chemical control group .	T7	T22	23608239
NA	CHEMICAL	GENE-N	24	10	Consequently significant changes were observed in enzyme activities such as gene , gene , chemical and LPO in the stomach tissues when compared with chemical control group .	T8	T21	23608239
NA	CHEMICAL	GENE-Y	24	12	Consequently significant changes were observed in enzyme activities such as gene , gene , chemical and LPO in the stomach tissues when compared with chemical control group .	T8	T22	23608239
NA	CHEMICAL	GENE-Y	3	4	Aberrant regulation of chemical synthetase by gene in human epithelial ovarian cancer .	T9	T28	17354225
NA	CHEMICAL	GENE-Y	3	6	Aberrant regulation of chemical synthetase by gene in human epithelial ovarian cancer .	T9	T29	17354225
NA	CHEMICAL	GENE-Y	12	5	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T6	T19	17354225
NA	CHEMICAL	GENE-Y	12	17	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T6	T20	17354225
NA	CHEMICAL	GENE-Y	12	19	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T6	T21	17354225
NA	CHEMICAL	GENE-Y	12	5	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T7	T19	17354225
NA	CHEMICAL	GENE-Y	12	17	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T7	T20	17354225
NA	CHEMICAL	GENE-Y	12	19	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T7	T21	17354225
NA	CHEMICAL	GENE-Y	12	5	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T8	T19	17354225
NA	CHEMICAL	GENE-Y	12	17	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T8	T20	17354225
NA	CHEMICAL	GENE-Y	12	19	Here , we show that gene also induces expression of arate-limiting enzyme in chemical synthesis , chemical synthetase ( gene ) , thereby linking inflammation with several chemical-dependent metabolic pathways , implicated in accelerated carcinogenesis and tumour progression .	T8	T21	17354225
NA	CHEMICAL	GENE-Y	8	2	Blockade of gene- and desensitization of gene reduce chemical-induced cardiac fibrosis .	T11	T20	14757145
NA	CHEMICAL	GENE-Y	8	6	Blockade of gene- and desensitization of gene reduce chemical-induced cardiac fibrosis .	T11	T21	14757145
NA	CHEMICAL	GENE-N	13	7	The aim of the present study was to analyse the role of gene in the chemical-induced myocardial remodeling , especially the interstitial fibrosis .	T10	T17	14757145
CPR:6	CHEMICAL	GENE-Y	11	2	Rats received a concomitant treatment with the selective gene antagonist , chemical ( 50 mg/kg/day p.o . )	T3	T14	14757145
CPR:5	CHEMICAL	GENE-Y	9	0	or were chronically pretreated with the selective gene agonist chemical ( 40 microg/kg/h ) for 1 week to induce gene desensitization .	T4	T15	14757145
NA	CHEMICAL	GENE-Y	9	0	or were chronically pretreated with the selective gene agonist chemical ( 40 microg/kg/h ) for 1 week to induce gene desensitization .	T4	T16	14757145
CPR:4	CHEMICAL	GENE-Y	3	5	The pretreatment with chemical induced a 59 % down-regulation of left ventricular gene compared to control .	T5	T18	14757145
NA	CHEMICAL	GENE-N	2	3	Conversion of chemical synthase into a more active enzyme by linking the two subunits : spectroscopic and kinetic properties .	T12	T27	15840827
NA	CHEMICAL	GENE-N	6	7	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T6	T19	15840827
NA	CHEMICAL	GENE-N	6	9	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T6	T23	15840827
NA	CHEMICAL	GENE-N	12	7	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T7	T19	15840827
NA	CHEMICAL	GENE-N	12	9	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T7	T23	15840827
NA	CHEMICAL	GENE-N	15	7	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T10	T19	15840827
NA	CHEMICAL	GENE-N	15	9	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T10	T23	15840827
NA	CHEMICAL	GENE-N	12	7	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T5	T19	15840827
NA	CHEMICAL	GENE-N	12	9	The two active sites of dimeric chemical synthase ( gene ) , a chemical ( chemical ) -dependent enzyme , are located on the subunit interface with contribution of essential chemical from each subunit .	T5	T23	15840827
NA	CHEMICAL	GENE-N	10	25	Transient kinetic analysis of the formation and decay of the chemical intermediate EQ ( 2 ) indicated that , although their rates were similar in gene and gene , accumulation of this intermediate was greater in the gene-catalyzed reaction .	T3	T13	15840827
NA	CHEMICAL	GENE-N	10	14	Transient kinetic analysis of the formation and decay of the chemical intermediate EQ ( 2 ) indicated that , although their rates were similar in gene and gene , accumulation of this intermediate was greater in the gene-catalyzed reaction .	T3	T14	15840827
NA	CHEMICAL	GENE-N	10	14	Transient kinetic analysis of the formation and decay of the chemical intermediate EQ ( 2 ) indicated that , although their rates were similar in gene and gene , accumulation of this intermediate was greater in the gene-catalyzed reaction .	T3	T15	15840827
CPR:3	CHEMICAL	GENE-N	0	10	chemical increased the number and area of chemical chemical-transferase placental form ( gene ) ( + ) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections .	T8	T26	23318833
CPR:3	CHEMICAL	GENE-N	0	12	chemical increased the number and area of chemical chemical-transferase placental form ( gene ) ( + ) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections .	T8	T27	23318833
NA	CHEMICAL	GENE-N	7	10	chemical increased the number and area of chemical chemical-transferase placental form ( gene ) ( + ) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections .	T9	T26	23318833
NA	CHEMICAL	GENE-N	7	12	chemical increased the number and area of chemical chemical-transferase placental form ( gene ) ( + ) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections .	T9	T27	23318833
NA	CHEMICAL	GENE-N	8	10	chemical increased the number and area of chemical chemical-transferase placental form ( gene ) ( + ) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections .	T10	T26	23318833
NA	CHEMICAL	GENE-N	8	12	chemical increased the number and area of chemical chemical-transferase placental form ( gene ) ( + ) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections .	T10	T27	23318833
CPR:4	CHEMICAL	GENE-Y	0	11	chemical also increased the numbers of ED2 ( + ) , gene ( + ) , and chemical oxygenase-1 ( + ) liver cells , as well as the number of gene ( + ) lymphocytes .	T12	T28	23318833
CPR:4	CHEMICAL	GENE-Y	0	18	chemical also increased the numbers of ED2 ( + ) , gene ( + ) , and chemical oxygenase-1 ( + ) liver cells , as well as the number of gene ( + ) lymphocytes .	T12	T29	23318833
CPR:4	CHEMICAL	GENE-N	0	31	chemical also increased the numbers of ED2 ( + ) , gene ( + ) , and chemical oxygenase-1 ( + ) liver cells , as well as the number of gene ( + ) lymphocytes .	T12	T30	23318833
NA	CHEMICAL	GENE-Y	17	11	chemical also increased the numbers of ED2 ( + ) , gene ( + ) , and chemical oxygenase-1 ( + ) liver cells , as well as the number of gene ( + ) lymphocytes .	T13	T28	23318833
NA	CHEMICAL	GENE-Y	17	18	chemical also increased the numbers of ED2 ( + ) , gene ( + ) , and chemical oxygenase-1 ( + ) liver cells , as well as the number of gene ( + ) lymphocytes .	T13	T29	23318833
NA	CHEMICAL	GENE-N	17	31	chemical also increased the numbers of ED2 ( + ) , gene ( + ) , and chemical oxygenase-1 ( + ) liver cells , as well as the number of gene ( + ) lymphocytes .	T13	T30	23318833
NA	CHEMICAL	GENE-Y	5	18	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T14	T17	23318833
NA	CHEMICAL	GENE-Y	5	20	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T14	T18	23318833
NA	CHEMICAL	GENE-N	5	33	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T14	T19	23318833
NA	CHEMICAL	GENE-Y	5	18	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T1	T17	23318833
NA	CHEMICAL	GENE-Y	5	20	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T1	T18	23318833
NA	CHEMICAL	GENE-N	5	33	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T1	T19	23318833
NA	CHEMICAL	GENE-Y	27	18	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T2	T17	23318833
NA	CHEMICAL	GENE-Y	27	20	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T2	T18	23318833
NA	CHEMICAL	GENE-N	27	33	EMIQ increased liver levels of chemical-reactive substance and chemical , and TUNEL ( + ) apoptotic cells , gene ( gene ) ( + ) cells and chemical ( + ) cells within gene ( + ) foci .	T2	T19	23318833
CPR:4	CHEMICAL	GENE-Y	0	6	chemical is a small-molecule inhibitor of gene and gene and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate- or high-risk myelofibrosis .	T1	T13	23307549
CPR:4	CHEMICAL	GENE-Y	0	8	chemical is a small-molecule inhibitor of gene and gene and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate- or high-risk myelofibrosis .	T1	T14	23307549
NA	CHEMICAL	GENE-Y	2	3	Regulation of chemical transporter abundance by chemical and chemical in vivo .	T13	T31	12137927
NA	CHEMICAL	GENE-Y	6	3	Regulation of chemical transporter abundance by chemical and chemical in vivo .	T14	T31	12137927
NA	CHEMICAL	GENE-Y	8	3	Regulation of chemical transporter abundance by chemical and chemical in vivo .	T15	T31	12137927
NA	CHEMICAL	GENE-Y	1	2	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T5	T22	12137927
NA	CHEMICAL	GENE-Y	1	4	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T5	T20	12137927
NA	CHEMICAL	GENE-N	1	7	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T5	T24	12137927
NA	CHEMICAL	GENE-Y	15	2	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T1	T22	12137927
NA	CHEMICAL	GENE-Y	15	4	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T1	T20	12137927
NA	CHEMICAL	GENE-N	15	7	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T1	T24	12137927
NA	CHEMICAL	GENE-Y	4	2	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T2	T22	12137927
NA	CHEMICAL	GENE-Y	4	4	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T2	T20	12137927
NA	CHEMICAL	GENE-N	4	7	The chemical transporter ( gene ) regulates gene signaling by controlling the availability of synaptic chemical ( chemical ) , and it is a direct target for some classes of antidepressant drugs .	T2	T24	12137927
NA	CHEMICAL	GENE-Y	14	0	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T3	T16	12137927
NA	CHEMICAL	GENE-Y	14	5	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T3	T17	12137927
NA	CHEMICAL	GENE-Y	14	8	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T3	T18	12137927
NA	CHEMICAL	GENE-Y	14	19	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T3	T19	12137927
NA	CHEMICAL	GENE-Y	24	0	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T4	T16	12137927
NA	CHEMICAL	GENE-Y	24	5	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T4	T17	12137927
NA	CHEMICAL	GENE-Y	24	8	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T4	T18	12137927
NA	CHEMICAL	GENE-Y	24	19	gene levels are normal in gene knockout ( gene -/- ) mice that lack chemical , demonstrating that the gene does not require endogenous chemical for appropriate regulation under physiological conditions .	T4	T19	12137927
NA	CHEMICAL	GENE-Y	13	3	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T6	T21	12137927
NA	CHEMICAL	GENE-Y	13	6	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T6	T23	12137927
NA	CHEMICAL	GENE-Y	13	23	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T6	T25	12137927
NA	CHEMICAL	GENE-Y	15	3	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T7	T21	12137927
NA	CHEMICAL	GENE-Y	15	6	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T7	T23	12137927
NA	CHEMICAL	GENE-Y	15	23	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T7	T25	12137927
NA	CHEMICAL	GENE-Y	17	3	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T8	T21	12137927
NA	CHEMICAL	GENE-Y	17	6	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T8	T23	12137927
NA	CHEMICAL	GENE-Y	17	23	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T8	T25	12137927
NA	CHEMICAL	GENE-Y	31	3	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T9	T21	12137927
NA	CHEMICAL	GENE-Y	31	6	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T9	T23	12137927
NA	CHEMICAL	GENE-Y	31	23	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T9	T25	12137927
NA	CHEMICAL	GENE-Y	38	3	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T10	T21	12137927
NA	CHEMICAL	GENE-Y	38	6	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T10	T23	12137927
NA	CHEMICAL	GENE-Y	38	23	In contrast , gene knockout ( gene -/- ) mice that lack both chemical and chemical ( chemical ) have reduced levels of gene , suggesting that it is down-regulated by a complete absence of chemical and not chemical per se .	T10	T25	12137927
CPR:4	CHEMICAL	GENE-Y	7	4	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T11	T26	12137927
CPR:4	CHEMICAL	GENE-Y	7	13	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T11	T27	12137927
NA	CHEMICAL	GENE-Y	7	19	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T11	T28	12137927
NA	CHEMICAL	GENE-Y	7	33	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T11	T29	12137927
NA	CHEMICAL	GENE-Y	25	4	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T12	T26	12137927
NA	CHEMICAL	GENE-Y	25	13	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T12	T27	12137927
NA	CHEMICAL	GENE-Y	25	19	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T12	T28	12137927
NA	CHEMICAL	GENE-Y	25	33	Chronic treatment with the gene inhibitor , chemical ( DMI ) , reduced gene levels in both control and gene -/- mice , demonstrating that chemical is not required for the regulation of gene by antidepressant drugs .	T12	T29	12137927
NA	CHEMICAL	GENE-Y	0	5	A combination strategy to inhibit gene : synergism between noncompetitive and chemical-competitive inhibitors .	T13	T21	23436791
NA	CHEMICAL	GENE-Y	3	0	gene is a chemical/chemical kinase critically involved in the initiation and progression of various types of cancer , especially leukemia , lymphomas and solid tumors such as prostate , pancreas and colon , and is considered a potential drug target against these malignancies .	T3	T14	23436791
NA	CHEMICAL	GENE-N	3	2	gene is a chemical/chemical kinase critically involved in the initiation and progression of various types of cancer , especially leukemia , lymphomas and solid tumors such as prostate , pancreas and colon , and is considered a potential drug target against these malignancies .	T3	T15	23436791
NA	CHEMICAL	GENE-Y	3	0	gene is a chemical/chemical kinase critically involved in the initiation and progression of various types of cancer , especially leukemia , lymphomas and solid tumors such as prostate , pancreas and colon , and is considered a potential drug target against these malignancies .	T5	T14	23436791
NA	CHEMICAL	GENE-N	3	2	gene is a chemical/chemical kinase critically involved in the initiation and progression of various types of cancer , especially leukemia , lymphomas and solid tumors such as prostate , pancreas and colon , and is considered a potential drug target against these malignancies .	T5	T15	23436791
NA	CHEMICAL	GENE-Y	13	7	In an effort to discover new potent gene inhibitors , a previously identified chemical-competitive chemical scaffold was expanded to derive structure-activity relationship data .	T6	T19	23436791
NA	CHEMICAL	GENE-Y	14	7	In an effort to discover new potent gene inhibitors , a previously identified chemical-competitive chemical scaffold was expanded to derive structure-activity relationship data .	T7	T19	23436791
NA	CHEMICAL	GENE-Y	0	28	A synergistic effect in the inhibition of cell proliferation by chemical-competitive and chemical-noncompetitive compounds was also observed in prostate cancer cell lines ( PC3 ) , where all gene inhibitors tested in showed synergism with the known anticancer agent , chemical .	T1	T16	23436791
NA	CHEMICAL	GENE-Y	0	28	A synergistic effect in the inhibition of cell proliferation by chemical-competitive and chemical-noncompetitive compounds was also observed in prostate cancer cell lines ( PC3 ) , where all gene inhibitors tested in showed synergism with the known anticancer agent , chemical .	T2	T16	23436791
NA	CHEMICAL	GENE-Y	40	28	A synergistic effect in the inhibition of cell proliferation by chemical-competitive and chemical-noncompetitive compounds was also observed in prostate cancer cell lines ( PC3 ) , where all gene inhibitors tested in showed synergism with the known anticancer agent , chemical .	T4	T16	23436791
CPR:4	CHEMICAL	GENE-N	0	4	chemical derived chemical as gene/gene inhibitors .	T7	T17	23416002
CPR:4	CHEMICAL	GENE-N	0	4	chemical derived chemical as gene/gene inhibitors .	T7	T18	23416002
CPR:4	CHEMICAL	GENE-N	2	4	chemical derived chemical as gene/gene inhibitors .	T8	T17	23416002
CPR:4	CHEMICAL	GENE-N	2	4	chemical derived chemical as gene/gene inhibitors .	T8	T18	23416002
CPR:4	CHEMICAL	GENE-N	10	6	SAR and lead optimization studies for gene inhibitors based on chemical-derived chemical are described .	T5	T13	23416002
CPR:4	CHEMICAL	GENE-N	11	6	SAR and lead optimization studies for gene inhibitors based on chemical-derived chemical are described .	T6	T13	23416002
NA	CHEMICAL	GENE-N	4	9	Studies demonstrated that these chemical derived chemical were mainly pan-gene inhibitors .	T1	T9	23416002
NA	CHEMICAL	GENE-N	6	9	Studies demonstrated that these chemical derived chemical were mainly pan-gene inhibitors .	T2	T9	23416002
CPR:4	CHEMICAL	GENE-N	8	4	This is distinct from gene inhibitors based on non-chemical derived chemical , where high selectivity against gene could be obtained .	T3	T12	23416002
CPR:4	CHEMICAL	GENE-N	8	16	This is distinct from gene inhibitors based on non-chemical derived chemical , where high selectivity against gene could be obtained .	T3	T14	23416002
CPR:4	CHEMICAL	GENE-N	7	4	This is distinct from gene inhibitors based on non-chemical derived chemical , where high selectivity against gene could be obtained .	T4	T12	23416002
CPR:4	CHEMICAL	GENE-N	7	16	This is distinct from gene inhibitors based on non-chemical derived chemical , where high selectivity against gene could be obtained .	T4	T14	23416002
NA	CHEMICAL	GENE-N	7	4	With the exception of gene , where chemical is a constituent of the chemical-cofactor , chemical is bound to a chemical , thus forming the chemical cofactor ( chemicalco ) which is the active compound at the catalytic site of all other Mo-enzymes .	T22	T47	16784786
NA	CHEMICAL	GENE-N	13	4	With the exception of gene , where chemical is a constituent of the chemical-cofactor , chemical is bound to a chemical , thus forming the chemical cofactor ( chemicalco ) which is the active compound at the catalytic site of all other Mo-enzymes .	T23	T47	16784786
NA	CHEMICAL	GENE-N	15	4	With the exception of gene , where chemical is a constituent of the chemical-cofactor , chemical is bound to a chemical , thus forming the chemical cofactor ( chemicalco ) which is the active compound at the catalytic site of all other Mo-enzymes .	T24	T47	16784786
NA	CHEMICAL	GENE-N	20	4	With the exception of gene , where chemical is a constituent of the chemical-cofactor , chemical is bound to a chemical , thus forming the chemical cofactor ( chemicalco ) which is the active compound at the catalytic site of all other Mo-enzymes .	T25	T47	16784786
NA	CHEMICAL	GENE-N	25	4	With the exception of gene , where chemical is a constituent of the chemical-cofactor , chemical is bound to a chemical , thus forming the chemical cofactor ( chemicalco ) which is the active compound at the catalytic site of all other Mo-enzymes .	T26	T47	16784786
NA	CHEMICAL	GENE-N	28	4	With the exception of gene , where chemical is a constituent of the chemical-cofactor , chemical is bound to a chemical , thus forming the chemical cofactor ( chemicalco ) which is the active compound at the catalytic site of all other Mo-enzymes .	T27	T47	16784786
NA	CHEMICAL	GENE-Y	6	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T28	T48	16784786
NA	CHEMICAL	GENE-Y	6	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T28	T49	16784786
NA	CHEMICAL	GENE-Y	6	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T28	T50	16784786
NA	CHEMICAL	GENE-N	6	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T28	T39	16784786
CPR:9	CHEMICAL	GENE-Y	22	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T29	T48	16784786
NA	CHEMICAL	GENE-Y	22	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T29	T49	16784786
NA	CHEMICAL	GENE-Y	22	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T29	T50	16784786
NA	CHEMICAL	GENE-N	22	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T29	T39	16784786
NA	CHEMICAL	GENE-Y	23	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T30	T48	16784786
NA	CHEMICAL	GENE-Y	23	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T30	T49	16784786
NA	CHEMICAL	GENE-Y	23	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T30	T50	16784786
NA	CHEMICAL	GENE-N	23	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T30	T39	16784786
NA	CHEMICAL	GENE-Y	30	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T31	T48	16784786
NA	CHEMICAL	GENE-Y	30	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T31	T49	16784786
NA	CHEMICAL	GENE-Y	30	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T31	T50	16784786
NA	CHEMICAL	GENE-N	30	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T31	T39	16784786
NA	CHEMICAL	GENE-Y	18	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T32	T48	16784786
NA	CHEMICAL	GENE-Y	18	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T32	T49	16784786
NA	CHEMICAL	GENE-Y	18	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T32	T50	16784786
NA	CHEMICAL	GENE-N	18	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T32	T39	16784786
NA	CHEMICAL	GENE-Y	18	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T33	T48	16784786
NA	CHEMICAL	GENE-Y	18	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T33	T49	16784786
NA	CHEMICAL	GENE-Y	18	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T33	T50	16784786
NA	CHEMICAL	GENE-N	18	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T33	T39	16784786
NA	CHEMICAL	GENE-Y	46	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T34	T48	16784786
NA	CHEMICAL	GENE-Y	46	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T34	T49	16784786
NA	CHEMICAL	GENE-Y	46	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T34	T50	16784786
NA	CHEMICAL	GENE-N	46	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T34	T39	16784786
NA	CHEMICAL	GENE-Y	52	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T35	T48	16784786
NA	CHEMICAL	GENE-Y	52	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T35	T49	16784786
NA	CHEMICAL	GENE-Y	52	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T35	T50	16784786
NA	CHEMICAL	GENE-N	52	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T35	T39	16784786
NA	CHEMICAL	GENE-Y	57	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T36	T48	16784786
NA	CHEMICAL	GENE-Y	57	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T36	T49	16784786
NA	CHEMICAL	GENE-Y	57	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T36	T50	16784786
NA	CHEMICAL	GENE-N	57	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T36	T39	16784786
NA	CHEMICAL	GENE-Y	57	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T37	T48	16784786
NA	CHEMICAL	GENE-Y	57	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T37	T49	16784786
NA	CHEMICAL	GENE-Y	57	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T37	T50	16784786
NA	CHEMICAL	GENE-N	57	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T37	T39	16784786
NA	CHEMICAL	GENE-Y	57	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T1	T48	16784786
NA	CHEMICAL	GENE-Y	57	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T1	T49	16784786
NA	CHEMICAL	GENE-Y	57	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T1	T50	16784786
NA	CHEMICAL	GENE-N	57	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T1	T39	16784786
NA	CHEMICAL	GENE-Y	6	11	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T2	T48	16784786
NA	CHEMICAL	GENE-Y	6	36	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T2	T49	16784786
NA	CHEMICAL	GENE-Y	6	53	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T2	T50	16784786
NA	CHEMICAL	GENE-N	6	57	In eukaryotes , the most prominent chemical-enzymes are ( 1 ) gene , which catalyzes the final step in the degradation of chemical-containing chemical and is involved in detoxifying excess chemical , ( 2 ) chemical dehydrogenase , which is involved in chemical catabolism and reactive chemical production , ( 3 ) chemical oxidase , which oxidizes a variety of chemical and is essential for the biosynthesis of the phytohormone chemical , and in autotrophic organisms also ( 4 ) chemical reductase , which catalyzes the key step in inorganic chemical assimilation .	T2	T39	16784786
NA	CHEMICAL	GENE-N	1	4	All chemical-enzymes , except gene , need at least one more redox active center , many of them involving chemical in electron transfer .	T3	T40	16784786
NA	CHEMICAL	GENE-N	4	4	All chemical-enzymes , except gene , need at least one more redox active center , many of them involving chemical in electron transfer .	T4	T40	16784786
NA	CHEMICAL	GENE-N	19	4	All chemical-enzymes , except gene , need at least one more redox active center , many of them involving chemical in electron transfer .	T5	T40	16784786
NA	CHEMICAL	GENE-Y	0	1	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T8	T41	16784786
NA	CHEMICAL	GENE-Y	0	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T8	T42	16784786
NA	CHEMICAL	GENE-Y	0	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T8	T43	16784786
NA	CHEMICAL	GENE-N	0	12	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T8	T44	16784786
NA	CHEMICAL	GENE-Y	3	1	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T9	T41	16784786
NA	CHEMICAL	GENE-Y	3	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T9	T42	16784786
NA	CHEMICAL	GENE-Y	3	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T9	T43	16784786
NA	CHEMICAL	GENE-N	3	12	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T9	T44	16784786
NA	CHEMICAL	GENE-Y	8	1	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T10	T41	16784786
NA	CHEMICAL	GENE-Y	8	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T10	T42	16784786
NA	CHEMICAL	GENE-Y	8	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T10	T43	16784786
NA	CHEMICAL	GENE-N	8	12	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T10	T44	16784786
NA	CHEMICAL	GENE-Y	11	1	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T11	T41	16784786
NA	CHEMICAL	GENE-Y	11	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T11	T42	16784786
NA	CHEMICAL	GENE-Y	11	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T11	T43	16784786
NA	CHEMICAL	GENE-N	11	12	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T11	T44	16784786
NA	CHEMICAL	GENE-Y	20	1	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T12	T41	16784786
NA	CHEMICAL	GENE-Y	20	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T12	T42	16784786
NA	CHEMICAL	GENE-Y	20	4	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T12	T43	16784786
NA	CHEMICAL	GENE-N	20	12	chemical dehydrogenase and chemical oxidase , but not chemical oxidase and chemical reductase , require the post-translational sulfuration of their chemical-site for becoming active .	T12	T44	16784786
NA	CHEMICAL	GENE-N	6	2	Refining the gene haplotype associated with chemical-induced hematological toxicity in metastatic colorectal cancer patients treated with chemical/chemical-based regimens .	T14	T26	23386248
NA	CHEMICAL	GENE-N	16	2	Refining the gene haplotype associated with chemical-induced hematological toxicity in metastatic colorectal cancer patients treated with chemical/chemical-based regimens .	T12	T26	23386248
NA	CHEMICAL	GENE-N	9	2	Refining the gene haplotype associated with chemical-induced hematological toxicity in metastatic colorectal cancer patients treated with chemical/chemical-based regimens .	T13	T26	23386248
NA	CHEMICAL	GENE-Y	5	15	Toxicological profiles of selected synthetic chemical showing high binding affinities to the chemical receptor subtype CB1 .	T15	T27	23494106
NA	CHEMICAL	GENE-Y	12	15	Toxicological profiles of selected synthetic chemical showing high binding affinities to the chemical receptor subtype CB1 .	T16	T27	23494106
NA	CHEMICAL	GENE-N	21	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T4	T26	23494106
NA	CHEMICAL	GENE-N	24	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T5	T26	23494106
NA	CHEMICAL	GENE-N	26	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T6	T26	23494106
NA	CHEMICAL	GENE-N	28	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T7	T26	23494106
NA	CHEMICAL	GENE-N	30	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T8	T26	23494106
NA	CHEMICAL	GENE-N	35	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T9	T26	23494106
NA	CHEMICAL	GENE-N	37	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T10	T26	23494106
NA	CHEMICAL	GENE-N	41	56	Because data concerning their toxicological properties are scarce , the cytotoxic , genotoxic , immunomodulatory , and hormonal activities of four chemical compounds ( chemical , chemical , chemical and chemical ) and of one chemical ( chemical ) were studied in human cell lines and primary cells ; chemical was included as the classical non-endogenous gene ligand .	T11	T26	23494106
NA	CHEMICAL	GENE-Y	10	22	Ex vivo samples of human oral mucosa were exposed to chemical or chemical , and immunohistochemical staining was performed to evaluate active gene , chemical ( chemical ) , and chemical ( chemical ) .	T12	T25	23318731
NA	CHEMICAL	GENE-Y	12	22	Ex vivo samples of human oral mucosa were exposed to chemical or chemical , and immunohistochemical staining was performed to evaluate active gene , chemical ( chemical ) , and chemical ( chemical ) .	T13	T25	23318731
NA	CHEMICAL	GENE-Y	24	22	Ex vivo samples of human oral mucosa were exposed to chemical or chemical , and immunohistochemical staining was performed to evaluate active gene , chemical ( chemical ) , and chemical ( chemical ) .	T15	T25	23318731
NA	CHEMICAL	GENE-Y	26	22	Ex vivo samples of human oral mucosa were exposed to chemical or chemical , and immunohistochemical staining was performed to evaluate active gene , chemical ( chemical ) , and chemical ( chemical ) .	T16	T25	23318731
NA	CHEMICAL	GENE-Y	30	22	Ex vivo samples of human oral mucosa were exposed to chemical or chemical , and immunohistochemical staining was performed to evaluate active gene , chemical ( chemical ) , and chemical ( chemical ) .	T17	T25	23318731
NA	CHEMICAL	GENE-Y	32	22	Ex vivo samples of human oral mucosa were exposed to chemical or chemical , and immunohistochemical staining was performed to evaluate active gene , chemical ( chemical ) , and chemical ( chemical ) .	T18	T25	23318731
CPR:3	CHEMICAL	GENE-Y	0	7	chemical and chemical treatments significantly increased active gene levels in a time-dependent manner .	T19	T26	23318731
CPR:3	CHEMICAL	GENE-Y	2	7	chemical and chemical treatments significantly increased active gene levels in a time-dependent manner .	T20	T26	23318731
CPR:4	CHEMICAL	GENE-N	0	9	chemical selectively inhibits conversion of chemical to chemical by gene : relevance to bipolar disorder .	T25	T36	16344985
CPR:9	CHEMICAL	GENE-N	5	9	chemical selectively inhibits conversion of chemical to chemical by gene : relevance to bipolar disorder .	T27	T36	16344985
CPR:9	CHEMICAL	GENE-N	7	9	chemical selectively inhibits conversion of chemical to chemical by gene : relevance to bipolar disorder .	T28	T36	16344985
CPR:4	CHEMICAL	GENE-N	10	9	RATIONALE : Several drugs used to treat bipolar disorder ( chemical and chemical ) , when administered chronically to rats , reduce the turnover of chemical , but not chemical , in brain phospholipids by decreasing the activity of an chemical-selective gene .	T16	T31	16344985
CPR:4	CHEMICAL	GENE-N	12	9	RATIONALE : Several drugs used to treat bipolar disorder ( chemical and chemical ) , when administered chronically to rats , reduce the turnover of chemical , but not chemical , in brain phospholipids by decreasing the activity of an chemical-selective gene .	T19	T31	16344985
NA	CHEMICAL	GENE-N	25	9	RATIONALE : Several drugs used to treat bipolar disorder ( chemical and chemical ) , when administered chronically to rats , reduce the turnover of chemical , but not chemical , in brain phospholipids by decreasing the activity of an chemical-selective gene .	T7	T31	16344985
NA	CHEMICAL	GENE-N	29	9	RATIONALE : Several drugs used to treat bipolar disorder ( chemical and chemical ) , when administered chronically to rats , reduce the turnover of chemical , but not chemical , in brain phospholipids by decreasing the activity of an chemical-selective gene .	T11	T31	16344985
NA	CHEMICAL	GENE-N	40	9	RATIONALE : Several drugs used to treat bipolar disorder ( chemical and chemical ) , when administered chronically to rats , reduce the turnover of chemical , but not chemical , in brain phospholipids by decreasing the activity of an chemical-selective gene .	T12	T31	16344985
NA	CHEMICAL	GENE-N	2	17	Although chronic chemical produces similar effects on brain chemical and chemical turnover , it does not alter gene activity , suggesting that it targets a different enzyme in the turnover pathway .	T13	T32	16344985
NA	CHEMICAL	GENE-N	8	17	Although chronic chemical produces similar effects on brain chemical and chemical turnover , it does not alter gene activity , suggesting that it targets a different enzyme in the turnover pathway .	T14	T32	16344985
NA	CHEMICAL	GENE-N	10	17	Although chronic chemical produces similar effects on brain chemical and chemical turnover , it does not alter gene activity , suggesting that it targets a different enzyme in the turnover pathway .	T15	T32	16344985
NA	CHEMICAL	GENE-N	18	6	MATERIALS AND METHODS/RESULTS : By isolating gene ( gene ) , we show in vitro that chemical is a non-competitive inhibitor of gene , as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme .	T17	T33	16344985
NA	CHEMICAL	GENE-N	18	8	MATERIALS AND METHODS/RESULTS : By isolating gene ( gene ) , we show in vitro that chemical is a non-competitive inhibitor of gene , as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme .	T17	T34	16344985
NA	CHEMICAL	GENE-N	18	22	MATERIALS AND METHODS/RESULTS : By isolating gene ( gene ) , we show in vitro that chemical is a non-competitive inhibitor of gene , as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme .	T17	T35	16344985
NA	CHEMICAL	GENE-N	16	6	MATERIALS AND METHODS/RESULTS : By isolating gene ( gene ) , we show in vitro that chemical is a non-competitive inhibitor of gene , as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme .	T18	T33	16344985
NA	CHEMICAL	GENE-N	16	8	MATERIALS AND METHODS/RESULTS : By isolating gene ( gene ) , we show in vitro that chemical is a non-competitive inhibitor of gene , as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme .	T18	T34	16344985
CPR:4	CHEMICAL	GENE-N	16	22	MATERIALS AND METHODS/RESULTS : By isolating gene ( gene ) , we show in vitro that chemical is a non-competitive inhibitor of gene , as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme .	T18	T35	16344985
NA	CHEMICAL	GENE-N	6	2	Furthermore , gene did not produce chemical .	T5	T29	16344985
CPR:4	CHEMICAL	GENE-N	6	13	CONCLUSIONS : This study shows that chemical acts as a non-competitive inhibitor of gene , and that inhibition is substrate-selective .	T6	T30	16344985
NA	CHEMICAL	GENE-Y	19	0	gene currents are about 15 times larger than gene currents , but both exhibit outward rectification in a physiological chemical gradient and mild inward rectification in symmetrical chemical conditions .	T3	T16	10887187
NA	CHEMICAL	GENE-Y	19	8	gene currents are about 15 times larger than gene currents , but both exhibit outward rectification in a physiological chemical gradient and mild inward rectification in symmetrical chemical conditions .	T3	T18	10887187
NA	CHEMICAL	GENE-Y	27	0	gene currents are about 15 times larger than gene currents , but both exhibit outward rectification in a physiological chemical gradient and mild inward rectification in symmetrical chemical conditions .	T4	T16	10887187
NA	CHEMICAL	GENE-Y	27	8	gene currents are about 15 times larger than gene currents , but both exhibit outward rectification in a physiological chemical gradient and mild inward rectification in symmetrical chemical conditions .	T4	T18	10887187
NA	CHEMICAL	GENE-Y	3	6	In a physiological chemical gradient , gene is half inhibited by 0.1 mm chemical , chemical , and chemical .	T6	T23	10887187
CPR:4	CHEMICAL	GENE-Y	1	6	In a physiological chemical gradient , gene is half inhibited by 0.1 mm chemical , chemical , and chemical .	T7	T23	10887187
CPR:4	CHEMICAL	GENE-Y	15	6	In a physiological chemical gradient , gene is half inhibited by 0.1 mm chemical , chemical , and chemical .	T8	T23	10887187
CPR:4	CHEMICAL	GENE-Y	18	6	In a physiological chemical gradient , gene is half inhibited by 0.1 mm chemical , chemical , and chemical .	T9	T23	10887187
NA	CHEMICAL	GENE-N	2	6	Finally , chemical 53 in the gene is required for functional expression of gene but is not critical for subunit self-assembly .	T10	T24	10887187
NA	CHEMICAL	GENE-Y	2	13	Finally , chemical 53 in the gene is required for functional expression of gene but is not critical for subunit self-assembly .	T10	T25	10887187
NA	CHEMICAL	GENE-Y	5	0	gene is the first reported gene that inactivates .	T1	T26	10887187
NA	CHEMICAL	GENE-Y	5	5	gene is the first reported gene that inactivates .	T1	T12	10887187
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T1	T14	11742712
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T1	T15	11742712
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T1	T16	11742712
CPR:4	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T6	T14	11742712
CPR:4	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T6	T15	11742712
CPR:4	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T6	T16	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T11	T14	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T11	T15	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T11	T16	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T2	T14	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T2	T15	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T2	T16	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T3	T14	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T3	T15	11742712
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T3	T16	11742712
NA	CHEMICAL	GENE-Y	23	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T4	T14	11742712
NA	CHEMICAL	GENE-Y	23	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T4	T15	11742712
NA	CHEMICAL	GENE-Y	23	5	chemical ( chemical ) is a novel antimetabolite that inhibits at least three chemical-dependent enzymes , chemical synthase , chemical reductase , and chemical formyltransferase .	T4	T16	11742712
NA	CHEMICAL	GENE-Y	4	0	gene is a lysosomal chemical protease whose biological function remains poorly defined .	T1	T2	23215039
NA	CHEMICAL	GENE-N	4	2	gene is a lysosomal chemical protease whose biological function remains poorly defined .	T1	T3	23215039
NA	CHEMICAL	GENE-Y	7	0	gene displays species-dependent stereoselectivity for isomers of methamphetchemical , chemical , and chemical .	T34	T54	17218486
NA	CHEMICAL	GENE-Y	9	0	gene displays species-dependent stereoselectivity for isomers of methamphetchemical , chemical , and chemical .	T32	T54	17218486
NA	CHEMICAL	GENE-Y	12	0	gene displays species-dependent stereoselectivity for isomers of methamphetchemical , chemical , and chemical .	T33	T54	17218486
NA	CHEMICAL	GENE-Y	6	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T11	T47	17218486
NA	CHEMICAL	GENE-Y	6	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T11	T48	17218486
NA	CHEMICAL	GENE-Y	8	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T12	T47	17218486
NA	CHEMICAL	GENE-Y	8	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T12	T48	17218486
NA	CHEMICAL	GENE-Y	10	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T13	T47	17218486
NA	CHEMICAL	GENE-Y	10	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T13	T48	17218486
NA	CHEMICAL	GENE-Y	15	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T14	T47	17218486
NA	CHEMICAL	GENE-Y	15	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T14	T48	17218486
NA	CHEMICAL	GENE-Y	17	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T15	T47	17218486
NA	CHEMICAL	GENE-Y	17	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T15	T48	17218486
NA	CHEMICAL	GENE-Y	20	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T16	T47	17218486
NA	CHEMICAL	GENE-Y	20	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T16	T48	17218486
NA	CHEMICAL	GENE-Y	22	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T18	T47	17218486
NA	CHEMICAL	GENE-Y	22	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T18	T48	17218486
NA	CHEMICAL	GENE-Y	25	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T19	T47	17218486
NA	CHEMICAL	GENE-Y	25	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T19	T48	17218486
NA	CHEMICAL	GENE-Y	27	37	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T21	T47	17218486
NA	CHEMICAL	GENE-Y	27	39	Recently , it was reported that chemical , chemical , chemical , and the TAs chemical ( chemical ) and chemical ( chemical ) stimulate chemical production in human embryonic kidney ( HEK ) -293 cells expressing gene ( gene ) .	T21	T48	17218486
CPR:3	CHEMICAL	GENE-Y	3	8	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T22	T49	17218486
NA	CHEMICAL	GENE-Y	3	20	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T22	T50	17218486
NA	CHEMICAL	GENE-Y	3	22	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T22	T51	17218486
NA	CHEMICAL	GENE-Y	3	29	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T22	T52	17218486
CPR:3	CHEMICAL	GENE-Y	5	8	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T23	T49	17218486
NA	CHEMICAL	GENE-Y	5	20	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T23	T50	17218486
NA	CHEMICAL	GENE-Y	5	22	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T23	T51	17218486
NA	CHEMICAL	GENE-Y	5	29	The discovery that chemical and chemical activate the gene motivated us to study the effect of these drugs on the gene ( gene ) and a human-rat chimera ( gene ) .	T23	T52	17218486
CPR:3	CHEMICAL	GENE-Y	9	38	Furthermore , because S- ( + ) -isomers of chemical and chemical are reported to be more potent and efficacious in vivo than R- ( - ) , we determined the enantiomeric selectivity of all three species of gene .	T25	T53	17218486
CPR:3	CHEMICAL	GENE-Y	11	38	Furthermore , because S- ( + ) -isomers of chemical and chemical are reported to be more potent and efficacious in vivo than R- ( - ) , we determined the enantiomeric selectivity of all three species of gene .	T26	T53	17218486
NA	CHEMICAL	GENE-Y	3	23	In response to chemical , chemical , or chemical exposure , the accumulation of chemical by HEK-293 cells stably expressing different species of gene was concentration- and isomer-dependent .	T28	T36	17218486
NA	CHEMICAL	GENE-Y	5	23	In response to chemical , chemical , or chemical exposure , the accumulation of chemical by HEK-293 cells stably expressing different species of gene was concentration- and isomer-dependent .	T29	T36	17218486
NA	CHEMICAL	GENE-Y	8	23	In response to chemical , chemical , or chemical exposure , the accumulation of chemical by HEK-293 cells stably expressing different species of gene was concentration- and isomer-dependent .	T30	T36	17218486
NA	CHEMICAL	GENE-Y	14	23	In response to chemical , chemical , or chemical exposure , the accumulation of chemical by HEK-293 cells stably expressing different species of gene was concentration- and isomer-dependent .	T31	T36	17218486
CPR:3	CHEMICAL	GENE-Y	3	13	EC50 values for chemical were 0.89 , 0.92 , and 4.44 microM for gene , gene , and gene , respectively .	T1	T37	17218486
CPR:3	CHEMICAL	GENE-Y	3	15	EC50 values for chemical were 0.89 , 0.92 , and 4.44 microM for gene , gene , and gene , respectively .	T1	T38	17218486
CPR:3	CHEMICAL	GENE-Y	3	18	EC50 values for chemical were 0.89 , 0.92 , and 4.44 microM for gene , gene , and gene , respectively .	T1	T39	17218486
CPR:5	CHEMICAL	GENE-Y	0	11	chemical was a potent and full agonist at each species of gene , whereas chemical was a full agonist for the gene but was a partial agonist at gene .	T3	T40	17218486
NA	CHEMICAL	GENE-Y	0	21	chemical was a potent and full agonist at each species of gene , whereas chemical was a full agonist for the gene but was a partial agonist at gene .	T3	T41	17218486
NA	CHEMICAL	GENE-Y	0	28	chemical was a potent and full agonist at each species of gene , whereas chemical was a full agonist for the gene but was a partial agonist at gene .	T3	T42	17218486
NA	CHEMICAL	GENE-Y	11	11	chemical was a potent and full agonist at each species of gene , whereas chemical was a full agonist for the gene but was a partial agonist at gene .	T4	T40	17218486
CPR:5	CHEMICAL	GENE-Y	11	21	chemical was a potent and full agonist at each species of gene , whereas chemical was a full agonist for the gene but was a partial agonist at gene .	T4	T41	17218486
CPR:5	CHEMICAL	GENE-Y	11	28	chemical was a potent and full agonist at each species of gene , whereas chemical was a full agonist for the gene but was a partial agonist at gene .	T4	T42	17218486
CPR:5	CHEMICAL	GENE-Y	5	10	Interestingly , both isomers of chemical were full agonists at gene and gene , whereas both were partial agonists at gene .	T5	T43	17218486
CPR:5	CHEMICAL	GENE-Y	5	12	Interestingly , both isomers of chemical were full agonists at gene and gene , whereas both were partial agonists at gene .	T5	T44	17218486
CPR:5	CHEMICAL	GENE-Y	5	20	Interestingly , both isomers of chemical were full agonists at gene and gene , whereas both were partial agonists at gene .	T5	T45	17218486
NA	CHEMICAL	GENE-N	10	11	The current report describes progress in development of a selective chemical receptor modulator , GC-1 .	T6	T12	15109613
NA	CHEMICAL	GENE-Y	11	28	Studies in rats , mice and monkeys show that GC-1 lowers chemical with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than chemical , a compound that blocks chemical reductase .	T2	T10	15109613
CPR:4	CHEMICAL	GENE-Y	1	28	Studies in rats , mice and monkeys show that GC-1 lowers chemical with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than chemical , a compound that blocks chemical reductase .	T3	T10	15109613
NA	CHEMICAL	GENE-Y	32	28	Studies in rats , mice and monkeys show that GC-1 lowers chemical with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than chemical , a compound that blocks chemical reductase .	T4	T10	15109613
CPR:9	CHEMICAL	GENE-Y	16	21	Mitochondria in the steroidogenic cells of the adrenal , gonad , placenta and brain contain the chemical side-chain cleavage enzyme , gene , and its two electron-transfer partners , gene and gene .	T4	T24	23628605
NA	CHEMICAL	GENE-N	16	29	Mitochondria in the steroidogenic cells of the adrenal , gonad , placenta and brain contain the chemical side-chain cleavage enzyme , gene , and its two electron-transfer partners , gene and gene .	T4	T25	23628605
NA	CHEMICAL	GENE-N	16	1	Mitochondria in the steroidogenic cells of the adrenal , gonad , placenta and brain contain the chemical side-chain cleavage enzyme , gene , and its two electron-transfer partners , gene and gene .	T4	T26	23628605
NA	CHEMICAL	GENE-Y	6	7	Several other steroidogenic enzymes , including chemical dehydrogenase , gene and chemical synthase also reside in mitochondria .	T8	T27	23628605
NA	CHEMICAL	GENE-Y	6	9	Several other steroidogenic enzymes , including chemical dehydrogenase , gene and chemical synthase also reside in mitochondria .	T8	T28	23628605
NA	CHEMICAL	GENE-Y	6	12	Several other steroidogenic enzymes , including chemical dehydrogenase , gene and chemical synthase also reside in mitochondria .	T8	T29	23628605
NA	CHEMICAL	GENE-Y	11	7	Several other steroidogenic enzymes , including chemical dehydrogenase , gene and chemical synthase also reside in mitochondria .	T9	T27	23628605
NA	CHEMICAL	GENE-Y	11	9	Several other steroidogenic enzymes , including chemical dehydrogenase , gene and chemical synthase also reside in mitochondria .	T9	T28	23628605
NA	CHEMICAL	GENE-Y	11	12	Several other steroidogenic enzymes , including chemical dehydrogenase , gene and chemical synthase also reside in mitochondria .	T9	T29	23628605
NA	CHEMICAL	GENE-Y	19	13	Similarly , the mitochondria of renal tubular cells contain two key enzymes participating in the activation and degradation of chemical . The access of chemical to the mitochondria is regulated by the gene , gene , serving as the acute regulator of steroidogenesis .	T10	T30	23628605
NA	CHEMICAL	GENE-Y	19	34	Similarly , the mitochondria of renal tubular cells contain two key enzymes participating in the activation and degradation of chemical . The access of chemical to the mitochondria is regulated by the gene , gene , serving as the acute regulator of steroidogenesis .	T10	T31	23628605
NA	CHEMICAL	GENE-Y	24	13	Similarly , the mitochondria of renal tubular cells contain two key enzymes participating in the activation and degradation of chemical . The access of chemical to the mitochondria is regulated by the gene , gene , serving as the acute regulator of steroidogenesis .	T11	T30	23628605
NA	CHEMICAL	GENE-Y	24	34	Similarly , the mitochondria of renal tubular cells contain two key enzymes participating in the activation and degradation of chemical . The access of chemical to the mitochondria is regulated by the gene , gene , serving as the acute regulator of steroidogenesis .	T11	T31	23628605
CPR:9	CHEMICAL	GENE-Y	10	15	The precise fashion in which these proteins interact and move chemical from the OMM to gene , and the means by which chemical is loaded into the OMM , remain unclear .	T1	T22	23628605
NA	CHEMICAL	GENE-Y	15	15	The precise fashion in which these proteins interact and move chemical from the OMM to gene , and the means by which chemical is loaded into the OMM , remain unclear .	T2	T22	23628605
NA	CHEMICAL	GENE-Y	3	4	Environmental stress , chemical receptor gene ( gene ) polymorphism , and mental health following collective stress .	T3	T8	23470776
NA	CHEMICAL	GENE-Y	3	7	Environmental stress , chemical receptor gene ( gene ) polymorphism , and mental health following collective stress .	T3	T9	23470776
NA	CHEMICAL	GENE-Y	4	5	We examined whether the chemical receptor gene ( gene ) single chemical polymorphism ( SNP ) rs53576 genotype buffers the combined impact of negative social environments ( e.g. , interpersonal conflict/constraint ) and economic stress on post-traumatic stress ( PTS ) symptoms and impaired daily functioning following collective stress ( September 11th terrorist attacks ) .	T1	T5	23470776
NA	CHEMICAL	GENE-Y	4	8	We examined whether the chemical receptor gene ( gene ) single chemical polymorphism ( SNP ) rs53576 genotype buffers the combined impact of negative social environments ( e.g. , interpersonal conflict/constraint ) and economic stress on post-traumatic stress ( PTS ) symptoms and impaired daily functioning following collective stress ( September 11th terrorist attacks ) .	T1	T6	23470776
NA	CHEMICAL	GENE-Y	11	5	We examined whether the chemical receptor gene ( gene ) single chemical polymorphism ( SNP ) rs53576 genotype buffers the combined impact of negative social environments ( e.g. , interpersonal conflict/constraint ) and economic stress on post-traumatic stress ( PTS ) symptoms and impaired daily functioning following collective stress ( September 11th terrorist attacks ) .	T2	T5	23470776
NA	CHEMICAL	GENE-Y	11	8	We examined whether the chemical receptor gene ( gene ) single chemical polymorphism ( SNP ) rs53576 genotype buffers the combined impact of negative social environments ( e.g. , interpersonal conflict/constraint ) and economic stress on post-traumatic stress ( PTS ) symptoms and impaired daily functioning following collective stress ( September 11th terrorist attacks ) .	T2	T6	23470776
NA	CHEMICAL	GENE-Y	0	4	chemical did not prevent or reverse that modulatory activity ; moreover , pretreatment with the acetylated peptide did not change the pA2 value displayed by the antagonist at the gene .	T17	T28	1318989
CPR:5	CHEMICAL	GENE-N	7	5	The antinociceptive activity of the gene agonist chemical was also increased in mice treated with alpha chemical beta-endorphin- ( 1-31 ) .	T18	T29	1318989
NA	CHEMICAL	GENE-N	16	5	The antinociceptive activity of the gene agonist chemical was also increased in mice treated with alpha chemical beta-endorphin- ( 1-31 ) .	T19	T29	1318989
NA	CHEMICAL	GENE-N	5	35	The reducing activity of alpha chemical beta-endorphin- ( 1-31 ) upon chemical- and beta-endorphin-induced analgesia was not exhibited in mice undergoing treatment with pertussis toxin or chemical , agents known to impair the function of gene/gene transducer proteins .	T20	T22	1318989
NA	CHEMICAL	GENE-N	5	35	The reducing activity of alpha chemical beta-endorphin- ( 1-31 ) upon chemical- and beta-endorphin-induced analgesia was not exhibited in mice undergoing treatment with pertussis toxin or chemical , agents known to impair the function of gene/gene transducer proteins .	T20	T23	1318989
NA	CHEMICAL	GENE-N	11	35	The reducing activity of alpha chemical beta-endorphin- ( 1-31 ) upon chemical- and beta-endorphin-induced analgesia was not exhibited in mice undergoing treatment with pertussis toxin or chemical , agents known to impair the function of gene/gene transducer proteins .	T1	T22	1318989
NA	CHEMICAL	GENE-N	11	35	The reducing activity of alpha chemical beta-endorphin- ( 1-31 ) upon chemical- and beta-endorphin-induced analgesia was not exhibited in mice undergoing treatment with pertussis toxin or chemical , agents known to impair the function of gene/gene transducer proteins .	T1	T23	1318989
NA	CHEMICAL	GENE-N	5	35	The reducing activity of alpha chemical beta-endorphin- ( 1-31 ) upon chemical- and beta-endorphin-induced analgesia was not exhibited in mice undergoing treatment with pertussis toxin or chemical , agents known to impair the function of gene/gene transducer proteins .	T2	T22	1318989
NA	CHEMICAL	GENE-N	5	35	The reducing activity of alpha chemical beta-endorphin- ( 1-31 ) upon chemical- and beta-endorphin-induced analgesia was not exhibited in mice undergoing treatment with pertussis toxin or chemical , agents known to impair the function of gene/gene transducer proteins .	T2	T23	1318989
NA	CHEMICAL	GENE-Y	9	20	These results confirm and strengthen the idea of alpha chemical beta-endorphin- ( 1-31 ) acting as a non-competitive regulator of gene- and gene-mediated supraspinal antinociception .	T6	T24	1318989
NA	CHEMICAL	GENE-N	9	16	These results confirm and strengthen the idea of alpha chemical beta-endorphin- ( 1-31 ) acting as a non-competitive regulator of gene- and gene-mediated supraspinal antinociception .	T6	T25	1318989
NA	CHEMICAL	GENE-N	9	18	Synovitis in horses is frequently treated by administration of non-chemical anti-inflammatory drugs ( NSAIDs ) , which inhibit gene isoforms ( gene and gene ) .	T10	T17	15563928
NA	CHEMICAL	GENE-Y	9	21	Synovitis in horses is frequently treated by administration of non-chemical anti-inflammatory drugs ( NSAIDs ) , which inhibit gene isoforms ( gene and gene ) .	T10	T18	15563928
NA	CHEMICAL	GENE-Y	9	23	Synovitis in horses is frequently treated by administration of non-chemical anti-inflammatory drugs ( NSAIDs ) , which inhibit gene isoforms ( gene and gene ) .	T10	T19	15563928
NA	CHEMICAL	GENE-Y	23	15	The objective of the present study was to compare the anti-inflammatory effects of the preferential gene inhibitor etodolac with the non-selective gene inhibitor chemical in horses with lipopolysaccharide ( LPS ) -induced synovitis .	T9	T24	15563928
CPR:4	CHEMICAL	GENE-N	23	21	The objective of the present study was to compare the anti-inflammatory effects of the preferential gene inhibitor etodolac with the non-selective gene inhibitor chemical in horses with lipopolysaccharide ( LPS ) -induced synovitis .	T9	T25	15563928
NA	CHEMICAL	GENE-Y	7	22	In addition , both drugs significantly reduced chemical levels ( P < 0.05 ) 6-h following LPS injection , whereas the probable gene chemical chemical was significantly reduced by chemical ( P < 0.05 ) , but not chemical .	T2	T16	15563928
NA	CHEMICAL	GENE-Y	23	22	In addition , both drugs significantly reduced chemical levels ( P < 0.05 ) 6-h following LPS injection , whereas the probable gene chemical chemical was significantly reduced by chemical ( P < 0.05 ) , but not chemical .	T3	T16	15563928
NA	CHEMICAL	GENE-Y	24	22	In addition , both drugs significantly reduced chemical levels ( P < 0.05 ) 6-h following LPS injection , whereas the probable gene chemical chemical was significantly reduced by chemical ( P < 0.05 ) , but not chemical .	T4	T16	15563928
CPR:4	CHEMICAL	GENE-Y	29	22	In addition , both drugs significantly reduced chemical levels ( P < 0.05 ) 6-h following LPS injection , whereas the probable gene chemical chemical was significantly reduced by chemical ( P < 0.05 ) , but not chemical .	T5	T16	15563928
NA	CHEMICAL	GENE-Y	38	22	In addition , both drugs significantly reduced chemical levels ( P < 0.05 ) 6-h following LPS injection , whereas the probable gene chemical chemical was significantly reduced by chemical ( P < 0.05 ) , but not chemical .	T6	T16	15563928
NA	CHEMICAL	GENE-Y	19	2	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T31	16268464
NA	CHEMICAL	GENE-N	19	2	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T32	16268464
NA	CHEMICAL	GENE-Y	19	8	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T33	16268464
NA	CHEMICAL	GENE-N	19	9	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T34	16268464
NA	CHEMICAL	GENE-N	19	11	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T35	16268464
NA	CHEMICAL	GENE-Y	19	13	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T36	16268464
NA	CHEMICAL	GENE-N	19	13	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T37	16268464
NA	CHEMICAL	GENE-N	19	15	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T38	16268464
NA	CHEMICAL	GENE-N	19	16	Association of genegene polymorphism ( but not of gene gene and gene , genegene , gene gene ) with chemical and coronary artery disease in the French population .	T12	T39	16268464
NA	CHEMICAL	GENE-Y	0	1	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T1	T13	16268464
NA	CHEMICAL	GENE-Y	0	4	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T1	T27	16268464
NA	CHEMICAL	GENE-N	0	5	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T1	T28	16268464
NA	CHEMICAL	GENE-Y	12	1	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T11	T13	16268464
NA	CHEMICAL	GENE-Y	12	4	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T11	T27	16268464
NA	CHEMICAL	GENE-N	12	5	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T11	T28	16268464
NA	CHEMICAL	GENE-Y	16	1	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T3	T13	16268464
NA	CHEMICAL	GENE-Y	16	4	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T3	T27	16268464
NA	CHEMICAL	GENE-N	16	5	chemical reductase polymorphism ( gene gene ) is an established determinant of chemical plasma level ( t-chemical ) while its association with coronary artery disease ( CAD ) seems to be more limited .	T3	T28	16268464
NA	CHEMICAL	GENE-N	10	8	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T18	16268464
NA	CHEMICAL	GENE-Y	10	11	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T19	16268464
NA	CHEMICAL	GENE-Y	10	13	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T20	16268464
NA	CHEMICAL	GENE-N	10	16	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T21	16268464
NA	CHEMICAL	GENE-Y	10	19	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T22	16268464
NA	CHEMICAL	GENE-Y	10	21	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T23	16268464
NA	CHEMICAL	GENE-N	10	24	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T24	16268464
NA	CHEMICAL	GENE-N	10	26	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T25	16268464
NA	CHEMICAL	GENE-N	10	28	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T4	T26	16268464
NA	CHEMICAL	GENE-N	32	8	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T18	16268464
NA	CHEMICAL	GENE-Y	32	11	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T19	16268464
NA	CHEMICAL	GENE-Y	32	13	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T20	16268464
NA	CHEMICAL	GENE-N	32	16	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T21	16268464
NA	CHEMICAL	GENE-Y	32	19	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T22	16268464
NA	CHEMICAL	GENE-Y	32	21	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T23	16268464
NA	CHEMICAL	GENE-N	32	24	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T24	16268464
NA	CHEMICAL	GENE-N	32	26	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T25	16268464
NA	CHEMICAL	GENE-N	32	28	In contrast , the association of the substitutions gene of chemical synthase ( gene ) , gene of gene reductase ( gene ) and gene of gene ( gene ) to both t-chemical and CAD needs to be evaluated further .	T6	T26	16268464
NA	CHEMICAL	GENE-Y	0	24	t-chemical was higher in the CAD group than in controls ( 11.8 vs 10.4 microM , P < 0.0001 ) and in carriers of geneAA and gene 677TT than in those carrying the most frequent allele of both polymorphisms ( 13.8 vs 11.4 microM , P = 0.0102 and 12.5 vs 11.0 mM , P = 0.0065 respectively ) .	T10	T29	16268464
NA	CHEMICAL	GENE-Y	0	26	t-chemical was higher in the CAD group than in controls ( 11.8 vs 10.4 microM , P < 0.0001 ) and in carriers of geneAA and gene 677TT than in those carrying the most frequent allele of both polymorphisms ( 13.8 vs 11.4 microM , P = 0.0102 and 12.5 vs 11.0 mM , P = 0.0065 respectively ) .	T10	T30	16268464
NA	CHEMICAL	GENE-Y	4	8	In multivariate analysis , t-chemical > median and geneAA genotype were two significant independent predictors of CAD with respective odds ratios of 3.1 ( 95 % CI : 1.8-5.1 , P < 0.0001 ) and 4.5 ( 95 % CI : 1.5-13.1 , P = 0.0051 ) .	T2	T16	16268464
NA	CHEMICAL	GENE-N	0	2	chemical-mediated changes in adipose chemical metabolism are exaggerated , not diminished , in the absence of a functional gene .	T10	T30	23493372
NA	CHEMICAL	GENE-N	4	2	chemical-mediated changes in adipose chemical metabolism are exaggerated , not diminished , in the absence of a functional gene .	T11	T30	23493372
NA	CHEMICAL	GENE-Y	41	5	To understand the role of gene dimerization-dependent targets in multiple tissues , we measured metabolic fluxes through several disease-relevant GC target pathways using heavy water labeling and mass spectrometry in wild-type and gene ( dim/dim ) mice administered the potent GC chemical ( chemical ) .	T6	T26	23493372
NA	CHEMICAL	GENE-Y	41	32	To understand the role of gene dimerization-dependent targets in multiple tissues , we measured metabolic fluxes through several disease-relevant GC target pathways using heavy water labeling and mass spectrometry in wild-type and gene ( dim/dim ) mice administered the potent GC chemical ( chemical ) .	T6	T27	23493372
NA	CHEMICAL	GENE-Y	43	5	To understand the role of gene dimerization-dependent targets in multiple tissues , we measured metabolic fluxes through several disease-relevant GC target pathways using heavy water labeling and mass spectrometry in wild-type and gene ( dim/dim ) mice administered the potent GC chemical ( chemical ) .	T7	T26	23493372
NA	CHEMICAL	GENE-Y	43	32	To understand the role of gene dimerization-dependent targets in multiple tissues , we measured metabolic fluxes through several disease-relevant GC target pathways using heavy water labeling and mass spectrometry in wild-type and gene ( dim/dim ) mice administered the potent GC chemical ( chemical ) .	T7	T27	23493372
NA	CHEMICAL	GENE-Y	1	9	Absolute chemical synthesis was increased in both wild-type and gene ( dim/dim ) mice by chemical in the inguinal and epididymal fat depots .	T8	T28	23493372
NA	CHEMICAL	GENE-Y	15	9	Absolute chemical synthesis was increased in both wild-type and gene ( dim/dim ) mice by chemical in the inguinal and epididymal fat depots .	T9	T28	23493372
NA	CHEMICAL	GENE-Y	10	0	gene ( dim/dim ) mice showed an exaggerated response to chemical in both depots .	T1	T29	23493372
NA	CHEMICAL	GENE-Y	13	15	De novo lipogenesis was also greatly increased in both depots in response to chemical in gene ( dim/dim ) , but not wild-type mice .	T2	T12	23493372
NA	CHEMICAL	GENE-Y	7	21	In contrast , the inhibitory effect of chemical on bone and skin collagen synthesis rates was greater in wild-type compared with gene ( dim/dim ) mice .	T3	T13	23493372
NA	CHEMICAL	GENE-N	6	8	Wild-type mice were more sensitive to chemical-dependent decreases in gene sensitivity than gene ( dim/dim ) mice .	T4	T14	23493372
NA	CHEMICAL	GENE-Y	6	12	Wild-type mice were more sensitive to chemical-dependent decreases in gene sensitivity than gene ( dim/dim ) mice .	T4	T15	23493372
NA	CHEMICAL	GENE-Y	11	2	Wild-type and gene ( dim/dim ) mice were equally sensitive to chemical-dependent decreases in muscle protein synthesis .	T5	T16	23493372
NA	CHEMICAL	GENE-Y	0	2	gene , gene and gene ) and increased expression of gene ( gene ) .	T1	T5	10800083
NA	CHEMICAL	GENE-Y	0	4	gene , gene and gene ) and increased expression of gene ( gene ) .	T1	T6	10800083
NA	CHEMICAL	GENE-Y	0	10	gene , gene and gene ) and increased expression of gene ( gene ) .	T1	T7	10800083
NA	CHEMICAL	GENE-Y	0	12	gene , gene and gene ) and increased expression of gene ( gene ) .	T1	T8	10800083
CPR:4	CHEMICAL	GENE-N	0	4	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T15	23376356
CPR:4	CHEMICAL	GENE-N	0	4	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T16	23376356
CPR:3	CHEMICAL	GENE-N	0	10	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T17	23376356
CPR:3	CHEMICAL	GENE-N	0	11	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T18	23376356
CPR:3	CHEMICAL	GENE-N	0	2	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T19	23376356
CPR:3	CHEMICAL	GENE-Y	0	16	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T20	23376356
NA	CHEMICAL	GENE-N	0	23	chemical , a specific gene/gene inhibitor , selectively activated the gene gene gene pathway and enhanced gene phosphorylation , but did not activate gene .	T1	T21	23376356
CPR:4	CHEMICAL	GENE-N	3	5	The pharmacological inhibitors chemical ( gene inhibitor ) and chemical ( a gene inhibitor ) protected primary cultures of rat CGCs from chemical-induced apoptosis .	T2	T22	23376356
NA	CHEMICAL	GENE-N	3	12	The pharmacological inhibitors chemical ( gene inhibitor ) and chemical ( a gene inhibitor ) protected primary cultures of rat CGCs from chemical-induced apoptosis .	T2	T23	23376356
NA	CHEMICAL	GENE-N	9	5	The pharmacological inhibitors chemical ( gene inhibitor ) and chemical ( a gene inhibitor ) protected primary cultures of rat CGCs from chemical-induced apoptosis .	T3	T22	23376356
CPR:4	CHEMICAL	GENE-N	9	12	The pharmacological inhibitors chemical ( gene inhibitor ) and chemical ( a gene inhibitor ) protected primary cultures of rat CGCs from chemical-induced apoptosis .	T3	T23	23376356
NA	CHEMICAL	GENE-N	22	5	The pharmacological inhibitors chemical ( gene inhibitor ) and chemical ( a gene inhibitor ) protected primary cultures of rat CGCs from chemical-induced apoptosis .	T4	T22	23376356
NA	CHEMICAL	GENE-N	22	12	The pharmacological inhibitors chemical ( gene inhibitor ) and chemical ( a gene inhibitor ) protected primary cultures of rat CGCs from chemical-induced apoptosis .	T4	T23	23376356
NA	CHEMICAL	GENE-N	4	5	The discovery of fused chemical as gene modulators for treatment of Alzheimer 's disease .	T3	T6	23253441
NA	CHEMICAL	GENE-Y	8	10	Characterization of the mouse promoter region of the chemical synthetase 4 gene : role of gene and gene .	T5	T22	23376217
NA	CHEMICAL	GENE-Y	8	15	Characterization of the mouse promoter region of the chemical synthetase 4 gene : role of gene and gene .	T5	T23	23376217
NA	CHEMICAL	GENE-N	8	17	Characterization of the mouse promoter region of the chemical synthetase 4 gene : role of gene and gene .	T5	T24	23376217
NA	CHEMICAL	GENE-Y	0	2	chemical synthetase 4 ( gene ) is involved in several cellular functions including steroidogenesis , synaptic development and cancer metastasis .	T1	T6	23376217
NA	CHEMICAL	GENE-Y	0	2	chemical synthetase 4 ( gene ) is involved in several cellular functions including steroidogenesis , synaptic development and cancer metastasis .	T1	T9	23376217
NA	CHEMICAL	GENE-N	4	2	We demonstrated gene and chemical regulation of gene mRNA in mouse steroidogenic MA-10 Leydig cells .	T3	T10	23376217
NA	CHEMICAL	GENE-Y	4	7	We demonstrated gene and chemical regulation of gene mRNA in mouse steroidogenic MA-10 Leydig cells .	T3	T11	23376217
NA	CHEMICAL	GENE-Y	8	11	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T34	T77	18655903
NA	CHEMICAL	GENE-Y	8	13	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T34	T78	18655903
NA	CHEMICAL	GENE-Y	8	15	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T34	T79	18655903
NA	CHEMICAL	GENE-Y	8	18	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T34	T80	18655903
NA	CHEMICAL	GENE-Y	10	11	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T35	T77	18655903
NA	CHEMICAL	GENE-Y	10	13	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T35	T78	18655903
NA	CHEMICAL	GENE-Y	10	15	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T35	T79	18655903
NA	CHEMICAL	GENE-Y	10	18	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T35	T80	18655903
NA	CHEMICAL	GENE-Y	17	11	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T36	T77	18655903
NA	CHEMICAL	GENE-Y	17	13	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T36	T78	18655903
NA	CHEMICAL	GENE-Y	17	15	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T36	T79	18655903
NA	CHEMICAL	GENE-Y	17	18	Peptide and non-peptide agonists and antagonists for the chemical and chemical gene , gene , gene and chemical receptors : research tools and potential therapeutic agents .	T36	T80	18655903
NA	CHEMICAL	GENE-Y	21	0	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T37	18655903
NA	CHEMICAL	GENE-Y	21	2	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T38	18655903
NA	CHEMICAL	GENE-Y	21	5	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T59	18655903
NA	CHEMICAL	GENE-Y	21	7	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T68	18655903
NA	CHEMICAL	GENE-Y	21	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T43	18655903
NA	CHEMICAL	GENE-Y	21	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T53	18655903
NA	CHEMICAL	GENE-Y	21	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T57	18655903
NA	CHEMICAL	GENE-N	21	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T2	T67	18655903
NA	CHEMICAL	GENE-Y	44	0	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T37	18655903
NA	CHEMICAL	GENE-Y	44	2	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T38	18655903
NA	CHEMICAL	GENE-Y	44	5	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T59	18655903
NA	CHEMICAL	GENE-Y	44	7	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T68	18655903
NA	CHEMICAL	GENE-Y	44	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T43	18655903
NA	CHEMICAL	GENE-Y	44	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T53	18655903
NA	CHEMICAL	GENE-Y	44	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T57	18655903
NA	CHEMICAL	GENE-N	44	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T22	T67	18655903
NA	CHEMICAL	GENE-Y	27	0	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T37	18655903
NA	CHEMICAL	GENE-Y	27	2	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T38	18655903
NA	CHEMICAL	GENE-Y	27	5	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T59	18655903
NA	CHEMICAL	GENE-Y	27	7	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T68	18655903
NA	CHEMICAL	GENE-Y	27	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T43	18655903
NA	CHEMICAL	GENE-Y	27	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T53	18655903
NA	CHEMICAL	GENE-Y	27	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T57	18655903
NA	CHEMICAL	GENE-N	27	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T28	T67	18655903
NA	CHEMICAL	GENE-Y	0	0	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T37	18655903
NA	CHEMICAL	GENE-Y	0	2	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T38	18655903
NA	CHEMICAL	GENE-Y	0	5	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T59	18655903
NA	CHEMICAL	GENE-Y	0	7	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T68	18655903
NA	CHEMICAL	GENE-Y	0	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T43	18655903
NA	CHEMICAL	GENE-Y	0	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T53	18655903
NA	CHEMICAL	GENE-Y	0	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T57	18655903
NA	CHEMICAL	GENE-N	0	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T3	T67	18655903
NA	CHEMICAL	GENE-Y	7	0	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T37	18655903
NA	CHEMICAL	GENE-Y	7	2	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T38	18655903
NA	CHEMICAL	GENE-Y	7	5	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T59	18655903
NA	CHEMICAL	GENE-Y	7	7	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T68	18655903
NA	CHEMICAL	GENE-Y	7	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T43	18655903
NA	CHEMICAL	GENE-Y	7	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T53	18655903
NA	CHEMICAL	GENE-Y	7	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T57	18655903
NA	CHEMICAL	GENE-N	7	1	gene ( gene ) and gene ( gene ) mediate their biological actions by acting on four known receptors : The chemical ( uterine ) and the chemical gene ( vasopressor ) , gene ( pituitary ) , gene ( renal ) receptors and a fifth putative chemical gene ?	T6	T67	18655903
NA	CHEMICAL	GENE-Y	7	10	The pharmacological properties of promising new selective chemical antagonists and gene agonists are also presented .	T29	T70	18655903
NA	CHEMICAL	GENE-Y	3	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T7	T44	18655903
NA	CHEMICAL	GENE-Y	3	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T7	T45	18655903
NA	CHEMICAL	GENE-Y	3	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T7	T46	18655903
NA	CHEMICAL	GENE-Y	3	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T7	T50	18655903
NA	CHEMICAL	GENE-Y	3	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T7	T51	18655903
NA	CHEMICAL	GENE-Y	3	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T7	T52	18655903
NA	CHEMICAL	GENE-Y	9	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T8	T44	18655903
NA	CHEMICAL	GENE-Y	9	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T8	T45	18655903
NA	CHEMICAL	GENE-Y	9	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T8	T46	18655903
NA	CHEMICAL	GENE-Y	9	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T8	T50	18655903
NA	CHEMICAL	GENE-Y	9	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T8	T51	18655903
NA	CHEMICAL	GENE-Y	9	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T8	T52	18655903
NA	CHEMICAL	GENE-Y	26	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T9	T44	18655903
NA	CHEMICAL	GENE-Y	26	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T9	T45	18655903
NA	CHEMICAL	GENE-Y	26	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T9	T46	18655903
NA	CHEMICAL	GENE-Y	26	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T9	T50	18655903
NA	CHEMICAL	GENE-Y	26	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T9	T51	18655903
NA	CHEMICAL	GENE-Y	26	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T9	T52	18655903
NA	CHEMICAL	GENE-Y	29	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T10	T44	18655903
NA	CHEMICAL	GENE-Y	29	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T10	T45	18655903
NA	CHEMICAL	GENE-Y	29	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T10	T46	18655903
NA	CHEMICAL	GENE-Y	29	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T10	T50	18655903
NA	CHEMICAL	GENE-Y	29	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T10	T51	18655903
NA	CHEMICAL	GENE-Y	29	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T10	T52	18655903
NA	CHEMICAL	GENE-Y	2	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T11	T44	18655903
NA	CHEMICAL	GENE-Y	2	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T11	T45	18655903
NA	CHEMICAL	GENE-Y	2	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T11	T46	18655903
NA	CHEMICAL	GENE-Y	2	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T11	T50	18655903
NA	CHEMICAL	GENE-Y	2	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T11	T51	18655903
NA	CHEMICAL	GENE-Y	2	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T11	T52	18655903
NA	CHEMICAL	GENE-Y	31	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T13	T44	18655903
NA	CHEMICAL	GENE-Y	31	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T13	T45	18655903
NA	CHEMICAL	GENE-Y	31	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T13	T46	18655903
CPR:5	CHEMICAL	GENE-Y	31	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T13	T50	18655903
NA	CHEMICAL	GENE-Y	31	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T13	T51	18655903
NA	CHEMICAL	GENE-Y	31	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T13	T52	18655903
NA	CHEMICAL	GENE-Y	37	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T14	T44	18655903
NA	CHEMICAL	GENE-Y	37	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T14	T45	18655903
NA	CHEMICAL	GENE-Y	37	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T14	T46	18655903
NA	CHEMICAL	GENE-Y	37	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T14	T50	18655903
CPR:5	CHEMICAL	GENE-Y	37	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T14	T51	18655903
NA	CHEMICAL	GENE-Y	37	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T14	T52	18655903
NA	CHEMICAL	GENE-Y	43	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T15	T44	18655903
NA	CHEMICAL	GENE-Y	43	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T15	T45	18655903
NA	CHEMICAL	GENE-Y	43	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T15	T46	18655903
NA	CHEMICAL	GENE-Y	43	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T15	T50	18655903
NA	CHEMICAL	GENE-Y	43	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T15	T51	18655903
CPR:5	CHEMICAL	GENE-Y	43	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T15	T52	18655903
NA	CHEMICAL	GENE-Y	2	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T16	T44	18655903
NA	CHEMICAL	GENE-Y	2	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T16	T45	18655903
NA	CHEMICAL	GENE-Y	2	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T16	T46	18655903
NA	CHEMICAL	GENE-Y	2	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T16	T50	18655903
NA	CHEMICAL	GENE-Y	2	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T16	T51	18655903
NA	CHEMICAL	GENE-Y	2	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T16	T52	18655903
NA	CHEMICAL	GENE-Y	2	17	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T17	T44	18655903
NA	CHEMICAL	GENE-Y	2	19	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T17	T45	18655903
NA	CHEMICAL	GENE-Y	2	52	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T17	T46	18655903
NA	CHEMICAL	GENE-Y	2	10	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T17	T50	18655903
NA	CHEMICAL	GENE-Y	2	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T17	T51	18655903
NA	CHEMICAL	GENE-Y	2	6	In addition to chemical and to a lesser extent chemical ( pitressin ) , a number of gene and gene analogues ; such as chemical ( chemical agonist ) dDchemical ( chemical , gene agonist ) , chemical ( gene agonist ) , chemical ( gene agonist ) and chemical ( chemical gene antagonist ) are also in clinical use .	T17	T52	18655903
CPR:6	CHEMICAL	GENE-Y	1	7	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T19	T58	18655903
NA	CHEMICAL	GENE-Y	1	9	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T19	T60	18655903
NA	CHEMICAL	GENE-Y	1	1	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T19	T61	18655903
CPR:6	CHEMICAL	GENE-Y	1	7	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T20	T58	18655903
NA	CHEMICAL	GENE-Y	1	9	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T20	T60	18655903
NA	CHEMICAL	GENE-Y	1	1	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T20	T61	18655903
CPR:6	CHEMICAL	GENE-Y	1	7	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T21	T58	18655903
NA	CHEMICAL	GENE-Y	1	9	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T21	T60	18655903
NA	CHEMICAL	GENE-Y	1	1	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T21	T61	18655903
NA	CHEMICAL	GENE-Y	1	7	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T23	T58	18655903
CPR:6	CHEMICAL	GENE-Y	1	9	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T23	T60	18655903
CPR:6	CHEMICAL	GENE-Y	1	1	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T23	T61	18655903
NA	CHEMICAL	GENE-Y	1	7	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T24	T58	18655903
CPR:6	CHEMICAL	GENE-Y	1	9	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T24	T60	18655903
CPR:6	CHEMICAL	GENE-Y	1	1	While a number of orally active non-peptide gene antagonists ( Vaptans ) ; notably , chemical , chemical and chemical , are currently in Phase III clinical trials ; to date , only the mixed gene/gene , antagonist chemical ( chemical ) , has been approved by the US FDA for clinical use ( by i.v .	T24	T61	18655903
CPR:4	CHEMICAL	GENE-Y	14	3	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T2	T15	3146348
CPR:4	CHEMICAL	GENE-Y	14	5	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T2	T19	3146348
CPR:4	CHEMICAL	GENE-Y	14	14	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T2	T23	3146348
CPR:4	CHEMICAL	GENE-Y	14	16	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T2	T13	3146348
CPR:3	CHEMICAL	GENE-Y	30	3	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T3	T15	3146348
CPR:3	CHEMICAL	GENE-Y	30	5	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T3	T19	3146348
CPR:3	CHEMICAL	GENE-Y	30	14	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T3	T23	3146348
CPR:3	CHEMICAL	GENE-Y	30	16	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T3	T13	3146348
CPR:3	CHEMICAL	GENE-Y	32	3	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T4	T15	3146348
CPR:3	CHEMICAL	GENE-Y	32	5	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T4	T19	3146348
CPR:3	CHEMICAL	GENE-Y	32	14	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T4	T23	3146348
CPR:3	CHEMICAL	GENE-Y	32	16	The activation of gene [ gene ) by human recombinant ( rec ) two-chain gene ( gene ) is inhibited by chemical , at physiological concentrations , and stimulated by chemical ( chemical ) , as well as fibrin ( ogen ) .	T4	T13	3146348
NA	CHEMICAL	GENE-Y	0	9	chemical functions as a result of its binding to gene , with a Ki of approximately 9.0 mM , thereby rendering gene a less effective substrate for two-chain rec-gene .	T5	T16	3146348
NA	CHEMICAL	GENE-Y	0	21	chemical functions as a result of its binding to gene , with a Ki of approximately 9.0 mM , thereby rendering gene a less effective substrate for two-chain rec-gene .	T5	T17	3146348
NA	CHEMICAL	GENE-Y	0	28	chemical functions as a result of its binding to gene , with a Ki of approximately 9.0 mM , thereby rendering gene a less effective substrate for two-chain rec-gene .	T5	T18	3146348
NA	CHEMICAL	GENE-N	31	0	gene appears to exert its stimulatory properties mainly through effects on the enzyme , two-chain rec-gene , with a Ka of approximately 3.7 microM in activation systems containing physiological levels of chemical .	T9	T20	3146348
NA	CHEMICAL	GENE-Y	31	15	gene appears to exert its stimulatory properties mainly through effects on the enzyme , two-chain rec-gene , with a Ka of approximately 3.7 microM in activation systems containing physiological levels of chemical .	T9	T21	3146348
NA	CHEMICAL	GENE-N	13	15	Analysis of the results of this paper reveals that normal plasma components , chemical and gene , exert major regulatory roles on the ability of gene to be activated by two-chain rec-gene , in in vitro systems .	T10	T22	3146348
NA	CHEMICAL	GENE-Y	13	25	Analysis of the results of this paper reveals that normal plasma components , chemical and gene , exert major regulatory roles on the ability of gene to be activated by two-chain rec-gene , in in vitro systems .	T10	T24	3146348
NA	CHEMICAL	GENE-Y	13	31	Analysis of the results of this paper reveals that normal plasma components , chemical and gene , exert major regulatory roles on the ability of gene to be activated by two-chain rec-gene , in in vitro systems .	T10	T25	3146348
CPR:6	CHEMICAL	GENE-Y	0	7	chemical functionally antagonizes chemical activation of the gene in prostate cells through focal adhesion complexes involving gene .	T25	T69	17202804
NA	CHEMICAL	GENE-Y	0	16	chemical functionally antagonizes chemical activation of the gene in prostate cells through focal adhesion complexes involving gene .	T25	T68	17202804
CPR:3	CHEMICAL	GENE-Y	3	7	chemical functionally antagonizes chemical activation of the gene in prostate cells through focal adhesion complexes involving gene .	T26	T69	17202804
NA	CHEMICAL	GENE-Y	3	16	chemical functionally antagonizes chemical activation of the gene in prostate cells through focal adhesion complexes involving gene .	T26	T68	17202804
NA	CHEMICAL	GENE-Y	2	3	Since the chemical receptor has been shown to affect gene function , we considered that part of chemical analog actions on prostate cells may be mediated through modulation of the gene .	T18	T55	17202804
NA	CHEMICAL	GENE-N	2	3	Since the chemical receptor has been shown to affect gene function , we considered that part of chemical analog actions on prostate cells may be mediated through modulation of the gene .	T18	T56	17202804
NA	CHEMICAL	GENE-Y	2	3	Since the chemical receptor has been shown to affect gene function , we considered that part of chemical analog actions on prostate cells may be mediated through modulation of the gene .	T18	T58	17202804
NA	CHEMICAL	GENE-Y	17	3	Since the chemical receptor has been shown to affect gene function , we considered that part of chemical analog actions on prostate cells may be mediated through modulation of the gene .	T19	T55	17202804
NA	CHEMICAL	GENE-N	17	3	Since the chemical receptor has been shown to affect gene function , we considered that part of chemical analog actions on prostate cells may be mediated through modulation of the gene .	T19	T56	17202804
NA	CHEMICAL	GENE-Y	17	3	Since the chemical receptor has been shown to affect gene function , we considered that part of chemical analog actions on prostate cells may be mediated through modulation of the gene .	T19	T58	17202804
NA	CHEMICAL	GENE-Y	8	9	Using a model HEK293 cell line expressing the chemical receptor , we demonstrated a novel signalling pathway of the gene that induces nuclear translocation of the gene that renders it transcriptionally inactive .	T20	T59	17202804
NA	CHEMICAL	GENE-Y	8	9	Using a model HEK293 cell line expressing the chemical receptor , we demonstrated a novel signalling pathway of the gene that induces nuclear translocation of the gene that renders it transcriptionally inactive .	T20	T60	17202804
NA	CHEMICAL	GENE-Y	8	9	Using a model HEK293 cell line expressing the chemical receptor , we demonstrated a novel signalling pathway of the gene that induces nuclear translocation of the gene that renders it transcriptionally inactive .	T20	T61	17202804
NA	CHEMICAL	GENE-N	4	6	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T62	17202804
NA	CHEMICAL	GENE-Y	4	7	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T63	17202804
NA	CHEMICAL	GENE-N	4	6	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T64	17202804
NA	CHEMICAL	GENE-Y	4	12	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T65	17202804
NA	CHEMICAL	GENE-N	4	15	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T66	17202804
NA	CHEMICAL	GENE-N	4	15	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T28	17202804
NA	CHEMICAL	GENE-Y	4	17	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T22	T29	17202804
NA	CHEMICAL	GENE-N	5	6	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T62	17202804
NA	CHEMICAL	GENE-Y	5	7	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T63	17202804
NA	CHEMICAL	GENE-N	5	6	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T64	17202804
NA	CHEMICAL	GENE-Y	5	12	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T65	17202804
NA	CHEMICAL	GENE-N	5	15	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T66	17202804
NA	CHEMICAL	GENE-N	5	15	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T28	17202804
NA	CHEMICAL	GENE-Y	5	17	This mechanism involves the chemical-dependent chemical kinase gene , the non-receptor gene gene and the gene/gene , gene .	T23	T29	17202804
NA	CHEMICAL	GENE-Y	0	0	gene-induced gene activation opposed the association of gene with gene as overexpression of a dominant negative gene enhanced the chemical-induced nuclear translocation of a green fluorescent protein-tagged gene .	T3	T33	17202804
CPR:3	CHEMICAL	GENE-Y	0	1	gene-induced gene activation opposed the association of gene with gene as overexpression of a dominant negative gene enhanced the chemical-induced nuclear translocation of a green fluorescent protein-tagged gene .	T3	T34	17202804
CPR:4	CHEMICAL	GENE-Y	0	7	gene-induced gene activation opposed the association of gene with gene as overexpression of a dominant negative gene enhanced the chemical-induced nuclear translocation of a green fluorescent protein-tagged gene .	T3	T35	17202804
CPR:4	CHEMICAL	GENE-Y	0	9	gene-induced gene activation opposed the association of gene with gene as overexpression of a dominant negative gene enhanced the chemical-induced nuclear translocation of a green fluorescent protein-tagged gene .	T3	T36	17202804
NA	CHEMICAL	GENE-Y	0	16	gene-induced gene activation opposed the association of gene with gene as overexpression of a dominant negative gene enhanced the chemical-induced nuclear translocation of a green fluorescent protein-tagged gene .	T3	T37	17202804
NA	CHEMICAL	GENE-Y	0	27	gene-induced gene activation opposed the association of gene with gene as overexpression of a dominant negative gene enhanced the chemical-induced nuclear translocation of a green fluorescent protein-tagged gene .	T3	T39	17202804
CPR:3	CHEMICAL	GENE-Y	0	1	chemical-induced gene activation resulted in the phosphorylation of expressed gene and promoted its association with the gene .	T5	T41	17202804
NA	CHEMICAL	GENE-Y	0	9	chemical-induced gene activation resulted in the phosphorylation of expressed gene and promoted its association with the gene .	T5	T42	17202804
NA	CHEMICAL	GENE-Y	0	16	chemical-induced gene activation resulted in the phosphorylation of expressed gene and promoted its association with the gene .	T5	T43	17202804
CPR:3	CHEMICAL	GENE-Y	2	2	In contrast to chemical , chemical-induced nuclear translocation did not transcriptionally activate the gene .	T6	T45	17202804
NA	CHEMICAL	GENE-Y	5	2	In contrast to chemical , chemical-induced nuclear translocation did not transcriptionally activate the gene .	T7	T45	17202804
NA	CHEMICAL	GENE-Y	4	8	We then demonstrated that chemical can also stimulate gene mobilization in human prostate PC3 , BPH-1 and LNCaP cells , and in cultured rat ventral prostate cells through the same mechanism .	T8	T47	17202804
NA	CHEMICAL	GENE-Y	3	17	To determine if chemical could antagonize androgen effects in normal tissue , we examined the effect of gene on rat ventral prostate organ cultures and demonstrated that chemical can functionally antagonize the actions of chemical on prostate cell proliferation and tissue growth .	T9	T48	17202804
NA	CHEMICAL	GENE-Y	27	17	To determine if chemical could antagonize androgen effects in normal tissue , we examined the effect of gene on rat ventral prostate organ cultures and demonstrated that chemical can functionally antagonize the actions of chemical on prostate cell proliferation and tissue growth .	T10	T48	17202804
NA	CHEMICAL	GENE-Y	18	17	To determine if chemical could antagonize androgen effects in normal tissue , we examined the effect of gene on rat ventral prostate organ cultures and demonstrated that chemical can functionally antagonize the actions of chemical on prostate cell proliferation and tissue growth .	T12	T48	17202804
NA	CHEMICAL	GENE-N	5	21	The antiarrhythmic effects of exogenous chemical and Valsalva on this form of VT may be due to receptor-mediated inhibition of chemical cyclase or to noncardiac receptor-mediated effects , i.e. , exogenous chemical may modulate VT through alterations in autonomic tone by activation of arterial gene , and Valsalva has been shown to decrease venous return , resulting in a reduction in cardiac dimensions and myocardial stretch .	T26	T40	8425287
NA	CHEMICAL	GENE-N	5	16	The antiarrhythmic effects of exogenous chemical and Valsalva on this form of VT may be due to receptor-mediated inhibition of chemical cyclase or to noncardiac receptor-mediated effects , i.e. , exogenous chemical may modulate VT through alterations in autonomic tone by activation of arterial gene , and Valsalva has been shown to decrease venous return , resulting in a reduction in cardiac dimensions and myocardial stretch .	T26	T41	8425287
NA	CHEMICAL	GENE-N	20	21	The antiarrhythmic effects of exogenous chemical and Valsalva on this form of VT may be due to receptor-mediated inhibition of chemical cyclase or to noncardiac receptor-mediated effects , i.e. , exogenous chemical may modulate VT through alterations in autonomic tone by activation of arterial gene , and Valsalva has been shown to decrease venous return , resulting in a reduction in cardiac dimensions and myocardial stretch .	T27	T40	8425287
NA	CHEMICAL	GENE-N	20	16	The antiarrhythmic effects of exogenous chemical and Valsalva on this form of VT may be due to receptor-mediated inhibition of chemical cyclase or to noncardiac receptor-mediated effects , i.e. , exogenous chemical may modulate VT through alterations in autonomic tone by activation of arterial gene , and Valsalva has been shown to decrease venous return , resulting in a reduction in cardiac dimensions and myocardial stretch .	T27	T41	8425287
NA	CHEMICAL	GENE-N	31	21	The antiarrhythmic effects of exogenous chemical and Valsalva on this form of VT may be due to receptor-mediated inhibition of chemical cyclase or to noncardiac receptor-mediated effects , i.e. , exogenous chemical may modulate VT through alterations in autonomic tone by activation of arterial gene , and Valsalva has been shown to decrease venous return , resulting in a reduction in cardiac dimensions and myocardial stretch .	T28	T40	8425287
CPR:3	CHEMICAL	GENE-N	31	16	The antiarrhythmic effects of exogenous chemical and Valsalva on this form of VT may be due to receptor-mediated inhibition of chemical cyclase or to noncardiac receptor-mediated effects , i.e. , exogenous chemical may modulate VT through alterations in autonomic tone by activation of arterial gene , and Valsalva has been shown to decrease venous return , resulting in a reduction in cardiac dimensions and myocardial stretch .	T28	T41	8425287
CPR:6	CHEMICAL	GENE-Y	6	11	VT recurred with the addition of chemical , a chemical chemical A1-receptor antagonist .	T8	T34	8425287
NA	CHEMICAL	GENE-Y	9	11	VT recurred with the addition of chemical , a chemical chemical A1-receptor antagonist .	T42	T34	8425287
NA	CHEMICAL	GENE-Y	8	11	VT recurred with the addition of chemical , a chemical chemical A1-receptor antagonist .	T9	T34	8425287
NA	CHEMICAL	GENE-Y	2	2	) , a gene inhibitor that potentiates the effects of chemical at the gene , terminated VT in four of four patients , an effect that was reversed by chemical .	T11	T35	8425287
NA	CHEMICAL	GENE-N	2	13	) , a gene inhibitor that potentiates the effects of chemical at the gene , terminated VT in four of four patients , an effect that was reversed by chemical .	T11	T36	8425287
NA	CHEMICAL	GENE-Y	2	2	) , a gene inhibitor that potentiates the effects of chemical at the gene , terminated VT in four of four patients , an effect that was reversed by chemical .	T13	T35	8425287
CPR:4	CHEMICAL	GENE-N	2	13	) , a gene inhibitor that potentiates the effects of chemical at the gene , terminated VT in four of four patients , an effect that was reversed by chemical .	T13	T36	8425287
NA	CHEMICAL	GENE-Y	9	16	It can be identified by termination of the tachycardia in response to activation of the chemical A1 or gene , which results in inhibition of chemical cyclase .	T19	T37	8425287
NA	CHEMICAL	GENE-N	9	11	It can be identified by termination of the tachycardia in response to activation of the chemical A1 or gene , which results in inhibition of chemical cyclase .	T19	T38	8425287
NA	CHEMICAL	GENE-N	9	26	It can be identified by termination of the tachycardia in response to activation of the chemical A1 or gene , which results in inhibition of chemical cyclase .	T19	T39	8425287
NA	CHEMICAL	GENE-Y	25	16	It can be identified by termination of the tachycardia in response to activation of the chemical A1 or gene , which results in inhibition of chemical cyclase .	T20	T37	8425287
NA	CHEMICAL	GENE-N	25	11	It can be identified by termination of the tachycardia in response to activation of the chemical A1 or gene , which results in inhibition of chemical cyclase .	T20	T38	8425287
NA	CHEMICAL	GENE-N	25	26	It can be identified by termination of the tachycardia in response to activation of the chemical A1 or gene , which results in inhibition of chemical cyclase .	T20	T39	8425287
NA	CHEMICAL	GENE-N	5	0	gene gene is a novel chemical receptor target associating with high grade breast tumors .	T3	T19	23142699
NA	CHEMICAL	GENE-Y	5	1	gene gene is a novel chemical receptor target associating with high grade breast tumors .	T3	T20	23142699
NA	CHEMICAL	GENE-Y	5	6	gene gene is a novel chemical receptor target associating with high grade breast tumors .	T3	T21	23142699
CPR:3	CHEMICAL	GENE-Y	12	6	We show that the expression of gene is induced in response to chemical in MCF-7 cells and that the induction is mediated by gene-regulated enhancers located distally upstream from the gene .	T1	T7	23142699
CPR:3	CHEMICAL	GENE-Y	12	23	We show that the expression of gene is induced in response to chemical in MCF-7 cells and that the induction is mediated by gene-regulated enhancers located distally upstream from the gene .	T1	T8	23142699
NA	CHEMICAL	GENE-Y	3	4	Developmental changes in chemical dehydrogenase-X activity in young jaundiced male rats .	T9	T17	2751392
NA	CHEMICAL	GENE-Y	29	23	This study was designed to examine the testicular maturation in both jaundiced ( jj ) and nonjaundiced ( Jj ) male Gunn rats as indicated by the activity of a testis and sperm-specific enzyme , chemical dehydrogenase-X ( gene ) , and serum chemical levels .	T1	T10	2751392
NA	CHEMICAL	GENE-Y	29	38	This study was designed to examine the testicular maturation in both jaundiced ( jj ) and nonjaundiced ( Jj ) male Gunn rats as indicated by the activity of a testis and sperm-specific enzyme , chemical dehydrogenase-X ( gene ) , and serum chemical levels .	T1	T11	2751392
NA	CHEMICAL	GENE-Y	4	23	This study was designed to examine the testicular maturation in both jaundiced ( jj ) and nonjaundiced ( Jj ) male Gunn rats as indicated by the activity of a testis and sperm-specific enzyme , chemical dehydrogenase-X ( gene ) , and serum chemical levels .	T2	T10	2751392
NA	CHEMICAL	GENE-Y	4	38	This study was designed to examine the testicular maturation in both jaundiced ( jj ) and nonjaundiced ( Jj ) male Gunn rats as indicated by the activity of a testis and sperm-specific enzyme , chemical dehydrogenase-X ( gene ) , and serum chemical levels .	T2	T11	2751392
NA	CHEMICAL	GENE-Y	10	2	Testicular cytosolic gene activity was determined by oxidation of reduced chemical ( chemical ) .	T3	T12	2751392
NA	CHEMICAL	GENE-Y	12	2	Testicular cytosolic gene activity was determined by oxidation of reduced chemical ( chemical ) .	T4	T12	2751392
NA	CHEMICAL	GENE-Y	4	0	gene activity and serum chemical levels were similar for both genotypes at 180 days of age .	T7	T15	2751392
CPR:4	CHEMICAL	GENE-Y	12	17	Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of chemical ( chemical ) blocked gene activity , the terminal enzymatic step in chemical synthesis .	T21	T32	10917903
CPR:4	CHEMICAL	GENE-Y	14	17	Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of chemical ( chemical ) blocked gene activity , the terminal enzymatic step in chemical synthesis .	T22	T32	10917903
NA	CHEMICAL	GENE-Y	25	17	Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of chemical ( chemical ) blocked gene activity , the terminal enzymatic step in chemical synthesis .	T23	T32	10917903
NA	CHEMICAL	GENE-N	3	4	Further characterization of chemical receptors ( putative gene ) in rat stomach fundus longitudinal muscle .	T59	T70	8032658
NA	CHEMICAL	GENE-Y	3	7	Further characterization of chemical receptors ( putative gene ) in rat stomach fundus longitudinal muscle .	T59	T71	8032658
NA	CHEMICAL	GENE-N	13	5	The present study was undertaken to isolate and characterize pharmacologically homogeneous populations of chemical ( chemical ) receptors from a possible mixed receptor population mediating concentration of the longitudinal muscle of rat stomach fundus .	T7	T60	8032658
NA	CHEMICAL	GENE-N	15	5	The present study was undertaken to isolate and characterize pharmacologically homogeneous populations of chemical ( chemical ) receptors from a possible mixed receptor population mediating concentration of the longitudinal muscle of rat stomach fundus .	T14	T60	8032658
NA	CHEMICAL	GENE-N	6	7	Under these conditions , blockade of chemical oxidase with chemical ( 100 microM for 15 min ) caused a leftward displacement of concentration-effect curves for both chemical ( chemical ) and chemical .	T49	T69	8032658
CPR:4	CHEMICAL	GENE-N	9	7	Under these conditions , blockade of chemical oxidase with chemical ( 100 microM for 15 min ) caused a leftward displacement of concentration-effect curves for both chemical ( chemical ) and chemical .	T50	T69	8032658
NA	CHEMICAL	GENE-N	15	7	Under these conditions , blockade of chemical oxidase with chemical ( 100 microM for 15 min ) caused a leftward displacement of concentration-effect curves for both chemical ( chemical ) and chemical .	T51	T69	8032658
NA	CHEMICAL	GENE-N	28	7	Under these conditions , blockade of chemical oxidase with chemical ( 100 microM for 15 min ) caused a leftward displacement of concentration-effect curves for both chemical ( chemical ) and chemical .	T52	T69	8032658
NA	CHEMICAL	GENE-N	15	7	Under these conditions , blockade of chemical oxidase with chemical ( 100 microM for 15 min ) caused a leftward displacement of concentration-effect curves for both chemical ( chemical ) and chemical .	T53	T69	8032658
CPR:5	CHEMICAL	GENE-Y	12	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T8	T61	8032658
CPR:5	CHEMICAL	GENE-Y	12	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T8	T62	8032658
CPR:5	CHEMICAL	GENE-Y	18	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T9	T61	8032658
CPR:5	CHEMICAL	GENE-Y	18	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T9	T62	8032658
CPR:5	CHEMICAL	GENE-Y	21	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T10	T61	8032658
CPR:5	CHEMICAL	GENE-Y	21	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T10	T62	8032658
CPR:5	CHEMICAL	GENE-Y	23	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T11	T61	8032658
CPR:5	CHEMICAL	GENE-Y	23	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T11	T62	8032658
CPR:5	CHEMICAL	GENE-Y	25	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T12	T61	8032658
CPR:5	CHEMICAL	GENE-Y	25	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T12	T62	8032658
NA	CHEMICAL	GENE-Y	9	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T13	T61	8032658
NA	CHEMICAL	GENE-Y	9	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T13	T62	8032658
NA	CHEMICAL	GENE-Y	35	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T15	T61	8032658
NA	CHEMICAL	GENE-Y	35	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T15	T62	8032658
NA	CHEMICAL	GENE-Y	29	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T16	T61	8032658
NA	CHEMICAL	GENE-Y	29	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T16	T62	8032658
NA	CHEMICAL	GENE-Y	39	11	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T17	T61	8032658
NA	CHEMICAL	GENE-Y	39	13	In addition several ligands known to act as agonists at either gene or gene receptors including chemical ( chemical ) , chemical , chemical and chemical were also agonists in rat fundus whilst chemical , chemical and chemical ( chemical ) were very weak or inactive .	T17	T62	8032658
NA	CHEMICAL	GENE-N	13	23	We conclude that despite small differences concerning the enantiomeric selectivity and affinity of chemical and chemical , the close pharmacological identity of chemical receptors in rat stomach fundus and the recently cloned gene receptor is maintained .	T44	T64	8032658
NA	CHEMICAL	GENE-Y	13	32	We conclude that despite small differences concerning the enantiomeric selectivity and affinity of chemical and chemical , the close pharmacological identity of chemical receptors in rat stomach fundus and the recently cloned gene receptor is maintained .	T44	T65	8032658
NA	CHEMICAL	GENE-N	15	23	We conclude that despite small differences concerning the enantiomeric selectivity and affinity of chemical and chemical , the close pharmacological identity of chemical receptors in rat stomach fundus and the recently cloned gene receptor is maintained .	T45	T64	8032658
NA	CHEMICAL	GENE-Y	15	32	We conclude that despite small differences concerning the enantiomeric selectivity and affinity of chemical and chemical , the close pharmacological identity of chemical receptors in rat stomach fundus and the recently cloned gene receptor is maintained .	T45	T65	8032658
NA	CHEMICAL	GENE-N	22	23	We conclude that despite small differences concerning the enantiomeric selectivity and affinity of chemical and chemical , the close pharmacological identity of chemical receptors in rat stomach fundus and the recently cloned gene receptor is maintained .	T46	T64	8032658
NA	CHEMICAL	GENE-Y	22	32	We conclude that despite small differences concerning the enantiomeric selectivity and affinity of chemical and chemical , the close pharmacological identity of chemical receptors in rat stomach fundus and the recently cloned gene receptor is maintained .	T46	T65	8032658
CPR:4	CHEMICAL	GENE-N	3	1	The gene inhibitor chemical modifies proliferation , gene expression and epigenetic marks in thyroid cancer cell lines .	T7	T23	22982218
NA	CHEMICAL	GENE-Y	3	7	The gene inhibitor chemical modifies proliferation , gene expression and epigenetic marks in thyroid cancer cell lines .	T7	T22	22982218
NA	CHEMICAL	GENE-Y	12	1	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T6	T13	22982218
NA	CHEMICAL	GENE-Y	12	13	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T6	T15	22982218
NA	CHEMICAL	GENE-Y	12	15	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T6	T19	22982218
NA	CHEMICAL	GENE-N	12	26	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T6	T9	22982218
NA	CHEMICAL	GENE-Y	1	1	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T1	T13	22982218
NA	CHEMICAL	GENE-Y	1	13	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T1	T15	22982218
NA	CHEMICAL	GENE-Y	1	15	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T1	T19	22982218
CPR:4	CHEMICAL	GENE-N	1	26	Since gene is supposed to be part of a multimeric repressor of chemical symporter ( gene ) expression , in this study the effect of the gene inhibitor chemical on several properties of thyroid cancer cell lines was investigated .	T1	T9	22982218
CPR:3	CHEMICAL	GENE-Y	10	16	In TPC1 , BCPAP , FRO , WRO cell lines chemical induced a strong increase in gene mRNA levels .	T2	T10	22982218
CPR:3	CHEMICAL	GENE-N	12	14	Accordingly , in transfection experiments performed in TPC1 cells , treatment with chemical increased gene activity without affecting gene binding to the promoter sequence .	T4	T11	22982218
NA	CHEMICAL	GENE-Y	12	18	Accordingly , in transfection experiments performed in TPC1 cells , treatment with chemical increased gene activity without affecting gene binding to the promoter sequence .	T4	T12	22982218
NA	CHEMICAL	GENE-N	9	7	We also investigated the epigenetic status of gene after chemical treatment in TPC1 cell line : in addition to an increase of gene ( gene , gene ) , surprisingly we observed also an increase of H3K27me3 , a classical repressive mark .	T5	T14	22982218
CPR:3	CHEMICAL	GENE-N	9	22	We also investigated the epigenetic status of gene after chemical treatment in TPC1 cell line : in addition to an increase of gene ( gene , gene ) , surprisingly we observed also an increase of H3K27me3 , a classical repressive mark .	T5	T16	22982218
CPR:3	CHEMICAL	GENE-N	9	24	We also investigated the epigenetic status of gene after chemical treatment in TPC1 cell line : in addition to an increase of gene ( gene , gene ) , surprisingly we observed also an increase of H3K27me3 , a classical repressive mark .	T5	T17	22982218
CPR:3	CHEMICAL	GENE-N	9	26	We also investigated the epigenetic status of gene after chemical treatment in TPC1 cell line : in addition to an increase of gene ( gene , gene ) , surprisingly we observed also an increase of H3K27me3 , a classical repressive mark .	T5	T18	22982218
CPR:6	CHEMICAL	GENE-Y	3	10	Preclinical efficacy of chemical , a potent , selective chemical H1 antagonist for topical ocular use .	T22	T25	7714410
NA	CHEMICAL	GENE-Y	5	10	Preclinical efficacy of chemical , a potent , selective chemical H1 antagonist for topical ocular use .	T23	T25	7714410
NA	CHEMICAL	GENE-Y	0	6	chemical ( 0.1 % ) failed to significantly attenuate either serotonin or platelet-activating-factor induced vascular permeability changes indicating high selectivity for the chemical H1 receptor .	T21	T24	7714410
NA	CHEMICAL	GENE-Y	0	6	chemical ( 0.1 % ) failed to significantly attenuate either serotonin or platelet-activating-factor induced vascular permeability changes indicating high selectivity for the chemical H1 receptor .	T2	T24	7714410
CPR:6	CHEMICAL	GENE-Y	2	4	Effect of chemical ( gene/gene receptor antagonist ) on metabolic changes during stress and diabetes .	T10	T23	15629255
CPR:6	CHEMICAL	GENE-Y	2	4	Effect of chemical ( gene/gene receptor antagonist ) on metabolic changes during stress and diabetes .	T10	T24	15629255
CPR:6	CHEMICAL	GENE-N	14	11	To test this , we studied the possible effect of the gene antagonist , chemical ( 50 and 100 mg kg ( -1 ) ) on serum chemical and gene levels as well as on liver glycogen contents in normoglycemic stressed animals .	T4	T17	15629255
NA	CHEMICAL	GENE-N	14	29	To test this , we studied the possible effect of the gene antagonist , chemical ( 50 and 100 mg kg ( -1 ) ) on serum chemical and gene levels as well as on liver glycogen contents in normoglycemic stressed animals .	T4	T18	15629255
NA	CHEMICAL	GENE-N	27	11	To test this , we studied the possible effect of the gene antagonist , chemical ( 50 and 100 mg kg ( -1 ) ) on serum chemical and gene levels as well as on liver glycogen contents in normoglycemic stressed animals .	T5	T17	15629255
NA	CHEMICAL	GENE-N	27	29	To test this , we studied the possible effect of the gene antagonist , chemical ( 50 and 100 mg kg ( -1 ) ) on serum chemical and gene levels as well as on liver glycogen contents in normoglycemic stressed animals .	T5	T18	15629255
NA	CHEMICAL	GENE-N	6	11	In addition , the effect of chemical on serum chemical and gene levels in both mild and severely diabetic rats and its effect on gene-induced hypoglycemia were also determined .	T6	T19	15629255
NA	CHEMICAL	GENE-N	6	13	In addition , the effect of chemical on serum chemical and gene levels in both mild and severely diabetic rats and its effect on gene-induced hypoglycemia were also determined .	T6	T20	15629255
NA	CHEMICAL	GENE-N	9	11	In addition , the effect of chemical on serum chemical and gene levels in both mild and severely diabetic rats and its effect on gene-induced hypoglycemia were also determined .	T7	T19	15629255
NA	CHEMICAL	GENE-N	9	13	In addition , the effect of chemical on serum chemical and gene levels in both mild and severely diabetic rats and its effect on gene-induced hypoglycemia were also determined .	T7	T20	15629255
NA	CHEMICAL	GENE-N	0	8	chemical partially prevented stress-induced both hyperglycemia and decrease in glycogen content while it completely blocked the stress-induced decrease in gene level in normoglycemic stressed rats .	T1	T11	15629255
CPR:4	CHEMICAL	GENE-Y	4	6	Pharmacokinetics and metabolism of chemical , a novel gene inhibitor , in humans .	T9	T19	23075005
CPR:4	CHEMICAL	GENE-Y	3	11	The disposition of chemical , an orally active , highly selective gene inhibitor , was investigated after a single oral dose of 100 mg/1.92 MBq chemical to six healthy men .	T4	T18	23075005
NA	CHEMICAL	GENE-Y	5	11	The disposition of chemical , an orally active , highly selective gene inhibitor , was investigated after a single oral dose of 100 mg/1.92 MBq chemical to six healthy men .	T3	T18	23075005
NA	CHEMICAL	GENE-Y	0	8	chemical was shown to induce rapid oncosis in gene-expressing cells .	T9	T24	23519149
NA	CHEMICAL	GENE-Y	4	8	We have shown that chemical is more active in cells harboring epithelial phenotype with high gene and low gene expression .	T14	T25	23519149
NA	CHEMICAL	GENE-Y	4	8	We have shown that chemical is more active in cells harboring epithelial phenotype with high gene and low gene expression .	T14	T26	23519149
NA	CHEMICAL	GENE-Y	13	4	In addition , high gene and gene expression was correlated with sensitivity to chemical , whereas the presence of gene activating mutations was associated with resistance .	T16	T27	23519149
NA	CHEMICAL	GENE-Y	13	6	In addition , high gene and gene expression was correlated with sensitivity to chemical , whereas the presence of gene activating mutations was associated with resistance .	T16	T28	23519149
NA	CHEMICAL	GENE-Y	13	19	In addition , high gene and gene expression was correlated with sensitivity to chemical , whereas the presence of gene activating mutations was associated with resistance .	T16	T29	23519149
CPR:4	CHEMICAL	GENE-Y	7	9	In DU-PM cells with acquired resistance to chemical , gene expression was decreased , while gene was increased .	T2	T19	23519149
CPR:3	CHEMICAL	GENE-Y	7	15	In DU-PM cells with acquired resistance to chemical , gene expression was decreased , while gene was increased .	T2	T20	23519149
NA	CHEMICAL	GENE-Y	12	14	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T1	T5	14564902
NA	CHEMICAL	GENE-Y	12	16	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T1	T6	14564902
NA	CHEMICAL	GENE-Y	12	18	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T1	T7	14564902
NA	CHEMICAL	GENE-Y	12	18	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T1	T8	14564902
NA	CHEMICAL	GENE-Y	12	14	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T2	T5	14564902
NA	CHEMICAL	GENE-Y	12	16	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T2	T6	14564902
NA	CHEMICAL	GENE-Y	12	18	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T2	T7	14564902
NA	CHEMICAL	GENE-Y	12	18	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T2	T8	14564902
NA	CHEMICAL	GENE-Y	23	14	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T3	T5	14564902
NA	CHEMICAL	GENE-Y	23	16	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T3	T6	14564902
NA	CHEMICAL	GENE-Y	23	18	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T3	T7	14564902
NA	CHEMICAL	GENE-Y	23	18	Twenty-nine taxi drivers ( 41-67 years old ) were examined for urine chemical/chemical , gene , gene , gene-gene-complex , hematocrit , blood chemical and blood pressure in the morning and at midnight during a duty day and in the following morning .	T3	T8	14564902
NA	CHEMICAL	GENE-Y	16	15	We show here for zebrafish that embryonic retinoid homeostasis essentially depends on the activity of a chemical : chemical acyltransferase ( gene ) .	T5	T17	17098734
NA	CHEMICAL	GENE-Y	16	15	We show here for zebrafish that embryonic retinoid homeostasis essentially depends on the activity of a chemical : chemical acyltransferase ( gene ) .	T5	T18	17098734
NA	CHEMICAL	GENE-Y	18	15	We show here for zebrafish that embryonic retinoid homeostasis essentially depends on the activity of a chemical : chemical acyltransferase ( gene ) .	T6	T17	17098734
NA	CHEMICAL	GENE-Y	18	15	We show here for zebrafish that embryonic retinoid homeostasis essentially depends on the activity of a chemical : chemical acyltransferase ( gene ) .	T6	T18	17098734
NA	CHEMICAL	GENE-Y	6	3	During embryogenesis , gene is expressed in mostly non-overlapping domains opposite to chemical dehydrogenase 2 ( gene ) , the key enzyme for chemical synthesis .	T8	T19	17098734
NA	CHEMICAL	GENE-Y	6	14	During embryogenesis , gene is expressed in mostly non-overlapping domains opposite to chemical dehydrogenase 2 ( gene ) , the key enzyme for chemical synthesis .	T8	T20	17098734
NA	CHEMICAL	GENE-Y	6	14	During embryogenesis , gene is expressed in mostly non-overlapping domains opposite to chemical dehydrogenase 2 ( gene ) , the key enzyme for chemical synthesis .	T8	T21	17098734
NA	CHEMICAL	GENE-Y	23	3	During embryogenesis , gene is expressed in mostly non-overlapping domains opposite to chemical dehydrogenase 2 ( gene ) , the key enzyme for chemical synthesis .	T9	T19	17098734
CPR:9	CHEMICAL	GENE-Y	23	14	During embryogenesis , gene is expressed in mostly non-overlapping domains opposite to chemical dehydrogenase 2 ( gene ) , the key enzyme for chemical synthesis .	T9	T20	17098734
CPR:9	CHEMICAL	GENE-Y	23	14	During embryogenesis , gene is expressed in mostly non-overlapping domains opposite to chemical dehydrogenase 2 ( gene ) , the key enzyme for chemical synthesis .	T9	T21	17098734
CPR:9	CHEMICAL	GENE-Y	1	4	Blocking chemical formation by a targeted knock down of gene results in significantly increased chemical levels , which lead to severe embryonic patterning defects .	T10	T22	17098734
NA	CHEMICAL	GENE-Y	4	4	Blocking chemical formation by a targeted knock down of gene results in significantly increased chemical levels , which lead to severe embryonic patterning defects .	T11	T22	17098734
NA	CHEMICAL	GENE-Y	15	6	Thus , we provide evidence that a balanced competition between gene and gene for yolk chemical defines embryonic compartments either for chemical or chemical synthesis .	T12	T23	17098734
NA	CHEMICAL	GENE-Y	15	6	Thus , we provide evidence that a balanced competition between gene and gene for yolk chemical defines embryonic compartments either for chemical or chemical synthesis .	T12	T24	17098734
NA	CHEMICAL	GENE-Y	21	6	Thus , we provide evidence that a balanced competition between gene and gene for yolk chemical defines embryonic compartments either for chemical or chemical synthesis .	T13	T23	17098734
NA	CHEMICAL	GENE-Y	21	6	Thus , we provide evidence that a balanced competition between gene and gene for yolk chemical defines embryonic compartments either for chemical or chemical synthesis .	T13	T24	17098734
NA	CHEMICAL	GENE-Y	6	6	Thus , we provide evidence that a balanced competition between gene and gene for yolk chemical defines embryonic compartments either for chemical or chemical synthesis .	T14	T23	17098734
NA	CHEMICAL	GENE-Y	6	6	Thus , we provide evidence that a balanced competition between gene and gene for yolk chemical defines embryonic compartments either for chemical or chemical synthesis .	T14	T24	17098734
CPR:4	CHEMICAL	GENE-Y	3	8	The mechanism of chemical poisoning involves inhibition of gene ( gene ) leading to inactivation of the enzyme which has an important role in neurotransmission .	T17	T27	19651196
CPR:4	CHEMICAL	GENE-Y	3	10	The mechanism of chemical poisoning involves inhibition of gene ( gene ) leading to inactivation of the enzyme which has an important role in neurotransmission .	T17	T28	19651196
NA	CHEMICAL	GENE-Y	3	0	gene inhibition results in the accumulation of chemical at cholinergic receptor sites , producing continuous stimulation of cholinergic fibers throughout the nervous systems .	T18	T29	19651196
CPR:4	CHEMICAL	GENE-Y	8	5	They act by reactivation of gene inhibited by chemical .	T21	T30	19651196
CPR:3	CHEMICAL	GENE-Y	0	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T7	T26	19651196
CPR:3	CHEMICAL	GENE-Y	10	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T8	T26	19651196
CPR:3	CHEMICAL	GENE-Y	12	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T9	T26	19651196
CPR:3	CHEMICAL	GENE-Y	14	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T10	T26	19651196
CPR:3	CHEMICAL	GENE-Y	16	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T11	T26	19651196
CPR:3	CHEMICAL	GENE-Y	18	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T12	T26	19651196
CPR:3	CHEMICAL	GENE-Y	21	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T13	T26	19651196
CPR:4	CHEMICAL	GENE-Y	28	2	chemical , gene reactivator such as one of the recommended chemical ( chemical , chemical , chemical and chemical ) and chemical are used for the treatment of chemical poisoning in humans .	T14	T26	19651196
NA	CHEMICAL	GENE-Y	14	1	The gene/gene T2D locus is associated with decreased gene secretion in response to oral chemical stimulation in humans .	T1	T6	23349488
NA	CHEMICAL	GENE-Y	14	1	The gene/gene T2D locus is associated with decreased gene secretion in response to oral chemical stimulation in humans .	T1	T7	23349488
NA	CHEMICAL	GENE-Y	14	8	The gene/gene T2D locus is associated with decreased gene secretion in response to oral chemical stimulation in humans .	T1	T8	23349488
NA	CHEMICAL	GENE-N	3	5	We find that chemical stimulated gene secretion ( GSIS ) is decreased in gene KO mice due to impaired replenishment of the releasable pool of granules and that the gene gene is haploinsufficient .	T2	T10	23349488
NA	CHEMICAL	GENE-Y	3	13	We find that chemical stimulated gene secretion ( GSIS ) is decreased in gene KO mice due to impaired replenishment of the releasable pool of granules and that the gene gene is haploinsufficient .	T2	T11	23349488
NA	CHEMICAL	GENE-Y	3	29	We find that chemical stimulated gene secretion ( GSIS ) is decreased in gene KO mice due to impaired replenishment of the releasable pool of granules and that the gene gene is haploinsufficient .	T2	T12	23349488
NA	CHEMICAL	GENE-Y	0	24	chemical attenuates allergic airway inflammation by regulation of CD4 ( + ) CD25 ( + ) regulatory T cells ( Tregs ) /Th17 balance in gene-sensitized mice .	T11	T21	23500387
NA	CHEMICAL	GENE-Y	14	16	The present study aimed to determine the protective effects and the underlying mechanisms of chemical on gene ( gene ) -induced allergic inflammation in a mouse model of allergic asthma .	T10	T12	23500387
NA	CHEMICAL	GENE-Y	14	18	The present study aimed to determine the protective effects and the underlying mechanisms of chemical on gene ( gene ) -induced allergic inflammation in a mouse model of allergic asthma .	T10	T14	23500387
NA	CHEMICAL	GENE-N	16	16	Airway resistance ( Raw ) was measured by the forced oscillation technique , differential cell count in BAL fluid ( BALF ) was measured by Wright-Giemsa staining , histological assessment was measured by chemical and chemical ( HE ) staining , BALF levels of Treg/Th17 gene were measured by enzyme-linked immunosorbent assay , Treg cells and Th17 cells were evaluated by flow cytometry ( FCM ) .	T7	T17	23500387
NA	CHEMICAL	GENE-N	16	16	Airway resistance ( Raw ) was measured by the forced oscillation technique , differential cell count in BAL fluid ( BALF ) was measured by Wright-Giemsa staining , histological assessment was measured by chemical and chemical ( HE ) staining , BALF levels of Treg/Th17 gene were measured by enzyme-linked immunosorbent assay , Treg cells and Th17 cells were evaluated by flow cytometry ( FCM ) .	T8	T17	23500387
CPR:4	CHEMICAL	GENE-Y	4	6	Our study demonstrated that chemical inhibited gene-induced increases in eosinophil count ; gene level were recovered in bronchoalveolar lavage fluid increased gene level in bronchoalveolar lavage fluid .	T9	T18	23500387
CPR:4	CHEMICAL	GENE-Y	4	12	Our study demonstrated that chemical inhibited gene-induced increases in eosinophil count ; gene level were recovered in bronchoalveolar lavage fluid increased gene level in bronchoalveolar lavage fluid .	T9	T19	23500387
CPR:3	CHEMICAL	GENE-Y	4	21	Our study demonstrated that chemical inhibited gene-induced increases in eosinophil count ; gene level were recovered in bronchoalveolar lavage fluid increased gene level in bronchoalveolar lavage fluid .	T9	T20	23500387
CPR:4	CHEMICAL	GENE-Y	4	7	Histological studies demonstrated that chemical substantially inhibited gene-induced eosinophilia in lung tissue .	T1	T13	23500387
CPR:4	CHEMICAL	GENE-Y	2	2	The results in vivo show gene-induced significantly broke Treg/Th17 balance ; chemical treatments markedly attenuated the inflammatory in asthma model by regulating Treg/Th17 balance .	T3	T15	23500387
CPR:3	CHEMICAL	GENE-Y	0	6	chemical induced ER stress and enhanced gene cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations .	T16	T21	23047912
CPR:3	CHEMICAL	GENE-N	3	16	Nevertheless , low chemical concentrations ( ≥ 0.1mM , 48 h ) increased protein ubiquitination , gene and gene activity , expression of the endoplasmic reticulum ( ER ) stress marker gene , and enhanced phosphorylation of gene in SH-SY5Y cells .	T15	T17	23047912
CPR:3	CHEMICAL	GENE-Y	3	18	Nevertheless , low chemical concentrations ( ≥ 0.1mM , 48 h ) increased protein ubiquitination , gene and gene activity , expression of the endoplasmic reticulum ( ER ) stress marker gene , and enhanced phosphorylation of gene in SH-SY5Y cells .	T15	T18	23047912
CPR:3	CHEMICAL	GENE-Y	3	31	Nevertheless , low chemical concentrations ( ≥ 0.1mM , 48 h ) increased protein ubiquitination , gene and gene activity , expression of the endoplasmic reticulum ( ER ) stress marker gene , and enhanced phosphorylation of gene in SH-SY5Y cells .	T15	T19	23047912
CPR:3	CHEMICAL	GENE-Y	3	37	Nevertheless , low chemical concentrations ( ≥ 0.1mM , 48 h ) increased protein ubiquitination , gene and gene activity , expression of the endoplasmic reticulum ( ER ) stress marker gene , and enhanced phosphorylation of gene in SH-SY5Y cells .	T15	T20	23047912
NA	CHEMICAL	GENE-Y	4	2	Role of gene in chemical metabolism and clearance .	T21	T33	23361846
CPR:9	CHEMICAL	GENE-Y	0	8	chemical chemical-demethylation in vitro is catalyzed by hepatic gene ( gene ) and gene , but clinical disposition is often attributed to gene .	T2	T30	23361846
CPR:9	CHEMICAL	GENE-Y	0	10	chemical chemical-demethylation in vitro is catalyzed by hepatic gene ( gene ) and gene , but clinical disposition is often attributed to gene .	T2	T31	23361846
CPR:9	CHEMICAL	GENE-Y	0	13	chemical chemical-demethylation in vitro is catalyzed by hepatic gene ( gene ) and gene , but clinical disposition is often attributed to gene .	T2	T32	23361846
CPR:9	CHEMICAL	GENE-Y	0	22	chemical chemical-demethylation in vitro is catalyzed by hepatic gene ( gene ) and gene , but clinical disposition is often attributed to gene .	T2	T24	23361846
CPR:9	CHEMICAL	GENE-N	8	10	This investigation tested the hypothesis that gene is a prominent gene isoform responsible for clinical chemical chemical-demethylation and clearance , using the in vivo mechanism-based gene inhibitor chemical , given orally for 4 days .	T7	T26	23361846
NA	CHEMICAL	GENE-Y	8	25	This investigation tested the hypothesis that gene is a prominent gene isoform responsible for clinical chemical chemical-demethylation and clearance , using the in vivo mechanism-based gene inhibitor chemical , given orally for 4 days .	T7	T27	23361846
CPR:9	CHEMICAL	GENE-N	6	10	This investigation tested the hypothesis that gene is a prominent gene isoform responsible for clinical chemical chemical-demethylation and clearance , using the in vivo mechanism-based gene inhibitor chemical , given orally for 4 days .	T8	T26	23361846
NA	CHEMICAL	GENE-Y	6	25	This investigation tested the hypothesis that gene is a prominent gene isoform responsible for clinical chemical chemical-demethylation and clearance , using the in vivo mechanism-based gene inhibitor chemical , given orally for 4 days .	T8	T27	23361846
NA	CHEMICAL	GENE-N	22	10	This investigation tested the hypothesis that gene is a prominent gene isoform responsible for clinical chemical chemical-demethylation and clearance , using the in vivo mechanism-based gene inhibitor chemical , given orally for 4 days .	T9	T26	23361846
CPR:4	CHEMICAL	GENE-Y	22	25	This investigation tested the hypothesis that gene is a prominent gene isoform responsible for clinical chemical chemical-demethylation and clearance , using the in vivo mechanism-based gene inhibitor chemical , given orally for 4 days .	T9	T27	23361846
NA	CHEMICAL	GENE-N	9	0	A preliminary clinical investigation with the gene substrate probe chemical established that chemical did not inhibit intestinal or hepatic gene .	T10	T28	23361846
NA	CHEMICAL	GENE-N	9	0	A preliminary clinical investigation with the gene substrate probe chemical established that chemical did not inhibit intestinal or hepatic gene .	T10	T29	23361846
NA	CHEMICAL	GENE-N	12	0	A preliminary clinical investigation with the gene substrate probe chemical established that chemical did not inhibit intestinal or hepatic gene .	T11	T28	23361846
NA	CHEMICAL	GENE-N	12	0	A preliminary clinical investigation with the gene substrate probe chemical established that chemical did not inhibit intestinal or hepatic gene .	T11	T29	23361846
NA	CHEMICAL	GENE-N	9	0	gene are a class of cell surface receptors for chemical that prefer chemical or chemical over chemical .	T19	T24	17110146
NA	CHEMICAL	GENE-N	12	0	gene are a class of cell surface receptors for chemical that prefer chemical or chemical over chemical .	T20	T24	17110146
NA	CHEMICAL	GENE-N	14	0	gene are a class of cell surface receptors for chemical that prefer chemical or chemical over chemical .	T21	T24	17110146
NA	CHEMICAL	GENE-N	2	0	gene are a class of cell surface receptors for chemical that prefer chemical or chemical over chemical .	T23	T24	17110146
NA	CHEMICAL	GENE-N	5	2	The surface receptors for extracellular chemical are called gene .	T9	T35	17110146
CPR:3	CHEMICAL	GENE-N	0	9	chemical initiates platelet aggregation by 'simultaneous activation of two gene , gene and gene .	T13	T36	17110146
CPR:3	CHEMICAL	GENE-Y	0	11	chemical initiates platelet aggregation by 'simultaneous activation of two gene , gene and gene .	T13	T37	17110146
CPR:3	CHEMICAL	GENE-Y	0	13	chemical initiates platelet aggregation by 'simultaneous activation of two gene , gene and gene .	T13	T38	17110146
NA	CHEMICAL	GENE-Y	10	0	gene has been shown to be the target of the chemical drugs , chemical and chemical .	T14	T39	17110146
NA	CHEMICAL	GENE-Y	13	0	gene has been shown to be the target of the chemical drugs , chemical and chemical .	T15	T39	17110146
NA	CHEMICAL	GENE-Y	15	0	gene has been shown to be the target of the chemical drugs , chemical and chemical .	T16	T39	17110146
NA	CHEMICAL	GENE-Y	8	6	Here , the active sites of gene for chemical as well as chemical are predicted by bioinformatics and molecular modeling .	T17	T40	17110146
NA	CHEMICAL	GENE-Y	12	6	Here , the active sites of gene for chemical as well as chemical are predicted by bioinformatics and molecular modeling .	T18	T40	17110146
NA	CHEMICAL	GENE-Y	26	7	And the most probable active sites of gene were predicted using the scoring matrix , which include three distant areas : `` head area '' ( chemical , 87-96 ) , `` middle area '' ( chemical , 38-47 , and chemical , 139-148 ) , and `` bottom area '' ( chemical , 222-231 ) .	T1	T25	17110146
NA	CHEMICAL	GENE-Y	7	7	And the most probable active sites of gene were predicted using the scoring matrix , which include three distant areas : `` head area '' ( chemical , 87-96 ) , `` middle area '' ( chemical , 38-47 , and chemical , 139-148 ) , and `` bottom area '' ( chemical , 222-231 ) .	T2	T25	17110146
NA	CHEMICAL	GENE-Y	41	7	And the most probable active sites of gene were predicted using the scoring matrix , which include three distant areas : `` head area '' ( chemical , 87-96 ) , `` middle area '' ( chemical , 38-47 , and chemical , 139-148 ) , and `` bottom area '' ( chemical , 222-231 ) .	T3	T25	17110146
NA	CHEMICAL	GENE-Y	52	7	And the most probable active sites of gene were predicted using the scoring matrix , which include three distant areas : `` head area '' ( chemical , 87-96 ) , `` middle area '' ( chemical , 38-47 , and chemical , 139-148 ) , and `` bottom area '' ( chemical , 222-231 ) .	T4	T25	17110146
NA	CHEMICAL	GENE-Y	9	5	Subsequently the structural model of gene was docked with chemical/chemical in comparison with gene ( gene ) .	T5	T30	17110146
NA	CHEMICAL	GENE-Y	9	13	Subsequently the structural model of gene was docked with chemical/chemical in comparison with gene ( gene ) .	T5	T31	17110146
NA	CHEMICAL	GENE-Y	9	15	Subsequently the structural model of gene was docked with chemical/chemical in comparison with gene ( gene ) .	T5	T32	17110146
NA	CHEMICAL	GENE-Y	9	5	Subsequently the structural model of gene was docked with chemical/chemical in comparison with gene ( gene ) .	T6	T30	17110146
NA	CHEMICAL	GENE-Y	9	13	Subsequently the structural model of gene was docked with chemical/chemical in comparison with gene ( gene ) .	T6	T31	17110146
NA	CHEMICAL	GENE-Y	9	15	Subsequently the structural model of gene was docked with chemical/chemical in comparison with gene ( gene ) .	T6	T32	17110146
NA	CHEMICAL	GENE-Y	0	11	chemical uptake in brain and skeletal muscle of mice lacking chemical methyltransferase assessed by magnetic resonance spectroscopy .	T27	T35	17347380
NA	CHEMICAL	GENE-Y	2	11	chemical uptake in brain and skeletal muscle of mice lacking chemical methyltransferase assessed by magnetic resonance spectroscopy .	T28	T35	17347380
NA	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T1	T34	17347380
NA	CHEMICAL	GENE-Y	0	23	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T1	T30	17347380
NA	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T3	T34	17347380
NA	CHEMICAL	GENE-Y	2	23	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T3	T30	17347380
NA	CHEMICAL	GENE-Y	15	11	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T21	T34	17347380
NA	CHEMICAL	GENE-Y	15	23	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T21	T30	17347380
NA	CHEMICAL	GENE-Y	5	11	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T25	T34	17347380
NA	CHEMICAL	GENE-Y	5	23	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T25	T30	17347380
NA	CHEMICAL	GENE-Y	28	11	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T11	T34	17347380
NA	CHEMICAL	GENE-Y	28	23	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T11	T30	17347380
NA	CHEMICAL	GENE-Y	35	11	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T12	T34	17347380
NA	CHEMICAL	GENE-Y	35	23	chemical ( chemical ) levels in skeletal muscle and brain of a mouse model of chemical deficiency caused by chemical methyltransferase absence ( gene-/- ) were studied after chemical supplementation with 2 g.kg body wt-1.day-1 chemical for 35 days .	T12	T30	17347380
NA	CHEMICAL	GENE-Y	1	23	Localized chemical magnetic resonance spectroscopy ( MRS ) was performed in brain ( cerebellum and thalamus/hippocampus ) and in hind leg muscle of gene-/- mice before and after chemical supplementation and in control ( Con ) mice .	T13	T32	17347380
NA	CHEMICAL	GENE-Y	28	23	Localized chemical magnetic resonance spectroscopy ( MRS ) was performed in brain ( cerebellum and thalamus/hippocampus ) and in hind leg muscle of gene-/- mice before and after chemical supplementation and in control ( Con ) mice .	T14	T32	17347380
NA	CHEMICAL	GENE-Y	6	14	As expected , a signal for chemical was hardly detectable in MR spectra of gene-/- mice before chemical supplementation .	T15	T33	17347380
NA	CHEMICAL	GENE-Y	17	14	As expected , a signal for chemical was hardly detectable in MR spectra of gene-/- mice before chemical supplementation .	T16	T33	17347380
NA	CHEMICAL	GENE-Y	11	15	Only because of the repeated MRS measurements performed in this longitudinal chemical supplementation study on gene-/- mice were we able to discover the initial faster uptake of chemical in skeletal muscle compared with brain , which may represent muscular chemical uptake independent of chemical transporter expression .	T4	T29	17347380
NA	CHEMICAL	GENE-Y	27	15	Only because of the repeated MRS measurements performed in this longitudinal chemical supplementation study on gene-/- mice were we able to discover the initial faster uptake of chemical in skeletal muscle compared with brain , which may represent muscular chemical uptake independent of chemical transporter expression .	T5	T29	17347380
NA	CHEMICAL	GENE-Y	39	15	Only because of the repeated MRS measurements performed in this longitudinal chemical supplementation study on gene-/- mice were we able to discover the initial faster uptake of chemical in skeletal muscle compared with brain , which may represent muscular chemical uptake independent of chemical transporter expression .	T6	T29	17347380
NA	CHEMICAL	GENE-Y	43	15	Only because of the repeated MRS measurements performed in this longitudinal chemical supplementation study on gene-/- mice were we able to discover the initial faster uptake of chemical in skeletal muscle compared with brain , which may represent muscular chemical uptake independent of chemical transporter expression .	T7	T29	17347380
CPR:4	CHEMICAL	GENE-N	3	13	Protective effect of chemical anesthesia on retinal light damage : inhibition of metabolic gene regeneration .	T8	T21	11157886
NA	CHEMICAL	GENE-N	8	12	PURPOSE : To determine whether the volatile anesthetic chemical protects against light-induced gene degeneration in the rodent retina .	T5	T20	11157886
CPR:4	CHEMICAL	GENE-N	2	7	RESULTS : chemical anesthesia reversibly inhibited metabolic gene regeneration and thus prevented gene from absorbing high numbers of photons during light exposure .	T6	T17	11157886
CPR:4	CHEMICAL	GENE-N	2	12	RESULTS : chemical anesthesia reversibly inhibited metabolic gene regeneration and thus prevented gene from absorbing high numbers of photons during light exposure .	T6	T18	11157886
NA	CHEMICAL	GENE-N	9	2	Consequently , gene of mice and rats anesthetized with chemical were completely protected against degeneration induced by white light .	T7	T19	11157886
NA	CHEMICAL	GENE-N	7	12	CONCLUSIONS : After the initial bleach , chemical impeded photon absorption by gene by inhibiting metabolic gene regeneration .	T2	T9	11157886
CPR:4	CHEMICAL	GENE-N	7	16	CONCLUSIONS : After the initial bleach , chemical impeded photon absorption by gene by inhibiting metabolic gene regeneration .	T2	T10	11157886
CPR:4	CHEMICAL	GENE-N	0	2	chemical inhibits gene and has shown therapeutic effects in patients with hematologic malignancies .	T2	T9	17023173
NA	CHEMICAL	GENE-N	0	2	chemical binding protein in primary tumours and metastases of malignant melanoma .	T3	T11	7703721
NA	CHEMICAL	GENE-N	3	5	The presence of chemical binding protein ( gene ) , a 54 kD cytosolic glycoprotein , which is distinct from the chemical receptor , was investigated in a pilot study of primary malignant melanomas and their metastases .	T2	T5	7703721
NA	CHEMICAL	GENE-N	3	7	The presence of chemical binding protein ( gene ) , a 54 kD cytosolic glycoprotein , which is distinct from the chemical receptor , was investigated in a pilot study of primary malignant melanomas and their metastases .	T2	T8	7703721
NA	CHEMICAL	GENE-Y	3	22	The presence of chemical binding protein ( gene ) , a 54 kD cytosolic glycoprotein , which is distinct from the chemical receptor , was investigated in a pilot study of primary malignant melanomas and their metastases .	T2	T4	7703721
NA	CHEMICAL	GENE-N	21	5	The presence of chemical binding protein ( gene ) , a 54 kD cytosolic glycoprotein , which is distinct from the chemical receptor , was investigated in a pilot study of primary malignant melanomas and their metastases .	T1	T5	7703721
NA	CHEMICAL	GENE-N	21	7	The presence of chemical binding protein ( gene ) , a 54 kD cytosolic glycoprotein , which is distinct from the chemical receptor , was investigated in a pilot study of primary malignant melanomas and their metastases .	T1	T8	7703721
NA	CHEMICAL	GENE-Y	21	22	The presence of chemical binding protein ( gene ) , a 54 kD cytosolic glycoprotein , which is distinct from the chemical receptor , was investigated in a pilot study of primary malignant melanomas and their metastases .	T1	T4	7703721
CPR:9	CHEMICAL	GENE-N	8	0	A Nanogram Dose of the gene Probe Substrate chemical to Evaluate Drug Interactions .	T12	T20	23511711
NA	CHEMICAL	GENE-N	25	14	The objective of the study was to establish an in vivo method for assessing gene ( gene ) activity using therapeutically inert nanogram doses of chemical .	T3	T18	23511711
NA	CHEMICAL	GENE-N	25	16	The objective of the study was to establish an in vivo method for assessing gene ( gene ) activity using therapeutically inert nanogram doses of chemical .	T3	T19	23511711
NA	CHEMICAL	GENE-Y	8	21	We administered four escalating single doses of oral chemical ( 0.0001-3 mg ) to 12 healthy participants , stratified according to gene carrier status , to assess pharmacokinetics linearity .	T4	T15	23511711
CPR:4	CHEMICAL	GENE-N	9	7	We then evaluated the interactions with the gene inhibitor chemical ( 400 mg q.d . )	T5	T16	23511711
CPR:9	CHEMICAL	GENE-Y	7	0	gene carrier status had no influence on chemical oral clearance or its inhibition by chemical .	T9	T17	23511711
CPR:4	CHEMICAL	GENE-Y	6	0	gene carrier status had no influence on chemical oral clearance or its inhibition by chemical .	T10	T17	23511711
NA	CHEMICAL	GENE-Y	3	4	These PCSCs possessed chemical receptors and gene , but not chemical receptor as determined by RT-PCR and Western blot , respectively .	T3	T23	16854582
NA	CHEMICAL	GENE-Y	3	6	These PCSCs possessed chemical receptors and gene , but not chemical receptor as determined by RT-PCR and Western blot , respectively .	T3	T25	16854582
NA	CHEMICAL	GENE-Y	3	11	These PCSCs possessed chemical receptors and gene , but not chemical receptor as determined by RT-PCR and Western blot , respectively .	T3	T26	16854582
NA	CHEMICAL	GENE-Y	5	4	These PCSCs possessed chemical receptors and gene , but not chemical receptor as determined by RT-PCR and Western blot , respectively .	T4	T23	16854582
NA	CHEMICAL	GENE-Y	5	6	These PCSCs possessed chemical receptors and gene , but not chemical receptor as determined by RT-PCR and Western blot , respectively .	T4	T25	16854582
NA	CHEMICAL	GENE-Y	5	11	These PCSCs possessed chemical receptors and gene , but not chemical receptor as determined by RT-PCR and Western blot , respectively .	T4	T26	16854582
NA	CHEMICAL	GENE-Y	5	18	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T1	T10	16854582
NA	CHEMICAL	GENE-Y	5	26	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T1	T11	16854582
NA	CHEMICAL	GENE-Y	5	32	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T1	T12	16854582
NA	CHEMICAL	GENE-N	5	34	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T1	T13	16854582
NA	CHEMICAL	GENE-Y	7	18	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T2	T10	16854582
NA	CHEMICAL	GENE-Y	7	26	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T2	T11	16854582
NA	CHEMICAL	GENE-Y	7	32	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T2	T12	16854582
NA	CHEMICAL	GENE-N	7	34	Cell proliferation analysis indicated that chemical or chemical reduced cell viability in a dose-dependent manner ; however , gene prevented this inhibition , which further demonstrated gene triggered anti-apoptotic machinery through activating gene and gene expression .	T2	T13	16854582
NA	CHEMICAL	GENE-Y	0	12	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T11	22447684
NA	CHEMICAL	GENE-Y	0	14	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T12	22447684
NA	CHEMICAL	GENE-Y	0	16	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T13	22447684
NA	CHEMICAL	GENE-Y	0	18	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T14	22447684
NA	CHEMICAL	GENE-Y	0	20	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T15	22447684
NA	CHEMICAL	GENE-Y	0	22	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T16	22447684
NA	CHEMICAL	GENE-Y	0	24	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T17	22447684
NA	CHEMICAL	GENE-Y	0	26	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T18	22447684
NA	CHEMICAL	GENE-Y	0	28	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T19	22447684
NA	CHEMICAL	GENE-Y	0	30	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T20	22447684
NA	CHEMICAL	GENE-Y	0	33	chemical supplementation altered expression profiles of several lipid metabolism-related genes , including gene , gene , gene , gene , gene , gene , gene , gene , gene , gene , and gene , relative to those in HFD control mice .	T9	T21	22447684
NA	CHEMICAL	GENE-N	3	2	Effects of a chemical channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1 , LQT2 , and LQT3 models of the long-QT syndrome .	T15	T25	10931813
CPR:3	CHEMICAL	GENE-N	8	10	BACKGROUND : This study examines the effects of chemical , a chemical channel opener , on transmural dispersion of repolarization ( TDR ) and induction of torsade de pointes ( TdP ) under conditions mimicking the LQT1 , LQT2 , and LQT3 forms of the congenital long-QT syndrome ( LQTS ) .	T7	T21	10931813
NA	CHEMICAL	GENE-N	11	10	BACKGROUND : This study examines the effects of chemical , a chemical channel opener , on transmural dispersion of repolarization ( TDR ) and induction of torsade de pointes ( TdP ) under conditions mimicking the LQT1 , LQT2 , and LQT3 forms of the congenital long-QT syndrome ( LQTS ) .	T9	T21	10931813
CPR:4	CHEMICAL	GENE-N	0	1	chemical ( 50 to 100 nmol/L ) was used to mimic an increase in beta-adrenergic tone , chemical ( 100 micromol/L ) to block gene ( LQT2 model ) , and gene ( 20 nmol/L ) to augment late I ( chemical ) ( LQT3 model ) .	T8	T22	10931813
CPR:4	CHEMICAL	GENE-Y	0	31	chemical ( 50 to 100 nmol/L ) was used to mimic an increase in beta-adrenergic tone , chemical ( 100 micromol/L ) to block gene ( LQT2 model ) , and gene ( 20 nmol/L ) to augment late I ( chemical ) ( LQT3 model ) .	T8	T23	10931813
CPR:4	CHEMICAL	GENE-N	17	1	chemical ( 50 to 100 nmol/L ) was used to mimic an increase in beta-adrenergic tone , chemical ( 100 micromol/L ) to block gene ( LQT2 model ) , and gene ( 20 nmol/L ) to augment late I ( chemical ) ( LQT3 model ) .	T10	T22	10931813
CPR:4	CHEMICAL	GENE-Y	17	31	chemical ( 50 to 100 nmol/L ) was used to mimic an increase in beta-adrenergic tone , chemical ( 100 micromol/L ) to block gene ( LQT2 model ) , and gene ( 20 nmol/L ) to augment late I ( chemical ) ( LQT3 model ) .	T10	T23	10931813
NA	CHEMICAL	GENE-N	41	1	chemical ( 50 to 100 nmol/L ) was used to mimic an increase in beta-adrenergic tone , chemical ( 100 micromol/L ) to block gene ( LQT2 model ) , and gene ( 20 nmol/L ) to augment late I ( chemical ) ( LQT3 model ) .	T11	T22	10931813
NA	CHEMICAL	GENE-Y	41	31	chemical ( 50 to 100 nmol/L ) was used to mimic an increase in beta-adrenergic tone , chemical ( 100 micromol/L ) to block gene ( LQT2 model ) , and gene ( 20 nmol/L ) to augment late I ( chemical ) ( LQT3 model ) .	T11	T23	10931813
NA	CHEMICAL	GENE-Y	0	5	chemical+chemical , chemical , and gene produced preferential prolongation of the action potential duration at 90 % repolarization ( APD ( 90 ) ) of the M cell , an increase of TDR , and spontaneous as well as stimulation-induced TdP ( LQT1 , 3/6 ; LQT2 , 3/6 ; LQT3 , 5/6 ) .	T12	T24	10931813
NA	CHEMICAL	GENE-Y	0	5	chemical+chemical , chemical , and gene produced preferential prolongation of the action potential duration at 90 % repolarization ( APD ( 90 ) ) of the M cell , an increase of TDR , and spontaneous as well as stimulation-induced TdP ( LQT1 , 3/6 ; LQT2 , 3/6 ; LQT3 , 5/6 ) .	T13	T24	10931813
NA	CHEMICAL	GENE-Y	2	5	chemical+chemical , chemical , and gene produced preferential prolongation of the action potential duration at 90 % repolarization ( APD ( 90 ) ) of the M cell , an increase of TDR , and spontaneous as well as stimulation-induced TdP ( LQT1 , 3/6 ; LQT2 , 3/6 ; LQT3 , 5/6 ) .	T14	T24	10931813
NA	CHEMICAL	GENE-Y	0	11	chemical 20 micromol/L reversed only 50 % of the effect of gene and failed to completely suppress TdP in the LQT3 model ( 5/6 to 3/6 ) .	T4	T16	10931813
NA	CHEMICAL	GENE-N	5	1	The gene blocking activities of chemical and its RR-SR ( 50:50 ) stereoisomers .	T19	T27	1687367
NA	CHEMICAL	GENE-N	7	3	We compared the gene blocking potencies of chemical with those of its two stereoisomers ( RR and SR ) in pithed rats and in homogenized rat cerebral cortex and heart .	T17	T25	1687367
NA	CHEMICAL	GENE-N	1	2	and chemical 1 and 5 mg kg-1 body wt. , were given intravenously for comparison studies of potency at gene , respectively .	T13	T26	1687367
NA	CHEMICAL	GENE-N	14	18	Following both oral and intravenous dosing , the RR-SR combination was twice potent as chemical in terms of gene antagonism at equivalent doses .	T2	T20	1687367
NA	CHEMICAL	GENE-N	0	7	chemical and the enantiomers lacked affinity at gene while at gene the order of potency was chemical much greater than RR-SR greater than chemical .	T3	T21	1687367
NA	CHEMICAL	GENE-N	0	10	chemical and the enantiomers lacked affinity at gene while at gene the order of potency was chemical much greater than RR-SR greater than chemical .	T3	T22	1687367
NA	CHEMICAL	GENE-N	16	7	chemical and the enantiomers lacked affinity at gene while at gene the order of potency was chemical much greater than RR-SR greater than chemical .	T4	T21	1687367
NA	CHEMICAL	GENE-N	16	10	chemical and the enantiomers lacked affinity at gene while at gene the order of potency was chemical much greater than RR-SR greater than chemical .	T4	T22	1687367
NA	CHEMICAL	GENE-N	23	7	chemical and the enantiomers lacked affinity at gene while at gene the order of potency was chemical much greater than RR-SR greater than chemical .	T5	T21	1687367
NA	CHEMICAL	GENE-N	23	10	chemical and the enantiomers lacked affinity at gene while at gene the order of potency was chemical much greater than RR-SR greater than chemical .	T5	T22	1687367
NA	CHEMICAL	GENE-Y	15	1	At gene , the affinity of the compound RR-SR was about 3 times that of chemical.5 .	T6	T23	1687367
NA	CHEMICAL	GENE-N	1	24	As chemical is a mixture of active ( RR and SR ) and inactive ( SS and SR ) enantiomers ( in terms of gene actions ) , the combination of RR and SR may be a valuable substitute for chemical in the treatment of systemic hypertension .	T7	T24	1687367
NA	CHEMICAL	GENE-N	3	24	As chemical is a mixture of active ( RR and SR ) and inactive ( SS and SR ) enantiomers ( in terms of gene actions ) , the combination of RR and SR may be a valuable substitute for chemical in the treatment of systemic hypertension .	T8	T24	1687367
NA	CHEMICAL	GENE-Y	11	13	Direct and exome sequencing identified the presence of a T-to-C exchange in exon 1 of gene , corresponding to a chemical-to-chemical mutation at residue 107 .	T1	T8	23473037
NA	CHEMICAL	GENE-N	11	13	Direct and exome sequencing identified the presence of a T-to-C exchange in exon 1 of gene , corresponding to a chemical-to-chemical mutation at residue 107 .	T1	T9	23473037
NA	CHEMICAL	GENE-Y	11	13	Direct and exome sequencing identified the presence of a T-to-C exchange in exon 1 of gene , corresponding to a chemical-to-chemical mutation at residue 107 .	T2	T8	23473037
NA	CHEMICAL	GENE-N	11	13	Direct and exome sequencing identified the presence of a T-to-C exchange in exon 1 of gene , corresponding to a chemical-to-chemical mutation at residue 107 .	T2	T9	23473037
NA	CHEMICAL	GENE-Y	10	2	Expression of gene-gene in gene-producing cells resulted in overproduction of chemical , gene , and gene .	T3	T10	23473037
NA	CHEMICAL	GENE-N	10	2	Expression of gene-gene in gene-producing cells resulted in overproduction of chemical , gene , and gene .	T3	T11	23473037
NA	CHEMICAL	GENE-Y	10	3	Expression of gene-gene in gene-producing cells resulted in overproduction of chemical , gene , and gene .	T3	T12	23473037
NA	CHEMICAL	GENE-N	10	3	Expression of gene-gene in gene-producing cells resulted in overproduction of chemical , gene , and gene .	T3	T14	23473037
NA	CHEMICAL	GENE-N	10	3	Expression of gene-gene in gene-producing cells resulted in overproduction of chemical , gene , and gene .	T3	T15	23473037
NA	CHEMICAL	GENE-Y	0	7	chemical modifies but does not block the gene-induced gene response in patients with Addison 's disease .	T3	T17	2832297
NA	CHEMICAL	GENE-Y	0	8	chemical modifies but does not block the gene-induced gene response in patients with Addison 's disease .	T3	T18	2832297
NA	CHEMICAL	GENE-Y	3	12	The effect of chemical - a peripheral opiate agonist - on plasma gene response to gene ( gene ) has been investigated in 6 patients with Addison 's disease .	T1	T15	2832297
NA	CHEMICAL	GENE-Y	3	10	The effect of chemical - a peripheral opiate agonist - on plasma gene response to gene ( gene ) has been investigated in 6 patients with Addison 's disease .	T1	T16	2832297
NA	CHEMICAL	GENE-Y	3	17	The effect of chemical - a peripheral opiate agonist - on plasma gene response to gene ( gene ) has been investigated in 6 patients with Addison 's disease .	T1	T4	2832297
CPR:4	CHEMICAL	GENE-Y	1	3	After chemical administration gene levels fell to a nadir of 135 +/- 76 pg/ml , and then gene was still able to induce an gene increase ; the pattern of gene response to gene was slightly delayed .	T2	T7	2832297
NA	CHEMICAL	GENE-Y	1	17	After chemical administration gene levels fell to a nadir of 135 +/- 76 pg/ml , and then gene was still able to induce an gene increase ; the pattern of gene response to gene was slightly delayed .	T2	T8	2832297
CPR:3	CHEMICAL	GENE-Y	1	24	After chemical administration gene levels fell to a nadir of 135 +/- 76 pg/ml , and then gene was still able to induce an gene increase ; the pattern of gene response to gene was slightly delayed .	T2	T9	2832297
NA	CHEMICAL	GENE-Y	1	30	After chemical administration gene levels fell to a nadir of 135 +/- 76 pg/ml , and then gene was still able to induce an gene increase ; the pattern of gene response to gene was slightly delayed .	T2	T10	2832297
NA	CHEMICAL	GENE-Y	1	33	After chemical administration gene levels fell to a nadir of 135 +/- 76 pg/ml , and then gene was still able to induce an gene increase ; the pattern of gene response to gene was slightly delayed .	T2	T11	2832297
NA	CHEMICAL	GENE-N	3	7	Differential activation of chemical response element binding protein in discrete nucleus accumbens subregions during early and late chemical sensitization .	T11	T20	17324065
CPR:3	CHEMICAL	GENE-N	8	7	Differential activation of chemical response element binding protein in discrete nucleus accumbens subregions during early and late chemical sensitization .	T10	T20	17324065
CPR:3	CHEMICAL	GENE-N	6	17	The present study examined the differential chemical-induced activation of the chemical ( chemical ) response element binding protein ( gene ) throughout discrete zones of analysis of the nucleus accumbens ( NAc ) in rats .	T5	T18	17324065
CPR:3	CHEMICAL	GENE-N	6	19	The present study examined the differential chemical-induced activation of the chemical ( chemical ) response element binding protein ( gene ) throughout discrete zones of analysis of the nucleus accumbens ( NAc ) in rats .	T5	T15	17324065
NA	CHEMICAL	GENE-N	10	17	The present study examined the differential chemical-induced activation of the chemical ( chemical ) response element binding protein ( gene ) throughout discrete zones of analysis of the nucleus accumbens ( NAc ) in rats .	T8	T18	17324065
NA	CHEMICAL	GENE-N	10	19	The present study examined the differential chemical-induced activation of the chemical ( chemical ) response element binding protein ( gene ) throughout discrete zones of analysis of the nucleus accumbens ( NAc ) in rats .	T8	T15	17324065
NA	CHEMICAL	GENE-N	12	17	The present study examined the differential chemical-induced activation of the chemical ( chemical ) response element binding protein ( gene ) throughout discrete zones of analysis of the nucleus accumbens ( NAc ) in rats .	T1	T18	17324065
NA	CHEMICAL	GENE-N	12	19	The present study examined the differential chemical-induced activation of the chemical ( chemical ) response element binding protein ( gene ) throughout discrete zones of analysis of the nucleus accumbens ( NAc ) in rats .	T1	T15	17324065
NA	CHEMICAL	GENE-N	10	0	gene-dependent gene transcription , which may underlie long-lasting drug-induced changes in behavior and the subjective effects of chemical , varies depending on the stage of drug exposure or withdrawal and the cell population involved .	T4	T16	17324065
CPR:3	CHEMICAL	GENE-N	7	8	Using immunohistochemistry , the authors analyzed changes in gene phosphorylation in the NAc after 5 days of chemical , a short or long drug-free period , and a subsequent challenge injection .	T6	T17	17324065
CPR:3	CHEMICAL	GENE-N	1	4	Repeated chemical resulted in gene phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated chemical , but rats challenged after 2 drug-free days yielded a more localized activation of gene in the 3 most dorsomedial zones of the shell .	T7	T19	17324065
NA	CHEMICAL	GENE-N	1	42	Repeated chemical resulted in gene phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated chemical , but rats challenged after 2 drug-free days yielded a more localized activation of gene in the 3 most dorsomedial zones of the shell .	T7	T12	17324065
NA	CHEMICAL	GENE-N	3	4	Repeated chemical resulted in gene phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated chemical , but rats challenged after 2 drug-free days yielded a more localized activation of gene in the 3 most dorsomedial zones of the shell .	T9	T19	17324065
CPR:3	CHEMICAL	GENE-N	3	42	Repeated chemical resulted in gene phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated chemical , but rats challenged after 2 drug-free days yielded a more localized activation of gene in the 3 most dorsomedial zones of the shell .	T9	T12	17324065
CPR:3	CHEMICAL	GENE-Y	0	6	chemical inhibits autophagic flux activating the gene-gene pathway in a gene-dependent manner .	T10	T30	23589329
CPR:3	CHEMICAL	GENE-Y	0	6	chemical inhibits autophagic flux activating the gene-gene pathway in a gene-dependent manner .	T10	T31	23589329
NA	CHEMICAL	GENE-Y	0	10	chemical inhibits autophagic flux activating the gene-gene pathway in a gene-dependent manner .	T10	T32	23589329
CPR:4	CHEMICAL	GENE-Y	0	19	chemical deregulates the autophagic pathway through blockage of autophagic flux , resulting in accumulation of autophagosomes and sequestration of gene , gene , and gene .	T5	T20	23589329
CPR:4	CHEMICAL	GENE-Y	0	21	chemical deregulates the autophagic pathway through blockage of autophagic flux , resulting in accumulation of autophagosomes and sequestration of gene , gene , and gene .	T5	T21	23589329
CPR:4	CHEMICAL	GENE-N	0	24	chemical deregulates the autophagic pathway through blockage of autophagic flux , resulting in accumulation of autophagosomes and sequestration of gene , gene , and gene .	T5	T22	23589329
CPR:3	CHEMICAL	GENE-Y	2	4	Thus , chemical activates gene through a non-canonical mechanism ( gene-dependent ) , leading to a chronic , sustained activation of gene .	T6	T23	23589329
NA	CHEMICAL	GENE-Y	2	10	Thus , chemical activates gene through a non-canonical mechanism ( gene-dependent ) , leading to a chronic , sustained activation of gene .	T6	T24	23589329
CPR:3	CHEMICAL	GENE-Y	2	21	Thus , chemical activates gene through a non-canonical mechanism ( gene-dependent ) , leading to a chronic , sustained activation of gene .	T6	T25	23589329
CPR:3	CHEMICAL	GENE-Y	7	5	In contrast , activation of gene by chemical and chemical depend upon gene-C151 and not gene ( the canonical mechanism ) .	T7	T26	23589329
NA	CHEMICAL	GENE-Y	7	12	In contrast , activation of gene by chemical and chemical depend upon gene-C151 and not gene ( the canonical mechanism ) .	T7	T27	23589329
NA	CHEMICAL	GENE-Y	7	15	In contrast , activation of gene by chemical and chemical depend upon gene-C151 and not gene ( the canonical mechanism ) .	T7	T29	23589329
CPR:3	CHEMICAL	GENE-Y	9	5	In contrast , activation of gene by chemical and chemical depend upon gene-C151 and not gene ( the canonical mechanism ) .	T8	T26	23589329
NA	CHEMICAL	GENE-Y	9	12	In contrast , activation of gene by chemical and chemical depend upon gene-C151 and not gene ( the canonical mechanism ) .	T8	T27	23589329
NA	CHEMICAL	GENE-Y	9	15	In contrast , activation of gene by chemical and chemical depend upon gene-C151 and not gene ( the canonical mechanism ) .	T8	T29	23589329
CPR:3	CHEMICAL	GENE-Y	7	12	Collectively , these findings provide evidence that chemical causes prolonged activation of gene through autophagy dysfunction , possibly providing a similar scenario to constitutive activation of gene found in certain human cancers .	T3	T12	23589329
CPR:3	CHEMICAL	GENE-Y	7	26	Collectively , these findings provide evidence that chemical causes prolonged activation of gene through autophagy dysfunction , possibly providing a similar scenario to constitutive activation of gene found in certain human cancers .	T3	T13	23589329
CPR:4	CHEMICAL	GENE-Y	0	14	chemical ( chemical ) , a selective , irreversible inhibitor of chemical oxidase type B ( gene ) is widely used in the treatment of Parkinson 's disease .	T1	T40	9673855
CPR:4	CHEMICAL	GENE-Y	0	14	chemical ( chemical ) , a selective , irreversible inhibitor of chemical oxidase type B ( gene ) is widely used in the treatment of Parkinson 's disease .	T1	T41	9673855
CPR:4	CHEMICAL	GENE-Y	2	14	chemical ( chemical ) , a selective , irreversible inhibitor of chemical oxidase type B ( gene ) is widely used in the treatment of Parkinson 's disease .	T2	T40	9673855
CPR:4	CHEMICAL	GENE-Y	2	14	chemical ( chemical ) , a selective , irreversible inhibitor of chemical oxidase type B ( gene ) is widely used in the treatment of Parkinson 's disease .	T2	T41	9673855
NA	CHEMICAL	GENE-Y	5	14	chemical ( chemical ) , a selective , irreversible inhibitor of chemical oxidase type B ( gene ) is widely used in the treatment of Parkinson 's disease .	T28	T40	9673855
NA	CHEMICAL	GENE-Y	5	14	chemical ( chemical ) , a selective , irreversible inhibitor of chemical oxidase type B ( gene ) is widely used in the treatment of Parkinson 's disease .	T28	T41	9673855
CPR:4	CHEMICAL	GENE-N	6	3	Unlike the nonselective gene inhibitors , chemical does not significantly potentiate chemical-induced hypertension ( the 'cheese effect ' ) at the dosages ( 5 to 10 mg daily ) used for the treatment of Parkinson 's disease .	T25	T39	9673855
NA	CHEMICAL	GENE-N	11	3	Unlike the nonselective gene inhibitors , chemical does not significantly potentiate chemical-induced hypertension ( the 'cheese effect ' ) at the dosages ( 5 to 10 mg daily ) used for the treatment of Parkinson 's disease .	T26	T39	9673855
NA	CHEMICAL	GENE-N	2	0	A low chemical diet is recommended if chemical is used together with nonselective gene inhibitors or the selective , reversible gene inhibitor , chemical .	T11	T36	9673855
NA	CHEMICAL	GENE-Y	2	0	A low chemical diet is recommended if chemical is used together with nonselective gene inhibitors or the selective , reversible gene inhibitor , chemical .	T11	T37	9673855
CPR:4	CHEMICAL	GENE-N	7	0	A low chemical diet is recommended if chemical is used together with nonselective gene inhibitors or the selective , reversible gene inhibitor , chemical .	T12	T36	9673855
NA	CHEMICAL	GENE-Y	7	0	A low chemical diet is recommended if chemical is used together with nonselective gene inhibitors or the selective , reversible gene inhibitor , chemical .	T12	T37	9673855
NA	CHEMICAL	GENE-N	23	0	A low chemical diet is recommended if chemical is used together with nonselective gene inhibitors or the selective , reversible gene inhibitor , chemical .	T13	T36	9673855
CPR:4	CHEMICAL	GENE-Y	23	0	A low chemical diet is recommended if chemical is used together with nonselective gene inhibitors or the selective , reversible gene inhibitor , chemical .	T13	T37	9673855
NA	CHEMICAL	GENE-N	5	11	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T3	T14	22893351
NA	CHEMICAL	GENE-Y	5	17	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T3	T15	22893351
NA	CHEMICAL	GENE-N	15	11	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T4	T14	22893351
NA	CHEMICAL	GENE-Y	15	17	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T4	T15	22893351
NA	CHEMICAL	GENE-N	15	11	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T5	T14	22893351
NA	CHEMICAL	GENE-Y	15	17	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T5	T15	22893351
NA	CHEMICAL	GENE-N	39	11	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T6	T14	22893351
NA	CHEMICAL	GENE-Y	39	17	It was hypothesized that because chemical accumulates in the proximal tubules ( PTs ) , chemical-chemical-transferases ( GST ) -α ( suggestive of kidney damage at the level of PT ) would be expected to be more related to chemical exposure than gene ( suggestive of kidney damage at the level of the distal tubules ) .	T6	T15	22893351
NA	CHEMICAL	GENE-N	12	18	Our study determined whether there was a significant dose-dependent correlation between increasing chemical exposure from dental amalgams and gene and gene as biomarkers of kidney integrity .	T7	T16	22893351
NA	CHEMICAL	GENE-Y	12	20	Our study determined whether there was a significant dose-dependent correlation between increasing chemical exposure from dental amalgams and gene and gene as biomarkers of kidney integrity .	T7	T17	22893351
NA	CHEMICAL	GENE-N	29	37	Overall , the present study , using a different and more sensitive statistical model than the parent study , revealed a statistically significant dose-dependent correlation between cumulative exposure to chemical from dental amalgams and urinary levels of gene , after covariate adjustment ; where as , a nonsignificant relationship was observed with urinary levels of gene .	T1	T11	22893351
NA	CHEMICAL	GENE-Y	29	55	Overall , the present study , using a different and more sensitive statistical model than the parent study , revealed a statistically significant dose-dependent correlation between cumulative exposure to chemical from dental amalgams and urinary levels of gene , after covariate adjustment ; where as , a nonsignificant relationship was observed with urinary levels of gene .	T1	T12	22893351
NA	CHEMICAL	GENE-Y	5	10	Cell culture studies demonstrated that chemical is capable of delivering anti-gene gene siRNA to lipopolysaccharide ( LPS ) -stimulated macrophages and significantly inhibits the expression of gene .	T15	T21	23240892
NA	CHEMICAL	GENE-Y	5	11	Cell culture studies demonstrated that chemical is capable of delivering anti-gene gene siRNA to lipopolysaccharide ( LPS ) -stimulated macrophages and significantly inhibits the expression of gene .	T15	T22	23240892
CPR:4	CHEMICAL	GENE-Y	5	26	Cell culture studies demonstrated that chemical is capable of delivering anti-gene gene siRNA to lipopolysaccharide ( LPS ) -stimulated macrophages and significantly inhibits the expression of gene .	T15	T17	23240892
NA	CHEMICAL	GENE-Y	0	0	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T4	T18	23240892
CPR:4	CHEMICAL	GENE-N	0	6	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T4	T19	23240892
CPR:4	CHEMICAL	GENE-N	0	9	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T4	T20	23240892
NA	CHEMICAL	GENE-Y	8	0	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T5	T18	23240892
NA	CHEMICAL	GENE-N	8	6	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T5	T19	23240892
NA	CHEMICAL	GENE-N	8	9	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T5	T20	23240892
NA	CHEMICAL	GENE-Y	17	0	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T6	T18	23240892
NA	CHEMICAL	GENE-N	17	6	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T6	T19	23240892
NA	CHEMICAL	GENE-N	17	9	chemical/anti-gene siRNA nanocomplexes significantly reduced the gene ( chemical transaminase ) and the hepatic cellular damages in chemical-intoxicated mice .	T6	T20	23240892
NA	CHEMICAL	GENE-N	14	15	Multipart Copolyelectrolyte Adhesive of the Sandcastle Worm , Phragmatopoma californica ( Fewkes ) : chemical Oxidase Catalyzed Curing through Peptidyl-chemical .	T6	T15	23530959
NA	CHEMICAL	GENE-N	19	15	Multipart Copolyelectrolyte Adhesive of the Sandcastle Worm , Phragmatopoma californica ( Fewkes ) : chemical Oxidase Catalyzed Curing through Peptidyl-chemical .	T5	T15	23530959
NA	CHEMICAL	GENE-N	5	6	Both types of granules contain chemical oxidase that catalyzes oxidative cross-linking of chemical .	T1	T12	23530959
CPR:9	CHEMICAL	GENE-N	12	6	Both types of granules contain chemical oxidase that catalyzes oxidative cross-linking of chemical .	T2	T12	23530959
NA	CHEMICAL	GENE-N	2	3	Co-secretion of chemical oxidase guarantees rapid and spatially homogeneous curing with limited mixing of the preassembled adhesive packets .	T3	T13	23530959
NA	CHEMICAL	GENE-Y	0	6	chemical sequence of the gene for gene ( gene ) .	T5	T10	2994716
NA	CHEMICAL	GENE-Y	0	8	chemical sequence of the gene for gene ( gene ) .	T5	T11	2994716
NA	CHEMICAL	GENE-Y	10	6	Its pathophysiological process is mainly via the competitive inhibition of chemical synthetase .	T1	T10	21207059
NA	CHEMICAL	GENE-Y	8	15	Isovaleric acidemia is an autosomal recessive disease of chemical metabolism due to deficiency of chemical dehydrogenase .	T4	T11	21207059
NA	CHEMICAL	GENE-Y	2	15	Isovaleric acidemia is an autosomal recessive disease of chemical metabolism due to deficiency of chemical dehydrogenase .	T5	T11	21207059
NA	CHEMICAL	GENE-Y	0	1	chemical transporters have channel modes of conduction .	T13	T21	8710929
NA	CHEMICAL	GENE-N	3	4	Members of the chemical transporter gene family presumably function with fixed stoichiometry in which a set number of ions cotransport with one transmitter molecule .	T1	T16	8710929
NA	CHEMICAL	GENE-Y	11	26	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T2	T17	8710929
NA	CHEMICAL	GENE-N	11	6	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T2	T18	8710929
NA	CHEMICAL	GENE-Y	13	26	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T3	T17	8710929
NA	CHEMICAL	GENE-N	13	6	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T3	T18	8710929
NA	CHEMICAL	GENE-Y	6	26	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T4	T17	8710929
NA	CHEMICAL	GENE-N	6	6	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T4	T18	8710929
NA	CHEMICAL	GENE-Y	20	26	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T5	T17	8710929
NA	CHEMICAL	GENE-N	20	6	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T5	T18	8710929
NA	CHEMICAL	GENE-Y	24	26	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T6	T17	8710929
NA	CHEMICAL	GENE-N	24	6	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T6	T18	8710929
NA	CHEMICAL	GENE-Y	6	26	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T7	T17	8710929
NA	CHEMICAL	GENE-N	6	6	Here we report channel-like events from a presumably fixed stoichiometry [ chemical ( chemical ) + , chemical , and chemical ] , human chemical ( gene ) in the chemical transporter gene family .	T7	T18	8710929
CPR:9	CHEMICAL	GENE-Y	5	11	These events are stimulated by chemical and by chemical , an gene substrate , and they are blocked by chemical and the antidepressant chemical .	T8	T19	8710929
CPR:9	CHEMICAL	GENE-Y	8	11	These events are stimulated by chemical and by chemical , an gene substrate , and they are blocked by chemical and the antidepressant chemical .	T9	T19	8710929
CPR:4	CHEMICAL	GENE-Y	19	11	These events are stimulated by chemical and by chemical , an gene substrate , and they are blocked by chemical and the antidepressant chemical .	T10	T19	8710929
CPR:4	CHEMICAL	GENE-Y	23	11	These events are stimulated by chemical and by chemical , an gene substrate , and they are blocked by chemical and the antidepressant chemical .	T11	T19	8710929
NA	CHEMICAL	GENE-Y	4	5	The case study of chemical synthase ( gene ) illustrates how such an equilibrium holds lessons for disease mechanisms , drug discovery , understanding drug side effects , and identifying proteins wherein drug discovery efforts might focus on quaternary structure dynamics .	T3	T9	23409765
NA	CHEMICAL	GENE-Y	4	7	The case study of chemical synthase ( gene ) illustrates how such an equilibrium holds lessons for disease mechanisms , drug discovery , understanding drug side effects , and identifying proteins wherein drug discovery efforts might focus on quaternary structure dynamics .	T3	T10	23409765
NA	CHEMICAL	GENE-Y	3	5	Inhibition of the chemical export pump ( gene ) can cause intracellular accumulation of chemical and is a risk factor for drug-induced liver injury in humans .	T20	T52	23091188
NA	CHEMICAL	GENE-Y	3	7	Inhibition of the chemical export pump ( gene ) can cause intracellular accumulation of chemical and is a risk factor for drug-induced liver injury in humans .	T20	T54	23091188
NA	CHEMICAL	GENE-Y	14	5	Inhibition of the chemical export pump ( gene ) can cause intracellular accumulation of chemical and is a risk factor for drug-induced liver injury in humans .	T43	T52	23091188
NA	CHEMICAL	GENE-Y	14	7	Inhibition of the chemical export pump ( gene ) can cause intracellular accumulation of chemical and is a risk factor for drug-induced liver injury in humans .	T43	T54	23091188
CPR:4	CHEMICAL	GENE-N	3	1	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T21	T51	23091188
CPR:4	CHEMICAL	GENE-Y	3	14	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T21	T53	23091188
CPR:4	CHEMICAL	GENE-N	5	1	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T22	T51	23091188
CPR:4	CHEMICAL	GENE-Y	5	14	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T22	T53	23091188
CPR:4	CHEMICAL	GENE-N	8	1	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T23	T51	23091188
CPR:4	CHEMICAL	GENE-Y	8	14	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T23	T53	23091188
CPR:4	CHEMICAL	GENE-N	10	1	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T24	T51	23091188
CPR:4	CHEMICAL	GENE-Y	10	14	Antiretroviral gene inhibitors chemical ( chemical ) and chemical ( chemical ) are reported gene inhibitors .	T24	T53	23091188
NA	CHEMICAL	GENE-N	9	40	In this report , we utilized a library of chemical that produce two and three GAG chains on the same scaffold , respectively , thus mimicking PGs , to examine the importance of GAG valency and chain type in regulating gene/gene interactions in vivo in zebrafish .	T4	T19	23614643
NA	CHEMICAL	GENE-N	9	40	In this report , we utilized a library of chemical that produce two and three GAG chains on the same scaffold , respectively , thus mimicking PGs , to examine the importance of GAG valency and chain type in regulating gene/gene interactions in vivo in zebrafish .	T4	T20	23614643
CPR:4	CHEMICAL	GENE-N	14	12	In support of this observation , elongation can be reversed by the gene inhibitor chemical , mRNA for the gene antagonist gene , or gene morpholino .	T1	T9	23614643
NA	CHEMICAL	GENE-N	14	19	In support of this observation , elongation can be reversed by the gene inhibitor chemical , mRNA for the gene antagonist gene , or gene morpholino .	T1	T10	23614643
NA	CHEMICAL	GENE-Y	14	21	In support of this observation , elongation can be reversed by the gene inhibitor chemical , mRNA for the gene antagonist gene , or gene morpholino .	T1	T11	23614643
NA	CHEMICAL	GENE-Y	14	24	In support of this observation , elongation can be reversed by the gene inhibitor chemical , mRNA for the gene antagonist gene , or gene morpholino .	T1	T12	23614643
NA	CHEMICAL	GENE-N	22	4	Furthermore , expression of a multivalent but not a monovalent GAG containing gene proteoglycan recapitulates the elongation phenotype observed with the bivalent chemical .	T3	T13	23614643
NA	CHEMICAL	GENE-Y	4	6	BACKGROUND AND OBJECTIVE : chemical dehydrogenase 2 is required for purine synthesis in activated lymphocytes .	T7	T21	17496727
NA	CHEMICAL	GENE-Y	26	3	Variants in the gene gene may account for the large inter-individual variability in baseline enzyme activity , immunosuppressive efficacy and side effects in transplant recipients receiving chemical .	T8	T16	17496727
NA	CHEMICAL	GENE-N	4	4	A novel nonsynonymous variant gene was identified , and the kinetic assay demonstrated that the chemical dehydrogenase activity of gene variant was decreased to 10 % of the wild-type .	T1	T12	17496727
NA	CHEMICAL	GENE-N	4	16	A novel nonsynonymous variant gene was identified , and the kinetic assay demonstrated that the chemical dehydrogenase activity of gene variant was decreased to 10 % of the wild-type .	T1	T13	17496727
NA	CHEMICAL	GENE-N	4	19	A novel nonsynonymous variant gene was identified , and the kinetic assay demonstrated that the chemical dehydrogenase activity of gene variant was decreased to 10 % of the wild-type .	T1	T14	17496727
CPR:4	CHEMICAL	GENE-N	3	7	The Ki for chemical inhibition of the gene variant was comparable with the wild-type , and the variant Km for chemical and chemical did not change significantly .	T2	T15	17496727
NA	CHEMICAL	GENE-N	20	7	The Ki for chemical inhibition of the gene variant was comparable with the wild-type , and the variant Km for chemical and chemical did not change significantly .	T3	T15	17496727
NA	CHEMICAL	GENE-N	22	7	The Ki for chemical inhibition of the gene variant was comparable with the wild-type , and the variant Km for chemical and chemical did not change significantly .	T4	T15	17496727
NA	CHEMICAL	GENE-Y	14	2	CONCLUSIONS : gene has low genetic diversity , but the nonsynonymous variant gene has a significant impact on chemical dehydrogenase activity .	T5	T17	17496727
NA	CHEMICAL	GENE-N	14	12	CONCLUSIONS : gene has low genetic diversity , but the nonsynonymous variant gene has a significant impact on chemical dehydrogenase activity .	T5	T18	17496727
NA	CHEMICAL	GENE-N	14	14	CONCLUSIONS : gene has low genetic diversity , but the nonsynonymous variant gene has a significant impact on chemical dehydrogenase activity .	T5	T19	17496727
NA	CHEMICAL	GENE-Y	5	10	[ Effects of Panax notoginseng chemical on mRNA expressions of gene , its correlative factors and chemical specific protease after cerebral ischemia-reperfusion in rats ] .	T4	T43	17498496
NA	CHEMICAL	GENE-N	5	18	[ Effects of Panax notoginseng chemical on mRNA expressions of gene , its correlative factors and chemical specific protease after cerebral ischemia-reperfusion in rats ] .	T4	T42	17498496
NA	CHEMICAL	GENE-Y	16	10	[ Effects of Panax notoginseng chemical on mRNA expressions of gene , its correlative factors and chemical specific protease after cerebral ischemia-reperfusion in rats ] .	T3	T43	17498496
NA	CHEMICAL	GENE-N	16	18	[ Effects of Panax notoginseng chemical on mRNA expressions of gene , its correlative factors and chemical specific protease after cerebral ischemia-reperfusion in rats ] .	T3	T42	17498496
NA	CHEMICAL	GENE-Y	9	17	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T41	17498496
NA	CHEMICAL	GENE-Y	9	19	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T12	17498496
NA	CHEMICAL	GENE-Y	9	22	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T16	17498496
NA	CHEMICAL	GENE-Y	9	24	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T18	17498496
NA	CHEMICAL	GENE-Y	9	13	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T19	17498496
NA	CHEMICAL	GENE-Y	9	29	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T25	17498496
NA	CHEMICAL	GENE-Y	9	32	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T28	17498496
NA	CHEMICAL	GENE-Y	9	34	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T29	17498496
NA	CHEMICAL	GENE-Y	9	39	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T30	17498496
NA	CHEMICAL	GENE-Y	9	41	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T31	17498496
NA	CHEMICAL	GENE-Y	9	44	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T32	17498496
NA	CHEMICAL	GENE-Y	9	46	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T2	T33	17498496
NA	CHEMICAL	GENE-Y	19	17	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T41	17498496
NA	CHEMICAL	GENE-Y	19	19	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T12	17498496
NA	CHEMICAL	GENE-Y	19	22	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T16	17498496
NA	CHEMICAL	GENE-Y	19	24	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T18	17498496
NA	CHEMICAL	GENE-Y	19	13	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T19	17498496
NA	CHEMICAL	GENE-Y	19	29	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T25	17498496
NA	CHEMICAL	GENE-Y	19	32	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T28	17498496
NA	CHEMICAL	GENE-Y	19	34	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T29	17498496
NA	CHEMICAL	GENE-Y	19	39	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T30	17498496
NA	CHEMICAL	GENE-Y	19	41	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T31	17498496
NA	CHEMICAL	GENE-Y	19	44	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T32	17498496
NA	CHEMICAL	GENE-Y	19	46	OBJECTIVE : To investigate the effects of Panax notoginseng chemical ( PNS ) on mRNA expressions of gene ( gene ) , gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical specific protease-1 ( gene ) , gene and gene after cerebral ischemia-reperfusion in rats .	T1	T33	17498496
CPR:3	CHEMICAL	GENE-N	3	6	The food contaminant chemical activates the gene in the intestine : interest of ex vivo models as an alternative to in vivo experiments .	T9	T20	23403092
NA	CHEMICAL	GENE-N	22	34	Using ex vivo and in vivo approaches , the purpose of this study was to investigate the ability of low doses of chemical to induce histological changes in the intestine and to activate the gene gene , gene and gene .	T3	T14	23403092
NA	CHEMICAL	GENE-N	22	35	Using ex vivo and in vivo approaches , the purpose of this study was to investigate the ability of low doses of chemical to induce histological changes in the intestine and to activate the gene gene , gene and gene .	T3	T15	23403092
NA	CHEMICAL	GENE-N	22	37	Using ex vivo and in vivo approaches , the purpose of this study was to investigate the ability of low doses of chemical to induce histological changes in the intestine and to activate the gene gene , gene and gene .	T3	T16	23403092
NA	CHEMICAL	GENE-N	22	39	Using ex vivo and in vivo approaches , the purpose of this study was to investigate the ability of low doses of chemical to induce histological changes in the intestine and to activate the gene gene , gene and gene .	T3	T17	23403092
CPR:4	CHEMICAL	GENE-Y	3	5	Phorbol esters and chemical destabilize gene mRNA in vascular smooth muscle cells .	T20	T37	8294418
CPR:4	CHEMICAL	GENE-Y	4	9	The mechanism by which chemical ( chemical ) down-regulates gene ( gene ) mRNA was studied in rabbit aortic smooth muscle cells .	T3	T29	8294418
CPR:4	CHEMICAL	GENE-N	4	11	The mechanism by which chemical ( chemical ) down-regulates gene ( gene ) mRNA was studied in rabbit aortic smooth muscle cells .	T3	T35	8294418
CPR:4	CHEMICAL	GENE-Y	6	9	The mechanism by which chemical ( chemical ) down-regulates gene ( gene ) mRNA was studied in rabbit aortic smooth muscle cells .	T8	T29	8294418
CPR:4	CHEMICAL	GENE-N	6	11	The mechanism by which chemical ( chemical ) down-regulates gene ( gene ) mRNA was studied in rabbit aortic smooth muscle cells .	T8	T35	8294418
NA	CHEMICAL	GENE-Y	0	5	chemical , chemical , and gene each decreased gene mRNA levels by 70-80 % .	T1	T24	8294418
CPR:4	CHEMICAL	GENE-N	0	8	chemical , chemical , and gene each decreased gene mRNA levels by 70-80 % .	T1	T25	8294418
NA	CHEMICAL	GENE-Y	2	5	chemical , chemical , and gene each decreased gene mRNA levels by 70-80 % .	T2	T24	8294418
CPR:4	CHEMICAL	GENE-N	2	8	chemical , chemical , and gene each decreased gene mRNA levels by 70-80 % .	T2	T25	8294418
CPR:4	CHEMICAL	GENE-N	3	1	The gene inhibitor chemical ( chemical ) abolished the effects of chemical and chemical and decreased basal mRNA levels by 52 +/- 3 % .	T4	T26	8294418
CPR:4	CHEMICAL	GENE-N	5	1	The gene inhibitor chemical ( chemical ) abolished the effects of chemical and chemical and decreased basal mRNA levels by 52 +/- 3 % .	T5	T26	8294418
NA	CHEMICAL	GENE-N	11	1	The gene inhibitor chemical ( chemical ) abolished the effects of chemical and chemical and decreased basal mRNA levels by 52 +/- 3 % .	T6	T26	8294418
NA	CHEMICAL	GENE-N	13	1	The gene inhibitor chemical ( chemical ) abolished the effects of chemical and chemical and decreased basal mRNA levels by 52 +/- 3 % .	T7	T26	8294418
CPR:3	CHEMICAL	GENE-N	1	7	Neither chemical nor chemical inhibited down-regulation of gene mRNA by chemical .	T9	T27	8294418
CPR:3	CHEMICAL	GENE-N	3	7	Neither chemical nor chemical inhibited down-regulation of gene mRNA by chemical .	T10	T27	8294418
CPR:4	CHEMICAL	GENE-N	10	7	Neither chemical nor chemical inhibited down-regulation of gene mRNA by chemical .	T11	T27	8294418
CPR:4	CHEMICAL	GENE-N	0	2	chemical caused gene mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of chemical to decrease basal gene mRNA level .	T12	T28	8294418
CPR:4	CHEMICAL	GENE-N	0	8	chemical caused gene mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of chemical to decrease basal gene mRNA level .	T12	T30	8294418
NA	CHEMICAL	GENE-N	20	2	chemical caused gene mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of chemical to decrease basal gene mRNA level .	T13	T28	8294418
NA	CHEMICAL	GENE-N	20	8	chemical caused gene mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of chemical to decrease basal gene mRNA level .	T13	T30	8294418
CPR:4	CHEMICAL	GENE-N	1	8	Both chemical and chemical increased the rate of gene mRNA degradation .	T14	T31	8294418
CPR:4	CHEMICAL	GENE-N	3	8	Both chemical and chemical increased the rate of gene mRNA degradation .	T15	T31	8294418
NA	CHEMICAL	GENE-Y	1	6	In chemical-desensitized cells , chemical and gene each caused the expected down-regulation of gene mRNA .	T16	T32	8294418
CPR:4	CHEMICAL	GENE-N	1	13	In chemical-desensitized cells , chemical and gene each caused the expected down-regulation of gene mRNA .	T16	T33	8294418
NA	CHEMICAL	GENE-Y	4	6	In chemical-desensitized cells , chemical and gene each caused the expected down-regulation of gene mRNA .	T17	T32	8294418
CPR:4	CHEMICAL	GENE-N	4	13	In chemical-desensitized cells , chemical and gene each caused the expected down-regulation of gene mRNA .	T17	T33	8294418
NA	CHEMICAL	GENE-Y	23	12	Using reporter gene and electrophoretic gel mobility shift assays we demonstrated that gene catalytic activity directly regulated the promoters of the fast fiber-specific gene and the slow fiber-specific gene gene .	T2	T19	23608535
NA	CHEMICAL	GENE-N	23	23	Using reporter gene and electrophoretic gel mobility shift assays we demonstrated that gene catalytic activity directly regulated the promoters of the fast fiber-specific gene and the slow fiber-specific gene gene .	T2	T21	23608535
NA	CHEMICAL	GENE-Y	23	28	Using reporter gene and electrophoretic gel mobility shift assays we demonstrated that gene catalytic activity directly regulated the promoters of the fast fiber-specific gene and the slow fiber-specific gene gene .	T2	T22	23608535
NA	CHEMICAL	GENE-N	8	3	These results link gene to the regulation of chemical dynamics and identify enzymatic activity of gene as a critical factor for modulating cross-striated muscle function by generating a unique muscle phenotype exhibiting both , reduced fatigability and enhanced force in gene ( -/- ) mice .	T1	T3	23608535
NA	CHEMICAL	GENE-N	8	15	These results link gene to the regulation of chemical dynamics and identify enzymatic activity of gene as a critical factor for modulating cross-striated muscle function by generating a unique muscle phenotype exhibiting both , reduced fatigability and enhanced force in gene ( -/- ) mice .	T1	T5	23608535
NA	CHEMICAL	GENE-N	8	40	These results link gene to the regulation of chemical dynamics and identify enzymatic activity of gene as a critical factor for modulating cross-striated muscle function by generating a unique muscle phenotype exhibiting both , reduced fatigability and enhanced force in gene ( -/- ) mice .	T1	T7	23608535
CPR:9	CHEMICAL	GENE-Y	12	3	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T19	T26	17409318
CPR:9	CHEMICAL	GENE-Y	12	5	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T19	T28	17409318
CPR:9	CHEMICAL	GENE-Y	14	3	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T23	T26	17409318
CPR:9	CHEMICAL	GENE-Y	14	5	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T23	T28	17409318
CPR:9	CHEMICAL	GENE-Y	3	3	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T2	T26	17409318
CPR:9	CHEMICAL	GENE-Y	3	5	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T2	T28	17409318
CPR:9	CHEMICAL	GENE-Y	21	3	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T8	T26	17409318
CPR:9	CHEMICAL	GENE-Y	21	5	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T8	T28	17409318
CPR:9	CHEMICAL	GENE-Y	41	3	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T11	T26	17409318
CPR:9	CHEMICAL	GENE-Y	41	5	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T11	T28	17409318
CPR:9	CHEMICAL	GENE-Y	43	3	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T12	T26	17409318
CPR:9	CHEMICAL	GENE-Y	43	5	The use of gene ( gene ) twice in the conversion of chemical ( chemical ; 18:3n-3 ) to chemical ( chemical ; 22:6n-3 ) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of chemical from chemical .	T12	T28	17409318
CPR:9	CHEMICAL	GENE-Y	11	4	The accumulation of the post-gene products of 22:5n-3 , 24:6n-3 and chemical , in cell phospholipids was saturated at concentrations of > 18 microM chemical .	T20	T29	17409318
NA	CHEMICAL	GENE-Y	24	4	The accumulation of the post-gene products of 22:5n-3 , 24:6n-3 and chemical , in cell phospholipids was saturated at concentrations of > 18 microM chemical .	T21	T29	17409318
NA	CHEMICAL	GENE-N	6	9	The functional inhibitory characteristics of the chemical type 1 receptor blockers ( ARB ) chemical ; chemical ; and chemical and its active metabolite chemical ( chemical ) were studied in rabbit aortic strips and rat portal vein preparations in vitro .	T14	T31	10373224
CPR:4	CHEMICAL	GENE-N	14	9	The functional inhibitory characteristics of the chemical type 1 receptor blockers ( ARB ) chemical ; chemical ; and chemical and its active metabolite chemical ( chemical ) were studied in rabbit aortic strips and rat portal vein preparations in vitro .	T24	T31	10373224
CPR:4	CHEMICAL	GENE-N	6	9	The functional inhibitory characteristics of the chemical type 1 receptor blockers ( ARB ) chemical ; chemical ; and chemical and its active metabolite chemical ( chemical ) were studied in rabbit aortic strips and rat portal vein preparations in vitro .	T1	T31	10373224
CPR:4	CHEMICAL	GENE-N	19	9	The functional inhibitory characteristics of the chemical type 1 receptor blockers ( ARB ) chemical ; chemical ; and chemical and its active metabolite chemical ( chemical ) were studied in rabbit aortic strips and rat portal vein preparations in vitro .	T3	T31	10373224
CPR:4	CHEMICAL	GENE-N	8	9	The functional inhibitory characteristics of the chemical type 1 receptor blockers ( ARB ) chemical ; chemical ; and chemical and its active metabolite chemical ( chemical ) were studied in rabbit aortic strips and rat portal vein preparations in vitro .	T8	T31	10373224
CPR:4	CHEMICAL	GENE-N	26	9	The functional inhibitory characteristics of the chemical type 1 receptor blockers ( ARB ) chemical ; chemical ; and chemical and its active metabolite chemical ( chemical ) were studied in rabbit aortic strips and rat portal vein preparations in vitro .	T9	T31	10373224
NA	CHEMICAL	GENE-N	0	20	chemical , chemical , and chemical caused a rightward parallel shift without any major effects on the maximal response to gene .	T18	T34	10373224
NA	CHEMICAL	GENE-N	2	20	chemical , chemical , and chemical caused a rightward parallel shift without any major effects on the maximal response to gene .	T19	T34	10373224
NA	CHEMICAL	GENE-N	5	20	chemical , chemical , and chemical caused a rightward parallel shift without any major effects on the maximal response to gene .	T20	T34	10373224
NA	CHEMICAL	GENE-Y	14	44	Cooling of the rat portal vein preparations to 4 degrees C before administration of chemical prevented the persistent inhibition of chemical response seen at 37 degrees C. For the other ARBs studied , the magnitude of inhibition and the speed of recovery of the gene response were independent of the incubation temperature before washing .	T2	T27	10373224
NA	CHEMICAL	GENE-Y	20	44	Cooling of the rat portal vein preparations to 4 degrees C before administration of chemical prevented the persistent inhibition of chemical response seen at 37 degrees C. For the other ARBs studied , the magnitude of inhibition and the speed of recovery of the gene response were independent of the incubation temperature before washing .	T4	T27	10373224
NA	CHEMICAL	GENE-N	0	1	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T27	T43	23578993
NA	CHEMICAL	GENE-N	0	3	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T27	T44	23578993
NA	CHEMICAL	GENE-N	0	1	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T27	T45	23578993
NA	CHEMICAL	GENE-N	0	9	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T27	T46	23578993
NA	CHEMICAL	GENE-N	0	12	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T27	T47	23578993
NA	CHEMICAL	GENE-N	0	14	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T27	T48	23578993
NA	CHEMICAL	GENE-N	6	1	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T28	T43	23578993
NA	CHEMICAL	GENE-N	6	3	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T28	T44	23578993
NA	CHEMICAL	GENE-N	6	1	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T28	T45	23578993
NA	CHEMICAL	GENE-N	6	9	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T28	T46	23578993
NA	CHEMICAL	GENE-N	6	12	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T28	T47	23578993
NA	CHEMICAL	GENE-N	6	14	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T28	T48	23578993
NA	CHEMICAL	GENE-N	17	1	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T29	T43	23578993
NA	CHEMICAL	GENE-N	17	3	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T29	T44	23578993
NA	CHEMICAL	GENE-N	17	1	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T29	T45	23578993
NA	CHEMICAL	GENE-N	17	9	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T29	T46	23578993
NA	CHEMICAL	GENE-N	17	12	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T29	T47	23578993
NA	CHEMICAL	GENE-N	17	14	chemical aminotransferase ( gene ) , chemical aminotransferase ( gene ) , gene ( gene ) , chemical were measured in serum .	T29	T48	23578993
NA	CHEMICAL	GENE-Y	0	11	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T30	T49	23578993
NA	CHEMICAL	GENE-Y	0	13	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T30	T50	23578993
NA	CHEMICAL	GENE-N	0	17	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T30	T51	23578993
NA	CHEMICAL	GENE-N	0	19	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T30	T52	23578993
NA	CHEMICAL	GENE-Y	16	11	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T31	T49	23578993
NA	CHEMICAL	GENE-Y	16	13	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T31	T50	23578993
NA	CHEMICAL	GENE-N	16	17	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T31	T51	23578993
NA	CHEMICAL	GENE-N	16	19	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T31	T52	23578993
NA	CHEMICAL	GENE-Y	22	11	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T32	T49	23578993
NA	CHEMICAL	GENE-Y	22	13	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T32	T50	23578993
NA	CHEMICAL	GENE-N	22	17	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T32	T51	23578993
NA	CHEMICAL	GENE-N	22	19	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T32	T52	23578993
NA	CHEMICAL	GENE-Y	24	11	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T33	T49	23578993
NA	CHEMICAL	GENE-Y	24	13	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T33	T50	23578993
NA	CHEMICAL	GENE-N	24	17	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T33	T51	23578993
NA	CHEMICAL	GENE-N	24	19	chemical ( HP ) , lipid peroxidation ( LPO ) , gene ( gene ) , chemical peroxidase ( gene ) and chemical ( chemical ) were determined in liver samples by colorimetric methods .	T33	T52	23578993
CPR:9	CHEMICAL	GENE-Y	11	0	gene ( gene ) , activity was determined as hydroxylation of chemical in liver microsomes .	T34	T53	23578993
CPR:9	CHEMICAL	GENE-Y	11	2	gene ( gene ) , activity was determined as hydroxylation of chemical in liver microsomes .	T34	T54	23578993
NA	CHEMICAL	GENE-N	12	6	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T1	T38	23578993
NA	CHEMICAL	GENE-N	12	8	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T1	T39	23578993
NA	CHEMICAL	GENE-N	12	10	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T1	T40	23578993
CPR:3	CHEMICAL	GENE-N	6	6	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T3	T38	23578993
CPR:3	CHEMICAL	GENE-N	6	8	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T3	T39	23578993
CPR:3	CHEMICAL	GENE-N	6	10	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T3	T40	23578993
CPR:3	CHEMICAL	GENE-N	10	6	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T4	T38	23578993
CPR:3	CHEMICAL	GENE-N	10	8	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T4	T39	23578993
CPR:3	CHEMICAL	GENE-N	10	10	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T4	T40	23578993
CPR:4	CHEMICAL	GENE-N	30	6	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T5	T38	23578993
CPR:4	CHEMICAL	GENE-N	30	8	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T5	T39	23578993
CPR:4	CHEMICAL	GENE-N	30	10	Serum markers of liver damage ( gene , gene , gene and chemical ) were increased by chemical and chemical intoxication ( p < 0.001 ) , whereas co-treatment with chemical reversed such changes ( p < 0.001 ) .	T5	T40	23578993
NA	CHEMICAL	GENE-Y	5	7	LPO was increased while as chemical , gene and gene decreased by the administration of CCl4 and TAA ( p < 0.001 ) ; co-administration of chemical restored these liver markers to normal levels ( p < 0.001 ) .	T10	T41	23578993
NA	CHEMICAL	GENE-N	5	9	LPO was increased while as chemical , gene and gene decreased by the administration of CCl4 and TAA ( p < 0.001 ) ; co-administration of chemical restored these liver markers to normal levels ( p < 0.001 ) .	T10	T42	23578993
CPR:3	CHEMICAL	GENE-Y	26	7	LPO was increased while as chemical , gene and gene decreased by the administration of CCl4 and TAA ( p < 0.001 ) ; co-administration of chemical restored these liver markers to normal levels ( p < 0.001 ) .	T12	T41	23578993
CPR:3	CHEMICAL	GENE-N	26	9	LPO was increased while as chemical , gene and gene decreased by the administration of CCl4 and TAA ( p < 0.001 ) ; co-administration of chemical restored these liver markers to normal levels ( p < 0.001 ) .	T12	T42	23578993
CPR:5	CHEMICAL	GENE-Y	9	14	Design , Synthesis , and Pharmacological Characterization of Novel chemical Analogues as Extremely Potent gene Agonists .	T17	T21	23477419
NA	CHEMICAL	GENE-Y	5	30	Of the new compounds , chemical ( 1 ) -chemical ( 2 ) -chemical ( 3 ) -chemical ( 4 ) ( analogue 12 ) displayed the highest affinity toward gene , in the picomolar range ( Ki ( μ ) = 3.72 pM ) .	T8	T20	23477419
NA	CHEMICAL	GENE-Y	6	30	Of the new compounds , chemical ( 1 ) -chemical ( 2 ) -chemical ( 3 ) -chemical ( 4 ) ( analogue 12 ) displayed the highest affinity toward gene , in the picomolar range ( Ki ( μ ) = 3.72 pM ) .	T9	T20	23477419
NA	CHEMICAL	GENE-Y	13	30	Of the new compounds , chemical ( 1 ) -chemical ( 2 ) -chemical ( 3 ) -chemical ( 4 ) ( analogue 12 ) displayed the highest affinity toward gene , in the picomolar range ( Ki ( μ ) = 3.72 pM ) .	T10	T20	23477419
NA	CHEMICAL	GENE-Y	6	30	Of the new compounds , chemical ( 1 ) -chemical ( 2 ) -chemical ( 3 ) -chemical ( 4 ) ( analogue 12 ) displayed the highest affinity toward gene , in the picomolar range ( Ki ( μ ) = 3.72 pM ) .	T11	T20	23477419
CPR:4	CHEMICAL	GENE-N	2	10	Activity of chemical ( chemical ) , an oral chemical kinase inhibitor , in patients with medullary thyroid cancer .	T7	T21	21606412
CPR:4	CHEMICAL	GENE-N	4	10	Activity of chemical ( chemical ) , an oral chemical kinase inhibitor , in patients with medullary thyroid cancer .	T8	T21	21606412
NA	CHEMICAL	GENE-N	9	10	Activity of chemical ( chemical ) , an oral chemical kinase inhibitor , in patients with medullary thyroid cancer .	T9	T21	21606412
CPR:4	CHEMICAL	GENE-Y	2	11	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T6	T18	21606412
CPR:4	CHEMICAL	GENE-Y	2	13	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T6	T19	21606412
CPR:4	CHEMICAL	GENE-Y	2	15	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T6	T13	21606412
CPR:4	CHEMICAL	GENE-Y	2	19	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T6	T14	21606412
CPR:4	CHEMICAL	GENE-Y	4	11	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T3	T18	21606412
CPR:4	CHEMICAL	GENE-Y	4	13	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T3	T19	21606412
CPR:4	CHEMICAL	GENE-Y	4	15	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T3	T13	21606412
CPR:4	CHEMICAL	GENE-Y	4	19	PURPOSE : chemical ( chemical ) is a potent inhibitor of gene , gene ( gene ) , and gene , with robust antiangiogenic , antitumor , and anti-invasive effects in preclinical models .	T3	T14	21606412
CPR:6	CHEMICAL	GENE-Y	10	4	A number of selective gene antagonists have been developed including chemical , chemical , chemical chemical and chemical .	T6	T23	1600046
CPR:6	CHEMICAL	GENE-Y	12	4	A number of selective gene antagonists have been developed including chemical , chemical , chemical chemical and chemical .	T7	T23	1600046
CPR:6	CHEMICAL	GENE-Y	14	4	A number of selective gene antagonists have been developed including chemical , chemical , chemical chemical and chemical .	T8	T23	1600046
CPR:6	CHEMICAL	GENE-Y	15	4	A number of selective gene antagonists have been developed including chemical , chemical , chemical chemical and chemical .	T9	T23	1600046
CPR:6	CHEMICAL	GENE-Y	17	4	A number of selective gene antagonists have been developed including chemical , chemical , chemical chemical and chemical .	T10	T23	1600046
CPR:4	CHEMICAL	GENE-Y	3	15	While the substituted chemical prokinetics ( for example , chemical , chemical ) also block gene receptors in high concentrations , their prokinetic action is believed to be on the basis of their agonist effects on the putative gene receptor .	T11	T24	1600046
CPR:5	CHEMICAL	GENE-Y	3	38	While the substituted chemical prokinetics ( for example , chemical , chemical ) also block gene receptors in high concentrations , their prokinetic action is believed to be on the basis of their agonist effects on the putative gene receptor .	T11	T25	1600046
CPR:4	CHEMICAL	GENE-Y	9	15	While the substituted chemical prokinetics ( for example , chemical , chemical ) also block gene receptors in high concentrations , their prokinetic action is believed to be on the basis of their agonist effects on the putative gene receptor .	T12	T24	1600046
CPR:5	CHEMICAL	GENE-Y	9	38	While the substituted chemical prokinetics ( for example , chemical , chemical ) also block gene receptors in high concentrations , their prokinetic action is believed to be on the basis of their agonist effects on the putative gene receptor .	T12	T25	1600046
CPR:4	CHEMICAL	GENE-Y	11	15	While the substituted chemical prokinetics ( for example , chemical , chemical ) also block gene receptors in high concentrations , their prokinetic action is believed to be on the basis of their agonist effects on the putative gene receptor .	T13	T24	1600046
CPR:5	CHEMICAL	GENE-Y	11	38	While the substituted chemical prokinetics ( for example , chemical , chemical ) also block gene receptors in high concentrations , their prokinetic action is believed to be on the basis of their agonist effects on the putative gene receptor .	T13	T25	1600046
CPR:6	CHEMICAL	GENE-Y	11	1	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T14	T26	1600046
CPR:5	CHEMICAL	GENE-Y	11	4	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T14	T27	1600046
NA	CHEMICAL	GENE-Y	11	35	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T14	T19	1600046
CPR:6	CHEMICAL	GENE-Y	13	1	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T15	T26	1600046
CPR:5	CHEMICAL	GENE-Y	13	4	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T15	T27	1600046
NA	CHEMICAL	GENE-Y	13	35	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T15	T19	1600046
NA	CHEMICAL	GENE-Y	23	1	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T16	T26	1600046
NA	CHEMICAL	GENE-Y	23	4	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T16	T27	1600046
NA	CHEMICAL	GENE-Y	23	35	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T16	T19	1600046
NA	CHEMICAL	GENE-Y	25	1	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T17	T26	1600046
NA	CHEMICAL	GENE-Y	25	4	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T17	T27	1600046
NA	CHEMICAL	GENE-Y	25	35	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T17	T19	1600046
NA	CHEMICAL	GENE-Y	1	1	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T2	T26	1600046
NA	CHEMICAL	GENE-Y	1	4	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T2	T27	1600046
CPR:6	CHEMICAL	GENE-Y	1	35	Some gene antagonists have gene agonist activity ( for example , chemical , chemical ) and others do not ( for example , chemical , chemical ) , while chemical in high concentrations is a gene antagonist .	T2	T19	1600046
NA	CHEMICAL	GENE-Y	7	0	gene receptors mediate the satiating effect of chemical , whereas the mechanism by which chemical uptake inhibitors such as chemical and chemical cause anorexia is not clear .	T3	T17	7902561
NA	CHEMICAL	GENE-Y	14	0	gene receptors mediate the satiating effect of chemical , whereas the mechanism by which chemical uptake inhibitors such as chemical and chemical cause anorexia is not clear .	T4	T17	7902561
NA	CHEMICAL	GENE-Y	19	0	gene receptors mediate the satiating effect of chemical , whereas the mechanism by which chemical uptake inhibitors such as chemical and chemical cause anorexia is not clear .	T5	T17	7902561
NA	CHEMICAL	GENE-Y	21	0	gene receptors mediate the satiating effect of chemical , whereas the mechanism by which chemical uptake inhibitors such as chemical and chemical cause anorexia is not clear .	T6	T17	7902561
NA	CHEMICAL	GENE-N	3	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T7	T18	7902561
NA	CHEMICAL	GENE-N	5	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T8	T18	7902561
NA	CHEMICAL	GENE-N	7	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T9	T18	7902561
NA	CHEMICAL	GENE-N	9	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T10	T18	7902561
NA	CHEMICAL	GENE-N	23	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T11	T18	7902561
NA	CHEMICAL	GENE-N	25	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T12	T18	7902561
CPR:3	CHEMICAL	GENE-N	35	11	Anorexia induced by chemical , chemical , chemical and chemical seems to be the result of their ability to increase the release of chemical and/or chemical from nerve terminals and inhibit their reuptake or , in the case of chemical , to stimulate directly gene .	T14	T18	7902561
NA	CHEMICAL	GENE-N	6	2	Role of gene and mast cells in gaseous chemical-induced airway microvascular leakage in rats .	T18	T25	8836617
NA	CHEMICAL	GENE-N	8	2	Role of gene and mast cells in gaseous chemical-induced airway microvascular leakage in rats .	T19	T25	8836617
CPR:6	CHEMICAL	GENE-Y	6	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T11	T20	8836617
NA	CHEMICAL	GENE-Y	6	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T11	T23	8836617
NA	CHEMICAL	GENE-Y	6	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T11	T24	8836617
CPR:6	CHEMICAL	GENE-Y	7	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T12	T20	8836617
NA	CHEMICAL	GENE-Y	7	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T12	T23	8836617
NA	CHEMICAL	GENE-Y	7	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T12	T24	8836617
NA	CHEMICAL	GENE-Y	13	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T5	T20	8836617
CPR:6	CHEMICAL	GENE-Y	13	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T5	T23	8836617
NA	CHEMICAL	GENE-Y	13	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T5	T24	8836617
NA	CHEMICAL	GENE-Y	8	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T6	T20	8836617
CPR:6	CHEMICAL	GENE-Y	8	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T6	T23	8836617
NA	CHEMICAL	GENE-Y	8	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T6	T24	8836617
NA	CHEMICAL	GENE-Y	9	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T7	T20	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T7	T23	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T7	T24	8836617
NA	CHEMICAL	GENE-Y	23	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T8	T20	8836617
NA	CHEMICAL	GENE-Y	23	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T8	T23	8836617
CPR:6	CHEMICAL	GENE-Y	23	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T8	T24	8836617
NA	CHEMICAL	GENE-Y	9	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T9	T20	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T9	T23	8836617
CPR:6	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T9	T24	8836617
NA	CHEMICAL	GENE-Y	9	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T10	T20	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T10	T23	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T10	T24	8836617
NA	CHEMICAL	GENE-Y	9	10	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T13	T20	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T13	T23	8836617
NA	CHEMICAL	GENE-Y	9	19	We have investigated the effects of chemical chemical , a gene antagonist , chemical chemical , a chemical B2 receptor antagonist , and chemical chemical , a chemical H1 receptor antagonist with mast cell-stabilizing properties , on microvascular leakage induced by gaseous chemical .	T13	T24	8836617
NA	CHEMICAL	GENE-Y	7	16	The increase in vascular permeability induced by chemical in the rat airway was mediated predominantly by gene stimulation .	T3	T21	8836617
CPR:3	CHEMICAL	GENE-Y	1	11	Novel chemical derivatives that modulate body weight through enhancement of hypothalamic gene ( gene ) and/or decreased gene ( gene ) .	T11	T24	23384387
CPR:3	CHEMICAL	GENE-Y	1	13	Novel chemical derivatives that modulate body weight through enhancement of hypothalamic gene ( gene ) and/or decreased gene ( gene ) .	T11	T21	23384387
CPR:4	CHEMICAL	GENE-Y	1	17	Novel chemical derivatives that modulate body weight through enhancement of hypothalamic gene ( gene ) and/or decreased gene ( gene ) .	T11	T22	23384387
CPR:4	CHEMICAL	GENE-Y	1	19	Novel chemical derivatives that modulate body weight through enhancement of hypothalamic gene ( gene ) and/or decreased gene ( gene ) .	T11	T23	23384387
NA	CHEMICAL	GENE-Y	5	0	gene as a drug target in leukemia .	T25	T53	15180525
NA	CHEMICAL	GENE-Y	16	3	Signal transduction of gene involves activation of several conserved pathways , including the gene/gene and the chemical-3-kinase/gene signaling cascades .	T23	T41	15180525
NA	CHEMICAL	GENE-N	16	13	Signal transduction of gene involves activation of several conserved pathways , including the gene/gene and the chemical-3-kinase/gene signaling cascades .	T23	T42	15180525
NA	CHEMICAL	GENE-N	16	13	Signal transduction of gene involves activation of several conserved pathways , including the gene/gene and the chemical-3-kinase/gene signaling cascades .	T23	T43	15180525
NA	CHEMICAL	GENE-N	16	16	Signal transduction of gene involves activation of several conserved pathways , including the gene/gene and the chemical-3-kinase/gene signaling cascades .	T23	T45	15180525
NA	CHEMICAL	GENE-Y	4	3	Selective inhibitors of gene chemical kinase activity have the potential to suppress aberrant gene signaling .	T24	T50	15180525
NA	CHEMICAL	GENE-N	4	5	Selective inhibitors of gene chemical kinase activity have the potential to suppress aberrant gene signaling .	T24	T51	15180525
NA	CHEMICAL	GENE-Y	4	13	Selective inhibitors of gene chemical kinase activity have the potential to suppress aberrant gene signaling .	T24	T52	15180525
NA	CHEMICAL	GENE-N	12	5	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T1	T26	15180525
NA	CHEMICAL	GENE-Y	12	7	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T1	T27	15180525
CPR:4	CHEMICAL	GENE-N	12	25	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T1	T28	15180525
CPR:4	CHEMICAL	GENE-Y	12	3	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T1	T29	15180525
CPR:4	CHEMICAL	GENE-Y	12	35	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T1	T30	15180525
NA	CHEMICAL	GENE-N	5	5	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T2	T26	15180525
NA	CHEMICAL	GENE-Y	5	7	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T2	T27	15180525
CPR:4	CHEMICAL	GENE-N	5	25	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T2	T28	15180525
CPR:4	CHEMICAL	GENE-Y	5	3	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T2	T29	15180525
CPR:4	CHEMICAL	GENE-Y	5	35	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T2	T30	15180525
NA	CHEMICAL	GENE-N	15	5	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T3	T26	15180525
NA	CHEMICAL	GENE-Y	15	7	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T3	T27	15180525
CPR:4	CHEMICAL	GENE-N	15	25	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T3	T28	15180525
CPR:4	CHEMICAL	GENE-Y	15	3	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T3	T29	15180525
CPR:4	CHEMICAL	GENE-Y	15	35	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T3	T30	15180525
NA	CHEMICAL	GENE-N	17	5	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T4	T26	15180525
NA	CHEMICAL	GENE-Y	17	7	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T4	T27	15180525
CPR:4	CHEMICAL	GENE-N	17	25	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T4	T28	15180525
CPR:4	CHEMICAL	GENE-Y	17	3	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T4	T29	15180525
CPR:4	CHEMICAL	GENE-Y	17	35	Although highly homologous to other gene , gene is resistant to the chemical chemical ( chemical , chemical ) , a potent inhibitor of other gene in the family , such as the gene or gene .	T4	T30	15180525
NA	CHEMICAL	GENE-Y	0	3	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T5	T31	15180525
NA	CHEMICAL	GENE-Y	0	25	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T5	T32	15180525
NA	CHEMICAL	GENE-Y	8	3	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T6	T31	15180525
NA	CHEMICAL	GENE-Y	8	25	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T6	T32	15180525
NA	CHEMICAL	GENE-Y	13	3	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T7	T31	15180525
NA	CHEMICAL	GENE-Y	13	25	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T7	T32	15180525
NA	CHEMICAL	GENE-Y	11	3	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T8	T31	15180525
NA	CHEMICAL	GENE-Y	11	25	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T8	T32	15180525
NA	CHEMICAL	GENE-Y	29	3	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T9	T31	15180525
CPR:4	CHEMICAL	GENE-Y	29	25	chemical binding to gene is prevented by the chemical 691 side-chain in the chemical binding center and mutating this site to chemical renders the corresponding gene mutant sensitive to chemical .	T9	T32	15180525
CPR:4	CHEMICAL	GENE-Y	9	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T10	T34	15180525
CPR:4	CHEMICAL	GENE-N	9	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T10	T35	15180525
CPR:4	CHEMICAL	GENE-Y	10	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T11	T34	15180525
CPR:4	CHEMICAL	GENE-N	10	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T11	T35	15180525
CPR:4	CHEMICAL	GENE-Y	13	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T12	T34	15180525
CPR:4	CHEMICAL	GENE-N	13	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T12	T35	15180525
CPR:4	CHEMICAL	GENE-Y	14	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T13	T34	15180525
CPR:4	CHEMICAL	GENE-N	14	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T13	T35	15180525
CPR:4	CHEMICAL	GENE-Y	17	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T14	T34	15180525
CPR:4	CHEMICAL	GENE-N	17	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T14	T35	15180525
CPR:4	CHEMICAL	GENE-Y	18	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T15	T34	15180525
CPR:4	CHEMICAL	GENE-N	18	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T15	T35	15180525
CPR:4	CHEMICAL	GENE-Y	20	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T16	T34	15180525
CPR:4	CHEMICAL	GENE-N	20	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T16	T35	15180525
CPR:4	CHEMICAL	GENE-Y	23	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T17	T34	15180525
CPR:4	CHEMICAL	GENE-N	23	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T17	T35	15180525
CPR:4	CHEMICAL	GENE-Y	24	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T18	T34	15180525
CPR:4	CHEMICAL	GENE-N	24	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T18	T35	15180525
CPR:4	CHEMICAL	GENE-Y	26	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T19	T34	15180525
CPR:4	CHEMICAL	GENE-N	26	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T19	T35	15180525
CPR:4	CHEMICAL	GENE-Y	30	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T20	T34	15180525
CPR:4	CHEMICAL	GENE-N	30	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T20	T35	15180525
CPR:4	CHEMICAL	GENE-Y	31	37	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T21	T34	15180525
CPR:4	CHEMICAL	GENE-N	31	38	Compounds of several other structural families , including the chemical chemical , the chemical chemical , the chemical chemical and chemical , the chemical chemical and chemical , and the chemical chemical , are potent inhibitors of gene gene .	T21	T35	15180525
CPR:5	CHEMICAL	GENE-Y	3	12	Characterization of substituted chemical as highly selective agonists at the chemical MT2 receptor .	T12	T28	23131177
NA	CHEMICAL	GENE-Y	8	12	Characterization of substituted chemical as highly selective agonists at the chemical MT2 receptor .	T13	T28	23131177
NA	CHEMICAL	GENE-N	13	4	The two subtypes of gene are primarily responsible for mediating the actions of chemical .	T5	T22	23131177
NA	CHEMICAL	GENE-N	2	8	Because synthetic chemical agonists have considerable therapeutic potentials in modulating insomnia and circadian- related sleep disorders , it is highly desirable to develop subtype-selective geneergic compounds .	T6	T23	23131177
NA	CHEMICAL	GENE-Y	4	10	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T7	T24	23131177
NA	CHEMICAL	GENE-Y	4	12	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T7	T25	23131177
NA	CHEMICAL	GENE-N	4	29	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T7	T26	23131177
NA	CHEMICAL	GENE-Y	4	10	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T8	T24	23131177
NA	CHEMICAL	GENE-Y	4	12	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T8	T25	23131177
NA	CHEMICAL	GENE-N	4	29	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T8	T26	23131177
NA	CHEMICAL	GENE-Y	32	10	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T9	T24	23131177
NA	CHEMICAL	GENE-Y	32	12	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T9	T25	23131177
NA	CHEMICAL	GENE-N	32	29	The pharmacological potencies of a series of substituted chemical towards gene and gene were evaluated by the FLIPR high-throughput screening assay , whilst their subtype-selectivity was subsequently verified with gene phosphorylation and chemical assays .	T9	T26	23131177
NA	CHEMICAL	GENE-Y	20	8	Structure-activity relationship analysis of highly potent subtype-selective ligands ( gene EC ( 50 ) 10-90 pM ) revealed that a chemical substituent incorporated at C6 position of the chemical ring dramatically enhanced the gene potency and at the same time decreased gene potency .	T10	T27	23131177
NA	CHEMICAL	GENE-Y	20	8	Structure-activity relationship analysis of highly potent subtype-selective ligands ( gene EC ( 50 ) 10-90 pM ) revealed that a chemical substituent incorporated at C6 position of the chemical ring dramatically enhanced the gene potency and at the same time decreased gene potency .	T10	T14	23131177
NA	CHEMICAL	GENE-Y	20	8	Structure-activity relationship analysis of highly potent subtype-selective ligands ( gene EC ( 50 ) 10-90 pM ) revealed that a chemical substituent incorporated at C6 position of the chemical ring dramatically enhanced the gene potency and at the same time decreased gene potency .	T10	T15	23131177
NA	CHEMICAL	GENE-Y	28	8	Structure-activity relationship analysis of highly potent subtype-selective ligands ( gene EC ( 50 ) 10-90 pM ) revealed that a chemical substituent incorporated at C6 position of the chemical ring dramatically enhanced the gene potency and at the same time decreased gene potency .	T11	T27	23131177
NA	CHEMICAL	GENE-Y	28	8	Structure-activity relationship analysis of highly potent subtype-selective ligands ( gene EC ( 50 ) 10-90 pM ) revealed that a chemical substituent incorporated at C6 position of the chemical ring dramatically enhanced the gene potency and at the same time decreased gene potency .	T11	T14	23131177
NA	CHEMICAL	GENE-Y	28	8	Structure-activity relationship analysis of highly potent subtype-selective ligands ( gene EC ( 50 ) 10-90 pM ) revealed that a chemical substituent incorporated at C6 position of the chemical ring dramatically enhanced the gene potency and at the same time decreased gene potency .	T11	T15	23131177
NA	CHEMICAL	GENE-Y	8	13	The most potent subtype-selective ligand , 2q had a substantially higher potency for gene than chemical for elevation of [ chemical ] i and inhibition of forskolin-elevated cAMP .	T2	T17	23131177
NA	CHEMICAL	GENE-Y	8	13	The most potent subtype-selective ligand , 2q had a substantially higher potency for gene than chemical for elevation of [ chemical ] i and inhibition of forskolin-elevated cAMP .	T3	T17	23131177
NA	CHEMICAL	GENE-Y	14	7	To better understand the molecular mechanism of gene on tumor suppression , we utilized a complementary chemical microarray composed of approximately 6,000 human cancer-related genes to determine the gene expression pattern altered by re-introduction of gene into PC-3 prostate tumor cells .	T8	T37	16316409
NA	CHEMICAL	GENE-Y	14	35	To better understand the molecular mechanism of gene on tumor suppression , we utilized a complementary chemical microarray composed of approximately 6,000 human cancer-related genes to determine the gene expression pattern altered by re-introduction of gene into PC-3 prostate tumor cells .	T8	T39	16316409
NA	CHEMICAL	GENE-Y	7	5	Immunoblot analysis further confirmed increased gene ( gene ) and gene protein levels and decreased level of gene protein with increasing gene protein expression .	T1	T9	16316409
NA	CHEMICAL	GENE-Y	7	7	Immunoblot analysis further confirmed increased gene ( gene ) and gene protein levels and decreased level of gene protein with increasing gene protein expression .	T1	T10	16316409
NA	CHEMICAL	GENE-Y	7	10	Immunoblot analysis further confirmed increased gene ( gene ) and gene protein levels and decreased level of gene protein with increasing gene protein expression .	T1	T11	16316409
NA	CHEMICAL	GENE-Y	7	17	Immunoblot analysis further confirmed increased gene ( gene ) and gene protein levels and decreased level of gene protein with increasing gene protein expression .	T1	T12	16316409
NA	CHEMICAL	GENE-Y	7	21	Immunoblot analysis further confirmed increased gene ( gene ) and gene protein levels and decreased level of gene protein with increasing gene protein expression .	T1	T13	16316409
NA	CHEMICAL	GENE-Y	15	1	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T2	T14	16316409
NA	CHEMICAL	GENE-Y	15	23	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T2	T15	16316409
NA	CHEMICAL	GENE-Y	15	31	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T2	T16	16316409
NA	CHEMICAL	GENE-Y	17	1	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T3	T14	16316409
NA	CHEMICAL	GENE-Y	17	23	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T3	T15	16316409
NA	CHEMICAL	GENE-Y	17	31	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T3	T16	16316409
NA	CHEMICAL	GENE-Y	19	1	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T4	T14	16316409
NA	CHEMICAL	GENE-Y	19	23	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T4	T15	16316409
NA	CHEMICAL	GENE-Y	19	31	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T4	T16	16316409
NA	CHEMICAL	GENE-Y	26	1	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T5	T14	16316409
NA	CHEMICAL	GENE-Y	26	23	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T5	T15	16316409
NA	CHEMICAL	GENE-Y	26	31	As gene was elevated far more than any other genes , we observed that the chemical , chemical and chemical , that bind gene , promoted chemical-associated functional cell differentiation in gene PC-3 cells , but not in neo control PC-3 cells .	T5	T16	16316409
NA	CHEMICAL	GENE-N	4	5	Subsequent examination of the chemical receptors gene ) expression levels demonstrated an absence of gene in the neo control cells and re-expression in the gene expressing cells , consistent with previous findings where gene is believed to play a critical role as a tumor suppressor gene that is lost during de-differentiation of prostate epithelial cells .	T6	T17	16316409
NA	CHEMICAL	GENE-N	4	6	Subsequent examination of the chemical receptors gene ) expression levels demonstrated an absence of gene in the neo control cells and re-expression in the gene expressing cells , consistent with previous findings where gene is believed to play a critical role as a tumor suppressor gene that is lost during de-differentiation of prostate epithelial cells .	T6	T18	16316409
NA	CHEMICAL	GENE-Y	4	14	Subsequent examination of the chemical receptors gene ) expression levels demonstrated an absence of gene in the neo control cells and re-expression in the gene expressing cells , consistent with previous findings where gene is believed to play a critical role as a tumor suppressor gene that is lost during de-differentiation of prostate epithelial cells .	T6	T19	16316409
NA	CHEMICAL	GENE-Y	4	24	Subsequent examination of the chemical receptors gene ) expression levels demonstrated an absence of gene in the neo control cells and re-expression in the gene expressing cells , consistent with previous findings where gene is believed to play a critical role as a tumor suppressor gene that is lost during de-differentiation of prostate epithelial cells .	T6	T20	16316409
NA	CHEMICAL	GENE-Y	4	33	Subsequent examination of the chemical receptors gene ) expression levels demonstrated an absence of gene in the neo control cells and re-expression in the gene expressing cells , consistent with previous findings where gene is believed to play a critical role as a tumor suppressor gene that is lost during de-differentiation of prostate epithelial cells .	T6	T21	16316409
NA	CHEMICAL	GENE-Y	7	0	gene inhibition reveals endogenous nicotinic modulation of chemical inputs to CA1 stratum radiatum interneurons in hippocampal slices .	T12	T25	23511125
NA	CHEMICAL	GENE-N	8	4	The involvement of brain gene ( gene ) in the neurotoxicological effects of soman , a potent chemicalsterase ( gene ) inhibitor and a chemical warfare agent , is not clear .	T8	T17	23511125
NA	CHEMICAL	GENE-N	8	6	The involvement of brain gene ( gene ) in the neurotoxicological effects of soman , a potent chemicalsterase ( gene ) inhibitor and a chemical warfare agent , is not clear .	T8	T22	23511125
NA	CHEMICAL	GENE-Y	8	8	The involvement of brain gene ( gene ) in the neurotoxicological effects of soman , a potent chemicalsterase ( gene ) inhibitor and a chemical warfare agent , is not clear .	T8	T13	23511125
NA	CHEMICAL	GENE-Y	8	19	The involvement of brain gene ( gene ) in the neurotoxicological effects of soman , a potent chemicalsterase ( gene ) inhibitor and a chemical warfare agent , is not clear .	T8	T14	23511125
NA	CHEMICAL	GENE-Y	9	5	To test the hypothesis that gene inhibition builds sufficient chemical ( ACh ) in the brain and facilitates gene-dependent chemical transmission , we used whole-cell patch-clamp technique to record spontaneous chemical excitatory postsynaptic currents ( EPSCs ) from CA1 stratum radiatum interneurons ( SRI ) in hippocampal slices .	T9	T20	23511125
NA	CHEMICAL	GENE-N	9	11	To test the hypothesis that gene inhibition builds sufficient chemical ( ACh ) in the brain and facilitates gene-dependent chemical transmission , we used whole-cell patch-clamp technique to record spontaneous chemical excitatory postsynaptic currents ( EPSCs ) from CA1 stratum radiatum interneurons ( SRI ) in hippocampal slices .	T9	T21	23511125
NA	CHEMICAL	GENE-Y	19	5	To test the hypothesis that gene inhibition builds sufficient chemical ( ACh ) in the brain and facilitates gene-dependent chemical transmission , we used whole-cell patch-clamp technique to record spontaneous chemical excitatory postsynaptic currents ( EPSCs ) from CA1 stratum radiatum interneurons ( SRI ) in hippocampal slices .	T10	T20	23511125
NA	CHEMICAL	GENE-N	19	11	To test the hypothesis that gene inhibition builds sufficient chemical ( ACh ) in the brain and facilitates gene-dependent chemical transmission , we used whole-cell patch-clamp technique to record spontaneous chemical excitatory postsynaptic currents ( EPSCs ) from CA1 stratum radiatum interneurons ( SRI ) in hippocampal slices .	T10	T21	23511125
NA	CHEMICAL	GENE-Y	30	5	To test the hypothesis that gene inhibition builds sufficient chemical ( ACh ) in the brain and facilitates gene-dependent chemical transmission , we used whole-cell patch-clamp technique to record spontaneous chemical excitatory postsynaptic currents ( EPSCs ) from CA1 stratum radiatum interneurons ( SRI ) in hippocampal slices .	T11	T20	23511125
NA	CHEMICAL	GENE-N	30	11	To test the hypothesis that gene inhibition builds sufficient chemical ( ACh ) in the brain and facilitates gene-dependent chemical transmission , we used whole-cell patch-clamp technique to record spontaneous chemical excitatory postsynaptic currents ( EPSCs ) from CA1 stratum radiatum interneurons ( SRI ) in hippocampal slices .	T11	T21	23511125
CPR:4	CHEMICAL	GENE-Y	19	17	Second , EPSCs were recorded from rat hippocampal slices before and after their superfusion with the reversible gene inhibitor chemical ( 100nM ) .	T1	T24	23511125
NA	CHEMICAL	GENE-N	12	1	The gene of gene associates with gene and is prerequisite to gene-induced chemical release in Jurkat T lymphocytes .	T10	T41	17550897
NA	CHEMICAL	GENE-Y	12	3	The gene of gene associates with gene and is prerequisite to gene-induced chemical release in Jurkat T lymphocytes .	T10	T40	17550897
NA	CHEMICAL	GENE-Y	12	6	The gene of gene associates with gene and is prerequisite to gene-induced chemical release in Jurkat T lymphocytes .	T10	T42	17550897
NA	CHEMICAL	GENE-N	12	10	The gene of gene associates with gene and is prerequisite to gene-induced chemical release in Jurkat T lymphocytes .	T10	T43	17550897
NA	CHEMICAL	GENE-Y	0	0	gene is a chemical exchange factor that is expressed specifically in hematopoietic cells and plays important roles in T cell development and activation .	T1	T11	17550897
NA	CHEMICAL	GENE-N	0	2	gene is a chemical exchange factor that is expressed specifically in hematopoietic cells and plays important roles in T cell development and activation .	T1	T14	17550897
NA	CHEMICAL	GENE-Y	12	0	gene consists of multiple structural domains so as to facilitate both its chemical exchange activity and scaffold function following gene ( gene ) engagement .	T5	T22	17550897
NA	CHEMICAL	GENE-N	12	8	gene consists of multiple structural domains so as to facilitate both its chemical exchange activity and scaffold function following gene ( gene ) engagement .	T5	T23	17550897
NA	CHEMICAL	GENE-N	12	21	gene consists of multiple structural domains so as to facilitate both its chemical exchange activity and scaffold function following gene ( gene ) engagement .	T5	T24	17550897
NA	CHEMICAL	GENE-N	12	5	Previous studies demonstrated that the gene of gene is required for gene-stimulated chemical mobilization and thus downstream activation of gene .	T6	T25	17550897
NA	CHEMICAL	GENE-Y	12	7	Previous studies demonstrated that the gene of gene is required for gene-stimulated chemical mobilization and thus downstream activation of gene .	T6	T26	17550897
NA	CHEMICAL	GENE-Y	12	11	Previous studies demonstrated that the gene of gene is required for gene-stimulated chemical mobilization and thus downstream activation of gene .	T6	T27	17550897
NA	CHEMICAL	GENE-N	12	19	Previous studies demonstrated that the gene of gene is required for gene-stimulated chemical mobilization and thus downstream activation of gene .	T6	T28	17550897
NA	CHEMICAL	GENE-Y	10	6	However , it remained obscure how gene functions in regulating chemical flux .	T7	T29	17550897
NA	CHEMICAL	GENE-Y	18	8	In an effort to explore molecules interacting with gene , we found that gene bound to gene in a chemical-dependent and gene activation-independent manner .	T8	T30	17550897
NA	CHEMICAL	GENE-Y	18	13	In an effort to explore molecules interacting with gene , we found that gene bound to gene in a chemical-dependent and gene activation-independent manner .	T8	T31	17550897
NA	CHEMICAL	GENE-Y	18	16	In an effort to explore molecules interacting with gene , we found that gene bound to gene in a chemical-dependent and gene activation-independent manner .	T8	T32	17550897
NA	CHEMICAL	GENE-N	18	21	In an effort to explore molecules interacting with gene , we found that gene bound to gene in a chemical-dependent and gene activation-independent manner .	T8	T33	17550897
NA	CHEMICAL	GENE-Y	13	2	Reconstitution of gene-null Jurkat T cells ( J.gene ) with gene-deleted gene exhibited a severe deficiency in chemical release to the same extent as that of Jurkat cells treated with the gene inhibitor or J.gene cells .	T9	T36	17550897
NA	CHEMICAL	GENE-Y	13	7	Reconstitution of gene-null Jurkat T cells ( J.gene ) with gene-deleted gene exhibited a severe deficiency in chemical release to the same extent as that of Jurkat cells treated with the gene inhibitor or J.gene cells .	T9	T37	17550897
NA	CHEMICAL	GENE-N	13	10	Reconstitution of gene-null Jurkat T cells ( J.gene ) with gene-deleted gene exhibited a severe deficiency in chemical release to the same extent as that of Jurkat cells treated with the gene inhibitor or J.gene cells .	T9	T38	17550897
NA	CHEMICAL	GENE-Y	13	11	Reconstitution of gene-null Jurkat T cells ( J.gene ) with gene-deleted gene exhibited a severe deficiency in chemical release to the same extent as that of Jurkat cells treated with the gene inhibitor or J.gene cells .	T9	T39	17550897
NA	CHEMICAL	GENE-Y	13	13	Reconstitution of gene-null Jurkat T cells ( J.gene ) with gene-deleted gene exhibited a severe deficiency in chemical release to the same extent as that of Jurkat cells treated with the gene inhibitor or J.gene cells .	T9	T12	17550897
NA	CHEMICAL	GENE-Y	13	13	Reconstitution of gene-null Jurkat T cells ( J.gene ) with gene-deleted gene exhibited a severe deficiency in chemical release to the same extent as that of Jurkat cells treated with the gene inhibitor or J.gene cells .	T9	T13	17550897
NA	CHEMICAL	GENE-Y	11	5	The defect persisted even when gene was fully activated , indicating a prerequisite role of gene in chemical signaling .	T2	T15	17550897
NA	CHEMICAL	GENE-N	11	11	The defect persisted even when gene was fully activated , indicating a prerequisite role of gene in chemical signaling .	T2	T16	17550897
NA	CHEMICAL	GENE-Y	12	4	The results suggest that gene and gene function cooperatively to potentiate gene-induced chemical release .	T3	T17	17550897
NA	CHEMICAL	GENE-Y	12	6	The results suggest that gene and gene function cooperatively to potentiate gene-induced chemical release .	T3	T18	17550897
NA	CHEMICAL	GENE-N	12	11	The results suggest that gene and gene function cooperatively to potentiate gene-induced chemical release .	T3	T19	17550897
CPR:9	CHEMICAL	GENE-Y	7	13	KIEs were measured on the arsenolysis of chemical ( chemical ) catalyzed by gene and were corrected for the forward commitment to catalysis .	T17	T31	17090056
CPR:9	CHEMICAL	GENE-Y	9	13	KIEs were measured on the arsenolysis of chemical ( chemical ) catalyzed by gene and were corrected for the forward commitment to catalysis .	T18	T31	17090056
NA	CHEMICAL	GENE-Y	4	11	The primary intrinsic KIEs ( chemical and chemical ) suggest that gene has a dissociative S ( N ) 1 transition state with its cationic center at the anomeric chemical and insignificant bond order to the leaving group .	T20	T32	17090056
NA	CHEMICAL	GENE-Y	4	11	The primary intrinsic KIEs ( chemical and chemical ) suggest that gene has a dissociative S ( N ) 1 transition state with its cationic center at the anomeric chemical and insignificant bond order to the leaving group .	T21	T32	17090056
NA	CHEMICAL	GENE-Y	13	11	The primary intrinsic KIEs ( chemical and chemical ) suggest that gene has a dissociative S ( N ) 1 transition state with its cationic center at the anomeric chemical and insignificant bond order to the leaving group .	T22	T32	17090056
NA	CHEMICAL	GENE-N	0	1	chemical transporters : targets of natural chemical and new lipid lowering drugs .	T19	T37	15737409
NA	CHEMICAL	GENE-N	6	1	chemical transporters : targets of natural chemical and new lipid lowering drugs .	T20	T37	15737409
NA	CHEMICAL	GENE-N	6	11	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T10	T24	15737409
NA	CHEMICAL	GENE-Y	6	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T10	T32	15737409
NA	CHEMICAL	GENE-Y	6	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T10	T34	15737409
NA	CHEMICAL	GENE-Y	6	35	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T10	T22	15737409
NA	CHEMICAL	GENE-Y	6	37	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T10	T23	15737409
NA	CHEMICAL	GENE-N	19	11	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T2	T24	15737409
NA	CHEMICAL	GENE-Y	19	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T2	T32	15737409
NA	CHEMICAL	GENE-Y	19	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T2	T34	15737409
NA	CHEMICAL	GENE-Y	19	35	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T2	T22	15737409
NA	CHEMICAL	GENE-Y	19	37	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T2	T23	15737409
NA	CHEMICAL	GENE-N	25	11	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T7	T24	15737409
NA	CHEMICAL	GENE-Y	25	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T7	T32	15737409
NA	CHEMICAL	GENE-Y	25	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T7	T34	15737409
NA	CHEMICAL	GENE-Y	25	35	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T7	T22	15737409
NA	CHEMICAL	GENE-Y	25	37	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T7	T23	15737409
NA	CHEMICAL	GENE-N	41	11	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T8	T24	15737409
NA	CHEMICAL	GENE-Y	41	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T8	T32	15737409
NA	CHEMICAL	GENE-Y	41	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T8	T34	15737409
NA	CHEMICAL	GENE-Y	41	35	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T8	T22	15737409
NA	CHEMICAL	GENE-Y	41	37	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T8	T23	15737409
NA	CHEMICAL	GENE-N	50	11	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T9	T24	15737409
NA	CHEMICAL	GENE-Y	50	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T9	T32	15737409
NA	CHEMICAL	GENE-Y	50	9	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T9	T34	15737409
NA	CHEMICAL	GENE-Y	50	35	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T9	T22	15737409
NA	CHEMICAL	GENE-Y	50	37	Recent insights in the role of chemical-binding cassette ( ABC ) transporters gene and gene , the discovery of chemical , the first approved direct chemical absorption inhibitor , as well as the identification of gene ( gene ) protein as chemical transporter in the gut , focused attention on chemical transport processes in the small intestine and the liver .	T9	T23	15737409
NA	CHEMICAL	GENE-Y	18	7	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T11	T25	15737409
NA	CHEMICAL	GENE-Y	18	9	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T11	T26	15737409
NA	CHEMICAL	GENE-N	18	23	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T11	T27	15737409
NA	CHEMICAL	GENE-Y	31	7	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T12	T25	15737409
NA	CHEMICAL	GENE-Y	31	9	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T12	T26	15737409
NA	CHEMICAL	GENE-N	31	23	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T12	T27	15737409
NA	CHEMICAL	GENE-Y	36	7	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T13	T25	15737409
NA	CHEMICAL	GENE-Y	36	9	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T13	T26	15737409
NA	CHEMICAL	GENE-N	36	23	The identification of defective structures in the gene or gene transporters in patients with the rare disease of sitochemicalemia elucidated their role as gene regulating at least in parts the intestinal chemical absorption and the hepatic chemical output .	T13	T27	15737409
NA	CHEMICAL	GENE-Y	7	0	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T14	T28	15737409
NA	CHEMICAL	GENE-Y	7	2	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T14	T29	15737409
NA	CHEMICAL	GENE-N	7	9	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T14	T30	15737409
NA	CHEMICAL	GENE-N	7	11	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T14	T31	15737409
NA	CHEMICAL	GENE-Y	19	0	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T15	T28	15737409
NA	CHEMICAL	GENE-Y	19	2	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T15	T29	15737409
NA	CHEMICAL	GENE-N	19	9	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T15	T30	15737409
CPR:3	CHEMICAL	GENE-N	19	11	gene and gene themselves are regulated by chemical via gene ( gene ) , which are also activated by oxychemical and some derivatives of plant sterols .	T15	T31	15737409
NA	CHEMICAL	GENE-Y	8	0	gene could recently be identified as a major chemical transporter for the intestinal uptake of chemical as well as plant chemical .	T16	T33	15737409
NA	CHEMICAL	GENE-N	8	6	gene could recently be identified as a major chemical transporter for the intestinal uptake of chemical as well as plant chemical .	T16	T35	15737409
CPR:9	CHEMICAL	GENE-Y	15	0	gene could recently be identified as a major chemical transporter for the intestinal uptake of chemical as well as plant chemical .	T17	T33	15737409
CPR:9	CHEMICAL	GENE-N	15	6	gene could recently be identified as a major chemical transporter for the intestinal uptake of chemical as well as plant chemical .	T17	T35	15737409
CPR:9	CHEMICAL	GENE-Y	20	0	gene could recently be identified as a major chemical transporter for the intestinal uptake of chemical as well as plant chemical .	T18	T33	15737409
CPR:9	CHEMICAL	GENE-N	20	6	gene could recently be identified as a major chemical transporter for the intestinal uptake of chemical as well as plant chemical .	T18	T35	15737409
NA	CHEMICAL	GENE-Y	16	2	Studies in gene knockout mice indicate that this transporter is essential for the intestinal uptake of chemical and that gene might also be involved in the mechanism of action of chemical .	T1	T36	15737409
NA	CHEMICAL	GENE-Y	16	19	Studies in gene knockout mice indicate that this transporter is essential for the intestinal uptake of chemical and that gene might also be involved in the mechanism of action of chemical .	T1	T21	15737409
NA	CHEMICAL	GENE-Y	2	2	Studies in gene knockout mice indicate that this transporter is essential for the intestinal uptake of chemical and that gene might also be involved in the mechanism of action of chemical .	T3	T36	15737409
NA	CHEMICAL	GENE-Y	2	19	Studies in gene knockout mice indicate that this transporter is essential for the intestinal uptake of chemical and that gene might also be involved in the mechanism of action of chemical .	T3	T21	15737409
NA	CHEMICAL	GENE-N	20	2	Inactivation of gene in both transformed and nontransformed cells promotes a metabolic shift to aerobic glycolysis , increased allocation of chemical chemical into lipids , and biomass accumulation .	T1	T9	23274086
NA	CHEMICAL	GENE-N	10	2	Inactivation of gene in both transformed and nontransformed cells promotes a metabolic shift to aerobic glycolysis , increased allocation of chemical chemical into lipids , and biomass accumulation .	T2	T9	23274086
NA	CHEMICAL	GENE-Y	3	7	We recently identified chemical ( chemical ) reductase , the rate-limiting enzyme of the mevalonate pathway , as a potential therapeutic target of the head and neck squamous cell carcinomas ( HNSCC ) and cervical carcinomas ( CC ) .	T14	T28	12082550
NA	CHEMICAL	GENE-Y	5	7	We recently identified chemical ( chemical ) reductase , the rate-limiting enzyme of the mevalonate pathway , as a potential therapeutic target of the head and neck squamous cell carcinomas ( HNSCC ) and cervical carcinomas ( CC ) .	T18	T28	12082550
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a specific inhibitor of chemical reductase , induces a pronounced apoptotic response in a specific subset of tumor types , including HNSCC and CC .	T16	T29	12082550
NA	CHEMICAL	GENE-Y	6	2	chemical , a specific inhibitor of chemical reductase , induces a pronounced apoptotic response in a specific subset of tumor types , including HNSCC and CC .	T17	T29	12082550
NA	CHEMICAL	GENE-Y	2	4	These included chemical-binding inhibitor/chemical-binding protein , the gene and gene .	T2	T23	12082550
NA	CHEMICAL	GENE-Y	2	7	These included chemical-binding inhibitor/chemical-binding protein , the gene and gene .	T2	T24	12082550
NA	CHEMICAL	GENE-Y	2	9	These included chemical-binding inhibitor/chemical-binding protein , the gene and gene .	T2	T25	12082550
NA	CHEMICAL	GENE-Y	3	4	These included chemical-binding inhibitor/chemical-binding protein , the gene and gene .	T3	T23	12082550
NA	CHEMICAL	GENE-Y	3	7	These included chemical-binding inhibitor/chemical-binding protein , the gene and gene .	T3	T24	12082550
NA	CHEMICAL	GENE-Y	3	9	These included chemical-binding inhibitor/chemical-binding protein , the gene and gene .	T3	T25	12082550
NA	CHEMICAL	GENE-Y	3	1	Because gene requires chemical for its function , this links the microarray and biochemical data and identifies gene as a potential mediator of the anticancer properties of chemical .	T10	T26	12082550
NA	CHEMICAL	GENE-Y	3	17	Because gene requires chemical for its function , this links the microarray and biochemical data and identifies gene as a potential mediator of the anticancer properties of chemical .	T10	T27	12082550
NA	CHEMICAL	GENE-Y	18	1	Because gene requires chemical for its function , this links the microarray and biochemical data and identifies gene as a potential mediator of the anticancer properties of chemical .	T11	T26	12082550
NA	CHEMICAL	GENE-Y	18	17	Because gene requires chemical for its function , this links the microarray and biochemical data and identifies gene as a potential mediator of the anticancer properties of chemical .	T11	T27	12082550
NA	CHEMICAL	GENE-Y	2	12	Rescue of chemical-damaged oocytes from programmed cell death through inactivation of the gene family signaling network .	T20	T52	23598363
CPR:4	CHEMICAL	GENE-Y	6	3	Recently , the gene gene inhibitor chemical ( chemical ) has become the focus of research as a fertoprotective drug against chemical .	T11	T46	23598363
CPR:4	CHEMICAL	GENE-N	6	4	Recently , the gene gene inhibitor chemical ( chemical ) has become the focus of research as a fertoprotective drug against chemical .	T11	T47	23598363
CPR:4	CHEMICAL	GENE-Y	8	3	Recently , the gene gene inhibitor chemical ( chemical ) has become the focus of research as a fertoprotective drug against chemical .	T12	T46	23598363
CPR:4	CHEMICAL	GENE-N	8	4	Recently , the gene gene inhibitor chemical ( chemical ) has become the focus of research as a fertoprotective drug against chemical .	T12	T47	23598363
NA	CHEMICAL	GENE-Y	17	3	Recently , the gene gene inhibitor chemical ( chemical ) has become the focus of research as a fertoprotective drug against chemical .	T13	T46	23598363
NA	CHEMICAL	GENE-N	17	4	Recently , the gene gene inhibitor chemical ( chemical ) has become the focus of research as a fertoprotective drug against chemical .	T13	T47	23598363
CPR:3	CHEMICAL	GENE-Y	7	9	We found that , before apoptosis , chemical induces gene and gene expression in the oocyte .	T17	T48	23598363
CPR:3	CHEMICAL	GENE-Y	7	11	We found that , before apoptosis , chemical induces gene and gene expression in the oocyte .	T17	T49	23598363
NA	CHEMICAL	GENE-Y	1	18	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T18	T21	23598363
NA	CHEMICAL	GENE-Y	1	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T18	T22	23598363
NA	CHEMICAL	GENE-Y	1	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T18	T23	23598363
NA	CHEMICAL	GENE-Y	1	33	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T18	T24	23598363
NA	CHEMICAL	GENE-Y	1	37	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T18	T25	23598363
CPR:3	CHEMICAL	GENE-Y	6	18	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T19	T21	23598363
NA	CHEMICAL	GENE-Y	6	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T19	T22	23598363
NA	CHEMICAL	GENE-Y	6	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T19	T23	23598363
NA	CHEMICAL	GENE-Y	6	33	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T19	T24	23598363
NA	CHEMICAL	GENE-Y	6	37	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T19	T25	23598363
NA	CHEMICAL	GENE-Y	1	18	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T1	T21	23598363
CPR:4	CHEMICAL	GENE-Y	1	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T1	T22	23598363
CPR:4	CHEMICAL	GENE-Y	1	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T1	T23	23598363
CPR:3	CHEMICAL	GENE-Y	1	33	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T1	T24	23598363
CPR:4	CHEMICAL	GENE-Y	1	37	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T1	T25	23598363
NA	CHEMICAL	GENE-Y	18	18	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T2	T21	23598363
CPR:3	CHEMICAL	GENE-Y	18	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T2	T22	23598363
CPR:3	CHEMICAL	GENE-Y	18	27	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T2	T23	23598363
CPR:4	CHEMICAL	GENE-Y	18	33	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T2	T24	23598363
CPR:3	CHEMICAL	GENE-Y	18	37	While chemical was unable to block chemical-induced DNA damage and damage response , such as the upregulation of gene , chemical inhibited the chemical-induced nuclear accumulation of gene/gene and the subsequent downregulation of gene and upregulation of gene , thereby abrogating oocyte cell death .	T2	T25	23598363
NA	CHEMICAL	GENE-Y	6	10	Surprisingly , the conditional deletion of chemical63 , but not gene , in oocytes inhibited apoptosis , as well as the accumulation of gene and gene caused by chemical .	T3	T27	23598363
NA	CHEMICAL	GENE-Y	6	23	Surprisingly , the conditional deletion of chemical63 , but not gene , in oocytes inhibited apoptosis , as well as the accumulation of gene and gene caused by chemical .	T3	T28	23598363
NA	CHEMICAL	GENE-Y	6	25	Surprisingly , the conditional deletion of chemical63 , but not gene , in oocytes inhibited apoptosis , as well as the accumulation of gene and gene caused by chemical .	T3	T29	23598363
NA	CHEMICAL	GENE-Y	12	10	Surprisingly , the conditional deletion of chemical63 , but not gene , in oocytes inhibited apoptosis , as well as the accumulation of gene and gene caused by chemical .	T4	T27	23598363
CPR:3	CHEMICAL	GENE-Y	12	23	Surprisingly , the conditional deletion of chemical63 , but not gene , in oocytes inhibited apoptosis , as well as the accumulation of gene and gene caused by chemical .	T4	T28	23598363
CPR:3	CHEMICAL	GENE-Y	12	25	Surprisingly , the conditional deletion of chemical63 , but not gene , in oocytes inhibited apoptosis , as well as the accumulation of gene and gene caused by chemical .	T4	T29	23598363
NA	CHEMICAL	GENE-Y	5	4	These data suggest that gene is the master regulator of chemical-induced oocyte death .	T5	T30	23598363
NA	CHEMICAL	GENE-Y	11	4	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T31	23598363
NA	CHEMICAL	GENE-Y	11	6	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T32	23598363
NA	CHEMICAL	GENE-Y	11	8	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T33	23598363
CPR:3	CHEMICAL	GENE-Y	11	13	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T34	23598363
CPR:3	CHEMICAL	GENE-Y	11	16	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T35	23598363
CPR:3	CHEMICAL	GENE-Y	11	18	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T36	23598363
CPR:3	CHEMICAL	GENE-Y	11	27	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T37	23598363
CPR:3	CHEMICAL	GENE-Y	11	29	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T38	23598363
CPR:3	CHEMICAL	GENE-Y	11	30	The expression kinetics of gene , gene and gene suggest that chemical activates gene-dependent expression of gene and gene and , in turn , the activation of gene by gene-induced gene expression .	T6	T39	23598363
CPR:4	CHEMICAL	GENE-Y	4	13	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T7	T40	23598363
CPR:3	CHEMICAL	GENE-N	4	14	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T7	T41	23598363
CPR:4	CHEMICAL	GENE-Y	4	20	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T7	T42	23598363
CPR:4	CHEMICAL	GENE-Y	4	20	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T7	T43	23598363
CPR:3	CHEMICAL	GENE-Y	8	13	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T8	T40	23598363
CPR:3	CHEMICAL	GENE-N	8	14	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T8	T41	23598363
CPR:3	CHEMICAL	GENE-Y	8	20	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T8	T42	23598363
CPR:3	CHEMICAL	GENE-Y	8	20	Our findings indicate that chemical protects oocytes from chemical-induced cell death by inhibiting gene gene , which would otherwise activate gene-gene-mediated apoptosis .	T8	T43	23598363
CPR:4	CHEMICAL	GENE-N	42	17	Both CE and E ( 2 ) alone increased DNA synthesis and reduced apoptosis with activation of gene , gene , and gene and up-regulation of antiapoptotic factors gene , gene , and gene , These effects could be completely blocked by chemical .	T14	T22	23254198
CPR:4	CHEMICAL	GENE-N	42	19	Both CE and E ( 2 ) alone increased DNA synthesis and reduced apoptosis with activation of gene , gene , and gene and up-regulation of antiapoptotic factors gene , gene , and gene , These effects could be completely blocked by chemical .	T14	T23	23254198
CPR:4	CHEMICAL	GENE-N	42	22	Both CE and E ( 2 ) alone increased DNA synthesis and reduced apoptosis with activation of gene , gene , and gene and up-regulation of antiapoptotic factors gene , gene , and gene , These effects could be completely blocked by chemical .	T14	T24	23254198
CPR:4	CHEMICAL	GENE-Y	42	28	Both CE and E ( 2 ) alone increased DNA synthesis and reduced apoptosis with activation of gene , gene , and gene and up-regulation of antiapoptotic factors gene , gene , and gene , These effects could be completely blocked by chemical .	T14	T25	23254198
CPR:4	CHEMICAL	GENE-Y	42	5	Both CE and E ( 2 ) alone increased DNA synthesis and reduced apoptosis with activation of gene , gene , and gene and up-regulation of antiapoptotic factors gene , gene , and gene , These effects could be completely blocked by chemical .	T14	T26	23254198
CPR:4	CHEMICAL	GENE-Y	42	33	Both CE and E ( 2 ) alone increased DNA synthesis and reduced apoptosis with activation of gene , gene , and gene and up-regulation of antiapoptotic factors gene , gene , and gene , These effects could be completely blocked by chemical .	T14	T27	23254198
NA	CHEMICAL	GENE-Y	14	17	Gene expression studies demonstrated that CE and E ( 2 ) were equally potent on expression of gene , gene , and gene , whereas the stimulatory effects of CE on chemical receptor and gene expression were weaker than E ( 2 ) .	T1	T17	23254198
NA	CHEMICAL	GENE-Y	14	9	Gene expression studies demonstrated that CE and E ( 2 ) were equally potent on expression of gene , gene , and gene , whereas the stimulatory effects of CE on chemical receptor and gene expression were weaker than E ( 2 ) .	T1	T18	23254198
NA	CHEMICAL	GENE-Y	14	9	Gene expression studies demonstrated that CE and E ( 2 ) were equally potent on expression of gene , gene , and gene , whereas the stimulatory effects of CE on chemical receptor and gene expression were weaker than E ( 2 ) .	T1	T19	23254198
NA	CHEMICAL	GENE-Y	14	32	Gene expression studies demonstrated that CE and E ( 2 ) were equally potent on expression of gene , gene , and gene , whereas the stimulatory effects of CE on chemical receptor and gene expression were weaker than E ( 2 ) .	T1	T20	23254198
NA	CHEMICAL	GENE-Y	14	34	Gene expression studies demonstrated that CE and E ( 2 ) were equally potent on expression of gene , gene , and gene , whereas the stimulatory effects of CE on chemical receptor and gene expression were weaker than E ( 2 ) .	T1	T21	23254198
NA	CHEMICAL	GENE-N	3	6	Phlebotomy and dietary chemical restriction reduces gene in NAFLD/NASH patients .	T5	T29	23538201
NA	CHEMICAL	GENE-N	46	4	Hepatic mRNA expression of gene , gene , and gene were increased more in CE than C , and in HE than H. In duodenum , gene , gene , and gene mRNA levels were increased in CE compared to C. In Experiment 2 , hepatic chemical concentrations were higher in HIE than HI .	T1	T20	23538201
NA	CHEMICAL	GENE-N	46	6	Hepatic mRNA expression of gene , gene , and gene were increased more in CE than C , and in HE than H. In duodenum , gene , gene , and gene mRNA levels were increased in CE compared to C. In Experiment 2 , hepatic chemical concentrations were higher in HIE than HI .	T1	T21	23538201
NA	CHEMICAL	GENE-Y	46	9	Hepatic mRNA expression of gene , gene , and gene were increased more in CE than C , and in HE than H. In duodenum , gene , gene , and gene mRNA levels were increased in CE compared to C. In Experiment 2 , hepatic chemical concentrations were higher in HIE than HI .	T1	T22	23538201
NA	CHEMICAL	GENE-Y	46	26	Hepatic mRNA expression of gene , gene , and gene were increased more in CE than C , and in HE than H. In duodenum , gene , gene , and gene mRNA levels were increased in CE compared to C. In Experiment 2 , hepatic chemical concentrations were higher in HIE than HI .	T1	T23	23538201
NA	CHEMICAL	GENE-Y	46	13	Hepatic mRNA expression of gene , gene , and gene were increased more in CE than C , and in HE than H. In duodenum , gene , gene , and gene mRNA levels were increased in CE compared to C. In Experiment 2 , hepatic chemical concentrations were higher in HIE than HI .	T1	T24	23538201
NA	CHEMICAL	GENE-Y	46	13	Hepatic mRNA expression of gene , gene , and gene were increased more in CE than C , and in HE than H. In duodenum , gene , gene , and gene mRNA levels were increased in CE compared to C. In Experiment 2 , hepatic chemical concentrations were higher in HIE than HI .	T1	T25	23538201
NA	CHEMICAL	GENE-N	5	9	The interplay between cardiac sarcoplasmic chemicalATPase and gene is a key regulating factor of contraction and relaxation in the cardiac muscle .	T4	T16	22578098
NA	CHEMICAL	GENE-Y	5	7	The interplay between cardiac sarcoplasmic chemicalATPase and gene is a key regulating factor of contraction and relaxation in the cardiac muscle .	T4	T19	22578098
NA	CHEMICAL	GENE-Y	10	12	In heart failure , aberrations in the inhibition of sarcoplasmic chemicalATPase by gene are associated with anomalies in cardiac functions .	T3	T15	22578098
NA	CHEMICAL	GENE-Y	20	17	The aim of our research was to find molecules able to interfere with the inhibitory activity of gene on sarcoplasmic chemicalATPase .	T5	T17	22578098
NA	CHEMICAL	GENE-N	4	9	By synthesizing and testing a series of chemical point-mutated gene , we identified which chemical was important for the inhibition of the gene function .	T7	T8	22578098
NA	CHEMICAL	GENE-Y	4	4	By synthesizing and testing a series of chemical point-mutated gene , we identified which chemical was important for the inhibition of the gene function .	T7	T9	22578098
NA	CHEMICAL	GENE-N	4	9	By synthesizing and testing a series of chemical point-mutated gene , we identified which chemical was important for the inhibition of the gene function .	T1	T8	22578098
NA	CHEMICAL	GENE-Y	4	4	By synthesizing and testing a series of chemical point-mutated gene , we identified which chemical was important for the inhibition of the gene function .	T1	T9	22578098
NA	CHEMICAL	GENE-N	6	7	The structures of active and inactive chemical-mutated gene , and of gene , were determined by NMR .	T2	T10	22578098
NA	CHEMICAL	GENE-Y	6	11	The structures of active and inactive chemical-mutated gene , and of gene , were determined by NMR .	T2	T11	22578098
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T8	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T8	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T9	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T9	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T10	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T10	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T11	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T11	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T12	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T12	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T13	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T13	T23	19002123
NA	CHEMICAL	GENE-N	70	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T14	T22	19002123
NA	CHEMICAL	GENE-N	70	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T14	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T15	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T15	T23	19002123
NA	CHEMICAL	GENE-N	74	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T16	T22	19002123
NA	CHEMICAL	GENE-N	74	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T16	T23	19002123
NA	CHEMICAL	GENE-N	76	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T17	T22	19002123
NA	CHEMICAL	GENE-N	76	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T17	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T18	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T18	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T19	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T19	T23	19002123
NA	CHEMICAL	GENE-N	15	45	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T20	T22	19002123
NA	CHEMICAL	GENE-N	15	15	To assess the safety and efficacy of combination therapies for LUTS associated with BPH , a search of the MEDLINE and Cochrane databases ( 1976-2008 ) was conducted for relevant trials and reviews using the terms benign prostatic hyperplasia , lower urinary tract symptoms , gene antagonists , gene inhibitors , anti-muscarinics , anticholinergics , combination therapy , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , erectile dysfunction , chemical , chemical and chemical .	T20	T23	19002123
CPR:3	CHEMICAL	GENE-N	27	6	This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory gene , gene and gene , caused by a mixture of chemical representative of a high chemical diet .	T11	T23	23583258
CPR:3	CHEMICAL	GENE-Y	27	18	This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory gene , gene and gene , caused by a mixture of chemical representative of a high chemical diet .	T11	T24	23583258
CPR:3	CHEMICAL	GENE-Y	27	20	This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory gene , gene and gene , caused by a mixture of chemical representative of a high chemical diet .	T11	T25	23583258
CPR:3	CHEMICAL	GENE-N	32	6	This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory gene , gene and gene , caused by a mixture of chemical representative of a high chemical diet .	T12	T23	23583258
CPR:3	CHEMICAL	GENE-Y	32	18	This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory gene , gene and gene , caused by a mixture of chemical representative of a high chemical diet .	T12	T24	23583258
CPR:3	CHEMICAL	GENE-Y	32	20	This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory gene , gene and gene , caused by a mixture of chemical representative of a high chemical diet .	T12	T25	23583258
NA	CHEMICAL	GENE-Y	23	29	This strong pro-inflammatory effect appeared to be dependent on the net imbalance of red-ox equilibrium with the production of excessive levels of reactive chemical species through the colonic chemical-oxidase gene activation .	T14	T27	23583258
NA	CHEMICAL	GENE-Y	28	29	This strong pro-inflammatory effect appeared to be dependent on the net imbalance of red-ox equilibrium with the production of excessive levels of reactive chemical species through the colonic chemical-oxidase gene activation .	T15	T27	23583258
CPR:3	CHEMICAL	GENE-Y	0	1	chemical-dependent gene activation , as well as gene synthesis , were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction , in particular chemical and chemical .	T17	T29	23583258
CPR:3	CHEMICAL	GENE-N	0	7	chemical-dependent gene activation , as well as gene synthesis , were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction , in particular chemical and chemical .	T17	T30	23583258
CPR:4	CHEMICAL	GENE-Y	1	1	chemical-dependent gene activation , as well as gene synthesis , were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction , in particular chemical and chemical .	T2	T29	23583258
CPR:4	CHEMICAL	GENE-N	1	7	chemical-dependent gene activation , as well as gene synthesis , were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction , in particular chemical and chemical .	T2	T30	23583258
CPR:4	CHEMICAL	GENE-Y	7	1	chemical-dependent gene activation , as well as gene synthesis , were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction , in particular chemical and chemical .	T3	T29	23583258
CPR:4	CHEMICAL	GENE-N	7	7	chemical-dependent gene activation , as well as gene synthesis , were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction , in particular chemical and chemical .	T3	T30	23583258
CPR:3	CHEMICAL	GENE-Y	28	17	Conversely , cell pre-treatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial gene down-regulation and was ineffective in gene synthesis induced by dietary chemical .	T4	T20	23583258
CPR:3	CHEMICAL	GENE-N	28	22	Conversely , cell pre-treatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial gene down-regulation and was ineffective in gene synthesis induced by dietary chemical .	T4	T21	23583258
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene expression in malignant glioma cells .	T9	T25	17234158
CPR:4	CHEMICAL	GENE-Y	8	19	Here , we report that the antifibrotic drug chemical ( chemical , chemical ) elicits growth-inhibitory effects and reduces gene protein levels in human glioma cell lines .	T1	T11	17234158
CPR:4	CHEMICAL	GENE-Y	10	19	Here , we report that the antifibrotic drug chemical ( chemical , chemical ) elicits growth-inhibitory effects and reduces gene protein levels in human glioma cell lines .	T2	T11	17234158
CPR:4	CHEMICAL	GENE-Y	12	19	Here , we report that the antifibrotic drug chemical ( chemical , chemical ) elicits growth-inhibitory effects and reduces gene protein levels in human glioma cell lines .	T3	T11	17234158
CPR:4	CHEMICAL	GENE-Y	8	3	This reduction in gene is biologically relevant since chemical treatment reduces the growth inhibition of gene-sensitive CCL-64 cells mediated by conditioned media of glioma cells .	T4	T12	17234158
CPR:4	CHEMICAL	GENE-Y	8	15	This reduction in gene is biologically relevant since chemical treatment reduces the growth inhibition of gene-sensitive CCL-64 cells mediated by conditioned media of glioma cells .	T4	T14	17234158
CPR:4	CHEMICAL	GENE-Y	0	3	chemical leads to a reduction of gene mRNA levels and of the mature gene protein due to decreased expression and direct inhibition of the gene gene gene .	T5	T17	17234158
CPR:4	CHEMICAL	GENE-Y	0	3	chemical leads to a reduction of gene mRNA levels and of the mature gene protein due to decreased expression and direct inhibition of the gene gene gene .	T5	T18	17234158
CPR:4	CHEMICAL	GENE-Y	0	3	chemical leads to a reduction of gene mRNA levels and of the mature gene protein due to decreased expression and direct inhibition of the gene gene gene .	T5	T19	17234158
CPR:4	CHEMICAL	GENE-N	0	3	chemical leads to a reduction of gene mRNA levels and of the mature gene protein due to decreased expression and direct inhibition of the gene gene gene .	T5	T20	17234158
CPR:4	CHEMICAL	GENE-Y	0	26	chemical leads to a reduction of gene mRNA levels and of the mature gene protein due to decreased expression and direct inhibition of the gene gene gene .	T5	T21	17234158
CPR:4	CHEMICAL	GENE-Y	3	10	In addition , chemical reduces the protein levels of the gene , a gene target gene and gene substrate involved in carcinogenesis .	T6	T22	17234158
CPR:4	CHEMICAL	GENE-Y	3	12	In addition , chemical reduces the protein levels of the gene , a gene target gene and gene substrate involved in carcinogenesis .	T6	T23	17234158
NA	CHEMICAL	GENE-Y	3	17	In addition , chemical reduces the protein levels of the gene , a gene target gene and gene substrate involved in carcinogenesis .	T6	T24	17234158
NA	CHEMICAL	GENE-Y	4	6	[ The effects of chemical on gene of liver and sexual glands in burned rats ] .	T10	T19	14619588
NA	CHEMICAL	GENE-Y	7	12	OBJECTIVE : To assess the effects of chemical ( chemical ) on gene ( gene ) of liver and sexual glands in burned rats for supporting the clinical application of anabolic steroids .	T3	T16	14619588
NA	CHEMICAL	GENE-Y	7	14	OBJECTIVE : To assess the effects of chemical ( chemical ) on gene ( gene ) of liver and sexual glands in burned rats for supporting the clinical application of anabolic steroids .	T3	T18	14619588
NA	CHEMICAL	GENE-Y	9	12	OBJECTIVE : To assess the effects of chemical ( chemical ) on gene ( gene ) of liver and sexual glands in burned rats for supporting the clinical application of anabolic steroids .	T6	T16	14619588
NA	CHEMICAL	GENE-Y	9	14	OBJECTIVE : To assess the effects of chemical ( chemical ) on gene ( gene ) of liver and sexual glands in burned rats for supporting the clinical application of anabolic steroids .	T6	T18	14619588
CPR:3	CHEMICAL	GENE-Y	10	5	RESULTS : The density of gene in liver tissue in chemical group was higher than that in control group ( P < 0.05 ) .	T7	T15	14619588
NA	CHEMICAL	GENE-Y	14	3	The density of gene in testis and ovary tissues showed no significant difference between chemical group and control group at every time-point ( P > 0.05 ) .	T8	T17	14619588
CPR:3	CHEMICAL	GENE-Y	2	7	CONCLUSION : chemical up-regulated the density of gene in liver tissue , whereas it had no significant effects on the density of gene in testis and ovary tissues .	T1	T11	14619588
NA	CHEMICAL	GENE-Y	2	22	CONCLUSION : chemical up-regulated the density of gene in liver tissue , whereas it had no significant effects on the density of gene in testis and ovary tissues .	T1	T12	14619588
NA	CHEMICAL	GENE-Y	5	8	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T5	T23	1284246
NA	CHEMICAL	GENE-Y	5	11	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T5	T25	1284246
NA	CHEMICAL	GENE-Y	5	0	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T5	T17	1284246
NA	CHEMICAL	GENE-Y	5	16	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T5	T18	1284246
NA	CHEMICAL	GENE-N	5	19	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T5	T21	1284246
NA	CHEMICAL	GENE-Y	10	8	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T12	T23	1284246
NA	CHEMICAL	GENE-Y	10	11	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T12	T25	1284246
NA	CHEMICAL	GENE-Y	10	0	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T12	T17	1284246
NA	CHEMICAL	GENE-Y	10	16	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T12	T18	1284246
NA	CHEMICAL	GENE-N	10	19	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T12	T21	1284246
NA	CHEMICAL	GENE-Y	8	8	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T2	T23	1284246
NA	CHEMICAL	GENE-Y	8	11	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T2	T25	1284246
NA	CHEMICAL	GENE-Y	8	0	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T2	T17	1284246
NA	CHEMICAL	GENE-Y	8	16	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T2	T18	1284246
NA	CHEMICAL	GENE-N	8	19	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T2	T21	1284246
CPR:9	CHEMICAL	GENE-Y	19	8	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T3	T23	1284246
CPR:9	CHEMICAL	GENE-Y	19	11	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T3	T25	1284246
CPR:9	CHEMICAL	GENE-Y	19	0	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T3	T17	1284246
CPR:9	CHEMICAL	GENE-Y	19	16	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T3	T18	1284246
CPR:9	CHEMICAL	GENE-N	19	19	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T3	T21	1284246
NA	CHEMICAL	GENE-Y	19	8	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T4	T23	1284246
NA	CHEMICAL	GENE-Y	19	11	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T4	T25	1284246
NA	CHEMICAL	GENE-Y	19	0	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T4	T17	1284246
NA	CHEMICAL	GENE-Y	19	16	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T4	T18	1284246
NA	CHEMICAL	GENE-N	19	19	A cDNA encoding the complete chemical sequence of gene ( chemical aminohydrolase , gene ) [ gene ] , a dimeric gene having two chemical in the molecule , which catalyzes the deacylation of chemical except chemical , has been isolated from porcine kidney lambda gt10 cDNA library and sequenced .	T4	T21	1284246
NA	CHEMICAL	GENE-Y	10	22	From sequence analysis of the cDchemicalA and the chemical- and chemical-terminal chemical analyses of the purified protein , it is deduced that gene consists of two identical subunits ( M ( r ) 45,260 ) , each of which consists of a single chain of 406 chemical with chemical at the N-terminus .	T7	T22	1284246
NA	CHEMICAL	GENE-Y	11	22	From sequence analysis of the cDchemicalA and the chemical- and chemical-terminal chemical analyses of the purified protein , it is deduced that gene consists of two identical subunits ( M ( r ) 45,260 ) , each of which consists of a single chain of 406 chemical with chemical at the N-terminus .	T8	T22	1284246
NA	CHEMICAL	GENE-Y	41	22	From sequence analysis of the cDchemicalA and the chemical- and chemical-terminal chemical analyses of the purified protein , it is deduced that gene consists of two identical subunits ( M ( r ) 45,260 ) , each of which consists of a single chain of 406 chemical with chemical at the N-terminus .	T9	T22	1284246
NA	CHEMICAL	GENE-Y	41	22	From sequence analysis of the cDchemicalA and the chemical- and chemical-terminal chemical analyses of the purified protein , it is deduced that gene consists of two identical subunits ( M ( r ) 45,260 ) , each of which consists of a single chain of 406 chemical with chemical at the N-terminus .	T10	T22	1284246
NA	CHEMICAL	GENE-Y	5	22	From sequence analysis of the cDchemicalA and the chemical- and chemical-terminal chemical analyses of the purified protein , it is deduced that gene consists of two identical subunits ( M ( r ) 45,260 ) , each of which consists of a single chain of 406 chemical with chemical at the N-terminus .	T11	T22	1284246
NA	CHEMICAL	GENE-Y	1	20	The chemical sequence deduced from the chemical sequence of the cDNA from porcine liver was identical to that deduced for gene .	T13	T26	1284246
NA	CHEMICAL	GENE-Y	6	20	The chemical sequence deduced from the chemical sequence of the cDNA from porcine liver was identical to that deduced for gene .	T14	T26	1284246
NA	CHEMICAL	GENE-Y	3	6	Comparison of the chemical sequence of gene with those of other chemical-binding metalloenzymes showed no significant homologies in either the overall sequence or the consensus sequences for the metal binding sites .	T15	T28	1284246
NA	CHEMICAL	GENE-N	3	12	Comparison of the chemical sequence of gene with those of other chemical-binding metalloenzymes showed no significant homologies in either the overall sequence or the consensus sequences for the metal binding sites .	T15	T16	1284246
NA	CHEMICAL	GENE-Y	3	6	Comparison of the chemical sequence of gene with those of other chemical-binding metalloenzymes showed no significant homologies in either the overall sequence or the consensus sequences for the metal binding sites .	T1	T28	1284246
NA	CHEMICAL	GENE-N	3	12	Comparison of the chemical sequence of gene with those of other chemical-binding metalloenzymes showed no significant homologies in either the overall sequence or the consensus sequences for the metal binding sites .	T1	T16	1284246
CPR:4	CHEMICAL	GENE-Y	5	9	Synthesis and biological evaluation of chemical analogues as novel gene and gene inhibitors .	T3	T13	23376249
CPR:4	CHEMICAL	GENE-Y	5	11	Synthesis and biological evaluation of chemical analogues as novel gene and gene inhibitors .	T3	T14	23376249
CPR:4	CHEMICAL	GENE-N	3	3	In this paper a series of new chemical derivatives has been designed , synthesized and evaluated as the chemical- and butyrylcholinesterase inhibitors .	T2	T4	23376249
NA	CHEMICAL	GENE-N	3	3	In this paper a series of new chemical derivatives has been designed , synthesized and evaluated as the chemical- and butyrylcholinesterase inhibitors .	T1	T4	23376249
CPR:4	CHEMICAL	GENE-N	0	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T15	T31	23261676
CPR:4	CHEMICAL	GENE-Y	0	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T15	T32	23261676
CPR:4	CHEMICAL	GENE-N	0	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T15	T33	23261676
CPR:4	CHEMICAL	GENE-N	0	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T15	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T16	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T16	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T16	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T16	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T17	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T17	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T17	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T17	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T18	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T18	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T18	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T18	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T19	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T19	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T19	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T19	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T20	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T20	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T20	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T20	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T21	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T21	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T21	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T21	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T22	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T22	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T22	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T22	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T23	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T23	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T23	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T23	T34	23261676
NA	CHEMICAL	GENE-N	50	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T24	T31	23261676
NA	CHEMICAL	GENE-Y	50	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T24	T32	23261676
NA	CHEMICAL	GENE-N	50	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T24	T33	23261676
NA	CHEMICAL	GENE-N	50	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T24	T34	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T25	T31	23261676
NA	CHEMICAL	GENE-Y	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T25	T32	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T25	T33	23261676
NA	CHEMICAL	GENE-N	6	6	chemical induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers , heart mitochondrial lipid peroxidation , chemical , and a significant decrease in the activities/levels of heart mitochondrial chemical peroxidase , chemical reductase , chemical , chemical , chemical , chemical , chemical and chemical-dehydrogenases , gene and chemical .	T25	T34	23261676
NA	CHEMICAL	GENE-Y	0	1	chemical Receptor mRNA Measured by Quantitative Real Time PCR is Decreased in the Urethral Mucosa of Patients with Middle Idiopathic Hypospadias .	T13	T26	23386417
NA	CHEMICAL	GENE-Y	0	7	chemical action is exerted through the chemical receptor .	T1	T22	23386417
NA	CHEMICAL	GENE-Y	6	7	chemical action is exerted through the chemical receptor .	T9	T22	23386417
NA	CHEMICAL	GENE-Y	9	10	The normal 46 , XY genital virilization depends on chemical receptor gene expression , which is tissue specific , and requires normal gene mRNA levels in chemical sensitive tissues .	T3	T15	23386417
NA	CHEMICAL	GENE-Y	9	10	The normal 46 , XY genital virilization depends on chemical receptor gene expression , which is tissue specific , and requires normal gene mRNA levels in chemical sensitive tissues .	T3	T21	23386417
NA	CHEMICAL	GENE-Y	19	10	The normal 46 , XY genital virilization depends on chemical receptor gene expression , which is tissue specific , and requires normal gene mRNA levels in chemical sensitive tissues .	T6	T15	23386417
NA	CHEMICAL	GENE-Y	19	10	The normal 46 , XY genital virilization depends on chemical receptor gene expression , which is tissue specific , and requires normal gene mRNA levels in chemical sensitive tissues .	T6	T21	23386417
NA	CHEMICAL	GENE-Y	19	10	The normal 46 , XY genital virilization depends on chemical receptor gene expression , which is tissue specific , and requires normal gene mRNA levels in chemical sensitive tissues .	T7	T15	23386417
NA	CHEMICAL	GENE-Y	19	10	The normal 46 , XY genital virilization depends on chemical receptor gene expression , which is tissue specific , and requires normal gene mRNA levels in chemical sensitive tissues .	T7	T21	23386417
NA	CHEMICAL	GENE-Y	18	6	The aim of this study was to compare , by quantitative real time PCR , the amount of chemical receptor mRNA in cells obtained from the urethral mucosa of patients with middle idiopathic hypospadias with the gene mRNA levels observed in control phimosis subjects with eutopic urethral opening .	T10	T23	23386417
NA	CHEMICAL	GENE-Y	18	6	The aim of this study was to compare , by quantitative real time PCR , the amount of chemical receptor mRNA in cells obtained from the urethral mucosa of patients with middle idiopathic hypospadias with the gene mRNA levels observed in control phimosis subjects with eutopic urethral opening .	T10	T24	23386417
NA	CHEMICAL	GENE-Y	4	5	We observed significantly less chemical receptor mRNA in the urethral mucosa of patients with hypospadias than in the controls ( p=0.002 ) .	T12	T25	23386417
NA	CHEMICAL	GENE-Y	6	7	The correlation between the level of chemical receptor mRNA expression and the penile size was almost statistically significant only in hypospadias patients ( r=0.47 ; p=0.053 ) .	T2	T14	23386417
NA	CHEMICAL	GENE-N	12	6	We also established the number of gene in exon 1 of the chemical receptor gene by GeneScan analysis .	T4	T16	23386417
NA	CHEMICAL	GENE-Y	12	13	We also established the number of gene in exon 1 of the chemical receptor gene by GeneScan analysis .	T4	T17	23386417
NA	CHEMICAL	GENE-N	3	5	Metabolic syndrome : chemical-activated protein kinase and chemical . The metabolic syndrome can be defined as a state of metabolic dysregulation characterized by gene resistance , central obesity , and a predisposition to type 2 diabetes , dyslipidemia , premature atherosclerosis , and other diseases .	T6	T13	16642960
NA	CHEMICAL	GENE-Y	3	23	Metabolic syndrome : chemical-activated protein kinase and chemical . The metabolic syndrome can be defined as a state of metabolic dysregulation characterized by gene resistance , central obesity , and a predisposition to type 2 diabetes , dyslipidemia , premature atherosclerosis , and other diseases .	T6	T12	16642960
NA	CHEMICAL	GENE-N	7	5	Metabolic syndrome : chemical-activated protein kinase and chemical . The metabolic syndrome can be defined as a state of metabolic dysregulation characterized by gene resistance , central obesity , and a predisposition to type 2 diabetes , dyslipidemia , premature atherosclerosis , and other diseases .	T7	T13	16642960
NA	CHEMICAL	GENE-Y	7	23	Metabolic syndrome : chemical-activated protein kinase and chemical . The metabolic syndrome can be defined as a state of metabolic dysregulation characterized by gene resistance , central obesity , and a predisposition to type 2 diabetes , dyslipidemia , premature atherosclerosis , and other diseases .	T7	T12	16642960
NA	CHEMICAL	GENE-N	19	7	We review here the hypothesis that , in many instances , the cause of these lipid abnormalities could be a dysregulation of the chemical-activated protein kinase ( gene ) /chemical ( CoA ) fuel-sensing and signaling mechanism .	T1	T8	16642960
NA	CHEMICAL	GENE-N	19	27	We review here the hypothesis that , in many instances , the cause of these lipid abnormalities could be a dysregulation of the chemical-activated protein kinase ( gene ) /chemical ( CoA ) fuel-sensing and signaling mechanism .	T1	T9	16642960
NA	CHEMICAL	GENE-N	29	7	We review here the hypothesis that , in many instances , the cause of these lipid abnormalities could be a dysregulation of the chemical-activated protein kinase ( gene ) /chemical ( CoA ) fuel-sensing and signaling mechanism .	T2	T8	16642960
NA	CHEMICAL	GENE-N	29	27	We review here the hypothesis that , in many instances , the cause of these lipid abnormalities could be a dysregulation of the chemical-activated protein kinase ( gene ) /chemical ( CoA ) fuel-sensing and signaling mechanism .	T2	T9	16642960
NA	CHEMICAL	GENE-N	9	17	Such dysregulation could be reflected by isolated increases in chemical or by concurrent changes in chemical and gene , both of which would alter intracellular fatty acid partitioning .	T3	T10	16642960
NA	CHEMICAL	GENE-N	15	17	Such dysregulation could be reflected by isolated increases in chemical or by concurrent changes in chemical and gene , both of which would alter intracellular fatty acid partitioning .	T4	T10	16642960
NA	CHEMICAL	GENE-Y	1	0	gene chemical-finger missense mutations lead to hypomorphic alleles and a mild Mowat-Wilson syndrome .	T2	T17	23466526
NA	CHEMICAL	GENE-N	17	17	In this study , we report and analyze the functional consequences of three novel missense mutations , gene , gene and gene , identified in the highly conserved gene of gene .	T1	T12	23466526
NA	CHEMICAL	GENE-N	17	19	In this study , we report and analyze the functional consequences of three novel missense mutations , gene , gene and gene , identified in the highly conserved gene of gene .	T1	T13	23466526
NA	CHEMICAL	GENE-N	17	21	In this study , we report and analyze the functional consequences of three novel missense mutations , gene , gene and gene , identified in the highly conserved gene of gene .	T1	T14	23466526
NA	CHEMICAL	GENE-N	17	24	In this study , we report and analyze the functional consequences of three novel missense mutations , gene , gene and gene , identified in the highly conserved gene of gene .	T1	T15	23466526
NA	CHEMICAL	GENE-Y	17	30	In this study , we report and analyze the functional consequences of three novel missense mutations , gene , gene and gene , identified in the highly conserved gene of gene .	T1	T16	23466526
CPR:4	CHEMICAL	GENE-Y	0	10	chemical : mode of action and properties of the chemical epoxidase inhibition .	T18	T25	1543672
NA	CHEMICAL	GENE-Y	9	10	chemical : mode of action and properties of the chemical epoxidase inhibition .	T19	T25	1543672
CPR:4	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) has primarily fungicidal action against many fungi as a result of its specific mechanism of chemical epoxidase inhibition .	T1	T20	1543672
CPR:4	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) has primarily fungicidal action against many fungi as a result of its specific mechanism of chemical epoxidase inhibition .	T7	T20	1543672
NA	CHEMICAL	GENE-Y	12	11	chemical ( chemical ) has primarily fungicidal action against many fungi as a result of its specific mechanism of chemical epoxidase inhibition .	T5	T20	1543672
CPR:4	CHEMICAL	GENE-Y	0	2	chemical is a potent non-competitive inhibitor of chemical epoxidase from Candida ( Ki = 30 nM ) .	T15	T23	1543672
NA	CHEMICAL	GENE-Y	2	2	chemical is a potent non-competitive inhibitor of chemical epoxidase from Candida ( Ki = 30 nM ) .	T16	T23	1543672
NA	CHEMICAL	GENE-Y	23	5	In contrast , inhibition of gene only occurs at higher drug concentrations ( Ki = 77 microM ) , and is competitive with chemical .	T17	T24	1543672
CPR:4	CHEMICAL	GENE-Y	5	5	In contrast , inhibition of gene only occurs at higher drug concentrations ( Ki = 77 microM ) , and is competitive with chemical .	T2	T24	1543672
NA	CHEMICAL	GENE-Y	7	22	Paroxysmal nocturnal hemoglobinuria ( PNH ) is a rare , acquired hemolytic anemia caused by somatic mutations in the chemical glycan-complementation class A gene and the resulting absence of a key complement regulatory protein , gene .	T1	T3	19399743
NA	CHEMICAL	GENE-Y	7	35	Paroxysmal nocturnal hemoglobinuria ( PNH ) is a rare , acquired hemolytic anemia caused by somatic mutations in the chemical glycan-complementation class A gene and the resulting absence of a key complement regulatory protein , gene .	T1	T4	19399743
NA	CHEMICAL	GENE-N	2	6	Regulation of chemical receptors alpha , beta and chemical X receptor alpha after sciatic nerve injury .	T18	T35	16782282
NA	CHEMICAL	GENE-Y	2	4	Regulation of chemical receptors alpha , beta and chemical X receptor alpha after sciatic nerve injury .	T18	T36	16782282
NA	CHEMICAL	GENE-N	8	6	Regulation of chemical receptors alpha , beta and chemical X receptor alpha after sciatic nerve injury .	T19	T35	16782282
NA	CHEMICAL	GENE-Y	8	4	Regulation of chemical receptors alpha , beta and chemical X receptor alpha after sciatic nerve injury .	T19	T36	16782282
NA	CHEMICAL	GENE-N	4	9	Since the effect of chemical is mediated via chemical receptors and chemical X receptors , we investigated mRNA and protein expression of these receptors during injury-induced degeneration and regeneration .	T6	T25	16782282
NA	CHEMICAL	GENE-N	4	9	Since the effect of chemical is mediated via chemical receptors and chemical X receptors , we investigated mRNA and protein expression of these receptors during injury-induced degeneration and regeneration .	T6	T26	16782282
NA	CHEMICAL	GENE-N	8	9	Since the effect of chemical is mediated via chemical receptors and chemical X receptors , we investigated mRNA and protein expression of these receptors during injury-induced degeneration and regeneration .	T7	T25	16782282
NA	CHEMICAL	GENE-N	8	9	Since the effect of chemical is mediated via chemical receptors and chemical X receptors , we investigated mRNA and protein expression of these receptors during injury-induced degeneration and regeneration .	T7	T26	16782282
NA	CHEMICAL	GENE-N	11	9	Since the effect of chemical is mediated via chemical receptors and chemical X receptors , we investigated mRNA and protein expression of these receptors during injury-induced degeneration and regeneration .	T8	T25	16782282
NA	CHEMICAL	GENE-N	11	9	Since the effect of chemical is mediated via chemical receptors and chemical X receptors , we investigated mRNA and protein expression of these receptors during injury-induced degeneration and regeneration .	T8	T26	16782282
NA	CHEMICAL	GENE-N	10	11	Seven days after crush injury , transcript concentrations of all chemical receptors and of chemical X receptor alpha were significantly higher than in non-lesioned nerves .	T9	T27	16782282
NA	CHEMICAL	GENE-Y	10	17	Seven days after crush injury , transcript concentrations of all chemical receptors and of chemical X receptor alpha were significantly higher than in non-lesioned nerves .	T9	T28	16782282
NA	CHEMICAL	GENE-N	14	11	Seven days after crush injury , transcript concentrations of all chemical receptors and of chemical X receptor alpha were significantly higher than in non-lesioned nerves .	T10	T27	16782282
NA	CHEMICAL	GENE-Y	14	17	Seven days after crush injury , transcript concentrations of all chemical receptors and of chemical X receptor alpha were significantly higher than in non-lesioned nerves .	T10	T28	16782282
NA	CHEMICAL	GENE-Y	3	5	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T12	T29	16782282
NA	CHEMICAL	GENE-Y	3	9	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T12	T30	16782282
NA	CHEMICAL	GENE-Y	3	5	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T12	T31	16782282
NA	CHEMICAL	GENE-Y	7	5	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T13	T29	16782282
NA	CHEMICAL	GENE-Y	7	9	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T13	T30	16782282
NA	CHEMICAL	GENE-Y	7	5	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T13	T31	16782282
NA	CHEMICAL	GENE-Y	11	5	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T14	T29	16782282
NA	CHEMICAL	GENE-Y	11	9	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T14	T30	16782282
NA	CHEMICAL	GENE-Y	11	5	Protein levels of chemical receptor alpha , chemical receptor beta and chemical X receptor alpha were upregulated 4 , 7 and 14 days after injury .	T14	T31	16782282
NA	CHEMICAL	GENE-Y	3	3	In degenerating nerves a significant increase of chemical receptor alpha was detected 7 and 14 days , and of chemical receptor beta 14 and 21 days after complete transection .	T15	T32	16782282
NA	CHEMICAL	GENE-Y	3	3	In degenerating nerves a significant increase of chemical receptor alpha was detected 7 and 14 days , and of chemical receptor beta 14 and 21 days after complete transection .	T15	T33	16782282
NA	CHEMICAL	GENE-Y	3	3	In degenerating nerves a significant increase of chemical receptor alpha was detected 7 and 14 days , and of chemical receptor beta 14 and 21 days after complete transection .	T16	T32	16782282
NA	CHEMICAL	GENE-Y	3	3	In degenerating nerves a significant increase of chemical receptor alpha was detected 7 and 14 days , and of chemical receptor beta 14 and 21 days after complete transection .	T16	T33	16782282
NA	CHEMICAL	GENE-N	3	4	Immunohistochemical staining of chemical receptors revealed their expression in Schwann cells and macrophages .	T17	T34	16782282
NA	CHEMICAL	GENE-Y	6	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T1	T20	16782282
NA	CHEMICAL	GENE-Y	6	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T1	T21	16782282
NA	CHEMICAL	GENE-Y	6	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T1	T22	16782282
NA	CHEMICAL	GENE-Y	10	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T2	T20	16782282
NA	CHEMICAL	GENE-Y	10	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T2	T21	16782282
NA	CHEMICAL	GENE-Y	10	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T2	T22	16782282
NA	CHEMICAL	GENE-Y	15	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T3	T20	16782282
NA	CHEMICAL	GENE-Y	15	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T3	T21	16782282
NA	CHEMICAL	GENE-Y	15	8	In addition , we observed that chemical receptor alpha and chemical X receptor alpha appeared in the cell nuclei of macrophages during the lesion-induced inflammatory reaction , and that gene-staining co-localized with some regenerating axons .	T3	T22	16782282
NA	CHEMICAL	GENE-Y	13	4	Genomic variation in the gene gene is associated with β-thalassemia disease severity and chemical treatment efficacy .	T2	T13	23556445
NA	CHEMICAL	GENE-Y	15	13	Aim : In this study we explored the association between genetic variations in gene and gene genes , residing on chromosome 6q23 , and disease severity in β-hemoglobinopathy patients , as well as the association between these variants with response to chemical ( HU ) treatment .	T1	T9	23556445
NA	CHEMICAL	GENE-Y	15	15	Aim : In this study we explored the association between genetic variations in gene and gene genes , residing on chromosome 6q23 , and disease severity in β-hemoglobinopathy patients , as well as the association between these variants with response to chemical ( HU ) treatment .	T1	T10	23556445
NA	CHEMICAL	GENE-N	3	4	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T17	T35	10193663
NA	CHEMICAL	GENE-Y	3	15	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T17	T33	10193663
NA	CHEMICAL	GENE-Y	3	17	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T17	T34	10193663
NA	CHEMICAL	GENE-N	8	4	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T18	T35	10193663
NA	CHEMICAL	GENE-Y	8	15	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T18	T33	10193663
NA	CHEMICAL	GENE-Y	8	17	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T18	T34	10193663
NA	CHEMICAL	GENE-N	12	4	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T19	T35	10193663
NA	CHEMICAL	GENE-Y	12	15	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T19	T33	10193663
NA	CHEMICAL	GENE-Y	12	17	Characterisation of the chemical receptor binding profile of chemical and kinetics of chemical binding at gene and gene receptors .	T19	T34	10193663
NA	CHEMICAL	GENE-N	3	12	The affinity of chemical ( chemical ) for a range of chemical receptors was compared to values obtained for other gene receptor agonists known to be effective in the treatment of migraine .	T5	T21	10193663
NA	CHEMICAL	GENE-N	3	20	The affinity of chemical ( chemical ) for a range of chemical receptors was compared to values obtained for other gene receptor agonists known to be effective in the treatment of migraine .	T5	T25	10193663
NA	CHEMICAL	GENE-N	5	12	The affinity of chemical ( chemical ) for a range of chemical receptors was compared to values obtained for other gene receptor agonists known to be effective in the treatment of migraine .	T8	T21	10193663
NA	CHEMICAL	GENE-N	5	20	The affinity of chemical ( chemical ) for a range of chemical receptors was compared to values obtained for other gene receptor agonists known to be effective in the treatment of migraine .	T8	T25	10193663
NA	CHEMICAL	GENE-N	11	12	The affinity of chemical ( chemical ) for a range of chemical receptors was compared to values obtained for other gene receptor agonists known to be effective in the treatment of migraine .	T3	T21	10193663
NA	CHEMICAL	GENE-N	11	20	The affinity of chemical ( chemical ) for a range of chemical receptors was compared to values obtained for other gene receptor agonists known to be effective in the treatment of migraine .	T3	T25	10193663
NA	CHEMICAL	GENE-Y	0	15	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T6	T26	10193663
NA	CHEMICAL	GENE-Y	0	17	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T6	T27	10193663
NA	CHEMICAL	GENE-Y	0	20	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T6	T28	10193663
NA	CHEMICAL	GENE-Y	3	15	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T7	T26	10193663
NA	CHEMICAL	GENE-Y	3	17	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T7	T27	10193663
NA	CHEMICAL	GENE-Y	3	20	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T7	T28	10193663
NA	CHEMICAL	GENE-Y	5	15	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T9	T26	10193663
NA	CHEMICAL	GENE-Y	5	17	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T9	T27	10193663
NA	CHEMICAL	GENE-Y	5	20	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T9	T28	10193663
NA	CHEMICAL	GENE-Y	7	15	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T10	T26	10193663
NA	CHEMICAL	GENE-Y	7	17	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T10	T27	10193663
NA	CHEMICAL	GENE-Y	7	20	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T10	T28	10193663
NA	CHEMICAL	GENE-Y	9	15	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T11	T26	10193663
NA	CHEMICAL	GENE-Y	9	17	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T11	T27	10193663
NA	CHEMICAL	GENE-Y	9	20	chemical , like chemical , chemical , chemical and chemical had highest affinity for the gene , gene and putative gene receptor .	T11	T28	10193663
NA	CHEMICAL	GENE-Y	6	11	Kinetic studies comparing the binding of chemical and chemical to the gene and gene receptors expressed in HeLa cells revealed that both radioligands bound with high specificity ( > 90 % ) and reached equilibrium within 10-15 min .	T12	T29	10193663
NA	CHEMICAL	GENE-Y	6	13	Kinetic studies comparing the binding of chemical and chemical to the gene and gene receptors expressed in HeLa cells revealed that both radioligands bound with high specificity ( > 90 % ) and reached equilibrium within 10-15 min .	T12	T30	10193663
NA	CHEMICAL	GENE-Y	8	11	Kinetic studies comparing the binding of chemical and chemical to the gene and gene receptors expressed in HeLa cells revealed that both radioligands bound with high specificity ( > 90 % ) and reached equilibrium within 10-15 min .	T13	T29	10193663
NA	CHEMICAL	GENE-Y	8	13	Kinetic studies comparing the binding of chemical and chemical to the gene and gene receptors expressed in HeLa cells revealed that both radioligands bound with high specificity ( > 90 % ) and reached equilibrium within 10-15 min .	T13	T30	10193663
NA	CHEMICAL	GENE-Y	2	12	However , chemical had over 6-fold higher affinity than chemical at the gene receptor ( K ( D ) ) : 0.92 and 6.58 nM , respectively ) and over 3-fold higher affinity than chemical at the gene receptor ( K ( D ) : 3.14 and 11.07 nM , respectively ) .	T14	T31	10193663
NA	CHEMICAL	GENE-Y	2	37	However , chemical had over 6-fold higher affinity than chemical at the gene receptor ( K ( D ) ) : 0.92 and 6.58 nM , respectively ) and over 3-fold higher affinity than chemical at the gene receptor ( K ( D ) : 3.14 and 11.07 nM , respectively ) .	T14	T32	10193663
NA	CHEMICAL	GENE-Y	9	12	However , chemical had over 6-fold higher affinity than chemical at the gene receptor ( K ( D ) ) : 0.92 and 6.58 nM , respectively ) and over 3-fold higher affinity than chemical at the gene receptor ( K ( D ) : 3.14 and 11.07 nM , respectively ) .	T15	T31	10193663
NA	CHEMICAL	GENE-Y	9	37	However , chemical had over 6-fold higher affinity than chemical at the gene receptor ( K ( D ) ) : 0.92 and 6.58 nM , respectively ) and over 3-fold higher affinity than chemical at the gene receptor ( K ( D ) : 3.14 and 11.07 nM , respectively ) .	T15	T32	10193663
NA	CHEMICAL	GENE-Y	10	12	However , chemical had over 6-fold higher affinity than chemical at the gene receptor ( K ( D ) ) : 0.92 and 6.58 nM , respectively ) and over 3-fold higher affinity than chemical at the gene receptor ( K ( D ) : 3.14 and 11.07 nM , respectively ) .	T16	T31	10193663
NA	CHEMICAL	GENE-Y	10	37	However , chemical had over 6-fold higher affinity than chemical at the gene receptor ( K ( D ) ) : 0.92 and 6.58 nM , respectively ) and over 3-fold higher affinity than chemical at the gene receptor ( K ( D ) : 3.14 and 11.07 nM , respectively ) .	T16	T32	10193663
NA	CHEMICAL	GENE-Y	27	14	Association and dissociation rates for both radioligands could only be accurately determined at the gene receptor and then only at 4 degrees C. At this temperature , chemical had a significantly ( P < 0.05 ) faster association rate ( K ( on ) 0.249 min ( -1 ) nM ( -1 ) ) than chemical ( K ( on ) 0.024 min ( -1 ) nM ( -1 ) ) and a significantly ( P < 0.05 ) slower off-rate ( K ( off ) 0.027 min ( -1 ) compared to 0.037 min ( -1 ) for chemical ) .	T1	T20	10193663
NA	CHEMICAL	GENE-Y	12	14	Association and dissociation rates for both radioligands could only be accurately determined at the gene receptor and then only at 4 degrees C. At this temperature , chemical had a significantly ( P < 0.05 ) faster association rate ( K ( on ) 0.249 min ( -1 ) nM ( -1 ) ) than chemical ( K ( on ) 0.024 min ( -1 ) nM ( -1 ) ) and a significantly ( P < 0.05 ) slower off-rate ( K ( off ) 0.027 min ( -1 ) compared to 0.037 min ( -1 ) for chemical ) .	T2	T20	10193663
NA	CHEMICAL	GENE-Y	12	14	Association and dissociation rates for both radioligands could only be accurately determined at the gene receptor and then only at 4 degrees C. At this temperature , chemical had a significantly ( P < 0.05 ) faster association rate ( K ( on ) 0.249 min ( -1 ) nM ( -1 ) ) than chemical ( K ( on ) 0.024 min ( -1 ) nM ( -1 ) ) and a significantly ( P < 0.05 ) slower off-rate ( K ( off ) 0.027 min ( -1 ) compared to 0.037 min ( -1 ) for chemical ) .	T4	T20	10193663
NA	CHEMICAL	GENE-N	6	1	Circulating very-gene from subjects with impaired chemical tolerance accelerates adrenocortical chemical and chemical synthesis .	T14	T27	23047828
NA	CHEMICAL	GENE-N	10	1	Circulating very-gene from subjects with impaired chemical tolerance accelerates adrenocortical chemical and chemical synthesis .	T12	T27	23047828
NA	CHEMICAL	GENE-N	12	1	Circulating very-gene from subjects with impaired chemical tolerance accelerates adrenocortical chemical and chemical synthesis .	T13	T27	23047828
NA	CHEMICAL	GENE-Y	10	4	Apart from their role in cardiovascular homeostasis and immunomodulation , chemical and chemical are also implicated in the pathogenesis of gene resistance and type 2 diabetes mellitus ( T2DM ) .	T9	T22	23047828
NA	CHEMICAL	GENE-Y	12	4	Apart from their role in cardiovascular homeostasis and immunomodulation , chemical and chemical are also implicated in the pathogenesis of gene resistance and type 2 diabetes mellitus ( T2DM ) .	T11	T22	23047828
NA	CHEMICAL	GENE-N	2	0	gene induced a greater stimulating effect on adrenocortical chemical and chemical release compared to gene and gene .	T3	T15	23047828
NA	CHEMICAL	GENE-N	2	14	gene induced a greater stimulating effect on adrenocortical chemical and chemical release compared to gene and gene .	T3	T16	23047828
NA	CHEMICAL	GENE-N	2	16	gene induced a greater stimulating effect on adrenocortical chemical and chemical release compared to gene and gene .	T3	T17	23047828
NA	CHEMICAL	GENE-N	10	0	gene induced a greater stimulating effect on adrenocortical chemical and chemical release compared to gene and gene .	T4	T15	23047828
NA	CHEMICAL	GENE-N	10	14	gene induced a greater stimulating effect on adrenocortical chemical and chemical release compared to gene and gene .	T4	T16	23047828
NA	CHEMICAL	GENE-N	10	16	gene induced a greater stimulating effect on adrenocortical chemical and chemical release compared to gene and gene .	T4	T17	23047828
NA	CHEMICAL	GENE-Y	2	1	Plants as a source of gene variants designed for enhanced chemical hydrolase activity .	T7	T16	23000451
NA	CHEMICAL	GENE-N	2	1	Plants as a source of gene variants designed for enhanced chemical hydrolase activity .	T7	T17	23000451
CPR:9	CHEMICAL	GENE-Y	7	7	Recent studies , however , have demonstrated a promising potential treatment option with the help of the serum enzyme gene ( gene ) , which is capable of breaking down naturally occurring chemical before the drug can influence the reward centers of the brain or affect other areas of the body .	T3	T10	23000451
CPR:9	CHEMICAL	GENE-Y	7	21	Recent studies , however , have demonstrated a promising potential treatment option with the help of the serum enzyme gene ( gene ) , which is capable of breaking down naturally occurring chemical before the drug can influence the reward centers of the brain or affect other areas of the body .	T3	T11	23000451
CPR:9	CHEMICAL	GENE-Y	15	7	This prompted the design of variants of gene which exhibit significantly improved catalytic activity against chemical .	T4	T13	23000451
NA	CHEMICAL	GENE-N	2	2	Plants are a promising means to produce large amounts of these chemical hydrolase variants of gene , cheaply , safely with no concerns regarding human pathogens and functionally equivalent to enzymes derived from other sources .	T5	T14	23000451
NA	CHEMICAL	GENE-N	2	15	Plants are a promising means to produce large amounts of these chemical hydrolase variants of gene , cheaply , safely with no concerns regarding human pathogens and functionally equivalent to enzymes derived from other sources .	T5	T15	23000451
NA	CHEMICAL	GENE-Y	5	17	On the other hand , chemical did not modify the eosinophil spontaneous adhesion to the resting or gene plus gene-stimulated pulmonary endothelial cells .	T6	T13	12692940
NA	CHEMICAL	GENE-Y	5	19	On the other hand , chemical did not modify the eosinophil spontaneous adhesion to the resting or gene plus gene-stimulated pulmonary endothelial cells .	T6	T14	12692940
NA	CHEMICAL	GENE-Y	2	6	Similarly , chemical did not modulate gene- or FMLP-activated eosinophil adhesion to the resting endothelial cells .	T8	T15	12692940
NA	CHEMICAL	GENE-Y	5	4	Melanoma targeting property of a chemical-labeled chemical bridge-cyclized gene peptide .	T8	T11	23473679
NA	CHEMICAL	GENE-Y	4	4	Melanoma targeting property of a chemical-labeled chemical bridge-cyclized gene peptide .	T9	T11	23473679
CPR:4	CHEMICAL	GENE-N	3	9	Synthesis of a chemical ( chemical ) -conjugate of gene inhibitor chemical for gastric wall imaging studies .	T6	T11	23511016
CPR:4	CHEMICAL	GENE-N	4	9	Synthesis of a chemical ( chemical ) -conjugate of gene inhibitor chemical for gastric wall imaging studies .	T7	T11	23511016
CPR:4	CHEMICAL	GENE-N	2	9	Synthesis of a chemical ( chemical ) -conjugate of gene inhibitor chemical for gastric wall imaging studies .	T8	T11	23511016
CPR:4	CHEMICAL	GENE-N	15	37	To overcome this limitation , we de novo synthesized a conjugate that covalently combines a chemical-based MRI contrast agent , encaged with a chelating agent ( chemical ) , with chemical , which is a widely used gene inhibitor that binds to gene in the stomach and colon .	T1	T9	23511016
NA	CHEMICAL	GENE-N	15	42	To overcome this limitation , we de novo synthesized a conjugate that covalently combines a chemical-based MRI contrast agent , encaged with a chelating agent ( chemical ) , with chemical , which is a widely used gene inhibitor that binds to gene in the stomach and colon .	T1	T10	23511016
CPR:4	CHEMICAL	GENE-N	26	37	To overcome this limitation , we de novo synthesized a conjugate that covalently combines a chemical-based MRI contrast agent , encaged with a chelating agent ( chemical ) , with chemical , which is a widely used gene inhibitor that binds to gene in the stomach and colon .	T2	T9	23511016
NA	CHEMICAL	GENE-N	26	42	To overcome this limitation , we de novo synthesized a conjugate that covalently combines a chemical-based MRI contrast agent , encaged with a chelating agent ( chemical ) , with chemical , which is a widely used gene inhibitor that binds to gene in the stomach and colon .	T2	T10	23511016
CPR:4	CHEMICAL	GENE-N	9	37	To overcome this limitation , we de novo synthesized a conjugate that covalently combines a chemical-based MRI contrast agent , encaged with a chelating agent ( chemical ) , with chemical , which is a widely used gene inhibitor that binds to gene in the stomach and colon .	T3	T9	23511016
NA	CHEMICAL	GENE-N	9	42	To overcome this limitation , we de novo synthesized a conjugate that covalently combines a chemical-based MRI contrast agent , encaged with a chelating agent ( chemical ) , with chemical , which is a widely used gene inhibitor that binds to gene in the stomach and colon .	T3	T10	23511016
CPR:3	CHEMICAL	GENE-Y	22	4	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T9	T15	23603382
CPR:3	CHEMICAL	GENE-Y	22	6	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T9	T16	23603382
CPR:3	CHEMICAL	GENE-N	22	8	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T9	T17	23603382
CPR:4	CHEMICAL	GENE-Y	22	10	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T9	T18	23603382
CPR:4	CHEMICAL	GENE-Y	22	4	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T10	T15	23603382
CPR:4	CHEMICAL	GENE-Y	22	6	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T10	T16	23603382
CPR:4	CHEMICAL	GENE-N	22	8	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T10	T17	23603382
CPR:4	CHEMICAL	GENE-Y	22	10	The mRNA levels of gene , gene , gene and gene were increased significantly ( P < 0.05 ) in the combined chemical+chemical treatment group .	T10	T18	23603382
CPR:3	CHEMICAL	GENE-N	16	3	The expressions of gene and gene were significantly ( P < 0.05 ) increased in the chemical group and reduced in the combined treatment group .	T12	T19	23603382
CPR:3	CHEMICAL	GENE-Y	16	5	The expressions of gene and gene were significantly ( P < 0.05 ) increased in the chemical group and reduced in the combined treatment group .	T12	T20	23603382
CPR:4	CHEMICAL	GENE-Y	2	7	OBJECTIVE : chemical is the first in a new class of synthetic gene inhibitors that binds reversibly with high affinity to gene .	T2	T8	12383039
NA	CHEMICAL	GENE-Y	2	21	OBJECTIVE : chemical is the first in a new class of synthetic gene inhibitors that binds reversibly with high affinity to gene .	T2	T7	12383039
NA	CHEMICAL	GENE-Y	0	9	chemical Cause G2/M Arrest Associated with the Modulation of gene and gene in Human Breast Cancer MCF-7 Cells .	T11	T21	23432582
NA	CHEMICAL	GENE-Y	0	11	chemical Cause G2/M Arrest Associated with the Modulation of gene and gene in Human Breast Cancer MCF-7 Cells .	T11	T22	23432582
NA	CHEMICAL	GENE-N	17	6	However , the involvement of the gene-dependent pathway in the process of cell death induced by either chemical 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pangene inhibitor chemical .	T9	T17	23432582
NA	CHEMICAL	GENE-N	17	34	However , the involvement of the gene-dependent pathway in the process of cell death induced by either chemical 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pangene inhibitor chemical .	T9	T18	23432582
NA	CHEMICAL	GENE-N	36	6	However , the involvement of the gene-dependent pathway in the process of cell death induced by either chemical 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pangene inhibitor chemical .	T10	T17	23432582
CPR:4	CHEMICAL	GENE-N	36	34	However , the involvement of the gene-dependent pathway in the process of cell death induced by either chemical 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pangene inhibitor chemical .	T10	T18	23432582
NA	CHEMICAL	GENE-Y	2	9	Discovery of chemical : The first sub-micromolar , selective gene PAM .	T14	T21	23562060
NA	CHEMICAL	GENE-Y	13	9	This Letter describes the further chemical optimization of the gene PAM MLPCN probes chemical and chemical .	T12	T18	23562060
NA	CHEMICAL	GENE-Y	15	9	This Letter describes the further chemical optimization of the gene PAM MLPCN probes chemical and chemical .	T13	T18	23562060
NA	CHEMICAL	GENE-Y	15	6	An HTS campaign identified several weak gene PAMs ( gene EC50 > 10μM ) with a structurally related chemical core that possessed a southern chemical linkage .	T4	T15	23562060
NA	CHEMICAL	GENE-Y	15	9	An HTS campaign identified several weak gene PAMs ( gene EC50 > 10μM ) with a structurally related chemical core that possessed a southern chemical linkage .	T4	T16	23562060
NA	CHEMICAL	GENE-Y	24	6	An HTS campaign identified several weak gene PAMs ( gene EC50 > 10μM ) with a structurally related chemical core that possessed a southern chemical linkage .	T5	T15	23562060
NA	CHEMICAL	GENE-Y	24	9	An HTS campaign identified several weak gene PAMs ( gene EC50 > 10μM ) with a structurally related chemical core that possessed a southern chemical linkage .	T5	T16	23562060
CPR:4	CHEMICAL	GENE-N	0	3	chemical-mediated downregulation of gene gene-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to chemical .	T16	T40	23228696
CPR:4	CHEMICAL	GENE-N	0	4	chemical-mediated downregulation of gene gene-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to chemical .	T16	T41	23228696
NA	CHEMICAL	GENE-N	20	3	chemical-mediated downregulation of gene gene-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to chemical .	T17	T40	23228696
NA	CHEMICAL	GENE-N	20	4	chemical-mediated downregulation of gene gene-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to chemical .	T17	T41	23228696
NA	CHEMICAL	GENE-Y	8	4	High expression levels of gene ( gene ) in cancers have been positively associated with the DNA repair capacity and a poor prognosis in NSCLC patients treated with chemical-containing chemotherapy .	T12	T28	23228696
NA	CHEMICAL	GENE-Y	8	6	High expression levels of gene ( gene ) in cancers have been positively associated with the DNA repair capacity and a poor prognosis in NSCLC patients treated with chemical-containing chemotherapy .	T12	T29	23228696
CPR:3	CHEMICAL	GENE-N	5	12	In this current study , chemical was found to increase phosphorylation of gene ( gene ) kinase 3/6 ( gene ) -gene MAPK as well as protein and mRNA levels of gene in H1650 and H1703 cells .	T13	T30	23228696
NA	CHEMICAL	GENE-N	5	17	In this current study , chemical was found to increase phosphorylation of gene ( gene ) kinase 3/6 ( gene ) -gene MAPK as well as protein and mRNA levels of gene in H1650 and H1703 cells .	T13	T31	23228696
CPR:3	CHEMICAL	GENE-N	5	21	In this current study , chemical was found to increase phosphorylation of gene ( gene ) kinase 3/6 ( gene ) -gene MAPK as well as protein and mRNA levels of gene in H1650 and H1703 cells .	T13	T32	23228696
CPR:3	CHEMICAL	GENE-N	5	14	In this current study , chemical was found to increase phosphorylation of gene ( gene ) kinase 3/6 ( gene ) -gene MAPK as well as protein and mRNA levels of gene in H1650 and H1703 cells .	T13	T33	23228696
CPR:3	CHEMICAL	GENE-Y	5	31	In this current study , chemical was found to increase phosphorylation of gene ( gene ) kinase 3/6 ( gene ) -gene MAPK as well as protein and mRNA levels of gene in H1650 and H1703 cells .	T13	T34	23228696
CPR:3	CHEMICAL	GENE-Y	2	3	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T14	T35	23228696
NA	CHEMICAL	GENE-N	2	14	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T14	T36	23228696
NA	CHEMICAL	GENE-N	2	19	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T14	T37	23228696
NA	CHEMICAL	GENE-N	2	20	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T14	T38	23228696
NA	CHEMICAL	GENE-N	2	24	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T14	T39	23228696
NA	CHEMICAL	GENE-Y	22	3	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T15	T35	23228696
CPR:4	CHEMICAL	GENE-N	22	14	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T15	T36	23228696
CPR:4	CHEMICAL	GENE-N	22	19	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T15	T37	23228696
CPR:4	CHEMICAL	GENE-N	22	20	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T15	T38	23228696
NA	CHEMICAL	GENE-N	22	24	Moreover , chemical-induced gene protein and mRNA levels significantly decreased via the downregulation of gene activity by either a gene gene inhibitor chemical or gene knockdown with specific small interfering RNA ( siRNA ) .	T15	T39	23228696
NA	CHEMICAL	GENE-Y	11	3	Specific inhibition of gene with siRNA was found to enhance the chemical-induced cytotoxic effect and growth inhibition .	T2	T18	23228696
CPR:4	CHEMICAL	GENE-N	2	11	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T3	T19	23228696
CPR:4	CHEMICAL	GENE-N	2	12	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T3	T20	23228696
CPR:4	CHEMICAL	GENE-Y	2	13	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T3	T21	23228696
CPR:3	CHEMICAL	GENE-N	10	11	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T4	T19	23228696
CPR:3	CHEMICAL	GENE-N	10	12	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T4	T20	23228696
CPR:3	CHEMICAL	GENE-Y	10	13	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T4	T21	23228696
NA	CHEMICAL	GENE-N	24	11	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T5	T19	23228696
NA	CHEMICAL	GENE-N	24	12	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T5	T20	23228696
NA	CHEMICAL	GENE-Y	24	13	Furthermore , chemical was able to not only decrease the chemical-induced gene gene-mediated gene expression , but also augment the cytotoxic effect induced by chemical .	T5	T21	23228696
NA	CHEMICAL	GENE-Y	7	6	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T6	T22	23228696
NA	CHEMICAL	GENE-N	7	8	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T6	T23	23228696
NA	CHEMICAL	GENE-N	7	9	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T6	T24	23228696
CPR:4	CHEMICAL	GENE-Y	7	19	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T6	T25	23228696
NA	CHEMICAL	GENE-Y	24	6	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T7	T22	23228696
NA	CHEMICAL	GENE-N	24	8	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T7	T23	23228696
NA	CHEMICAL	GENE-N	24	9	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T7	T24	23228696
CPR:4	CHEMICAL	GENE-Y	24	19	Finally , expression of constitutive activate gene or HA-gene gene vectors in lung cancer cells was able to abrogate gene downregulation by chemical and chemical as well as cell viability and DNA repair capacity .	T7	T25	23228696
NA	CHEMICAL	GENE-Y	1	0	gene is a highly sensitive target of the antiobesity agent chemical with profound implications in the activation of anticancer prodrugs .	T13	T35	23228697
CPR:4	CHEMICAL	GENE-N	0	22	chemical has been the most used anti-obesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal gene .	T1	T17	23228697
CPR:4	CHEMICAL	GENE-N	9	11	This study was designed to test the hypothesis that chemical inhibits gene with higher potency toward gene than gene , a gene with little gene activity .	T6	T25	23228697
CPR:4	CHEMICAL	GENE-Y	9	16	This study was designed to test the hypothesis that chemical inhibits gene with higher potency toward gene than gene , a gene with little gene activity .	T6	T26	23228697
CPR:4	CHEMICAL	GENE-Y	9	18	This study was designed to test the hypothesis that chemical inhibits gene with higher potency toward gene than gene , a gene with little gene activity .	T6	T27	23228697
CPR:4	CHEMICAL	GENE-N	9	20	This study was designed to test the hypothesis that chemical inhibits gene with higher potency toward gene than gene , a gene with little gene activity .	T6	T28	23228697
CPR:4	CHEMICAL	GENE-N	9	20	This study was designed to test the hypothesis that chemical inhibits gene with higher potency toward gene than gene , a gene with little gene activity .	T6	T29	23228697
NA	CHEMICAL	GENE-N	20	4	Liver microsomes and recombinant gene were tested for the inhibition of the hydrolysis of standard substrates and the anticancer prodrugs chemical of chemical of chemical ( chemical ) and chemical .	T7	T30	23228697
NA	CHEMICAL	GENE-N	22	4	Liver microsomes and recombinant gene were tested for the inhibition of the hydrolysis of standard substrates and the anticancer prodrugs chemical of chemical of chemical ( chemical ) and chemical .	T8	T30	23228697
NA	CHEMICAL	GENE-N	24	4	Liver microsomes and recombinant gene were tested for the inhibition of the hydrolysis of standard substrates and the anticancer prodrugs chemical of chemical of chemical ( chemical ) and chemical .	T9	T30	23228697
NA	CHEMICAL	GENE-N	26	4	Liver microsomes and recombinant gene were tested for the inhibition of the hydrolysis of standard substrates and the anticancer prodrugs chemical of chemical of chemical ( chemical ) and chemical .	T10	T30	23228697
NA	CHEMICAL	GENE-N	29	4	Liver microsomes and recombinant gene were tested for the inhibition of the hydrolysis of standard substrates and the anticancer prodrugs chemical of chemical of chemical ( chemical ) and chemical .	T11	T30	23228697
CPR:4	CHEMICAL	GENE-Y	5	10	Contrary to the hypothesis , chemical at 1 nM inhibited gene activity by 75 % but no inhibition on gene , placing gene one of the most sensitive targets of orlistat .	T12	T31	23228697
NA	CHEMICAL	GENE-Y	5	7	Contrary to the hypothesis , chemical at 1 nM inhibited gene activity by 75 % but no inhibition on gene , placing gene one of the most sensitive targets of orlistat .	T12	T32	23228697
CPR:4	CHEMICAL	GENE-Y	5	22	Contrary to the hypothesis , chemical at 1 nM inhibited gene activity by 75 % but no inhibition on gene , placing gene one of the most sensitive targets of orlistat .	T12	T33	23228697
CPR:4	CHEMICAL	GENE-N	6	3	Inhibition of this gene probably presents a major source for altered therapeutic activity of these medicines if co-administered with chemical .	T4	T16	23228697
NA	CHEMICAL	GENE-Y	0	1	chemical synthase and chemical kinase are key enzymes involved in the de novo and salvage pathways for chemical synthesis , respectively .	T1	T20	10697523
NA	CHEMICAL	GENE-Y	0	4	chemical synthase and chemical kinase are key enzymes involved in the de novo and salvage pathways for chemical synthesis , respectively .	T1	T22	10697523
NA	CHEMICAL	GENE-Y	3	1	chemical synthase and chemical kinase are key enzymes involved in the de novo and salvage pathways for chemical synthesis , respectively .	T5	T20	10697523
NA	CHEMICAL	GENE-Y	3	4	chemical synthase and chemical kinase are key enzymes involved in the de novo and salvage pathways for chemical synthesis , respectively .	T5	T22	10697523
CPR:9	CHEMICAL	GENE-Y	11	1	chemical synthase and chemical kinase are key enzymes involved in the de novo and salvage pathways for chemical synthesis , respectively .	T2	T20	10697523
CPR:9	CHEMICAL	GENE-Y	11	4	chemical synthase and chemical kinase are key enzymes involved in the de novo and salvage pathways for chemical synthesis , respectively .	T2	T22	10697523
NA	CHEMICAL	GENE-Y	0	1	chemical synthase is inhibited by chemical , forming an inactive ternary complex with intracellular chemical .	T3	T21	10697523
CPR:4	CHEMICAL	GENE-Y	5	1	chemical synthase is inhibited by chemical , forming an inactive ternary complex with intracellular chemical .	T4	T21	10697523
NA	CHEMICAL	GENE-Y	14	1	chemical synthase is inhibited by chemical , forming an inactive ternary complex with intracellular chemical .	T6	T21	10697523
CPR:4	CHEMICAL	GENE-Y	3	23	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T12	T23	10697523
CPR:4	CHEMICAL	GENE-Y	3	18	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T12	T24	10697523
CPR:4	CHEMICAL	GENE-Y	5	23	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T13	T23	10697523
CPR:4	CHEMICAL	GENE-Y	5	18	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T13	T24	10697523
NA	CHEMICAL	GENE-Y	22	23	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T14	T23	10697523
NA	CHEMICAL	GENE-Y	22	18	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T14	T24	10697523
NA	CHEMICAL	GENE-Y	18	23	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T15	T23	10697523
NA	CHEMICAL	GENE-Y	18	18	Thirty-week administration of chemical with or without chemical markedly suppressed both colorectal carcinogenesis and tumor growth , resulted in the increase of chemical synthase inhibition and the decrease of chemical kinase activity in the tumor cells .	T15	T24	10697523
NA	CHEMICAL	GENE-Y	0	0	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T1	T10	15837926
NA	CHEMICAL	GENE-N	0	2	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T1	T11	15837926
NA	CHEMICAL	GENE-Y	0	7	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T1	T12	15837926
CPR:9	CHEMICAL	GENE-Y	3	0	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T2	T10	15837926
CPR:9	CHEMICAL	GENE-N	3	2	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T2	T11	15837926
CPR:9	CHEMICAL	GENE-Y	3	7	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T2	T12	15837926
CPR:9	CHEMICAL	GENE-Y	3	0	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T3	T10	15837926
CPR:9	CHEMICAL	GENE-N	3	2	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T3	T11	15837926
CPR:9	CHEMICAL	GENE-Y	3	7	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T3	T12	15837926
CPR:9	CHEMICAL	GENE-Y	2	0	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T4	T10	15837926
CPR:9	CHEMICAL	GENE-N	2	2	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T4	T11	15837926
NA	CHEMICAL	GENE-Y	2	7	gene acts as a chemical carboxypeptidase ( gene ) on small molecule substrates , including chemical , the anticancer drug chemical , and the neuropeptide chemical .	T4	T12	15837926
NA	CHEMICAL	GENE-N	24	9	Here we present the 3.5-A crystal structure of the gene , which reveals a homodimer with structural similarity to gene , a receptor for chemical-loaded gene that lacks gene activity .	T5	T14	15837926
NA	CHEMICAL	GENE-N	24	18	Here we present the 3.5-A crystal structure of the gene , which reveals a homodimer with structural similarity to gene , a receptor for chemical-loaded gene that lacks gene activity .	T5	T15	15837926
NA	CHEMICAL	GENE-Y	24	13	Here we present the 3.5-A crystal structure of the gene , which reveals a homodimer with structural similarity to gene , a receptor for chemical-loaded gene that lacks gene activity .	T5	T16	15837926
NA	CHEMICAL	GENE-N	24	13	Here we present the 3.5-A crystal structure of the gene , which reveals a homodimer with structural similarity to gene , a receptor for chemical-loaded gene that lacks gene activity .	T5	T17	15837926
NA	CHEMICAL	GENE-N	10	1	Unlike gene , the gene of gene contains a binuclear chemical site , catalytic residues , and a proposed substrate-binding chemical patch .	T6	T18	15837926
NA	CHEMICAL	GENE-N	10	4	Unlike gene , the gene of gene contains a binuclear chemical site , catalytic residues , and a proposed substrate-binding chemical patch .	T6	T19	15837926
NA	CHEMICAL	GENE-Y	10	6	Unlike gene , the gene of gene contains a binuclear chemical site , catalytic residues , and a proposed substrate-binding chemical patch .	T6	T20	15837926
NA	CHEMICAL	GENE-N	8	1	Unlike gene , the gene of gene contains a binuclear chemical site , catalytic residues , and a proposed substrate-binding chemical patch .	T7	T18	15837926
NA	CHEMICAL	GENE-N	8	4	Unlike gene , the gene of gene contains a binuclear chemical site , catalytic residues , and a proposed substrate-binding chemical patch .	T7	T19	15837926
NA	CHEMICAL	GENE-Y	8	6	Unlike gene , the gene of gene contains a binuclear chemical site , catalytic residues , and a proposed substrate-binding chemical patch .	T7	T20	15837926
CPR:9	CHEMICAL	GENE-Y	10	3	Elucidation of the gene structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate chemical .	T8	T21	15837926
CPR:4	CHEMICAL	GENE-N	5	0	gene Inhibitors Based on the chemical Core .	T9	T21	23631440
CPR:4	CHEMICAL	GENE-N	3	9	New series of chemical , chemical , and chemical gene inhibitors ( MMPIs ) were designed , synthesized , and evaluated .	T1	T11	23631440
CPR:4	CHEMICAL	GENE-N	5	9	New series of chemical , chemical , and chemical gene inhibitors ( MMPIs ) were designed , synthesized , and evaluated .	T3	T11	23631440
CPR:4	CHEMICAL	GENE-N	8	9	New series of chemical , chemical , and chemical gene inhibitors ( MMPIs ) were designed , synthesized , and evaluated .	T7	T11	23631440
CPR:4	CHEMICAL	GENE-N	9	23	Exhibiting unique properties over other MMPIs ( e.g. , chemical ) , these newly reported compounds are capable of modulating activities of several gene in the low nanomolar range , including gene ( ~2 to 50 nM ) , gene ( ~2 to 50 nM ) , and gene ( ~4 to 60 nM ) .	T2	T12	23631440
CPR:4	CHEMICAL	GENE-Y	9	31	Exhibiting unique properties over other MMPIs ( e.g. , chemical ) , these newly reported compounds are capable of modulating activities of several gene in the low nanomolar range , including gene ( ~2 to 50 nM ) , gene ( ~2 to 50 nM ) , and gene ( ~4 to 60 nM ) .	T2	T13	23631440
CPR:4	CHEMICAL	GENE-Y	9	39	Exhibiting unique properties over other MMPIs ( e.g. , chemical ) , these newly reported compounds are capable of modulating activities of several gene in the low nanomolar range , including gene ( ~2 to 50 nM ) , gene ( ~2 to 50 nM ) , and gene ( ~4 to 60 nM ) .	T2	T14	23631440
CPR:4	CHEMICAL	GENE-Y	9	48	Exhibiting unique properties over other MMPIs ( e.g. , chemical ) , these newly reported compounds are capable of modulating activities of several gene in the low nanomolar range , including gene ( ~2 to 50 nM ) , gene ( ~2 to 50 nM ) , and gene ( ~4 to 60 nM ) .	T2	T15	23631440
NA	CHEMICAL	GENE-N	5	29	Our previous work with the chemical functionality attached to both chemical and chemical frameworks demonstrated that the cis- ( 3S,4R ) - stereochemistry was optimal for all of the gene tested .	T4	T20	23631440
NA	CHEMICAL	GENE-N	10	29	Our previous work with the chemical functionality attached to both chemical and chemical frameworks demonstrated that the cis- ( 3S,4R ) - stereochemistry was optimal for all of the gene tested .	T5	T20	23631440
NA	CHEMICAL	GENE-N	12	29	Our previous work with the chemical functionality attached to both chemical and chemical frameworks demonstrated that the cis- ( 3S,4R ) - stereochemistry was optimal for all of the gene tested .	T6	T20	23631440
NA	CHEMICAL	GENE-Y	5	24	We previously found that the chemical-enriched microdomains ( chemical clusters ) in presynaptic neuronal membranes play a key role in the initiation of the gene assembly process .	T2	T10	23294326
NA	CHEMICAL	GENE-Y	8	24	We previously found that the chemical-enriched microdomains ( chemical clusters ) in presynaptic neuronal membranes play a key role in the initiation of the gene assembly process .	T3	T10	23294326
NA	CHEMICAL	GENE-Y	4	7	However , not all chemical clusters accelerate gene assembly .	T4	T11	23294326
NA	CHEMICAL	GENE-Y	6	1	The gene assembly was generated on a distinctive gene , which was characterized as the gene-sensitive chemical nanocluster ( ASIGN ) .	T5	T14	23294326
NA	CHEMICAL	GENE-N	6	6	The gene assembly was generated on a distinctive gene , which was characterized as the gene-sensitive chemical nanocluster ( ASIGN ) .	T5	T15	23294326
NA	CHEMICAL	GENE-Y	6	15	The gene assembly was generated on a distinctive gene , which was characterized as the gene-sensitive chemical nanocluster ( ASIGN ) .	T5	T16	23294326
NA	CHEMICAL	GENE-Y	1	0	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T19	T55	14757700
NA	CHEMICAL	GENE-Y	1	2	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T19	T40	14757700
NA	CHEMICAL	GENE-N	1	5	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T19	T51	14757700
CPR:3	CHEMICAL	GENE-Y	17	0	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T35	T55	14757700
CPR:3	CHEMICAL	GENE-Y	17	2	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T35	T40	14757700
CPR:3	CHEMICAL	GENE-N	17	5	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T35	T51	14757700
CPR:3	CHEMICAL	GENE-Y	5	0	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T1	T55	14757700
CPR:3	CHEMICAL	GENE-Y	5	2	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T1	T40	14757700
CPR:3	CHEMICAL	GENE-N	5	5	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T1	T51	14757700
CPR:3	CHEMICAL	GENE-Y	21	0	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T7	T55	14757700
CPR:3	CHEMICAL	GENE-Y	21	2	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T7	T40	14757700
CPR:3	CHEMICAL	GENE-N	21	5	gene ( gene ) is a chemical-permeable channel , which can be activated by low temperatures , chemical , chemical and chemical .	T7	T51	14757700
NA	CHEMICAL	GENE-Y	9	20	We tested whether substances which are structurally related to chemical , or which produce a cooling sensation , could activate gene , and compared the responses of gene and gene to these ligands .	T20	T54	14757700
NA	CHEMICAL	GENE-Y	9	27	We tested whether substances which are structurally related to chemical , or which produce a cooling sensation , could activate gene , and compared the responses of gene and gene to these ligands .	T20	T56	14757700
NA	CHEMICAL	GENE-Y	9	29	We tested whether substances which are structurally related to chemical , or which produce a cooling sensation , could activate gene , and compared the responses of gene and gene to these ligands .	T20	T57	14757700
NA	CHEMICAL	GENE-Y	6	10	The effects of 70 odorants and chemical-related substances on recombinant gene ( gene ) , expressed in HEK293 cells , were examined using a FLIPR assay .	T21	T58	14757700
NA	CHEMICAL	GENE-Y	6	12	The effects of 70 odorants and chemical-related substances on recombinant gene ( gene ) , expressed in HEK293 cells , were examined using a FLIPR assay .	T21	T59	14757700
CPR:6	CHEMICAL	GENE-Y	4	1	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T11	T41	14757700
CPR:4	CHEMICAL	GENE-Y	4	18	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T11	T42	14757700
CPR:6	CHEMICAL	GENE-Y	6	1	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T12	T41	14757700
CPR:4	CHEMICAL	GENE-Y	6	18	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T12	T42	14757700
CPR:6	CHEMICAL	GENE-Y	8	1	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T13	T41	14757700
CPR:4	CHEMICAL	GENE-Y	8	18	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T13	T42	14757700
NA	CHEMICAL	GENE-Y	20	1	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T14	T41	14757700
CPR:3	CHEMICAL	GENE-Y	20	18	Known gene antagonists ( chemical , chemical and chemical ) were also able to block the response of gene to chemical ( IC ( 50 ) : 0.8+/-1.0 , 3.5+/-1.1 and 18+/-1.1 microM , respectively ) .	T14	T42	14757700
NA	CHEMICAL	GENE-Y	1	4	The chemical response of gene-transfected HEK293 cells to the endogenous gene agonist chemical was potentiated by low pH .	T15	T44	14757700
NA	CHEMICAL	GENE-Y	1	10	The chemical response of gene-transfected HEK293 cells to the endogenous gene agonist chemical was potentiated by low pH .	T15	T45	14757700
CPR:3	CHEMICAL	GENE-Y	12	4	The chemical response of gene-transfected HEK293 cells to the endogenous gene agonist chemical was potentiated by low pH .	T16	T44	14757700
CPR:5	CHEMICAL	GENE-Y	12	10	The chemical response of gene-transfected HEK293 cells to the endogenous gene agonist chemical was potentiated by low pH .	T16	T45	14757700
CPR:3	CHEMICAL	GENE-Y	3	6	In contrast , chemical- and chemical-activated gene currents were suppressed by low pH .	T17	T46	14757700
CPR:3	CHEMICAL	GENE-Y	5	6	In contrast , chemical- and chemical-activated gene currents were suppressed by low pH .	T18	T46	14757700
NA	CHEMICAL	GENE-Y	35	0	gene ( gene ) is a transcription factor that plays a crucial role in the unfolded protein response ( UPR ) and its deficiency in β-cells has been reported to impair gene secretion leading to chemical intolerance .	T4	T16	23493568
NA	CHEMICAL	GENE-Y	35	2	gene ( gene ) is a transcription factor that plays a crucial role in the unfolded protein response ( UPR ) and its deficiency in β-cells has been reported to impair gene secretion leading to chemical intolerance .	T4	T17	23493568
NA	CHEMICAL	GENE-N	35	13	gene ( gene ) is a transcription factor that plays a crucial role in the unfolded protein response ( UPR ) and its deficiency in β-cells has been reported to impair gene secretion leading to chemical intolerance .	T4	T18	23493568
NA	CHEMICAL	GENE-Y	3	0	αgeneKO mice exhibited chemical intolerance , mild gene resistance and an inability to suppress gene secretion following chemical stimulation .	T5	T24	23493568
NA	CHEMICAL	GENE-N	3	7	αgeneKO mice exhibited chemical intolerance , mild gene resistance and an inability to suppress gene secretion following chemical stimulation .	T5	T25	23493568
NA	CHEMICAL	GENE-Y	3	14	αgeneKO mice exhibited chemical intolerance , mild gene resistance and an inability to suppress gene secretion following chemical stimulation .	T5	T26	23493568
NA	CHEMICAL	GENE-Y	17	0	αgeneKO mice exhibited chemical intolerance , mild gene resistance and an inability to suppress gene secretion following chemical stimulation .	T6	T24	23493568
NA	CHEMICAL	GENE-N	17	7	αgeneKO mice exhibited chemical intolerance , mild gene resistance and an inability to suppress gene secretion following chemical stimulation .	T6	T25	23493568
NA	CHEMICAL	GENE-Y	17	14	αgeneKO mice exhibited chemical intolerance , mild gene resistance and an inability to suppress gene secretion following chemical stimulation .	T6	T26	23493568
NA	CHEMICAL	GENE-Y	8	2	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T1	T31	23493568
NA	CHEMICAL	GENE-Y	8	5	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T1	T32	23493568
NA	CHEMICAL	GENE-Y	8	11	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T1	T7	23493568
NA	CHEMICAL	GENE-N	8	22	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T1	T8	23493568
NA	CHEMICAL	GENE-Y	8	35	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T1	T9	23493568
NA	CHEMICAL	GENE-Y	26	2	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T2	T31	23493568
NA	CHEMICAL	GENE-Y	26	5	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T2	T32	23493568
NA	CHEMICAL	GENE-Y	26	11	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T2	T7	23493568
NA	CHEMICAL	GENE-N	26	22	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T2	T8	23493568
NA	CHEMICAL	GENE-Y	26	35	Interestingly , gene treatment of αgeneKD cells reduced chemical phosphorylation of gene ( pY ( 896 ) ) , and phosphorylation of gene , while enhancing chemical phosphorylation ( pS ( 307 ) ) of gene .	T2	T9	23493568
NA	CHEMICAL	GENE-Y	18	2	Consequently the αgeneKD cells exhibited blunted suppression of gene secretion following gene treatment in the presence of high chemical .	T3	T10	23493568
NA	CHEMICAL	GENE-Y	18	8	Consequently the αgeneKD cells exhibited blunted suppression of gene secretion following gene treatment in the presence of high chemical .	T3	T11	23493568
NA	CHEMICAL	GENE-Y	18	11	Consequently the αgeneKD cells exhibited blunted suppression of gene secretion following gene treatment in the presence of high chemical .	T3	T12	23493568
NA	CHEMICAL	GENE-Y	2	4	Effect of chemical on gene production in HepG2 cell .	T16	T41	15474503
NA	CHEMICAL	GENE-N	11	8	There are few reports describing the mechanism of gene-elevating action of chemical reductase inhibitors ( statins ) .	T10	T30	15474503
NA	CHEMICAL	GENE-Y	11	12	There are few reports describing the mechanism of gene-elevating action of chemical reductase inhibitors ( statins ) .	T10	T35	15474503
NA	CHEMICAL	GENE-Y	1	3	Each statin induced gene expression ( mRNA and protein ) dose-dependently : the rank order of the gene induction chemical ( 3 microM ) > chemical ( 10 microM ) > chemical ( 30 microM ) .	T3	T28	15474503
CPR:3	CHEMICAL	GENE-Y	1	17	Each statin induced gene expression ( mRNA and protein ) dose-dependently : the rank order of the gene induction chemical ( 3 microM ) > chemical ( 10 microM ) > chemical ( 30 microM ) .	T3	T29	15474503
NA	CHEMICAL	GENE-Y	1	3	Each statin induced gene expression ( mRNA and protein ) dose-dependently : the rank order of the gene induction chemical ( 3 microM ) > chemical ( 10 microM ) > chemical ( 30 microM ) .	T4	T28	15474503
CPR:3	CHEMICAL	GENE-Y	1	17	Each statin induced gene expression ( mRNA and protein ) dose-dependently : the rank order of the gene induction chemical ( 3 microM ) > chemical ( 10 microM ) > chemical ( 30 microM ) .	T4	T29	15474503
NA	CHEMICAL	GENE-Y	1	3	Each statin induced gene expression ( mRNA and protein ) dose-dependently : the rank order of the gene induction chemical ( 3 microM ) > chemical ( 10 microM ) > chemical ( 30 microM ) .	T5	T28	15474503
CPR:3	CHEMICAL	GENE-Y	1	17	Each statin induced gene expression ( mRNA and protein ) dose-dependently : the rank order of the gene induction chemical ( 3 microM ) > chemical ( 10 microM ) > chemical ( 30 microM ) .	T5	T29	15474503
CPR:4	CHEMICAL	GENE-Y	10	3	The induction of gene by statins disappeared with addition of chemical , which indicates that the effect is chemical reductase inhibition-dependent .	T6	T31	15474503
NA	CHEMICAL	GENE-Y	10	19	The induction of gene by statins disappeared with addition of chemical , which indicates that the effect is chemical reductase inhibition-dependent .	T6	T32	15474503
NA	CHEMICAL	GENE-Y	18	3	The induction of gene by statins disappeared with addition of chemical , which indicates that the effect is chemical reductase inhibition-dependent .	T7	T31	15474503
NA	CHEMICAL	GENE-Y	18	19	The induction of gene by statins disappeared with addition of chemical , which indicates that the effect is chemical reductase inhibition-dependent .	T7	T32	15474503
NA	CHEMICAL	GENE-Y	2	3	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T8	T33	15474503
NA	CHEMICAL	GENE-Y	2	7	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T8	T34	15474503
NA	CHEMICAL	GENE-Y	6	3	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T9	T33	15474503
CPR:3	CHEMICAL	GENE-Y	6	7	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T9	T34	15474503
NA	CHEMICAL	GENE-Y	11	3	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T11	T33	15474503
CPR:3	CHEMICAL	GENE-Y	11	7	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T11	T34	15474503
NA	CHEMICAL	GENE-Y	13	3	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T12	T33	15474503
CPR:3	CHEMICAL	GENE-Y	13	7	Based on chemical reductase inhibition , chemical-induced gene more efficiently than chemical and chemical .	T12	T34	15474503
CPR:3	CHEMICAL	GENE-Y	4	6	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T13	T36	15474503
NA	CHEMICAL	GENE-N	4	14	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T13	T38	15474503
NA	CHEMICAL	GENE-N	4	8	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T13	T39	15474503
NA	CHEMICAL	GENE-Y	4	24	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T13	T40	15474503
NA	CHEMICAL	GENE-Y	9	6	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T14	T36	15474503
NA	CHEMICAL	GENE-N	9	14	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T14	T38	15474503
NA	CHEMICAL	GENE-N	9	8	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T14	T39	15474503
NA	CHEMICAL	GENE-Y	9	24	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T14	T40	15474503
NA	CHEMICAL	GENE-Y	21	6	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T15	T36	15474503
CPR:4	CHEMICAL	GENE-N	21	14	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T15	T38	15474503
CPR:4	CHEMICAL	GENE-N	21	8	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T15	T39	15474503
CPR:3	CHEMICAL	GENE-Y	21	24	Further study revealed that chemical increased gene mRNA in chemical reductase-dependent manner and that gene and gene inhibitor ( C3T and chemical ) increased gene production in the HepG2 cells .	T15	T40	15474503
CPR:6	CHEMICAL	GENE-Y	6	12	Assessment of the abuse liability of chemical , a novel chemical H3 receptor antagonist .	T15	T21	23455597
NA	CHEMICAL	GENE-Y	8	12	Assessment of the abuse liability of chemical , a novel chemical H3 receptor antagonist .	T16	T21	23455597
NA	CHEMICAL	GENE-Y	2	4	RATIONALE : chemical H3 receptor antagonists , such as chemical , have been shown to possess cognitive-enhancing and wakefulness-promoting effects .	T2	T17	23455597
CPR:6	CHEMICAL	GENE-Y	9	4	RATIONALE : chemical H3 receptor antagonists , such as chemical , have been shown to possess cognitive-enhancing and wakefulness-promoting effects .	T10	T17	23455597
NA	CHEMICAL	GENE-Y	2	16	Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the chemical transporter .	T15	T23	12623106
NA	CHEMICAL	GENE-Y	6	8	These radiotracers are close analogues of chemical , a potent and selective ligand for the chemical transporter ( gene ) .	T9	T18	12623106
NA	CHEMICAL	GENE-Y	6	18	These radiotracers are close analogues of chemical , a potent and selective ligand for the chemical transporter ( gene ) .	T9	T19	12623106
NA	CHEMICAL	GENE-Y	15	8	These radiotracers are close analogues of chemical , a potent and selective ligand for the chemical transporter ( gene ) .	T10	T18	12623106
NA	CHEMICAL	GENE-Y	15	18	These radiotracers are close analogues of chemical , a potent and selective ligand for the chemical transporter ( gene ) .	T10	T19	12623106
NA	CHEMICAL	GENE-Y	4	24	In vitro autoradiography studies ( rat brain slices ) with chemical produced a regional distribution pattern that was consistent with the reported distribution of gene .	T7	T16	12623106
NA	CHEMICAL	GENE-Y	5	4	A Structural Snapshot of gene in Complex with chemical Provides Insights into Ligand Binding and Clusters of Conformational States .	T6	T11	23633618
NA	CHEMICAL	GENE-Y	6	5	An X-ray crystal structure of gene in complex with the drug chemical was solved at 2.14 Å resolution .	T5	T8	23633618
NA	CHEMICAL	GENE-Y	1	1	The gene-chemical structure is nearly superimposable on a previously solved closed structure in a ligand free state .	T3	T10	23633618
NA	CHEMICAL	GENE-Y	0	4	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T4	T25	12783542
NA	CHEMICAL	GENE-Y	0	11	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T4	T26	12783542
NA	CHEMICAL	GENE-Y	4	4	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T5	T25	12783542
NA	CHEMICAL	GENE-Y	4	11	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T5	T26	12783542
NA	CHEMICAL	GENE-Y	14	4	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T6	T25	12783542
NA	CHEMICAL	GENE-Y	14	11	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T6	T26	12783542
NA	CHEMICAL	GENE-Y	24	4	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T8	T25	12783542
NA	CHEMICAL	GENE-Y	24	11	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T8	T26	12783542
NA	CHEMICAL	GENE-Y	14	4	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T9	T25	12783542
NA	CHEMICAL	GENE-Y	14	11	chemical was incorporated into a model target protein , gene ( gene ) , in an chemical auxotrophic Escherichia coli host strain suspended in chemical-supplemented minimal medium depleted of chemical .	T9	T26	12783542
NA	CHEMICAL	GENE-Y	7	2	Measurement of the rate of activation of chemical by the gene ( gene ) yielded a specificity constant ( k ( cat ) /K ( m ) ) 134-fold lower than that for chemical .	T15	T27	12783542
NA	CHEMICAL	GENE-Y	7	12	Measurement of the rate of activation of chemical by the gene ( gene ) yielded a specificity constant ( k ( cat ) /K ( m ) ) 134-fold lower than that for chemical .	T15	T28	12783542
NA	CHEMICAL	GENE-Y	33	2	Measurement of the rate of activation of chemical by the gene ( gene ) yielded a specificity constant ( k ( cat ) /K ( m ) ) 134-fold lower than that for chemical .	T17	T27	12783542
NA	CHEMICAL	GENE-Y	33	12	Measurement of the rate of activation of chemical by the gene ( gene ) yielded a specificity constant ( k ( cat ) /K ( m ) ) 134-fold lower than that for chemical .	T17	T28	12783542
NA	CHEMICAL	GENE-N	0	6	chemical was successfully introduced into the gene gene ( gene ) at the encoded chemical positions .	T18	T29	12783542
NA	CHEMICAL	GENE-Y	0	7	chemical was successfully introduced into the gene gene ( gene ) at the encoded chemical positions .	T18	T30	12783542
NA	CHEMICAL	GENE-Y	0	9	chemical was successfully introduced into the gene gene ( gene ) at the encoded chemical positions .	T18	T31	12783542
NA	CHEMICAL	GENE-N	14	6	chemical was successfully introduced into the gene gene ( gene ) at the encoded chemical positions .	T20	T29	12783542
NA	CHEMICAL	GENE-Y	14	7	chemical was successfully introduced into the gene gene ( gene ) at the encoded chemical positions .	T20	T30	12783542
NA	CHEMICAL	GENE-Y	14	9	chemical was successfully introduced into the gene gene ( gene ) at the encoded chemical positions .	T20	T31	12783542
NA	CHEMICAL	GENE-Y	10	3	Pharmacological modulation of gene synthesis : a mechanistic comparison of chemical receptor and gene agonists .	T14	T34	11146120
NA	CHEMICAL	GENE-Y	10	11	Pharmacological modulation of gene synthesis : a mechanistic comparison of chemical receptor and gene agonists .	T14	T35	11146120
NA	CHEMICAL	GENE-Y	10	6	Pharmacological modulation of gene synthesis : a mechanistic comparison of chemical receptor and gene agonists .	T14	T33	11146120
NA	CHEMICAL	GENE-Y	11	5	The present studies were undertaken to compare two compounds , a chemical analogue ( chemical ) with minimal calcaemic effects , and chemical , a long-acting gene agonist , both of which induce gene synthesis in vivo .	T5	T24	11146120
CPR:4	CHEMICAL	GENE-Y	11	33	The present studies were undertaken to compare two compounds , a chemical analogue ( chemical ) with minimal calcaemic effects , and chemical , a long-acting gene agonist , both of which induce gene synthesis in vivo .	T5	T26	11146120
NA	CHEMICAL	GENE-Y	14	5	The present studies were undertaken to compare two compounds , a chemical analogue ( chemical ) with minimal calcaemic effects , and chemical , a long-acting gene agonist , both of which induce gene synthesis in vivo .	T6	T24	11146120
CPR:3	CHEMICAL	GENE-Y	14	33	The present studies were undertaken to compare two compounds , a chemical analogue ( chemical ) with minimal calcaemic effects , and chemical , a long-acting gene agonist , both of which induce gene synthesis in vivo .	T6	T26	11146120
CPR:5	CHEMICAL	GENE-Y	22	5	The present studies were undertaken to compare two compounds , a chemical analogue ( chemical ) with minimal calcaemic effects , and chemical , a long-acting gene agonist , both of which induce gene synthesis in vivo .	T7	T24	11146120
CPR:3	CHEMICAL	GENE-Y	22	33	The present studies were undertaken to compare two compounds , a chemical analogue ( chemical ) with minimal calcaemic effects , and chemical , a long-acting gene agonist , both of which induce gene synthesis in vivo .	T7	T26	11146120
CPR:3	CHEMICAL	GENE-Y	0	6	chemical caused significant increases in both gene mRNA and protein in 3T3 cells ; with maxima at 10 nM and at 8-12 h exposure .	T8	T27	11146120
NA	CHEMICAL	GENE-Y	2	4	Effects of chemical on gene mRNA were antagonized by chemical .	T9	T28	11146120
NA	CHEMICAL	GENE-Y	9	4	Effects of chemical on gene mRNA were antagonized by chemical .	T10	T28	11146120
NA	CHEMICAL	GENE-Y	9	11	Mobility shift assays on whole cell extracts showed that chemical increased gene binding in 3T3 cells prior to increasing gene synthesis .	T11	T29	11146120
CPR:3	CHEMICAL	GENE-Y	9	19	Mobility shift assays on whole cell extracts showed that chemical increased gene binding in 3T3 cells prior to increasing gene synthesis .	T11	T30	11146120
NA	CHEMICAL	GENE-Y	0	5	chemical was without effect on gene mRNA levels in L929 cells , whereas chemical caused significant increases in both gene mRNA and protein levels in both 3T3 and L929 cells .	T12	T31	11146120
NA	CHEMICAL	GENE-Y	0	19	chemical was without effect on gene mRNA levels in L929 cells , whereas chemical caused significant increases in both gene mRNA and protein levels in both 3T3 and L929 cells .	T12	T32	11146120
NA	CHEMICAL	GENE-Y	13	5	chemical was without effect on gene mRNA levels in L929 cells , whereas chemical caused significant increases in both gene mRNA and protein levels in both 3T3 and L929 cells .	T13	T31	11146120
CPR:3	CHEMICAL	GENE-Y	13	19	chemical was without effect on gene mRNA levels in L929 cells , whereas chemical caused significant increases in both gene mRNA and protein levels in both 3T3 and L929 cells .	T13	T32	11146120
NA	CHEMICAL	GENE-Y	3	1	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T1	T15	11146120
NA	CHEMICAL	GENE-Y	3	7	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T1	T16	11146120
NA	CHEMICAL	GENE-Y	3	37	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T1	T18	11146120
NA	CHEMICAL	GENE-Y	3	41	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T1	T19	11146120
NA	CHEMICAL	GENE-Y	29	1	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T2	T15	11146120
NA	CHEMICAL	GENE-Y	29	7	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T2	T16	11146120
NA	CHEMICAL	GENE-Y	29	37	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T2	T18	11146120
NA	CHEMICAL	GENE-Y	29	41	Binding to the chemical nuclear receptor ( gene ) , which acts as a transcription factor itself , was increased as early as 30 min after exposure to of chemical and maintained up to 24 h. Increased gene binding preceded increased gene mRNA .	T2	T19	11146120
CPR:4	CHEMICAL	GENE-Y	3	7	Neuroprotective effect of chemical , a preferential gene inhibitor , against chemical ( chemical ) -induced chemical kindling and associated biochemical parameters in mice .	T20	T30	17604186
NA	CHEMICAL	GENE-Y	5	7	Neuroprotective effect of chemical , a preferential gene inhibitor , against chemical ( chemical ) -induced chemical kindling and associated biochemical parameters in mice .	T21	T30	17604186
NA	CHEMICAL	GENE-Y	13	7	Neuroprotective effect of chemical , a preferential gene inhibitor , against chemical ( chemical ) -induced chemical kindling and associated biochemical parameters in mice .	T22	T30	17604186
CPR:9	CHEMICAL	GENE-N	9	1	Brain gene ( gene ) , the rate-limiting enzyme in chemical synthesis , is rapidly and transiently induced by convulsions in hippocampal and cortical neurons .	T15	T29	17604186
CPR:9	CHEMICAL	GENE-N	9	3	Brain gene ( gene ) , the rate-limiting enzyme in chemical synthesis , is rapidly and transiently induced by convulsions in hippocampal and cortical neurons .	T15	T25	17604186
CPR:4	CHEMICAL	GENE-N	8	11	Previous studies have explored the protective effect of chemical ( non-selective gene-inhibitor ) or chemical ( selective gene inhibitor ) against chemical kindling in mice .	T9	T26	17604186
NA	CHEMICAL	GENE-Y	8	17	Previous studies have explored the protective effect of chemical ( non-selective gene-inhibitor ) or chemical ( selective gene inhibitor ) against chemical kindling in mice .	T9	T27	17604186
NA	CHEMICAL	GENE-N	7	11	Previous studies have explored the protective effect of chemical ( non-selective gene-inhibitor ) or chemical ( selective gene inhibitor ) against chemical kindling in mice .	T10	T26	17604186
CPR:4	CHEMICAL	GENE-Y	7	17	Previous studies have explored the protective effect of chemical ( non-selective gene-inhibitor ) or chemical ( selective gene inhibitor ) against chemical kindling in mice .	T10	T27	17604186
CPR:4	CHEMICAL	GENE-Y	15	19	With this background , the present study was designed to explore the possible effect of chemical ( a preferential gene inhibitor ) against chemical ( chemical ) -induced kindling epilepsy in mice .	T11	T28	17604186
NA	CHEMICAL	GENE-Y	17	19	With this background , the present study was designed to explore the possible effect of chemical ( a preferential gene inhibitor ) against chemical ( chemical ) -induced kindling epilepsy in mice .	T12	T28	17604186
NA	CHEMICAL	GENE-Y	25	19	With this background , the present study was designed to explore the possible effect of chemical ( a preferential gene inhibitor ) against chemical ( chemical ) -induced kindling epilepsy in mice .	T13	T28	17604186
CPR:3	CHEMICAL	GENE-Y	6	17	Compared with normal control group , chemical-kindled mice had significantly higher levels of chemical , chemical , gene but had lower levels of reduced chemical in the whole brain homogenate .	T1	T23	17604186
NA	CHEMICAL	GENE-Y	13	17	Compared with normal control group , chemical-kindled mice had significantly higher levels of chemical , chemical , gene but had lower levels of reduced chemical in the whole brain homogenate .	T2	T23	17604186
NA	CHEMICAL	GENE-Y	15	17	Compared with normal control group , chemical-kindled mice had significantly higher levels of chemical , chemical , gene but had lower levels of reduced chemical in the whole brain homogenate .	T3	T23	17604186
NA	CHEMICAL	GENE-Y	24	17	Compared with normal control group , chemical-kindled mice had significantly higher levels of chemical , chemical , gene but had lower levels of reduced chemical in the whole brain homogenate .	T4	T23	17604186
CPR:4	CHEMICAL	GENE-Y	9	4	Dose-dependent inhibition of platelet gene and monocyte gene by chemical in healthy subjects .	T11	T21	10381787
CPR:4	CHEMICAL	GENE-Y	9	7	Dose-dependent inhibition of platelet gene and monocyte gene by chemical in healthy subjects .	T11	T22	10381787
NA	CHEMICAL	GENE-Y	7	15	We evaluated whether therapeutic blood levels of chemical are associated with selective inhibition of monocyte gene in vitro and ex vivo .	T7	T12	10381787
CPR:4	CHEMICAL	GENE-Y	19	7	Concentration-response curves for the inhibition of monocyte gene and platelet gene were obtained in vitro after the incubation of chemical with whole blood samples .	T5	T17	10381787
CPR:4	CHEMICAL	GENE-Y	19	10	Concentration-response curves for the inhibition of monocyte gene and platelet gene were obtained in vitro after the incubation of chemical with whole blood samples .	T5	T18	10381787
CPR:9	CHEMICAL	GENE-Y	34	31	Before dosing and 24 h after the seventh dose of each regimen , heparinized whole blood samples were incubated with lipopolysaccharide ( 10 microgram/ml ) for 24 h at 37 degrees C , and chemical was measured in plasma as an index of monocyte gene activity .	T8	T19	10381787
CPR:9	CHEMICAL	GENE-Y	3	13	The production of chemical in whole blood allowed to clot at 37 degrees C for 60 min was assessed as an index of platelet gene activity .	T9	T20	10381787
CPR:4	CHEMICAL	GENE-Y	11	17	In contrast , the administration of 7.5 and 15 mg of chemical caused dose-dependent reductions in monocyte gene activity by 51 % and 70 % , respectively , and in platelet gene activity by 25 % and 35 % , respectively .	T2	T13	10381787
CPR:4	CHEMICAL	GENE-Y	11	31	In contrast , the administration of 7.5 and 15 mg of chemical caused dose-dependent reductions in monocyte gene activity by 51 % and 70 % , respectively , and in platelet gene activity by 25 % and 35 % , respectively .	T2	T14	10381787
NA	CHEMICAL	GENE-N	0	5	chemical-glucuronosyltransferases ( gene ) are a group of drug-metabolizing enzymes that catalyse the conjugation of endogeonous compounds and xenobiotics to yield hydrophilic glucuronides which subsequently undergo excretion .	T1	T8	22943130
NA	CHEMICAL	GENE-N	0	2	chemical-glucuronosyltransferases ( gene ) are a group of drug-metabolizing enzymes that catalyse the conjugation of endogeonous compounds and xenobiotics to yield hydrophilic glucuronides which subsequently undergo excretion .	T1	T9	22943130
CPR:4	CHEMICAL	GENE-Y	8	22	A case of therapy-related acute myeloblastic leukemia with t ( 16 ; 21 ) ( q24 ; q22 ) after chemotherapy with gene inhibitors , chemical and chemical , and the alkylating agent , chemical .	T5	T12	9631585
CPR:4	CHEMICAL	GENE-Y	8	22	A case of therapy-related acute myeloblastic leukemia with t ( 16 ; 21 ) ( q24 ; q22 ) after chemotherapy with gene inhibitors , chemical and chemical , and the alkylating agent , chemical .	T6	T12	9631585
NA	CHEMICAL	GENE-Y	34	22	A case of therapy-related acute myeloblastic leukemia with t ( 16 ; 21 ) ( q24 ; q22 ) after chemotherapy with gene inhibitors , chemical and chemical , and the alkylating agent , chemical .	T7	T12	9631585
CPR:4	CHEMICAL	GENE-Y	24	21	A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia ( t-AML ) after chemotherapy consisting of treatment with gene inhibitors , chemical and chemical , and an alkylating agent , chemical .	T1	T8	9631585
CPR:4	CHEMICAL	GENE-Y	26	21	A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia ( t-AML ) after chemotherapy consisting of treatment with gene inhibitors , chemical and chemical , and an alkylating agent , chemical .	T2	T8	9631585
NA	CHEMICAL	GENE-Y	33	21	A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia ( t-AML ) after chemotherapy consisting of treatment with gene inhibitors , chemical and chemical , and an alkylating agent , chemical .	T3	T8	9631585
CPR:4	CHEMICAL	GENE-N	0	2	chemical , a derivative of chemical , was first described as an inhibitor of gene ( gene ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	T1	T27	17594192
CPR:4	CHEMICAL	GENE-N	0	16	chemical , a derivative of chemical , was first described as an inhibitor of gene ( gene ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	T1	T16	17594192
CPR:4	CHEMICAL	GENE-N	5	2	chemical , a derivative of chemical , was first described as an inhibitor of gene ( gene ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	T7	T27	17594192
CPR:4	CHEMICAL	GENE-N	5	16	chemical , a derivative of chemical , was first described as an inhibitor of gene ( gene ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	T7	T16	17594192
CPR:4	CHEMICAL	GENE-Y	0	14	chemical deserves attention for an additional quality of action : in addition to inhibiting gene , it modulates the amount of gene ( gene ) in neuronal cell culture by reducing gene translation .	T8	T20	17594192
NA	CHEMICAL	GENE-Y	0	10	chemical deserves attention for an additional quality of action : in addition to inhibiting gene , it modulates the amount of gene ( gene ) in neuronal cell culture by reducing gene translation .	T8	T21	17594192
NA	CHEMICAL	GENE-Y	0	23	chemical deserves attention for an additional quality of action : in addition to inhibiting gene , it modulates the amount of gene ( gene ) in neuronal cell culture by reducing gene translation .	T8	T22	17594192
CPR:4	CHEMICAL	GENE-Y	0	31	chemical deserves attention for an additional quality of action : in addition to inhibiting gene , it modulates the amount of gene ( gene ) in neuronal cell culture by reducing gene translation .	T8	T23	17594192
NA	CHEMICAL	GENE-Y	6	17	This effect probably involves interaction of chemical with a regulatory element in the 5'-untranslated region of the gene gene that controls gene expression .	T9	T24	17594192
NA	CHEMICAL	GENE-Y	6	21	This effect probably involves interaction of chemical with a regulatory element in the 5'-untranslated region of the gene gene that controls gene expression .	T9	T25	17594192
CPR:4	CHEMICAL	GENE-Y	0	6	chemical apparently reduces translational efficiency of gene mRNA into protein , a process that may involve an interaction with chemical and/or an chemical-responsive element .	T10	T26	17594192
NA	CHEMICAL	GENE-Y	19	6	chemical apparently reduces translational efficiency of gene mRNA into protein , a process that may involve an interaction with chemical and/or an chemical-responsive element .	T11	T26	17594192
NA	CHEMICAL	GENE-Y	22	6	chemical apparently reduces translational efficiency of gene mRNA into protein , a process that may involve an interaction with chemical and/or an chemical-responsive element .	T12	T26	17594192
CPR:4	CHEMICAL	GENE-Y	4	1	As a consequence , chemical reduces gene peptide ( gene ) formation in vitro and in vivo .	T13	T28	17594192
CPR:4	CHEMICAL	GENE-Y	4	1	As a consequence , chemical reduces gene peptide ( gene ) formation in vitro and in vivo .	T13	T29	17594192
NA	CHEMICAL	GENE-Y	0	20	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T14	T17	17594192
NA	CHEMICAL	GENE-Y	0	33	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T14	T18	17594192
CPR:4	CHEMICAL	GENE-Y	12	20	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T2	T17	17594192
NA	CHEMICAL	GENE-Y	12	33	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T2	T18	17594192
NA	CHEMICAL	GENE-Y	23	20	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T3	T17	17594192
CPR:4	CHEMICAL	GENE-Y	23	33	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T3	T18	17594192
NA	CHEMICAL	GENE-Y	25	20	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T4	T17	17594192
CPR:4	CHEMICAL	GENE-Y	25	33	chemical is also unique because of differing actions of its enantiomers : chemical is the active enantiomer for inhibition of gene , whereas chemical ( 'chemical ' ) has weak activity as an gene inhibitor and can be dosed much higher .	T4	T18	17594192
CPR:5	CHEMICAL	GENE-Y	1	1	In gene transfected cells the rank order of agonist potency was chemical ( mean pEC ( 50 ) =8.96 ) > chemical ( 8.88 ) > chemical ( 8.42 ) > chemical ( 7.05 ) > chemical ( 6.92 ) .	T2	T22	10742288
CPR:5	CHEMICAL	GENE-Y	21	1	In gene transfected cells the rank order of agonist potency was chemical ( mean pEC ( 50 ) =8.96 ) > chemical ( 8.88 ) > chemical ( 8.42 ) > chemical ( 7.05 ) > chemical ( 6.92 ) .	T3	T22	10742288
CPR:5	CHEMICAL	GENE-Y	26	1	In gene transfected cells the rank order of agonist potency was chemical ( mean pEC ( 50 ) =8.96 ) > chemical ( 8.88 ) > chemical ( 8.42 ) > chemical ( 7.05 ) > chemical ( 6.92 ) .	T4	T22	10742288
CPR:5	CHEMICAL	GENE-Y	31	1	In gene transfected cells the rank order of agonist potency was chemical ( mean pEC ( 50 ) =8.96 ) > chemical ( 8.88 ) > chemical ( 8.42 ) > chemical ( 7.05 ) > chemical ( 6.92 ) .	T5	T22	10742288
CPR:5	CHEMICAL	GENE-Y	36	1	In gene transfected cells the rank order of agonist potency was chemical ( mean pEC ( 50 ) =8.96 ) > chemical ( 8.88 ) > chemical ( 8.42 ) > chemical ( 7.05 ) > chemical ( 6.92 ) .	T6	T22	10742288
NA	CHEMICAL	GENE-N	4	2	The selective gene ligand chemical antagonized acidification rate changes with an affinity independent of the agonist used ; the affinity ( mean pK ( B ) ) against chemical was 8.43 .	T12	T23	10742288
NA	CHEMICAL	GENE-N	28	2	The selective gene ligand chemical antagonized acidification rate changes with an affinity independent of the agonist used ; the affinity ( mean pK ( B ) ) against chemical was 8.43 .	T13	T23	10742288
NA	CHEMICAL	GENE-N	4	2	The selective gene ligands chemical and chemical ( each 3 microM ) had no effect on chemical responses .	T14	T24	10742288
NA	CHEMICAL	GENE-N	6	2	The selective gene ligands chemical and chemical ( each 3 microM ) had no effect on chemical responses .	T15	T24	10742288
NA	CHEMICAL	GENE-N	13	2	The selective gene ligands chemical and chemical ( each 3 microM ) had no effect on chemical responses .	T16	T24	10742288
NA	CHEMICAL	GENE-Y	0	2	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T22	T46	23322164
NA	CHEMICAL	GENE-Y	0	5	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T22	T47	23322164
NA	CHEMICAL	GENE-Y	4	2	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T24	T46	23322164
NA	CHEMICAL	GENE-Y	4	5	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T24	T47	23322164
NA	CHEMICAL	GENE-Y	4	2	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T25	T46	23322164
NA	CHEMICAL	GENE-Y	4	5	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T25	T47	23322164
CPR:9	CHEMICAL	GENE-Y	8	2	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T23	T46	23322164
CPR:9	CHEMICAL	GENE-Y	8	5	chemical palmitoyltransferase 2 and chemical/chemical translocase are involved in the mitochondrial synthesis and export of chemical .	T23	T47	23322164
NA	CHEMICAL	GENE-Y	23	10	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T36	23322164
NA	CHEMICAL	GENE-Y	23	12	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T37	23322164
NA	CHEMICAL	GENE-Y	23	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T38	23322164
NA	CHEMICAL	GENE-Y	23	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T39	23322164
NA	CHEMICAL	GENE-Y	23	26	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T40	23322164
NA	CHEMICAL	GENE-Y	23	28	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T41	23322164
NA	CHEMICAL	GENE-N	23	35	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T42	23322164
NA	CHEMICAL	GENE-Y	23	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T12	T43	23322164
NA	CHEMICAL	GENE-Y	14	10	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T36	23322164
NA	CHEMICAL	GENE-Y	14	12	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T37	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T38	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T39	23322164
NA	CHEMICAL	GENE-Y	14	26	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T40	23322164
NA	CHEMICAL	GENE-Y	14	28	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T41	23322164
NA	CHEMICAL	GENE-N	14	35	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T42	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T13	T43	23322164
NA	CHEMICAL	GENE-Y	14	10	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T36	23322164
NA	CHEMICAL	GENE-Y	14	12	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T37	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T38	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T39	23322164
NA	CHEMICAL	GENE-Y	14	26	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T40	23322164
NA	CHEMICAL	GENE-Y	14	28	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T41	23322164
NA	CHEMICAL	GENE-N	14	35	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T42	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T14	T43	23322164
NA	CHEMICAL	GENE-Y	14	10	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T36	23322164
NA	CHEMICAL	GENE-Y	14	12	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T37	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T38	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T39	23322164
NA	CHEMICAL	GENE-Y	14	26	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T40	23322164
NA	CHEMICAL	GENE-Y	14	28	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T41	23322164
NA	CHEMICAL	GENE-N	14	35	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T42	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T15	T43	23322164
NA	CHEMICAL	GENE-Y	14	10	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T36	23322164
NA	CHEMICAL	GENE-Y	14	12	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T37	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T38	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T39	23322164
NA	CHEMICAL	GENE-Y	14	26	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T40	23322164
NA	CHEMICAL	GENE-Y	14	28	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T41	23322164
NA	CHEMICAL	GENE-N	14	35	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T42	23322164
NA	CHEMICAL	GENE-Y	14	19	We used lentiviral shRNA to knock down the expression of gene ( gene ) in control and chemical palmitoyltransferase 2 ( gene ) - , chemical/chemical translocase ( gene ) - , and plasmalemmal chemical transporter ( gene ) -deficient human fibroblasts .	T16	T43	23322164
NA	CHEMICAL	GENE-Y	11	4	In control fibroblasts , gene knockdown markedly increased the production of chemical ( 3-fold , P < 0.01 ) .	T21	T44	23322164
NA	CHEMICAL	GENE-Y	8	0	gene-deficient cell lines also showed extracellular accumulation of chemical ( 2.8-fold , P < 0.01 ) , suggesting that the cellular export of chemical does not depend on gene .	T2	T45	23322164
NA	CHEMICAL	GENE-Y	8	28	gene-deficient cell lines also showed extracellular accumulation of chemical ( 2.8-fold , P < 0.01 ) , suggesting that the cellular export of chemical does not depend on gene .	T2	T26	23322164
NA	CHEMICAL	GENE-Y	23	0	gene-deficient cell lines also showed extracellular accumulation of chemical ( 2.8-fold , P < 0.01 ) , suggesting that the cellular export of chemical does not depend on gene .	T3	T45	23322164
NA	CHEMICAL	GENE-Y	23	28	gene-deficient cell lines also showed extracellular accumulation of chemical ( 2.8-fold , P < 0.01 ) , suggesting that the cellular export of chemical does not depend on gene .	T3	T26	23322164
NA	CHEMICAL	GENE-Y	3	4	In contrast , in gene- and gene-deficient cells , the accumulation of chemical in the medium did not significantly increase in the gene knockdown .	T4	T27	23322164
NA	CHEMICAL	GENE-Y	3	6	In contrast , in gene- and gene-deficient cells , the accumulation of chemical in the medium did not significantly increase in the gene knockdown .	T4	T28	23322164
NA	CHEMICAL	GENE-Y	3	22	In contrast , in gene- and gene-deficient cells , the accumulation of chemical in the medium did not significantly increase in the gene knockdown .	T4	T29	23322164
NA	CHEMICAL	GENE-N	2	9	Identification of chemical-terminal receptor activity-modifying protein residues important for gene , gene , and gene function .	T1	T64	18593822
NA	CHEMICAL	GENE-Y	2	11	Identification of chemical-terminal receptor activity-modifying protein residues important for gene , gene , and gene function .	T1	T62	18593822
NA	CHEMICAL	GENE-N	2	3	Identification of chemical-terminal receptor activity-modifying protein residues important for gene , gene , and gene function .	T1	T63	18593822
CPR:3	CHEMICAL	GENE-N	0	9	chemical is a collective term for compounds which bind to and activate gene ( gene and gene ) , members of gene superfamily .	T1	T19	16819260
NA	CHEMICAL	GENE-N	0	2	chemical is a collective term for compounds which bind to and activate gene ( gene and gene ) , members of gene superfamily .	T1	T20	16819260
NA	CHEMICAL	GENE-N	0	2	chemical is a collective term for compounds which bind to and activate gene ( gene and gene ) , members of gene superfamily .	T1	T12	16819260
CPR:3	CHEMICAL	GENE-N	0	9	chemical is a collective term for compounds which bind to and activate gene ( gene and gene ) , members of gene superfamily .	T1	T13	16819260
NA	CHEMICAL	GENE-N	4	13	The most important endogeneous chemical is chemical ( chemical ) which is an gene ligand .	T3	T14	16819260
NA	CHEMICAL	GENE-N	6	13	The most important endogeneous chemical is chemical ( chemical ) which is an gene ligand .	T4	T14	16819260
NA	CHEMICAL	GENE-N	8	13	The most important endogeneous chemical is chemical ( chemical ) which is an gene ligand .	T5	T14	16819260
NA	CHEMICAL	GENE-Y	3	9	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T7	T15	16819260
NA	CHEMICAL	GENE-Y	3	11	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T7	T16	16819260
NA	CHEMICAL	GENE-Y	3	14	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T7	T17	16819260
NA	CHEMICAL	GENE-N	3	16	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T7	T18	16819260
NA	CHEMICAL	GENE-Y	5	9	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T8	T15	16819260
NA	CHEMICAL	GENE-Y	5	11	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T8	T16	16819260
NA	CHEMICAL	GENE-Y	5	14	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T8	T17	16819260
NA	CHEMICAL	GENE-N	5	16	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T8	T18	16819260
NA	CHEMICAL	GENE-Y	19	9	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T9	T15	16819260
NA	CHEMICAL	GENE-Y	19	11	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T9	T16	16819260
NA	CHEMICAL	GENE-Y	19	14	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T9	T17	16819260
NA	CHEMICAL	GENE-N	19	16	Among them , chemical ( chemical ) is an gene- and gene-specific ( but gene- and gene-nonbinding ) synthetic chemical that is effective in the treatment of psoriasis patients and relapsed APL .	T9	T18	16819260
CPR:4	CHEMICAL	GENE-Y	2	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T10	T33	23220618
CPR:4	CHEMICAL	GENE-Y	2	20	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T10	T34	23220618
NA	CHEMICAL	GENE-Y	2	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T10	T35	23220618
NA	CHEMICAL	GENE-Y	2	31	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T10	T36	23220618
CPR:4	CHEMICAL	GENE-Y	4	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T11	T33	23220618
CPR:4	CHEMICAL	GENE-Y	4	20	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T11	T34	23220618
NA	CHEMICAL	GENE-Y	4	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T11	T35	23220618
NA	CHEMICAL	GENE-Y	4	31	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T11	T36	23220618
NA	CHEMICAL	GENE-Y	23	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T12	T33	23220618
NA	CHEMICAL	GENE-Y	23	20	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T12	T34	23220618
CPR:3	CHEMICAL	GENE-Y	23	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T12	T35	23220618
CPR:4	CHEMICAL	GENE-Y	23	31	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T12	T36	23220618
NA	CHEMICAL	GENE-Y	25	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T13	T33	23220618
NA	CHEMICAL	GENE-Y	25	20	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T13	T34	23220618
CPR:4	CHEMICAL	GENE-Y	25	6	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T13	T35	23220618
CPR:4	CHEMICAL	GENE-Y	25	31	Treatment with chemical and chemical resulted in significantly prolonged aPTT and PT and inhibition of the activities of gene and gene , and chemical or chemical inhibited production of gene and gene in HUVECs .	T13	T36	23220618
CPR:4	CHEMICAL	GENE-Y	5	12	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T15	T19	23220618
CPR:4	CHEMICAL	GENE-Y	5	15	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T15	T20	23220618
NA	CHEMICAL	GENE-Y	5	27	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T15	T21	23220618
NA	CHEMICAL	GENE-Y	5	29	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T15	T22	23220618
CPR:4	CHEMICAL	GENE-Y	7	12	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T16	T19	23220618
CPR:4	CHEMICAL	GENE-Y	7	15	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T16	T20	23220618
NA	CHEMICAL	GENE-Y	7	27	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T16	T21	23220618
NA	CHEMICAL	GENE-Y	7	29	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T16	T22	23220618
NA	CHEMICAL	GENE-Y	15	12	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T2	T19	23220618
NA	CHEMICAL	GENE-Y	15	15	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T2	T20	23220618
CPR:4	CHEMICAL	GENE-Y	15	27	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T2	T21	23220618
CPR:4	CHEMICAL	GENE-Y	15	29	In addition , treatment with chemical and chemical resulted in inhibition of gene-induced production of gene , and treatment with chemical resulted in significant reduction of the gene to gene ratio .	T2	T22	23220618
NA	CHEMICAL	GENE-N	6	9	Characterization and partial purification of microsomal chemical : chemical oxidoreductases .	T17	T36	10683249
NA	CHEMICAL	GENE-N	8	9	Characterization and partial purification of microsomal chemical : chemical oxidoreductases .	T18	T36	10683249
NA	CHEMICAL	GENE-N	0	1	chemical oxidoreductases are flavoproteins that catalyze two-electron reduction and detoxification of chemical .	T1	T19	10683249
CPR:9	CHEMICAL	GENE-N	11	1	chemical oxidoreductases are flavoproteins that catalyze two-electron reduction and detoxification of chemical .	T2	T19	10683249
NA	CHEMICAL	GENE-N	4	5	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T7	T24	10683249
NA	CHEMICAL	GENE-Y	4	6	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T7	T25	10683249
NA	CHEMICAL	GENE-Y	4	8	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T7	T26	10683249
NA	CHEMICAL	GENE-Y	4	15	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T7	T27	10683249
NA	CHEMICAL	GENE-Y	4	15	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T7	T28	10683249
NA	CHEMICAL	GENE-N	7	5	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T8	T24	10683249
NA	CHEMICAL	GENE-Y	7	6	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T8	T25	10683249
NA	CHEMICAL	GENE-Y	7	8	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T8	T26	10683249
NA	CHEMICAL	GENE-Y	7	15	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T8	T27	10683249
NA	CHEMICAL	GENE-Y	7	15	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T8	T28	10683249
NA	CHEMICAL	GENE-N	13	5	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T9	T24	10683249
NA	CHEMICAL	GENE-Y	13	6	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T9	T25	10683249
NA	CHEMICAL	GENE-Y	13	8	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T9	T26	10683249
NA	CHEMICAL	GENE-Y	13	15	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T9	T27	10683249
NA	CHEMICAL	GENE-Y	13	15	Two cytosolic forms of chemical oxidoreductases gene ( gene ) and NRH : chemical oxidoreductase 2 ( gene ) ] were previously identified , purified , and cloned .	T9	T28	10683249
CPR:9	CHEMICAL	GENE-Y	5	4	A role of cytosolic gene in protection of cells from oxidative stress , cytotoxicity , and mutagenicity of chemical was established .	T11	T29	10683249
NA	CHEMICAL	GENE-N	8	1	The gene activity showed significantly higher affinity for chemical than chemical as electron donors and catalyzed reduction of chemical and chemical .	T12	T33	10683249
NA	CHEMICAL	GENE-N	10	1	The gene activity showed significantly higher affinity for chemical than chemical as electron donors and catalyzed reduction of chemical and chemical .	T13	T33	10683249
CPR:9	CHEMICAL	GENE-N	18	1	The gene activity showed significantly higher affinity for chemical than chemical as electron donors and catalyzed reduction of chemical and chemical .	T14	T33	10683249
CPR:9	CHEMICAL	GENE-N	20	1	The gene activity showed significantly higher affinity for chemical than chemical as electron donors and catalyzed reduction of chemical and chemical .	T15	T33	10683249
NA	CHEMICAL	GENE-N	6	1	The gene activity was insensitive to chemical , a potent inhibitor of cytosolic gene .	T16	T34	10683249
CPR:4	CHEMICAL	GENE-Y	6	13	The gene activity was insensitive to chemical , a potent inhibitor of cytosolic gene .	T16	T35	10683249
NA	CHEMICAL	GENE-N	14	1	The gene activity was partially purified by solubilization of microsomes with detergent Chaps , chemical fractionation , and chemical-Sephacel column chromatography .	T3	T21	10683249
NA	CHEMICAL	GENE-N	18	1	The gene activity was partially purified by solubilization of microsomes with detergent Chaps , chemical fractionation , and chemical-Sephacel column chromatography .	T4	T21	10683249
NA	CHEMICAL	GENE-N	14	3	In mammalian mitochondria the translational machinery is of dual origin with tRNAs encoded by a simplified and rapidly evolving mitochondrial ( mt ) genome and chemical-tRNA synthetases ( gene ) coded by the nuclear genome , and imported .	T6	T14	16597625
NA	CHEMICAL	GENE-N	14	14	In mammalian mitochondria the translational machinery is of dual origin with tRNAs encoded by a simplified and rapidly evolving mitochondrial ( mt ) genome and chemical-tRNA synthetases ( gene ) coded by the nuclear genome , and imported .	T6	T15	16597625
NA	CHEMICAL	GENE-N	6	11	We have explored here the human mt-chemical system in which a gene , highly similar to the Escherichia coli enzyme , recognizes a bizarre tRNA ( Asp ) .	T7	T18	16597625
NA	CHEMICAL	GENE-N	5	17	This position is otherwise known as the site of a universally conserved major chemical identity element , gene , also known as a primordial identity signal .	T8	T20	16597625
NA	CHEMICAL	GENE-N	7	4	Sequence alignments of various gene allowed placing chemical-269 at a position occupied by chemical-220 , the residue contacting gene in the crystallographic structure of gene-tRNA ( Asp ) complex .	T2	T9	16597625
NA	CHEMICAL	GENE-N	7	18	Sequence alignments of various gene allowed placing chemical-269 at a position occupied by chemical-220 , the residue contacting gene in the crystallographic structure of gene-tRNA ( Asp ) complex .	T2	T10	16597625
NA	CHEMICAL	GENE-Y	7	24	Sequence alignments of various gene allowed placing chemical-269 at a position occupied by chemical-220 , the residue contacting gene in the crystallographic structure of gene-tRNA ( Asp ) complex .	T2	T11	16597625
NA	CHEMICAL	GENE-N	13	4	Sequence alignments of various gene allowed placing chemical-269 at a position occupied by chemical-220 , the residue contacting gene in the crystallographic structure of gene-tRNA ( Asp ) complex .	T3	T9	16597625
NA	CHEMICAL	GENE-N	13	18	Sequence alignments of various gene allowed placing chemical-269 at a position occupied by chemical-220 , the residue contacting gene in the crystallographic structure of gene-tRNA ( Asp ) complex .	T3	T10	16597625
NA	CHEMICAL	GENE-Y	13	24	Sequence alignments of various gene allowed placing chemical-269 at a position occupied by chemical-220 , the residue contacting gene in the crystallographic structure of gene-tRNA ( Asp ) complex .	T3	T11	16597625
NA	CHEMICAL	GENE-N	8	0	gene signaling pathways regulate mitochondrial-mediated apoptosis induced by chemical in human hepatoblastoma cancer cells .	T23	T49	23220614
CPR:4	CHEMICAL	GENE-N	0	12	chemical is able to induce apoptosis through mitochondrial dysfunction and inhibition of gene/gene signaling pathway in HepG2 cells , however , the effects of chemical on gene signaling pathways remain unknown .	T13	T35	23220614
CPR:4	CHEMICAL	GENE-N	0	12	chemical is able to induce apoptosis through mitochondrial dysfunction and inhibition of gene/gene signaling pathway in HepG2 cells , however , the effects of chemical on gene signaling pathways remain unknown .	T13	T36	23220614
NA	CHEMICAL	GENE-N	0	26	chemical is able to induce apoptosis through mitochondrial dysfunction and inhibition of gene/gene signaling pathway in HepG2 cells , however , the effects of chemical on gene signaling pathways remain unknown .	T13	T37	23220614
NA	CHEMICAL	GENE-N	24	12	chemical is able to induce apoptosis through mitochondrial dysfunction and inhibition of gene/gene signaling pathway in HepG2 cells , however , the effects of chemical on gene signaling pathways remain unknown .	T15	T35	23220614
NA	CHEMICAL	GENE-N	24	12	chemical is able to induce apoptosis through mitochondrial dysfunction and inhibition of gene/gene signaling pathway in HepG2 cells , however , the effects of chemical on gene signaling pathways remain unknown .	T15	T36	23220614
NA	CHEMICAL	GENE-N	24	26	chemical is able to induce apoptosis through mitochondrial dysfunction and inhibition of gene/gene signaling pathway in HepG2 cells , however , the effects of chemical on gene signaling pathways remain unknown .	T15	T37	23220614
NA	CHEMICAL	GENE-N	7	16	The present study investigated the effects of chemical on this pathway , and the roles of gene gene on mitochondrial-mediated apoptosis in HepG2 cells .	T16	T38	23220614
NA	CHEMICAL	GENE-N	7	17	The present study investigated the effects of chemical on this pathway , and the roles of gene gene on mitochondrial-mediated apoptosis in HepG2 cells .	T16	T39	23220614
NA	CHEMICAL	GENE-N	0	6	chemical significantly inhibited the levels of gene kinase and increased the expression of gene and gene gene .	T20	T40	23220614
CPR:3	CHEMICAL	GENE-N	0	13	chemical significantly inhibited the levels of gene kinase and increased the expression of gene and gene gene .	T20	T41	23220614
CPR:3	CHEMICAL	GENE-N	0	15	chemical significantly inhibited the levels of gene kinase and increased the expression of gene and gene gene .	T20	T42	23220614
CPR:3	CHEMICAL	GENE-N	0	7	chemical significantly inhibited the levels of gene kinase and increased the expression of gene and gene gene .	T20	T43	23220614
NA	CHEMICAL	GENE-N	2	5	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T21	T44	23220614
CPR:3	CHEMICAL	GENE-Y	2	13	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T21	T45	23220614
CPR:3	CHEMICAL	GENE-Y	2	13	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T21	T46	23220614
NA	CHEMICAL	GENE-Y	2	19	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T21	T47	23220614
NA	CHEMICAL	GENE-Y	2	30	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T21	T48	23220614
NA	CHEMICAL	GENE-N	11	5	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T22	T44	23220614
CPR:3	CHEMICAL	GENE-Y	11	13	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T22	T45	23220614
CPR:3	CHEMICAL	GENE-Y	11	13	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T22	T46	23220614
NA	CHEMICAL	GENE-Y	11	19	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T22	T47	23220614
NA	CHEMICAL	GENE-Y	11	30	Furthermore , chemical ( an gene inhibitor ) significantly enhanced the chemical-induced the gene/gene ratio , the release of gene to the cytosol fraction , and the levels of cleaved gene .	T22	T48	23220614
CPR:4	CHEMICAL	GENE-N	1	4	While chemical ( a gene inhibitor ) and chemical ( a gene inhibitor ) markedly prevented the expression of these proteins induced by chemical .	T2	T24	23220614
NA	CHEMICAL	GENE-N	1	11	While chemical ( a gene inhibitor ) and chemical ( a gene inhibitor ) markedly prevented the expression of these proteins induced by chemical .	T2	T25	23220614
NA	CHEMICAL	GENE-N	8	4	While chemical ( a gene inhibitor ) and chemical ( a gene inhibitor ) markedly prevented the expression of these proteins induced by chemical .	T3	T24	23220614
CPR:4	CHEMICAL	GENE-N	8	11	While chemical ( a gene inhibitor ) and chemical ( a gene inhibitor ) markedly prevented the expression of these proteins induced by chemical .	T3	T25	23220614
CPR:3	CHEMICAL	GENE-N	23	4	While chemical ( a gene inhibitor ) and chemical ( a gene inhibitor ) markedly prevented the expression of these proteins induced by chemical .	T4	T24	23220614
CPR:3	CHEMICAL	GENE-N	23	11	While chemical ( a gene inhibitor ) and chemical ( a gene inhibitor ) markedly prevented the expression of these proteins induced by chemical .	T4	T25	23220614
NA	CHEMICAL	GENE-N	6	17	Furthermore , the ROS inhibitor ( chemical ) notably promoted the inhibited effect of chemical on the gene kinase .	T5	T26	23220614
NA	CHEMICAL	GENE-N	14	17	Furthermore , the ROS inhibitor ( chemical ) notably promoted the inhibited effect of chemical on the gene kinase .	T6	T26	23220614
CPR:4	CHEMICAL	GENE-N	0	4	chemical also suppressed the p-gene and gene , but failed to reverse the effects of chemical .	T7	T27	23220614
CPR:4	CHEMICAL	GENE-N	0	6	chemical also suppressed the p-gene and gene , but failed to reverse the effects of chemical .	T7	T28	23220614
NA	CHEMICAL	GENE-N	15	4	chemical also suppressed the p-gene and gene , but failed to reverse the effects of chemical .	T8	T27	23220614
NA	CHEMICAL	GENE-N	15	6	chemical also suppressed the p-gene and gene , but failed to reverse the effects of chemical .	T8	T28	23220614
NA	CHEMICAL	GENE-N	8	16	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T10	T29	23220614
CPR:3	CHEMICAL	GENE-N	8	20	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T10	T30	23220614
CPR:3	CHEMICAL	GENE-N	8	22	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T10	T31	23220614
CPR:3	CHEMICAL	GENE-N	8	11	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T10	T32	23220614
NA	CHEMICAL	GENE-N	8	35	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T10	T33	23220614
NA	CHEMICAL	GENE-N	29	16	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T11	T29	23220614
NA	CHEMICAL	GENE-N	29	20	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T11	T30	23220614
NA	CHEMICAL	GENE-N	29	22	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T11	T31	23220614
NA	CHEMICAL	GENE-N	29	11	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T11	T32	23220614
CPR:3	CHEMICAL	GENE-N	29	35	These results demonstrated for the first time that chemical induces apoptosis in HepG2 cells through inactivating gene kinase and activating gene and gene gene , and ROS stimulated by chemical is able to activate the gene singaling pathway as the upstream signaling molecules .	T11	T33	23220614
NA	CHEMICAL	GENE-Y	37	7	We report that two common variants of gene ( gene ) that increase the inherited risk of neovascular age-related macular degeneration ( NvAMD ) harbor synonymous SNPs within exon 1 of gene that convert common codons for chemical34 and chemical36 to less frequently used codons .	T2	T5	23478260
NA	CHEMICAL	GENE-Y	37	9	We report that two common variants of gene ( gene ) that increase the inherited risk of neovascular age-related macular degeneration ( NvAMD ) harbor synonymous SNPs within exon 1 of gene that convert common codons for chemical34 and chemical36 to less frequently used codons .	T2	T6	23478260
NA	CHEMICAL	GENE-Y	37	29	We report that two common variants of gene ( gene ) that increase the inherited risk of neovascular age-related macular degeneration ( NvAMD ) harbor synonymous SNPs within exon 1 of gene that convert common codons for chemical34 and chemical36 to less frequently used codons .	T2	T7	23478260
NA	CHEMICAL	GENE-Y	39	7	We report that two common variants of gene ( gene ) that increase the inherited risk of neovascular age-related macular degeneration ( NvAMD ) harbor synonymous SNPs within exon 1 of gene that convert common codons for chemical34 and chemical36 to less frequently used codons .	T3	T5	23478260
NA	CHEMICAL	GENE-Y	39	9	We report that two common variants of gene ( gene ) that increase the inherited risk of neovascular age-related macular degeneration ( NvAMD ) harbor synonymous SNPs within exon 1 of gene that convert common codons for chemical34 and chemical36 to less frequently used codons .	T3	T6	23478260
NA	CHEMICAL	GENE-Y	39	29	We report that two common variants of gene ( gene ) that increase the inherited risk of neovascular age-related macular degeneration ( NvAMD ) harbor synonymous SNPs within exon 1 of gene that convert common codons for chemical34 and chemical36 to less frequently used codons .	T3	T7	23478260
CPR:4	CHEMICAL	GENE-Y	1	5	Novel chemical derivatives as potent gene inhibitors .	T4	T11	23474386
NA	CHEMICAL	GENE-Y	4	13	A series of novel chemical were designed , synthesized and biologically evaluated for gene inhibition .	T3	T5	23474386
NA	CHEMICAL	GENE-Y	11	17	Brain abnormalities in +/rl are similar to psychotic brain and include a reduction in chemical de carboxylase 67 ( gene ) , dendritic arbors and spine density in cortex and hippocampus , and abnormalities in synaptic function including long-term potentiation ( LTP ) .	T2	T6	16769115
NA	CHEMICAL	GENE-Y	11	17	Brain abnormalities in +/rl are similar to psychotic brain and include a reduction in chemical de carboxylase 67 ( gene ) , dendritic arbors and spine density in cortex and hippocampus , and abnormalities in synaptic function including long-term potentiation ( LTP ) .	T2	T7	16769115
CPR:3	CHEMICAL	GENE-N	2	2	Hypermethlyation of gene can be induced by treating mice with chemical , and these mice display brain and behavioral abnormalities similar to +/rl .	T1	T11	16769115
CPR:9	CHEMICAL	GENE-N	0	6	chemical and chemical are substrates of gene and potent inhibitors of chemical oxidase in perfused lungs of rats .	T32	T57	8740147
CPR:4	CHEMICAL	GENE-N	0	12	chemical and chemical are substrates of gene and potent inhibitors of chemical oxidase in perfused lungs of rats .	T32	T58	8740147
CPR:9	CHEMICAL	GENE-N	2	6	chemical and chemical are substrates of gene and potent inhibitors of chemical oxidase in perfused lungs of rats .	T33	T57	8740147
CPR:4	CHEMICAL	GENE-N	2	12	chemical and chemical are substrates of gene and potent inhibitors of chemical oxidase in perfused lungs of rats .	T33	T58	8740147
NA	CHEMICAL	GENE-N	11	6	chemical and chemical are substrates of gene and potent inhibitors of chemical oxidase in perfused lungs of rats .	T34	T57	8740147
NA	CHEMICAL	GENE-N	11	12	chemical and chemical are substrates of gene and potent inhibitors of chemical oxidase in perfused lungs of rats .	T34	T58	8740147
CPR:4	CHEMICAL	GENE-N	4	9	Previous studies have resulted in the classification of chemical as a selective inhibitor of neuronal chemical oxidase ( gene ) , because it is a much more potent gene inhibitor in intact tissues , in which it is accumulated in noradrenergic neurones by uptake1 , than in tissue homogenates .	T22	T35	8740147
CPR:4	CHEMICAL	GENE-N	4	18	Previous studies have resulted in the classification of chemical as a selective inhibitor of neuronal chemical oxidase ( gene ) , because it is a much more potent gene inhibitor in intact tissues , in which it is accumulated in noradrenergic neurones by uptake1 , than in tissue homogenates .	T22	T36	8740147
CPR:4	CHEMICAL	GENE-N	4	28	Previous studies have resulted in the classification of chemical as a selective inhibitor of neuronal chemical oxidase ( gene ) , because it is a much more potent gene inhibitor in intact tissues , in which it is accumulated in noradrenergic neurones by uptake1 , than in tissue homogenates .	T22	T40	8740147
NA	CHEMICAL	GENE-N	4	9	Previous studies have resulted in the classification of chemical as a selective inhibitor of neuronal chemical oxidase ( gene ) , because it is a much more potent gene inhibitor in intact tissues , in which it is accumulated in noradrenergic neurones by uptake1 , than in tissue homogenates .	T1	T35	8740147
NA	CHEMICAL	GENE-N	4	18	Previous studies have resulted in the classification of chemical as a selective inhibitor of neuronal chemical oxidase ( gene ) , because it is a much more potent gene inhibitor in intact tissues , in which it is accumulated in noradrenergic neurones by uptake1 , than in tissue homogenates .	T1	T36	8740147
NA	CHEMICAL	GENE-N	4	28	Previous studies have resulted in the classification of chemical as a selective inhibitor of neuronal chemical oxidase ( gene ) , because it is a much more potent gene inhibitor in intact tissues , in which it is accumulated in noradrenergic neurones by uptake1 , than in tissue homogenates .	T1	T40	8740147
NA	CHEMICAL	GENE-N	8	28	In the present study , the effects of chemical on the deamination of chemical were investigated in intact lungs of rats , since the pulmonary endothelial cells are a site where the chemical transporter is non-neuronal gene .	T19	T50	8740147
NA	CHEMICAL	GENE-N	13	28	In the present study , the effects of chemical on the deamination of chemical were investigated in intact lungs of rats , since the pulmonary endothelial cells are a site where the chemical transporter is non-neuronal gene .	T20	T50	8740147
NA	CHEMICAL	GENE-N	16	28	In the present study , the effects of chemical on the deamination of chemical were investigated in intact lungs of rats , since the pulmonary endothelial cells are a site where the chemical transporter is non-neuronal gene .	T21	T50	8740147
CPR:9	CHEMICAL	GENE-N	6	8	In addition , another drug that is both a substrate of gene and a gene inhibitor , chemical , was investigated in the study .	T23	T51	8740147
CPR:4	CHEMICAL	GENE-N	6	14	In addition , another drug that is both a substrate of gene and a gene inhibitor , chemical , was investigated in the study .	T23	T52	8740147
NA	CHEMICAL	GENE-N	10	16	The first aim of the study was to show whether chemical and chemical are substrates of gene in rat lungs .	T24	T53	8740147
NA	CHEMICAL	GENE-N	12	16	The first aim of the study was to show whether chemical and chemical are substrates of gene in rat lungs .	T25	T53	8740147
NA	CHEMICAL	GENE-N	7	9	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T26	T54	8740147
NA	CHEMICAL	GENE-Y	7	13	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T26	T56	8740147
NA	CHEMICAL	GENE-N	11	9	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T27	T54	8740147
NA	CHEMICAL	GENE-Y	11	13	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T27	T56	8740147
NA	CHEMICAL	GENE-N	11	9	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T28	T54	8740147
NA	CHEMICAL	GENE-Y	11	13	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T28	T56	8740147
NA	CHEMICAL	GENE-N	21	9	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T29	T54	8740147
NA	CHEMICAL	GENE-Y	21	13	After loading of isolated perfused lungs with chemical ( gene and chemical-chemical-methyltransferase ( gene ) inhibited ) , the efflux of chemical was measured for 30 min .	T29	T56	8740147
NA	CHEMICAL	GENE-Y	6	8	In lungs perfused with 1 nmol/l chemical ( gene inhibited ) , 10 , 30 and 300 nmol/l chemical caused 58 % , 76 % and 74 % inhibition of chemical deamination , respectively , and 30 , 300 and 3000 nmol/l chemical caused 56 % , 89 % and 96 % inhibition of chemical deamination , respectively .	T4	T38	8740147
NA	CHEMICAL	GENE-Y	18	8	In lungs perfused with 1 nmol/l chemical ( gene inhibited ) , 10 , 30 and 300 nmol/l chemical caused 58 % , 76 % and 74 % inhibition of chemical deamination , respectively , and 30 , 300 and 3000 nmol/l chemical caused 56 % , 89 % and 96 % inhibition of chemical deamination , respectively .	T5	T38	8740147
NA	CHEMICAL	GENE-Y	30	8	In lungs perfused with 1 nmol/l chemical ( gene inhibited ) , 10 , 30 and 300 nmol/l chemical caused 58 % , 76 % and 74 % inhibition of chemical deamination , respectively , and 30 , 300 and 3000 nmol/l chemical caused 56 % , 89 % and 96 % inhibition of chemical deamination , respectively .	T6	T38	8740147
NA	CHEMICAL	GENE-Y	42	8	In lungs perfused with 1 nmol/l chemical ( gene inhibited ) , 10 , 30 and 300 nmol/l chemical caused 58 % , 76 % and 74 % inhibition of chemical deamination , respectively , and 30 , 300 and 3000 nmol/l chemical caused 56 % , 89 % and 96 % inhibition of chemical deamination , respectively .	T7	T38	8740147
NA	CHEMICAL	GENE-Y	54	8	In lungs perfused with 1 nmol/l chemical ( gene inhibited ) , 10 , 30 and 300 nmol/l chemical caused 58 % , 76 % and 74 % inhibition of chemical deamination , respectively , and 30 , 300 and 3000 nmol/l chemical caused 56 % , 89 % and 96 % inhibition of chemical deamination , respectively .	T8	T38	8740147
NA	CHEMICAL	GENE-Y	8	1	When gene was also inhibited , 10 nmol/l chemical caused 84 % inhibition of the deamination of chemical by gene in the lungs .	T9	T39	8740147
CPR:4	CHEMICAL	GENE-Y	8	19	When gene was also inhibited , 10 nmol/l chemical caused 84 % inhibition of the deamination of chemical by gene in the lungs .	T9	T41	8740147
NA	CHEMICAL	GENE-Y	17	1	When gene was also inhibited , 10 nmol/l chemical caused 84 % inhibition of the deamination of chemical by gene in the lungs .	T10	T39	8740147
NA	CHEMICAL	GENE-Y	17	19	When gene was also inhibited , 10 nmol/l chemical caused 84 % inhibition of the deamination of chemical by gene in the lungs .	T10	T41	8740147
NA	CHEMICAL	GENE-N	3	18	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T11	T42	8740147
NA	CHEMICAL	GENE-Y	3	20	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T11	T43	8740147
NA	CHEMICAL	GENE-N	3	22	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T11	T44	8740147
NA	CHEMICAL	GENE-N	3	18	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T12	T42	8740147
NA	CHEMICAL	GENE-Y	3	20	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T12	T43	8740147
NA	CHEMICAL	GENE-N	3	22	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T12	T44	8740147
NA	CHEMICAL	GENE-N	3	18	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T13	T42	8740147
NA	CHEMICAL	GENE-Y	3	20	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T13	T43	8740147
NA	CHEMICAL	GENE-N	3	22	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T13	T44	8740147
NA	CHEMICAL	GENE-N	3	18	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T14	T42	8740147
NA	CHEMICAL	GENE-Y	3	20	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T14	T43	8740147
NA	CHEMICAL	GENE-N	3	22	In contrast , in hearts perfused with 10 nmol/l chemical under conditions where the amine was accumulated by gene ( gene , gene and vesicular transport inhibited ) , 10 nmol/l chemical had no effect and 300 nmol/l chemical caused only 36 % inhibition of deamination of chemical .	T14	T44	8740147
CPR:4	CHEMICAL	GENE-N	7	28	The results when considered with previous reports in the literature show that chemical is about 1000 times more potent and chemical is about 20 times more potent for gene inhibition in rat lungs than in tissue homogenates , and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by gene .	T15	T45	8740147
CPR:9	CHEMICAL	GENE-N	7	62	The results when considered with previous reports in the literature show that chemical is about 1000 times more potent and chemical is about 20 times more potent for gene inhibition in rat lungs than in tissue homogenates , and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by gene .	T15	T46	8740147
CPR:4	CHEMICAL	GENE-N	7	28	The results when considered with previous reports in the literature show that chemical is about 1000 times more potent and chemical is about 20 times more potent for gene inhibition in rat lungs than in tissue homogenates , and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by gene .	T16	T45	8740147
CPR:9	CHEMICAL	GENE-N	7	62	The results when considered with previous reports in the literature show that chemical is about 1000 times more potent and chemical is about 20 times more potent for gene inhibition in rat lungs than in tissue homogenates , and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by gene .	T16	T46	8740147
CPR:4	CHEMICAL	GENE-N	0	7	chemical is much less potent as a gene inhibitor in cells with the gene , such as the myocardial cells of the heart .	T17	T47	8740147
CPR:9	CHEMICAL	GENE-N	0	6	chemical is much less potent as a gene inhibitor in cells with the gene , such as the myocardial cells of the heart .	T17	T48	8740147
NA	CHEMICAL	GENE-Y	5	6	Fatal hemorrhage in mice lacking chemical carboxylase .	T7	T20	17327402
CPR:9	CHEMICAL	GENE-Y	3	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T2	T16	17327402
CPR:9	CHEMICAL	GENE-Y	3	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T2	T9	17327402
CPR:9	CHEMICAL	GENE-Y	6	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T3	T16	17327402
CPR:9	CHEMICAL	GENE-Y	6	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T3	T9	17327402
CPR:9	CHEMICAL	GENE-Y	8	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T5	T16	17327402
CPR:9	CHEMICAL	GENE-Y	8	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T5	T9	17327402
NA	CHEMICAL	GENE-Y	12	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T6	T16	17327402
NA	CHEMICAL	GENE-Y	12	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T6	T9	17327402
NA	CHEMICAL	GENE-Y	13	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T1	T16	17327402
NA	CHEMICAL	GENE-Y	13	14	The carboxylation of chemical residues to chemical ( chemical ) by the chemical-dependent chemical carboxylase ( gene ) is an essential posttranslational modification required for the biological activity of a number of proteins , including proteins involved in blood coagulation and its regulation .	T1	T9	17327402
NA	CHEMICAL	GENE-Y	29	3	Heterozygous mice carrying a null mutation at the gene ( gene ) gene exhibit normal development and survival with no evidence of hemorrhage and normal functional activity of the chemical-dependent clotting factors IX , X , and gene .	T4	T10	17327402
NA	CHEMICAL	GENE-Y	29	10	Heterozygous mice carrying a null mutation at the gene ( gene ) gene exhibit normal development and survival with no evidence of hemorrhage and normal functional activity of the chemical-dependent clotting factors IX , X , and gene .	T4	T11	17327402
NA	CHEMICAL	GENE-N	29	34	Heterozygous mice carrying a null mutation at the gene ( gene ) gene exhibit normal development and survival with no evidence of hemorrhage and normal functional activity of the chemical-dependent clotting factors IX , X , and gene .	T4	T12	17327402
NA	CHEMICAL	GENE-Y	29	37	Heterozygous mice carrying a null mutation at the gene ( gene ) gene exhibit normal development and survival with no evidence of hemorrhage and normal functional activity of the chemical-dependent clotting factors IX , X , and gene .	T4	T13	17327402
NA	CHEMICAL	GENE-N	3	27	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T2	T23	15291969
NA	CHEMICAL	GENE-N	3	28	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T2	T26	15291969
NA	CHEMICAL	GENE-N	5	27	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T3	T23	15291969
NA	CHEMICAL	GENE-N	5	28	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T3	T26	15291969
NA	CHEMICAL	GENE-N	7	27	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T4	T23	15291969
NA	CHEMICAL	GENE-N	7	28	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T4	T26	15291969
NA	CHEMICAL	GENE-N	9	27	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T5	T23	15291969
NA	CHEMICAL	GENE-N	9	28	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T5	T26	15291969
NA	CHEMICAL	GENE-N	11	27	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T6	T23	15291969
NA	CHEMICAL	GENE-N	11	28	BACKGROUND : Extracellular chemical ( chemical , chemical , chemical and chemical ) exert a wide range of biological effects in blood cells mediated by multiple ionotropic gene receptors and gene .	T6	T26	15291969
NA	CHEMICAL	GENE-Y	22	12	CONCLUSIONS : The most interesting findings were the high mRNA expression of gene receptors in lymphocytes potentially explaining the anti-inflammatory effects of chemical , gene receptors in monocytes and a previously unrecognised expression of gene in lymphocytes and monocytes .	T1	T22	15291969
NA	CHEMICAL	GENE-Y	22	24	CONCLUSIONS : The most interesting findings were the high mRNA expression of gene receptors in lymphocytes potentially explaining the anti-inflammatory effects of chemical , gene receptors in monocytes and a previously unrecognised expression of gene in lymphocytes and monocytes .	T1	T24	15291969
NA	CHEMICAL	GENE-Y	22	34	CONCLUSIONS : The most interesting findings were the high mRNA expression of gene receptors in lymphocytes potentially explaining the anti-inflammatory effects of chemical , gene receptors in monocytes and a previously unrecognised expression of gene in lymphocytes and monocytes .	T1	T25	15291969
NA	CHEMICAL	GENE-N	5	10	There are two isozymes of chemical endoperoxide ( PGH ) synthase ( gene ) called gene or gene .	T12	T25	7825862
NA	CHEMICAL	GENE-N	5	12	There are two isozymes of chemical endoperoxide ( PGH ) synthase ( gene ) called gene or gene .	T12	T32	7825862
NA	CHEMICAL	GENE-N	5	15	There are two isozymes of chemical endoperoxide ( PGH ) synthase ( gene ) called gene or gene .	T12	T35	7825862
NA	CHEMICAL	GENE-N	5	17	There are two isozymes of chemical endoperoxide ( PGH ) synthase ( gene ) called gene or gene .	T12	T14	7825862
CPR:4	CHEMICAL	GENE-Y	0	11	chemical , chemical , and chemical were found to preferentially inhibit gene .	T1	T13	7825862
CPR:4	CHEMICAL	GENE-Y	2	11	chemical , chemical , and chemical were found to preferentially inhibit gene .	T2	T13	7825862
CPR:4	CHEMICAL	GENE-Y	5	11	chemical , chemical , and chemical were found to preferentially inhibit gene .	T3	T13	7825862
CPR:4	CHEMICAL	GENE-Y	0	10	chemical , the active metabolite of chemical , inhibits murine gene preferentially .	T5	T15	7825862
CPR:4	CHEMICAL	GENE-Y	6	10	chemical , the active metabolite of chemical , inhibits murine gene preferentially .	T6	T15	7825862
CPR:4	CHEMICAL	GENE-Y	0	3	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T7	T16	7825862
NA	CHEMICAL	GENE-Y	0	23	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T7	T17	7825862
NA	CHEMICAL	GENE-Y	17	3	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T8	T16	7825862
NA	CHEMICAL	GENE-Y	17	23	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T8	T17	7825862
NA	CHEMICAL	GENE-Y	29	3	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T9	T16	7825862
CPR:9	CHEMICAL	GENE-Y	29	23	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T9	T17	7825862
NA	CHEMICAL	GENE-Y	31	3	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T10	T16	7825862
CPR:9	CHEMICAL	GENE-Y	31	23	chemical irreversibly inhibits gene , preventing this isozyme from forming PGH2 or any other oxygenated product ; in contrast , chemical treatment of gene causes this enzyme to form chemical ( chemical ) instead of PGH2 .	T10	T17	7825862
NA	CHEMICAL	GENE-Y	5	8	Pressor and bradycardic effects of chemical and other gene inhibitors in the rat .	T23	T37	9851542
CPR:4	CHEMICAL	GENE-Y	9	6	The cardiovascular effects of three different gene inhibitors : chemical , chemical and chemical injected by intravenous ( i.v . )	T19	T32	9851542
CPR:4	CHEMICAL	GENE-Y	11	6	The cardiovascular effects of three different gene inhibitors : chemical , chemical and chemical injected by intravenous ( i.v . )	T21	T32	9851542
CPR:4	CHEMICAL	GENE-Y	11	6	The cardiovascular effects of three different gene inhibitors : chemical , chemical and chemical injected by intravenous ( i.v . )	T2	T32	9851542
CPR:6	CHEMICAL	GENE-N	3	1	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T17	T34	9851542
NA	CHEMICAL	GENE-N	3	4	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T17	T35	9851542
NA	CHEMICAL	GENE-N	6	1	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T18	T34	9851542
NA	CHEMICAL	GENE-N	6	4	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T18	T35	9851542
NA	CHEMICAL	GENE-N	11	1	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T20	T34	9851542
CPR:6	CHEMICAL	GENE-N	11	4	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T20	T35	9851542
NA	CHEMICAL	GENE-N	16	1	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T22	T34	9851542
NA	CHEMICAL	GENE-N	16	4	The gene antagonist chemical or the chemical V1 receptor antagonist , chemical partially but significantly reduced chemical pressor effect and mostly abolished it when administered concomitantly .	T22	T35	9851542
CPR:6	CHEMICAL	GENE-N	6	4	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T3	T24	9851542
NA	CHEMICAL	GENE-Y	6	15	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T3	T25	9851542
NA	CHEMICAL	GENE-Y	6	26	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T3	T26	9851542
NA	CHEMICAL	GENE-Y	6	37	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T3	T27	9851542
NA	CHEMICAL	GENE-N	17	4	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T4	T24	9851542
CPR:6	CHEMICAL	GENE-Y	17	15	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T4	T25	9851542
NA	CHEMICAL	GENE-Y	17	26	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T4	T26	9851542
NA	CHEMICAL	GENE-Y	17	37	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T4	T27	9851542
NA	CHEMICAL	GENE-N	28	4	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T5	T24	9851542
NA	CHEMICAL	GENE-Y	28	15	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T5	T25	9851542
CPR:6	CHEMICAL	GENE-Y	28	26	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T5	T26	9851542
NA	CHEMICAL	GENE-Y	28	37	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T5	T27	9851542
NA	CHEMICAL	GENE-N	39	4	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T6	T24	9851542
NA	CHEMICAL	GENE-Y	39	15	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T6	T25	9851542
NA	CHEMICAL	GENE-Y	39	26	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T6	T26	9851542
CPR:6	CHEMICAL	GENE-Y	39	37	administration of the non-selective gene antagonist chemical ( ID50 = 1.45 microg ) , the gene antagonist chemical ( ID50 = 4.33 microg ) , the gene antagonist chemical ( ID50 = 1.39 microg ) and the gene antagonist chemical ( ID50 = 31.19 microg ) .	T6	T27	9851542
NA	CHEMICAL	GENE-N	9	4	Central injection of such gene antagonists did not affect chemical-induced bradycardia .	T7	T28	9851542
NA	CHEMICAL	GENE-Y	11	4	Our results show that gene inhibitors induce significant cardiovascular effects with a pressor response mediated mainly by the stimulation of central gene inducing a secondary increase in sympathetic outflow and chemical release .	T8	T29	9851542
NA	CHEMICAL	GENE-Y	11	21	Our results show that gene inhibitors induce significant cardiovascular effects with a pressor response mediated mainly by the stimulation of central gene inducing a secondary increase in sympathetic outflow and chemical release .	T8	T30	9851542
NA	CHEMICAL	GENE-N	0	1	chemical receptor expression in the obligatory paedomorphic salamander Necturus maculosus .	T10	T28	16741870
NA	CHEMICAL	GENE-N	11	10	These hormones induce metamorphosis by controlling gene expression through binding to chemical receptors ( gene ) .	T1	T17	16741870
NA	CHEMICAL	GENE-N	11	14	These hormones induce metamorphosis by controlling gene expression through binding to chemical receptors ( gene ) .	T1	T18	16741870
NA	CHEMICAL	GENE-N	3	18	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T3	T19	16741870
NA	CHEMICAL	GENE-N	3	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T3	T20	16741870
NA	CHEMICAL	GENE-N	3	37	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T3	T21	16741870
NA	CHEMICAL	GENE-N	3	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T3	T22	16741870
NA	CHEMICAL	GENE-N	3	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T3	T23	16741870
NA	CHEMICAL	GENE-Y	3	47	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T3	T24	16741870
NA	CHEMICAL	GENE-N	32	18	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T5	T19	16741870
NA	CHEMICAL	GENE-N	32	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T5	T20	16741870
NA	CHEMICAL	GENE-N	32	37	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T5	T21	16741870
NA	CHEMICAL	GENE-N	32	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T5	T22	16741870
NA	CHEMICAL	GENE-N	32	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T5	T23	16741870
NA	CHEMICAL	GENE-Y	32	47	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T5	T24	16741870
NA	CHEMICAL	GENE-N	3	18	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T6	T19	16741870
NA	CHEMICAL	GENE-N	3	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T6	T20	16741870
NA	CHEMICAL	GENE-N	3	37	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T6	T21	16741870
NA	CHEMICAL	GENE-N	3	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T6	T22	16741870
NA	CHEMICAL	GENE-N	3	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T6	T23	16741870
NA	CHEMICAL	GENE-Y	3	47	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T6	T24	16741870
NA	CHEMICAL	GENE-N	41	18	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T7	T19	16741870
NA	CHEMICAL	GENE-N	41	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T7	T20	16741870
NA	CHEMICAL	GENE-N	41	37	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T7	T21	16741870
NA	CHEMICAL	GENE-N	41	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T7	T22	16741870
NA	CHEMICAL	GENE-N	41	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T7	T23	16741870
NA	CHEMICAL	GENE-Y	41	47	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T7	T24	16741870
NA	CHEMICAL	GENE-N	51	18	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T8	T19	16741870
NA	CHEMICAL	GENE-N	51	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T8	T20	16741870
NA	CHEMICAL	GENE-N	51	37	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T8	T21	16741870
NA	CHEMICAL	GENE-N	51	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T8	T22	16741870
NA	CHEMICAL	GENE-N	51	22	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T8	T23	16741870
NA	CHEMICAL	GENE-Y	51	47	Since metamorphosis depends on the acquisition of response of tadpole tissues to chemical , we aimed to determine gene gene expression patterns in Necturus maculosus as well as the expression of two chemical-related genes : gene ( gene ) -gene , a gene encoding a gene and gene , a direct chemical target gene in Xenopus laevis .	T8	T24	16741870
NA	CHEMICAL	GENE-N	3	6	Human and rat chemical-chemical : chemical chemical-acyltransferase are liver-specific peroxisomal enzymes : implications for intracellular chemical transport .	T13	T42	17256745
NA	CHEMICAL	GENE-N	5	6	Human and rat chemical-chemical : chemical chemical-acyltransferase are liver-specific peroxisomal enzymes : implications for intracellular chemical transport .	T14	T42	17256745
NA	CHEMICAL	GENE-N	3	6	Human and rat chemical-chemical : chemical chemical-acyltransferase are liver-specific peroxisomal enzymes : implications for intracellular chemical transport .	T15	T42	17256745
NA	CHEMICAL	GENE-N	15	6	Human and rat chemical-chemical : chemical chemical-acyltransferase are liver-specific peroxisomal enzymes : implications for intracellular chemical transport .	T11	T42	17256745
NA	CHEMICAL	GENE-Y	2	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T1	T21	17256745
NA	CHEMICAL	GENE-Y	2	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T1	T32	17256745
NA	CHEMICAL	GENE-Y	2	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T6	T21	17256745
NA	CHEMICAL	GENE-Y	2	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T6	T32	17256745
NA	CHEMICAL	GENE-Y	4	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T7	T21	17256745
NA	CHEMICAL	GENE-Y	4	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T7	T32	17256745
NA	CHEMICAL	GENE-Y	0	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T8	T21	17256745
NA	CHEMICAL	GENE-Y	0	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T8	T32	17256745
CPR:9	CHEMICAL	GENE-Y	20	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T2	T21	17256745
CPR:9	CHEMICAL	GENE-Y	20	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T2	T32	17256745
CPR:9	CHEMICAL	GENE-Y	7	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T3	T21	17256745
CPR:9	CHEMICAL	GENE-Y	7	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T3	T32	17256745
CPR:9	CHEMICAL	GENE-Y	24	5	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T5	T21	17256745
CPR:9	CHEMICAL	GENE-Y	24	7	UchemicalLABELLED : chemical-chemical : chemical N-acyltransferase ( gene ) is the sole enzyme responsible for conjugation of primary and secondary chemical to chemical and chemical .	T5	T32	17256745
CPR:9	CHEMICAL	GENE-Y	5	9	The absence or presence of a cytosolic pool of gene has important implications for the intracellular transport of unconjugated/deconjugated chemical .	T9	T30	17256745
NA	CHEMICAL	GENE-N	5	15	We used immunofluorescence microscopy and chemical permeabilization assays to determine the subcellular location of endogenous gene in primary human and rat hepatocytes .	T10	T31	17256745
NA	CHEMICAL	GENE-Y	1	4	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T23	T60	16926278
NA	CHEMICAL	GENE-N	1	3	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T23	T61	16926278
NA	CHEMICAL	GENE-Y	1	19	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T23	T59	16926278
NA	CHEMICAL	GENE-Y	9	4	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T24	T60	16926278
NA	CHEMICAL	GENE-N	9	3	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T24	T61	16926278
NA	CHEMICAL	GENE-Y	9	19	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T24	T59	16926278
NA	CHEMICAL	GENE-Y	12	4	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T21	T60	16926278
NA	CHEMICAL	GENE-N	12	3	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T21	T61	16926278
NA	CHEMICAL	GENE-Y	12	19	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T21	T59	16926278
NA	CHEMICAL	GENE-Y	14	4	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T22	T60	16926278
NA	CHEMICAL	GENE-N	14	3	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T22	T61	16926278
NA	CHEMICAL	GENE-Y	14	19	A 46-chemical segment in gene gene provides for high chemical potency over chemical and chemical and is involved in gene dimerization .	T22	T59	16926278
CPR:9	CHEMICAL	GENE-Y	14	0	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T25	16926278
CPR:9	CHEMICAL	GENE-Y	14	2	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T40	16926278
NA	CHEMICAL	GENE-N	14	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T32	16926278
NA	CHEMICAL	GENE-Y	14	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T38	16926278
NA	CHEMICAL	GENE-Y	14	30	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T39	16926278
NA	CHEMICAL	GENE-N	14	3	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T41	16926278
NA	CHEMICAL	GENE-N	14	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T42	16926278
NA	CHEMICAL	GENE-N	14	41	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T19	T43	16926278
NA	CHEMICAL	GENE-Y	5	0	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T25	16926278
NA	CHEMICAL	GENE-Y	5	2	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T40	16926278
NA	CHEMICAL	GENE-N	5	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T32	16926278
NA	CHEMICAL	GENE-Y	5	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T38	16926278
NA	CHEMICAL	GENE-Y	5	30	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T39	16926278
NA	CHEMICAL	GENE-N	5	3	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T41	16926278
NA	CHEMICAL	GENE-N	5	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T42	16926278
NA	CHEMICAL	GENE-N	5	41	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T13	T43	16926278
NA	CHEMICAL	GENE-Y	37	0	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T25	16926278
NA	CHEMICAL	GENE-Y	37	2	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T40	16926278
NA	CHEMICAL	GENE-N	37	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T32	16926278
NA	CHEMICAL	GENE-Y	37	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T38	16926278
NA	CHEMICAL	GENE-Y	37	30	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T39	16926278
NA	CHEMICAL	GENE-N	37	3	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T41	16926278
NA	CHEMICAL	GENE-N	37	5	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T42	16926278
NA	CHEMICAL	GENE-N	37	41	gene ( gene ) contains a catalytic domain ( C domain ) that hydrolyzes chemical and a regulatory domain ( R domain ) that contains two gene , gene , gene gene and a phosphorylation site for chemical-dependent protein kinases ( gene ) .	T14	T43	16926278
NA	CHEMICAL	GENE-N	2	4	Binding of chemical to gene increases gene phosphorylation of gene and improves catalytic site affinity for chemical or inhibitors .	T15	T44	16926278
CPR:3	CHEMICAL	GENE-N	2	6	Binding of chemical to gene increases gene phosphorylation of gene and improves catalytic site affinity for chemical or inhibitors .	T15	T45	16926278
CPR:3	CHEMICAL	GENE-Y	2	9	Binding of chemical to gene increases gene phosphorylation of gene and improves catalytic site affinity for chemical or inhibitors .	T15	T46	16926278
NA	CHEMICAL	GENE-N	16	4	Binding of chemical to gene increases gene phosphorylation of gene and improves catalytic site affinity for chemical or inhibitors .	T16	T44	16926278
NA	CHEMICAL	GENE-N	16	6	Binding of chemical to gene increases gene phosphorylation of gene and improves catalytic site affinity for chemical or inhibitors .	T16	T45	16926278
NA	CHEMICAL	GENE-Y	16	9	Binding of chemical to gene increases gene phosphorylation of gene and improves catalytic site affinity for chemical or inhibitors .	T16	T46	16926278
NA	CHEMICAL	GENE-N	9	0	gene contributes to dimerization of gene , inhibition of chemical binding to gene , and sequestration of the phosphorylation site .	T17	T47	16926278
NA	CHEMICAL	GENE-Y	9	5	gene contributes to dimerization of gene , inhibition of chemical binding to gene , and sequestration of the phosphorylation site .	T17	T48	16926278
NA	CHEMICAL	GENE-N	9	12	gene contributes to dimerization of gene , inhibition of chemical binding to gene , and sequestration of the phosphorylation site .	T17	T49	16926278
NA	CHEMICAL	GENE-N	3	25	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T50	16926278
NA	CHEMICAL	GENE-Y	3	20	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T51	16926278
NA	CHEMICAL	GENE-N	3	22	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T52	16926278
NA	CHEMICAL	GENE-N	3	31	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T53	16926278
NA	CHEMICAL	GENE-Y	3	33	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T54	16926278
NA	CHEMICAL	GENE-N	3	25	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T55	16926278
NA	CHEMICAL	GENE-Y	3	37	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T56	16926278
NA	CHEMICAL	GENE-N	3	47	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T57	16926278
NA	CHEMICAL	GENE-Y	3	50	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T18	T58	16926278
NA	CHEMICAL	GENE-N	24	25	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T50	16926278
NA	CHEMICAL	GENE-Y	24	20	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T51	16926278
NA	CHEMICAL	GENE-N	24	22	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T52	16926278
NA	CHEMICAL	GENE-N	24	31	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T53	16926278
NA	CHEMICAL	GENE-Y	24	33	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T54	16926278
NA	CHEMICAL	GENE-N	24	25	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T55	16926278
NA	CHEMICAL	GENE-Y	24	37	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T56	16926278
NA	CHEMICAL	GENE-N	24	47	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T57	16926278
NA	CHEMICAL	GENE-Y	24	50	To probe potential gene effects on catalytic site affinity for certain inhibitors , four chemical-terminal truncation mutants were generated : gene contained gene , chemical domain , and the sequence between gene ; gene contained gene ; gene contained the C domain and the C-terminal portion of gene ; and gene contained only C domain .	T20	T58	16926278
NA	CHEMICAL	GENE-N	5	17	Truncated proteins with a complete gene were dimers , but those lacking the chemical-terminal 46 chemical of gene were monomers , indicating that these residues are vital for gene-mediated gene dimerization .	T1	T27	16926278
NA	CHEMICAL	GENE-N	5	28	Truncated proteins with a complete gene were dimers , but those lacking the chemical-terminal 46 chemical of gene were monomers , indicating that these residues are vital for gene-mediated gene dimerization .	T1	T28	16926278
NA	CHEMICAL	GENE-Y	5	29	Truncated proteins with a complete gene were dimers , but those lacking the chemical-terminal 46 chemical of gene were monomers , indicating that these residues are vital for gene-mediated gene dimerization .	T1	T29	16926278
NA	CHEMICAL	GENE-N	3	17	Truncated proteins with a complete gene were dimers , but those lacking the chemical-terminal 46 chemical of gene were monomers , indicating that these residues are vital for gene-mediated gene dimerization .	T2	T27	16926278
NA	CHEMICAL	GENE-N	3	28	Truncated proteins with a complete gene were dimers , but those lacking the chemical-terminal 46 chemical of gene were monomers , indicating that these residues are vital for gene-mediated gene dimerization .	T2	T28	16926278
NA	CHEMICAL	GENE-Y	3	29	Truncated proteins with a complete gene were dimers , but those lacking the chemical-terminal 46 chemical of gene were monomers , indicating that these residues are vital for gene-mediated gene dimerization .	T2	T29	16926278
CPR:9	CHEMICAL	GENE-Y	9	16	K ( m ) values of the mutants for chemical were similar to that of full-length gene .	T3	T30	16926278
NA	CHEMICAL	GENE-Y	7	1	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T4	T31	16926278
NA	CHEMICAL	GENE-N	7	21	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T4	T33	16926278
NA	CHEMICAL	GENE-N	7	37	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T4	T34	16926278
NA	CHEMICAL	GENE-Y	9	1	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T5	T31	16926278
NA	CHEMICAL	GENE-N	9	21	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T5	T33	16926278
NA	CHEMICAL	GENE-N	9	37	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T5	T34	16926278
NA	CHEMICAL	GENE-Y	11	1	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T6	T31	16926278
NA	CHEMICAL	GENE-N	11	21	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T6	T33	16926278
NA	CHEMICAL	GENE-N	11	37	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T6	T34	16926278
NA	CHEMICAL	GENE-Y	14	1	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T7	T31	16926278
NA	CHEMICAL	GENE-N	14	21	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T7	T33	16926278
NA	CHEMICAL	GENE-N	14	37	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T7	T34	16926278
NA	CHEMICAL	GENE-Y	19	1	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T8	T31	16926278
NA	CHEMICAL	GENE-N	19	21	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T8	T33	16926278
NA	CHEMICAL	GENE-N	19	37	All gene constructs had similar affinities for chemical , chemical , chemical , and chemical , but mutants containing a complete gene had 7- to 18-fold higher affinity for chemical-based compounds compared with those lacking a complete gene .	T8	T34	16926278
NA	CHEMICAL	GENE-N	4	8	This indicated that the chemical-terminal 46 chemical in gene are required for high chemical potency .	T10	T35	16926278
NA	CHEMICAL	GENE-N	6	8	This indicated that the chemical-terminal 46 chemical in gene are required for high chemical potency .	T11	T35	16926278
NA	CHEMICAL	GENE-N	13	8	This indicated that the chemical-terminal 46 chemical in gene are required for high chemical potency .	T12	T35	16926278
NA	CHEMICAL	GENE-Y	21	21	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T11	23510370
NA	CHEMICAL	GENE-Y	21	23	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T12	23510370
NA	CHEMICAL	GENE-Y	21	25	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T13	23510370
NA	CHEMICAL	GENE-Y	21	27	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T14	23510370
NA	CHEMICAL	GENE-Y	21	27	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T15	23510370
NA	CHEMICAL	GENE-Y	21	27	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T16	23510370
NA	CHEMICAL	GENE-N	21	30	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T17	23510370
NA	CHEMICAL	GENE-N	21	32	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T18	23510370
NA	CHEMICAL	GENE-Y	21	36	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T19	23510370
NA	CHEMICAL	GENE-Y	21	38	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T20	23510370
NA	CHEMICAL	GENE-Y	21	40	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T21	23510370
NA	CHEMICAL	GENE-Y	21	42	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T22	23510370
NA	CHEMICAL	GENE-Y	21	45	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T23	23510370
NA	CHEMICAL	GENE-Y	21	47	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T24	23510370
NA	CHEMICAL	GENE-Y	21	50	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T25	23510370
NA	CHEMICAL	GENE-Y	21	52	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T26	23510370
NA	CHEMICAL	GENE-Y	21	38	The ETTAG was histologically indistinguishable from normal orthotopic thyroid tissue , and its follicular nature was confirmed by immunohistochemical positivity for gene , gene , gene ( gene/gene/gene ) , gene ( gene ) AE1/AE3 , gene , gene , gene ( gene ) , gene ( gene ) and gene ( gene ) , as well as positivity for the messenger RNA of the gene gene by in situ hybridization analysis .	T1	T2	23510370
NA	CHEMICAL	GENE-N	15	2	Systemic injection to mice of siRNA lipoplexes , rather than of cationic liposome , triggered a production of several gene in mice and replacement of plasmid by chemical reduced the elevation of all assayed gene .	T1	T5	23123257
CPR:4	CHEMICAL	GENE-N	15	2	Systemic injection to mice of siRNA lipoplexes , rather than of cationic liposome , triggered a production of several gene in mice and replacement of plasmid by chemical reduced the elevation of all assayed gene .	T1	T6	23123257
NA	CHEMICAL	GENE-Y	3	16	The impact of chemical administration and maternal love withdrawal on event-related potential ( ERP ) responses to emotional faces with performance feedback .	T6	T12	23159479
NA	CHEMICAL	GENE-Y	20	17	Using a double-blind , placebo-controlled within-subjects design , we studied the effects of 16 IU of intranasal gene on ERPs to pictures combining performance feedback with emotional facial expressions in 48 female undergraduate students .	T1	T7	23159479
NA	CHEMICAL	GENE-Y	20	18	Vertex positive potential ( VPP ) and late positive potential ( LPP ) amplitudes were more positive after gene compared to placebo administration .	T3	T9	23159479
NA	CHEMICAL	GENE-Y	3	6	This suggests that chemical increased attention to the feedback stimuli ( LPP ) and enhanced the processing of emotional faces ( VPP ) .	T4	T10	23159479
CPR:4	CHEMICAL	GENE-N	0	1	chemical-Containing gene Inhibitors : Apoptosis Induction , Cytodifferentiation , and Antiproliferative Activities in Cancer Cells .	T9	T15	23526814
CPR:4	CHEMICAL	GENE-N	4	28	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T2	T10	23526814
CPR:4	CHEMICAL	GENE-N	4	31	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T2	T11	23526814
CPR:4	CHEMICAL	GENE-N	6	28	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T4	T10	23526814
CPR:4	CHEMICAL	GENE-N	6	31	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T4	T11	23526814
CPR:4	CHEMICAL	GENE-N	7	28	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T6	T10	23526814
CPR:4	CHEMICAL	GENE-N	7	31	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T6	T11	23526814
CPR:4	CHEMICAL	GENE-N	14	28	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T8	T10	23526814
CPR:4	CHEMICAL	GENE-N	14	31	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T8	T11	23526814
CPR:4	CHEMICAL	GENE-N	22	28	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T1	T10	23526814
CPR:4	CHEMICAL	GENE-N	22	31	Herein we report novel chemical- and chemical-based chemical ( 8 , 10 ) and chemical ( 9 , 11 ) bearing the chemical group at the CAP moiety as gene ( gene ) inhibitors .	T1	T11	23526814
NA	CHEMICAL	GENE-Y	9	8	Compounds 8 b and 10 c selectively inhibited gene at the nanomolar level , whereas the other chemical effected an increase in gene levels in human acute myeloid leukemia U937 cells .	T3	T12	23526814
CPR:3	CHEMICAL	GENE-N	9	2	Compounds 8 b and 10 c selectively inhibited gene at the nanomolar level , whereas the other chemical effected an increase in gene levels in human acute myeloid leukemia U937 cells .	T3	T13	23526814
NA	CHEMICAL	GENE-Y	14	15	Studies mainly in osteoporosis rodent models and limited data in postmenopausal women suggest that chemical-terminal gene peptides might be considered a promising bone anabolic therapy .	T3	T16	23500550
NA	CHEMICAL	GENE-Y	7	21	In addition , putative osteogenic actions of gene might be ascribed not only to its chemical-terminal domain but also to its gene-unrelated chemical-terminal region .	T1	T4	23500550
NA	CHEMICAL	GENE-Y	22	21	In addition , putative osteogenic actions of gene might be ascribed not only to its chemical-terminal domain but also to its gene-unrelated chemical-terminal region .	T2	T4	23500550
CPR:4	CHEMICAL	GENE-Y	0	10	chemical ( chemical ) has been shown to inhibit both gene and chemical decarboxylase and is active against several cancer cell lines and at least one mouse tumor model .	T1	T9	11318430
CPR:4	CHEMICAL	GENE-Y	0	13	chemical ( chemical ) has been shown to inhibit both gene and chemical decarboxylase and is active against several cancer cell lines and at least one mouse tumor model .	T1	T10	11318430
CPR:4	CHEMICAL	GENE-Y	2	10	chemical ( chemical ) has been shown to inhibit both gene and chemical decarboxylase and is active against several cancer cell lines and at least one mouse tumor model .	T3	T9	11318430
CPR:4	CHEMICAL	GENE-Y	2	13	chemical ( chemical ) has been shown to inhibit both gene and chemical decarboxylase and is active against several cancer cell lines and at least one mouse tumor model .	T3	T10	11318430
NA	CHEMICAL	GENE-Y	12	10	chemical ( chemical ) has been shown to inhibit both gene and chemical decarboxylase and is active against several cancer cell lines and at least one mouse tumor model .	T7	T9	11318430
NA	CHEMICAL	GENE-Y	12	13	chemical ( chemical ) has been shown to inhibit both gene and chemical decarboxylase and is active against several cancer cell lines and at least one mouse tumor model .	T7	T10	11318430
NA	CHEMICAL	GENE-N	0	2	chemical attenuates gene in chemical-induced right ventricular hypertrophy in rats .	T14	T29	19057128
NA	CHEMICAL	GENE-N	3	2	chemical attenuates gene in chemical-induced right ventricular hypertrophy in rats .	T15	T29	19057128
NA	CHEMICAL	GENE-Y	7	9	Little is known about the influence of chemical converting enzyme ( gene ) inhibitors on gene ( gene ) in right ventricular remodeling .	T10	T24	19057128
NA	CHEMICAL	GENE-Y	7	11	Little is known about the influence of chemical converting enzyme ( gene ) inhibitors on gene ( gene ) in right ventricular remodeling .	T10	T27	19057128
NA	CHEMICAL	GENE-N	7	15	Little is known about the influence of chemical converting enzyme ( gene ) inhibitors on gene ( gene ) in right ventricular remodeling .	T10	T28	19057128
NA	CHEMICAL	GENE-N	7	17	Little is known about the influence of chemical converting enzyme ( gene ) inhibitors on gene ( gene ) in right ventricular remodeling .	T10	T16	19057128
CPR:4	CHEMICAL	GENE-Y	5	8	We investigated the effect of chemical , an gene inhibitor , on gene and gene in chemical-induced right ventricular hypertrophy .	T7	T21	19057128
NA	CHEMICAL	GENE-Y	5	12	We investigated the effect of chemical , an gene inhibitor , on gene and gene in chemical-induced right ventricular hypertrophy .	T7	T22	19057128
NA	CHEMICAL	GENE-Y	5	14	We investigated the effect of chemical , an gene inhibitor , on gene and gene in chemical-induced right ventricular hypertrophy .	T7	T23	19057128
NA	CHEMICAL	GENE-Y	11	8	We investigated the effect of chemical , an gene inhibitor , on gene and gene in chemical-induced right ventricular hypertrophy .	T8	T21	19057128
NA	CHEMICAL	GENE-Y	11	12	We investigated the effect of chemical , an gene inhibitor , on gene and gene in chemical-induced right ventricular hypertrophy .	T8	T22	19057128
NA	CHEMICAL	GENE-Y	11	14	We investigated the effect of chemical , an gene inhibitor , on gene and gene in chemical-induced right ventricular hypertrophy .	T8	T23	19057128
CPR:3	CHEMICAL	GENE-Y	6	0	gene and gene expressions and activities in right ventricles increased significantly in chemical-injected rats and chemical inhibited them .	T3	T17	19057128
CPR:3	CHEMICAL	GENE-Y	6	2	gene and gene expressions and activities in right ventricles increased significantly in chemical-injected rats and chemical inhibited them .	T3	T18	19057128
CPR:4	CHEMICAL	GENE-Y	15	0	gene and gene expressions and activities in right ventricles increased significantly in chemical-injected rats and chemical inhibited them .	T4	T17	19057128
CPR:4	CHEMICAL	GENE-Y	15	2	gene and gene expressions and activities in right ventricles increased significantly in chemical-injected rats and chemical inhibited them .	T4	T18	19057128
NA	CHEMICAL	GENE-Y	0	1	chemical H1-receptor antagonists , chemical and chemical , increase the steady-state plasma concentrations of chemical and reduced chemical .	T23	T31	12657913
CPR:6	CHEMICAL	GENE-Y	4	1	chemical H1-receptor antagonists , chemical and chemical , increase the steady-state plasma concentrations of chemical and reduced chemical .	T26	T31	12657913
CPR:6	CHEMICAL	GENE-Y	6	1	chemical H1-receptor antagonists , chemical and chemical , increase the steady-state plasma concentrations of chemical and reduced chemical .	T27	T31	12657913
NA	CHEMICAL	GENE-Y	14	1	chemical H1-receptor antagonists , chemical and chemical , increase the steady-state plasma concentrations of chemical and reduced chemical .	T24	T31	12657913
NA	CHEMICAL	GENE-Y	17	1	chemical H1-receptor antagonists , chemical and chemical , increase the steady-state plasma concentrations of chemical and reduced chemical .	T25	T31	12657913
NA	CHEMICAL	GENE-Y	3	4	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T4	T29	12657913
NA	CHEMICAL	GENE-Y	3	17	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T4	T28	12657913
CPR:6	CHEMICAL	GENE-Y	7	4	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T16	T29	12657913
CPR:4	CHEMICAL	GENE-Y	7	17	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T16	T28	12657913
CPR:6	CHEMICAL	GENE-Y	9	4	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T19	T29	12657913
CPR:4	CHEMICAL	GENE-Y	9	17	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T19	T28	12657913
NA	CHEMICAL	GENE-Y	28	4	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T11	T29	12657913
NA	CHEMICAL	GENE-Y	28	17	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T11	T28	12657913
NA	CHEMICAL	GENE-Y	31	4	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T12	T29	12657913
NA	CHEMICAL	GENE-Y	31	17	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T12	T28	12657913
NA	CHEMICAL	GENE-Y	39	4	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T13	T29	12657913
NA	CHEMICAL	GENE-Y	39	17	The effects of chemical H1-receptor antagonists , chemical and chemical , both of which are inhibitors of gene , on the steady-state plasma concentrations ( Css ) of chemical and reduced chemical were studied in 23 schizophrenic inpatients receiving chemical , 12 to 36 mg/d , for 2 to 29 weeks .	T13	T28	12657913
NA	CHEMICAL	GENE-N	0	1	chemical reductase ( gene ) is responsible for the de novo conversion of the chemical to chemical , which are essential for DNA synthesis and repair .	T1	T7	14583450
NA	CHEMICAL	GENE-N	0	3	chemical reductase ( gene ) is responsible for the de novo conversion of the chemical to chemical , which are essential for DNA synthesis and repair .	T1	T40	14583450
CPR:9	CHEMICAL	GENE-N	14	1	chemical reductase ( gene ) is responsible for the de novo conversion of the chemical to chemical , which are essential for DNA synthesis and repair .	T5	T7	14583450
CPR:9	CHEMICAL	GENE-N	14	3	chemical reductase ( gene ) is responsible for the de novo conversion of the chemical to chemical , which are essential for DNA synthesis and repair .	T5	T40	14583450
CPR:9	CHEMICAL	GENE-N	16	1	chemical reductase ( gene ) is responsible for the de novo conversion of the chemical to chemical , which are essential for DNA synthesis and repair .	T2	T7	14583450
CPR:9	CHEMICAL	GENE-N	16	3	chemical reductase ( gene ) is responsible for the de novo conversion of the chemical to chemical , which are essential for DNA synthesis and repair .	T2	T40	14583450
NA	CHEMICAL	GENE-Y	11	11	In this study , we investigated the expression and function of gene and gene after UV treatment in human prostate cancer PC3 cells , which possess mutant gene with a truncated chemical-terminal , and in human oropharyngeal cancer KB cells , which possess wild-type gene .	T4	T44	14583450
NA	CHEMICAL	GENE-Y	11	13	In this study , we investigated the expression and function of gene and gene after UV treatment in human prostate cancer PC3 cells , which possess mutant gene with a truncated chemical-terminal , and in human oropharyngeal cancer KB cells , which possess wild-type gene .	T4	T45	14583450
NA	CHEMICAL	GENE-Y	11	27	In this study , we investigated the expression and function of gene and gene after UV treatment in human prostate cancer PC3 cells , which possess mutant gene with a truncated chemical-terminal , and in human oropharyngeal cancer KB cells , which possess wild-type gene .	T4	T46	14583450
NA	CHEMICAL	GENE-Y	11	44	In this study , we investigated the expression and function of gene and gene after UV treatment in human prostate cancer PC3 cells , which possess mutant gene with a truncated chemical-terminal , and in human oropharyngeal cancer KB cells , which possess wild-type gene .	T4	T47	14583450
CPR:4	CHEMICAL	GENE-Y	4	6	In PC3 cells , chemical inhibited gene and resulted in increased sensitivity to UV irradiation .	T3	T26	14583450
NA	CHEMICAL	GENE-Y	0	1	chemical decarboxylase ( gene ) catalyses the formation of chemical , a bioactive chemical .	T1	T12	23411280
NA	CHEMICAL	GENE-Y	0	3	chemical decarboxylase ( gene ) catalyses the formation of chemical , a bioactive chemical .	T1	T15	23411280
CPR:9	CHEMICAL	GENE-Y	9	1	chemical decarboxylase ( gene ) catalyses the formation of chemical , a bioactive chemical .	T8	T12	23411280
CPR:9	CHEMICAL	GENE-Y	9	3	chemical decarboxylase ( gene ) catalyses the formation of chemical , a bioactive chemical .	T8	T15	23411280
CPR:9	CHEMICAL	GENE-Y	11	1	chemical decarboxylase ( gene ) catalyses the formation of chemical , a bioactive chemical .	T10	T12	23411280
CPR:9	CHEMICAL	GENE-Y	11	3	chemical decarboxylase ( gene ) catalyses the formation of chemical , a bioactive chemical .	T10	T15	23411280
NA	CHEMICAL	GENE-Y	9	3	Agents that control gene activity are beneficial for treating chemical-mediated symptoms , such as allergies and stomach ulceration .	T2	T13	23411280
CPR:4	CHEMICAL	GENE-Y	8	5	We searched for inhibitors of gene from the chemical extract of the petal of Filipendula ulmaria , also called meadowsweet .	T3	T14	23411280
NA	CHEMICAL	GENE-Y	11	0	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T8	T24	23434829
NA	CHEMICAL	GENE-Y	11	2	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T8	T25	23434829
NA	CHEMICAL	GENE-N	11	11	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T8	T26	23434829
NA	CHEMICAL	GENE-N	11	21	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T8	T27	23434829
NA	CHEMICAL	GENE-Y	13	0	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T9	T24	23434829
NA	CHEMICAL	GENE-Y	13	2	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T9	T25	23434829
NA	CHEMICAL	GENE-N	13	11	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T9	T26	23434829
NA	CHEMICAL	GENE-N	13	21	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T9	T27	23434829
NA	CHEMICAL	GENE-Y	11	0	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T10	T24	23434829
NA	CHEMICAL	GENE-Y	11	2	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T10	T25	23434829
NA	CHEMICAL	GENE-N	11	11	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T10	T26	23434829
NA	CHEMICAL	GENE-N	11	21	gene ( gene ) , an extracellular matrix protein , has a functional chemical-chemical-chemical ( RGD ) domain for binding to gene .	T10	T27	23434829
NA	CHEMICAL	GENE-Y	16	0	gene increased the mRNA and protein expression of gene ( gene ) , a subfamily of chemical-binding cassette transporter in a concentration- and time-dependent manner .	T11	T29	23434829
NA	CHEMICAL	GENE-N	16	5	gene increased the mRNA and protein expression of gene ( gene ) , a subfamily of chemical-binding cassette transporter in a concentration- and time-dependent manner .	T11	T30	23434829
NA	CHEMICAL	GENE-N	16	10	gene increased the mRNA and protein expression of gene ( gene ) , a subfamily of chemical-binding cassette transporter in a concentration- and time-dependent manner .	T11	T31	23434829
NA	CHEMICAL	GENE-N	16	13	gene increased the mRNA and protein expression of gene ( gene ) , a subfamily of chemical-binding cassette transporter in a concentration- and time-dependent manner .	T11	T32	23434829
NA	CHEMICAL	GENE-Y	0	20	chemical ( chemical ) , a chemotherapeutic agent with autofluorescence , was used to evaluate the pump activity , and gene increased the drug pumping-out activity .	T12	T36	23434829
NA	CHEMICAL	GENE-Y	2	20	chemical ( chemical ) , a chemotherapeutic agent with autofluorescence , was used to evaluate the pump activity , and gene increased the drug pumping-out activity .	T13	T36	23434829
NA	CHEMICAL	GENE-Y	2	0	gene inhibited chemical-induced cell death , which was antagonized by gene monoclonal antibody .	T14	T37	23434829
NA	CHEMICAL	GENE-N	2	10	gene inhibited chemical-induced cell death , which was antagonized by gene monoclonal antibody .	T14	T38	23434829
NA	CHEMICAL	GENE-Y	3	9	Long-term treatment with chemical further enhanced the expression of gene .	T1	T15	23434829
NA	CHEMICAL	GENE-Y	6	3	Knockdown of endogenous gene potentiated the chemical-induced apoptosis of PC-3 cells .	T2	T16	23434829
NA	CHEMICAL	GENE-Y	14	4	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T3	T17	23434829
CPR:9	CHEMICAL	GENE-N	14	26	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T3	T18	23434829
NA	CHEMICAL	GENE-Y	16	4	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T4	T17	23434829
CPR:9	CHEMICAL	GENE-N	16	26	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T4	T18	23434829
NA	CHEMICAL	GENE-Y	18	4	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T5	T17	23434829
CPR:9	CHEMICAL	GENE-N	18	26	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T5	T18	23434829
NA	CHEMICAL	GENE-Y	21	4	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T6	T17	23434829
CPR:9	CHEMICAL	GENE-N	21	26	Furthermore , knockdown of gene enhanced cell death caused by other drugs , including chemical , chemical , chemical , and chemical , which are also gene substrates .	T6	T18	23434829
NA	CHEMICAL	GENE-Y	13	6	The animal studies also showed that gene knockdown enhanced the cytotoxic action of chemical .	T7	T19	23434829
CPR:4	CHEMICAL	GENE-N	5	13	In the present study , chemical ( 1 and 2μM ) inhibited the gene-induced aggregation of human platelets , but did not inhibit the activation of platelets by other agonists , including gene , chemical , and chemical .	T12	T26	23473801
NA	CHEMICAL	GENE-Y	5	32	In the present study , chemical ( 1 and 2μM ) inhibited the gene-induced aggregation of human platelets , but did not inhibit the activation of platelets by other agonists , including gene , chemical , and chemical .	T12	T27	23473801
NA	CHEMICAL	GENE-N	34	13	In the present study , chemical ( 1 and 2μM ) inhibited the gene-induced aggregation of human platelets , but did not inhibit the activation of platelets by other agonists , including gene , chemical , and chemical .	T13	T26	23473801
NA	CHEMICAL	GENE-Y	34	32	In the present study , chemical ( 1 and 2μM ) inhibited the gene-induced aggregation of human platelets , but did not inhibit the activation of platelets by other agonists , including gene , chemical , and chemical .	T13	T27	23473801
NA	CHEMICAL	GENE-N	37	13	In the present study , chemical ( 1 and 2μM ) inhibited the gene-induced aggregation of human platelets , but did not inhibit the activation of platelets by other agonists , including gene , chemical , and chemical .	T14	T26	23473801
NA	CHEMICAL	GENE-Y	37	32	In the present study , chemical ( 1 and 2μM ) inhibited the gene-induced aggregation of human platelets , but did not inhibit the activation of platelets by other agonists , including gene , chemical , and chemical .	T14	T27	23473801
CPR:4	CHEMICAL	GENE-Y	0	5	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T28	23473801
CPR:4	CHEMICAL	GENE-N	0	7	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T29	23473801
CPR:4	CHEMICAL	GENE-N	0	9	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T30	23473801
CPR:4	CHEMICAL	GENE-N	0	12	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T31	23473801
CPR:4	CHEMICAL	GENE-N	0	14	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T32	23473801
CPR:4	CHEMICAL	GENE-N	0	18	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T33	23473801
CPR:4	CHEMICAL	GENE-N	0	20	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T15	T34	23473801
NA	CHEMICAL	GENE-Y	28	5	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T28	23473801
NA	CHEMICAL	GENE-N	28	7	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T29	23473801
NA	CHEMICAL	GENE-N	28	9	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T30	23473801
NA	CHEMICAL	GENE-N	28	12	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T31	23473801
NA	CHEMICAL	GENE-N	28	14	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T32	23473801
NA	CHEMICAL	GENE-N	28	18	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T33	23473801
NA	CHEMICAL	GENE-N	28	20	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T16	T34	23473801
NA	CHEMICAL	GENE-Y	31	5	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T28	23473801
NA	CHEMICAL	GENE-N	31	7	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T29	23473801
NA	CHEMICAL	GENE-N	31	9	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T30	23473801
NA	CHEMICAL	GENE-N	31	12	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T31	23473801
NA	CHEMICAL	GENE-N	31	14	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T32	23473801
NA	CHEMICAL	GENE-N	31	18	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T33	23473801
NA	CHEMICAL	GENE-N	31	20	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T17	T34	23473801
NA	CHEMICAL	GENE-Y	34	5	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T28	23473801
NA	CHEMICAL	GENE-N	34	7	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T29	23473801
NA	CHEMICAL	GENE-N	34	9	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T30	23473801
NA	CHEMICAL	GENE-N	34	12	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T31	23473801
NA	CHEMICAL	GENE-N	34	14	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T32	23473801
NA	CHEMICAL	GENE-N	34	18	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T33	23473801
NA	CHEMICAL	GENE-N	34	20	chemical inhibited the phosphorylation of gene , gene ( gene ) , gene ( gene ) , and gene in gene-activated human platelets , and significantly reduced intracellular chemical mobilization and chemical radical ( chemical ) formation .	T18	T34	23473801
CPR:4	CHEMICAL	GENE-N	0	4	chemical also reduced the gene activation and platelet aggregation stimulated by PDBu .	T19	T35	23473801
NA	CHEMICAL	GENE-Y	0	13	chemical did not influence the binding of a fluorescent triflavin probe to the gene on platelet membrane , and neither chemical nor chemical significantly reversed the chemical-mediated inhibition of platelet aggregation .	T3	T21	23473801
NA	CHEMICAL	GENE-Y	20	13	chemical did not influence the binding of a fluorescent triflavin probe to the gene on platelet membrane , and neither chemical nor chemical significantly reversed the chemical-mediated inhibition of platelet aggregation .	T4	T21	23473801
NA	CHEMICAL	GENE-Y	22	13	chemical did not influence the binding of a fluorescent triflavin probe to the gene on platelet membrane , and neither chemical nor chemical significantly reversed the chemical-mediated inhibition of platelet aggregation .	T5	T21	23473801
NA	CHEMICAL	GENE-Y	26	13	chemical did not influence the binding of a fluorescent triflavin probe to the gene on platelet membrane , and neither chemical nor chemical significantly reversed the chemical-mediated inhibition of platelet aggregation .	T6	T21	23473801
CPR:4	CHEMICAL	GENE-Y	3	11	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T7	T22	23473801
CPR:4	CHEMICAL	GENE-N	3	11	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T7	T23	23473801
CPR:4	CHEMICAL	GENE-N	3	24	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T7	T24	23473801
CPR:4	CHEMICAL	GENE-N	3	26	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T7	T25	23473801
NA	CHEMICAL	GENE-Y	14	11	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T8	T22	23473801
NA	CHEMICAL	GENE-N	14	11	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T8	T23	23473801
NA	CHEMICAL	GENE-N	14	24	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T8	T24	23473801
NA	CHEMICAL	GENE-N	14	26	In conclusion , chemical may inhibit platelet activation by inhibiting the gene-gene cascade and chemical radical formation , followed by suppressing the activation of gene and gene .	T8	T25	23473801
CPR:4	CHEMICAL	GENE-Y	6	4	Discovery of a synthetic gene inhibitor chemical as a potential anticancer agent .	T6	T10	23528299
CPR:4	CHEMICAL	GENE-Y	0	5	chemical is the first synthetic gene inhibitor to be evaluated for both of its anti-invasion and anti-angiogenesis effects .	T5	T8	23528299
CPR:4	CHEMICAL	GENE-Y	1	4	As a potent synthetic gene inhibitor ( IC50=850nM , versus chemical of 8.1μM ) , chemical was determined to have more significant block effects to cancer cell invasion and angiogenesis than chemical .	T1	T9	23528299
CPR:4	CHEMICAL	GENE-Y	15	4	As a potent synthetic gene inhibitor ( IC50=850nM , versus chemical of 8.1μM ) , chemical was determined to have more significant block effects to cancer cell invasion and angiogenesis than chemical .	T2	T9	23528299
CPR:4	CHEMICAL	GENE-Y	1	4	As a potent synthetic gene inhibitor ( IC50=850nM , versus chemical of 8.1μM ) , chemical was determined to have more significant block effects to cancer cell invasion and angiogenesis than chemical .	T3	T9	23528299
NA	CHEMICAL	GENE-Y	1	2	Hydrophobic chemical in the hinge region of the gene mimetic peptide are essential for promoting chemical efflux by the gene transporter .	T10	T16	23042953
NA	CHEMICAL	GENE-Y	1	19	Hydrophobic chemical in the hinge region of the gene mimetic peptide are essential for promoting chemical efflux by the gene transporter .	T10	T15	23042953
NA	CHEMICAL	GENE-Y	15	2	Hydrophobic chemical in the hinge region of the gene mimetic peptide are essential for promoting chemical efflux by the gene transporter .	T9	T16	23042953
CPR:9	CHEMICAL	GENE-Y	15	19	Hydrophobic chemical in the hinge region of the gene mimetic peptide are essential for promoting chemical efflux by the gene transporter .	T9	T15	23042953
CPR:9	CHEMICAL	GENE-Y	4	2	The bihelical gene effluxes chemical from cells and reduces inflammation and atherosclerosis in animal models .	T5	T12	23042953
CPR:9	CHEMICAL	GENE-Y	26	29	Compared with active peptides containing F or W , peptides containing E in either of these two positions were more than 10-fold less effective in effluxing chemical by the gene transporter .	T7	T14	23042953
CPR:3	CHEMICAL	GENE-Y	0	13	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T8	T40	23042952
CPR:3	CHEMICAL	GENE-Y	0	8	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T8	T41	23042952
CPR:3	CHEMICAL	GENE-Y	0	21	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T8	T42	23042952
CPR:3	CHEMICAL	GENE-Y	0	23	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T8	T43	23042952
NA	CHEMICAL	GENE-Y	5	13	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T16	T40	23042952
NA	CHEMICAL	GENE-Y	5	8	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T16	T41	23042952
NA	CHEMICAL	GENE-Y	5	21	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T16	T42	23042952
NA	CHEMICAL	GENE-Y	5	23	chemical targets and activates the chemical-dependent protein deacetylase gene ; in turn , SIRT1 induces an intracellular antioxidative mechanism by inducing gene ( gene ) .	T16	T43	23042952
CPR:3	CHEMICAL	GENE-Y	2	9	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T35	T45	23042952
NA	CHEMICAL	GENE-N	2	10	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T35	T46	23042952
CPR:3	CHEMICAL	GENE-Y	2	13	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T35	T47	23042952
NA	CHEMICAL	GENE-Y	2	25	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T35	T39	23042952
NA	CHEMICAL	GENE-Y	6	9	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T36	T45	23042952
NA	CHEMICAL	GENE-N	6	10	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T36	T46	23042952
NA	CHEMICAL	GENE-Y	6	13	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T36	T47	23042952
NA	CHEMICAL	GENE-Y	6	25	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T36	T39	23042952
NA	CHEMICAL	GENE-Y	23	9	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T2	T45	23042952
NA	CHEMICAL	GENE-N	23	10	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T2	T46	23042952
NA	CHEMICAL	GENE-Y	23	13	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T2	T47	23042952
NA	CHEMICAL	GENE-Y	23	25	However , chemical , but not chemical , induced gene-dependent gene deacetylation and gene expression in mouse C2C12 skeletal myoblasts ; as with chemical , gene knockdown blunted these effects .	T2	T39	23042952
CPR:3	CHEMICAL	GENE-N	6	11	BACKGROUND : The novel antiepileptic drug chemical is the first selective gene opener for gene and gene channels .	T8	T17	12545144
CPR:3	CHEMICAL	GENE-N	6	14	BACKGROUND : The novel antiepileptic drug chemical is the first selective gene opener for gene and gene channels .	T8	T15	12545144
CPR:3	CHEMICAL	GENE-N	6	16	BACKGROUND : The novel antiepileptic drug chemical is the first selective gene opener for gene and gene channels .	T8	T16	12545144
NA	CHEMICAL	GENE-Y	3	3	Efficacy of the gene/chemical receptor antagonist chemical against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration .	T12	T17	23042954
NA	CHEMICAL	GENE-N	3	4	Efficacy of the gene/chemical receptor antagonist chemical against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration .	T12	T18	23042954
CPR:6	CHEMICAL	GENE-Y	6	3	Efficacy of the gene/chemical receptor antagonist chemical against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration .	T13	T17	23042954
CPR:6	CHEMICAL	GENE-N	6	4	Efficacy of the gene/chemical receptor antagonist chemical against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration .	T13	T18	23042954
NA	CHEMICAL	GENE-Y	29	25	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T8	T14	23042954
NA	CHEMICAL	GENE-Y	29	27	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T8	T15	23042954
NA	CHEMICAL	GENE-N	29	13	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T8	T16	23042954
NA	CHEMICAL	GENE-Y	31	25	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T9	T14	23042954
NA	CHEMICAL	GENE-Y	31	27	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T9	T15	23042954
NA	CHEMICAL	GENE-N	31	13	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T9	T16	23042954
CPR:6	CHEMICAL	GENE-Y	35	25	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T10	T14	23042954
CPR:6	CHEMICAL	GENE-Y	35	27	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T10	T15	23042954
CPR:6	CHEMICAL	GENE-N	35	13	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T10	T16	23042954
CPR:6	CHEMICAL	GENE-Y	37	25	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T11	T14	23042954
CPR:6	CHEMICAL	GENE-Y	37	27	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T11	T15	23042954
CPR:6	CHEMICAL	GENE-N	37	13	To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention , we studied the anticonvulsant efficacy of the gene ( gene ) /chemical ( chemical ) receptor antagonist chemical ( chemical ) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman .	T11	T16	23042954
NA	CHEMICAL	GENE-Y	5	2	PURPOSE : gene inhibitors and chemical are the mainstay of pharmacological intervention for the cognitive symptoms of Alzheimer 's disease ( AD ) .	T9	T14	23443628
NA	CHEMICAL	GENE-Y	4	7	Plasma S/R ratio of chemical co-varies with gene haplotype .	T10	T30	17413769
NA	CHEMICAL	GENE-Y	14	6	We recently reported that the low-dose gene*2 haplotype is an important genetic determinant for chemical dose requirement and is associated with difficulties to attain stable therapeutic gene time -- International Normalized Ratio in patients undergoing anticoagulation therapy .	T9	T19	17413769
NA	CHEMICAL	GENE-Y	14	26	We recently reported that the low-dose gene*2 haplotype is an important genetic determinant for chemical dose requirement and is associated with difficulties to attain stable therapeutic gene time -- International Normalized Ratio in patients undergoing anticoagulation therapy .	T9	T17	17413769
NA	CHEMICAL	GENE-Y	23	11	The aim of this study was to investigate whether patients with gene*2 compared with patients carrying high-dose haplotypes gene*3 or gene*4 had different chemical ratios in their plasma , and whether that was related to gene variants gene*2 and gene*3 or other factors .	T5	T18	17413769
NA	CHEMICAL	GENE-Y	23	18	The aim of this study was to investigate whether patients with gene*2 compared with patients carrying high-dose haplotypes gene*3 or gene*4 had different chemical ratios in their plasma , and whether that was related to gene variants gene*2 and gene*3 or other factors .	T5	T20	17413769
NA	CHEMICAL	GENE-Y	23	20	The aim of this study was to investigate whether patients with gene*2 compared with patients carrying high-dose haplotypes gene*3 or gene*4 had different chemical ratios in their plasma , and whether that was related to gene variants gene*2 and gene*3 or other factors .	T5	T21	17413769
NA	CHEMICAL	GENE-Y	23	35	The aim of this study was to investigate whether patients with gene*2 compared with patients carrying high-dose haplotypes gene*3 or gene*4 had different chemical ratios in their plasma , and whether that was related to gene variants gene*2 and gene*3 or other factors .	T5	T22	17413769
NA	CHEMICAL	GENE-Y	23	37	The aim of this study was to investigate whether patients with gene*2 compared with patients carrying high-dose haplotypes gene*3 or gene*4 had different chemical ratios in their plasma , and whether that was related to gene variants gene*2 and gene*3 or other factors .	T5	T23	17413769
NA	CHEMICAL	GENE-Y	23	39	The aim of this study was to investigate whether patients with gene*2 compared with patients carrying high-dose haplotypes gene*3 or gene*4 had different chemical ratios in their plasma , and whether that was related to gene variants gene*2 and gene*3 or other factors .	T5	T24	17413769
NA	CHEMICAL	GENE-Y	11	6	Samples from patients previously haplotyped for gene and measured for plasma chemical concentration were genotyped for the gene variants gene*2 and gene*3 .	T6	T25	17413769
NA	CHEMICAL	GENE-Y	11	17	Samples from patients previously haplotyped for gene and measured for plasma chemical concentration were genotyped for the gene variants gene*2 and gene*3 .	T6	T26	17413769
NA	CHEMICAL	GENE-Y	11	19	Samples from patients previously haplotyped for gene and measured for plasma chemical concentration were genotyped for the gene variants gene*2 and gene*3 .	T6	T27	17413769
NA	CHEMICAL	GENE-Y	11	21	Samples from patients previously haplotyped for gene and measured for plasma chemical concentration were genotyped for the gene variants gene*2 and gene*3 .	T6	T28	17413769
NA	CHEMICAL	GENE-Y	15	18	Our result shows that there is a significant difference ( P < 0.01 ) in chemical ratios between gene*2 and gene*3 or gene*4 patients .	T8	T29	17413769
NA	CHEMICAL	GENE-Y	15	20	Our result shows that there is a significant difference ( P < 0.01 ) in chemical ratios between gene*2 and gene*3 or gene*4 patients .	T8	T11	17413769
NA	CHEMICAL	GENE-Y	15	22	Our result shows that there is a significant difference ( P < 0.01 ) in chemical ratios between gene*2 and gene*3 or gene*4 patients .	T8	T12	17413769
NA	CHEMICAL	GENE-Y	3	3	We speculate that gene haplotypes possibly are linked to some unidentified factors involved in the metabolic clearance of chemical enantiomers .	T1	T16	17413769
NA	CHEMICAL	GENE-N	12	3	Rats treated with gene plus gene displayed abnormal estrous cycles with increasing chemical biosynthesis .	T1	T4	22798247
NA	CHEMICAL	GENE-N	12	5	Rats treated with gene plus gene displayed abnormal estrous cycles with increasing chemical biosynthesis .	T1	T5	22798247
NA	CHEMICAL	GENE-Y	0	1	chemical receptor gene length modifies the effect of chemical on receptor activity in human prostate cells .	T13	T32	23117151
NA	CHEMICAL	GENE-N	0	2	chemical receptor gene length modifies the effect of chemical on receptor activity in human prostate cells .	T13	T33	23117151
NA	CHEMICAL	GENE-Y	8	1	chemical receptor gene length modifies the effect of chemical on receptor activity in human prostate cells .	T14	T32	23117151
NA	CHEMICAL	GENE-N	8	2	chemical receptor gene length modifies the effect of chemical on receptor activity in human prostate cells .	T14	T33	23117151
NA	CHEMICAL	GENE-Y	0	5	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T2	T15	23117151
NA	CHEMICAL	GENE-Y	0	7	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T2	T16	23117151
NA	CHEMICAL	GENE-Y	0	5	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T2	T17	23117151
NA	CHEMICAL	GENE-Y	0	17	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T2	T18	23117151
NA	CHEMICAL	GENE-Y	4	5	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T3	T15	23117151
NA	CHEMICAL	GENE-Y	4	7	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T3	T16	23117151
NA	CHEMICAL	GENE-Y	4	5	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T3	T17	23117151
NA	CHEMICAL	GENE-Y	4	17	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T3	T18	23117151
NA	CHEMICAL	GENE-Y	14	5	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T4	T15	23117151
NA	CHEMICAL	GENE-Y	14	7	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T4	T16	23117151
NA	CHEMICAL	GENE-Y	14	5	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T4	T17	23117151
NA	CHEMICAL	GENE-Y	14	17	chemical acts through the chemical receptor ( gene ) , which interacts with the chemical receptor ( gene ) .	T4	T18	23117151
NA	CHEMICAL	GENE-Y	5	22	We investigated the influence of chemical on prostate cancer cells ( PC-3 ) and non-tumor prostate cells ( PNT1A ) on chemical-activated gene containing gene within normal length range ( 16 , 22 , and 28 ) .	T5	T21	23117151
NA	CHEMICAL	GENE-N	5	24	We investigated the influence of chemical on prostate cancer cells ( PC-3 ) and non-tumor prostate cells ( PNT1A ) on chemical-activated gene containing gene within normal length range ( 16 , 22 , and 28 ) .	T5	T22	23117151
NA	CHEMICAL	GENE-Y	6	22	We investigated the influence of chemical on prostate cancer cells ( PC-3 ) and non-tumor prostate cells ( PNT1A ) on chemical-activated gene containing gene within normal length range ( 16 , 22 , and 28 ) .	T6	T21	23117151
NA	CHEMICAL	GENE-N	6	24	We investigated the influence of chemical on prostate cancer cells ( PC-3 ) and non-tumor prostate cells ( PNT1A ) on chemical-activated gene containing gene within normal length range ( 16 , 22 , and 28 ) .	T6	T22	23117151
NA	CHEMICAL	GENE-Y	10	1	The gene target gene gene mRNA expression was induced by chemical , but was not affected by the gene gene length .	T7	T23	23117151
CPR:3	CHEMICAL	GENE-Y	10	4	The gene target gene gene mRNA expression was induced by chemical , but was not affected by the gene gene length .	T7	T24	23117151
NA	CHEMICAL	GENE-Y	10	18	The gene target gene gene mRNA expression was induced by chemical , but was not affected by the gene gene length .	T7	T25	23117151
NA	CHEMICAL	GENE-N	10	19	The gene target gene gene mRNA expression was induced by chemical , but was not affected by the gene gene length .	T7	T26	23117151
NA	CHEMICAL	GENE-Y	0	5	chemical had no effect on gene activity in PC-3 cells , whereas the shortest gene variant was induced by chemical in PNT1A cells .	T8	T27	23117151
NA	CHEMICAL	GENE-Y	0	14	chemical had no effect on gene activity in PC-3 cells , whereas the shortest gene variant was induced by chemical in PNT1A cells .	T8	T28	23117151
NA	CHEMICAL	GENE-Y	19	5	chemical had no effect on gene activity in PC-3 cells , whereas the shortest gene variant was induced by chemical in PNT1A cells .	T9	T27	23117151
CPR:3	CHEMICAL	GENE-Y	19	14	chemical had no effect on gene activity in PC-3 cells , whereas the shortest gene variant was induced by chemical in PNT1A cells .	T9	T28	23117151
NA	CHEMICAL	GENE-Y	10	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T27	23454148
NA	CHEMICAL	GENE-Y	10	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T28	23454148
NA	CHEMICAL	GENE-Y	10	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T29	23454148
NA	CHEMICAL	GENE-Y	10	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T30	23454148
NA	CHEMICAL	GENE-Y	10	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T31	23454148
NA	CHEMICAL	GENE-N	10	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T32	23454148
NA	CHEMICAL	GENE-N	10	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T33	23454148
NA	CHEMICAL	GENE-Y	10	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T13	T34	23454148
NA	CHEMICAL	GENE-Y	9	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T27	23454148
NA	CHEMICAL	GENE-Y	9	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T28	23454148
NA	CHEMICAL	GENE-Y	9	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T29	23454148
NA	CHEMICAL	GENE-Y	9	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T30	23454148
NA	CHEMICAL	GENE-Y	9	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T31	23454148
NA	CHEMICAL	GENE-N	9	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T32	23454148
NA	CHEMICAL	GENE-N	9	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T33	23454148
NA	CHEMICAL	GENE-Y	9	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T14	T34	23454148
NA	CHEMICAL	GENE-Y	14	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T27	23454148
NA	CHEMICAL	GENE-Y	14	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T28	23454148
NA	CHEMICAL	GENE-Y	14	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T29	23454148
NA	CHEMICAL	GENE-Y	14	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T30	23454148
NA	CHEMICAL	GENE-Y	14	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T31	23454148
NA	CHEMICAL	GENE-N	14	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T32	23454148
NA	CHEMICAL	GENE-N	14	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T33	23454148
NA	CHEMICAL	GENE-Y	14	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T15	T34	23454148
NA	CHEMICAL	GENE-Y	15	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T27	23454148
NA	CHEMICAL	GENE-Y	15	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T28	23454148
NA	CHEMICAL	GENE-Y	15	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T29	23454148
NA	CHEMICAL	GENE-Y	15	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T30	23454148
NA	CHEMICAL	GENE-Y	15	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T31	23454148
NA	CHEMICAL	GENE-N	15	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T32	23454148
NA	CHEMICAL	GENE-N	15	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T33	23454148
NA	CHEMICAL	GENE-Y	15	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T16	T34	23454148
NA	CHEMICAL	GENE-Y	29	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T27	23454148
NA	CHEMICAL	GENE-Y	29	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T28	23454148
NA	CHEMICAL	GENE-Y	29	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T29	23454148
NA	CHEMICAL	GENE-Y	29	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T30	23454148
NA	CHEMICAL	GENE-Y	29	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T31	23454148
NA	CHEMICAL	GENE-N	29	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T32	23454148
NA	CHEMICAL	GENE-N	29	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T33	23454148
NA	CHEMICAL	GENE-Y	29	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T17	T34	23454148
NA	CHEMICAL	GENE-Y	35	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T27	23454148
NA	CHEMICAL	GENE-Y	35	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T28	23454148
NA	CHEMICAL	GENE-Y	35	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T29	23454148
NA	CHEMICAL	GENE-Y	35	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T30	23454148
NA	CHEMICAL	GENE-Y	35	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T31	23454148
NA	CHEMICAL	GENE-N	35	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T32	23454148
CPR:3	CHEMICAL	GENE-N	35	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T33	23454148
CPR:4	CHEMICAL	GENE-Y	35	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T19	T34	23454148
NA	CHEMICAL	GENE-Y	39	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T27	23454148
NA	CHEMICAL	GENE-Y	39	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T28	23454148
NA	CHEMICAL	GENE-Y	39	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T29	23454148
NA	CHEMICAL	GENE-Y	39	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T30	23454148
NA	CHEMICAL	GENE-Y	39	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T31	23454148
NA	CHEMICAL	GENE-N	39	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T32	23454148
NA	CHEMICAL	GENE-N	39	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T33	23454148
NA	CHEMICAL	GENE-Y	39	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T20	T34	23454148
NA	CHEMICAL	GENE-Y	43	12	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T27	23454148
NA	CHEMICAL	GENE-Y	43	16	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T28	23454148
NA	CHEMICAL	GENE-Y	43	18	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T29	23454148
NA	CHEMICAL	GENE-Y	43	22	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T30	23454148
NA	CHEMICAL	GENE-Y	43	30	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T31	23454148
NA	CHEMICAL	GENE-N	43	32	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T32	23454148
NA	CHEMICAL	GENE-N	43	40	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T33	23454148
NA	CHEMICAL	GENE-Y	43	44	Compared with normally-fed counterparts , PM-CP rats exhibited higher chemical chemical-transferase , gene and chemical chemical-conjugate beta-lyase ( gene ) and lower gene activities , PM-FU rats exhibited decreased chemical dehydrogenase and gene activities and PM-chemical rats showed higher chemical reductase and depleted chemical oxidase activities .	T21	T34	23454148
NA	CHEMICAL	GENE-Y	5	5	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T1	T12	23164615
NA	CHEMICAL	GENE-Y	5	25	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T1	T10	23164615
NA	CHEMICAL	GENE-Y	5	33	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T1	T11	23164615
NA	CHEMICAL	GENE-Y	6	5	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T2	T12	23164615
NA	CHEMICAL	GENE-Y	6	25	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T2	T10	23164615
CPR:5	CHEMICAL	GENE-Y	6	33	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T2	T11	23164615
NA	CHEMICAL	GENE-Y	38	5	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T3	T12	23164615
NA	CHEMICAL	GENE-Y	38	25	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T3	T10	23164615
CPR:5	CHEMICAL	GENE-Y	38	33	To investigate the role of gene in modulating the synaptic responses of retinal ganglion cells , we used a recently identified positive allosteric modulator of gene , chemical ( AZ ) and the gene-specific orthosteric agonist chemical ( chemical ) .	T3	T11	23164615
NA	CHEMICAL	GENE-Y	22	31	The effects of the allosteric modulator were stronger for bright stimuli than for dim stimuli , consistent with receptor stimulation by endogenous chemical being stronger during bright light stimulation and with gene receptors mainly being localized away from chemical release sites , immuno-labeled with gene .	T5	T13	23164615
NA	CHEMICAL	GENE-Y	22	44	The effects of the allosteric modulator were stronger for bright stimuli than for dim stimuli , consistent with receptor stimulation by endogenous chemical being stronger during bright light stimulation and with gene receptors mainly being localized away from chemical release sites , immuno-labeled with gene .	T5	T14	23164615
NA	CHEMICAL	GENE-Y	38	31	The effects of the allosteric modulator were stronger for bright stimuli than for dim stimuli , consistent with receptor stimulation by endogenous chemical being stronger during bright light stimulation and with gene receptors mainly being localized away from chemical release sites , immuno-labeled with gene .	T6	T13	23164615
NA	CHEMICAL	GENE-Y	38	44	The effects of the allosteric modulator were stronger for bright stimuli than for dim stimuli , consistent with receptor stimulation by endogenous chemical being stronger during bright light stimulation and with gene receptors mainly being localized away from chemical release sites , immuno-labeled with gene .	T6	T14	23164615
NA	CHEMICAL	GENE-Y	3	10	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T5	T17	1868500
CPR:4	CHEMICAL	GENE-N	3	14	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T5	T18	1868500
CPR:4	CHEMICAL	GENE-N	3	16	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T5	T19	1868500
CPR:4	CHEMICAL	GENE-N	3	19	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T5	T20	1868500
CPR:4	CHEMICAL	GENE-N	3	21	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T5	T21	1868500
NA	CHEMICAL	GENE-Y	5	10	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T6	T17	1868500
CPR:4	CHEMICAL	GENE-N	5	14	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T6	T18	1868500
CPR:4	CHEMICAL	GENE-N	5	16	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T6	T19	1868500
CPR:4	CHEMICAL	GENE-N	5	19	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T6	T20	1868500
CPR:4	CHEMICAL	GENE-N	5	21	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T6	T21	1868500
NA	CHEMICAL	GENE-Y	7	10	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T7	T17	1868500
CPR:4	CHEMICAL	GENE-N	7	14	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T7	T18	1868500
CPR:4	CHEMICAL	GENE-N	7	16	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T7	T19	1868500
CPR:4	CHEMICAL	GENE-N	7	19	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T7	T20	1868500
CPR:4	CHEMICAL	GENE-N	7	21	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T7	T21	1868500
NA	CHEMICAL	GENE-Y	9	10	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T8	T17	1868500
NA	CHEMICAL	GENE-N	9	14	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T8	T18	1868500
NA	CHEMICAL	GENE-N	9	16	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T8	T19	1868500
NA	CHEMICAL	GENE-N	9	19	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T8	T20	1868500
NA	CHEMICAL	GENE-N	9	21	Absorbable drugs ( chemical , chemical , chemical , chemical reductase inhibitors ) reduce gene ( gene ) and/or gene ( gene ) by a variety of mechanisms .	T8	T21	1868500
CPR:4	CHEMICAL	GENE-N	0	11	chemical , in particular , act by stimulating the catabolism of gene and also , as a consequence , improving gene delipidation , thus favoring receptor uptake .	T9	T22	1868500
NA	CHEMICAL	GENE-N	0	20	chemical , in particular , act by stimulating the catabolism of gene and also , as a consequence , improving gene delipidation , thus favoring receptor uptake .	T9	T23	1868500
NA	CHEMICAL	GENE-N	0	8	chemical and acipimox interfere with the biosynthesis of gene and can also improve the clearance of gene/gene .	T10	T24	1868500
NA	CHEMICAL	GENE-N	0	16	chemical and acipimox interfere with the biosynthesis of gene and can also improve the clearance of gene/gene .	T10	T25	1868500
NA	CHEMICAL	GENE-N	0	16	chemical and acipimox interfere with the biosynthesis of gene and can also improve the clearance of gene/gene .	T10	T26	1868500
CPR:9	CHEMICAL	GENE-N	4	6	accelerating reverse transport of chemical from gene to gene .	T12	T27	1868500
CPR:9	CHEMICAL	GENE-N	4	8	accelerating reverse transport of chemical from gene to gene .	T12	T28	1868500
NA	CHEMICAL	GENE-Y	2	3	Finally , chemical reductase inhibitors , interfering with the biosynthesis of chemical , can induce an increased expression of liver high-affinity gene .	T13	T29	1868500
NA	CHEMICAL	GENE-N	2	21	Finally , chemical reductase inhibitors , interfering with the biosynthesis of chemical , can induce an increased expression of liver high-affinity gene .	T13	T15	1868500
NA	CHEMICAL	GENE-Y	11	3	Finally , chemical reductase inhibitors , interfering with the biosynthesis of chemical , can induce an increased expression of liver high-affinity gene .	T14	T29	1868500
NA	CHEMICAL	GENE-N	11	21	Finally , chemical reductase inhibitors , interfering with the biosynthesis of chemical , can induce an increased expression of liver high-affinity gene .	T14	T15	1868500
CPR:3	CHEMICAL	GENE-Y	5	9	Diet , physical exercise and chemical administration increase serum gene ( gene ) levels in women with polycystic ovary syndrome ( PCOS ) .	T8	T24	23194076
CPR:3	CHEMICAL	GENE-Y	5	11	Diet , physical exercise and chemical administration increase serum gene ( gene ) levels in women with polycystic ovary syndrome ( PCOS ) .	T8	T25	23194076
NA	CHEMICAL	GENE-Y	13	18	The present study investigates the combined effect of diet , physical exercise and chemical for 24 weeks , on serum genee ( gene ) levels in overweight and obese women with polycystic ovary syndrome ( PCOS ) and in overweight and obese controls .	T6	T9	23194076
NA	CHEMICAL	GENE-Y	13	22	The present study investigates the combined effect of diet , physical exercise and chemical for 24 weeks , on serum genee ( gene ) levels in overweight and obese women with polycystic ovary syndrome ( PCOS ) and in overweight and obese controls .	T6	T12	23194076
NA	CHEMICAL	GENE-Y	5	12	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T13	23194076
NA	CHEMICAL	GENE-N	5	14	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T14	23194076
NA	CHEMICAL	GENE-N	5	16	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T15	23194076
NA	CHEMICAL	GENE-Y	5	18	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T16	23194076
NA	CHEMICAL	GENE-Y	5	22	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T17	23194076
NA	CHEMICAL	GENE-Y	5	24	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T18	23194076
NA	CHEMICAL	GENE-Y	5	30	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T19	23194076
NA	CHEMICAL	GENE-Y	5	41	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T2	T20	23194076
NA	CHEMICAL	GENE-Y	27	12	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T13	23194076
NA	CHEMICAL	GENE-N	27	14	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T14	23194076
NA	CHEMICAL	GENE-N	27	16	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T15	23194076
NA	CHEMICAL	GENE-Y	27	18	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T16	23194076
NA	CHEMICAL	GENE-Y	27	22	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T17	23194076
NA	CHEMICAL	GENE-Y	27	24	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T18	23194076
NA	CHEMICAL	GENE-Y	27	30	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T19	23194076
NA	CHEMICAL	GENE-Y	27	41	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T3	T20	23194076
NA	CHEMICAL	GENE-Y	35	12	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T13	23194076
NA	CHEMICAL	GENE-N	35	14	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T14	23194076
NA	CHEMICAL	GENE-N	35	16	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T15	23194076
NA	CHEMICAL	GENE-Y	35	18	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T16	23194076
NA	CHEMICAL	GENE-Y	35	22	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T17	23194076
NA	CHEMICAL	GENE-Y	35	24	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T18	23194076
NA	CHEMICAL	GENE-Y	35	30	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T19	23194076
NA	CHEMICAL	GENE-Y	35	41	At baseline , week 12 and week 24 , serum levels of gene , gene , gene , gene , chemical , gene ( gene ) , chemical , and gene were measured and Free chemical Index ( FAI ) and gene Resistance ( IR ) indices were calculated .	T4	T20	23194076
NA	CHEMICAL	GENE-N	10	3	After 12 weeks gene and gene were increased , while chemical decreased .	T5	T22	23194076
NA	CHEMICAL	GENE-Y	10	5	After 12 weeks gene and gene were increased , while chemical decreased .	T5	T23	23194076
CPR:9	CHEMICAL	GENE-N	13	24	In this work , the metabolism of four frequently prescribed inhaled GCs , chemical , chemical , chemical , and chemical , by the gene family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites .	T14	T24	23143891
CPR:9	CHEMICAL	GENE-N	15	24	In this work , the metabolism of four frequently prescribed inhaled GCs , chemical , chemical , chemical , and chemical , by the gene family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites .	T15	T24	23143891
CPR:9	CHEMICAL	GENE-N	17	24	In this work , the metabolism of four frequently prescribed inhaled GCs , chemical , chemical , chemical , and chemical , by the gene family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites .	T16	T24	23143891
CPR:9	CHEMICAL	GENE-N	20	24	In this work , the metabolism of four frequently prescribed inhaled GCs , chemical , chemical , chemical , and chemical , by the gene family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites .	T17	T24	23143891
CPR:9	CHEMICAL	GENE-Y	0	0	gene , which is particularly relevant to GC metabolism in the lungs , was also shown to efficiently metabolize chemical , chemical , and chemical .	T1	T19	23143891
CPR:9	CHEMICAL	GENE-Y	21	0	gene , which is particularly relevant to GC metabolism in the lungs , was also shown to efficiently metabolize chemical , chemical , and chemical .	T2	T19	23143891
CPR:9	CHEMICAL	GENE-Y	24	0	gene , which is particularly relevant to GC metabolism in the lungs , was also shown to efficiently metabolize chemical , chemical , and chemical .	T3	T19	23143891
CPR:9	CHEMICAL	GENE-Y	3	8	In contrast , chemical was only metabolized via gene , with no significant turnover by gene or gene .	T4	T20	23143891
NA	CHEMICAL	GENE-Y	3	15	In contrast , chemical was only metabolized via gene , with no significant turnover by gene or gene .	T4	T21	23143891
NA	CHEMICAL	GENE-Y	3	17	In contrast , chemical was only metabolized via gene , with no significant turnover by gene or gene .	T4	T22	23143891
CPR:3	CHEMICAL	GENE-Y	0	8	chemical increases the expression of the pro-apoptotic gene gene by epigenetic mechanisms in tumor cells .	T11	T25	23103563
NA	CHEMICAL	GENE-Y	7	5	Further we found stimulation of gene-expression as a result of epigenetic DNA demethylation that was due to down-regulation of gene , which was rescued by re-isoprenylation by both chemical and chemical .	T8	T23	23103563
CPR:3	CHEMICAL	GENE-Y	7	19	Further we found stimulation of gene-expression as a result of epigenetic DNA demethylation that was due to down-regulation of gene , which was rescued by re-isoprenylation by both chemical and chemical .	T8	T24	23103563
NA	CHEMICAL	GENE-Y	7	5	Further we found stimulation of gene-expression as a result of epigenetic DNA demethylation that was due to down-regulation of gene , which was rescued by re-isoprenylation by both chemical and chemical .	T9	T23	23103563
CPR:3	CHEMICAL	GENE-Y	7	19	Further we found stimulation of gene-expression as a result of epigenetic DNA demethylation that was due to down-regulation of gene , which was rescued by re-isoprenylation by both chemical and chemical .	T9	T24	23103563
NA	CHEMICAL	GENE-Y	3	7	In contrast , chemical did not affect gene and gene expression in MC3T3-E1 non-neoplastic cells .	T10	T12	23103563
NA	CHEMICAL	GENE-Y	3	9	In contrast , chemical did not affect gene and gene expression in MC3T3-E1 non-neoplastic cells .	T10	T13	23103563
NA	CHEMICAL	GENE-N	3	10	Data suggest that chemical via modulation of the activity of small-gene induce apoptosis in neoplastic cells by DNA-gene-demethylation and stimulation of gene-expression .	T1	T14	23103563
NA	CHEMICAL	GENE-N	3	17	Data suggest that chemical via modulation of the activity of small-gene induce apoptosis in neoplastic cells by DNA-gene-demethylation and stimulation of gene-expression .	T1	T15	23103563
CPR:3	CHEMICAL	GENE-Y	3	21	Data suggest that chemical via modulation of the activity of small-gene induce apoptosis in neoplastic cells by DNA-gene-demethylation and stimulation of gene-expression .	T1	T16	23103563
CPR:4	CHEMICAL	GENE-N	5	7	Design and synthesis of novel chemical derivatives as gene inhibitors .	T2	T9	23265905
NA	CHEMICAL	GENE-Y	6	11	A multicenter , randomized study of chemical versus heparin as adjunct to gene ( gene ) in acute myocardial infarction : myocardial infarction with chemical and gene ( MINT ) study .	T14	T25	10362188
NA	CHEMICAL	GENE-Y	6	0	A multicenter , randomized study of chemical versus heparin as adjunct to gene ( gene ) in acute myocardial infarction : myocardial infarction with chemical and gene ( MINT ) study .	T14	T23	10362188
NA	CHEMICAL	GENE-Y	6	0	A multicenter , randomized study of chemical versus heparin as adjunct to gene ( gene ) in acute myocardial infarction : myocardial infarction with chemical and gene ( MINT ) study .	T14	T24	10362188
NA	CHEMICAL	GENE-Y	9	11	A multicenter , randomized study of chemical versus heparin as adjunct to gene ( gene ) in acute myocardial infarction : myocardial infarction with chemical and gene ( MINT ) study .	T13	T25	10362188
NA	CHEMICAL	GENE-Y	9	0	A multicenter , randomized study of chemical versus heparin as adjunct to gene ( gene ) in acute myocardial infarction : myocardial infarction with chemical and gene ( MINT ) study .	T13	T23	10362188
NA	CHEMICAL	GENE-Y	9	0	A multicenter , randomized study of chemical versus heparin as adjunct to gene ( gene ) in acute myocardial infarction : myocardial infarction with chemical and gene ( MINT ) study .	T13	T24	10362188
CPR:4	CHEMICAL	GENE-Y	8	12	OBJECTIVES : This study examined the effect of a small-molecule , direct gene inhibitor , chemical , on reperfusion induced by gene ( gene ) in patients with acute myocardial infarction ( AMI ) .	T12	T22	10362188
NA	CHEMICAL	GENE-Y	8	8	OBJECTIVES : This study examined the effect of a small-molecule , direct gene inhibitor , chemical , on reperfusion induced by gene ( gene ) in patients with acute myocardial infarction ( AMI ) .	T12	T15	10362188
NA	CHEMICAL	GENE-Y	8	23	OBJECTIVES : This study examined the effect of a small-molecule , direct gene inhibitor , chemical , on reperfusion induced by gene ( gene ) in patients with acute myocardial infarction ( AMI ) .	T12	T17	10362188
CPR:4	CHEMICAL	GENE-Y	9	3	In vitro and in vivo studies have shown that chemical has advantages over heparin for the inhibition of clot-bound gene and for the enhancement of thrombolysis with gene .	T7	T19	10362188
NA	CHEMICAL	GENE-Y	9	27	In vitro and in vivo studies have shown that chemical has advantages over heparin for the inhibition of clot-bound gene and for the enhancement of thrombolysis with gene .	T7	T20	10362188
NA	CHEMICAL	GENE-Y	18	25	METHODS : One hundred and twenty-five patients with AMI within 6 h were randomized to heparin , low-dose chemical or high-dose chemical in addition to gene .	T8	T21	10362188
NA	CHEMICAL	GENE-Y	21	25	METHODS : One hundred and twenty-five patients with AMI within 6 h were randomized to heparin , low-dose chemical or high-dose chemical in addition to gene .	T9	T21	10362188
NA	CHEMICAL	GENE-Y	2	14	CONCLUSIONS : chemical , as compared with heparin , appears to enhance reperfusion with gene in patients with AMI , particularly in those patients with delayed presentation .	T5	T16	10362188
NA	CHEMICAL	GENE-Y	3	4	The effects of chemical transporter inactivation on locomotor activity in mice .	T22	T33	16893531
NA	CHEMICAL	GENE-Y	1	3	Because chemical is an important regulator of spontaneous locomotor activity , we speculated that chemical transporter blockade contributes to the effects of some antidepressants on spontaneous locomotor activity .	T13	T30	16893531
NA	CHEMICAL	GENE-Y	14	3	Because chemical is an important regulator of spontaneous locomotor activity , we speculated that chemical transporter blockade contributes to the effects of some antidepressants on spontaneous locomotor activity .	T14	T30	16893531
NA	CHEMICAL	GENE-Y	5	21	METHODS : Antidepressant drugs ( chemical , chemical , chemical , chemical , chemical ) were administered acutely ( intraperitoneal ) or chronically ( via osmotic minipump ) to control and chemical transporter knockout mice , and spontaneous locomotor activity in novel or familiar environments was recorded .	T15	T31	16893531
NA	CHEMICAL	GENE-Y	7	21	METHODS : Antidepressant drugs ( chemical , chemical , chemical , chemical , chemical ) were administered acutely ( intraperitoneal ) or chronically ( via osmotic minipump ) to control and chemical transporter knockout mice , and spontaneous locomotor activity in novel or familiar environments was recorded .	T16	T31	16893531
NA	CHEMICAL	GENE-Y	9	21	METHODS : Antidepressant drugs ( chemical , chemical , chemical , chemical , chemical ) were administered acutely ( intraperitoneal ) or chronically ( via osmotic minipump ) to control and chemical transporter knockout mice , and spontaneous locomotor activity in novel or familiar environments was recorded .	T17	T31	16893531
NA	CHEMICAL	GENE-Y	11	21	METHODS : Antidepressant drugs ( chemical , chemical , chemical , chemical , chemical ) were administered acutely ( intraperitoneal ) or chronically ( via osmotic minipump ) to control and chemical transporter knockout mice , and spontaneous locomotor activity in novel or familiar environments was recorded .	T18	T31	16893531
NA	CHEMICAL	GENE-Y	13	21	METHODS : Antidepressant drugs ( chemical , chemical , chemical , chemical , chemical ) were administered acutely ( intraperitoneal ) or chronically ( via osmotic minipump ) to control and chemical transporter knockout mice , and spontaneous locomotor activity in novel or familiar environments was recorded .	T19	T31	16893531
NA	CHEMICAL	GENE-Y	21	21	METHODS : Antidepressant drugs ( chemical , chemical , chemical , chemical , chemical ) were administered acutely ( intraperitoneal ) or chronically ( via osmotic minipump ) to control and chemical transporter knockout mice , and spontaneous locomotor activity in novel or familiar environments was recorded .	T20	T31	16893531
NA	CHEMICAL	GENE-Y	6	14	RESULTS : Acute treatment with most chemical transporter-blocking antidepressants decreased spontaneous locomotor activity in a novel environment , whereas chronic treatment decreased spontaneous locomotor activity in both novel and familiar environments .	T21	T32	16893531
CPR:4	CHEMICAL	GENE-Y	3	5	The exception was chemical , a dual chemical transporter/chemical transporter blocker , which tended to increase spontaneous locomotor activity .	T1	T23	16893531
CPR:4	CHEMICAL	GENE-Y	3	5	The exception was chemical , a dual chemical transporter/chemical transporter blocker , which tended to increase spontaneous locomotor activity .	T1	T24	16893531
NA	CHEMICAL	GENE-Y	7	5	The exception was chemical , a dual chemical transporter/chemical transporter blocker , which tended to increase spontaneous locomotor activity .	T2	T23	16893531
NA	CHEMICAL	GENE-Y	7	5	The exception was chemical , a dual chemical transporter/chemical transporter blocker , which tended to increase spontaneous locomotor activity .	T2	T24	16893531
NA	CHEMICAL	GENE-Y	5	5	The exception was chemical , a dual chemical transporter/chemical transporter blocker , which tended to increase spontaneous locomotor activity .	T3	T23	16893531
NA	CHEMICAL	GENE-Y	5	5	The exception was chemical , a dual chemical transporter/chemical transporter blocker , which tended to increase spontaneous locomotor activity .	T3	T24	16893531
NA	CHEMICAL	GENE-Y	2	6	Coadministration of chemical and the chemical transporter blocker chemical also increased spontaneous locomotor activity .	T4	T25	16893531
NA	CHEMICAL	GENE-Y	5	6	Coadministration of chemical and the chemical transporter blocker chemical also increased spontaneous locomotor activity .	T5	T25	16893531
CPR:4	CHEMICAL	GENE-Y	8	6	Coadministration of chemical and the chemical transporter blocker chemical also increased spontaneous locomotor activity .	T6	T25	16893531
NA	CHEMICAL	GENE-Y	0	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T7	T26	16893531
NA	CHEMICAL	GENE-Y	0	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T7	T27	16893531
NA	CHEMICAL	GENE-Y	15	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T8	T26	16893531
NA	CHEMICAL	GENE-Y	15	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T8	T27	16893531
NA	CHEMICAL	GENE-Y	18	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T9	T26	16893531
NA	CHEMICAL	GENE-Y	18	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T9	T27	16893531
NA	CHEMICAL	GENE-Y	20	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T10	T26	16893531
NA	CHEMICAL	GENE-Y	20	1	chemical transporter knockout mice had low basal spontaneous locomotor activity , which was increased by chemical , whereas chemical had no effect in chemical transporter knockout mice .	T10	T27	16893531
CPR:4	CHEMICAL	GENE-Y	2	10	However , chemical produces less systemic beta 2- and possibly gene blockade than either chemical or chemical .	T2	T28	2891463
CPR:4	CHEMICAL	GENE-Y	14	10	However , chemical produces less systemic beta 2- and possibly gene blockade than either chemical or chemical .	T3	T28	2891463
CPR:4	CHEMICAL	GENE-Y	16	10	However , chemical produces less systemic beta 2- and possibly gene blockade than either chemical or chemical .	T4	T28	2891463
CPR:3	CHEMICAL	GENE-Y	0	8	chemical-induced intracellular chemical depletion activates transcription elongation in gene gene expression .	T17	T47	23050902
NA	CHEMICAL	GENE-Y	2	8	chemical-induced intracellular chemical depletion activates transcription elongation in gene gene expression .	T18	T47	23050902
NA	CHEMICAL	GENE-Y	6	0	gene ( gene ) is a chemical-dependent glycoprotein synthesized in hepatocytes .	T7	T19	23050902
NA	CHEMICAL	GENE-Y	6	2	gene ( gene ) is a chemical-dependent glycoprotein synthesized in hepatocytes .	T7	T36	23050902
CPR:3	CHEMICAL	GENE-Y	14	5	It was reported previously that gene gene ( gene ) expression was up-regulated by chemical treatment in hepatitis C virus-infected haemophilia patients ; however , its precise mechanism is still unknown .	T6	T28	23050902
CPR:3	CHEMICAL	GENE-Y	14	8	It was reported previously that gene gene ( gene ) expression was up-regulated by chemical treatment in hepatitis C virus-infected haemophilia patients ; however , its precise mechanism is still unknown .	T6	T34	23050902
CPR:3	CHEMICAL	GENE-Y	11	14	In the present study , we investigated the molecular mechanism of chemical-induced up-regulation of gene expression in HepG2 ( human hepatoma cell line ) .	T8	T37	23050902
NA	CHEMICAL	GENE-N	4	12	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T9	T38	23050902
NA	CHEMICAL	GENE-N	4	8	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T9	T39	23050902
NA	CHEMICAL	GENE-Y	4	26	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T9	T40	23050902
NA	CHEMICAL	GENE-N	7	12	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T10	T38	23050902
NA	CHEMICAL	GENE-N	7	8	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T10	T39	23050902
NA	CHEMICAL	GENE-Y	7	26	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T10	T40	23050902
NA	CHEMICAL	GENE-N	14	12	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T11	T38	23050902
NA	CHEMICAL	GENE-N	14	8	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T11	T39	23050902
NA	CHEMICAL	GENE-Y	14	26	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T11	T40	23050902
NA	CHEMICAL	GENE-N	21	12	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T12	T38	23050902
NA	CHEMICAL	GENE-N	21	8	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T12	T39	23050902
CPR:3	CHEMICAL	GENE-Y	21	26	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T12	T40	23050902
NA	CHEMICAL	GENE-N	23	12	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T13	T38	23050902
NA	CHEMICAL	GENE-N	23	8	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T13	T39	23050902
CPR:3	CHEMICAL	GENE-Y	23	26	We found that intracellular chemical depletion by chemical as well as other gene ( chemical dehydrogenase ) inhibitors , such as chemical and chemical , up-regulated gene expression .	T13	T40	23050902
CPR:3	CHEMICAL	GENE-Y	0	2	chemical unregulated gene ( gene mRNA expression before gene up-regulation .	T14	T44	23050902
CPR:3	CHEMICAL	GENE-Y	0	4	chemical unregulated gene ( gene mRNA expression before gene up-regulation .	T14	T45	23050902
CPR:3	CHEMICAL	GENE-Y	0	8	chemical unregulated gene ( gene mRNA expression before gene up-regulation .	T14	T46	23050902
CPR:3	CHEMICAL	GENE-Y	3	5	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T16	T20	23050902
CPR:3	CHEMICAL	GENE-Y	3	8	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T16	T21	23050902
NA	CHEMICAL	GENE-Y	3	13	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T16	T22	23050902
NA	CHEMICAL	GENE-Y	3	16	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T16	T23	23050902
NA	CHEMICAL	GENE-Y	3	5	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T1	T20	23050902
NA	CHEMICAL	GENE-Y	3	8	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T1	T21	23050902
NA	CHEMICAL	GENE-Y	3	13	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T1	T22	23050902
CPR:3	CHEMICAL	GENE-Y	3	16	We observed that chemical enhanced gene recruitment to gene , whereas knockdown of gene diminished chemical-induced gene mRNA up-regulation .	T1	T23	23050902
CPR:3	CHEMICAL	GENE-Y	0	5	chemical also enhanced recruitment of gene ( gene ) and gene to gene .	T2	T24	23050902
CPR:3	CHEMICAL	GENE-Y	0	7	chemical also enhanced recruitment of gene ( gene ) and gene to gene .	T2	T25	23050902
CPR:3	CHEMICAL	GENE-Y	0	10	chemical also enhanced recruitment of gene ( gene ) and gene to gene .	T2	T26	23050902
CPR:3	CHEMICAL	GENE-Y	0	12	chemical also enhanced recruitment of gene ( gene ) and gene to gene .	T2	T27	23050902
CPR:3	CHEMICAL	GENE-N	4	14	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T3	T29	23050902
CPR:3	CHEMICAL	GENE-Y	4	16	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T3	T30	23050902
CPR:3	CHEMICAL	GENE-Y	4	18	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T3	T31	23050902
CPR:3	CHEMICAL	GENE-Y	4	21	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T3	T32	23050902
NA	CHEMICAL	GENE-Y	4	25	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T3	T33	23050902
NA	CHEMICAL	GENE-N	6	14	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T4	T29	23050902
NA	CHEMICAL	GENE-Y	6	16	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T4	T30	23050902
NA	CHEMICAL	GENE-Y	6	18	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T4	T31	23050902
NA	CHEMICAL	GENE-Y	6	21	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T4	T32	23050902
NA	CHEMICAL	GENE-Y	6	25	These data suggest that chemical-induced intracellular chemical depletion recruits a super elongation complex containing gene , gene and gene , to gene , and modulates gene mRNA transcription elongation .	T4	T33	23050902
NA	CHEMICAL	GENE-Y	0	10	chemical induces mitogenic signaling in breast cancer cell by an gene-dependent mechanism .	T13	T43	17125913
NA	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) stimulates BC cells proliferation by binding the gene ( gene ) .	T6	T18	17125913
NA	CHEMICAL	GENE-Y	0	13	chemical ( chemical ) stimulates BC cells proliferation by binding the gene ( gene ) .	T6	T23	17125913
NA	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) stimulates BC cells proliferation by binding the gene ( gene ) .	T8	T18	17125913
NA	CHEMICAL	GENE-Y	2	13	chemical ( chemical ) stimulates BC cells proliferation by binding the gene ( gene ) .	T8	T23	17125913
NA	CHEMICAL	GENE-N	8	15	Purpose of our study was to evaluate whether chemical regulates MCF-7 cell proliferation by activating gene , gene and gene gene .	T4	T24	17125913
NA	CHEMICAL	GENE-N	8	17	Purpose of our study was to evaluate whether chemical regulates MCF-7 cell proliferation by activating gene , gene and gene gene .	T4	T25	17125913
NA	CHEMICAL	GENE-Y	8	19	Purpose of our study was to evaluate whether chemical regulates MCF-7 cell proliferation by activating gene , gene and gene gene .	T4	T26	17125913
NA	CHEMICAL	GENE-N	8	20	Purpose of our study was to evaluate whether chemical regulates MCF-7 cell proliferation by activating gene , gene and gene gene .	T4	T27	17125913
NA	CHEMICAL	GENE-Y	0	6	chemical increased cell proliferation and the gene-antagonist ICI 182,780 blunted it .	T5	T28	17125913
CPR:4	CHEMICAL	GENE-Y	0	2	chemical decreased gene expression , but not gene .	T7	T31	17125913
NA	CHEMICAL	GENE-Y	0	7	chemical decreased gene expression , but not gene .	T7	T32	17125913
NA	CHEMICAL	GENE-N	0	3	chemical also increased gene , gene and gene phosphorylation while ICI blocked it .	T9	T33	17125913
CPR:3	CHEMICAL	GENE-N	0	5	chemical also increased gene , gene and gene phosphorylation while ICI blocked it .	T9	T34	17125913
CPR:3	CHEMICAL	GENE-Y	0	7	chemical also increased gene , gene and gene phosphorylation while ICI blocked it .	T9	T35	17125913
CPR:3	CHEMICAL	GENE-N	0	3	chemical rapidly increased gene , gene and gene expression .	T10	T39	17125913
CPR:3	CHEMICAL	GENE-N	0	5	chemical rapidly increased gene , gene and gene expression .	T10	T40	17125913
CPR:3	CHEMICAL	GENE-Y	0	7	chemical rapidly increased gene , gene and gene expression .	T10	T41	17125913
NA	CHEMICAL	GENE-N	6	9	Cells were also co-incubated with the chemical and specific gene inhibitors , which blocked the chemical-stimulated proliferation .	T11	T42	17125913
NA	CHEMICAL	GENE-N	15	9	Cells were also co-incubated with the chemical and specific gene inhibitors , which blocked the chemical-stimulated proliferation .	T12	T42	17125913
NA	CHEMICAL	GENE-N	4	7	Structural Basis for the chemical-Induced Isomerization of gene .	T12	T24	23500491
NA	CHEMICAL	GENE-N	0	0	gene ( gene ) are gene driven by the energy derived from the hydrolysis of chemical .	T1	T13	23500491
NA	CHEMICAL	GENE-N	0	2	gene ( gene ) are gene driven by the energy derived from the hydrolysis of chemical .	T1	T19	23500491
NA	CHEMICAL	GENE-N	0	5	gene ( gene ) are gene driven by the energy derived from the hydrolysis of chemical .	T1	T22	23500491
NA	CHEMICAL	GENE-N	6	25	Previous studies have revealed that the chemical binding step is crucial both for the power stroke to produce motility and for the inter-domain regulation of gene activity to guarantee the processive movement of dimeric gene .	T2	T18	23500491
NA	CHEMICAL	GENE-N	6	34	Previous studies have revealed that the chemical binding step is crucial both for the power stroke to produce motility and for the inter-domain regulation of gene activity to guarantee the processive movement of dimeric gene .	T2	T20	23500491
NA	CHEMICAL	GENE-Y	14	9	Here , we report the first crystal structure of gene complexed with the non-hydrolyzable chemical analog , chemical ( chemical ) , at 1.7Å resolution .	T3	T21	23500491
NA	CHEMICAL	GENE-Y	17	9	Here , we report the first crystal structure of gene complexed with the non-hydrolyzable chemical analog , chemical ( chemical ) , at 1.7Å resolution .	T4	T21	23500491
NA	CHEMICAL	GENE-Y	19	9	Here , we report the first crystal structure of gene complexed with the non-hydrolyzable chemical analog , chemical ( chemical ) , at 1.7Å resolution .	T5	T21	23500491
NA	CHEMICAL	GENE-Y	12	7	By combining our structure with previously solved gene structures complexed with two chemical analogs , molecular snapshots during chemical binding reveal that the closure of the chemical-binding pocket during chemical binding is achieved by closure of the backdoor .	T6	T23	23500491
NA	CHEMICAL	GENE-Y	18	7	By combining our structure with previously solved gene structures complexed with two chemical analogs , molecular snapshots during chemical binding reveal that the closure of the chemical-binding pocket during chemical binding is achieved by closure of the backdoor .	T7	T23	23500491
NA	CHEMICAL	GENE-Y	26	7	By combining our structure with previously solved gene structures complexed with two chemical analogs , molecular snapshots during chemical binding reveal that the closure of the chemical-binding pocket during chemical binding is achieved by closure of the backdoor .	T8	T23	23500491
NA	CHEMICAL	GENE-Y	29	7	By combining our structure with previously solved gene structures complexed with two chemical analogs , molecular snapshots during chemical binding reveal that the closure of the chemical-binding pocket during chemical binding is achieved by closure of the backdoor .	T9	T23	23500491
NA	CHEMICAL	GENE-Y	7	11	A disorder to order transition accompanies catalysis in chemical dehydrogenase type II .	T6	T12	15299009
NA	CHEMICAL	GENE-Y	0	2	chemical dehydrogenase II ( gene ) converts retinal to the transcriptional regulator retinoic acid in the developing embryo .	T1	T7	15299009
NA	CHEMICAL	GENE-Y	0	4	chemical dehydrogenase II ( gene ) converts retinal to the transcriptional regulator retinoic acid in the developing embryo .	T1	T9	15299009
CPR:4	CHEMICAL	GENE-Y	0	24	chemical -- removed from widespread clinical use by 1962 because of severe teratogenicity -- has anti-angiogenic and immunomodulatory effects , including the inhibition of gene .	T1	T4	12046682
CPR:4	CHEMICAL	GENE-Y	0	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T8	T30	18480678
CPR:4	CHEMICAL	GENE-Y	0	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T8	T31	18480678
NA	CHEMICAL	GENE-Y	3	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T14	T30	18480678
NA	CHEMICAL	GENE-Y	3	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T14	T31	18480678
NA	CHEMICAL	GENE-Y	7	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T16	T30	18480678
NA	CHEMICAL	GENE-Y	7	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T16	T31	18480678
CPR:9	CHEMICAL	GENE-Y	11	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T17	T30	18480678
CPR:9	CHEMICAL	GENE-Y	11	4	chemical inhibits the chemical transporter and the chemical transporter , resulting in elevations of these chemical after impulse release .	T17	T31	18480678
NA	CHEMICAL	GENE-N	12	15	In both rodent and primate animal models , the binding of radiolabeled chemical to chemical transporter was found to be selective , saturable , and reversible , whereas binding of chemical was diffuse and nonspecific .	T24	T32	18480678
NA	CHEMICAL	GENE-N	14	15	In both rodent and primate animal models , the binding of radiolabeled chemical to chemical transporter was found to be selective , saturable , and reversible , whereas binding of chemical was diffuse and nonspecific .	T25	T32	18480678
NA	CHEMICAL	GENE-N	30	15	In both rodent and primate animal models , the binding of radiolabeled chemical to chemical transporter was found to be selective , saturable , and reversible , whereas binding of chemical was diffuse and nonspecific .	T26	T32	18480678
NA	CHEMICAL	GENE-N	3	5	The importance of chemical chirality to central nervous system chemical receptor targeting has culminated in human imaging studies revealing that chemical binds specifically to striatal structures , whereas chemical binding is nonspecific .	T9	T29	18480678
NA	CHEMICAL	GENE-N	9	5	The importance of chemical chirality to central nervous system chemical receptor targeting has culminated in human imaging studies revealing that chemical binds specifically to striatal structures , whereas chemical binding is nonspecific .	T10	T29	18480678
NA	CHEMICAL	GENE-N	20	5	The importance of chemical chirality to central nervous system chemical receptor targeting has culminated in human imaging studies revealing that chemical binds specifically to striatal structures , whereas chemical binding is nonspecific .	T11	T29	18480678
NA	CHEMICAL	GENE-N	28	5	The importance of chemical chirality to central nervous system chemical receptor targeting has culminated in human imaging studies revealing that chemical binds specifically to striatal structures , whereas chemical binding is nonspecific .	T12	T29	18480678
NA	CHEMICAL	GENE-Y	17	4	Almost all patients with gene ( 38/41 ) or gene ( 5/7 ) mutations were resistant to chemical .	T3	T11	11808879
NA	CHEMICAL	GENE-Y	17	9	Almost all patients with gene ( 38/41 ) or gene ( 5/7 ) mutations were resistant to chemical .	T3	T12	11808879
NA	CHEMICAL	GENE-N	6	6	Ten patients with hyperinsulinism-hyperammonaemia syndrome had a mutation in the chemical dehydrogenase gene ( three neonates and seven infants ) after reverse transcriptase-polymerase chain reaction and sequence analysis of cDNA .	T4	T13	11808879
CPR:4	CHEMICAL	GENE-Y	0	4	chemical , a selective gene inhibitor , improves glycemic control in chemical-induced diabetic rats and Zucker fatty rats .	T28	T38	19281809
NA	CHEMICAL	GENE-Y	10	4	chemical , a selective gene inhibitor , improves glycemic control in chemical-induced diabetic rats and Zucker fatty rats .	T29	T38	19281809
NA	CHEMICAL	GENE-N	2	4	The low-affinity chemical chemical cotransporter ( gene ) is responsible for most of the chemical reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes .	T11	T32	19281809
NA	CHEMICAL	GENE-Y	2	6	The low-affinity chemical chemical cotransporter ( gene ) is responsible for most of the chemical reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes .	T11	T35	19281809
NA	CHEMICAL	GENE-N	3	4	The low-affinity chemical chemical cotransporter ( gene ) is responsible for most of the chemical reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes .	T13	T32	19281809
NA	CHEMICAL	GENE-Y	3	6	The low-affinity chemical chemical cotransporter ( gene ) is responsible for most of the chemical reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes .	T13	T35	19281809
CPR:9	CHEMICAL	GENE-N	14	4	The low-affinity chemical chemical cotransporter ( gene ) is responsible for most of the chemical reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes .	T25	T32	19281809
CPR:9	CHEMICAL	GENE-Y	14	6	The low-affinity chemical chemical cotransporter ( gene ) is responsible for most of the chemical reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes .	T25	T35	19281809
CPR:4	CHEMICAL	GENE-Y	2	7	We discovered chemical , a novel selective gene inhibitor , and found that selective inhibition of gene increased urinary chemical excretion and consequently decreased plasma chemical levels .	T12	T33	19281809
CPR:4	CHEMICAL	GENE-Y	2	16	We discovered chemical , a novel selective gene inhibitor , and found that selective inhibition of gene increased urinary chemical excretion and consequently decreased plasma chemical levels .	T12	T34	19281809
NA	CHEMICAL	GENE-Y	19	7	We discovered chemical , a novel selective gene inhibitor , and found that selective inhibition of gene increased urinary chemical excretion and consequently decreased plasma chemical levels .	T14	T33	19281809
NA	CHEMICAL	GENE-Y	19	16	We discovered chemical , a novel selective gene inhibitor , and found that selective inhibition of gene increased urinary chemical excretion and consequently decreased plasma chemical levels .	T14	T34	19281809
NA	CHEMICAL	GENE-Y	25	7	We discovered chemical , a novel selective gene inhibitor , and found that selective inhibition of gene increased urinary chemical excretion and consequently decreased plasma chemical levels .	T15	T33	19281809
NA	CHEMICAL	GENE-Y	25	16	We discovered chemical , a novel selective gene inhibitor , and found that selective inhibition of gene increased urinary chemical excretion and consequently decreased plasma chemical levels .	T15	T34	19281809
NA	CHEMICAL	GENE-Y	10	21	In this report , we examined the antihyperglycemic effects of chemical in normal and diabetic rats in comparison with those of a chemical ( chemical ) and an gene inhibitor ( chemical ) .	T16	T36	19281809
NA	CHEMICAL	GENE-Y	21	21	In this report , we examined the antihyperglycemic effects of chemical in normal and diabetic rats in comparison with those of a chemical ( chemical ) and an gene inhibitor ( chemical ) .	T17	T36	19281809
NA	CHEMICAL	GENE-Y	21	21	In this report , we examined the antihyperglycemic effects of chemical in normal and diabetic rats in comparison with those of a chemical ( chemical ) and an gene inhibitor ( chemical ) .	T18	T36	19281809
CPR:4	CHEMICAL	GENE-Y	31	21	In this report , we examined the antihyperglycemic effects of chemical in normal and diabetic rats in comparison with those of a chemical ( chemical ) and an gene inhibitor ( chemical ) .	T19	T36	19281809
NA	CHEMICAL	GENE-N	0	5	chemical increased urinary chemical excretion in a dose-dependent manner , and inhibited the increase in plasma chemical after chemical loading independently of gene secretion in normal rats .	T20	T37	19281809
NA	CHEMICAL	GENE-N	3	5	chemical increased urinary chemical excretion in a dose-dependent manner , and inhibited the increase in plasma chemical after chemical loading independently of gene secretion in normal rats .	T21	T37	19281809
NA	CHEMICAL	GENE-N	16	5	chemical increased urinary chemical excretion in a dose-dependent manner , and inhibited the increase in plasma chemical after chemical loading independently of gene secretion in normal rats .	T22	T37	19281809
NA	CHEMICAL	GENE-N	18	5	chemical increased urinary chemical excretion in a dose-dependent manner , and inhibited the increase in plasma chemical after chemical loading independently of gene secretion in normal rats .	T23	T37	19281809
CPR:4	CHEMICAL	GENE-N	3	8	Chronic treatment with chemical reduced the levels of gene and fasting plasma chemical , and improved the glycemic response after chemical loading in Zucker fatty rats .	T6	T30	19281809
NA	CHEMICAL	GENE-N	12	8	Chronic treatment with chemical reduced the levels of gene and fasting plasma chemical , and improved the glycemic response after chemical loading in Zucker fatty rats .	T7	T30	19281809
NA	CHEMICAL	GENE-N	20	8	Chronic treatment with chemical reduced the levels of gene and fasting plasma chemical , and improved the glycemic response after chemical loading in Zucker fatty rats .	T8	T30	19281809
NA	CHEMICAL	GENE-Y	5	6	Histochemical staining and quantification of chemical dehydrogenase gene activity using blue native PAGE .	T16	T41	17315258
NA	CHEMICAL	GENE-N	5	7	Histochemical staining and quantification of chemical dehydrogenase gene activity using blue native PAGE .	T16	T42	17315258
NA	CHEMICAL	GENE-Y	10	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T10	T17	17315258
NA	CHEMICAL	GENE-Y	10	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T10	T34	17315258
NA	CHEMICAL	GENE-Y	10	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T10	T35	17315258
NA	CHEMICAL	GENE-N	10	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T10	T26	17315258
NA	CHEMICAL	GENE-Y	1	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T15	T17	17315258
NA	CHEMICAL	GENE-Y	1	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T15	T34	17315258
NA	CHEMICAL	GENE-Y	1	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T15	T35	17315258
NA	CHEMICAL	GENE-N	1	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T15	T26	17315258
NA	CHEMICAL	GENE-Y	18	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T2	T17	17315258
NA	CHEMICAL	GENE-Y	18	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T2	T34	17315258
NA	CHEMICAL	GENE-Y	18	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T2	T35	17315258
NA	CHEMICAL	GENE-N	18	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T2	T26	17315258
NA	CHEMICAL	GENE-Y	5	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T8	T17	17315258
NA	CHEMICAL	GENE-Y	5	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T8	T34	17315258
NA	CHEMICAL	GENE-Y	5	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T8	T35	17315258
NA	CHEMICAL	GENE-N	5	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T8	T26	17315258
NA	CHEMICAL	GENE-Y	25	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T9	T17	17315258
NA	CHEMICAL	GENE-Y	25	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T9	T34	17315258
NA	CHEMICAL	GENE-Y	25	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T9	T35	17315258
NA	CHEMICAL	GENE-N	25	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T9	T26	17315258
NA	CHEMICAL	GENE-Y	18	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T11	T17	17315258
NA	CHEMICAL	GENE-Y	18	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T11	T34	17315258
NA	CHEMICAL	GENE-Y	18	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T11	T35	17315258
NA	CHEMICAL	GENE-N	18	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T11	T26	17315258
NA	CHEMICAL	GENE-Y	38	0	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T12	T17	17315258
NA	CHEMICAL	GENE-Y	38	2	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T12	T34	17315258
NA	CHEMICAL	GENE-Y	38	4	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T12	T35	17315258
NA	CHEMICAL	GENE-N	38	17	gene ( gene , gene ) catalyzes chemical-dependent oxidation of chemical in vivo and can also act as a gene catalyzing in vitro chemical ( chemical ) -dependent reduction of electron-accepting molecules such as ubiquinone and chemical ( chemical ) .	T12	T26	17315258
NA	CHEMICAL	GENE-Y	30	10	Rat brain mitochondrial extracts , used as the source of gene , were resolved by nongradient BN-PAGE ( 9 % ) , which was followed by gene activity staining using chemical as the electron donor and chemical as the electron acceptor .	T13	T33	17315258
NA	CHEMICAL	GENE-N	30	6	Rat brain mitochondrial extracts , used as the source of gene , were resolved by nongradient BN-PAGE ( 9 % ) , which was followed by gene activity staining using chemical as the electron donor and chemical as the electron acceptor .	T13	T36	17315258
NA	CHEMICAL	GENE-Y	36	10	Rat brain mitochondrial extracts , used as the source of gene , were resolved by nongradient BN-PAGE ( 9 % ) , which was followed by gene activity staining using chemical as the electron donor and chemical as the electron acceptor .	T14	T33	17315258
NA	CHEMICAL	GENE-N	36	6	Rat brain mitochondrial extracts , used as the source of gene , were resolved by nongradient BN-PAGE ( 9 % ) , which was followed by gene activity staining using chemical as the electron donor and chemical as the electron acceptor .	T14	T36	17315258
NA	CHEMICAL	GENE-Y	24	20	Moreover , this in-gel activity-staining method was demonstrated to be in good agreement with the conventional spectrophotometric method that measures gene gene activity using chemical as the substrate .	T1	T39	17315258
NA	CHEMICAL	GENE-N	24	21	Moreover , this in-gel activity-staining method was demonstrated to be in good agreement with the conventional spectrophotometric method that measures gene gene activity using chemical as the substrate .	T1	T40	17315258
NA	CHEMICAL	GENE-Y	5	17	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T3	T22	17315258
NA	CHEMICAL	GENE-N	5	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T3	T23	17315258
NA	CHEMICAL	GENE-Y	5	30	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T3	T24	17315258
NA	CHEMICAL	GENE-N	5	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T3	T25	17315258
NA	CHEMICAL	GENE-Y	5	51	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T3	T27	17315258
NA	CHEMICAL	GENE-N	5	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T3	T28	17315258
NA	CHEMICAL	GENE-Y	9	17	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T4	T22	17315258
NA	CHEMICAL	GENE-N	9	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T4	T23	17315258
NA	CHEMICAL	GENE-Y	9	30	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T4	T24	17315258
NA	CHEMICAL	GENE-N	9	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T4	T25	17315258
NA	CHEMICAL	GENE-Y	9	51	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T4	T27	17315258
NA	CHEMICAL	GENE-N	9	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T4	T28	17315258
NA	CHEMICAL	GENE-Y	11	17	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T5	T22	17315258
NA	CHEMICAL	GENE-N	11	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T5	T23	17315258
NA	CHEMICAL	GENE-Y	11	30	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T5	T24	17315258
NA	CHEMICAL	GENE-N	11	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T5	T25	17315258
NA	CHEMICAL	GENE-Y	11	51	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T5	T27	17315258
NA	CHEMICAL	GENE-N	11	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T5	T28	17315258
NA	CHEMICAL	GENE-Y	14	17	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T6	T22	17315258
NA	CHEMICAL	GENE-N	14	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T6	T23	17315258
NA	CHEMICAL	GENE-Y	14	30	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T6	T24	17315258
NA	CHEMICAL	GENE-N	14	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T6	T25	17315258
NA	CHEMICAL	GENE-Y	14	51	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T6	T27	17315258
NA	CHEMICAL	GENE-N	14	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T6	T28	17315258
NA	CHEMICAL	GENE-Y	41	17	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T7	T22	17315258
NA	CHEMICAL	GENE-N	41	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T7	T23	17315258
NA	CHEMICAL	GENE-Y	41	30	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T7	T24	17315258
NA	CHEMICAL	GENE-N	41	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T7	T25	17315258
NA	CHEMICAL	GENE-Y	41	51	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T7	T27	17315258
NA	CHEMICAL	GENE-N	41	8	Finally , the effects of chemical-reactive reagents such as chemical ( chemical ) and chemical donors on gene gene activity were evaluated , demonstrating that , with this method , gene gene activity can be determined without having to remove these chemical-reactive reagents that may otherwise interfere with spectrophotometric measurement of gene gene activity .	T7	T28	17315258
CPR:4	CHEMICAL	GENE-Y	12	10	Electroencephalographic recordings during substance consumption showed reduced alpha activity and gene latencies in the chemical group compared to the control group .	T8	T11	22749926
CPR:3	CHEMICAL	GENE-N	7	12	These findings suggest that oral consumption of chemical enhances the efficacy of gene .	T2	T10	22749926
NA	CHEMICAL	GENE-Y	8	4	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T22	11970990
NA	CHEMICAL	GENE-N	8	10	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T23	11970990
NA	CHEMICAL	GENE-N	8	15	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T24	11970990
NA	CHEMICAL	GENE-Y	8	19	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T25	11970990
NA	CHEMICAL	GENE-Y	8	26	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T26	11970990
NA	CHEMICAL	GENE-N	8	28	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T27	11970990
NA	CHEMICAL	GENE-N	8	10	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T3	11970990
NA	CHEMICAL	GENE-Y	8	47	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T5	11970990
NA	CHEMICAL	GENE-Y	8	53	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T6	11970990
NA	CHEMICAL	GENE-Y	8	68	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T8	11970990
NA	CHEMICAL	GENE-N	8	70	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T9	11970990
NA	CHEMICAL	GENE-N	8	75	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T10	11970990
NA	CHEMICAL	GENE-Y	8	79	Experimentation using isoforms of gene engineered to have chemical substitutions in the gene that impact gene binding indicate that gene mediates cognate interactions between cells expressing gene and gene to activate cells , e.g. , increase gene phosphorylation , up-regulate cell surface expression of the activation marker gene , and induce release of gene . In the systems used , this signaling is shown to require binding to gene and gene and be mediated through gene , but not gene .	T1	T11	11970990
NA	CHEMICAL	GENE-Y	2	4	Effects of chemical on gene concentration and symptoms in patients with heart failure and preserved ejection fraction .	T7	T14	15325927
CPR:4	CHEMICAL	GENE-Y	6	16	After 12 months of treatment , chemical significantly improved all end points ( plasma concentration of gene [ gene ] from 175 ( 35 to 209 ) to 106 ( 52 to 160 ) pg/ml , mean ( 95 % confidence interval ) p < 0.01 ; New York Heart Association functional class from 2.37 ( 2.13 to 2.61 ) to 1.56 ( 1.21 to 1.91 ) , p < 0.01 ; exercise capacity estimated with the Specific Activity Scale from 4.75 ( 4.50 to 5.00 ) to 5.68 ( 5.22 to 6.14 ) METs , p < 0.02 ) , whereas conventional therapy did not ( gene concentration from 150 ( 114 to 186 ) to 174 ( 100 to 248 ) pg/ml ; New York Heart Association functional class from 2.29 ( 2.08 to 2.50 ) to 2.11 ( 1.73 to 2.49 ) ; exercise capacity from 4.57 ( 4.34 to 4.80 ) to 4.72 ( 4.41 to 5.03 ) METs ) .	T6	T11	15325927
CPR:4	CHEMICAL	GENE-Y	6	18	After 12 months of treatment , chemical significantly improved all end points ( plasma concentration of gene [ gene ] from 175 ( 35 to 209 ) to 106 ( 52 to 160 ) pg/ml , mean ( 95 % confidence interval ) p < 0.01 ; New York Heart Association functional class from 2.37 ( 2.13 to 2.61 ) to 1.56 ( 1.21 to 1.91 ) , p < 0.01 ; exercise capacity estimated with the Specific Activity Scale from 4.75 ( 4.50 to 5.00 ) to 5.68 ( 5.22 to 6.14 ) METs , p < 0.02 ) , whereas conventional therapy did not ( gene concentration from 150 ( 114 to 186 ) to 174 ( 100 to 248 ) pg/ml ; New York Heart Association functional class from 2.29 ( 2.08 to 2.50 ) to 2.11 ( 1.73 to 2.49 ) ; exercise capacity from 4.57 ( 4.34 to 4.80 ) to 4.72 ( 4.41 to 5.03 ) METs ) .	T6	T12	15325927
NA	CHEMICAL	GENE-Y	6	107	After 12 months of treatment , chemical significantly improved all end points ( plasma concentration of gene [ gene ] from 175 ( 35 to 209 ) to 106 ( 52 to 160 ) pg/ml , mean ( 95 % confidence interval ) p < 0.01 ; New York Heart Association functional class from 2.37 ( 2.13 to 2.61 ) to 1.56 ( 1.21 to 1.91 ) , p < 0.01 ; exercise capacity estimated with the Specific Activity Scale from 4.75 ( 4.50 to 5.00 ) to 5.68 ( 5.22 to 6.14 ) METs , p < 0.02 ) , whereas conventional therapy did not ( gene concentration from 150 ( 114 to 186 ) to 174 ( 100 to 248 ) pg/ml ; New York Heart Association functional class from 2.29 ( 2.08 to 2.50 ) to 2.11 ( 1.73 to 2.49 ) ; exercise capacity from 4.57 ( 4.34 to 4.80 ) to 4.72 ( 4.41 to 5.03 ) METs ) .	T6	T13	15325927
CPR:4	CHEMICAL	GENE-Y	9	16	Univariate regression analyses showed that only the use of chemical was correlated with the decrease in gene concentration ( p < 0.03 ) .	T1	T8	15325927
NA	CHEMICAL	GENE-Y	39	20	Multivariate analyses demonstrated that an ischemic cause of heart failure ( p < 0.02 ) , high plasma concentration of gene ( p < 0.02 ) , left ventricular dilation ( p < 0.03 ) , and use of chemical ( p < 0.04 ) at baseline were predictive of a decrease in plasma concentration of gene .	T2	T9	15325927
NA	CHEMICAL	GENE-Y	39	56	Multivariate analyses demonstrated that an ischemic cause of heart failure ( p < 0.02 ) , high plasma concentration of gene ( p < 0.02 ) , left ventricular dilation ( p < 0.03 ) , and use of chemical ( p < 0.04 ) at baseline were predictive of a decrease in plasma concentration of gene .	T2	T10	15325927
NA	CHEMICAL	GENE-Y	2	0	gene potentiates chemical-stimulated gene secretion and induces energy accumulation into adipose tissue , resulting in obesity .	T1	T9	23192339
CPR:3	CHEMICAL	GENE-Y	2	3	gene potentiates chemical-stimulated gene secretion and induces energy accumulation into adipose tissue , resulting in obesity .	T1	T13	23192339
NA	CHEMICAL	GENE-Y	20	18	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T1	T9	23339682
NA	CHEMICAL	GENE-Y	20	20	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T1	T10	23339682
NA	CHEMICAL	GENE-Y	20	22	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T1	T11	23339682
NA	CHEMICAL	GENE-Y	20	24	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T1	T12	23339682
NA	CHEMICAL	GENE-Y	20	26	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T1	T13	23339682
NA	CHEMICAL	GENE-Y	14	18	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T2	T9	23339682
NA	CHEMICAL	GENE-Y	14	20	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T2	T10	23339682
NA	CHEMICAL	GENE-Y	14	22	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T2	T11	23339682
NA	CHEMICAL	GENE-Y	14	24	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T2	T12	23339682
NA	CHEMICAL	GENE-Y	14	26	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T2	T13	23339682
NA	CHEMICAL	GENE-Y	6	18	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T3	T9	23339682
NA	CHEMICAL	GENE-Y	6	20	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T3	T10	23339682
NA	CHEMICAL	GENE-Y	6	22	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T3	T11	23339682
NA	CHEMICAL	GENE-Y	6	24	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T3	T12	23339682
NA	CHEMICAL	GENE-Y	6	26	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T3	T13	23339682
NA	CHEMICAL	GENE-Y	6	18	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T4	T9	23339682
NA	CHEMICAL	GENE-Y	6	20	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T4	T10	23339682
NA	CHEMICAL	GENE-Y	6	22	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T4	T11	23339682
NA	CHEMICAL	GENE-Y	6	24	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T4	T12	23339682
NA	CHEMICAL	GENE-Y	6	26	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T4	T13	23339682
NA	CHEMICAL	GENE-Y	51	18	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T5	T9	23339682
NA	CHEMICAL	GENE-Y	51	20	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T5	T10	23339682
NA	CHEMICAL	GENE-Y	51	22	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T5	T11	23339682
NA	CHEMICAL	GENE-Y	51	24	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T5	T12	23339682
NA	CHEMICAL	GENE-Y	51	26	Methods : Cocktail approach was used to evaluate the influence of IR and IPC on the activities of gene , gene , gene , gene and gene , which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs : chemical , chemical , chemical , chemical and chemical , respectively .	T5	T13	23339682
NA	CHEMICAL	GENE-Y	9	3	Molecular analysis of gene gene in Korean patients with chemical acidemia .	T11	T30	12409268
NA	CHEMICAL	GENE-N	7	4	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T5	T22	12409268
NA	CHEMICAL	GENE-N	7	10	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T5	T23	12409268
NA	CHEMICAL	GENE-Y	7	12	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T5	T24	12409268
NA	CHEMICAL	GENE-N	16	4	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T6	T22	12409268
NA	CHEMICAL	GENE-N	16	10	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T6	T23	12409268
NA	CHEMICAL	GENE-Y	16	12	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T6	T24	12409268
CPR:9	CHEMICAL	GENE-N	23	4	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T7	T22	12409268
CPR:9	CHEMICAL	GENE-N	23	10	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T7	T23	12409268
CPR:9	CHEMICAL	GENE-Y	23	12	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T7	T24	12409268
CPR:9	CHEMICAL	GENE-N	4	4	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T8	T22	12409268
CPR:9	CHEMICAL	GENE-N	4	10	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T8	T23	12409268
CPR:9	CHEMICAL	GENE-Y	4	12	It is caused by a deficiency of chemical carboxylase ( gene , gene ) , a chemical-dependent enzyme that catalyzes the carboxylation of chemical to chemical .	T8	T24	12409268
NA	CHEMICAL	GENE-N	3	5	Role of the chemical modulated cyclases in the development of the chemical projections .	T10	T48	17229090
NA	CHEMICAL	GENE-N	6	5	Role of the chemical modulated cyclases in the development of the chemical projections .	T11	T48	17229090
NA	CHEMICAL	GENE-N	3	4	Transmembrane isoforms of chemical cyclases ( gene ) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate chemical production in response to chemical entry .	T5	T24	17229090
NA	CHEMICAL	GENE-N	3	6	Transmembrane isoforms of chemical cyclases ( gene ) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate chemical production in response to chemical entry .	T5	T28	17229090
CPR:9	CHEMICAL	GENE-N	23	4	Transmembrane isoforms of chemical cyclases ( gene ) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate chemical production in response to chemical entry .	T3	T24	17229090
CPR:9	CHEMICAL	GENE-N	23	6	Transmembrane isoforms of chemical cyclases ( gene ) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate chemical production in response to chemical entry .	T3	T28	17229090
NA	CHEMICAL	GENE-N	9	4	Transmembrane isoforms of chemical cyclases ( gene ) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate chemical production in response to chemical entry .	T4	T24	17229090
NA	CHEMICAL	GENE-N	9	6	Transmembrane isoforms of chemical cyclases ( gene ) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate chemical production in response to chemical entry .	T4	T28	17229090
NA	CHEMICAL	GENE-Y	3	10	Based on observations in the barrelless mouse strain , the gene gene ( gene ) was involved in the segregation of binocular chemical inputs .	T6	T23	17229090
NA	CHEMICAL	GENE-Y	3	13	Based on observations in the barrelless mouse strain , the gene gene ( gene ) was involved in the segregation of binocular chemical inputs .	T6	T25	17229090
NA	CHEMICAL	GENE-N	1	1	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T7	T44	17229090
NA	CHEMICAL	GENE-Y	1	13	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T7	T45	17229090
NA	CHEMICAL	GENE-Y	1	15	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T7	T46	17229090
NA	CHEMICAL	GENE-Y	1	17	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T7	T47	17229090
NA	CHEMICAL	GENE-N	1	1	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T8	T44	17229090
NA	CHEMICAL	GENE-Y	1	13	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T8	T45	17229090
NA	CHEMICAL	GENE-Y	1	15	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T8	T46	17229090
NA	CHEMICAL	GENE-Y	1	17	Using a genetic approach we tested the role of the chemical modulated cyclases gene , gene and gene for the segregation chemical fibres .	T8	T47	17229090
NA	CHEMICAL	GENE-Y	1	7	Ipsilateral chemical axons remained exuberant in the gene ( -/- ) mice , with overlapping chemical projections from both eyes in the superior colliculus and the visual thalamus .	T9	T12	17229090
NA	CHEMICAL	GENE-Y	5	7	Ipsilateral chemical axons remained exuberant in the gene ( -/- ) mice , with overlapping chemical projections from both eyes in the superior colliculus and the visual thalamus .	T1	T12	17229090
NA	CHEMICAL	GENE-Y	11	3	Thus , only gene is required for the maturation of the chemical axon terminals whereas gene and gene are not needed .	T2	T18	17229090
NA	CHEMICAL	GENE-Y	11	15	Thus , only gene is required for the maturation of the chemical axon terminals whereas gene and gene are not needed .	T2	T19	17229090
NA	CHEMICAL	GENE-Y	11	17	Thus , only gene is required for the maturation of the chemical axon terminals whereas gene and gene are not needed .	T2	T20	17229090
NA	CHEMICAL	GENE-Y	2	3	Reversal of chemical D2 agonist-induced inhibition of ventral tegmental area neurons by gene-linked neurotransmitters is dependent on gene , gene , and gene .	T11	T34	23019137
NA	CHEMICAL	GENE-N	2	12	Reversal of chemical D2 agonist-induced inhibition of ventral tegmental area neurons by gene-linked neurotransmitters is dependent on gene , gene , and gene .	T11	T38	23019137
NA	CHEMICAL	GENE-N	2	17	Reversal of chemical D2 agonist-induced inhibition of ventral tegmental area neurons by gene-linked neurotransmitters is dependent on gene , gene , and gene .	T11	T35	23019137
NA	CHEMICAL	GENE-N	2	19	Reversal of chemical D2 agonist-induced inhibition of ventral tegmental area neurons by gene-linked neurotransmitters is dependent on gene , gene , and gene .	T11	T36	23019137
NA	CHEMICAL	GENE-N	2	22	Reversal of chemical D2 agonist-induced inhibition of ventral tegmental area neurons by gene-linked neurotransmitters is dependent on gene , gene , and gene .	T11	T37	23019137
NA	CHEMICAL	GENE-N	26	4	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T19	23019137
NA	CHEMICAL	GENE-N	26	6	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T20	23019137
NA	CHEMICAL	GENE-N	26	8	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T21	23019137
NA	CHEMICAL	GENE-Y	26	14	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T22	23019137
NA	CHEMICAL	GENE-N	26	16	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T23	23019137
NA	CHEMICAL	GENE-Y	26	20	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T24	23019137
NA	CHEMICAL	GENE-N	26	7	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T25	23019137
NA	CHEMICAL	GENE-N	26	18	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T6	T26	23019137
NA	CHEMICAL	GENE-N	31	4	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T19	23019137
NA	CHEMICAL	GENE-N	31	6	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T20	23019137
NA	CHEMICAL	GENE-N	31	8	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T21	23019137
NA	CHEMICAL	GENE-Y	31	14	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T22	23019137
NA	CHEMICAL	GENE-N	31	16	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T23	23019137
NA	CHEMICAL	GENE-Y	31	20	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T24	23019137
NA	CHEMICAL	GENE-N	31	7	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T25	23019137
NA	CHEMICAL	GENE-N	31	18	DIR is mediated by gene and gene ( gene ) through concurrent stimulation of gene and gene , or by gene stimulation concurrent with activation of chemical ( 2 ) or chemical receptors .	T7	T26	23019137
CPR:5	CHEMICAL	GENE-Y	6	4	Reversal of inhibition by gene agonist chemical was produced by chemical ( 50 µM ) and by chemical ( 5-10 nM ) .	T8	T32	23019137
CPR:3	CHEMICAL	GENE-Y	10	4	Reversal of inhibition by gene agonist chemical was produced by chemical ( 50 µM ) and by chemical ( 5-10 nM ) .	T9	T32	23019137
CPR:3	CHEMICAL	GENE-Y	17	4	Reversal of inhibition by gene agonist chemical was produced by chemical ( 50 µM ) and by chemical ( 5-10 nM ) .	T10	T32	23019137
NA	CHEMICAL	GENE-Y	0	2	chemical-induced or gene-induced reversal was blocked by β-ARK1 inhibitor , dynasore , or gene antagonist chemical ( chemical ) .	T1	T12	23019137
NA	CHEMICAL	GENE-N	0	13	chemical-induced or gene-induced reversal was blocked by β-ARK1 inhibitor , dynasore , or gene antagonist chemical ( chemical ) .	T1	T13	23019137
NA	CHEMICAL	GENE-Y	9	2	chemical-induced or gene-induced reversal was blocked by β-ARK1 inhibitor , dynasore , or gene antagonist chemical ( chemical ) .	T3	T12	23019137
CPR:6	CHEMICAL	GENE-N	9	13	chemical-induced or gene-induced reversal was blocked by β-ARK1 inhibitor , dynasore , or gene antagonist chemical ( chemical ) .	T3	T13	23019137
NA	CHEMICAL	GENE-Y	17	2	chemical-induced or gene-induced reversal was blocked by β-ARK1 inhibitor , dynasore , or gene antagonist chemical ( chemical ) .	T4	T12	23019137
CPR:6	CHEMICAL	GENE-N	17	13	chemical-induced or gene-induced reversal was blocked by β-ARK1 inhibitor , dynasore , or gene antagonist chemical ( chemical ) .	T4	T13	23019137
NA	CHEMICAL	GENE-N	2	12	[ Construction of the flavinogenic yeast Candida famata strains with high chemical kinase activity using gene engineering ] .	T7	T16	17290783
NA	CHEMICAL	GENE-N	3	18	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T1	T8	17290783
NA	CHEMICAL	GENE-N	3	24	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T1	T9	17290783
NA	CHEMICAL	GENE-N	3	41	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T1	T10	17290783
NA	CHEMICAL	GENE-N	3	44	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T1	T11	17290783
NA	CHEMICAL	GENE-N	3	18	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T2	T8	17290783
CPR:9	CHEMICAL	GENE-N	3	24	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T2	T9	17290783
NA	CHEMICAL	GENE-N	3	41	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T2	T10	17290783
NA	CHEMICAL	GENE-N	3	44	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T2	T11	17290783
NA	CHEMICAL	GENE-N	31	18	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T3	T8	17290783
CPR:9	CHEMICAL	GENE-N	31	24	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T3	T9	17290783
NA	CHEMICAL	GENE-N	31	41	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T3	T10	17290783
NA	CHEMICAL	GENE-N	31	44	The recombinant strains of the flavinogenic yeast Candida famata , which contain the DNA fragment consisting of the gene gene ( encoding the chemical kinase , enzyme that converts chemical to chemical ) driven by the strong promoters ( the regulated gene or constitutive gene ) were isolated .	T3	T11	17290783
NA	CHEMICAL	GENE-N	0	1	chemical kinase activity in the isolated transformants was tested .	T4	T12	17290783
NA	CHEMICAL	GENE-N	3	6	The 6-8-fold increase of the chemical kinase activity was shown in the recombinant strains containing the integrated gene gene under the strong constitutive gene .	T5	T13	17290783
NA	CHEMICAL	GENE-N	3	17	The 6-8-fold increase of the chemical kinase activity was shown in the recombinant strains containing the integrated gene gene under the strong constitutive gene .	T5	T14	17290783
NA	CHEMICAL	GENE-N	3	23	The 6-8-fold increase of the chemical kinase activity was shown in the recombinant strains containing the integrated gene gene under the strong constitutive gene .	T5	T15	17290783
NA	CHEMICAL	GENE-N	7	4	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T14	16597468
NA	CHEMICAL	GENE-Y	7	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T15	16597468
NA	CHEMICAL	GENE-Y	7	10	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T9	16597468
NA	CHEMICAL	GENE-Y	7	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T10	16597468
NA	CHEMICAL	GENE-Y	7	16	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T11	16597468
NA	CHEMICAL	GENE-Y	7	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T12	16597468
NA	CHEMICAL	GENE-Y	7	23	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T5	T13	16597468
NA	CHEMICAL	GENE-N	13	4	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T14	16597468
NA	CHEMICAL	GENE-Y	13	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T15	16597468
NA	CHEMICAL	GENE-Y	13	10	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T9	16597468
NA	CHEMICAL	GENE-Y	13	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T10	16597468
NA	CHEMICAL	GENE-Y	13	16	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T11	16597468
NA	CHEMICAL	GENE-Y	13	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T12	16597468
NA	CHEMICAL	GENE-Y	13	23	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T2	T13	16597468
NA	CHEMICAL	GENE-N	20	4	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T14	16597468
NA	CHEMICAL	GENE-Y	20	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T15	16597468
NA	CHEMICAL	GENE-Y	20	10	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T9	16597468
NA	CHEMICAL	GENE-Y	20	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T10	16597468
NA	CHEMICAL	GENE-Y	20	16	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T11	16597468
NA	CHEMICAL	GENE-Y	20	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T12	16597468
NA	CHEMICAL	GENE-Y	20	23	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T3	T13	16597468
NA	CHEMICAL	GENE-N	32	4	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T14	16597468
NA	CHEMICAL	GENE-Y	32	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T15	16597468
NA	CHEMICAL	GENE-Y	32	10	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T9	16597468
NA	CHEMICAL	GENE-Y	32	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T10	16597468
NA	CHEMICAL	GENE-Y	32	16	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T11	16597468
NA	CHEMICAL	GENE-Y	32	8	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T12	16597468
NA	CHEMICAL	GENE-Y	32	23	Leishmania species express three gene enzymes , chemical phosphoribosyltransferase ( gene ) , chemical phosphoribosyltransferase ( gene ) , and chemical phosphoribosyltransferase ( gene ) , which enable this genus to acquire chemical nutrients from their hosts .	T4	T13	16597468
NA	CHEMICAL	GENE-N	14	10	These data support the hypothesis that none of the three gene is essential for chemical salvage or viability by itself and that chemical salvage occurs through multiple anabolic routes in both parasite life cycle stages .	T6	T16	16597468
NA	CHEMICAL	GENE-N	22	10	These data support the hypothesis that none of the three gene is essential for chemical salvage or viability by itself and that chemical salvage occurs through multiple anabolic routes in both parasite life cycle stages .	T7	T16	16597468
NA	CHEMICAL	GENE-N	3	5	Pharmacological profile of chemical at gene .	T24	T30	10193665
NA	CHEMICAL	GENE-N	19	24	Using radioligand binding techniques , we determined the equilibrium dissociation constants ( K ( D ) ) for 37 chemical and one metabolite of a neuroleptic ( chemical metabolite ) for the gene with chemical , chemical , and chemical , respectively .	T1	T26	10193665
NA	CHEMICAL	GENE-N	24	24	Using radioligand binding techniques , we determined the equilibrium dissociation constants ( K ( D ) ) for 37 chemical and one metabolite of a neuroleptic ( chemical metabolite ) for the gene with chemical , chemical , and chemical , respectively .	T2	T26	10193665
NA	CHEMICAL	GENE-N	24	24	Using radioligand binding techniques , we determined the equilibrium dissociation constants ( K ( D ) ) for 37 chemical and one metabolite of a neuroleptic ( chemical metabolite ) for the gene with chemical , chemical , and chemical , respectively .	T5	T26	10193665
NA	CHEMICAL	GENE-N	24	24	Using radioligand binding techniques , we determined the equilibrium dissociation constants ( K ( D ) ) for 37 chemical and one metabolite of a neuroleptic ( chemical metabolite ) for the gene with chemical , chemical , and chemical , respectively .	T6	T26	10193665
NA	CHEMICAL	GENE-N	36	24	Using radioligand binding techniques , we determined the equilibrium dissociation constants ( K ( D ) ) for 37 chemical and one metabolite of a neuroleptic ( chemical metabolite ) for the gene with chemical , chemical , and chemical , respectively .	T7	T26	10193665
NA	CHEMICAL	GENE-N	39	24	Using radioligand binding techniques , we determined the equilibrium dissociation constants ( K ( D ) ) for 37 chemical and one metabolite of a neuroleptic ( chemical metabolite ) for the gene with chemical , chemical , and chemical , respectively .	T8	T26	10193665
NA	CHEMICAL	GENE-Y	1	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T9	T27	10193665
NA	CHEMICAL	GENE-Y	1	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T9	T28	10193665
NA	CHEMICAL	GENE-Y	12	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T11	T27	10193665
NA	CHEMICAL	GENE-Y	12	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T11	T28	10193665
NA	CHEMICAL	GENE-Y	14	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T12	T27	10193665
NA	CHEMICAL	GENE-Y	14	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T12	T28	10193665
NA	CHEMICAL	GENE-Y	16	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T13	T27	10193665
NA	CHEMICAL	GENE-Y	16	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T13	T28	10193665
NA	CHEMICAL	GENE-Y	19	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T14	T27	10193665
NA	CHEMICAL	GENE-Y	19	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T14	T28	10193665
NA	CHEMICAL	GENE-Y	32	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T15	T27	10193665
NA	CHEMICAL	GENE-Y	32	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T15	T28	10193665
NA	CHEMICAL	GENE-Y	35	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T16	T27	10193665
NA	CHEMICAL	GENE-Y	35	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T16	T28	10193665
NA	CHEMICAL	GENE-Y	37	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T17	T27	10193665
NA	CHEMICAL	GENE-Y	37	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T17	T28	10193665
NA	CHEMICAL	GENE-Y	39	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T18	T27	10193665
NA	CHEMICAL	GENE-Y	39	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T18	T28	10193665
NA	CHEMICAL	GENE-Y	42	10	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T19	T27	10193665
NA	CHEMICAL	GENE-Y	42	33	Among chemical , the four most potent compounds at the gene were chemical , chemical , chemical , and chemical ( K ( D ) 24-39 nM ) ; and at the chemical transporter , chemical , chemical , chemical , and chemical ( K ( D ) 19-25 nM ) .	T19	T28	10193665
NA	CHEMICAL	GENE-Y	5	2	At the gene , only chemical ( K ( D ) = 69+/-3 ) chemical ( K ( D ) = 76+/-5 ) had notable potency .	T21	T29	10193665
NA	CHEMICAL	GENE-Y	14	2	At the gene , only chemical ( K ( D ) = 69+/-3 ) chemical ( K ( D ) = 76+/-5 ) had notable potency .	T22	T29	10193665
NA	CHEMICAL	GENE-Y	14	2	Disruption of gene Enhances Tolerance of Arabidopsis to Salt and Osmotic Stresses via Modulating chemical Content and Activities of gene and gene .	T11	T30	23535337
NA	CHEMICAL	GENE-N	14	19	Disruption of gene Enhances Tolerance of Arabidopsis to Salt and Osmotic Stresses via Modulating chemical Content and Activities of gene and gene .	T11	T29	23535337
NA	CHEMICAL	GENE-N	14	21	Disruption of gene Enhances Tolerance of Arabidopsis to Salt and Osmotic Stresses via Modulating chemical Content and Activities of gene and gene .	T11	T31	23535337
NA	CHEMICAL	GENE-N	7	0	gene ( gene ) play important roles in plant growth and development .	T10	T12	23535337
NA	CHEMICAL	GENE-N	7	2	gene ( gene ) play important roles in plant growth and development .	T10	T18	23535337
NA	CHEMICAL	GENE-Y	22	5	Here , we report that gene is mainly expressed in primary root , hypocotyl , stamen and pistil and is induced by chemical and chemical treatment .	T2	T17	23535337
NA	CHEMICAL	GENE-Y	24	5	Here , we report that gene is mainly expressed in primary root , hypocotyl , stamen and pistil and is induced by chemical and chemical treatment .	T3	T17	23535337
NA	CHEMICAL	GENE-Y	33	8	Compared to the wild-type , the T-DNA knock-out gene mutant was more tolerant to severe salinity and osmotic stresses , as indicated by 27 % and 198 % more fresh weight in the chemical and chemical treatment , respectively .	T4	T19	23535337
NA	CHEMICAL	GENE-Y	1	8	Compared to the wild-type , the T-DNA knock-out gene mutant was more tolerant to severe salinity and osmotic stresses , as indicated by 27 % and 198 % more fresh weight in the chemical and chemical treatment , respectively .	T5	T19	23535337
NA	CHEMICAL	GENE-Y	7	1	The gene mutant also accumulated 1.43-fold more chemical than the wild-type in the chemical treatment .	T6	T20	23535337
NA	CHEMICAL	GENE-Y	13	1	The gene mutant also accumulated 1.43-fold more chemical than the wild-type in the chemical treatment .	T7	T20	23535337
CPR:3	CHEMICAL	GENE-N	1	6	Under chemical and chemical stresses , gene ( gene ) activity in gene mutant was 1.92- and 3.7-times of that in Col-0 , respectively .	T8	T21	23535337
CPR:3	CHEMICAL	GENE-N	1	8	Under chemical and chemical stresses , gene ( gene ) activity in gene mutant was 1.92- and 3.7-times of that in Col-0 , respectively .	T8	T22	23535337
NA	CHEMICAL	GENE-Y	1	12	Under chemical and chemical stresses , gene ( gene ) activity in gene mutant was 1.92- and 3.7-times of that in Col-0 , respectively .	T8	T23	23535337
CPR:3	CHEMICAL	GENE-N	3	6	Under chemical and chemical stresses , gene ( gene ) activity in gene mutant was 1.92- and 3.7-times of that in Col-0 , respectively .	T9	T21	23535337
CPR:3	CHEMICAL	GENE-N	3	8	Under chemical and chemical stresses , gene ( gene ) activity in gene mutant was 1.92- and 3.7-times of that in Col-0 , respectively .	T9	T22	23535337
NA	CHEMICAL	GENE-Y	3	12	Under chemical and chemical stresses , gene ( gene ) activity in gene mutant was 1.92- and 3.7-times of that in Col-0 , respectively .	T9	T23	23535337
CPR:4	CHEMICAL	GENE-N	0	16	chemical depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of gene pathway .	T7	T13	23542114
CPR:4	CHEMICAL	GENE-N	0	7	chemical inhibited the phosphorylation and activation of gene and gene through gene signaling blockade .	T5	T9	23542114
CPR:4	CHEMICAL	GENE-Y	0	9	chemical inhibited the phosphorylation and activation of gene and gene through gene signaling blockade .	T5	T10	23542114
CPR:4	CHEMICAL	GENE-N	0	11	chemical inhibited the phosphorylation and activation of gene and gene through gene signaling blockade .	T5	T11	23542114
NA	CHEMICAL	GENE-Y	8	14	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T15	T33	16232421
NA	CHEMICAL	GENE-Y	8	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T15	T34	16232421
NA	CHEMICAL	GENE-Y	8	35	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T15	T35	16232421
NA	CHEMICAL	GENE-Y	8	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T15	T36	16232421
NA	CHEMICAL	GENE-Y	16	14	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T16	T33	16232421
NA	CHEMICAL	GENE-Y	16	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T16	T34	16232421
NA	CHEMICAL	GENE-Y	16	35	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T16	T35	16232421
NA	CHEMICAL	GENE-Y	16	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T16	T36	16232421
CPR:9	CHEMICAL	GENE-Y	2	14	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T17	T33	16232421
CPR:9	CHEMICAL	GENE-Y	2	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T17	T34	16232421
NA	CHEMICAL	GENE-Y	2	35	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T17	T35	16232421
NA	CHEMICAL	GENE-Y	2	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T17	T36	16232421
NA	CHEMICAL	GENE-Y	2	14	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T18	T33	16232421
NA	CHEMICAL	GENE-Y	2	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T18	T34	16232421
NA	CHEMICAL	GENE-Y	2	35	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T18	T35	16232421
NA	CHEMICAL	GENE-Y	2	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T18	T36	16232421
NA	CHEMICAL	GENE-Y	2	14	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T19	T33	16232421
NA	CHEMICAL	GENE-Y	2	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T19	T34	16232421
CPR:9	CHEMICAL	GENE-Y	2	35	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T19	T35	16232421
CPR:9	CHEMICAL	GENE-Y	2	17	When cultured in YPD medium containing 15 % chemical under aerobic conditions , the gene ( chemical dehydrogenase ) gene disrupted mutant produced a lower level of chemical than the wild-type strain , while the gene ( chemical dehydrogenase ) gene-disrupted mutant produced an increased level of chemical .	T19	T36	16232421
CPR:9	CHEMICAL	GENE-Y	18	6	On the other hand , the gene ( gene ) gene disrupted mutant produced significantly higher levels of chemical but did not form chemical at all .	T20	T37	16232421
CPR:9	CHEMICAL	GENE-Y	18	8	On the other hand , the gene ( gene ) gene disrupted mutant produced significantly higher levels of chemical but did not form chemical at all .	T20	T38	16232421
NA	CHEMICAL	GENE-Y	23	6	On the other hand , the gene ( gene ) gene disrupted mutant produced significantly higher levels of chemical but did not form chemical at all .	T21	T37	16232421
NA	CHEMICAL	GENE-Y	23	8	On the other hand , the gene ( gene ) gene disrupted mutant produced significantly higher levels of chemical but did not form chemical at all .	T21	T38	16232421
CPR:9	CHEMICAL	GENE-Y	15	17	When the growth condition was shifted from aerobic to anaerobic , the increased level of chemical in gene disruptants was no longer observed , whereas the decreased level of chemical in the gene diruptant was still observed .	T3	T28	16232421
NA	CHEMICAL	GENE-Y	15	32	When the growth condition was shifted from aerobic to anaerobic , the increased level of chemical in gene disruptants was no longer observed , whereas the decreased level of chemical in the gene diruptant was still observed .	T3	T29	16232421
NA	CHEMICAL	GENE-Y	16	17	When the growth condition was shifted from aerobic to anaerobic , the increased level of chemical in gene disruptants was no longer observed , whereas the decreased level of chemical in the gene diruptant was still observed .	T4	T28	16232421
CPR:9	CHEMICAL	GENE-Y	16	32	When the growth condition was shifted from aerobic to anaerobic , the increased level of chemical in gene disruptants was no longer observed , whereas the decreased level of chemical in the gene diruptant was still observed .	T4	T29	16232421
NA	CHEMICAL	GENE-N	6	7	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T5	T30	16232421
NA	CHEMICAL	GENE-Y	6	11	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T5	T31	16232421
NA	CHEMICAL	GENE-Y	6	13	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T5	T32	16232421
CPR:9	CHEMICAL	GENE-N	16	7	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T6	T30	16232421
CPR:9	CHEMICAL	GENE-Y	16	11	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T6	T31	16232421
CPR:9	CHEMICAL	GENE-Y	16	13	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T6	T32	16232421
NA	CHEMICAL	GENE-N	32	7	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T8	T30	16232421
NA	CHEMICAL	GENE-Y	32	11	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T8	T31	16232421
NA	CHEMICAL	GENE-Y	32	13	A double mutant of the two chemical reductase isozyme genes ( gene and gene ) showed a chemical productivity of 50 % as compared to the parent when cells were incubated in chemical-buffered solution .	T8	T32	16232421
NA	CHEMICAL	GENE-Y	7	2	Expression of gene correlates with resistance to chemical in human patient tumors .	T9	T34	16741658
NA	CHEMICAL	GENE-N	8	5	We investigated the relationship between gene expression and chemical activity in tumors from bladder , breast , head and neck , ovarian , and prostate cancer patients .	T6	T19	16741658
NA	CHEMICAL	GENE-Y	5	30	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T7	T22	16741658
NA	CHEMICAL	GENE-Y	5	32	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T7	T23	16741658
NA	CHEMICAL	GENE-N	5	34	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T7	T24	16741658
NA	CHEMICAL	GENE-N	5	36	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T7	T25	16741658
NA	CHEMICAL	GENE-Y	5	39	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T7	T26	16741658
NA	CHEMICAL	GENE-Y	5	7	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T7	T27	16741658
NA	CHEMICAL	GENE-Y	22	30	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T8	T22	16741658
NA	CHEMICAL	GENE-Y	22	32	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T8	T23	16741658
NA	CHEMICAL	GENE-N	22	34	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T8	T24	16741658
NA	CHEMICAL	GENE-N	22	36	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T8	T25	16741658
NA	CHEMICAL	GENE-Y	22	39	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T8	T26	16741658
NA	CHEMICAL	GENE-Y	22	7	Bladder tumors were treated with chemical for 2 h , and the other tumors for 24 h. Antiproliferative and proapoptotic effects of chemical were quantified and correlated with expression of gene , gene , gene ( gene ) , gene , and gene .	T8	T27	16741658
NA	CHEMICAL	GENE-Y	9	0	gene expression did not correlate with tumor sensitivity to chemical , whereas gene expression showed an inverse correlation ( p < 0.01 ) .	T3	T11	16741658
NA	CHEMICAL	GENE-Y	9	12	gene expression did not correlate with tumor sensitivity to chemical , whereas gene expression showed an inverse correlation ( p < 0.01 ) .	T3	T12	16741658
NA	CHEMICAL	GENE-Y	3	0	gene expression was a stronger predictor of chemical resistance compared to gene , gene , or gene .	T4	T13	16741658
NA	CHEMICAL	GENE-N	3	11	gene expression was a stronger predictor of chemical resistance compared to gene , gene , or gene .	T4	T14	16741658
NA	CHEMICAL	GENE-Y	3	13	gene expression was a stronger predictor of chemical resistance compared to gene , gene , or gene .	T4	T15	16741658
NA	CHEMICAL	GENE-Y	3	16	gene expression was a stronger predictor of chemical resistance compared to gene , gene , or gene .	T4	T16	16741658
NA	CHEMICAL	GENE-N	14	6	Lessons from the dissection of the gene ( gene and gene ) of the chemical receptor alpha in vivo .	T8	T22	23200732
NA	CHEMICAL	GENE-N	14	8	Lessons from the dissection of the gene ( gene and gene ) of the chemical receptor alpha in vivo .	T8	T23	23200732
NA	CHEMICAL	GENE-N	14	10	Lessons from the dissection of the gene ( gene and gene ) of the chemical receptor alpha in vivo .	T8	T24	23200732
NA	CHEMICAL	GENE-Y	14	16	Lessons from the dissection of the gene ( gene and gene ) of the chemical receptor alpha in vivo .	T8	T25	23200732
NA	CHEMICAL	GENE-N	8	18	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T6	T14	23200732
NA	CHEMICAL	GENE-Y	8	11	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T6	T15	23200732
NA	CHEMICAL	GENE-N	8	35	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T6	T16	23200732
NA	CHEMICAL	GENE-N	8	10	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T6	T17	23200732
NA	CHEMICAL	GENE-N	8	38	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T6	T18	23200732
NA	CHEMICAL	GENE-N	47	18	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T7	T14	23200732
NA	CHEMICAL	GENE-Y	47	11	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T7	T15	23200732
NA	CHEMICAL	GENE-N	47	35	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T7	T16	23200732
NA	CHEMICAL	GENE-N	47	10	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T7	T17	23200732
NA	CHEMICAL	GENE-N	47	38	These actions are mediated by the activation of chemical receptors ( ER ) alpha ( ERα ) and beta ( gene ) , which regulate target gene transcription ( genomic action ) through two independent gene gene and gene , but can also elicit rapid membrane initiated chemical signals ( MISS ) .	T7	T18	23200732
NA	CHEMICAL	GENE-Y	6	7	However , the use of these chemical or selective chemical receptors modulators ( SERMs ) have also induced undesired effects .	T2	T11	23200732
NA	CHEMICAL	GENE-Y	9	7	However , the use of these chemical or selective chemical receptors modulators ( SERMs ) have also induced undesired effects .	T3	T11	23200732
NA	CHEMICAL	GENE-N	3	18	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T11	T14	23411235
NA	CHEMICAL	GENE-N	3	48	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T11	T15	23411235
NA	CHEMICAL	GENE-N	3	18	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T1	T14	23411235
NA	CHEMICAL	GENE-N	3	48	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T1	T15	23411235
NA	CHEMICAL	GENE-N	3	18	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T2	T14	23411235
NA	CHEMICAL	GENE-N	3	48	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T2	T15	23411235
NA	CHEMICAL	GENE-N	46	18	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T3	T14	23411235
NA	CHEMICAL	GENE-N	46	48	As part of a comprehensive study of the physiochemical and biological properties of chemical , successfully synthesized chemoenzymatically in our lab , their antioxidant activity was evaluated using three different in vitro model systems , namely bulk oil model system , chemical-chemical model system and gene chemical ( gene-C ) oxidation assay .	T3	T15	23411235
CPR:4	CHEMICAL	GENE-N	7	4	Moderate inhibitory effect of gene-C oxidation by chemical was observed .	T10	T16	23411235
CPR:9	CHEMICAL	GENE-Y	2	8	Uptake of chemical ( 5 nM ) by gene was reduced by 82 % -95 % .	T3	T12	23461378
CPR:9	CHEMICAL	GENE-Y	17	11	This methodology was subsequently used to assess the relative contribution of gene uptake in human hepatocytes for chemical ( 42 % -62 % ) , chemical ( 28 % -81 % ) , chemical ( 64 % -72 % ) , chemical ( 84 % -98 % ) and chemical ( 64 % -89 % ) .	T4	T13	23461378
CPR:9	CHEMICAL	GENE-Y	25	11	This methodology was subsequently used to assess the relative contribution of gene uptake in human hepatocytes for chemical ( 42 % -62 % ) , chemical ( 28 % -81 % ) , chemical ( 64 % -72 % ) , chemical ( 84 % -98 % ) and chemical ( 64 % -89 % ) .	T5	T13	23461378
CPR:9	CHEMICAL	GENE-Y	13	11	This methodology was subsequently used to assess the relative contribution of gene uptake in human hepatocytes for chemical ( 42 % -62 % ) , chemical ( 28 % -81 % ) , chemical ( 64 % -72 % ) , chemical ( 84 % -98 % ) and chemical ( 64 % -89 % ) .	T6	T13	23461378
CPR:9	CHEMICAL	GENE-Y	11	11	This methodology was subsequently used to assess the relative contribution of gene uptake in human hepatocytes for chemical ( 42 % -62 % ) , chemical ( 28 % -81 % ) , chemical ( 64 % -72 % ) , chemical ( 84 % -98 % ) and chemical ( 64 % -89 % ) .	T1	T13	23461378
CPR:9	CHEMICAL	GENE-Y	13	11	This methodology was subsequently used to assess the relative contribution of gene uptake in human hepatocytes for chemical ( 42 % -62 % ) , chemical ( 28 % -81 % ) , chemical ( 64 % -72 % ) , chemical ( 84 % -98 % ) and chemical ( 64 % -89 % ) .	T2	T13	23461378
NA	CHEMICAL	GENE-Y	7	12	Cerebrovascular Dilation via Selective Targeting of the chemical chemical-Recognition Site in the gene by a Novel Nonsteroidal Agent .	T21	T37	23455312
NA	CHEMICAL	GENE-Y	8	12	Cerebrovascular Dilation via Selective Targeting of the chemical chemical-Recognition Site in the gene by a Novel Nonsteroidal Agent .	T22	T37	23455312
NA	CHEMICAL	GENE-Y	1	11	The chemical ) /voltage-gated chemical large conductance ( BK ) channel β1 subunit is particularly abundant in vascular smooth muscle .	T14	T34	23455312
NA	CHEMICAL	GENE-Y	2	11	The chemical ) /voltage-gated chemical large conductance ( BK ) channel β1 subunit is particularly abundant in vascular smooth muscle .	T10	T34	23455312
NA	CHEMICAL	GENE-N	2	11	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T9	T32	23455312
NA	CHEMICAL	GENE-Y	2	19	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T9	T33	23455312
NA	CHEMICAL	GENE-N	3	11	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T11	T32	23455312
NA	CHEMICAL	GENE-Y	3	19	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T11	T33	23455312
NA	CHEMICAL	GENE-N	5	11	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T12	T32	23455312
NA	CHEMICAL	GENE-Y	5	19	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T12	T33	23455312
NA	CHEMICAL	GENE-N	23	11	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T13	T32	23455312
NA	CHEMICAL	GENE-Y	23	19	The endogenous chemical chemical ( chemical ) dilates cerebral arteries via gene activation , which requires recognition by a gene site that includes chemical169 .	T13	T33	23455312
CPR:3	CHEMICAL	GENE-Y	0	3	chemical activated the gene cloned from rat cerebral artery myocytes with a potency ( EC50 = 53 μM ) similar to and an efficacy ( ×2.5 potentiation ) significantly greater than that of chemical .	T18	T36	23455312
CPR:3	CHEMICAL	GENE-Y	33	3	chemical activated the gene cloned from rat cerebral artery myocytes with a potency ( EC50 = 53 μM ) similar to and an efficacy ( ×2.5 potentiation ) significantly greater than that of chemical .	T19	T36	23455312
CPR:3	CHEMICAL	GENE-N	0	5	chemical failed to activate the channels made of cbv1 + β2 , β3 , β4 , or β1T169A , indicating that this drug selectively targets gene via the gene chemical-sensing site .	T1	T23	23455312
NA	CHEMICAL	GENE-Y	0	28	chemical failed to activate the channels made of cbv1 + β2 , β3 , β4 , or β1T169A , indicating that this drug selectively targets gene via the gene chemical-sensing site .	T1	T24	23455312
NA	CHEMICAL	GENE-N	25	5	chemical failed to activate the channels made of cbv1 + β2 , β3 , β4 , or β1T169A , indicating that this drug selectively targets gene via the gene chemical-sensing site .	T2	T23	23455312
NA	CHEMICAL	GENE-Y	25	28	chemical failed to activate the channels made of cbv1 + β2 , β3 , β4 , or β1T169A , indicating that this drug selectively targets gene via the gene chemical-sensing site .	T2	T24	23455312
NA	CHEMICAL	GENE-Y	0	8	chemical failed to dilate the arteries from the gene knockout mouse , underscoring gene 's role in chemical action .	T5	T25	23455312
NA	CHEMICAL	GENE-Y	0	13	chemical failed to dilate the arteries from the gene knockout mouse , underscoring gene 's role in chemical action .	T5	T26	23455312
NA	CHEMICAL	GENE-Y	17	8	chemical failed to dilate the arteries from the gene knockout mouse , underscoring gene 's role in chemical action .	T6	T25	23455312
NA	CHEMICAL	GENE-Y	17	13	chemical failed to dilate the arteries from the gene knockout mouse , underscoring gene 's role in chemical action .	T6	T26	23455312
NA	CHEMICAL	GENE-N	5	17	Finally , carotid artery-infusion of chemical ( 45 μM ) dilated the pial cerebral arterioles via selective gene targeting .	T7	T28	23455312
NA	CHEMICAL	GENE-N	8	4	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T13	T20	23621358
NA	CHEMICAL	GENE-N	8	24	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T13	T21	23621358
NA	CHEMICAL	GENE-N	11	4	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T15	T20	23621358
NA	CHEMICAL	GENE-N	11	24	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T15	T21	23621358
NA	CHEMICAL	GENE-N	8	4	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T2	T20	23621358
NA	CHEMICAL	GENE-N	8	24	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T2	T21	23621358
NA	CHEMICAL	GENE-N	8	4	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T3	T20	23621358
NA	CHEMICAL	GENE-N	8	24	Polymeric micelles potentially able to carry to hepatocytes a chemical ( chemical ) prodrug , exploiting the presence of chemical receptors , i.e. , gene , were prepared starting from a chemical conjugate .	T3	T21	23621358
NA	CHEMICAL	GENE-Y	34	9	In aphakia mice , virtually all surviving mDA neurons in the substantia nigra ( SN ) and the majority of neurons in the adjacent ventral tegmental area ( VTA ) also express gene-gene , a chemical-binding protein previously associated with resistance to injury in PD and in animal models .	T4	T17	23331067
NA	CHEMICAL	GENE-Y	34	32	In aphakia mice , virtually all surviving mDA neurons in the substantia nigra ( SN ) and the majority of neurons in the adjacent ventral tegmental area ( VTA ) also express gene-gene , a chemical-binding protein previously associated with resistance to injury in PD and in animal models .	T4	T18	23331067
NA	CHEMICAL	GENE-N	34	9	In aphakia mice , virtually all surviving mDA neurons in the substantia nigra ( SN ) and the majority of neurons in the adjacent ventral tegmental area ( VTA ) also express gene-gene , a chemical-binding protein previously associated with resistance to injury in PD and in animal models .	T4	T19	23331067
NA	CHEMICAL	GENE-Y	21	7	Cell-mapping studies in wild-type mice revealed that gene is primarily expressed in the ventral SN , a region particularly susceptible to chemical and other dopaminergic neurotoxins .	T5	T20	23331067
NA	CHEMICAL	GENE-Y	9	2	Furthermore , gene-expressing SN cells are preferentially lost following chemical treatment .	T1	T21	23331067
NA	CHEMICAL	GENE-Y	15	6	Finally , SN mDA neurons in gene hemizygous mice show increased sensitivity when exposed to chemical .	T2	T6	23331067
NA	CHEMICAL	GENE-Y	14	15	Thus , SN mDA neurons are represented by at least two distinct subpopulations including chemical-resistant gene-autonomous , gene-positive neurons , and gene-negative gene-dependent cells that display elevated vulnerability to toxic injury , and probably correspond to the subpopulation that degenerates in PD .	T3	T8	23331067
NA	CHEMICAL	GENE-Y	14	17	Thus , SN mDA neurons are represented by at least two distinct subpopulations including chemical-resistant gene-autonomous , gene-positive neurons , and gene-negative gene-dependent cells that display elevated vulnerability to toxic injury , and probably correspond to the subpopulation that degenerates in PD .	T3	T9	23331067
NA	CHEMICAL	GENE-Y	14	21	Thus , SN mDA neurons are represented by at least two distinct subpopulations including chemical-resistant gene-autonomous , gene-positive neurons , and gene-negative gene-dependent cells that display elevated vulnerability to toxic injury , and probably correspond to the subpopulation that degenerates in PD .	T3	T10	23331067
NA	CHEMICAL	GENE-Y	14	22	Thus , SN mDA neurons are represented by at least two distinct subpopulations including chemical-resistant gene-autonomous , gene-positive neurons , and gene-negative gene-dependent cells that display elevated vulnerability to toxic injury , and probably correspond to the subpopulation that degenerates in PD .	T3	T11	23331067
NA	CHEMICAL	GENE-N	4	7	Psychopharmacology of anticonvulsants : chemical as a gene modulator .	T3	T6	15367040
NA	CHEMICAL	GENE-Y	8	6	Mechanism of the irreversible inactivation of gene by alpha-difluoromethylchemical .	T29	T44	1730582
NA	CHEMICAL	GENE-Y	6	0	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T23	T31	1730582
NA	CHEMICAL	GENE-Y	6	2	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T23	T36	1730582
NA	CHEMICAL	GENE-Y	22	0	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T6	T31	1730582
NA	CHEMICAL	GENE-Y	22	2	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T6	T36	1730582
CPR:4	CHEMICAL	GENE-Y	6	0	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T16	T31	1730582
CPR:4	CHEMICAL	GENE-Y	6	2	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T16	T36	1730582
CPR:4	CHEMICAL	GENE-Y	42	0	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T17	T31	1730582
CPR:4	CHEMICAL	GENE-Y	42	2	gene ( gene ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for chemical and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylchemical ( chemical ) .	T17	T36	1730582
NA	CHEMICAL	GENE-Y	1	5	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T18	T37	1730582
NA	CHEMICAL	GENE-Y	1	32	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T18	T38	1730582
NA	CHEMICAL	GENE-Y	3	5	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T19	T37	1730582
NA	CHEMICAL	GENE-Y	3	32	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T19	T38	1730582
NA	CHEMICAL	GENE-Y	4	5	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T20	T37	1730582
NA	CHEMICAL	GENE-Y	4	32	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T20	T38	1730582
NA	CHEMICAL	GENE-Y	23	5	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T21	T37	1730582
NA	CHEMICAL	GENE-Y	23	32	The chemical binding chemical in gene was identified as chemical 69 of the mouse sequence by reduction of the purified holoenzyme form with chemical followed by digestion of the carboxymethylated protein with gene , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	T21	T38	1730582
NA	CHEMICAL	GENE-N	1	7	This chemical is contained in the sequence gene , which is found in all known gene from eukaryotes .	T24	T39	1730582
NA	CHEMICAL	GENE-N	1	15	This chemical is contained in the sequence gene , which is found in all known gene from eukaryotes .	T24	T40	1730582
NA	CHEMICAL	GENE-N	2	11	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T26	T41	1730582
NA	CHEMICAL	GENE-N	2	20	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T26	T42	1730582
NA	CHEMICAL	GENE-N	2	26	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T26	T43	1730582
NA	CHEMICAL	GENE-N	16	11	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T27	T41	1730582
NA	CHEMICAL	GENE-N	16	20	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T27	T42	1730582
NA	CHEMICAL	GENE-N	16	26	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T27	T43	1730582
NA	CHEMICAL	GENE-N	18	11	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T28	T41	1730582
NA	CHEMICAL	GENE-N	18	20	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T28	T42	1730582
NA	CHEMICAL	GENE-N	18	26	The preceding chemical do not conform to the consensus sequence of gene , which contains the chemical binding chemical in a number of other gene including gene from E. coli .	T28	T43	1730582
NA	CHEMICAL	GENE-Y	11	6	Using a similar procedure to analyze gene labeled by reaction with chemical , it was found that chemical 69 and chemical 360 formed covalent adducts with the inhibitor .	T1	T32	1730582
NA	CHEMICAL	GENE-Y	17	6	Using a similar procedure to analyze gene labeled by reaction with chemical , it was found that chemical 69 and chemical 360 formed covalent adducts with the inhibitor .	T2	T32	1730582
NA	CHEMICAL	GENE-Y	6	6	Using a similar procedure to analyze gene labeled by reaction with chemical , it was found that chemical 69 and chemical 360 formed covalent adducts with the inhibitor .	T3	T32	1730582
NA	CHEMICAL	GENE-N	0	23	chemical 360 , which was the major adduct accounting for about 90 % of the total labeling , is contained within the sequence -gene- , which is present in all known gene .	T4	T33	1730582
NA	CHEMICAL	GENE-N	0	31	chemical 360 , which was the major adduct accounting for about 90 % of the total labeling , is contained within the sequence -gene- , which is present in all known gene .	T4	T34	1730582
CPR:4	CHEMICAL	GENE-Y	1	15	Both chemical also decreased CSE-induced ROS production , chemical formation and reduced the increase in gene and gene expressions caused by CSE .	T15	T24	22989703
CPR:4	CHEMICAL	GENE-Y	1	17	Both chemical also decreased CSE-induced ROS production , chemical formation and reduced the increase in gene and gene expressions caused by CSE .	T15	T25	22989703
NA	CHEMICAL	GENE-Y	8	15	Both chemical also decreased CSE-induced ROS production , chemical formation and reduced the increase in gene and gene expressions caused by CSE .	T16	T24	22989703
NA	CHEMICAL	GENE-Y	8	17	Both chemical also decreased CSE-induced ROS production , chemical formation and reduced the increase in gene and gene expressions caused by CSE .	T16	T25	22989703
NA	CHEMICAL	GENE-N	0	3	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T23	T38	16292755
NA	CHEMICAL	GENE-Y	0	6	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T23	T39	16292755
NA	CHEMICAL	GENE-N	3	3	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T26	T38	16292755
NA	CHEMICAL	GENE-Y	3	6	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T26	T39	16292755
NA	CHEMICAL	GENE-N	11	3	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T24	T38	16292755
NA	CHEMICAL	GENE-Y	11	6	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T24	T39	16292755
NA	CHEMICAL	GENE-N	16	3	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T25	T38	16292755
NA	CHEMICAL	GENE-Y	16	6	chemical supplementation alters gene-chemical concentration and gene activity in rabbits fed high-chemical diet : comparison with chemical .	T25	T39	16292755
CPR:4	CHEMICAL	GENE-N	0	7	chemical and chemical significantly suppressed an increase in plasma total-chemical ( total-C ) and gene chemical compared to HC-control group .	T10	T31	16292755
CPR:4	CHEMICAL	GENE-N	2	7	chemical and chemical significantly suppressed an increase in plasma total-chemical ( total-C ) and gene chemical compared to HC-control group .	T11	T31	16292755
NA	CHEMICAL	GENE-N	9	7	chemical and chemical significantly suppressed an increase in plasma total-chemical ( total-C ) and gene chemical compared to HC-control group .	T12	T31	16292755
NA	CHEMICAL	GENE-N	15	7	chemical and chemical significantly suppressed an increase in plasma total-chemical ( total-C ) and gene chemical compared to HC-control group .	T13	T31	16292755
NA	CHEMICAL	GENE-N	3	3	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T14	T32	16292755
NA	CHEMICAL	GENE-N	3	5	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T14	T33	16292755
NA	CHEMICAL	GENE-N	3	8	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T14	T34	16292755
NA	CHEMICAL	GENE-Y	3	13	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T14	T35	16292755
CPR:3	CHEMICAL	GENE-N	20	3	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T15	T32	16292755
CPR:3	CHEMICAL	GENE-N	20	5	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T15	T33	16292755
CPR:3	CHEMICAL	GENE-N	20	8	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T15	T34	16292755
CPR:3	CHEMICAL	GENE-Y	20	13	However , plasma gene-chemical ( gene-C ) and gene-C/total-C ratio levels and plasma gene activity were only significantly higher in chemical group after 8 weeks .	T15	T35	16292755
CPR:4	CHEMICAL	GENE-Y	8	1	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T16	T36	16292755
NA	CHEMICAL	GENE-Y	8	19	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T16	T37	16292755
CPR:4	CHEMICAL	GENE-Y	10	1	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T17	T36	16292755
NA	CHEMICAL	GENE-Y	10	19	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T17	T37	16292755
NA	CHEMICAL	GENE-Y	18	1	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T18	T36	16292755
NA	CHEMICAL	GENE-Y	18	19	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T18	T37	16292755
NA	CHEMICAL	GENE-Y	27	1	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T19	T36	16292755
CPR:3	CHEMICAL	GENE-Y	27	19	Hepatic gene activity was significantly lower in both chemical and chemical groups than in HC-control group , while chemical reductase activity was the highest only in the chemical group .	T19	T37	16292755
CPR:4	CHEMICAL	GENE-Y	4	4	Hepatic mRNA expressions of gene and gene were significantly lower in chemical group than in other groups .	T2	T27	16292755
CPR:4	CHEMICAL	GENE-Y	4	6	Hepatic mRNA expressions of gene and gene were significantly lower in chemical group than in other groups .	T2	T28	16292755
NA	CHEMICAL	GENE-Y	4	5	Because of their low chemical synthetase ( gene ) expression and chemical biosynthesis , acute lymphoblastic leukemia ( ALL ) cells are exquisitely sensitive to chemical depletion .	T4	T9	17380207
NA	CHEMICAL	GENE-Y	4	7	Because of their low chemical synthetase ( gene ) expression and chemical biosynthesis , acute lymphoblastic leukemia ( ALL ) cells are exquisitely sensitive to chemical depletion .	T4	T11	17380207
CPR:9	CHEMICAL	GENE-Y	11	5	Because of their low chemical synthetase ( gene ) expression and chemical biosynthesis , acute lymphoblastic leukemia ( ALL ) cells are exquisitely sensitive to chemical depletion .	T5	T9	17380207
CPR:9	CHEMICAL	GENE-Y	11	7	Because of their low chemical synthetase ( gene ) expression and chemical biosynthesis , acute lymphoblastic leukemia ( ALL ) cells are exquisitely sensitive to chemical depletion .	T5	T11	17380207
NA	CHEMICAL	GENE-Y	25	5	Because of their low chemical synthetase ( gene ) expression and chemical biosynthesis , acute lymphoblastic leukemia ( ALL ) cells are exquisitely sensitive to chemical depletion .	T3	T9	17380207
NA	CHEMICAL	GENE-Y	25	7	Because of their low chemical synthetase ( gene ) expression and chemical biosynthesis , acute lymphoblastic leukemia ( ALL ) cells are exquisitely sensitive to chemical depletion .	T3	T11	17380207
CPR:9	CHEMICAL	GENE-Y	0	9	chemical secretion by MSCs was directly related to their gene expression levels , suggesting a mechanism - increased concentrations of chemical in the leukemic cell microenvironment - for the protective effects we observed .	T1	T6	17380207
NA	CHEMICAL	GENE-Y	14	9	chemical secretion by MSCs was directly related to their gene expression levels , suggesting a mechanism - increased concentrations of chemical in the leukemic cell microenvironment - for the protective effects we observed .	T2	T6	17380207
NA	CHEMICAL	GENE-Y	6	6	By modulating expression levels of endogenous gene in primary cortical neurons , the frequency and amplitude of chemical oscillations is modified , implying a key role for gene in maintaining neuronal chemical homeostasis essential for synaptic transmission .	T1	T18	23495999
NA	CHEMICAL	GENE-Y	6	27	By modulating expression levels of endogenous gene in primary cortical neurons , the frequency and amplitude of chemical oscillations is modified , implying a key role for gene in maintaining neuronal chemical homeostasis essential for synaptic transmission .	T1	T20	23495999
NA	CHEMICAL	GENE-Y	23	6	By modulating expression levels of endogenous gene in primary cortical neurons , the frequency and amplitude of chemical oscillations is modified , implying a key role for gene in maintaining neuronal chemical homeostasis essential for synaptic transmission .	T2	T18	23495999
NA	CHEMICAL	GENE-Y	23	27	By modulating expression levels of endogenous gene in primary cortical neurons , the frequency and amplitude of chemical oscillations is modified , implying a key role for gene in maintaining neuronal chemical homeostasis essential for synaptic transmission .	T2	T20	23495999
NA	CHEMICAL	GENE-N	6	0	gene ( gene ) convert protein-bound chemical residues into chemical residues in a chemical ion-dependent manner .	T2	T4	15854045
NA	CHEMICAL	GENE-N	6	2	gene ( gene ) convert protein-bound chemical residues into chemical residues in a chemical ion-dependent manner .	T2	T8	15854045
NA	CHEMICAL	GENE-N	9	0	gene ( gene ) convert protein-bound chemical residues into chemical residues in a chemical ion-dependent manner .	T3	T4	15854045
NA	CHEMICAL	GENE-N	9	2	gene ( gene ) convert protein-bound chemical residues into chemical residues in a chemical ion-dependent manner .	T3	T8	15854045
NA	CHEMICAL	GENE-N	1	0	gene ( gene ) convert protein-bound chemical residues into chemical residues in a chemical ion-dependent manner .	T1	T4	15854045
NA	CHEMICAL	GENE-N	1	2	gene ( gene ) convert protein-bound chemical residues into chemical residues in a chemical ion-dependent manner .	T1	T8	15854045
CPR:9	CHEMICAL	GENE-N	4	1	The gene gene mediates chemical uptake at inner hair cell afferent synapses in the mammalian cochlea .	T16	T28	16855093
CPR:9	CHEMICAL	GENE-N	4	2	The gene gene mediates chemical uptake at inner hair cell afferent synapses in the mammalian cochlea .	T16	T27	16855093
NA	CHEMICAL	GENE-N	6	25	Focal application of the transporter substrate chemical elicited inward currents in IPCs , which were larger in the presence of anions that permeate the transporter-associated gene and blocked by the transporter antagonist chemical .	T8	T20	16855093
CPR:6	CHEMICAL	GENE-N	12	25	Focal application of the transporter substrate chemical elicited inward currents in IPCs , which were larger in the presence of anions that permeate the transporter-associated gene and blocked by the transporter antagonist chemical .	T9	T20	16855093
NA	CHEMICAL	GENE-Y	5	6	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T10	T21	16855093
NA	CHEMICAL	GENE-Y	5	8	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T10	T22	16855093
NA	CHEMICAL	GENE-Y	5	11	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T10	T23	16855093
NA	CHEMICAL	GENE-Y	5	21	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T10	T24	16855093
NA	CHEMICAL	GENE-Y	5	30	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T10	T25	16855093
NA	CHEMICAL	GENE-Y	5	38	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T10	T26	16855093
NA	CHEMICAL	GENE-Y	5	6	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T11	T21	16855093
NA	CHEMICAL	GENE-Y	5	8	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T11	T22	16855093
NA	CHEMICAL	GENE-Y	5	11	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T11	T23	16855093
NA	CHEMICAL	GENE-Y	5	21	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T11	T24	16855093
NA	CHEMICAL	GENE-Y	5	30	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T11	T25	16855093
NA	CHEMICAL	GENE-Y	5	38	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T11	T26	16855093
NA	CHEMICAL	GENE-Y	28	6	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T12	T21	16855093
NA	CHEMICAL	GENE-Y	28	8	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T12	T22	16855093
NA	CHEMICAL	GENE-Y	28	11	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T12	T23	16855093
NA	CHEMICAL	GENE-Y	28	21	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T12	T24	16855093
NA	CHEMICAL	GENE-Y	28	30	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T12	T25	16855093
NA	CHEMICAL	GENE-Y	28	38	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T12	T26	16855093
CPR:4	CHEMICAL	GENE-Y	19	6	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T13	T21	16855093
CPR:4	CHEMICAL	GENE-Y	19	8	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T13	T22	16855093
CPR:4	CHEMICAL	GENE-Y	19	11	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T13	T23	16855093
CPR:6	CHEMICAL	GENE-Y	19	21	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T13	T24	16855093
CPR:6	CHEMICAL	GENE-Y	19	30	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T13	T25	16855093
NA	CHEMICAL	GENE-Y	19	38	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T13	T26	16855093
NA	CHEMICAL	GENE-Y	24	6	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T14	T21	16855093
NA	CHEMICAL	GENE-Y	24	8	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T14	T22	16855093
NA	CHEMICAL	GENE-Y	24	11	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T14	T23	16855093
NA	CHEMICAL	GENE-Y	24	21	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T14	T24	16855093
NA	CHEMICAL	GENE-Y	24	30	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T14	T25	16855093
NA	CHEMICAL	GENE-Y	24	38	These currents were produced by chemical-chemical transporters ( gene ) ( gene ) because they were weakly inhibited by chemical , an antagonist of chemical transporter-1 ( excitatory chemical transporter 2 ) and were absent from IPCs in gene-/- cochleas .	T14	T26	16855093
NA	CHEMICAL	GENE-Y	2	23	Furthermore , chemical-induced currents in outside-out patches from IPCs exhibited larger steady-state currents than responses elicited by chemical , a prominent feature of gene , and examination of cochlea from gene-Discosoma red ( DsRed ) promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs .	T1	T17	16855093
NA	CHEMICAL	GENE-Y	2	30	Furthermore , chemical-induced currents in outside-out patches from IPCs exhibited larger steady-state currents than responses elicited by chemical , a prominent feature of gene , and examination of cochlea from gene-Discosoma red ( DsRed ) promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs .	T1	T18	16855093
CPR:9	CHEMICAL	GENE-Y	17	23	Furthermore , chemical-induced currents in outside-out patches from IPCs exhibited larger steady-state currents than responses elicited by chemical , a prominent feature of gene , and examination of cochlea from gene-Discosoma red ( DsRed ) promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs .	T2	T17	16855093
NA	CHEMICAL	GENE-Y	17	30	Furthermore , chemical-induced currents in outside-out patches from IPCs exhibited larger steady-state currents than responses elicited by chemical , a prominent feature of gene , and examination of cochlea from gene-Discosoma red ( DsRed ) promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs .	T2	T18	16855093
CPR:3	CHEMICAL	GENE-N	0	5	chemical/chemical dipole couples agonist binding to chemical receptor activation .	T11	T27	17581967
CPR:3	CHEMICAL	GENE-N	0	5	chemical/chemical dipole couples agonist binding to chemical receptor activation .	T13	T27	17581967
NA	CHEMICAL	GENE-N	6	5	chemical/chemical dipole couples agonist binding to chemical receptor activation .	T12	T27	17581967
NA	CHEMICAL	GENE-N	0	3	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T1	T14	17581967
NA	CHEMICAL	GENE-N	0	5	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T1	T19	17581967
NA	CHEMICAL	GENE-N	2	3	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T4	T14	17581967
NA	CHEMICAL	GENE-N	2	5	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T4	T19	17581967
CPR:3	CHEMICAL	GENE-N	9	3	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T6	T14	17581967
CPR:3	CHEMICAL	GENE-N	9	5	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T6	T19	17581967
CPR:3	CHEMICAL	GENE-N	11	3	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T7	T14	17581967
CPR:3	CHEMICAL	GENE-N	11	5	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T7	T19	17581967
CPR:3	CHEMICAL	GENE-N	17	3	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T2	T14	17581967
CPR:3	CHEMICAL	GENE-N	17	5	chemical-selective ionotropic chemical receptors ( gene ) require external chemical and chemical as well as the neurotransmitter chemical for activation .	T2	T19	17581967
NA	CHEMICAL	GENE-N	8	9	Although , external anions and cations apparently coactivate chemical receptors ( gene ) in an identical manner , it has yet to be established how ions of opposite charge achieve this .	T3	T16	17581967
NA	CHEMICAL	GENE-N	8	11	Although , external anions and cations apparently coactivate chemical receptors ( gene ) in an identical manner , it has yet to be established how ions of opposite charge achieve this .	T3	T17	17581967
NA	CHEMICAL	GENE-N	8	13	Consequently , other cation species may compete with chemical to regulate the time gene remain in the open state .	T5	T20	17581967
CPR:3	CHEMICAL	GENE-Y	2	7	Additionally , chemical and chemical ions coactivate gene receptors by establishing a dipole , accounting for their common effect on gene .	T8	T25	17581967
NA	CHEMICAL	GENE-N	2	20	Additionally , chemical and chemical ions coactivate gene receptors by establishing a dipole , accounting for their common effect on gene .	T8	T26	17581967
CPR:3	CHEMICAL	GENE-Y	4	7	Additionally , chemical and chemical ions coactivate gene receptors by establishing a dipole , accounting for their common effect on gene .	T9	T25	17581967
NA	CHEMICAL	GENE-N	4	20	Additionally , chemical and chemical ions coactivate gene receptors by establishing a dipole , accounting for their common effect on gene .	T9	T26	17581967
NA	CHEMICAL	GENE-Y	0	1	chemical transporter production and degradation rates : studies with chemical .	T8	T20	10546982
NA	CHEMICAL	GENE-Y	9	1	chemical transporter production and degradation rates : studies with chemical .	T9	T20	10546982
NA	CHEMICAL	GENE-Y	6	13	The objective of this study was to examine the turnover of the chemical transporter ( gene ) by determining its production rate ( r ) , degradation rate constant ( k ) and half-life of recovery ( t1/2 ) .	T6	T15	10546982
NA	CHEMICAL	GENE-Y	6	15	The objective of this study was to examine the turnover of the chemical transporter ( gene ) by determining its production rate ( r ) , degradation rate constant ( k ) and half-life of recovery ( t1/2 ) .	T6	T18	10546982
CPR:4	CHEMICAL	GENE-Y	16	3	The turnover of gene was determined from the rate of recovery of binding after administration of chemical , an irreversible inhibitor of ligand binding .	T2	T12	10546982
CPR:4	CHEMICAL	GENE-Y	12	21	In preliminary studies , in vitro incubation of rat cerebral cortex with chemical produced a wash and temperature resistant inhibition of gene binding densities ( Bmax ) .	T3	T13	10546982
NA	CHEMICAL	GENE-Y	0	7	chemical protected against the chemical-induced inhibition of gene binding .	T4	T14	10546982
CPR:4	CHEMICAL	GENE-Y	4	7	chemical protected against the chemical-induced inhibition of gene binding .	T5	T14	10546982
NA	CHEMICAL	GENE-Y	1	27	Following 6 h of in vivo intracerebroventricular injections of 100 nmol of chemical , there was a dose- and time-dependent reduction ( - 60 % ) of gene binding in hippocampus and striatum , without a change in the Kd .	T7	T16	10546982
CPR:4	CHEMICAL	GENE-N	1	5	State-dependent chemical block of chemical channel isoforms , chimeras , and channels coexpressed with the beta1 subunit .	T8	T23	9876137
NA	CHEMICAL	GENE-N	4	5	State-dependent chemical block of chemical channel isoforms , chimeras , and channels coexpressed with the beta1 subunit .	T9	T23	9876137
CPR:4	CHEMICAL	GENE-Y	0	3	chemical block of gene and gene was examined under whole-cell voltage clamp in transiently transfected HEK293t cells .	T1	T10	9876137
CPR:4	CHEMICAL	GENE-Y	0	5	chemical block of gene and gene was examined under whole-cell voltage clamp in transiently transfected HEK293t cells .	T1	T15	9876137
CPR:4	CHEMICAL	GENE-Y	0	3	chemical block of gene was greater than block of gene at voltages between -120 mV and -90 mV , suggesting that greater steady-state inactivation of gene in this voltage range makes them more susceptible to chemical block .	T5	T13	9876137
CPR:4	CHEMICAL	GENE-Y	0	9	chemical block of gene was greater than block of gene at voltages between -120 mV and -90 mV , suggesting that greater steady-state inactivation of gene in this voltage range makes them more susceptible to chemical block .	T5	T14	9876137
CPR:4	CHEMICAL	GENE-Y	0	25	chemical block of gene was greater than block of gene at voltages between -120 mV and -90 mV , suggesting that greater steady-state inactivation of gene in this voltage range makes them more susceptible to chemical block .	T5	T16	9876137
NA	CHEMICAL	GENE-Y	26	3	chemical block of gene was greater than block of gene at voltages between -120 mV and -90 mV , suggesting that greater steady-state inactivation of gene in this voltage range makes them more susceptible to chemical block .	T6	T13	9876137
NA	CHEMICAL	GENE-Y	26	9	chemical block of gene was greater than block of gene at voltages between -120 mV and -90 mV , suggesting that greater steady-state inactivation of gene in this voltage range makes them more susceptible to chemical block .	T6	T14	9876137
CPR:4	CHEMICAL	GENE-Y	26	25	chemical block of gene was greater than block of gene at voltages between -120 mV and -90 mV , suggesting that greater steady-state inactivation of gene in this voltage range makes them more susceptible to chemical block .	T6	T16	9876137
NA	CHEMICAL	GENE-Y	0	5	chemical decreased the stability of gene-mRNA and gene mRNA .	T11	T19	15446566
NA	CHEMICAL	GENE-Y	0	7	chemical decreased the stability of gene-mRNA and gene mRNA .	T11	T20	15446566
NA	CHEMICAL	GENE-N	1	11	Although chemical inhibits PG biosynthesis , most do not affect the gene activity of gene , which can generate proximate carcinogens .	T12	T24	15446566
NA	CHEMICAL	GENE-N	1	14	Although chemical inhibits PG biosynthesis , most do not affect the gene activity of gene , which can generate proximate carcinogens .	T12	T25	15446566
NA	CHEMICAL	GENE-Y	1	6	Because chemical does not completely inhibit gene expression or PG biosynthesis , a therapeutic strategy combining chemical with chemical might be more effective than using either agent alone .	T13	T26	15446566
NA	CHEMICAL	GENE-Y	16	6	Because chemical does not completely inhibit gene expression or PG biosynthesis , a therapeutic strategy combining chemical with chemical might be more effective than using either agent alone .	T14	T26	15446566
NA	CHEMICAL	GENE-Y	12	6	Because chemical does not completely inhibit gene expression or PG biosynthesis , a therapeutic strategy combining chemical with chemical might be more effective than using either agent alone .	T15	T26	15446566
NA	CHEMICAL	GENE-Y	3	4	The evolution of chemical receptor ligands .	T9	T15	17013809
NA	CHEMICAL	GENE-N	0	6	chemical is one of the first gene hormones to be described functionally and subsequently approached as a drug target .	T1	T12	17013809
NA	CHEMICAL	GENE-Y	1	13	Because chemical ( 1 ) affects both menstruation and gestation via the chemical receptor ( gene ) , research aimed at modulating its activity is usually surrounded by controversy .	T2	T10	17013809
NA	CHEMICAL	GENE-Y	1	15	Because chemical ( 1 ) affects both menstruation and gestation via the chemical receptor ( gene ) , research aimed at modulating its activity is usually surrounded by controversy .	T2	T11	17013809
NA	CHEMICAL	GENE-Y	12	13	Because chemical ( 1 ) affects both menstruation and gestation via the chemical receptor ( gene ) , research aimed at modulating its activity is usually surrounded by controversy .	T3	T10	17013809
NA	CHEMICAL	GENE-Y	12	15	Because chemical ( 1 ) affects both menstruation and gestation via the chemical receptor ( gene ) , research aimed at modulating its activity is usually surrounded by controversy .	T3	T11	17013809
NA	CHEMICAL	GENE-N	3	10	We assessed the chemical uptake kinetics , chemical dependence of transport , profiles of cis inhibition of uptake by cationic and neutral chemical , and sensitivity to trans stimulation of gene , and studied the expression of the genes encoding them by RT-PCR .	T15	T24	17065601
NA	CHEMICAL	GENE-N	7	10	We assessed the chemical uptake kinetics , chemical dependence of transport , profiles of cis inhibition of uptake by cationic and neutral chemical , and sensitivity to trans stimulation of gene , and studied the expression of the genes encoding them by RT-PCR .	T16	T24	17065601
NA	CHEMICAL	GENE-N	22	10	We assessed the chemical uptake kinetics , chemical dependence of transport , profiles of cis inhibition of uptake by cationic and neutral chemical , and sensitivity to trans stimulation of gene , and studied the expression of the genes encoding them by RT-PCR .	T17	T24	17065601
CPR:9	CHEMICAL	GENE-Y	4	22	Our data suggest that chemical is taken up by Sertoli cells and peritubular cells , principally via system y ( + ) L ( gene/gene ) and system y ( + ) ( gene and gene ) , with system B ( 0+ ) making a minor contribution .	T19	T25	17065601
NA	CHEMICAL	GENE-Y	4	22	Our data suggest that chemical is taken up by Sertoli cells and peritubular cells , principally via system y ( + ) L ( gene/gene ) and system y ( + ) ( gene and gene ) , with system B ( 0+ ) making a minor contribution .	T19	T26	17065601
NA	CHEMICAL	GENE-Y	4	22	Our data suggest that chemical is taken up by Sertoli cells and peritubular cells , principally via system y ( + ) L ( gene/gene ) and system y ( + ) ( gene and gene ) , with system B ( 0+ ) making a minor contribution .	T19	T27	17065601
NA	CHEMICAL	GENE-Y	4	22	Our data suggest that chemical is taken up by Sertoli cells and peritubular cells , principally via system y ( + ) L ( gene/gene ) and system y ( + ) ( gene and gene ) , with system B ( 0+ ) making a minor contribution .	T19	T28	17065601
NA	CHEMICAL	GENE-Y	18	16	By contrast , system B ( 0+ ) , associated with system y ( + ) L ( gene/gene and gene ) , made a major contribution to the transport of cationic chemical in pachytene spermatocytes and early spermatids .	T2	T29	17065601
NA	CHEMICAL	GENE-Y	18	16	By contrast , system B ( 0+ ) , associated with system y ( + ) L ( gene/gene and gene ) , made a major contribution to the transport of cationic chemical in pachytene spermatocytes and early spermatids .	T2	T30	17065601
NA	CHEMICAL	GENE-Y	18	16	By contrast , system B ( 0+ ) , associated with system y ( + ) L ( gene/gene and gene ) , made a major contribution to the transport of cationic chemical in pachytene spermatocytes and early spermatids .	T2	T31	17065601
NA	CHEMICAL	GENE-N	5	3	Furthermore , whereas gene induce chemical ( chemical ) production in peritubular and Sertoli cells , little or no upregulation of chemical transport by gene was observed in these cells .	T9	T21	17065601
NA	CHEMICAL	GENE-N	5	10	Furthermore , whereas gene induce chemical ( chemical ) production in peritubular and Sertoli cells , little or no upregulation of chemical transport by gene was observed in these cells .	T9	T22	17065601
NA	CHEMICAL	GENE-N	7	3	Furthermore , whereas gene induce chemical ( chemical ) production in peritubular and Sertoli cells , little or no upregulation of chemical transport by gene was observed in these cells .	T10	T21	17065601
NA	CHEMICAL	GENE-N	7	10	Furthermore , whereas gene induce chemical ( chemical ) production in peritubular and Sertoli cells , little or no upregulation of chemical transport by gene was observed in these cells .	T10	T22	17065601
NA	CHEMICAL	GENE-N	10	3	Furthermore , whereas gene induce chemical ( chemical ) production in peritubular and Sertoli cells , little or no upregulation of chemical transport by gene was observed in these cells .	T11	T21	17065601
NA	CHEMICAL	GENE-N	10	10	Furthermore , whereas gene induce chemical ( chemical ) production in peritubular and Sertoli cells , little or no upregulation of chemical transport by gene was observed in these cells .	T11	T22	17065601
NA	CHEMICAL	GENE-Y	3	0	gene-based design of a chemical prodrug .	T17	T27	23416065
CPR:4	CHEMICAL	GENE-Y	4	1	The gene inhibitor , chemical , is used in the clinic for its anti-inflammatory activity .	T5	T23	23416065
NA	CHEMICAL	GENE-Y	4	4	About 99 % of a dose of chemical is unavailable for reaction with the target enzyme , because chemical strongly binds to gene ( gene ) .	T2	T19	23416065
NA	CHEMICAL	GENE-Y	4	24	About 99 % of a dose of chemical is unavailable for reaction with the target enzyme , because chemical strongly binds to gene ( gene ) .	T2	T20	23416065
NA	CHEMICAL	GENE-Y	4	4	About 99 % of a dose of chemical is unavailable for reaction with the target enzyme , because chemical strongly binds to gene ( gene ) .	T3	T19	23416065
NA	CHEMICAL	GENE-Y	4	24	About 99 % of a dose of chemical is unavailable for reaction with the target enzyme , because chemical strongly binds to gene ( gene ) .	T3	T20	23416065
NA	CHEMICAL	GENE-Y	6	8	To reduce the binding affinity of chemical to gene , we designed and synthesized the prodrug chemical .	T4	T21	23416065
NA	CHEMICAL	GENE-Y	16	8	To reduce the binding affinity of chemical to gene , we designed and synthesized the prodrug chemical .	T6	T21	23416065
NA	CHEMICAL	GENE-Y	7	4	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T7	T22	23416065
NA	CHEMICAL	GENE-N	7	16	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T7	T24	23416065
NA	CHEMICAL	GENE-Y	9	4	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T8	T22	23416065
NA	CHEMICAL	GENE-N	9	16	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T8	T24	23416065
NA	CHEMICAL	GENE-Y	12	4	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T9	T22	23416065
NA	CHEMICAL	GENE-N	12	16	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T9	T24	23416065
NA	CHEMICAL	GENE-Y	24	4	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T10	T22	23416065
NA	CHEMICAL	GENE-N	24	16	The crystal structure of gene complexed with chemical and chemical revealed that chemical binds to the gene and that upon binding , it acetylates chemical 199 .	T10	T24	23416065
NA	CHEMICAL	GENE-Y	8	1	The gene had twofold weaker binding affinity for chemical as demonstrated by fluorescence quenching .	T13	T25	23416065
NA	CHEMICAL	GENE-Y	5	11	Reduced binding affinity means that chemical is more easily released from gene into the circulation .	T14	T26	23416065
NA	CHEMICAL	GENE-N	11	9	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T1	T9	23454527
NA	CHEMICAL	GENE-N	11	11	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T1	T10	23454527
NA	CHEMICAL	GENE-N	2	9	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T2	T9	23454527
NA	CHEMICAL	GENE-N	2	11	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T2	T10	23454527
NA	CHEMICAL	GENE-N	0	9	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T3	T9	23454527
NA	CHEMICAL	GENE-N	0	11	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T3	T10	23454527
CPR:4	CHEMICAL	GENE-N	15	9	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T4	T9	23454527
CPR:4	CHEMICAL	GENE-N	15	11	chemical ( chemical , 33 mM ) and the gene ( JchemicalK ) inhibitor ( chemical , 33 μM ) further decreased the viability in the presence of DEP ( 200 μg/ml ) and 3.3 % FCS .	T4	T10	23454527
NA	CHEMICAL	GENE-Y	15	11	The affinity and functional profile of opioids possessing activity at the gene was determined using [ 3H ] nociceptin and nociceptin-stimulated chemical binding .	T4	T31	10688973
CPR:5	CHEMICAL	GENE-Y	3	1	The gene-selective agonist chemical potently and competitively displaced [ 3H ] nociceptin at rat brain receptors ( IC ( 50 ) 62 nM ) .	T5	T32	10688973
CPR:5	CHEMICAL	GENE-Y	0	12	chemical exhibited full agonism for enhancement of chemical binding to human recombinant gene receptors ( EC ( 50 ) 50 nM ) .	T6	T33	10688973
NA	CHEMICAL	GENE-Y	7	12	chemical exhibited full agonism for enhancement of chemical binding to human recombinant gene receptors ( EC ( 50 ) 50 nM ) .	T7	T33	10688973
NA	CHEMICAL	GENE-N	2	9	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T8	T35	10688973
CPR:5	CHEMICAL	GENE-Y	2	15	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T8	T36	10688973
NA	CHEMICAL	GENE-N	3	9	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T9	T35	10688973
CPR:5	CHEMICAL	GENE-Y	3	15	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T9	T36	10688973
NA	CHEMICAL	GENE-N	5	9	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T10	T35	10688973
CPR:5	CHEMICAL	GENE-Y	5	15	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T10	T36	10688973
CPR:5	CHEMICAL	GENE-N	11	9	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T11	T35	10688973
CPR:5	CHEMICAL	GENE-Y	11	15	The related chemical chemical and chemical and the nonselective gene agonist chemical were less potent gene agonists .	T11	T36	10688973
CPR:6	CHEMICAL	GENE-Y	13	10	The kappa ( 1 ) +kappa ( 3 ) -opioid receptor agonist/gene antagonist chemical was a pure antagonist at both rat brain and human gene receptors .	T12	T37	10688973
CPR:6	CHEMICAL	GENE-N	13	3	The kappa ( 1 ) +kappa ( 3 ) -opioid receptor agonist/gene antagonist chemical was a pure antagonist at both rat brain and human gene receptors .	T12	T14	10688973
CPR:5	CHEMICAL	GENE-N	2	2	The nonselective gene partial agonist chemical and the nonselective gene antagonist chemical exhibited pure antagonism at rat brain receptors , but displayed partial agonism at gene receptors .	T1	T15	10688973
NA	CHEMICAL	GENE-N	2	9	The nonselective gene partial agonist chemical and the nonselective gene antagonist chemical exhibited pure antagonism at rat brain receptors , but displayed partial agonism at gene receptors .	T1	T16	10688973
NA	CHEMICAL	GENE-Y	2	25	The nonselective gene partial agonist chemical and the nonselective gene antagonist chemical exhibited pure antagonism at rat brain receptors , but displayed partial agonism at gene receptors .	T1	T19	10688973
NA	CHEMICAL	GENE-N	11	2	The nonselective gene partial agonist chemical and the nonselective gene antagonist chemical exhibited pure antagonism at rat brain receptors , but displayed partial agonism at gene receptors .	T2	T15	10688973
CPR:6	CHEMICAL	GENE-N	11	9	The nonselective gene partial agonist chemical and the nonselective gene antagonist chemical exhibited pure antagonism at rat brain receptors , but displayed partial agonism at gene receptors .	T2	T16	10688973
CPR:5	CHEMICAL	GENE-Y	11	25	The nonselective gene partial agonist chemical and the nonselective gene antagonist chemical exhibited pure antagonism at rat brain receptors , but displayed partial agonism at gene receptors .	T2	T19	10688973
NA	CHEMICAL	GENE-N	17	7	In addition , the stereospecificity required at gene appears to be retained at the gene , since chemical is inactive at both receptors .	T3	T24	10688973
NA	CHEMICAL	GENE-Y	17	9	In addition , the stereospecificity required at gene appears to be retained at the gene , since chemical is inactive at both receptors .	T3	T25	10688973
NA	CHEMICAL	GENE-Y	10	2	Toxicity of gene in HEK293 cells expressing gene/gene or gene/gene chemical receptor subunits .	T19	T57	17403555
NA	CHEMICAL	GENE-Y	10	7	Toxicity of gene in HEK293 cells expressing gene/gene or gene/gene chemical receptor subunits .	T19	T58	17403555
NA	CHEMICAL	GENE-Y	10	7	Toxicity of gene in HEK293 cells expressing gene/gene or gene/gene chemical receptor subunits .	T19	T59	17403555
NA	CHEMICAL	GENE-Y	10	9	Toxicity of gene in HEK293 cells expressing gene/gene or gene/gene chemical receptor subunits .	T19	T60	17403555
NA	CHEMICAL	GENE-Y	10	9	Toxicity of gene in HEK293 cells expressing gene/gene or gene/gene chemical receptor subunits .	T19	T61	17403555
NA	CHEMICAL	GENE-N	10	8	Toxicity of gene in HEK293 cells expressing gene/gene or gene/gene chemical receptor subunits .	T19	T62	17403555
NA	CHEMICAL	GENE-Y	8	3	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T14	T36	17403555
NA	CHEMICAL	GENE-Y	8	5	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T14	T45	17403555
NA	CHEMICAL	GENE-N	8	19	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T14	T25	17403555
NA	CHEMICAL	GENE-Y	8	3	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T1	T36	17403555
NA	CHEMICAL	GENE-Y	8	5	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T1	T45	17403555
NA	CHEMICAL	GENE-N	8	19	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T1	T25	17403555
NA	CHEMICAL	GENE-Y	17	3	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T6	T36	17403555
NA	CHEMICAL	GENE-Y	17	5	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T6	T45	17403555
NA	CHEMICAL	GENE-N	17	19	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T6	T25	17403555
NA	CHEMICAL	GENE-Y	24	3	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T9	T36	17403555
NA	CHEMICAL	GENE-Y	24	5	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T9	T45	17403555
NA	CHEMICAL	GENE-N	24	19	Neurotoxicity induced by gene ( gene ) involves chemical toxicity , resulting from overactivation of chemical ( chemical ) receptors and elevation of intracellular chemical .	T9	T25	17403555
NA	CHEMICAL	GENE-N	6	7	However , the heterogeneity of the chemical receptors , frequently composed of gene and gene subunits , has been less studied .	T10	T35	17403555
NA	CHEMICAL	GENE-Y	6	12	However , the heterogeneity of the chemical receptors , frequently composed of gene and gene subunits , has been less studied .	T10	T37	17403555
NA	CHEMICAL	GENE-N	6	14	However , the heterogeneity of the chemical receptors , frequently composed of gene and gene subunits , has been less studied .	T10	T38	17403555
NA	CHEMICAL	GENE-N	7	8	Thus , we determined the contribution of chemical receptor subtypes on gene toxicity in HEK293 cells transiently expressing gene/gene or gene/gene subunits .	T11	T39	17403555
NA	CHEMICAL	GENE-Y	7	11	Thus , we determined the contribution of chemical receptor subtypes on gene toxicity in HEK293 cells transiently expressing gene/gene or gene/gene subunits .	T11	T40	17403555
NA	CHEMICAL	GENE-Y	7	18	Thus , we determined the contribution of chemical receptor subtypes on gene toxicity in HEK293 cells transiently expressing gene/gene or gene/gene subunits .	T11	T41	17403555
NA	CHEMICAL	GENE-Y	7	18	Thus , we determined the contribution of chemical receptor subtypes on gene toxicity in HEK293 cells transiently expressing gene/gene or gene/gene subunits .	T11	T42	17403555
NA	CHEMICAL	GENE-Y	7	20	Thus , we determined the contribution of chemical receptor subtypes on gene toxicity in HEK293 cells transiently expressing gene/gene or gene/gene subunits .	T11	T43	17403555
NA	CHEMICAL	GENE-Y	7	20	Thus , we determined the contribution of chemical receptor subtypes on gene toxicity in HEK293 cells transiently expressing gene/gene or gene/gene subunits .	T11	T44	17403555
NA	CHEMICAL	GENE-N	2	3	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T46	17403555
NA	CHEMICAL	GENE-N	2	5	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T47	17403555
NA	CHEMICAL	GENE-Y	2	4	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T48	17403555
NA	CHEMICAL	GENE-Y	2	18	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T49	17403555
NA	CHEMICAL	GENE-Y	2	18	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T50	17403555
NA	CHEMICAL	GENE-Y	2	23	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T51	17403555
NA	CHEMICAL	GENE-Y	2	23	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T12	T52	17403555
NA	CHEMICAL	GENE-N	9	3	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T46	17403555
NA	CHEMICAL	GENE-N	9	5	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T47	17403555
NA	CHEMICAL	GENE-Y	9	4	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T48	17403555
NA	CHEMICAL	GENE-Y	9	18	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T49	17403555
NA	CHEMICAL	GENE-Y	9	18	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T50	17403555
NA	CHEMICAL	GENE-Y	9	23	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T51	17403555
NA	CHEMICAL	GENE-Y	9	23	Analysis of chemical dehydrogenase ( gene ) release and chemical exclusion revealed an increase in gene toxicity upon gene/gene expression , compared to gene/gene , indicating loss of plasma membrane integrity .	T13	T52	17403555
NA	CHEMICAL	GENE-Y	5	2	Furthermore , gene decreased intracellular chemical in cells expressing gene/gene .	T15	T53	17403555
NA	CHEMICAL	GENE-Y	5	9	Furthermore , gene decreased intracellular chemical in cells expressing gene/gene .	T15	T54	17403555
NA	CHEMICAL	GENE-Y	5	9	Furthermore , gene decreased intracellular chemical in cells expressing gene/gene .	T15	T55	17403555
CPR:6	CHEMICAL	GENE-N	0	8	chemical ( chemical ) , a noncompetitive chemical receptor antagonist , partially prevented the decrease in cell viability and the energy impairment .	T16	T56	17403555
CPR:6	CHEMICAL	GENE-N	2	8	chemical ( chemical ) , a noncompetitive chemical receptor antagonist , partially prevented the decrease in cell viability and the energy impairment .	T17	T56	17403555
NA	CHEMICAL	GENE-N	7	8	chemical ( chemical ) , a noncompetitive chemical receptor antagonist , partially prevented the decrease in cell viability and the energy impairment .	T18	T56	17403555
NA	CHEMICAL	GENE-Y	1	1	Functional gene/gene and gene/gene receptor subtypes were further evidenced by single-cell chemical imaging .	T2	T21	17403555
NA	CHEMICAL	GENE-Y	1	1	Functional gene/gene and gene/gene receptor subtypes were further evidenced by single-cell chemical imaging .	T2	T22	17403555
NA	CHEMICAL	GENE-Y	1	3	Functional gene/gene and gene/gene receptor subtypes were further evidenced by single-cell chemical imaging .	T2	T23	17403555
NA	CHEMICAL	GENE-Y	1	3	Functional gene/gene and gene/gene receptor subtypes were further evidenced by single-cell chemical imaging .	T2	T24	17403555
NA	CHEMICAL	GENE-Y	5	2	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T3	T26	17403555
NA	CHEMICAL	GENE-Y	5	2	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T3	T27	17403555
NA	CHEMICAL	GENE-Y	5	16	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T3	T28	17403555
NA	CHEMICAL	GENE-Y	5	2	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T4	T26	17403555
NA	CHEMICAL	GENE-Y	5	2	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T4	T27	17403555
NA	CHEMICAL	GENE-Y	5	16	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T4	T28	17403555
NA	CHEMICAL	GENE-Y	11	2	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T5	T26	17403555
NA	CHEMICAL	GENE-Y	11	2	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T5	T27	17403555
NA	CHEMICAL	GENE-Y	11	16	Stimulation of gene/gene receptors with chemical/chemical revealed an increase in intracellular chemical in cells pre-exposed to gene .	T5	T28	17403555
NA	CHEMICAL	GENE-N	1	9	The gene isoform , additionally , has an chemical-terminal gene .	T6	T17	23382379
NA	CHEMICAL	GENE-N	7	0	gene binding was unchanged by presence of chemical .	T1	T21	23382379
NA	CHEMICAL	GENE-Y	4	1	Both gene isoforms bound chemical , but the rate of chemical hydrolysis was very slow ( < 0.002 s ( -1 ) ) and not significantly enhanced by gene .	T2	T7	23382379
NA	CHEMICAL	GENE-N	4	28	Both gene isoforms bound chemical , but the rate of chemical hydrolysis was very slow ( < 0.002 s ( -1 ) ) and not significantly enhanced by gene .	T2	T8	23382379
NA	CHEMICAL	GENE-Y	10	1	Both gene isoforms bound chemical , but the rate of chemical hydrolysis was very slow ( < 0.002 s ( -1 ) ) and not significantly enhanced by gene .	T3	T7	23382379
NA	CHEMICAL	GENE-N	10	28	Both gene isoforms bound chemical , but the rate of chemical hydrolysis was very slow ( < 0.002 s ( -1 ) ) and not significantly enhanced by gene .	T3	T8	23382379
NA	CHEMICAL	GENE-Y	10	25	Phosphorylation of the regulatory light chain had no effect on chemical hydrolysis , and neither did the addition of tropomyosin or of GOLPH3 , a gene binding partner .	T4	T9	23382379
NA	CHEMICAL	GENE-Y	32	3	Electron microscopy of gene-S1 showed that the lever is strongly angled with respect to the long axis of the motor domain , suggesting a pre-power stroke conformation regardless of the presence of chemical .	T5	T10	23382379
CPR:4	CHEMICAL	GENE-N	25	2	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T3	T21	16425993
CPR:4	CHEMICAL	GENE-N	25	35	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T3	T23	16425993
CPR:4	CHEMICAL	GENE-Y	25	39	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T3	T24	16425993
CPR:4	CHEMICAL	GENE-N	2	2	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T4	T21	16425993
CPR:4	CHEMICAL	GENE-N	2	35	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T4	T23	16425993
CPR:4	CHEMICAL	GENE-Y	2	39	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T4	T24	16425993
CPR:4	CHEMICAL	GENE-N	30	2	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T5	T21	16425993
CPR:4	CHEMICAL	GENE-N	30	35	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T5	T23	16425993
CPR:4	CHEMICAL	GENE-Y	30	39	Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways , including the multiple-gene inhibitors ( MKIs ) chemical , chemical , and chemical , which target multiple gene as well as gene .	T5	T24	16425993
CPR:4	CHEMICAL	GENE-Y	0	9	chemical has the added advantage of inhibiting multiple different gene isoforms , which enables it to target gene/gene signaling and may also enhance its inhibition of gene and gene .	T6	T25	16425993
CPR:4	CHEMICAL	GENE-Y	0	17	chemical has the added advantage of inhibiting multiple different gene isoforms , which enables it to target gene/gene signaling and may also enhance its inhibition of gene and gene .	T6	T26	16425993
CPR:4	CHEMICAL	GENE-Y	0	17	chemical has the added advantage of inhibiting multiple different gene isoforms , which enables it to target gene/gene signaling and may also enhance its inhibition of gene and gene .	T6	T27	16425993
CPR:4	CHEMICAL	GENE-N	0	26	chemical has the added advantage of inhibiting multiple different gene isoforms , which enables it to target gene/gene signaling and may also enhance its inhibition of gene and gene .	T6	T28	16425993
CPR:4	CHEMICAL	GENE-Y	0	28	chemical has the added advantage of inhibiting multiple different gene isoforms , which enables it to target gene/gene signaling and may also enhance its inhibition of gene and gene .	T6	T29	16425993
NA	CHEMICAL	GENE-Y	0	1	chemical synthase activity was decreased when the assay was performed under both optimal and suboptimal reducing conditions , suggesting heterogeneity in the cblE disease .	T12	T16	3812589
NA	CHEMICAL	GENE-N	4	3	We apply DFTB in a QM/MM framework to perform vibrational analysis of buried chemical in gene and gene .	T6	T11	23385325
NA	CHEMICAL	GENE-N	4	3	We apply DFTB in a QM/MM framework to perform vibrational analysis of buried chemical in gene and gene .	T6	T12	23385325
NA	CHEMICAL	GENE-N	14	7	Sequential polymerase chain reaction experiments were performed to amplify a unique sequence representing a chemical-binding protein ( G-protein ) -coupled receptor from rat hypothalamic cDNA .	T1	T24	8384716
NA	CHEMICAL	GENE-Y	1	19	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T14	T35	8384716
NA	CHEMICAL	GENE-Y	1	21	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T14	T36	8384716
NA	CHEMICAL	GENE-Y	1	24	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T14	T37	8384716
NA	CHEMICAL	GENE-Y	5	19	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T15	T35	8384716
NA	CHEMICAL	GENE-Y	5	21	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T15	T36	8384716
NA	CHEMICAL	GENE-Y	5	24	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T15	T37	8384716
NA	CHEMICAL	GENE-Y	26	19	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T16	T35	8384716
NA	CHEMICAL	GENE-Y	26	21	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T16	T36	8384716
NA	CHEMICAL	GENE-Y	26	24	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T16	T37	8384716
NA	CHEMICAL	GENE-Y	3	19	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T17	T35	8384716
NA	CHEMICAL	GENE-Y	3	21	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T17	T36	8384716
NA	CHEMICAL	GENE-Y	3	24	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T17	T37	8384716
NA	CHEMICAL	GENE-Y	30	19	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T18	T35	8384716
NA	CHEMICAL	GENE-Y	30	21	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T18	T36	8384716
NA	CHEMICAL	GENE-Y	30	24	Degenerate chemical corresponding to conserved chemical from transmembrane domains III , V , and VI of known receptors [ gene , gene , and gene ; chemical is chemical ( chemical ) ] were used as primers for the sequential reactions .	T18	T37	8384716
NA	CHEMICAL	GENE-Y	9	19	The resulting product was subcloned and used to screen a rat genomic library to identify a full-length clone ( gene ) containing an gene encoding a gene .	T19	T38	8384716
NA	CHEMICAL	GENE-N	9	9	The resulting product was subcloned and used to screen a rat genomic library to identify a full-length clone ( gene ) containing an gene encoding a gene .	T19	T39	8384716
NA	CHEMICAL	GENE-N	9	26	The resulting product was subcloned and used to screen a rat genomic library to identify a full-length clone ( gene ) containing an gene encoding a gene .	T19	T40	8384716
NA	CHEMICAL	GENE-Y	22	27	Within the conserved transmembrane domains , the sequences exhibit approximately 52 % , 59 % , 65 % , and 68 % chemical identity with the known gene , gene , gene , and gene receptors , respectively .	T21	T41	8384716
NA	CHEMICAL	GENE-Y	22	29	Within the conserved transmembrane domains , the sequences exhibit approximately 52 % , 59 % , 65 % , and 68 % chemical identity with the known gene , gene , gene , and gene receptors , respectively .	T21	T42	8384716
NA	CHEMICAL	GENE-Y	22	31	Within the conserved transmembrane domains , the sequences exhibit approximately 52 % , 59 % , 65 % , and 68 % chemical identity with the known gene , gene , gene , and gene receptors , respectively .	T21	T43	8384716
NA	CHEMICAL	GENE-Y	22	34	Within the conserved transmembrane domains , the sequences exhibit approximately 52 % , 59 % , 65 % , and 68 % chemical identity with the known gene , gene , gene , and gene receptors , respectively .	T21	T44	8384716
CPR:5	CHEMICAL	GENE-Y	10	8	The specific binding is displaced by the selective gene agonist chemical but not by the mixed gene agonist chemical .	T6	T25	8384716
NA	CHEMICAL	GENE-N	10	16	The specific binding is displaced by the selective gene agonist chemical but not by the mixed gene agonist chemical .	T6	T26	8384716
NA	CHEMICAL	GENE-Y	18	8	The specific binding is displaced by the selective gene agonist chemical but not by the mixed gene agonist chemical .	T7	T25	8384716
NA	CHEMICAL	GENE-N	18	16	The specific binding is displaced by the selective gene agonist chemical but not by the mixed gene agonist chemical .	T7	T26	8384716
NA	CHEMICAL	GENE-Y	10	5	HeLa cells transfected with the gene gene exhibited inhibition of chemical cyclase in response to chemical .	T11	T27	8384716
NA	CHEMICAL	GENE-N	10	11	HeLa cells transfected with the gene gene exhibited inhibition of chemical cyclase in response to chemical .	T11	T28	8384716
NA	CHEMICAL	GENE-Y	12	5	HeLa cells transfected with the gene gene exhibited inhibition of chemical cyclase in response to chemical .	T12	T27	8384716
CPR:4	CHEMICAL	GENE-N	12	11	HeLa cells transfected with the gene gene exhibited inhibition of chemical cyclase in response to chemical .	T12	T28	8384716
NA	CHEMICAL	GENE-N	3	4	Pharmacological properties of chemical receptor antagonists .	T33	T45	10579749
NA	CHEMICAL	GENE-Y	13	19	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T29	T43	10579749
NA	CHEMICAL	GENE-Y	13	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T29	T37	10579749
NA	CHEMICAL	GENE-Y	13	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T29	T38	10579749
NA	CHEMICAL	GENE-Y	13	15	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T29	T39	10579749
NA	CHEMICAL	GENE-Y	13	56	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T29	T40	10579749
NA	CHEMICAL	GENE-Y	13	66	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T29	T41	10579749
NA	CHEMICAL	GENE-Y	55	19	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T16	T43	10579749
NA	CHEMICAL	GENE-Y	55	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T16	T37	10579749
NA	CHEMICAL	GENE-Y	55	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T16	T38	10579749
NA	CHEMICAL	GENE-Y	55	15	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T16	T39	10579749
NA	CHEMICAL	GENE-Y	55	56	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T16	T40	10579749
NA	CHEMICAL	GENE-Y	55	66	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T16	T41	10579749
NA	CHEMICAL	GENE-Y	33	19	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T17	T43	10579749
NA	CHEMICAL	GENE-Y	33	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T17	T37	10579749
NA	CHEMICAL	GENE-Y	33	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T17	T38	10579749
NA	CHEMICAL	GENE-Y	33	15	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T17	T39	10579749
NA	CHEMICAL	GENE-Y	33	56	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T17	T40	10579749
NA	CHEMICAL	GENE-Y	33	66	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T17	T41	10579749
NA	CHEMICAL	GENE-Y	56	19	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T18	T43	10579749
NA	CHEMICAL	GENE-Y	56	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T18	T37	10579749
NA	CHEMICAL	GENE-Y	56	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T18	T38	10579749
NA	CHEMICAL	GENE-Y	56	15	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T18	T39	10579749
NA	CHEMICAL	GENE-Y	56	56	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T18	T40	10579749
NA	CHEMICAL	GENE-Y	56	66	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T18	T41	10579749
NA	CHEMICAL	GENE-Y	64	19	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T19	T43	10579749
NA	CHEMICAL	GENE-Y	64	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T19	T37	10579749
NA	CHEMICAL	GENE-Y	64	33	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T19	T38	10579749
NA	CHEMICAL	GENE-Y	64	15	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T19	T39	10579749
NA	CHEMICAL	GENE-Y	64	56	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T19	T40	10579749
NA	CHEMICAL	GENE-Y	64	66	The availability of selective , potent , orally active and long acting nonpeptide chemical type 1 ( gene ) receptor antagonists has provided the opportunity to obtain the benefits of selectively blocking the gene-gene-chemical system at the level of the AT1 receptor that mediates most , if not all , of the important actions of chemical II , and avoid the nonspecificity of the chemical converting enzyme inhibitors .	T19	T41	10579749
CPR:6	CHEMICAL	GENE-Y	0	13	chemical was the first , but by no means remained the only , gene receptor antagonist .	T20	T42	10579749
CPR:6	CHEMICAL	GENE-Y	23	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T30	T44	10579749
CPR:6	CHEMICAL	GENE-Y	21	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T31	T44	10579749
CPR:6	CHEMICAL	GENE-Y	19	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T32	T44	10579749
CPR:6	CHEMICAL	GENE-Y	35	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T1	T44	10579749
CPR:6	CHEMICAL	GENE-Y	39	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T2	T44	10579749
CPR:6	CHEMICAL	GENE-Y	23	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T3	T44	10579749
CPR:6	CHEMICAL	GENE-Y	3	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T4	T44	10579749
CPR:6	CHEMICAL	GENE-Y	50	3	Among the current gene receptor antagonists , the rank order of the relative binding affinities ( highest affinity = 1 ) is : chemical 1 , chemical 10 , chemical ( the active metabolite of chemical ) 10 , chemical 20 , chemical 50 , chemical 100 and the prodrug chemical 280 .	T5	T44	10579749
CPR:6	CHEMICAL	GENE-Y	15	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T6	T34	10579749
CPR:6	CHEMICAL	GENE-Y	12	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T7	T34	10579749
CPR:6	CHEMICAL	GENE-Y	19	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T8	T34	10579749
CPR:6	CHEMICAL	GENE-Y	24	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T9	T34	10579749
CPR:6	CHEMICAL	GENE-Y	26	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T10	T34	10579749
CPR:6	CHEMICAL	GENE-Y	12	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T11	T34	10579749
CPR:6	CHEMICAL	GENE-Y	30	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T12	T34	10579749
CPR:6	CHEMICAL	GENE-Y	32	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T13	T34	10579749
CPR:6	CHEMICAL	GENE-Y	34	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T14	T34	10579749
CPR:6	CHEMICAL	GENE-Y	36	6	The mode of ( functional ) gene receptor antagonism has been characterized as surmountable/noncompetitive ( chemical , chemical , chemical ) or insurmountable/noncompetitive ( chemical , chemical , chemical , chemical , chemical , chemical , chemical ) .	T15	T34	10579749
NA	CHEMICAL	GENE-Y	6	15	The sCT released from NP stimulated chemical production in human T47D breast cancer cells expressing gene .	T1	T10	23391443
NA	CHEMICAL	GENE-Y	0	11	chemical biosynthesis in plants : molecular and functional characterization of chemical synthetase and three isoforms of gene in Arabidopsis thaliana .	T20	T38	11752472
NA	CHEMICAL	GENE-N	0	11	chemical biosynthesis in plants : molecular and functional characterization of chemical synthetase and three isoforms of gene in Arabidopsis thaliana .	T20	T37	11752472
NA	CHEMICAL	GENE-Y	9	11	chemical biosynthesis in plants : molecular and functional characterization of chemical synthetase and three isoforms of gene in Arabidopsis thaliana .	T21	T38	11752472
NA	CHEMICAL	GENE-N	9	11	chemical biosynthesis in plants : molecular and functional characterization of chemical synthetase and three isoforms of gene in Arabidopsis thaliana .	T21	T37	11752472
NA	CHEMICAL	GENE-Y	4	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T5	T26	11752472
NA	CHEMICAL	GENE-Y	4	11	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T5	T27	11752472
NA	CHEMICAL	GENE-N	4	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T5	T28	11752472
NA	CHEMICAL	GENE-N	4	17	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T5	T29	11752472
NA	CHEMICAL	GENE-Y	8	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T9	T26	11752472
NA	CHEMICAL	GENE-Y	8	11	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T9	T27	11752472
NA	CHEMICAL	GENE-N	8	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T9	T28	11752472
NA	CHEMICAL	GENE-N	8	17	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T9	T29	11752472
NA	CHEMICAL	GENE-Y	14	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T11	T26	11752472
NA	CHEMICAL	GENE-Y	14	11	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T11	T27	11752472
NA	CHEMICAL	GENE-N	14	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T11	T28	11752472
NA	CHEMICAL	GENE-N	14	17	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T11	T29	11752472
NA	CHEMICAL	GENE-Y	23	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T12	T26	11752472
NA	CHEMICAL	GENE-Y	23	11	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T12	T27	11752472
NA	CHEMICAL	GENE-N	23	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T12	T28	11752472
NA	CHEMICAL	GENE-N	23	17	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T12	T29	11752472
NA	CHEMICAL	GENE-Y	27	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T13	T26	11752472
NA	CHEMICAL	GENE-Y	27	11	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T13	T27	11752472
NA	CHEMICAL	GENE-N	27	9	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T13	T28	11752472
NA	CHEMICAL	GENE-N	27	17	In organisms that synthesize chemical de novo , chemical synthetase ( gene ) and chemical synthetase ( gene ) catalyze the attachment of chemical residues to the chemical molecule .	T13	T29	11752472
NA	CHEMICAL	GENE-Y	24	14	The function of each enzyme was demonstrated by complementation of yeast mutants deficient in gene or gene activity , and by measuring in vitro chemical incorporation into chemical or chemical .	T16	T32	11752472
NA	CHEMICAL	GENE-Y	24	16	The function of each enzyme was demonstrated by complementation of yeast mutants deficient in gene or gene activity , and by measuring in vitro chemical incorporation into chemical or chemical .	T16	T33	11752472
NA	CHEMICAL	GENE-Y	2	14	The function of each enzyme was demonstrated by complementation of yeast mutants deficient in gene or gene activity , and by measuring in vitro chemical incorporation into chemical or chemical .	T17	T32	11752472
NA	CHEMICAL	GENE-Y	2	16	The function of each enzyme was demonstrated by complementation of yeast mutants deficient in gene or gene activity , and by measuring in vitro chemical incorporation into chemical or chemical .	T17	T33	11752472
NA	CHEMICAL	GENE-Y	2	14	The function of each enzyme was demonstrated by complementation of yeast mutants deficient in gene or gene activity , and by measuring in vitro chemical incorporation into chemical or chemical .	T18	T32	11752472
NA	CHEMICAL	GENE-Y	2	16	The function of each enzyme was demonstrated by complementation of yeast mutants deficient in gene or gene activity , and by measuring in vitro chemical incorporation into chemical or chemical .	T18	T33	11752472
CPR:9	CHEMICAL	GENE-Y	14	0	gene is present exclusively in the mitochondria , making this compartment the sole site of synthesis of chemical in the plant cell .	T19	T34	11752472
NA	CHEMICAL	GENE-N	2	3	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T2	T36	11752472
NA	CHEMICAL	GENE-N	2	19	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T2	T22	11752472
NA	CHEMICAL	GENE-N	2	23	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T2	T23	11752472
NA	CHEMICAL	GENE-N	3	3	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T3	T36	11752472
NA	CHEMICAL	GENE-N	3	19	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T3	T22	11752472
NA	CHEMICAL	GENE-N	3	23	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T3	T23	11752472
NA	CHEMICAL	GENE-N	2	3	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T4	T36	11752472
NA	CHEMICAL	GENE-N	2	19	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T4	T22	11752472
NA	CHEMICAL	GENE-N	2	23	The compartmentation of gene isoforms is in agreement with the predominance of chemical derivatives and the presence of chemical hydroxymethyltransferase and chemical interconverting enzymes in the cytosol , the mitochondria , and the plastids .	T4	T23	11752472
NA	CHEMICAL	GENE-N	8	5	Thus , the combination of gene with these chemical-mediated reactions can supply each compartment with the polyglutamylated chemical coenzymes required for the reactions of chemical metabolism .	T6	T24	11752472
NA	CHEMICAL	GENE-N	17	5	Thus , the combination of gene with these chemical-mediated reactions can supply each compartment with the polyglutamylated chemical coenzymes required for the reactions of chemical metabolism .	T7	T24	11752472
NA	CHEMICAL	GENE-N	24	5	Thus , the combination of gene with these chemical-mediated reactions can supply each compartment with the polyglutamylated chemical coenzymes required for the reactions of chemical metabolism .	T8	T24	11752472
NA	CHEMICAL	GENE-N	4	8	chi-Conopeptide MrIA partially overlaps chemical and chemical binding sites on the gene .	T13	T26	12837768
NA	CHEMICAL	GENE-Y	4	11	chi-Conopeptide MrIA partially overlaps chemical and chemical binding sites on the gene .	T13	T27	12837768
NA	CHEMICAL	GENE-N	6	8	chi-Conopeptide MrIA partially overlaps chemical and chemical binding sites on the gene .	T14	T26	12837768
NA	CHEMICAL	GENE-Y	6	11	chi-Conopeptide MrIA partially overlaps chemical and chemical binding sites on the gene .	T14	T27	12837768
CPR:9	CHEMICAL	GENE-Y	13	11	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T5	T19	12837768
NA	CHEMICAL	GENE-Y	13	29	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T5	T20	12837768
NA	CHEMICAL	GENE-Y	13	32	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T5	T21	12837768
CPR:9	CHEMICAL	GENE-Y	20	11	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T6	T19	12837768
NA	CHEMICAL	GENE-Y	20	29	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T6	T20	12837768
NA	CHEMICAL	GENE-Y	20	32	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T6	T21	12837768
NA	CHEMICAL	GENE-Y	31	11	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T8	T19	12837768
NA	CHEMICAL	GENE-Y	31	29	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T8	T20	12837768
NA	CHEMICAL	GENE-Y	31	32	The potency of MrIA was greater for inhibition of uptake by gene of chemical ( Ki 1.89 microM ) than chemical ( Ki 4.33 microM ) , and the gene and chemical transporter were not inhibited by MrIA ( to 7 microM ) .	T8	T21	12837768
NA	CHEMICAL	GENE-Y	5	4	Of 18 mutations where gene chemical residues were exchanged with those of the gene , MrIA had increased potency for inhibition of chemical uptake for three mutations ( in predicted extracellular loops 3 and 4 and transmembrane domain ( TMD ) 8 ) and decreased potency for one mutation ( in TMD6 and intracellular loop ( IL ) 3 ) .	T9	T23	12837768
NA	CHEMICAL	GENE-Y	5	13	Of 18 mutations where gene chemical residues were exchanged with those of the gene , MrIA had increased potency for inhibition of chemical uptake for three mutations ( in predicted extracellular loops 3 and 4 and transmembrane domain ( TMD ) 8 ) and decreased potency for one mutation ( in TMD6 and intracellular loop ( IL ) 3 ) .	T9	T24	12837768
NA	CHEMICAL	GENE-Y	28	4	Of 18 mutations where gene chemical residues were exchanged with those of the gene , MrIA had increased potency for inhibition of chemical uptake for three mutations ( in predicted extracellular loops 3 and 4 and transmembrane domain ( TMD ) 8 ) and decreased potency for one mutation ( in TMD6 and intracellular loop ( IL ) 3 ) .	T11	T23	12837768
NA	CHEMICAL	GENE-Y	28	13	Of 18 mutations where gene chemical residues were exchanged with those of the gene , MrIA had increased potency for inhibition of chemical uptake for three mutations ( in predicted extracellular loops 3 and 4 and transmembrane domain ( TMD ) 8 ) and decreased potency for one mutation ( in TMD6 and intracellular loop ( IL ) 3 ) .	T11	T24	12837768
NA	CHEMICAL	GENE-Y	22	4	Of 18 mutations where gene chemical residues were exchanged with those of the gene , MrIA had increased potency for inhibition of chemical uptake for three mutations ( in predicted extracellular loops 3 and 4 and transmembrane domain ( TMD ) 8 ) and decreased potency for one mutation ( in TMD6 and intracellular loop ( IL ) 3 ) .	T12	T23	12837768
NA	CHEMICAL	GENE-Y	22	13	Of 18 mutations where gene chemical residues were exchanged with those of the gene , MrIA had increased potency for inhibition of chemical uptake for three mutations ( in predicted extracellular loops 3 and 4 and transmembrane domain ( TMD ) 8 ) and decreased potency for one mutation ( in TMD6 and intracellular loop ( IL ) 3 ) .	T12	T24	12837768
NA	CHEMICAL	GENE-Y	2	0	gene is a widely expressed protein that shares structural , but not chemical , homology with gap junction proteins , the gene .	T13	T17	19023039
NA	CHEMICAL	GENE-N	2	21	gene is a widely expressed protein that shares structural , but not chemical , homology with gap junction proteins , the gene .	T13	T20	19023039
CPR:4	CHEMICAL	GENE-Y	8	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T14	T39	19023039
CPR:4	CHEMICAL	GENE-Y	8	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T15	T39	19023039
CPR:4	CHEMICAL	GENE-Y	18	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T16	T39	19023039
CPR:4	CHEMICAL	GENE-Y	8	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T1	T39	19023039
CPR:4	CHEMICAL	GENE-Y	8	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T2	T39	19023039
CPR:4	CHEMICAL	GENE-Y	5	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T3	T39	19023039
CPR:4	CHEMICAL	GENE-Y	28	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T4	T39	19023039
CPR:4	CHEMICAL	GENE-Y	8	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T5	T39	19023039
CPR:4	CHEMICAL	GENE-Y	8	5	We found compounds that inhibited gene currents with a rank order of potency : chemical > chemical ( chemical ) approximately chemical approximately chemical > chemical > > chemical > > chemical = chemical .	T6	T39	19023039
CPR:4	CHEMICAL	GENE-Y	0	13	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T7	T18	19023039
NA	CHEMICAL	GENE-N	0	18	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T7	T19	19023039
CPR:4	CHEMICAL	GENE-Y	2	13	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T8	T18	19023039
NA	CHEMICAL	GENE-N	2	18	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T8	T19	19023039
CPR:4	CHEMICAL	GENE-Y	4	13	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T9	T18	19023039
NA	CHEMICAL	GENE-N	4	18	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T9	T19	19023039
CPR:4	CHEMICAL	GENE-Y	7	13	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T10	T18	19023039
NA	CHEMICAL	GENE-N	7	18	chemical ( chemical , chemical , and chemical ) rapidly and reversibly inhibited gene currents via mechanism ( s ) independent of gene .	T10	T19	19023039
NA	CHEMICAL	GENE-Y	10	1	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T11	T21	19023039
NA	CHEMICAL	GENE-Y	10	5	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T11	T22	19023039
NA	CHEMICAL	GENE-Y	10	6	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T11	T23	19023039
CPR:6	CHEMICAL	GENE-Y	10	6	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T11	T24	19023039
NA	CHEMICAL	GENE-Y	10	6	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T11	T26	19023039
NA	CHEMICAL	GENE-Y	21	1	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T12	T21	19023039
NA	CHEMICAL	GENE-Y	21	5	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T12	T22	19023039
NA	CHEMICAL	GENE-Y	21	6	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T12	T23	19023039
NA	CHEMICAL	GENE-Y	21	6	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T12	T24	19023039
NA	CHEMICAL	GENE-Y	21	6	When gene was coexpressed with gene ( gene ) , chemical was found to act as a gene antagonist to inhibit chemical-evoked currents , but none of the other compounds inhibited gene currents .	T12	T26	19023039
NA	CHEMICAL	GENE-Y	4	1	Potent gene-mediated vasoconstriction by chemical in porcine ciliary arteries .	T23	T39	11481271
CPR:5	CHEMICAL	GENE-N	8	6	The segments were contracted with the gene agonists chemical , chemical , and chemical .	T16	T29	11481271
CPR:5	CHEMICAL	GENE-N	10	6	The segments were contracted with the gene agonists chemical , chemical , and chemical .	T17	T29	11481271
CPR:5	CHEMICAL	GENE-N	13	6	The segments were contracted with the gene agonists chemical , chemical , and chemical .	T18	T29	11481271
NA	CHEMICAL	GENE-N	27	6	To determine which subtypes of the gene mediate this contraction , antagonists subselective for the different gene were added to the vessel bath before concentration-response curves for chemical were obtained .	T19	T30	11481271
NA	CHEMICAL	GENE-N	27	16	To determine which subtypes of the gene mediate this contraction , antagonists subselective for the different gene were added to the vessel bath before concentration-response curves for chemical were obtained .	T19	T31	11481271
NA	CHEMICAL	GENE-N	7	2	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T20	T32	11481271
CPR:6	CHEMICAL	GENE-Y	7	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T20	T33	11481271
NA	CHEMICAL	GENE-Y	7	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T20	T34	11481271
NA	CHEMICAL	GENE-Y	7	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T20	T35	11481271
NA	CHEMICAL	GENE-Y	7	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T20	T36	11481271
NA	CHEMICAL	GENE-Y	7	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T20	T37	11481271
NA	CHEMICAL	GENE-N	12	2	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T21	T32	11481271
NA	CHEMICAL	GENE-Y	12	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T21	T33	11481271
CPR:6	CHEMICAL	GENE-Y	12	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T21	T34	11481271
CPR:6	CHEMICAL	GENE-Y	12	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T21	T35	11481271
NA	CHEMICAL	GENE-Y	12	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T21	T36	11481271
NA	CHEMICAL	GENE-Y	12	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T21	T37	11481271
NA	CHEMICAL	GENE-N	20	2	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T22	T32	11481271
NA	CHEMICAL	GENE-Y	20	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T22	T33	11481271
NA	CHEMICAL	GENE-Y	20	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T22	T34	11481271
NA	CHEMICAL	GENE-Y	20	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T22	T35	11481271
CPR:6	CHEMICAL	GENE-Y	20	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T22	T36	11481271
CPR:6	CHEMICAL	GENE-Y	20	8	The following gene antagonists were applied : chemical ( gene-selective ) , chemical ( gene- and gene-selective ) , and chemical ( gene- and gene-selective ) .	T22	T37	11481271
CPR:5	CHEMICAL	GENE-N	7	3	RESULTS : The gene agonists induced vasoconstriction in the porcine ciliary artery with the following potency order ( EC ( 50 ) ) expressed in nanomolar : chemical 2.11 , chemical 5.26 , and chemical 13.0 .	T1	T38	11481271
CPR:5	CHEMICAL	GENE-N	7	3	RESULTS : The gene agonists induced vasoconstriction in the porcine ciliary artery with the following potency order ( EC ( 50 ) ) expressed in nanomolar : chemical 2.11 , chemical 5.26 , and chemical 13.0 .	T2	T38	11481271
CPR:5	CHEMICAL	GENE-N	3	3	RESULTS : The gene agonists induced vasoconstriction in the porcine ciliary artery with the following potency order ( EC ( 50 ) ) expressed in nanomolar : chemical 2.11 , chemical 5.26 , and chemical 13.0 .	T3	T38	11481271
NA	CHEMICAL	GENE-Y	6	18	Schild analyses for the antagonists against chemical yielded regression lines with slopes of unity and functional antagonist potencies ( pK ( B ) ) for chemical ( 7.8 ) , chemical ( 5.8 ) and for chemical ( 6.0 ) suggesting the presence of functional gene .	T9	T24	11481271
CPR:6	CHEMICAL	GENE-Y	21	18	Schild analyses for the antagonists against chemical yielded regression lines with slopes of unity and functional antagonist potencies ( pK ( B ) ) for chemical ( 7.8 ) , chemical ( 5.8 ) and for chemical ( 6.0 ) suggesting the presence of functional gene .	T10	T24	11481271
CPR:6	CHEMICAL	GENE-Y	30	18	Schild analyses for the antagonists against chemical yielded regression lines with slopes of unity and functional antagonist potencies ( pK ( B ) ) for chemical ( 7.8 ) , chemical ( 5.8 ) and for chemical ( 6.0 ) suggesting the presence of functional gene .	T11	T24	11481271
CPR:6	CHEMICAL	GENE-Y	36	18	Schild analyses for the antagonists against chemical yielded regression lines with slopes of unity and functional antagonist potencies ( pK ( B ) ) for chemical ( 7.8 ) , chemical ( 5.8 ) and for chemical ( 6.0 ) suggesting the presence of functional gene .	T12	T24	11481271
CPR:5	CHEMICAL	GENE-N	5	3	CONCLUSIONS : The gene agonists chemical , chemical , and chemical are potent vasoconstrictors in the porcine ciliary artery .	T13	T26	11481271
CPR:5	CHEMICAL	GENE-N	7	3	CONCLUSIONS : The gene agonists chemical , chemical , and chemical are potent vasoconstrictors in the porcine ciliary artery .	T14	T26	11481271
CPR:5	CHEMICAL	GENE-N	10	3	CONCLUSIONS : The gene agonists chemical , chemical , and chemical are potent vasoconstrictors in the porcine ciliary artery .	T15	T26	11481271
NA	CHEMICAL	GENE-Y	34	4	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T3	T13	23085436
NA	CHEMICAL	GENE-N	34	5	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T3	T14	23085436
NA	CHEMICAL	GENE-N	34	34	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T3	T15	23085436
NA	CHEMICAL	GENE-N	34	5	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T3	T16	23085436
NA	CHEMICAL	GENE-Y	60	4	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T4	T13	23085436
NA	CHEMICAL	GENE-N	60	5	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T4	T14	23085436
NA	CHEMICAL	GENE-N	60	34	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T4	T15	23085436
NA	CHEMICAL	GENE-N	60	5	Twice daily injection of gene in normal mice transferred to a high fat diet reduced energy intake ( p < 0.001 ) , body weight ( p < 0.01 ) , circulating gene and gene-chemical ( p < 0.001 ) and improved gene sensitivity ( p < 0.001 ) as well as oral and intraperitoneal ( p < 0.001 ) chemical tolerance .	T4	T16	23085436
NA	CHEMICAL	GENE-N	9	7	Energy intake , body weight , circulating gene and chemical tolerance of gene mice were similar to lean controls .	T5	T18	23085436
NA	CHEMICAL	GENE-Y	9	12	Energy intake , body weight , circulating gene and chemical tolerance of gene mice were similar to lean controls .	T5	T19	23085436
NA	CHEMICAL	GENE-Y	12	3	In addition , gene prevented the effect of high fat feeding on chemical accumulation in liver and muscle .	T6	T20	23085436
NA	CHEMICAL	GENE-Y	42	13	Beneficial metabolic effects were observed similarly in ob/ob mice treated twice daily with gene for 18 days , including significantly reduced energy intake ( p < 0.05 ) , body weight ( p < 0.05 to p < 0.01 ) , circulating chemical ( p < 0.05 to p < 0.01 ) and gene ( p < 0.05 to p < 0.001 ) and improved chemical tolerance ( p < 0.05 ) and gene sensitivity ( p < 0.001 ) .	T1	T9	23085436
NA	CHEMICAL	GENE-N	42	6	Beneficial metabolic effects were observed similarly in ob/ob mice treated twice daily with gene for 18 days , including significantly reduced energy intake ( p < 0.05 ) , body weight ( p < 0.05 to p < 0.01 ) , circulating chemical ( p < 0.05 to p < 0.01 ) and gene ( p < 0.05 to p < 0.001 ) and improved chemical tolerance ( p < 0.05 ) and gene sensitivity ( p < 0.001 ) .	T1	T10	23085436
NA	CHEMICAL	GENE-N	42	6	Beneficial metabolic effects were observed similarly in ob/ob mice treated twice daily with gene for 18 days , including significantly reduced energy intake ( p < 0.05 ) , body weight ( p < 0.05 to p < 0.01 ) , circulating chemical ( p < 0.05 to p < 0.01 ) and gene ( p < 0.05 to p < 0.001 ) and improved chemical tolerance ( p < 0.05 ) and gene sensitivity ( p < 0.001 ) .	T1	T11	23085436
NA	CHEMICAL	GENE-Y	65	13	Beneficial metabolic effects were observed similarly in ob/ob mice treated twice daily with gene for 18 days , including significantly reduced energy intake ( p < 0.05 ) , body weight ( p < 0.05 to p < 0.01 ) , circulating chemical ( p < 0.05 to p < 0.01 ) and gene ( p < 0.05 to p < 0.001 ) and improved chemical tolerance ( p < 0.05 ) and gene sensitivity ( p < 0.001 ) .	T2	T9	23085436
NA	CHEMICAL	GENE-N	65	6	Beneficial metabolic effects were observed similarly in ob/ob mice treated twice daily with gene for 18 days , including significantly reduced energy intake ( p < 0.05 ) , body weight ( p < 0.05 to p < 0.01 ) , circulating chemical ( p < 0.05 to p < 0.01 ) and gene ( p < 0.05 to p < 0.001 ) and improved chemical tolerance ( p < 0.05 ) and gene sensitivity ( p < 0.001 ) .	T2	T10	23085436
NA	CHEMICAL	GENE-N	65	6	Beneficial metabolic effects were observed similarly in ob/ob mice treated twice daily with gene for 18 days , including significantly reduced energy intake ( p < 0.05 ) , body weight ( p < 0.05 to p < 0.01 ) , circulating chemical ( p < 0.05 to p < 0.01 ) and gene ( p < 0.05 to p < 0.001 ) and improved chemical tolerance ( p < 0.05 ) and gene sensitivity ( p < 0.001 ) .	T2	T11	23085436
NA	CHEMICAL	GENE-N	2	3	The increased chemical peroxidase activity in rats suffering from hyperthyroidism was associated with a fall of the reduced chemical in the homogenate and a marked increase in the chemical reductase activity .	T5	T9	17303537
NA	CHEMICAL	GENE-Y	2	13	The increased chemical peroxidase activity in rats suffering from hyperthyroidism was associated with a fall of the reduced chemical in the homogenate and a marked increase in the chemical reductase activity .	T5	T10	17303537
NA	CHEMICAL	GENE-N	13	3	The increased chemical peroxidase activity in rats suffering from hyperthyroidism was associated with a fall of the reduced chemical in the homogenate and a marked increase in the chemical reductase activity .	T6	T9	17303537
NA	CHEMICAL	GENE-Y	13	13	The increased chemical peroxidase activity in rats suffering from hyperthyroidism was associated with a fall of the reduced chemical in the homogenate and a marked increase in the chemical reductase activity .	T6	T10	17303537
NA	CHEMICAL	GENE-N	13	3	The increased chemical peroxidase activity in rats suffering from hyperthyroidism was associated with a fall of the reduced chemical in the homogenate and a marked increase in the chemical reductase activity .	T7	T9	17303537
NA	CHEMICAL	GENE-Y	13	13	The increased chemical peroxidase activity in rats suffering from hyperthyroidism was associated with a fall of the reduced chemical in the homogenate and a marked increase in the chemical reductase activity .	T7	T10	17303537
NA	CHEMICAL	GENE-N	20	3	The bacterial enzyme gene ( gene ) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins , removing the non-reducing chemical residues of linear oligosaccharides as chemical ( chemical ) .	T5	T27	12217700
NA	CHEMICAL	GENE-N	20	5	The bacterial enzyme gene ( gene ) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins , removing the non-reducing chemical residues of linear oligosaccharides as chemical ( chemical ) .	T5	T33	12217700
CPR:9	CHEMICAL	GENE-N	26	3	The bacterial enzyme gene ( gene ) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins , removing the non-reducing chemical residues of linear oligosaccharides as chemical ( chemical ) .	T13	T27	12217700
CPR:9	CHEMICAL	GENE-N	26	5	The bacterial enzyme gene ( gene ) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins , removing the non-reducing chemical residues of linear oligosaccharides as chemical ( chemical ) .	T13	T33	12217700
CPR:9	CHEMICAL	GENE-N	28	3	The bacterial enzyme gene ( gene ) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins , removing the non-reducing chemical residues of linear oligosaccharides as chemical ( chemical ) .	T14	T27	12217700
CPR:9	CHEMICAL	GENE-N	28	5	The bacterial enzyme gene ( gene ) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins , removing the non-reducing chemical residues of linear oligosaccharides as chemical ( chemical ) .	T14	T33	12217700
NA	CHEMICAL	GENE-Y	6	6	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T16	T34	12217700
NA	CHEMICAL	GENE-N	6	26	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T16	T35	12217700
NA	CHEMICAL	GENE-Y	12	6	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T17	T34	12217700
NA	CHEMICAL	GENE-N	12	26	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T17	T35	12217700
NA	CHEMICAL	GENE-Y	15	6	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T18	T34	12217700
NA	CHEMICAL	GENE-N	15	26	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T18	T35	12217700
NA	CHEMICAL	GENE-Y	15	6	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T19	T34	12217700
NA	CHEMICAL	GENE-N	15	26	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T19	T35	12217700
NA	CHEMICAL	GENE-Y	15	6	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T20	T34	12217700
NA	CHEMICAL	GENE-N	15	26	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T20	T35	12217700
NA	CHEMICAL	GENE-Y	45	6	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T21	T34	12217700
NA	CHEMICAL	GENE-N	45	26	The 2.0A crystal structure of the gene/chemical binary complex shows that the chemical substrate adopts a conformation seen previously with both inactive and active forms of gene , with the chemical group not in close contact with the chemical group of the essential chemical ( chemical ) cofactor .	T21	T35	12217700
NA	CHEMICAL	GENE-Y	12	3	In the active gene enzyme , the residue Arg569 stabilizes the negative-charged chemical , whereas in the inactive form of gene this key residue is held away from the catalytic site by loop 280s and an allosteric transition of the mammalian enzyme is required for activation .	T22	T36	12217700
NA	CHEMICAL	GENE-Y	12	20	In the active gene enzyme , the residue Arg569 stabilizes the negative-charged chemical , whereas in the inactive form of gene this key residue is held away from the catalytic site by loop 280s and an allosteric transition of the mammalian enzyme is required for activation .	T22	T37	12217700
NA	CHEMICAL	GENE-Y	15	3	The comparison between gene structures shows that His377 , through a hydrogen bond with the chemical group of chemical substrate , triggers a conformational change of the 380s loop .	T1	T23	12217700
NA	CHEMICAL	GENE-Y	3	3	The comparison between gene structures shows that His377 , through a hydrogen bond with the chemical group of chemical substrate , triggers a conformational change of the 380s loop .	T2	T23	12217700
NA	CHEMICAL	GENE-Y	10	19	The structures solved after the diffusion of oligosaccharides ( either chemical , G4 or chemical , G5 ) into gene/chemical crystals show the formation of chemical and elongation of the oligosaccharide chain .	T3	T25	12217700
NA	CHEMICAL	GENE-Y	14	19	The structures solved after the diffusion of oligosaccharides ( either chemical , G4 or chemical , G5 ) into gene/chemical crystals show the formation of chemical and elongation of the oligosaccharide chain .	T4	T25	12217700
NA	CHEMICAL	GENE-Y	19	19	The structures solved after the diffusion of oligosaccharides ( either chemical , G4 or chemical , G5 ) into gene/chemical crystals show the formation of chemical and elongation of the oligosaccharide chain .	T6	T25	12217700
NA	CHEMICAL	GENE-Y	25	19	The structures solved after the diffusion of oligosaccharides ( either chemical , G4 or chemical , G5 ) into gene/chemical crystals show the formation of chemical and elongation of the oligosaccharide chain .	T7	T25	12217700
NA	CHEMICAL	GENE-Y	10	10	The relatively large oligosaccharide substrates can diffuse quickly into the gene/chemical crystals and the enzymatic reaction can occur without significant crystal damage .	T12	T26	12217700
NA	CHEMICAL	GENE-Y	13	6	Concurrent Regulation of the Transcription Factors gene and gene Mediates the Enhancement of chemical Levels by the chemical chemical .	T22	T39	23618921
NA	CHEMICAL	GENE-Y	13	8	Concurrent Regulation of the Transcription Factors gene and gene Mediates the Enhancement of chemical Levels by the chemical chemical .	T22	T40	23618921
NA	CHEMICAL	GENE-Y	17	6	Concurrent Regulation of the Transcription Factors gene and gene Mediates the Enhancement of chemical Levels by the chemical chemical .	T20	T39	23618921
NA	CHEMICAL	GENE-Y	17	8	Concurrent Regulation of the Transcription Factors gene and gene Mediates the Enhancement of chemical Levels by the chemical chemical .	T20	T40	23618921
NA	CHEMICAL	GENE-Y	18	6	Concurrent Regulation of the Transcription Factors gene and gene Mediates the Enhancement of chemical Levels by the chemical chemical .	T21	T39	23618921
NA	CHEMICAL	GENE-Y	18	8	Concurrent Regulation of the Transcription Factors gene and gene Mediates the Enhancement of chemical Levels by the chemical chemical .	T21	T40	23618921
NA	CHEMICAL	GENE-Y	9	12	Among the transcription factors that play critical roles in chemical metabolism are gene ( gene ) and gene ( gene ) .	T13	T31	23618921
NA	CHEMICAL	GENE-Y	9	14	Among the transcription factors that play critical roles in chemical metabolism are gene ( gene ) and gene ( gene ) .	T13	T32	23618921
NA	CHEMICAL	GENE-Y	9	17	Among the transcription factors that play critical roles in chemical metabolism are gene ( gene ) and gene ( gene ) .	T13	T33	23618921
NA	CHEMICAL	GENE-Y	9	19	Among the transcription factors that play critical roles in chemical metabolism are gene ( gene ) and gene ( gene ) .	T13	T34	23618921
CPR:3	CHEMICAL	GENE-Y	4	11	Here we show that chemical rapidly increases the levels of both gene and gene as well as gene- and gene-dependent gene transcription via distinct mechanisms .	T19	T35	23618921
CPR:3	CHEMICAL	GENE-Y	4	13	Here we show that chemical rapidly increases the levels of both gene and gene as well as gene- and gene-dependent gene transcription via distinct mechanisms .	T19	T36	23618921
CPR:3	CHEMICAL	GENE-Y	4	17	Here we show that chemical rapidly increases the levels of both gene and gene as well as gene- and gene-dependent gene transcription via distinct mechanisms .	T19	T37	23618921
CPR:3	CHEMICAL	GENE-Y	4	19	Here we show that chemical rapidly increases the levels of both gene and gene as well as gene- and gene-dependent gene transcription via distinct mechanisms .	T19	T38	23618921
CPR:3	CHEMICAL	GENE-Y	1	8	Although chemical greatly increases the stability of both gene and gene , only the effect on gene is dependent on gene activity .	T2	T23	23618921
CPR:3	CHEMICAL	GENE-Y	1	10	Although chemical greatly increases the stability of both gene and gene , only the effect on gene is dependent on gene activity .	T2	T24	23618921
NA	CHEMICAL	GENE-Y	1	16	Although chemical greatly increases the stability of both gene and gene , only the effect on gene is dependent on gene activity .	T2	T25	23618921
NA	CHEMICAL	GENE-N	1	20	Although chemical greatly increases the stability of both gene and gene , only the effect on gene is dependent on gene activity .	T2	T26	23618921
NA	CHEMICAL	GENE-Y	11	5	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T3	T27	23618921
NA	CHEMICAL	GENE-Y	11	9	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T3	T28	23618921
NA	CHEMICAL	GENE-Y	11	26	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T3	T29	23618921
NA	CHEMICAL	GENE-Y	11	28	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T3	T30	23618921
NA	CHEMICAL	GENE-Y	19	5	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T4	T27	23618921
NA	CHEMICAL	GENE-Y	19	9	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T4	T28	23618921
NA	CHEMICAL	GENE-Y	19	26	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T4	T29	23618921
NA	CHEMICAL	GENE-Y	19	28	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T4	T30	23618921
NA	CHEMICAL	GENE-Y	34	5	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T6	T27	23618921
NA	CHEMICAL	GENE-Y	34	9	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T6	T28	23618921
NA	CHEMICAL	GENE-Y	34	26	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T6	T29	23618921
NA	CHEMICAL	GENE-Y	34	28	Using siRNA we found that gene , but not gene , is important for chemical 's ability to increase chemical levels under basal conditions whereas both gene and gene appear to cooperate to increase chemical levels under oxidative stress conditions .	T6	T30	23618921
CPR:4	CHEMICAL	GENE-N	0	4	chemical inhibits the checkpoint gene gene .	T6	T13	10531013
CPR:4	CHEMICAL	GENE-Y	0	5	chemical inhibits the checkpoint gene gene .	T6	T14	10531013
CPR:4	CHEMICAL	GENE-N	25	8	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T5	T10	10531013
CPR:4	CHEMICAL	GENE-Y	25	9	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T5	T11	10531013
CPR:4	CHEMICAL	GENE-Y	25	17	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T5	T12	10531013
NA	CHEMICAL	GENE-Y	25	30	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T5	T7	10531013
NA	CHEMICAL	GENE-N	25	16	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T5	T8	10531013
NA	CHEMICAL	GENE-N	8	8	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T1	T10	10531013
NA	CHEMICAL	GENE-Y	8	9	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T1	T11	10531013
NA	CHEMICAL	GENE-Y	8	17	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T1	T12	10531013
CPR:4	CHEMICAL	GENE-Y	8	30	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T1	T7	10531013
CPR:4	CHEMICAL	GENE-N	8	16	We report that the radiation-induced activation of the gene gene [ 4 ] ( also known as gene [ 5 ] ) is inhibited by chemical in vivo and that gene gene activity is directly inhibited by chemical in vitro .	T1	T8	10531013
NA	CHEMICAL	GENE-Y	7	8	Treatment of Postmenopausal Breast Cancer with Selective chemical Receptor Modulators ( SERMs ) .	T20	T33	16917142
NA	CHEMICAL	GENE-Y	5	6	Endocrine therapy that targets the chemical receptor ( gene ) is a standard of care for the treatment of postmenopausal women with gene-positive breast cancer .	T10	T29	16917142
NA	CHEMICAL	GENE-Y	5	8	Endocrine therapy that targets the chemical receptor ( gene ) is a standard of care for the treatment of postmenopausal women with gene-positive breast cancer .	T10	T32	16917142
NA	CHEMICAL	GENE-Y	5	22	Endocrine therapy that targets the chemical receptor ( gene ) is a standard of care for the treatment of postmenopausal women with gene-positive breast cancer .	T10	T22	16917142
NA	CHEMICAL	GENE-Y	7	2	The selective gene modulator ( SgeneM ) chemical has been in use for the treatment of advanced breast cancer for more than 30 years and is currently a treatment option for all stages of ER-positive disease .	T9	T26	16917142
NA	CHEMICAL	GENE-Y	7	5	The selective gene modulator ( SgeneM ) chemical has been in use for the treatment of advanced breast cancer for more than 30 years and is currently a treatment option for all stages of ER-positive disease .	T9	T28	16917142
NA	CHEMICAL	GENE-Y	0	10	chemical blocks the action of chemical by binding to the gene , and possesses both gene-agonist and antagonist properties .	T11	T30	16917142
CPR:6	CHEMICAL	GENE-Y	0	15	chemical blocks the action of chemical by binding to the gene , and possesses both gene-agonist and antagonist properties .	T11	T31	16917142
NA	CHEMICAL	GENE-Y	5	10	chemical blocks the action of chemical by binding to the gene , and possesses both gene-agonist and antagonist properties .	T12	T30	16917142
NA	CHEMICAL	GENE-Y	5	15	chemical blocks the action of chemical by binding to the gene , and possesses both gene-agonist and antagonist properties .	T12	T31	16917142
NA	CHEMICAL	GENE-Y	20	5	The subsequent development of the gene inhibitors ( AIs ) is an important therapeutic advance by creating a `` no chemical '' environment .	T3	T21	16917142
CPR:6	CHEMICAL	GENE-Y	0	4	chemical is a novel gene antagonist that destroys the gene and its signaling pathway and is not associated with chemical-like agonist effects .	T4	T23	16917142
CPR:4	CHEMICAL	GENE-Y	0	9	chemical is a novel gene antagonist that destroys the gene and its signaling pathway and is not associated with chemical-like agonist effects .	T4	T24	16917142
NA	CHEMICAL	GENE-Y	2	4	chemical is a novel gene antagonist that destroys the gene and its signaling pathway and is not associated with chemical-like agonist effects .	T5	T23	16917142
NA	CHEMICAL	GENE-Y	2	9	chemical is a novel gene antagonist that destroys the gene and its signaling pathway and is not associated with chemical-like agonist effects .	T5	T24	16917142
NA	CHEMICAL	GENE-Y	14	16	It produces high response rates compared with other SERMs and is not cross-resistant to chemical or gene inhibitors and is equally as effective as the AI chemical in the treatment of postmenopausal women with advanced breast cancer who have progressed on prior adjuvant chemical therapy .	T6	T25	16917142
NA	CHEMICAL	GENE-Y	21	16	It produces high response rates compared with other SERMs and is not cross-resistant to chemical or gene inhibitors and is equally as effective as the AI chemical in the treatment of postmenopausal women with advanced breast cancer who have progressed on prior adjuvant chemical therapy .	T7	T25	16917142
NA	CHEMICAL	GENE-Y	43	16	It produces high response rates compared with other SERMs and is not cross-resistant to chemical or gene inhibitors and is equally as effective as the AI chemical in the treatment of postmenopausal women with advanced breast cancer who have progressed on prior adjuvant chemical therapy .	T8	T25	16917142
NA	CHEMICAL	GENE-Y	7	51	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T4	T13	17916059
NA	CHEMICAL	GENE-N	7	28	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T4	T14	17916059
NA	CHEMICAL	GENE-Y	8	51	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T5	T13	17916059
NA	CHEMICAL	GENE-N	8	28	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T5	T14	17916059
NA	CHEMICAL	GENE-Y	8	51	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T7	T13	17916059
NA	CHEMICAL	GENE-N	8	28	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T7	T14	17916059
NA	CHEMICAL	GENE-Y	38	51	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T8	T13	17916059
NA	CHEMICAL	GENE-N	38	28	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T8	T14	17916059
NA	CHEMICAL	GENE-Y	1	51	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T9	T13	17916059
NA	CHEMICAL	GENE-N	1	28	It is more potent and selective than chemical in inhibiting chemical re-uptake in the CNS , and less potent than various other selective chemical re-uptake inhibitors in relation to other transporter proteins and receptors : in particular , it is six times less potent than chemical in binding to the chemical H1 and gene .	T9	T14	17916059
CPR:9	CHEMICAL	GENE-Y	16	12	Caution is necessary only when it is coadministered with drugs metabolised by gene , such as chemical , or administered to the elderly or patients with severe hepatic or renal impairment .	T11	T16	17916059
NA	CHEMICAL	GENE-N	4	11	Regulated function of the chemical-4-hydroxylase domain ( PHD ) chemical sensor proteins .	T19	T32	17627474
NA	CHEMICAL	GENE-N	9	11	Regulated function of the chemical-4-hydroxylase domain ( PHD ) chemical sensor proteins .	T20	T32	17627474
NA	CHEMICAL	GENE-N	1	10	Cellular chemical is sensed by chemical-4-hydroxylase domain ( PHD ) proteins that chemical gene subunits .	T17	T24	17627474
NA	CHEMICAL	GENE-N	1	13	Cellular chemical is sensed by chemical-4-hydroxylase domain ( PHD ) proteins that chemical gene subunits .	T17	T29	17627474
NA	CHEMICAL	GENE-N	5	10	Cellular chemical is sensed by chemical-4-hydroxylase domain ( PHD ) proteins that chemical gene subunits .	T12	T24	17627474
NA	CHEMICAL	GENE-N	5	13	Cellular chemical is sensed by chemical-4-hydroxylase domain ( PHD ) proteins that chemical gene subunits .	T12	T29	17627474
NA	CHEMICAL	GENE-N	12	10	Cellular chemical is sensed by chemical-4-hydroxylase domain ( PHD ) proteins that chemical gene subunits .	T14	T24	17627474
NA	CHEMICAL	GENE-N	12	13	Cellular chemical is sensed by chemical-4-hydroxylase domain ( PHD ) proteins that chemical gene subunits .	T14	T29	17627474
NA	CHEMICAL	GENE-N	4	3	Thus , the gene chemical sensors themselves represent effectors of cellular signalling pathways as well as potential drug targets .	T13	T28	17627474
NA	CHEMICAL	GENE-N	18	37	Here , a cell-free in vitro microtiter plate-based peptide hydroxylation assay was used to investigate the influence of chemical , Krebs cycle intermediates , transition metals , and chemical and other antioxidants on the activity of purified gene .	T15	T30	17627474
NA	CHEMICAL	GENE-N	28	37	Here , a cell-free in vitro microtiter plate-based peptide hydroxylation assay was used to investigate the influence of chemical , Krebs cycle intermediates , transition metals , and chemical and other antioxidants on the activity of purified gene .	T16	T30	17627474
NA	CHEMICAL	GENE-N	6	0	gene activity depends not only on chemical availability but is also regulated by chemical , chemical , and Krebs cycle intermediates , suggesting a physiological relevance of their cellular concentrations .	T18	T31	17627474
NA	CHEMICAL	GENE-N	5	0	gene activity depends not only on chemical availability but is also regulated by chemical , chemical , and Krebs cycle intermediates , suggesting a physiological relevance of their cellular concentrations .	T1	T31	17627474
NA	CHEMICAL	GENE-N	15	0	gene activity depends not only on chemical availability but is also regulated by chemical , chemical , and Krebs cycle intermediates , suggesting a physiological relevance of their cellular concentrations .	T2	T31	17627474
NA	CHEMICAL	GENE-Y	1	7	A chemical-inducible transgenic mouse model expressing truncated gene ( ΔN89gene ) that exhibited a strong intestinal hyperplasia was analyzed during the removal of oncogenic gene expression both in 3D 'crypt culture ' and in vivo .	T2	T6	22469981
NA	CHEMICAL	GENE-Y	1	9	A chemical-inducible transgenic mouse model expressing truncated gene ( ΔN89gene ) that exhibited a strong intestinal hyperplasia was analyzed during the removal of oncogenic gene expression both in 3D 'crypt culture ' and in vivo .	T2	T7	22469981
NA	CHEMICAL	GENE-Y	1	13	A chemical-inducible transgenic mouse model expressing truncated gene ( ΔN89gene ) that exhibited a strong intestinal hyperplasia was analyzed during the removal of oncogenic gene expression both in 3D 'crypt culture ' and in vivo .	T2	T8	22469981
NA	CHEMICAL	GENE-N	8	7	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T15	T28	23402856
NA	CHEMICAL	GENE-N	8	13	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T15	T29	23402856
NA	CHEMICAL	GENE-N	9	7	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T16	T28	23402856
NA	CHEMICAL	GENE-N	9	13	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T16	T29	23402856
CPR:3	CHEMICAL	GENE-N	32	7	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T18	T28	23402856
CPR:3	CHEMICAL	GENE-N	32	13	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T18	T29	23402856
CPR:3	CHEMICAL	GENE-N	34	7	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T19	T28	23402856
CPR:3	CHEMICAL	GENE-N	34	13	Number and area of preneoplastic foci positive for chemical chemical-transferase placental form ( gene ) were consistently higher in these groups than the sum of individual values in the groups treated with chemical or chemical alone .	T19	T29	23402856
NA	CHEMICAL	GENE-N	5	22	Consistent with these findings , chemical and chemical had additive or synergistic effects on cell proliferation induction within the preneoplastic foci and gene induction , which may lead to more efficient metabolic activation of chemical and chemical .	T20	T30	23402856
NA	CHEMICAL	GENE-N	7	22	Consistent with these findings , chemical and chemical had additive or synergistic effects on cell proliferation induction within the preneoplastic foci and gene induction , which may lead to more efficient metabolic activation of chemical and chemical .	T22	T30	23402856
NA	CHEMICAL	GENE-N	34	22	Consistent with these findings , chemical and chemical had additive or synergistic effects on cell proliferation induction within the preneoplastic foci and gene induction , which may lead to more efficient metabolic activation of chemical and chemical .	T1	T30	23402856
NA	CHEMICAL	GENE-N	5	22	Consistent with these findings , chemical and chemical had additive or synergistic effects on cell proliferation induction within the preneoplastic foci and gene induction , which may lead to more efficient metabolic activation of chemical and chemical .	T2	T30	23402856
CPR:4	CHEMICAL	GENE-N	2	2	Optimization of a chemical series of gene assembly inhibitors 2 : Structure-activity relationships ( SAR ) of the C3-chemical moiety .	T6	T11	23601710
CPR:4	CHEMICAL	GENE-N	18	2	Optimization of a chemical series of gene assembly inhibitors 2 : Structure-activity relationships ( SAR ) of the C3-chemical moiety .	T5	T11	23601710
NA	CHEMICAL	GENE-N	5	16	Detailed structure-activity relationships of the C3-chemical moiety that allow for the optimization of antiviral potency of a series of chemical inhibitors of gene ( gene ) assembly are described .	T4	T7	23601710
NA	CHEMICAL	GENE-N	5	24	Detailed structure-activity relationships of the C3-chemical moiety that allow for the optimization of antiviral potency of a series of chemical inhibitors of gene ( gene ) assembly are described .	T4	T8	23601710
CPR:4	CHEMICAL	GENE-N	16	16	Detailed structure-activity relationships of the C3-chemical moiety that allow for the optimization of antiviral potency of a series of chemical inhibitors of gene ( gene ) assembly are described .	T1	T7	23601710
CPR:4	CHEMICAL	GENE-N	16	24	Detailed structure-activity relationships of the C3-chemical moiety that allow for the optimization of antiviral potency of a series of chemical inhibitors of gene ( gene ) assembly are described .	T1	T8	23601710
NA	CHEMICAL	GENE-N	6	3	The preparation and gene profiling of chemical and chemical enantiomers .	T7	T15	18045203
NA	CHEMICAL	GENE-N	8	3	The preparation and gene profiling of chemical and chemical enantiomers .	T8	T15	18045203
CPR:6	CHEMICAL	GENE-N	0	7	chemical ( 1 ) is a non-selective gene antagonist that is used clinically for the treatment of urinary incontinence .	T1	T10	18045203
NA	CHEMICAL	GENE-N	15	13	We have prepared the enantiomers of 1 and 2 and evaluated their ability to displace chemical ( chemical ) binding on gene .	T4	T9	18045203
NA	CHEMICAL	GENE-N	16	13	We have prepared the enantiomers of 1 and 2 and evaluated their ability to displace chemical ( chemical ) binding on gene .	T5	T9	18045203
NA	CHEMICAL	GENE-N	6	9	Compounds 1 and 2 potently displaced chemical binding at gene , but were less potent at the gene and gene subtypes .	T6	T11	18045203
NA	CHEMICAL	GENE-Y	6	3	Compounds 1 and 2 potently displaced chemical binding at gene , but were less potent at the gene and gene subtypes .	T6	T12	18045203
NA	CHEMICAL	GENE-Y	6	19	Compounds 1 and 2 potently displaced chemical binding at gene , but were less potent at the gene and gene subtypes .	T6	T13	18045203
NA	CHEMICAL	GENE-N	6	7	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T9	17578749
NA	CHEMICAL	GENE-N	6	9	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T10	17578749
NA	CHEMICAL	GENE-Y	6	12	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T11	17578749
NA	CHEMICAL	GENE-Y	6	14	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T12	17578749
NA	CHEMICAL	GENE-N	6	18	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T13	17578749
NA	CHEMICAL	GENE-N	6	20	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T14	17578749
NA	CHEMICAL	GENE-N	6	35	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T15	17578749
NA	CHEMICAL	GENE-Y	6	42	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T16	17578749
NA	CHEMICAL	GENE-N	6	50	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T1	T17	17578749
NA	CHEMICAL	GENE-N	17	7	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T9	17578749
NA	CHEMICAL	GENE-N	17	9	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T10	17578749
NA	CHEMICAL	GENE-Y	17	12	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T11	17578749
NA	CHEMICAL	GENE-Y	17	14	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T12	17578749
NA	CHEMICAL	GENE-N	17	18	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T13	17578749
NA	CHEMICAL	GENE-N	17	20	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T14	17578749
NA	CHEMICAL	GENE-N	17	35	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T15	17578749
NA	CHEMICAL	GENE-Y	17	42	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T16	17578749
NA	CHEMICAL	GENE-N	17	50	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T2	T17	17578749
NA	CHEMICAL	GENE-N	23	7	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T9	17578749
NA	CHEMICAL	GENE-N	23	9	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T10	17578749
NA	CHEMICAL	GENE-Y	23	12	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T11	17578749
NA	CHEMICAL	GENE-Y	23	14	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T12	17578749
NA	CHEMICAL	GENE-N	23	18	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T13	17578749
NA	CHEMICAL	GENE-N	23	20	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T14	17578749
NA	CHEMICAL	GENE-N	23	35	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T15	17578749
NA	CHEMICAL	GENE-Y	23	42	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T16	17578749
NA	CHEMICAL	GENE-N	23	50	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T3	T17	17578749
NA	CHEMICAL	GENE-N	26	7	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T9	17578749
NA	CHEMICAL	GENE-N	26	9	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T10	17578749
NA	CHEMICAL	GENE-Y	26	12	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T11	17578749
NA	CHEMICAL	GENE-Y	26	14	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T12	17578749
NA	CHEMICAL	GENE-N	26	18	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T13	17578749
NA	CHEMICAL	GENE-N	26	20	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T14	17578749
NA	CHEMICAL	GENE-N	26	35	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T15	17578749
NA	CHEMICAL	GENE-Y	26	42	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T16	17578749
NA	CHEMICAL	GENE-N	26	50	The following AOD was examined : chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( gene ) , chemical , and chemical . Inactive persons with ID had significantly lower gene ( p < 0.05 ) , gene ( p < 0.05 ) , and gene ( p < 0.05 ) .	T4	T17	17578749
NA	CHEMICAL	GENE-Y	4	2	Interaction of gene with chemical : determination of binding parameters .	T8	T14	18620538
NA	CHEMICAL	GENE-Y	9	7	The interaction of holo- and apo-forms of gene with chemical was studied by a partition equilibrium method .	T7	T11	18620538
NA	CHEMICAL	GENE-Y	6	0	gene , obtained by treatment with chemical , displays one binding site for chemical , the association constants for chemical being 1.9.10 ( 6 ) and 4.2.10 ( 5 ) M ( -1 ) , respectively .	T1	T9	18620538
NA	CHEMICAL	GENE-Y	13	0	gene , obtained by treatment with chemical , displays one binding site for chemical , the association constants for chemical being 1.9.10 ( 6 ) and 4.2.10 ( 5 ) M ( -1 ) , respectively .	T2	T9	18620538
NA	CHEMICAL	GENE-Y	19	0	gene , obtained by treatment with chemical , displays one binding site for chemical , the association constants for chemical being 1.9.10 ( 6 ) and 4.2.10 ( 5 ) M ( -1 ) , respectively .	T3	T9	18620538
NA	CHEMICAL	GENE-Y	7	2	However , gene was unable to bind chemical as measured by this technique .	T4	T10	18620538
NA	CHEMICAL	GENE-Y	3	6	Likewise , no chemical bound to gene , isolated using nondenaturing conditions , were detected by gas chromatography .	T5	T12	18620538
NA	CHEMICAL	GENE-Y	28	0	gene and gene mRNA levels were much higher in TIC than granulosa cell and increased progressively during follicle maturation with gene peaking in large ( 11-18 mm ) chemical-active follicles and gene peaking in 9- to 10-mm follicles before declining in larger ( 11-18 mm ) follicles .	T3	T18	23546605
NA	CHEMICAL	GENE-Y	28	2	gene and gene mRNA levels were much higher in TIC than granulosa cell and increased progressively during follicle maturation with gene peaking in large ( 11-18 mm ) chemical-active follicles and gene peaking in 9- to 10-mm follicles before declining in larger ( 11-18 mm ) follicles .	T3	T19	23546605
NA	CHEMICAL	GENE-Y	28	20	gene and gene mRNA levels were much higher in TIC than granulosa cell and increased progressively during follicle maturation with gene peaking in large ( 11-18 mm ) chemical-active follicles and gene peaking in 9- to 10-mm follicles before declining in larger ( 11-18 mm ) follicles .	T3	T20	23546605
NA	CHEMICAL	GENE-Y	28	31	gene and gene mRNA levels were much higher in TIC than granulosa cell and increased progressively during follicle maturation with gene peaking in large ( 11-18 mm ) chemical-active follicles and gene peaking in 9- to 10-mm follicles before declining in larger ( 11-18 mm ) follicles .	T3	T21	23546605
NA	CHEMICAL	GENE-N	31	19	To corroborate the above findings , we showed that in vitro exposure of TIC to a luteinizing concentration of gene greatly attenuated expression of both gene and its receptor while increasing chemical secretion and expression of gene and gene .	T1	T5	23546605
NA	CHEMICAL	GENE-Y	31	25	To corroborate the above findings , we showed that in vitro exposure of TIC to a luteinizing concentration of gene greatly attenuated expression of both gene and its receptor while increasing chemical secretion and expression of gene and gene .	T1	T6	23546605
NA	CHEMICAL	GENE-Y	31	36	To corroborate the above findings , we showed that in vitro exposure of TIC to a luteinizing concentration of gene greatly attenuated expression of both gene and its receptor while increasing chemical secretion and expression of gene and gene .	T1	T7	23546605
NA	CHEMICAL	GENE-Y	31	38	To corroborate the above findings , we showed that in vitro exposure of TIC to a luteinizing concentration of gene greatly attenuated expression of both gene and its receptor while increasing chemical secretion and expression of gene and gene .	T1	T8	23546605
NA	CHEMICAL	GENE-Y	2	0	gene and chemical followed a similar pattern , both increasing after luteolysis , before falling sharply after the gene surge .	T2	T10	23546605
NA	CHEMICAL	GENE-N	2	18	gene and chemical followed a similar pattern , both increasing after luteolysis , before falling sharply after the gene surge .	T2	T11	23546605
NA	CHEMICAL	GENE-N	19	4	We previously demonstrated that gene ( gene ) modulation at the blood-brain barrier ( BBB ) contributes highly to chemical-related respiratory toxicity , by limiting chemical entrance into the brain .	T20	T34	23376546
NA	CHEMICAL	GENE-N	19	6	We previously demonstrated that gene ( gene ) modulation at the blood-brain barrier ( BBB ) contributes highly to chemical-related respiratory toxicity , by limiting chemical entrance into the brain .	T20	T35	23376546
NA	CHEMICAL	GENE-N	25	4	We previously demonstrated that gene ( gene ) modulation at the blood-brain barrier ( BBB ) contributes highly to chemical-related respiratory toxicity , by limiting chemical entrance into the brain .	T21	T34	23376546
NA	CHEMICAL	GENE-N	25	6	We previously demonstrated that gene ( gene ) modulation at the blood-brain barrier ( BBB ) contributes highly to chemical-related respiratory toxicity , by limiting chemical entrance into the brain .	T21	T35	23376546
NA	CHEMICAL	GENE-N	22	11	In this work , we sought to investigate the role of gene-mediated transport at the BBB in gender and strain-related variability of chemical and chemical-induced respiratory effects in mice .	T23	T36	23376546
NA	CHEMICAL	GENE-N	24	11	In this work , we sought to investigate the role of gene-mediated transport at the BBB in gender and strain-related variability of chemical and chemical-induced respiratory effects in mice .	T24	T36	23376546
NA	CHEMICAL	GENE-N	6	3	No differences in gene expression or chemical and chemical transport across the BBB were observed between male and female Fvb mice as well as between Swiss and Fvb mice .	T12	T32	23376546
NA	CHEMICAL	GENE-N	8	3	No differences in gene expression or chemical and chemical transport across the BBB were observed between male and female Fvb mice as well as between Swiss and Fvb mice .	T13	T32	23376546
NA	CHEMICAL	GENE-N	20	4	Our results suggest that gene-mediated transport across the BBB does not play a key-role in gender and strain-related variability in chemical and chemical-induced respiratory toxicity in mice .	T15	T33	23376546
NA	CHEMICAL	GENE-N	22	4	Our results suggest that gene-mediated transport across the BBB does not play a key-role in gender and strain-related variability in chemical and chemical-induced respiratory toxicity in mice .	T16	T33	23376546
NA	CHEMICAL	GENE-N	2	4	Effect of chemical on gene signal transduction and chemical oxidation in skeletal muscle of adult male albino rat .	T15	T32	23424204
NA	CHEMICAL	GENE-N	8	4	Effect of chemical on gene signal transduction and chemical oxidation in skeletal muscle of adult male albino rat .	T16	T32	23424204
NA	CHEMICAL	GENE-N	11	13	In the present study , we investigated the possible effects of chemical on gene-signaling molecules and chemical oxidation in skeletal muscle of male rat .	T10	T24	23424204
NA	CHEMICAL	GENE-N	16	13	In the present study , we investigated the possible effects of chemical on gene-signaling molecules and chemical oxidation in skeletal muscle of male rat .	T11	T24	23424204
NA	CHEMICAL	GENE-Y	19	9	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T25	23424204
NA	CHEMICAL	GENE-Y	19	11	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T26	23424204
NA	CHEMICAL	GENE-N	19	14	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T27	23424204
NA	CHEMICAL	GENE-N	19	16	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T28	23424204
NA	CHEMICAL	GENE-Y	19	20	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T29	23424204
NA	CHEMICAL	GENE-Y	19	22	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T30	23424204
NA	CHEMICAL	GENE-Y	19	31	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T31	23424204
NA	CHEMICAL	GENE-N	19	33	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T17	23424204
NA	CHEMICAL	GENE-Y	19	35	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T13	T18	23424204
NA	CHEMICAL	GENE-Y	27	9	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T25	23424204
NA	CHEMICAL	GENE-Y	27	11	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T26	23424204
NA	CHEMICAL	GENE-N	27	14	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T27	23424204
NA	CHEMICAL	GENE-N	27	16	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T28	23424204
NA	CHEMICAL	GENE-Y	27	20	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T29	23424204
NA	CHEMICAL	GENE-Y	27	22	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T30	23424204
CPR:4	CHEMICAL	GENE-Y	27	31	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T31	23424204
CPR:4	CHEMICAL	GENE-N	27	33	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T17	23424204
CPR:4	CHEMICAL	GENE-Y	27	35	Although there was no change in the levels of gene ( gene ) , gene ( gene ) and chemical transporter-4 ( gene ) messenger RNA , chemical significantly decreased the gene , gene and gene protein levels ( both plasma membrane and cytosolic fraction ) of the gastrocnemius muscle .	T14	T18	23424204
NA	CHEMICAL	GENE-N	11	4	There was an increase in serum gene and decrease in serum chemical levels but fasting blood chemical level remained unaltered .	T2	T19	23424204
NA	CHEMICAL	GENE-N	16	4	There was an increase in serum gene and decrease in serum chemical levels but fasting blood chemical level remained unaltered .	T3	T19	23424204
CPR:4	CHEMICAL	GENE-N	5	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T41	23424207
CPR:4	CHEMICAL	GENE-N	5	21	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T42	23424207
CPR:4	CHEMICAL	GENE-N	5	23	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T43	23424207
CPR:4	CHEMICAL	GENE-N	5	25	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T44	23424207
CPR:4	CHEMICAL	GENE-N	5	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T45	23424207
CPR:4	CHEMICAL	GENE-N	5	30	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T46	23424207
CPR:4	CHEMICAL	GENE-N	5	33	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T21	T47	23424207
NA	CHEMICAL	GENE-N	16	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T41	23424207
NA	CHEMICAL	GENE-N	16	21	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T42	23424207
NA	CHEMICAL	GENE-N	16	23	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T43	23424207
NA	CHEMICAL	GENE-N	16	25	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T44	23424207
NA	CHEMICAL	GENE-N	16	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T45	23424207
NA	CHEMICAL	GENE-N	16	30	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T46	23424207
NA	CHEMICAL	GENE-N	16	33	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T22	T47	23424207
NA	CHEMICAL	GENE-N	18	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T41	23424207
NA	CHEMICAL	GENE-N	18	21	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T42	23424207
NA	CHEMICAL	GENE-N	18	23	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T43	23424207
NA	CHEMICAL	GENE-N	18	25	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T44	23424207
NA	CHEMICAL	GENE-N	18	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T45	23424207
NA	CHEMICAL	GENE-N	18	30	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T46	23424207
NA	CHEMICAL	GENE-N	18	33	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T23	T47	23424207
NA	CHEMICAL	GENE-N	27	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T41	23424207
NA	CHEMICAL	GENE-N	27	21	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T42	23424207
NA	CHEMICAL	GENE-N	27	23	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T43	23424207
NA	CHEMICAL	GENE-N	27	25	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T44	23424207
NA	CHEMICAL	GENE-N	27	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T45	23424207
NA	CHEMICAL	GENE-N	27	30	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T46	23424207
NA	CHEMICAL	GENE-N	27	33	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T24	T47	23424207
NA	CHEMICAL	GENE-N	45	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T41	23424207
NA	CHEMICAL	GENE-N	45	21	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T42	23424207
NA	CHEMICAL	GENE-N	45	23	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T43	23424207
NA	CHEMICAL	GENE-N	45	25	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T44	23424207
NA	CHEMICAL	GENE-N	45	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T45	23424207
NA	CHEMICAL	GENE-N	45	30	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T46	23424207
NA	CHEMICAL	GENE-N	45	33	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T25	T47	23424207
NA	CHEMICAL	GENE-N	47	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T41	23424207
NA	CHEMICAL	GENE-N	47	21	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T42	23424207
NA	CHEMICAL	GENE-N	47	23	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T43	23424207
NA	CHEMICAL	GENE-N	47	25	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T44	23424207
NA	CHEMICAL	GENE-N	47	19	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T45	23424207
NA	CHEMICAL	GENE-N	47	30	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T46	23424207
NA	CHEMICAL	GENE-N	47	33	The obtained results showed that chemical increased lipid peroxidation and abnormal sperm count and decreased plasma chemical , chemical dehydrogenase , gene , gene and gene : chemical dehydrogenase ( gene ) , gene activities as well as epididymal sperm counts and motility , while chemical and chemical treatment reversed this change to control values .	T26	T47	23424207
CPR:4	CHEMICAL	GENE-N	3	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T48	23424207
CPR:4	CHEMICAL	GENE-N	3	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T49	23424207
CPR:4	CHEMICAL	GENE-Y	3	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T50	23424207
CPR:4	CHEMICAL	GENE-Y	3	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T51	23424207
CPR:4	CHEMICAL	GENE-N	3	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T52	23424207
CPR:4	CHEMICAL	GENE-Y	3	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T54	23424207
CPR:4	CHEMICAL	GENE-Y	3	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T55	23424207
CPR:4	CHEMICAL	GENE-N	3	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T27	T40	23424207
NA	CHEMICAL	GENE-N	17	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T48	23424207
NA	CHEMICAL	GENE-N	17	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T49	23424207
NA	CHEMICAL	GENE-Y	17	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T50	23424207
NA	CHEMICAL	GENE-Y	17	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T51	23424207
NA	CHEMICAL	GENE-N	17	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T52	23424207
NA	CHEMICAL	GENE-Y	17	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T54	23424207
NA	CHEMICAL	GENE-Y	17	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T55	23424207
NA	CHEMICAL	GENE-N	17	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T28	T40	23424207
NA	CHEMICAL	GENE-N	28	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T48	23424207
NA	CHEMICAL	GENE-N	28	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T49	23424207
NA	CHEMICAL	GENE-Y	28	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T50	23424207
NA	CHEMICAL	GENE-Y	28	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T51	23424207
NA	CHEMICAL	GENE-N	28	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T52	23424207
NA	CHEMICAL	GENE-Y	28	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T54	23424207
NA	CHEMICAL	GENE-Y	28	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T55	23424207
NA	CHEMICAL	GENE-N	28	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T29	T40	23424207
NA	CHEMICAL	GENE-N	31	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T48	23424207
NA	CHEMICAL	GENE-N	31	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T49	23424207
NA	CHEMICAL	GENE-Y	31	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T50	23424207
NA	CHEMICAL	GENE-Y	31	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T51	23424207
NA	CHEMICAL	GENE-N	31	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T52	23424207
NA	CHEMICAL	GENE-Y	31	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T54	23424207
NA	CHEMICAL	GENE-Y	31	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T55	23424207
NA	CHEMICAL	GENE-N	31	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T31	T40	23424207
NA	CHEMICAL	GENE-N	34	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T48	23424207
NA	CHEMICAL	GENE-N	34	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T49	23424207
NA	CHEMICAL	GENE-Y	34	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T50	23424207
NA	CHEMICAL	GENE-Y	34	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T51	23424207
NA	CHEMICAL	GENE-N	34	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T52	23424207
NA	CHEMICAL	GENE-Y	34	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T54	23424207
NA	CHEMICAL	GENE-Y	34	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T55	23424207
NA	CHEMICAL	GENE-N	34	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T32	T40	23424207
NA	CHEMICAL	GENE-N	40	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T48	23424207
NA	CHEMICAL	GENE-N	40	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T49	23424207
NA	CHEMICAL	GENE-Y	40	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T50	23424207
NA	CHEMICAL	GENE-Y	40	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T51	23424207
NA	CHEMICAL	GENE-N	40	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T52	23424207
NA	CHEMICAL	GENE-Y	40	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T54	23424207
NA	CHEMICAL	GENE-Y	40	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T55	23424207
NA	CHEMICAL	GENE-N	40	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T33	T40	23424207
NA	CHEMICAL	GENE-N	42	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T48	23424207
NA	CHEMICAL	GENE-N	42	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T49	23424207
NA	CHEMICAL	GENE-Y	42	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T50	23424207
NA	CHEMICAL	GENE-Y	42	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T51	23424207
NA	CHEMICAL	GENE-N	42	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T52	23424207
NA	CHEMICAL	GENE-Y	42	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T54	23424207
NA	CHEMICAL	GENE-Y	42	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T55	23424207
NA	CHEMICAL	GENE-N	42	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T34	T40	23424207
NA	CHEMICAL	GENE-N	46	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T48	23424207
NA	CHEMICAL	GENE-N	46	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T49	23424207
NA	CHEMICAL	GENE-Y	46	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T50	23424207
NA	CHEMICAL	GENE-Y	46	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T51	23424207
NA	CHEMICAL	GENE-N	46	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T52	23424207
NA	CHEMICAL	GENE-Y	46	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T54	23424207
NA	CHEMICAL	GENE-Y	46	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T55	23424207
NA	CHEMICAL	GENE-N	46	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T35	T40	23424207
NA	CHEMICAL	GENE-N	46	18	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T48	23424207
NA	CHEMICAL	GENE-N	46	20	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T49	23424207
NA	CHEMICAL	GENE-Y	46	23	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T50	23424207
NA	CHEMICAL	GENE-Y	46	25	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T51	23424207
NA	CHEMICAL	GENE-N	46	29	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T52	23424207
NA	CHEMICAL	GENE-Y	46	35	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T54	23424207
NA	CHEMICAL	GENE-Y	46	37	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T55	23424207
NA	CHEMICAL	GENE-N	46	48	Acute intoxication with chemical was also followed by significantly decreased activity of the antioxidant defence system ( chemical dismutase ( gene ) , gene ( gene ) , chemical peroxidase ( chemical-Px ) , chemical reductase ( gene ) , chemical ( chemical ) , and chemical-chemical-transferase ( gene ) ) .	T36	T40	23424207
CPR:4	CHEMICAL	GENE-Y	3	9	In addition , chemical treatment significantly reduced the specific gene activity after SCI as compared to that of vehicle control .	T3	T14	14588118
CPR:3	CHEMICAL	GENE-Y	6	11	Furthermore , RT-PCR analyses revealed that chemical treatment increased expression of gene mRNA but decreased gene expression .	T4	T15	14588118
CPR:4	CHEMICAL	GENE-Y	6	15	Furthermore , RT-PCR analyses revealed that chemical treatment increased expression of gene mRNA but decreased gene expression .	T4	T16	14588118
CPR:9	CHEMICAL	GENE-Y	8	4	Recent observations revealed that gene catalyzes N-glucuronidation of chemical-containing compounds .	T3	T40	23611809
CPR:9	CHEMICAL	GENE-Y	7	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T11	T41	23611809
CPR:9	CHEMICAL	GENE-Y	14	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T12	T41	23611809
CPR:9	CHEMICAL	GENE-Y	16	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T13	T41	23611809
CPR:9	CHEMICAL	GENE-Y	18	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T14	T41	23611809
CPR:9	CHEMICAL	GENE-Y	20	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T15	T41	23611809
CPR:9	CHEMICAL	GENE-Y	22	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T16	T41	23611809
CPR:9	CHEMICAL	GENE-Y	24	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T17	T41	23611809
CPR:9	CHEMICAL	GENE-Y	26	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T18	T41	23611809
CPR:9	CHEMICAL	GENE-Y	28	2	Using recombinant gene , we found that it catalyzes the N-glucuronidation of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical .	T19	T41	23611809
NA	CHEMICAL	GENE-Y	17	11	These are drugs that were previously reported to be substrates for gene or gene and that contain in their structure either chemical , chemical , or an chemical group .	T20	T42	23611809
NA	CHEMICAL	GENE-Y	17	13	These are drugs that were previously reported to be substrates for gene or gene and that contain in their structure either chemical , chemical , or an chemical group .	T20	T43	23611809
NA	CHEMICAL	GENE-Y	17	11	These are drugs that were previously reported to be substrates for gene or gene and that contain in their structure either chemical , chemical , or an chemical group .	T21	T42	23611809
NA	CHEMICAL	GENE-Y	17	13	These are drugs that were previously reported to be substrates for gene or gene and that contain in their structure either chemical , chemical , or an chemical group .	T21	T43	23611809
NA	CHEMICAL	GENE-Y	27	11	These are drugs that were previously reported to be substrates for gene or gene and that contain in their structure either chemical , chemical , or an chemical group .	T22	T42	23611809
NA	CHEMICAL	GENE-Y	27	13	These are drugs that were previously reported to be substrates for gene or gene and that contain in their structure either chemical , chemical , or an chemical group .	T22	T43	23611809
NA	CHEMICAL	GENE-Y	3	0	gene was inactive in the glucuronidation of chemical , chemical , chemical and chemical .	T23	T44	23611809
NA	CHEMICAL	GENE-Y	3	0	gene was inactive in the glucuronidation of chemical , chemical , chemical and chemical .	T24	T44	23611809
NA	CHEMICAL	GENE-Y	3	0	gene was inactive in the glucuronidation of chemical , chemical , chemical and chemical .	T25	T44	23611809
NA	CHEMICAL	GENE-Y	13	0	gene was inactive in the glucuronidation of chemical , chemical , chemical and chemical .	T26	T44	23611809
NA	CHEMICAL	GENE-Y	5	12	This group of drugs contains chemical , and these results suggest that gene preferably conjugates chemical .	T27	T45	23611809
CPR:9	CHEMICAL	GENE-Y	15	12	This group of drugs contains chemical , and these results suggest that gene preferably conjugates chemical .	T28	T45	23611809
NA	CHEMICAL	GENE-Y	10	5	This preference is partial because gene did not conjugate the chemical in chemical .	T1	T29	23611809
NA	CHEMICAL	GENE-Y	5	5	This preference is partial because gene did not conjugate the chemical in chemical .	T2	T29	23611809
CPR:9	CHEMICAL	GENE-Y	11	9	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T4	T30	23611809
CPR:9	CHEMICAL	GENE-Y	11	25	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T4	T31	23611809
NA	CHEMICAL	GENE-Y	11	27	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T4	T32	23611809
CPR:9	CHEMICAL	GENE-Y	11	34	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T4	T33	23611809
CPR:9	CHEMICAL	GENE-Y	13	9	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T5	T30	23611809
CPR:9	CHEMICAL	GENE-Y	13	25	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T5	T31	23611809
CPR:9	CHEMICAL	GENE-Y	13	27	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T5	T32	23611809
CPR:9	CHEMICAL	GENE-Y	13	34	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T5	T33	23611809
CPR:9	CHEMICAL	GENE-Y	16	9	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T6	T30	23611809
CPR:9	CHEMICAL	GENE-Y	16	25	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T6	T31	23611809
CPR:9	CHEMICAL	GENE-Y	16	27	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T6	T32	23611809
CPR:9	CHEMICAL	GENE-Y	16	34	Kinetic analyses revealed that the affinity and clearance of gene for chemical , chemical , and chemical are significantly higher than the corresponding values of gene and gene , although the Vmax values of gene toward these drugs are considerably higher .	T6	T33	23611809
CPR:4	CHEMICAL	GENE-Y	9	7	Intestinal and hepatic first-pass extraction of the gene inhibitor chemical in rats with chronic vascular catheters .	T6	T8	23517558
CPR:4	CHEMICAL	GENE-Y	21	18	A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an gene inhibitor , chemical .	T2	T7	23517558
CPR:3	CHEMICAL	GENE-Y	0	7	chemical protects against chemical-induced hepatotoxicity by enhancing gene activity .	T12	T20	10939639
NA	CHEMICAL	GENE-Y	3	7	chemical protects against chemical-induced hepatotoxicity by enhancing gene activity .	T13	T20	10939639
NA	CHEMICAL	GENE-N	3	8	Pretreating mice with chemical ( chemical ) , a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis , at a daily dose of 1 mmol/kg for 3 days protected against chemical-induced hepatic oxidative damage in mice , as evidenced by decreases in plasma gene activity ( 78 % ) and hepatic chemical level ( 70 % ) , when compared with the chemical intoxicated control .	T3	T14	10939639
NA	CHEMICAL	GENE-N	5	8	Pretreating mice with chemical ( chemical ) , a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis , at a daily dose of 1 mmol/kg for 3 days protected against chemical-induced hepatic oxidative damage in mice , as evidenced by decreases in plasma gene activity ( 78 % ) and hepatic chemical level ( 70 % ) , when compared with the chemical intoxicated control .	T5	T14	10939639
CPR:4	CHEMICAL	GENE-N	8	8	Pretreating mice with chemical ( chemical ) , a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis , at a daily dose of 1 mmol/kg for 3 days protected against chemical-induced hepatic oxidative damage in mice , as evidenced by decreases in plasma gene activity ( 78 % ) and hepatic chemical level ( 70 % ) , when compared with the chemical intoxicated control .	T2	T14	10939639
NA	CHEMICAL	GENE-N	8	8	Pretreating mice with chemical ( chemical ) , a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis , at a daily dose of 1 mmol/kg for 3 days protected against chemical-induced hepatic oxidative damage in mice , as evidenced by decreases in plasma gene activity ( 78 % ) and hepatic chemical level ( 70 % ) , when compared with the chemical intoxicated control .	T4	T14	10939639
NA	CHEMICAL	GENE-N	8	8	Pretreating mice with chemical ( chemical ) , a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis , at a daily dose of 1 mmol/kg for 3 days protected against chemical-induced hepatic oxidative damage in mice , as evidenced by decreases in plasma gene activity ( 78 % ) and hepatic chemical level ( 70 % ) , when compared with the chemical intoxicated control .	T6	T14	10939639
NA	CHEMICAL	GENE-Y	13	21	In order to define the biochemical mechanism involved in the hepatoprotection afforded by chemical pretreatment , we examined the activity of gene ( gene ) in hepatocytes isolated from chemical pretreated rats .	T7	T15	10939639
NA	CHEMICAL	GENE-Y	13	23	In order to define the biochemical mechanism involved in the hepatoprotection afforded by chemical pretreatment , we examined the activity of gene ( gene ) in hepatocytes isolated from chemical pretreated rats .	T7	T16	10939639
NA	CHEMICAL	GENE-Y	29	21	In order to define the biochemical mechanism involved in the hepatoprotection afforded by chemical pretreatment , we examined the activity of gene ( gene ) in hepatocytes isolated from chemical pretreated rats .	T8	T15	10939639
NA	CHEMICAL	GENE-Y	29	23	In order to define the biochemical mechanism involved in the hepatoprotection afforded by chemical pretreatment , we examined the activity of gene ( gene ) in hepatocytes isolated from chemical pretreated rats .	T8	T16	10939639
CPR:3	CHEMICAL	GENE-Y	3	26	Hepatocytes isolated from chemical pretreated ( a daily dose of 1 mmol/kg for 3 days ) rats showed a significant increase ( 25 % ) in gene activity .	T9	T17	10939639
NA	CHEMICAL	GENE-Y	12	3	The increase in gene activity was associated with the enhanced rate of chemical elimination in the hepatocyte culture .	T10	T18	10939639
NA	CHEMICAL	GENE-Y	8	3	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T9	T20	23265459
NA	CHEMICAL	GENE-Y	8	5	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T9	T21	23265459
NA	CHEMICAL	GENE-N	8	9	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T9	T22	23265459
NA	CHEMICAL	GENE-N	8	11	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T9	T23	23265459
NA	CHEMICAL	GENE-N	8	15	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T9	T24	23265459
NA	CHEMICAL	GENE-Y	14	3	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T10	T20	23265459
NA	CHEMICAL	GENE-Y	14	5	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T10	T21	23265459
NA	CHEMICAL	GENE-N	14	9	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T10	T22	23265459
NA	CHEMICAL	GENE-N	14	11	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T10	T23	23265459
NA	CHEMICAL	GENE-N	14	15	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T10	T24	23265459
NA	CHEMICAL	GENE-Y	17	3	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T11	T20	23265459
NA	CHEMICAL	GENE-Y	17	5	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T11	T21	23265459
NA	CHEMICAL	GENE-N	17	9	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T11	T22	23265459
NA	CHEMICAL	GENE-N	17	11	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T11	T23	23265459
NA	CHEMICAL	GENE-N	17	15	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T11	T24	23265459
NA	CHEMICAL	GENE-Y	23	3	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T12	T20	23265459
NA	CHEMICAL	GENE-Y	23	5	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T12	T21	23265459
NA	CHEMICAL	GENE-N	23	9	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T12	T22	23265459
NA	CHEMICAL	GENE-N	23	11	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T12	T23	23265459
NA	CHEMICAL	GENE-N	23	15	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T12	T24	23265459
NA	CHEMICAL	GENE-Y	25	3	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T13	T20	23265459
NA	CHEMICAL	GENE-Y	25	5	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T13	T21	23265459
NA	CHEMICAL	GENE-N	25	9	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T13	T22	23265459
NA	CHEMICAL	GENE-N	25	11	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T13	T23	23265459
NA	CHEMICAL	GENE-N	25	15	They also increased gene ( gene ) , chemical dismutase ( gene ) and chemical peroxidase ( chemical-Px ) activity , while decreasing chemical ( chemical ) levels in serum and in the livers of mice .	T13	T24	23265459
NA	CHEMICAL	GENE-Y	0	4	chemical-nitrosation of chemical transferase P1-1 is controlled by the conformation of a dynamic active-site helix .	T13	T21	23572520
NA	CHEMICAL	GENE-Y	2	4	chemical-nitrosation of chemical transferase P1-1 is controlled by the conformation of a dynamic active-site helix .	T14	T21	23572520
NA	CHEMICAL	GENE-Y	7	15	We used transient kinetic methods to determine a minimal mechanism for spontaneous GSNO-mediated transnitrosation of gene , a major detoxification enzyme and key regulator of cell proliferation .	T8	T17	23572520
NA	CHEMICAL	GENE-Y	4	2	C47 of gene is chemical-nitrosated in two steps , with the chemical step limited by a pre-equilibrium between the open and closed conformations of helix α2 at the active site .	T9	T18	23572520
NA	CHEMICAL	GENE-N	22	5	Despite the presence of a gene at the active site of gene , isothermal titration calorimetry as well as nitrosation experiments using chemical demonstrate that GchemicalNO binding does not precede S-nitrosation of gene .	T12	T19	23572520
NA	CHEMICAL	GENE-Y	22	11	Despite the presence of a gene at the active site of gene , isothermal titration calorimetry as well as nitrosation experiments using chemical demonstrate that GchemicalNO binding does not precede S-nitrosation of gene .	T12	T20	23572520
NA	CHEMICAL	GENE-Y	22	32	Despite the presence of a gene at the active site of gene , isothermal titration calorimetry as well as nitrosation experiments using chemical demonstrate that GchemicalNO binding does not precede S-nitrosation of gene .	T12	T15	23572520
NA	CHEMICAL	GENE-N	11	5	Despite the presence of a gene at the active site of gene , isothermal titration calorimetry as well as nitrosation experiments using chemical demonstrate that GchemicalNO binding does not precede S-nitrosation of gene .	T2	T19	23572520
NA	CHEMICAL	GENE-Y	11	11	Despite the presence of a gene at the active site of gene , isothermal titration calorimetry as well as nitrosation experiments using chemical demonstrate that GchemicalNO binding does not precede S-nitrosation of gene .	T2	T20	23572520
NA	CHEMICAL	GENE-Y	11	32	Despite the presence of a gene at the active site of gene , isothermal titration calorimetry as well as nitrosation experiments using chemical demonstrate that GchemicalNO binding does not precede S-nitrosation of gene .	T2	T15	23572520
NA	CHEMICAL	GENE-Y	5	0	gene polymorphisms and antihypertensive response to chemical .	T7	T17	12844134
NA	CHEMICAL	GENE-Y	18	12	We tested the hypothesis that 2 common polymorphisms in the gene for gene are associated with antihypertensive response to chemical in patients with uncomplicated hypertension .	T3	T14	12844134
NA	CHEMICAL	GENE-Y	6	6	CONCLUSIONS : Our data suggest that gene polymorphisms are important determinants of antihypertensive response to chemical .	T1	T13	12844134
NA	CHEMICAL	GENE-N	4	2	UNLABELLED : gene overexpressed in human tumors , such as chemical receptors , can be used for in vivo targeting for diagnostic and therapeutic purposes .	T1	T3	17475961
NA	CHEMICAL	GENE-N	4	11	UNLABELLED : gene overexpressed in human tumors , such as chemical receptors , can be used for in vivo targeting for diagnostic and therapeutic purposes .	T1	T16	17475961
NA	CHEMICAL	GENE-Y	4	0	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T11	T43	23052195
NA	CHEMICAL	GENE-N	4	5	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T11	T44	23052195
NA	CHEMICAL	GENE-N	4	10	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T11	T45	23052195
NA	CHEMICAL	GENE-Y	7	0	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T12	T43	23052195
NA	CHEMICAL	GENE-N	7	5	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T12	T44	23052195
NA	CHEMICAL	GENE-N	7	10	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T12	T45	23052195
NA	CHEMICAL	GENE-Y	11	0	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T10	T43	23052195
NA	CHEMICAL	GENE-N	11	5	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T10	T44	23052195
NA	CHEMICAL	GENE-N	11	10	gene knockdown can modify chemical peroxidase and chemical response element-binding protein in chemical-treated rats .	T10	T45	23052195
NA	CHEMICAL	GENE-Y	14	8	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T8	T28	23052195
NA	CHEMICAL	GENE-Y	14	10	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T8	T30	23052195
NA	CHEMICAL	GENE-N	14	17	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T8	T34	23052195
NA	CHEMICAL	GENE-N	14	19	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T8	T17	23052195
NA	CHEMICAL	GENE-Y	10	8	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T3	T28	23052195
NA	CHEMICAL	GENE-Y	10	10	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T3	T30	23052195
NA	CHEMICAL	GENE-N	10	17	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T3	T34	23052195
NA	CHEMICAL	GENE-N	10	19	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T3	T17	23052195
NA	CHEMICAL	GENE-Y	27	8	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T4	T28	23052195
NA	CHEMICAL	GENE-Y	27	10	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T4	T30	23052195
NA	CHEMICAL	GENE-N	27	17	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T4	T34	23052195
NA	CHEMICAL	GENE-N	27	19	It has been reported that antioxidative enzymes , gene ( gene ) , and chemical response element-binding protein ( gene ) are involved in regulating chemical ( chemical ) -mediated appetite suppression .	T4	T17	23052195
NA	CHEMICAL	GENE-Y	9	5	Changes in the contents of gene , gene , chemical peroxidase ( gene ) , and gene were assessed and compared .	T6	T20	23052195
NA	CHEMICAL	GENE-Y	9	7	Changes in the contents of gene , gene , chemical peroxidase ( gene ) , and gene were assessed and compared .	T6	T21	23052195
NA	CHEMICAL	GENE-N	9	10	Changes in the contents of gene , gene , chemical peroxidase ( gene ) , and gene were assessed and compared .	T6	T22	23052195
NA	CHEMICAL	GENE-N	9	12	Changes in the contents of gene , gene , chemical peroxidase ( gene ) , and gene were assessed and compared .	T6	T23	23052195
NA	CHEMICAL	GENE-N	9	16	Changes in the contents of gene , gene , chemical peroxidase ( gene ) , and gene were assessed and compared .	T6	T24	23052195
NA	CHEMICAL	GENE-Y	21	3	By contrast , gene decreased with a biggest reduction about 48 % on Day 2 and the pattern of expression during chemical treatment was opposite to those of gene , gene , and gene .	T7	T29	23052195
NA	CHEMICAL	GENE-Y	21	28	By contrast , gene decreased with a biggest reduction about 48 % on Day 2 and the pattern of expression during chemical treatment was opposite to those of gene , gene , and gene .	T7	T31	23052195
NA	CHEMICAL	GENE-N	21	30	By contrast , gene decreased with a biggest reduction about 48 % on Day 2 and the pattern of expression during chemical treatment was opposite to those of gene , gene , and gene .	T7	T32	23052195
NA	CHEMICAL	GENE-N	21	33	By contrast , gene decreased with a biggest reduction about 48 % on Day 2 and the pattern of expression during chemical treatment was opposite to those of gene , gene , and gene .	T7	T33	23052195
NA	CHEMICAL	GENE-Y	20	13	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T35	23052195
NA	CHEMICAL	GENE-Y	20	26	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T36	23052195
NA	CHEMICAL	GENE-N	20	28	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T37	23052195
NA	CHEMICAL	GENE-N	20	31	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T38	23052195
NA	CHEMICAL	GENE-Y	20	39	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T39	23052195
NA	CHEMICAL	GENE-Y	20	42	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T40	23052195
NA	CHEMICAL	GENE-N	20	44	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T41	23052195
NA	CHEMICAL	GENE-N	20	47	Central knockdown ( using antisense ) or inhibition ( using antagonist ) of gene expression modulated the anorectic response of chemical and the reciprocal regulation between gene and gene ( or gene ) , revealing an essential role of gene in regulating gene , gene , and gene .	T9	T42	23052195
NA	CHEMICAL	GENE-Y	4	4	These results suggest that gene participates in the reciprocal regulation of gene , gene , and gene in the hypothalamus during chemical treatment in conscious rats .	T1	T13	23052195
NA	CHEMICAL	GENE-Y	4	11	These results suggest that gene participates in the reciprocal regulation of gene , gene , and gene in the hypothalamus during chemical treatment in conscious rats .	T1	T14	23052195
NA	CHEMICAL	GENE-N	4	13	These results suggest that gene participates in the reciprocal regulation of gene , gene , and gene in the hypothalamus during chemical treatment in conscious rats .	T1	T15	23052195
NA	CHEMICAL	GENE-N	4	16	These results suggest that gene participates in the reciprocal regulation of gene , gene , and gene in the hypothalamus during chemical treatment in conscious rats .	T1	T16	23052195
NA	CHEMICAL	GENE-Y	8	10	Atypical and typical antipsychotic drug interactions with the chemical D2 receptor .	T10	T12	15694653
NA	CHEMICAL	GENE-Y	4	6	A model of the chemical D2 receptor was used to study the receptor interactions of chemical , the typical antipsychotics chemical and chemical , and the atypical antipsychotics chemical and chemical .	T3	T11	15694653
NA	CHEMICAL	GENE-Y	15	6	A model of the chemical D2 receptor was used to study the receptor interactions of chemical , the typical antipsychotics chemical and chemical , and the atypical antipsychotics chemical and chemical .	T9	T11	15694653
NA	CHEMICAL	GENE-Y	20	6	A model of the chemical D2 receptor was used to study the receptor interactions of chemical , the typical antipsychotics chemical and chemical , and the atypical antipsychotics chemical and chemical .	T1	T11	15694653
NA	CHEMICAL	GENE-Y	22	6	A model of the chemical D2 receptor was used to study the receptor interactions of chemical , the typical antipsychotics chemical and chemical , and the atypical antipsychotics chemical and chemical .	T2	T11	15694653
NA	CHEMICAL	GENE-Y	28	6	A model of the chemical D2 receptor was used to study the receptor interactions of chemical , the typical antipsychotics chemical and chemical , and the atypical antipsychotics chemical and chemical .	T4	T11	15694653
NA	CHEMICAL	GENE-Y	30	6	A model of the chemical D2 receptor was used to study the receptor interactions of chemical , the typical antipsychotics chemical and chemical , and the atypical antipsychotics chemical and chemical .	T5	T11	15694653
NA	CHEMICAL	GENE-Y	11	14	Pharmacologic advances in the field in the past decades , including chemical and the gene inhibitors , have contributed significantly to the reduced mortality of chemical-sensitive breast cancer .	T5	T14	20151846
NA	CHEMICAL	GENE-Y	25	14	Pharmacologic advances in the field in the past decades , including chemical and the gene inhibitors , have contributed significantly to the reduced mortality of chemical-sensitive breast cancer .	T6	T14	20151846
CPR:4	CHEMICAL	GENE-Y	0	5	chemical , a pure chemical receptor downregulator , is a new addition to the antiestrogen therapeutic armamentarium since its FDA approval in 2002 .	T8	T15	20151846
NA	CHEMICAL	GENE-Y	4	5	chemical , a pure chemical receptor downregulator , is a new addition to the antiestrogen therapeutic armamentarium since its FDA approval in 2002 .	T9	T15	20151846
NA	CHEMICAL	GENE-Y	0	3	chemical and other gene antagonists in prostate cancer .	T20	T30	20053189
CPR:5	CHEMICAL	GENE-Y	8	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T5	T22	20053189
CPR:5	CHEMICAL	GENE-Y	8	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T5	T23	20053189
CPR:3	CHEMICAL	GENE-Y	8	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T5	T24	20053189
CPR:4	CHEMICAL	GENE-N	8	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T5	T25	20053189
CPR:5	CHEMICAL	GENE-Y	10	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T6	T22	20053189
CPR:5	CHEMICAL	GENE-Y	10	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T6	T23	20053189
CPR:3	CHEMICAL	GENE-Y	10	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T6	T24	20053189
CPR:4	CHEMICAL	GENE-N	10	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T6	T25	20053189
CPR:5	CHEMICAL	GENE-Y	12	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T7	T22	20053189
CPR:5	CHEMICAL	GENE-Y	12	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T7	T23	20053189
CPR:3	CHEMICAL	GENE-Y	12	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T7	T24	20053189
CPR:4	CHEMICAL	GENE-N	12	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T7	T25	20053189
CPR:5	CHEMICAL	GENE-Y	14	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T8	T22	20053189
CPR:5	CHEMICAL	GENE-Y	14	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T8	T23	20053189
CPR:3	CHEMICAL	GENE-Y	14	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T8	T24	20053189
CPR:4	CHEMICAL	GENE-N	14	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T8	T25	20053189
NA	CHEMICAL	GENE-Y	20	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T9	T22	20053189
NA	CHEMICAL	GENE-Y	20	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T9	T23	20053189
NA	CHEMICAL	GENE-Y	20	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T9	T24	20053189
NA	CHEMICAL	GENE-N	20	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T9	T25	20053189
NA	CHEMICAL	GENE-Y	22	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T10	T22	20053189
NA	CHEMICAL	GENE-Y	22	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T10	T23	20053189
NA	CHEMICAL	GENE-Y	22	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T10	T24	20053189
NA	CHEMICAL	GENE-N	22	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T10	T25	20053189
NA	CHEMICAL	GENE-Y	28	0	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T11	T22	20053189
NA	CHEMICAL	GENE-Y	28	2	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T11	T23	20053189
NA	CHEMICAL	GENE-Y	28	24	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T11	T24	20053189
NA	CHEMICAL	GENE-N	28	35	gene ( gene ) agonists , such as chemical , chemical , chemical and chemical , stimulate the pituitary 's chemical ( chemical ) receptor , ultimately leading to its de-sensitization and subsequent reduction of gene and chemical levels .	T11	T25	20053189
NA	CHEMICAL	GENE-N	17	15	However , this reduction is accompanied by a well described increase or 'surge ' in gene and chemical levels , necessitating the concomitant administration of an antiandrogen to combat the potential effects of transient acceleration in cancer activity .	T12	T26	20053189
NA	CHEMICAL	GENE-Y	2	21	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T13	T27	20053189
NA	CHEMICAL	GENE-Y	2	22	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T13	T28	20053189
CPR:6	CHEMICAL	GENE-Y	8	21	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T14	T27	20053189
NA	CHEMICAL	GENE-Y	8	22	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T14	T28	20053189
CPR:6	CHEMICAL	GENE-Y	10	21	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T15	T27	20053189
NA	CHEMICAL	GENE-Y	10	22	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T15	T28	20053189
NA	CHEMICAL	GENE-Y	19	21	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T17	T27	20053189
NA	CHEMICAL	GENE-Y	19	22	Two pure chemical antagonists have been developed , chemical and chemical , that are devoid of any agonist effect on the gene receptor and consequently do not result in chemical flare .	T17	T28	20053189
NA	CHEMICAL	GENE-Y	18	24	The reasons why doses are not individualised routinely are difficulties in defining , predicting and achieving an optimal chemical exposure or dose because of a narrow therapeutic index , nonlinear pharmacokinetics , variabilities in administration rates and metabolism , and in targets like chemical synthase .	T11	T20	16719540
NA	CHEMICAL	GENE-Y	24	24	The reasons why doses are not individualised routinely are difficulties in defining , predicting and achieving an optimal chemical exposure or dose because of a narrow therapeutic index , nonlinear pharmacokinetics , variabilities in administration rates and metabolism , and in targets like chemical synthase .	T12	T20	16719540
NA	CHEMICAL	GENE-Y	2	14	To individualise chemical administration before the first dose , assessment of the individual chemical dehydrogenase ( gene ) activity may be useful , because this genetically highly polymorphic enzyme controls approximately 80 % of chemical elimination .	T13	T21	16719540
NA	CHEMICAL	GENE-Y	2	16	To individualise chemical administration before the first dose , assessment of the individual chemical dehydrogenase ( gene ) activity may be useful , because this genetically highly polymorphic enzyme controls approximately 80 % of chemical elimination .	T13	T22	16719540
NA	CHEMICAL	GENE-Y	13	14	To individualise chemical administration before the first dose , assessment of the individual chemical dehydrogenase ( gene ) activity may be useful , because this genetically highly polymorphic enzyme controls approximately 80 % of chemical elimination .	T14	T21	16719540
NA	CHEMICAL	GENE-Y	13	16	To individualise chemical administration before the first dose , assessment of the individual chemical dehydrogenase ( gene ) activity may be useful , because this genetically highly polymorphic enzyme controls approximately 80 % of chemical elimination .	T14	T22	16719540
NA	CHEMICAL	GENE-Y	34	14	To individualise chemical administration before the first dose , assessment of the individual chemical dehydrogenase ( gene ) activity may be useful , because this genetically highly polymorphic enzyme controls approximately 80 % of chemical elimination .	T16	T21	16719540
NA	CHEMICAL	GENE-Y	34	16	To individualise chemical administration before the first dose , assessment of the individual chemical dehydrogenase ( gene ) activity may be useful , because this genetically highly polymorphic enzyme controls approximately 80 % of chemical elimination .	T16	T22	16719540
NA	CHEMICAL	GENE-Y	2	6	A complete or partial loss of gene activity in 0.1 and 3-5 % of Caucasians , respectively , leads to increased chemical exposure and toxicity .	T17	T23	16719540
NA	CHEMICAL	GENE-Y	4	4	Several methods to assess gene activity in patients have been proposed ( genotyping , various phenotyping methods ) , but each of them has limitations , as has the chemical test dose approach .	T2	T24	16719540
NA	CHEMICAL	GENE-N	14	6	Mechanism of specific membrane targeting by gene : localized pools of target lipids enhance chemical affinity .	T19	T37	17367165
CPR:3	CHEMICAL	GENE-N	11	7	Although considerable functional diversity exists , most gene are activated by chemical binding and then dock to a specific cellular membrane .	T8	T23	17367165
NA	CHEMICAL	GENE-N	27	1	The gene of gene ( gene ) and gene ( gene ) , for example , are known to dock to different membrane surfaces during an intracellular chemical signal .	T11	T27	17367165
NA	CHEMICAL	GENE-Y	27	3	The gene of gene ( gene ) and gene ( gene ) , for example , are known to dock to different membrane surfaces during an intracellular chemical signal .	T11	T28	17367165
NA	CHEMICAL	GENE-Y	27	5	The gene of gene ( gene ) and gene ( gene ) , for example , are known to dock to different membrane surfaces during an intracellular chemical signal .	T11	T29	17367165
NA	CHEMICAL	GENE-Y	27	8	The gene of gene ( gene ) and gene ( gene ) , for example , are known to dock to different membrane surfaces during an intracellular chemical signal .	T11	T30	17367165
NA	CHEMICAL	GENE-Y	27	10	The gene of gene ( gene ) and gene ( gene ) , for example , are known to dock to different membrane surfaces during an intracellular chemical signal .	T11	T31	17367165
NA	CHEMICAL	GENE-N	0	4	chemical activation targets the gene to the plasma membrane and the gene to the internal membranes , with no detectable spatial overlap .	T12	T34	17367165
NA	CHEMICAL	GENE-N	0	11	chemical activation targets the gene to the plasma membrane and the gene to the internal membranes , with no detectable spatial overlap .	T12	T35	17367165
NA	CHEMICAL	GENE-N	9	3	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T14	T36	17367165
NA	CHEMICAL	GENE-N	9	30	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T14	T20	17367165
NA	CHEMICAL	GENE-N	4	3	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T15	T36	17367165
NA	CHEMICAL	GENE-N	4	30	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T15	T20	17367165
NA	CHEMICAL	GENE-N	17	3	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T16	T36	17367165
NA	CHEMICAL	GENE-N	17	30	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T16	T20	17367165
NA	CHEMICAL	GENE-N	4	3	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T17	T36	17367165
NA	CHEMICAL	GENE-N	4	30	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T17	T20	17367165
NA	CHEMICAL	GENE-N	22	3	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T18	T36	17367165
NA	CHEMICAL	GENE-N	22	30	For the isolated gene in the presence of physiological chemical levels , the target lipids chemical ( chemical ) and chemical ( chemical ) are together sufficient to recruit the genen to a lipid mixture mimicking the plasma membrane inner leaflet .	T18	T20	17367165
NA	CHEMICAL	GENE-N	7	2	For the gene , the target lipid chemical ( chemical ) appears to be sufficient to drive membrane targeting to an internal membrane mimic at physiological chemical levels , although the results do not rule out a second , unknown target molecule .	T1	T21	17367165
NA	CHEMICAL	GENE-N	2	2	For the gene , the target lipid chemical ( chemical ) appears to be sufficient to drive membrane targeting to an internal membrane mimic at physiological chemical levels , although the results do not rule out a second , unknown target molecule .	T2	T21	17367165
NA	CHEMICAL	GENE-N	26	2	For the gene , the target lipid chemical ( chemical ) appears to be sufficient to drive membrane targeting to an internal membrane mimic at physiological chemical levels , although the results do not rule out a second , unknown target molecule .	T3	T21	17367165
NA	CHEMICAL	GENE-N	15	3	In principle , gene-directed intracellular targeting , which requires coincidence detection of multiple signals ( chemical and one or more target lipids ) , can exhibit two different mechanisms : messenger-activated target affinity ( MATA ) and target-activated messenger affinity ( TAMA ) .	T5	T22	17367165
NA	CHEMICAL	GENE-N	14	1	The gene studied here both utilize the TAMA mechanism , in which the gene chemical affinity is too low to be activated by physiological chemical signals in most regions of the cell .	T6	T24	17367165
NA	CHEMICAL	GENE-N	14	10	The gene studied here both utilize the TAMA mechanism , in which the gene chemical affinity is too low to be activated by physiological chemical signals in most regions of the cell .	T6	T25	17367165
NA	CHEMICAL	GENE-N	24	1	The gene studied here both utilize the TAMA mechanism , in which the gene chemical affinity is too low to be activated by physiological chemical signals in most regions of the cell .	T7	T24	17367165
NA	CHEMICAL	GENE-N	24	10	The gene studied here both utilize the TAMA mechanism , in which the gene chemical affinity is too low to be activated by physiological chemical signals in most regions of the cell .	T7	T25	17367165
NA	CHEMICAL	GENE-N	9	24	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T14	T18	23517733
NA	CHEMICAL	GENE-N	9	26	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T14	T19	23517733
NA	CHEMICAL	GENE-Y	9	46	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T14	T20	23517733
NA	CHEMICAL	GENE-Y	9	48	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T14	T21	23517733
NA	CHEMICAL	GENE-N	11	24	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T15	T18	23517733
NA	CHEMICAL	GENE-N	11	26	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T15	T19	23517733
NA	CHEMICAL	GENE-Y	11	46	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T15	T20	23517733
NA	CHEMICAL	GENE-Y	11	48	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T15	T21	23517733
NA	CHEMICAL	GENE-N	13	24	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T16	T18	23517733
NA	CHEMICAL	GENE-N	13	26	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T16	T19	23517733
NA	CHEMICAL	GENE-Y	13	46	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T16	T20	23517733
NA	CHEMICAL	GENE-Y	13	48	Sixty one compounds , grouped as the 6H , chemical , chemical and chemical derivatives , were tested for cytotoxicity , their effects on gene ( gene ) -induced proliferative response of human peripheral blood mononuclear cells ( PBMC ) and lipopolysaccharide ( LPS ) -induced gene ( gene ) production by these cells .	T16	T21	23517733
CPR:4	CHEMICAL	GENE-Y	17	14	OBJECTIVE : Because of these physiological effects and the widespread use of the selective gene inhibitor , chemical , we wanted to determine if inhibition of gene would affect incisional skin wound healing .	T3	T12	12588370
NA	CHEMICAL	GENE-Y	17	26	OBJECTIVE : Because of these physiological effects and the widespread use of the selective gene inhibitor , chemical , we wanted to determine if inhibition of gene would affect incisional skin wound healing .	T3	T13	12588370
NA	CHEMICAL	GENE-Y	3	22	METHODS : Using a cutaneous full-thickness , sutured , incisional wound model in hairless SKH-1 mice , we evaluated the role of gene in the wound healing process by comparing the effects of a nonselective gene inhibitor , chemical , with a selective gene inhibitor , SC-791 .	T4	T15	12588370
CPR:4	CHEMICAL	GENE-N	3	35	METHODS : Using a cutaneous full-thickness , sutured , incisional wound model in hairless SKH-1 mice , we evaluated the role of gene in the wound healing process by comparing the effects of a nonselective gene inhibitor , chemical , with a selective gene inhibitor , SC-791 .	T4	T16	12588370
NA	CHEMICAL	GENE-Y	3	43	METHODS : Using a cutaneous full-thickness , sutured , incisional wound model in hairless SKH-1 mice , we evaluated the role of gene in the wound healing process by comparing the effects of a nonselective gene inhibitor , chemical , with a selective gene inhibitor , SC-791 .	T4	T17	12588370
NA	CHEMICAL	GENE-Y	9	2	Neither selective gene , nor nonselective gene inhibition had a significant effect on the macroscopic or microscopic morphology of the wounds , whereas chemical treatment resulted in epidermal and granulation tissue atrophy .	T1	T6	12588370
NA	CHEMICAL	GENE-N	9	6	Neither selective gene , nor nonselective gene inhibition had a significant effect on the macroscopic or microscopic morphology of the wounds , whereas chemical treatment resulted in epidermal and granulation tissue atrophy .	T1	T7	12588370
NA	CHEMICAL	GENE-Y	28	5	In addition , neither selective gene , nor nonselective gene inhibition altered keratinocyte proliferation and differentiation , dermal angiogenesis or the recovery of wound tensile strength , whereas chemical reduced the tensile strength of the wounds by 30-38 % throughout the healing period .	T2	T8	12588370
NA	CHEMICAL	GENE-N	28	9	In addition , neither selective gene , nor nonselective gene inhibition altered keratinocyte proliferation and differentiation , dermal angiogenesis or the recovery of wound tensile strength , whereas chemical reduced the tensile strength of the wounds by 30-38 % throughout the healing period .	T2	T9	12588370
NA	CHEMICAL	GENE-N	37	8	In the current study , we investigated whether gene , gene , and obesity can modulate gene in vivo in hypothalamic nuclei , and we investigated possible consequences on energy balance , neuropeptide expression , and hepatic chemical metabolism .	T4	T27	22966070
NA	CHEMICAL	GENE-Y	37	10	In the current study , we investigated whether gene , gene , and obesity can modulate gene in vivo in hypothalamic nuclei , and we investigated possible consequences on energy balance , neuropeptide expression , and hepatic chemical metabolism .	T4	T28	22966070
NA	CHEMICAL	GENE-Y	37	16	In the current study , we investigated whether gene , gene , and obesity can modulate gene in vivo in hypothalamic nuclei , and we investigated possible consequences on energy balance , neuropeptide expression , and hepatic chemical metabolism .	T4	T29	22966070
NA	CHEMICAL	GENE-Y	1	0	gene chemical phosphorylation ( Tub-p-chemical ) is modulated by nutritional status .	T5	T33	22966070
NA	CHEMICAL	GENE-Y	4	0	gene chemical phosphorylation ( Tub-p-chemical ) is modulated by nutritional status .	T6	T33	22966070
NA	CHEMICAL	GENE-Y	18	0	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T35	22966070
NA	CHEMICAL	GENE-Y	18	2	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T36	22966070
NA	CHEMICAL	GENE-Y	18	7	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T37	22966070
NA	CHEMICAL	GENE-Y	18	10	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T38	22966070
NA	CHEMICAL	GENE-Y	18	12	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T39	22966070
NA	CHEMICAL	GENE-Y	18	14	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T40	22966070
NA	CHEMICAL	GENE-Y	18	16	gene is a substrate of gene ( gene ) and gene ( gene ) -gene ( gene ) in hypothalamic nuclei .	T7	T41	22966070
NA	CHEMICAL	GENE-Y	14	2	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T45	22966070
NA	CHEMICAL	GENE-N	14	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T10	22966070
NA	CHEMICAL	GENE-Y	14	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T11	22966070
NA	CHEMICAL	GENE-Y	14	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T12	22966070
NA	CHEMICAL	GENE-Y	14	31	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T13	22966070
NA	CHEMICAL	GENE-Y	14	31	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T14	22966070
NA	CHEMICAL	GENE-Y	14	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T8	T15	22966070
NA	CHEMICAL	GENE-Y	18	2	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T45	22966070
NA	CHEMICAL	GENE-N	18	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T10	22966070
NA	CHEMICAL	GENE-Y	18	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T11	22966070
NA	CHEMICAL	GENE-Y	18	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T12	22966070
NA	CHEMICAL	GENE-Y	18	31	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T13	22966070
NA	CHEMICAL	GENE-Y	18	31	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T14	22966070
NA	CHEMICAL	GENE-Y	18	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T9	T15	22966070
NA	CHEMICAL	GENE-Y	22	2	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T45	22966070
NA	CHEMICAL	GENE-N	22	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T10	22966070
NA	CHEMICAL	GENE-Y	22	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T11	22966070
NA	CHEMICAL	GENE-Y	22	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T12	22966070
NA	CHEMICAL	GENE-Y	22	31	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T13	22966070
NA	CHEMICAL	GENE-Y	22	31	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T14	22966070
NA	CHEMICAL	GENE-Y	22	4	Inhibition of gene expression in hypothalamus by ASO increased food intake , fasting blood chemical , and hepatic chemical output , decreased chemical consumption , and blunted the effect of gene or gene on gene , gene , gene , and gene expression .	T1	T15	22966070
NA	CHEMICAL	GENE-Y	17	13	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T2	T17	22966070
NA	CHEMICAL	GENE-N	17	13	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T2	T18	22966070
NA	CHEMICAL	GENE-Y	17	17	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T2	T19	22966070
NA	CHEMICAL	GENE-Y	17	27	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T2	T20	22966070
NA	CHEMICAL	GENE-Y	13	13	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T3	T17	22966070
NA	CHEMICAL	GENE-N	13	13	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T3	T18	22966070
NA	CHEMICAL	GENE-Y	13	17	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T3	T19	22966070
NA	CHEMICAL	GENE-Y	13	27	In hypothalamus of mice administered a high-fat diet , there is a reduction in gene and gene-induced gene-p-chemical and nuclear translocation , which is reversed by reducing gene expression .	T3	T20	22966070
NA	CHEMICAL	GENE-Y	13	8	However , the favorable metabolic phenotype observed in gene-deficient hosts was lost in gene ( -/- ) mice also lacking adaptive immunity ( gene ( -/- ) xgene ( -/- ) ) , demonstrating that gene expression in the adaptive rather than the innate immune system impacts host chemical homeostasis .	T1	T9	23562076
NA	CHEMICAL	GENE-Y	13	13	However , the favorable metabolic phenotype observed in gene-deficient hosts was lost in gene ( -/- ) mice also lacking adaptive immunity ( gene ( -/- ) xgene ( -/- ) ) , demonstrating that gene expression in the adaptive rather than the innate immune system impacts host chemical homeostasis .	T1	T10	23562076
NA	CHEMICAL	GENE-Y	13	23	However , the favorable metabolic phenotype observed in gene-deficient hosts was lost in gene ( -/- ) mice also lacking adaptive immunity ( gene ( -/- ) xgene ( -/- ) ) , demonstrating that gene expression in the adaptive rather than the innate immune system impacts host chemical homeostasis .	T1	T11	23562076
NA	CHEMICAL	GENE-Y	13	27	However , the favorable metabolic phenotype observed in gene-deficient hosts was lost in gene ( -/- ) mice also lacking adaptive immunity ( gene ( -/- ) xgene ( -/- ) ) , demonstrating that gene expression in the adaptive rather than the innate immune system impacts host chemical homeostasis .	T1	T12	23562076
NA	CHEMICAL	GENE-Y	13	35	However , the favorable metabolic phenotype observed in gene-deficient hosts was lost in gene ( -/- ) mice also lacking adaptive immunity ( gene ( -/- ) xgene ( -/- ) ) , demonstrating that gene expression in the adaptive rather than the innate immune system impacts host chemical homeostasis .	T1	T13	23562076
NA	CHEMICAL	GENE-N	18	2	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T14	T27	12818701
CPR:6	CHEMICAL	GENE-N	18	15	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T14	T28	12818701
NA	CHEMICAL	GENE-N	18	19	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T14	T30	12818701
NA	CHEMICAL	GENE-N	24	2	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T15	T27	12818701
CPR:6	CHEMICAL	GENE-N	24	15	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T15	T28	12818701
NA	CHEMICAL	GENE-N	24	19	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T15	T30	12818701
NA	CHEMICAL	GENE-N	39	2	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T16	T27	12818701
NA	CHEMICAL	GENE-N	39	15	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T16	T28	12818701
CPR:6	CHEMICAL	GENE-N	39	19	Involvement of gene was established as mydriatic responses were inhibited by systemic administration of nonselective gene antagonists , chemical ( 0.3-3 mg/kg ) and chemical ( 0.03-0.3 mg/kg ) , as well as by the selective gene antagonist , chemical ( 0.3 mg/kg ) .	T16	T30	12818701
CPR:6	CHEMICAL	GENE-N	4	1	The gene antagonist , chemical ( 0.5 mg/kg ) , was without antagonistic effects .	T17	T31	12818701
CPR:6	CHEMICAL	GENE-Y	3	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T18	T32	12818701
NA	CHEMICAL	GENE-Y	3	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T18	T20	12818701
NA	CHEMICAL	GENE-Y	3	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T18	T21	12818701
NA	CHEMICAL	GENE-N	3	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T18	T22	12818701
CPR:6	CHEMICAL	GENE-Y	6	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T19	T32	12818701
NA	CHEMICAL	GENE-Y	6	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T19	T20	12818701
NA	CHEMICAL	GENE-Y	6	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T19	T21	12818701
NA	CHEMICAL	GENE-N	6	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T19	T22	12818701
CPR:6	CHEMICAL	GENE-Y	4	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T1	T32	12818701
NA	CHEMICAL	GENE-Y	4	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T1	T20	12818701
NA	CHEMICAL	GENE-Y	4	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T1	T21	12818701
NA	CHEMICAL	GENE-N	4	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T1	T22	12818701
NA	CHEMICAL	GENE-Y	3	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T2	T32	12818701
CPR:6	CHEMICAL	GENE-Y	3	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T2	T20	12818701
NA	CHEMICAL	GENE-Y	3	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T2	T21	12818701
NA	CHEMICAL	GENE-N	3	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T2	T22	12818701
NA	CHEMICAL	GENE-Y	0	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T3	T32	12818701
CPR:6	CHEMICAL	GENE-Y	0	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T3	T20	12818701
NA	CHEMICAL	GENE-Y	0	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T3	T21	12818701
NA	CHEMICAL	GENE-N	0	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T3	T22	12818701
NA	CHEMICAL	GENE-Y	3	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T4	T32	12818701
NA	CHEMICAL	GENE-Y	3	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T4	T20	12818701
CPR:6	CHEMICAL	GENE-Y	3	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T4	T21	12818701
NA	CHEMICAL	GENE-N	3	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T4	T22	12818701
NA	CHEMICAL	GENE-Y	41	0	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T5	T32	12818701
NA	CHEMICAL	GENE-Y	41	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T5	T20	12818701
CPR:6	CHEMICAL	GENE-Y	41	5	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T5	T21	12818701
NA	CHEMICAL	GENE-N	41	49	gene selective antagonists , chemical ( chemical ; 0.1-1 mg/kg ) and chemical ( 0.1-1 mg/kg ) , the gene selective antagonist , chemical ( chemical ; 0.3-1 mg/kg ) , as well as the gene selective antagonist , chemical ( chemical ; 1 mg/kg ) , were used to delineate the gene subtypes involved .	T5	T22	12818701
NA	CHEMICAL	GENE-Y	8	3	Interaction with the gene channel and cytotoxicity of chemical and chemical analogues .	T21	T29	18604229
NA	CHEMICAL	GENE-Y	10	3	Interaction with the gene channel and cytotoxicity of chemical and chemical analogues .	T22	T29	18604229
CPR:4	CHEMICAL	GENE-Y	9	13	The principal aim of the study was to find chemical analogues that retained gene inhibition but with reduced cytotoxicity .	T12	T27	18604229
NA	CHEMICAL	GENE-Y	21	13	Pharmacological and in silico investigations concerning the interactions of these compounds with the gene channel revealed that compounds carrying a basic chemical in the side chain display a much higher affinity than those lacking such a group .	T6	T23	18604229
NA	CHEMICAL	GENE-Y	2	10	Specifically , chemical and chemical revealed a higher affinity towards gene channels than chemical .	T7	T24	18604229
NA	CHEMICAL	GENE-Y	4	10	Specifically , chemical and chemical revealed a higher affinity towards gene channels than chemical .	T8	T24	18604229
NA	CHEMICAL	GENE-Y	6	10	Specifically , chemical and chemical revealed a higher affinity towards gene channels than chemical .	T9	T24	18604229
NA	CHEMICAL	GENE-Y	6	7	Identification of interaction sites of cyclic chemical gene with chemical and chemical using molecular modeling and site-directed mutagenesis .	T13	T32	12181427
NA	CHEMICAL	GENE-Y	9	7	Identification of interaction sites of cyclic chemical gene with chemical and chemical using molecular modeling and site-directed mutagenesis .	T14	T32	12181427
NA	CHEMICAL	GENE-Y	11	7	Identification of interaction sites of cyclic chemical gene with chemical and chemical using molecular modeling and site-directed mutagenesis .	T12	T32	12181427
NA	CHEMICAL	GENE-Y	2	6	To identify chemical residues involved in gene-selective inhibitor binding , we selected eight presumed interacting residues in the substrate-binding pocket of gene using a model created on basis of homology to the gene crystal structure .	T3	T22	12181427
NA	CHEMICAL	GENE-Y	2	21	To identify chemical residues involved in gene-selective inhibitor binding , we selected eight presumed interacting residues in the substrate-binding pocket of gene using a model created on basis of homology to the gene crystal structure .	T3	T20	12181427
NA	CHEMICAL	GENE-Y	2	32	To identify chemical residues involved in gene-selective inhibitor binding , we selected eight presumed interacting residues in the substrate-binding pocket of gene using a model created on basis of homology to the gene crystal structure .	T3	T21	12181427
NA	CHEMICAL	GENE-Y	5	39	We changed the residues to chemical using site-directed mutagenesis technique , expressed the mutants in a baculovirus/Sf9 cell system , and analyzed the kinetic characteristics of inhibition of the mutant enzymes by chemical and chemical , specific inhibitors of gene .	T5	T23	12181427
CPR:4	CHEMICAL	GENE-Y	14	39	We changed the residues to chemical using site-directed mutagenesis technique , expressed the mutants in a baculovirus/Sf9 cell system , and analyzed the kinetic characteristics of inhibition of the mutant enzymes by chemical and chemical , specific inhibitors of gene .	T6	T23	12181427
CPR:4	CHEMICAL	GENE-Y	15	39	We changed the residues to chemical using site-directed mutagenesis technique , expressed the mutants in a baculovirus/Sf9 cell system , and analyzed the kinetic characteristics of inhibition of the mutant enzymes by chemical and chemical , specific inhibitors of gene .	T7	T23	12181427
CPR:4	CHEMICAL	GENE-N	11	1	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T8	T24	12181427
CPR:4	CHEMICAL	GENE-N	11	3	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T8	T25	12181427
CPR:4	CHEMICAL	GENE-N	11	6	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T8	T26	12181427
CPR:4	CHEMICAL	GENE-Y	11	24	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T8	T27	12181427
NA	CHEMICAL	GENE-Y	11	58	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T8	T28	12181427
NA	CHEMICAL	GENE-N	15	1	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T9	T24	12181427
NA	CHEMICAL	GENE-N	15	3	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T9	T25	12181427
NA	CHEMICAL	GENE-N	15	6	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T9	T26	12181427
NA	CHEMICAL	GENE-Y	15	24	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T9	T27	12181427
CPR:4	CHEMICAL	GENE-Y	15	58	Mutants gene , gene , and gene had reduced sensitivity to chemical ( K ( i ) changed from 0.66 microM for the recombinant gene to 7.5 to 156 microM for the mutants ) , and diminished sensitivity to chemical ( K ( i ) of the mutants were 18- to 371-fold higher than that of the recombinant gene ) .	T9	T28	12181427
CPR:4	CHEMICAL	GENE-N	14	5	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T10	T29	12181427
CPR:4	CHEMICAL	GENE-N	14	7	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T10	T30	12181427
CPR:4	CHEMICAL	GENE-N	14	9	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T10	T31	12181427
CPR:4	CHEMICAL	GENE-Y	14	26	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T10	T15	12181427
CPR:4	CHEMICAL	GENE-N	14	5	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T11	T29	12181427
CPR:4	CHEMICAL	GENE-N	14	7	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T11	T30	12181427
CPR:4	CHEMICAL	GENE-N	14	9	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T11	T31	12181427
CPR:4	CHEMICAL	GENE-Y	14	26	In contrast , the mutants gene , gene and gene showed increased K ( i ) for chemical but no difference for chemical from the recombinant gene .	T11	T15	12181427
CPR:4	CHEMICAL	GENE-Y	5	5	Molecular models show that the gene inhibitors chemical and chemical share some of common residues but interact with distinct residues at the active site , suggesting that selective inhibitors can be designed with flexible size against gene active site .	T1	T16	12181427
NA	CHEMICAL	GENE-Y	5	36	Molecular models show that the gene inhibitors chemical and chemical share some of common residues but interact with distinct residues at the active site , suggesting that selective inhibitors can be designed with flexible size against gene active site .	T1	T17	12181427
CPR:4	CHEMICAL	GENE-Y	9	5	Molecular models show that the gene inhibitors chemical and chemical share some of common residues but interact with distinct residues at the active site , suggesting that selective inhibitors can be designed with flexible size against gene active site .	T2	T16	12181427
NA	CHEMICAL	GENE-Y	9	36	Molecular models show that the gene inhibitors chemical and chemical share some of common residues but interact with distinct residues at the active site , suggesting that selective inhibitors can be designed with flexible size against gene active site .	T2	T17	12181427
NA	CHEMICAL	GENE-N	6	0	gene ( gene ) is a chemical enzyme that catalyses the reversible hydration reaction of chemical and plays a major role in the acid-base balance .	T6	T25	11392054
NA	CHEMICAL	GENE-N	6	2	gene ( gene ) is a chemical enzyme that catalyses the reversible hydration reaction of chemical and plays a major role in the acid-base balance .	T6	T31	11392054
CPR:9	CHEMICAL	GENE-N	15	0	gene ( gene ) is a chemical enzyme that catalyses the reversible hydration reaction of chemical and plays a major role in the acid-base balance .	T24	T25	11392054
CPR:9	CHEMICAL	GENE-N	15	2	gene ( gene ) is a chemical enzyme that catalyses the reversible hydration reaction of chemical and plays a major role in the acid-base balance .	T24	T31	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T7	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T7	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T7	T38	11392054
NA	CHEMICAL	GENE-Y	9	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T8	T36	11392054
NA	CHEMICAL	GENE-Y	9	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T8	T37	11392054
NA	CHEMICAL	GENE-Y	9	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T8	T38	11392054
NA	CHEMICAL	GENE-Y	11	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T9	T36	11392054
NA	CHEMICAL	GENE-Y	11	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T9	T37	11392054
NA	CHEMICAL	GENE-Y	11	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T9	T38	11392054
NA	CHEMICAL	GENE-Y	13	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T10	T36	11392054
NA	CHEMICAL	GENE-Y	13	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T10	T37	11392054
NA	CHEMICAL	GENE-Y	13	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T10	T38	11392054
NA	CHEMICAL	GENE-Y	15	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T11	T36	11392054
NA	CHEMICAL	GENE-Y	15	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T11	T37	11392054
NA	CHEMICAL	GENE-Y	15	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T11	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T12	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T12	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T12	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T13	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T13	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T13	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T14	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T14	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T14	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T15	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T15	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T15	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T16	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T16	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T16	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T17	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T17	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T17	T38	11392054
NA	CHEMICAL	GENE-Y	29	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T18	T36	11392054
NA	CHEMICAL	GENE-Y	29	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T18	T37	11392054
NA	CHEMICAL	GENE-Y	29	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T18	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T19	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T19	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T19	T38	11392054
NA	CHEMICAL	GENE-Y	33	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T20	T36	11392054
NA	CHEMICAL	GENE-Y	33	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T20	T37	11392054
NA	CHEMICAL	GENE-Y	33	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T20	T38	11392054
NA	CHEMICAL	GENE-Y	3	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T21	T36	11392054
NA	CHEMICAL	GENE-Y	3	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T21	T37	11392054
NA	CHEMICAL	GENE-Y	3	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T21	T38	11392054
NA	CHEMICAL	GENE-Y	37	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T22	T36	11392054
NA	CHEMICAL	GENE-Y	37	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T22	T37	11392054
NA	CHEMICAL	GENE-Y	37	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T22	T38	11392054
NA	CHEMICAL	GENE-Y	39	3	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T23	T36	11392054
NA	CHEMICAL	GENE-Y	39	42	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T23	T37	11392054
NA	CHEMICAL	GENE-Y	39	47	We studied the in vitro effects of chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical and chemical on purified gene and vascular smooth muscle gene isolated from rabbits .	T23	T38	11392054
NA	CHEMICAL	GENE-Y	10	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T23	15612980
NA	CHEMICAL	GENE-Y	10	16	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T24	15612980
NA	CHEMICAL	GENE-N	10	18	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T25	15612980
NA	CHEMICAL	GENE-N	10	20	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T26	15612980
NA	CHEMICAL	GENE-Y	10	23	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T27	15612980
NA	CHEMICAL	GENE-Y	10	25	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T28	15612980
NA	CHEMICAL	GENE-N	10	27	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T29	15612980
NA	CHEMICAL	GENE-Y	10	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T30	15612980
NA	CHEMICAL	GENE-Y	10	32	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T31	15612980
NA	CHEMICAL	GENE-N	10	34	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T2	T32	15612980
NA	CHEMICAL	GENE-Y	13	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T23	15612980
NA	CHEMICAL	GENE-Y	13	16	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T24	15612980
NA	CHEMICAL	GENE-N	13	18	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T25	15612980
NA	CHEMICAL	GENE-N	13	20	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T26	15612980
NA	CHEMICAL	GENE-Y	13	23	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T27	15612980
NA	CHEMICAL	GENE-Y	13	25	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T28	15612980
NA	CHEMICAL	GENE-N	13	27	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T29	15612980
NA	CHEMICAL	GENE-Y	13	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T30	15612980
NA	CHEMICAL	GENE-Y	13	32	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T31	15612980
NA	CHEMICAL	GENE-N	13	34	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T4	T32	15612980
NA	CHEMICAL	GENE-Y	9	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T23	15612980
NA	CHEMICAL	GENE-Y	9	16	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T24	15612980
NA	CHEMICAL	GENE-N	9	18	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T25	15612980
NA	CHEMICAL	GENE-N	9	20	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T26	15612980
NA	CHEMICAL	GENE-Y	9	23	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T27	15612980
NA	CHEMICAL	GENE-Y	9	25	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T28	15612980
NA	CHEMICAL	GENE-N	9	27	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T29	15612980
NA	CHEMICAL	GENE-Y	9	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T30	15612980
NA	CHEMICAL	GENE-Y	9	32	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T31	15612980
NA	CHEMICAL	GENE-N	9	34	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T6	T32	15612980
NA	CHEMICAL	GENE-Y	9	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T23	15612980
NA	CHEMICAL	GENE-Y	9	16	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T24	15612980
NA	CHEMICAL	GENE-N	9	18	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T25	15612980
NA	CHEMICAL	GENE-N	9	20	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T26	15612980
NA	CHEMICAL	GENE-Y	9	23	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T27	15612980
NA	CHEMICAL	GENE-Y	9	25	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T28	15612980
NA	CHEMICAL	GENE-N	9	27	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T29	15612980
NA	CHEMICAL	GENE-Y	9	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T30	15612980
NA	CHEMICAL	GENE-Y	9	32	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T31	15612980
NA	CHEMICAL	GENE-N	9	34	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T7	T32	15612980
NA	CHEMICAL	GENE-Y	41	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T23	15612980
NA	CHEMICAL	GENE-Y	41	16	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T24	15612980
NA	CHEMICAL	GENE-N	41	18	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T25	15612980
NA	CHEMICAL	GENE-N	41	20	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T26	15612980
NA	CHEMICAL	GENE-Y	41	23	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T27	15612980
NA	CHEMICAL	GENE-Y	41	25	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T28	15612980
NA	CHEMICAL	GENE-N	41	27	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T29	15612980
NA	CHEMICAL	GENE-Y	41	14	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T30	15612980
NA	CHEMICAL	GENE-Y	41	32	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T31	15612980
NA	CHEMICAL	GENE-N	41	34	We studied several single nucleotide polymorphisms ( SNP ) in chemical-regulating genes [ chemical reductase ( gene ) gene and gene ; chemical synthase ( gene ) gene ; gene reductase ( gene ) gene ] in relation to total plasma chemical levels , transplant coronary artery disease and thromboembolic episodes in 84 heart transplant patients , and we compared the incidence of these polymorphisms with those in a healthy adult controls .	T9	T32	15612980
NA	CHEMICAL	GENE-Y	8	2	However , gene gene was significantly associated with chemical levels ( AA genotype : 290 +/- 122 pmol/l ; AG : 381 +/- 151 pmol/l and GG : 415 +/- 100 pmol/l ) , as was gene gene ( AA : 478 +/- 219 pmol/l , AG : 306 +/- 124 pmol/l and GG : 306 +/- 123 pmol/l ) .	T12	T35	15612980
NA	CHEMICAL	GENE-N	8	3	However , gene gene was significantly associated with chemical levels ( AA genotype : 290 +/- 122 pmol/l ; AG : 381 +/- 151 pmol/l and GG : 415 +/- 100 pmol/l ) , as was gene gene ( AA : 478 +/- 219 pmol/l , AG : 306 +/- 124 pmol/l and GG : 306 +/- 123 pmol/l ) .	T12	T36	15612980
NA	CHEMICAL	GENE-Y	8	36	However , gene gene was significantly associated with chemical levels ( AA genotype : 290 +/- 122 pmol/l ; AG : 381 +/- 151 pmol/l and GG : 415 +/- 100 pmol/l ) , as was gene gene ( AA : 478 +/- 219 pmol/l , AG : 306 +/- 124 pmol/l and GG : 306 +/- 123 pmol/l ) .	T12	T13	15612980
NA	CHEMICAL	GENE-N	8	37	However , gene gene was significantly associated with chemical levels ( AA genotype : 290 +/- 122 pmol/l ; AG : 381 +/- 151 pmol/l and GG : 415 +/- 100 pmol/l ) , as was gene gene ( AA : 478 +/- 219 pmol/l , AG : 306 +/- 124 pmol/l and GG : 306 +/- 123 pmol/l ) .	T12	T14	15612980
NA	CHEMICAL	GENE-Y	1	8	Differences in chemical and folate levels with the gene gene and gene gene polymorphisms were noted .	T1	T19	15612980
NA	CHEMICAL	GENE-N	1	9	Differences in chemical and folate levels with the gene gene and gene gene polymorphisms were noted .	T1	T20	15612980
NA	CHEMICAL	GENE-Y	1	11	Differences in chemical and folate levels with the gene gene and gene gene polymorphisms were noted .	T1	T21	15612980
NA	CHEMICAL	GENE-N	1	12	Differences in chemical and folate levels with the gene gene and gene gene polymorphisms were noted .	T1	T22	15612980
CPR:4	CHEMICAL	GENE-N	0	8	chemical markedly reduced AA performance and activities of gene ( gene ) and gene ( gene ) in all regions .	T9	T18	23494944
CPR:4	CHEMICAL	GENE-N	0	10	chemical markedly reduced AA performance and activities of gene ( gene ) and gene ( gene ) in all regions .	T9	T19	23494944
CPR:4	CHEMICAL	GENE-Y	0	13	chemical markedly reduced AA performance and activities of gene ( gene ) and gene ( gene ) in all regions .	T9	T20	23494944
CPR:4	CHEMICAL	GENE-Y	0	15	chemical markedly reduced AA performance and activities of gene ( gene ) and gene ( gene ) in all regions .	T9	T21	23494944
CPR:4	CHEMICAL	GENE-N	8	13	GTLE pretreatment completely reversed the damaging effects of chemical on AA and chemical dismutase activity , markedly corrected gene and gene activities , and moderately improved TGC .	T11	T13	23494944
CPR:4	CHEMICAL	GENE-N	8	18	GTLE pretreatment completely reversed the damaging effects of chemical on AA and chemical dismutase activity , markedly corrected gene and gene activities , and moderately improved TGC .	T11	T14	23494944
CPR:4	CHEMICAL	GENE-Y	8	20	GTLE pretreatment completely reversed the damaging effects of chemical on AA and chemical dismutase activity , markedly corrected gene and gene activities , and moderately improved TGC .	T11	T15	23494944
NA	CHEMICAL	GENE-N	12	13	GTLE pretreatment completely reversed the damaging effects of chemical on AA and chemical dismutase activity , markedly corrected gene and gene activities , and moderately improved TGC .	T2	T13	23494944
NA	CHEMICAL	GENE-N	12	18	GTLE pretreatment completely reversed the damaging effects of chemical on AA and chemical dismutase activity , markedly corrected gene and gene activities , and moderately improved TGC .	T2	T14	23494944
NA	CHEMICAL	GENE-Y	12	20	GTLE pretreatment completely reversed the damaging effects of chemical on AA and chemical dismutase activity , markedly corrected gene and gene activities , and moderately improved TGC .	T2	T15	23494944
NA	CHEMICAL	GENE-N	6	2	Involvement of gene and gene system in neuroprotection mediated by the flavonoid chemical isolated from Dracocephalum kotschyi .	T24	T45	23639191
NA	CHEMICAL	GENE-N	6	4	Involvement of gene and gene system in neuroprotection mediated by the flavonoid chemical isolated from Dracocephalum kotschyi .	T24	T46	23639191
NA	CHEMICAL	GENE-N	7	18	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T16	T33	23639191
NA	CHEMICAL	GENE-N	7	25	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T16	T34	23639191
NA	CHEMICAL	GENE-N	7	27	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T16	T35	23639191
CPR:4	CHEMICAL	GENE-N	15	18	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T17	T33	23639191
CPR:4	CHEMICAL	GENE-N	15	25	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T17	T34	23639191
CPR:4	CHEMICAL	GENE-N	15	27	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T17	T35	23639191
NA	CHEMICAL	GENE-N	21	18	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T18	T33	23639191
NA	CHEMICAL	GENE-N	21	25	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T18	T34	23639191
NA	CHEMICAL	GENE-N	21	27	Herein , we investigated the effect of a natural neuroprotective flavonoid , chemical , on chemical-induced disruption of gene system and chemical response element binding protein ( gene ) phosphorylation .	T18	T35	23639191
NA	CHEMICAL	GENE-N	10	3	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T36	23639191
NA	CHEMICAL	GENE-Y	10	5	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T37	23639191
NA	CHEMICAL	GENE-Y	10	7	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T38	23639191
NA	CHEMICAL	GENE-Y	10	11	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T39	23639191
NA	CHEMICAL	GENE-Y	10	13	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T40	23639191
NA	CHEMICAL	GENE-Y	10	16	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T41	23639191
NA	CHEMICAL	GENE-Y	10	18	The level of gene , gene ( gene ) , chemical synthetase ( gene ) and gene ( gene ) were measured by western blot method .	T21	T42	23639191
NA	CHEMICAL	GENE-Y	1	7	In chemical-treated cells , chemical also suppressed gene release to cytosol that is necessary for maintaining mitochondrial homeostasis in survived cells .	T6	T25	23639191
CPR:4	CHEMICAL	GENE-Y	4	7	In chemical-treated cells , chemical also suppressed gene release to cytosol that is necessary for maintaining mitochondrial homeostasis in survived cells .	T7	T25	23639191
CPR:3	CHEMICAL	GENE-N	2	20	Moreover , chemical , in presence of chemical inhibited the decrease caused by oxidative stress in stress-sensing transcription factors , gene and gene , which play an important role in antioxidant capacity of the cell .	T8	T26	23639191
CPR:3	CHEMICAL	GENE-Y	2	22	Moreover , chemical , in presence of chemical inhibited the decrease caused by oxidative stress in stress-sensing transcription factors , gene and gene , which play an important role in antioxidant capacity of the cell .	T8	T27	23639191
NA	CHEMICAL	GENE-N	7	20	Moreover , chemical , in presence of chemical inhibited the decrease caused by oxidative stress in stress-sensing transcription factors , gene and gene , which play an important role in antioxidant capacity of the cell .	T9	T26	23639191
NA	CHEMICAL	GENE-Y	7	22	Moreover , chemical , in presence of chemical inhibited the decrease caused by oxidative stress in stress-sensing transcription factors , gene and gene , which play an important role in antioxidant capacity of the cell .	T9	T27	23639191
CPR:3	CHEMICAL	GENE-Y	5	6	There was also an increase in gene and gene levels in chemical pretreated cells .	T10	T28	23639191
CPR:3	CHEMICAL	GENE-Y	5	8	There was also an increase in gene and gene levels in chemical pretreated cells .	T10	T29	23639191
NA	CHEMICAL	GENE-N	4	13	In the presence of chemical , chemical inhibited decrease in chemical level and gene activity .	T11	T30	23639191
CPR:3	CHEMICAL	GENE-N	6	13	In the presence of chemical , chemical inhibited decrease in chemical level and gene activity .	T12	T30	23639191
NA	CHEMICAL	GENE-N	10	13	In the presence of chemical , chemical inhibited decrease in chemical level and gene activity .	T13	T30	23639191
NA	CHEMICAL	GENE-Y	11	5	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T1	T12	23210662
NA	CHEMICAL	GENE-Y	11	13	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T1	T14	23210662
NA	CHEMICAL	GENE-Y	31	5	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T2	T12	23210662
NA	CHEMICAL	GENE-Y	31	13	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T2	T14	23210662
NA	CHEMICAL	GENE-Y	33	5	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T3	T12	23210662
NA	CHEMICAL	GENE-Y	33	13	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T3	T14	23210662
NA	CHEMICAL	GENE-Y	33	5	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T4	T12	23210662
NA	CHEMICAL	GENE-Y	33	13	We describe the synthesis of a core-shell biohybrid consisting of a gene ( gene ) core that serves as a reservoir for lipophilic molecules and a cationized shell region consisting of chemical-G2.0-chemical or chemical-G3.0-chemical dendrons .	T4	T14	23210662
NA	CHEMICAL	GENE-Y	3	6	The attachment of chemical-G2.0-chemical dendrons to gene yielded a nontoxic core-shell macromolecule that was clearly uptaken by A549 human epithelial cells due to the presence of the dendritic chemical shell .	T5	T11	23210662
NA	CHEMICAL	GENE-Y	3	6	The attachment of chemical-G2.0-chemical dendrons to gene yielded a nontoxic core-shell macromolecule that was clearly uptaken by A549 human epithelial cells due to the presence of the dendritic chemical shell .	T6	T11	23210662
NA	CHEMICAL	GENE-Y	28	6	The attachment of chemical-G2.0-chemical dendrons to gene yielded a nontoxic core-shell macromolecule that was clearly uptaken by A549 human epithelial cells due to the presence of the dendritic chemical shell .	T7	T11	23210662
NA	CHEMICAL	GENE-Y	4	9	Significantly higher loading of chemical was observed for dendronized G2-Dgene compared with the native protein due to the availability of binding pockets of the HSA core , and interaction with the dendritic shell .	T8	T13	23210662
CPR:4	CHEMICAL	GENE-Y	12	10	DNA cloning , characterization , and inhibition studies of the gene , a new target for chemical and chemical inhibitors .	T24	T40	17228881
CPR:4	CHEMICAL	GENE-Y	12	10	DNA cloning , characterization , and inhibition studies of the gene , a new target for chemical and chemical inhibitors .	T25	T40	17228881
CPR:9	CHEMICAL	GENE-Y	5	9	The kinetic parameters for the chemical hydration reaction proved gene to possess a kcat of 3.4 x 10 ( 5 ) s-1 and kcat/KM of 4.9 x 10 ( 7 ) M-1 s-1 ( at pH 7.5 and 20 degrees C ) .	T13	T30	17228881
NA	CHEMICAL	GENE-Y	1	5	Simple chemical were rather ineffective gene inhibitors , with inhibition constants in the range of 1090-6680 nM .	T16	T37	17228881
CPR:4	CHEMICAL	GENE-Y	7	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T21	T26	17228881
CPR:4	CHEMICAL	GENE-Y	9	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T22	T26	17228881
CPR:4	CHEMICAL	GENE-Y	11	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T23	T26	17228881
CPR:4	CHEMICAL	GENE-Y	13	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T1	T26	17228881
CPR:4	CHEMICAL	GENE-Y	7	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T2	T26	17228881
CPR:4	CHEMICAL	GENE-Y	17	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T3	T26	17228881
CPR:4	CHEMICAL	GENE-Y	19	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T4	T26	17228881
CPR:4	CHEMICAL	GENE-Y	21	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T5	T26	17228881
CPR:4	CHEMICAL	GENE-Y	24	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T6	T26	17228881
CPR:4	CHEMICAL	GENE-Y	30	34	Some clinically used compounds , such as chemical , chemical , chemical , chemical , chemical , chemical , chemical , chemical , and chemical , or the orphan drug chemical , showed effective gene inhibitory activity , with inhibition constants of 0.8-79 nM .	T7	T26	17228881
CPR:4	CHEMICAL	GENE-Y	4	21	The best inhibitors were chemical and chemical ( KI values of 0.8-0.9 nM ) , the latter compound being also a gene-selective inhibitor .	T8	T27	17228881
CPR:4	CHEMICAL	GENE-Y	6	21	The best inhibitors were chemical and chemical ( KI values of 0.8-0.9 nM ) , the latter compound being also a gene-selective inhibitor .	T9	T27	17228881
CPR:4	CHEMICAL	GENE-Y	5	22	The metallic taste reported as a side effect after the treatment with systemic chemical may be due to the inhibition of the gene .	T10	T28	17228881
NA	CHEMICAL	GENE-Y	5	6	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T43	T61	10432475
NA	CHEMICAL	GENE-Y	5	39	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T43	T62	10432475
NA	CHEMICAL	GENE-Y	7	6	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T44	T61	10432475
NA	CHEMICAL	GENE-Y	7	39	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T44	T62	10432475
NA	CHEMICAL	GENE-Y	10	6	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T45	T61	10432475
NA	CHEMICAL	GENE-Y	10	39	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T45	T62	10432475
NA	CHEMICAL	GENE-Y	12	6	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T46	T61	10432475
NA	CHEMICAL	GENE-Y	12	39	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T46	T62	10432475
NA	CHEMICAL	GENE-Y	11	6	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T41	T61	10432475
NA	CHEMICAL	GENE-Y	11	39	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T41	T62	10432475
NA	CHEMICAL	GENE-Y	28	6	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T42	T61	10432475
NA	CHEMICAL	GENE-Y	28	39	Modulation of dialysate levels of chemical , chemical , and chemical ( chemical ) in the frontal cortex of freely-moving rats by chemical alone and in association with chemical reuptake inhibitors : comparative roles of beta-adrenergic , gene and gene receptors .	T42	T62	10432475
NA	CHEMICAL	GENE-Y	0	7	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T1	T54	10432475
NA	CHEMICAL	GENE-Y	0	9	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T1	T56	10432475
NA	CHEMICAL	GENE-N	0	12	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T1	T58	10432475
NA	CHEMICAL	GENE-N	0	13	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T1	T48	10432475
NA	CHEMICAL	GENE-Y	20	7	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T21	T54	10432475
NA	CHEMICAL	GENE-Y	20	9	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T21	T56	10432475
NA	CHEMICAL	GENE-N	20	12	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T21	T58	10432475
NA	CHEMICAL	GENE-N	20	13	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T21	T48	10432475
NA	CHEMICAL	GENE-Y	22	7	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T22	T54	10432475
NA	CHEMICAL	GENE-Y	22	9	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T22	T56	10432475
NA	CHEMICAL	GENE-N	22	12	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T22	T58	10432475
NA	CHEMICAL	GENE-N	22	13	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T22	T48	10432475
NA	CHEMICAL	GENE-Y	25	7	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T24	T54	10432475
NA	CHEMICAL	GENE-Y	25	9	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T24	T56	10432475
NA	CHEMICAL	GENE-N	25	12	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T24	T58	10432475
NA	CHEMICAL	GENE-N	25	13	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T24	T48	10432475
NA	CHEMICAL	GENE-Y	27	7	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T25	T54	10432475
NA	CHEMICAL	GENE-Y	27	9	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T25	T56	10432475
NA	CHEMICAL	GENE-N	27	12	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T25	T58	10432475
NA	CHEMICAL	GENE-N	27	13	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T25	T48	10432475
NA	CHEMICAL	GENE-Y	30	7	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T26	T54	10432475
NA	CHEMICAL	GENE-Y	30	9	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T26	T56	10432475
NA	CHEMICAL	GENE-N	30	12	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T26	T58	10432475
NA	CHEMICAL	GENE-N	30	13	chemical , which possesses significant affinity for gene , gene , and gene gene , dose-dependently increased extracellular levels of chemical ( chemical ) and chemical ( chemical ) versus chemical , in dialysates of the frontal cortex ( FCX ) , but not accumbens and striatum , of freely-moving rats .	T26	T48	10432475
CPR:6	CHEMICAL	GENE-Y	8	5	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T27	T52	10432475
NA	CHEMICAL	GENE-Y	8	13	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T27	T53	10432475
NA	CHEMICAL	GENE-Y	2	5	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T28	T52	10432475
CPR:6	CHEMICAL	GENE-Y	2	13	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T28	T53	10432475
NA	CHEMICAL	GENE-Y	24	5	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T29	T52	10432475
NA	CHEMICAL	GENE-Y	24	13	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T29	T53	10432475
NA	CHEMICAL	GENE-Y	26	5	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T30	T52	10432475
NA	CHEMICAL	GENE-Y	26	13	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T30	T53	10432475
NA	CHEMICAL	GENE-Y	29	5	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T31	T52	10432475
NA	CHEMICAL	GENE-Y	29	13	In distinction , the preferential gene antagonist , chemical , and the preferential gene antagonist , chemical , did not increase basal levels of chemical , chemical , or chemical .	T31	T53	10432475
CPR:6	CHEMICAL	GENE-Y	5	2	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T35	T55	10432475
NA	CHEMICAL	GENE-Y	5	22	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T35	T57	10432475
NA	CHEMICAL	GENE-Y	11	2	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T36	T55	10432475
NA	CHEMICAL	GENE-Y	11	22	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T36	T57	10432475
NA	CHEMICAL	GENE-Y	14	2	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T37	T55	10432475
NA	CHEMICAL	GENE-Y	14	22	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T37	T57	10432475
NA	CHEMICAL	GENE-Y	16	2	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T38	T55	10432475
NA	CHEMICAL	GENE-Y	16	22	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T38	T57	10432475
NA	CHEMICAL	GENE-Y	5	2	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T39	T55	10432475
CPR:6	CHEMICAL	GENE-Y	5	22	The selective gene receptor antagonist , chemical , slightly attenuated the chemical-induced increase in chemical and chemical levels , while the selective gene antagonist , chemical , was ineffective .	T39	T57	10432475
NA	CHEMICAL	GENE-N	4	17	These data suggest that chemical facilitates frontocortical dopaminergic ( and adrenergic ) transmission primarily by activation of gene and , to a lesser degree , by stimulation of gene receptors , whereas gene receptors are not involved .	T40	T59	10432475
NA	CHEMICAL	GENE-Y	4	28	These data suggest that chemical facilitates frontocortical dopaminergic ( and adrenergic ) transmission primarily by activation of gene and , to a lesser degree , by stimulation of gene receptors , whereas gene receptors are not involved .	T40	T60	10432475
NA	CHEMICAL	GENE-Y	4	32	These data suggest that chemical facilitates frontocortical dopaminergic ( and adrenergic ) transmission primarily by activation of gene and , to a lesser degree , by stimulation of gene receptors , whereas gene receptors are not involved .	T40	T47	10432475
NA	CHEMICAL	GENE-N	3	32	In conclusion , chemical modulates , both alone and together with chemical reuptake inhibitors , dopaminergic , adrenergic , and serotonergic transmission in the FCX via a complex pattern of actions at gene , gene , and gene receptors .	T19	T49	10432475
NA	CHEMICAL	GENE-Y	3	34	In conclusion , chemical modulates , both alone and together with chemical reuptake inhibitors , dopaminergic , adrenergic , and serotonergic transmission in the FCX via a complex pattern of actions at gene , gene , and gene receptors .	T19	T50	10432475
NA	CHEMICAL	GENE-Y	3	37	In conclusion , chemical modulates , both alone and together with chemical reuptake inhibitors , dopaminergic , adrenergic , and serotonergic transmission in the FCX via a complex pattern of actions at gene , gene , and gene receptors .	T19	T51	10432475
NA	CHEMICAL	GENE-N	11	32	In conclusion , chemical modulates , both alone and together with chemical reuptake inhibitors , dopaminergic , adrenergic , and serotonergic transmission in the FCX via a complex pattern of actions at gene , gene , and gene receptors .	T20	T49	10432475
NA	CHEMICAL	GENE-Y	11	34	In conclusion , chemical modulates , both alone and together with chemical reuptake inhibitors , dopaminergic , adrenergic , and serotonergic transmission in the FCX via a complex pattern of actions at gene , gene , and gene receptors .	T20	T50	10432475
NA	CHEMICAL	GENE-Y	11	37	In conclusion , chemical modulates , both alone and together with chemical reuptake inhibitors , dopaminergic , adrenergic , and serotonergic transmission in the FCX via a complex pattern of actions at gene , gene , and gene receptors .	T20	T51	10432475
NA	CHEMICAL	GENE-Y	0	2	chemical D1 receptor agonist and gene antagonist effects of the natural product chemical : molecular modeling and dynamics simulations .	T14	T26	17468175
NA	CHEMICAL	GENE-Y	0	2	chemical D1 receptor agonist and gene antagonist effects of the natural product chemical : molecular modeling and dynamics simulations .	T14	T27	17468175
CPR:5	CHEMICAL	GENE-Y	12	2	chemical D1 receptor agonist and gene antagonist effects of the natural product chemical : molecular modeling and dynamics simulations .	T15	T26	17468175
CPR:6	CHEMICAL	GENE-Y	12	2	chemical D1 receptor agonist and gene antagonist effects of the natural product chemical : molecular modeling and dynamics simulations .	T15	T27	17468175
CPR:5	CHEMICAL	GENE-Y	0	27	chemical ( chemical ) , an active ingredient of the Chinese herb Stephania , is the first compound found to have dual function as a chemical receptor D1 agonist and gene antagonist .	T1	T18	17468175
CPR:6	CHEMICAL	GENE-Y	0	30	chemical ( chemical ) , an active ingredient of the Chinese herb Stephania , is the first compound found to have dual function as a chemical receptor D1 agonist and gene antagonist .	T1	T19	17468175
CPR:5	CHEMICAL	GENE-Y	2	27	chemical ( chemical ) , an active ingredient of the Chinese herb Stephania , is the first compound found to have dual function as a chemical receptor D1 agonist and gene antagonist .	T8	T18	17468175
CPR:6	CHEMICAL	GENE-Y	2	30	chemical ( chemical ) , an active ingredient of the Chinese herb Stephania , is the first compound found to have dual function as a chemical receptor D1 agonist and gene antagonist .	T8	T19	17468175
NA	CHEMICAL	GENE-Y	24	27	chemical ( chemical ) , an active ingredient of the Chinese herb Stephania , is the first compound found to have dual function as a chemical receptor D1 agonist and gene antagonist .	T4	T18	17468175
NA	CHEMICAL	GENE-Y	24	30	chemical ( chemical ) , an active ingredient of the Chinese herb Stephania , is the first compound found to have dual function as a chemical receptor D1 agonist and gene antagonist .	T4	T19	17468175
NA	CHEMICAL	GENE-N	11	5	Insights into dynamical behaviors of gene and their interaction modes with chemical are crucial in understanding the structural and functional characteristics of chemical receptors .	T9	T20	17468175
NA	CHEMICAL	GENE-N	11	23	Insights into dynamical behaviors of gene and their interaction modes with chemical are crucial in understanding the structural and functional characteristics of chemical receptors .	T9	T21	17468175
NA	CHEMICAL	GENE-N	14	5	Insights into dynamical behaviors of gene and their interaction modes with chemical are crucial in understanding the structural and functional characteristics of chemical receptors .	T10	T20	17468175
NA	CHEMICAL	GENE-N	14	23	Insights into dynamical behaviors of gene and their interaction modes with chemical are crucial in understanding the structural and functional characteristics of chemical receptors .	T10	T21	17468175
NA	CHEMICAL	GENE-N	29	22	In this study a computational approach , integrating protein structure prediction , automated molecular docking , and molecular dynamics simulations were employed to investigate the dual action mechanism of chemical on the gene , with the eventual aim to develop new drugs for treating diseases affecting the central nervous system such as schizophrenia .	T11	T22	17468175
NA	CHEMICAL	GENE-N	24	25	The dynamics simulations revealed the surface features of the electrostatic potentials and the conformational `` open-closed '' process of the binding entrances of two chemical receptors .	T12	T23	17468175
NA	CHEMICAL	GENE-N	10	4	Potential binding conformations of gene were obtained , and the gene-chemical and gene-chemical complexes were generated , which are in good agreement with most of experimental data .	T13	T24	17468175
NA	CHEMICAL	GENE-Y	10	10	Potential binding conformations of gene were obtained , and the gene-chemical and gene-chemical complexes were generated , which are in good agreement with most of experimental data .	T13	T25	17468175
NA	CHEMICAL	GENE-Y	10	12	Potential binding conformations of gene were obtained , and the gene-chemical and gene-chemical complexes were generated , which are in good agreement with most of experimental data .	T13	T16	17468175
NA	CHEMICAL	GENE-N	4	4	Potential binding conformations of gene were obtained , and the gene-chemical and gene-chemical complexes were generated , which are in good agreement with most of experimental data .	T2	T24	17468175
NA	CHEMICAL	GENE-Y	4	10	Potential binding conformations of gene were obtained , and the gene-chemical and gene-chemical complexes were generated , which are in good agreement with most of experimental data .	T2	T25	17468175
NA	CHEMICAL	GENE-Y	4	12	Potential binding conformations of gene were obtained , and the gene-chemical and gene-chemical complexes were generated , which are in good agreement with most of experimental data .	T2	T16	17468175
NA	CHEMICAL	GENE-Y	1	1	The gene-chemical structure shows that the K-167_EL-2-E-302_EL-3 ( EL-2 : extracellular loop 2 ; EL-3 : extracellular loop 3 ) salt bridge plays an important role for both the conformational change of the extracellular domain and the binding of chemical .	T3	T17	17468175
NA	CHEMICAL	GENE-Y	39	1	The gene-chemical structure shows that the K-167_EL-2-E-302_EL-3 ( EL-2 : extracellular loop 2 ; EL-3 : extracellular loop 3 ) salt bridge plays an important role for both the conformational change of the extracellular domain and the binding of chemical .	T5	T17	17468175
NA	CHEMICAL	GENE-N	2	2	Methylation of gene on chemical 4 by the chemical methyltransferase gene protein is needed for normal clock gene expression .	T1	T17	23319591
NA	CHEMICAL	GENE-N	2	9	Methylation of gene on chemical 4 by the chemical methyltransferase gene protein is needed for normal clock gene expression .	T1	T18	23319591
NA	CHEMICAL	GENE-Y	2	10	Methylation of gene on chemical 4 by the chemical methyltransferase gene protein is needed for normal clock gene expression .	T1	T19	23319591
NA	CHEMICAL	GENE-N	8	2	Methylation of gene on chemical 4 by the chemical methyltransferase gene protein is needed for normal clock gene expression .	T2	T17	23319591
NA	CHEMICAL	GENE-N	8	9	Methylation of gene on chemical 4 by the chemical methyltransferase gene protein is needed for normal clock gene expression .	T2	T18	23319591
NA	CHEMICAL	GENE-Y	8	10	Methylation of gene on chemical 4 by the chemical methyltransferase gene protein is needed for normal clock gene expression .	T2	T19	23319591
CPR:4	CHEMICAL	GENE-Y	0	6	chemical : a dual inhibitor of gene chemical kinases .	T30	T52	18803986
CPR:4	CHEMICAL	GENE-N	0	2	chemical : a dual inhibitor of gene chemical kinases .	T30	T53	18803986
NA	CHEMICAL	GENE-Y	7	6	chemical : a dual inhibitor of gene chemical kinases .	T31	T52	18803986
NA	CHEMICAL	GENE-N	7	2	chemical : a dual inhibitor of gene chemical kinases .	T31	T53	18803986
CPR:4	CHEMICAL	GENE-Y	2	9	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T5	T49	18803986
CPR:4	CHEMICAL	GENE-Y	2	11	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T5	T50	18803986
CPR:4	CHEMICAL	GENE-Y	2	14	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T5	T51	18803986
CPR:4	CHEMICAL	GENE-Y	2	16	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T5	T35	18803986
CPR:4	CHEMICAL	GENE-N	2	19	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T5	T37	18803986
NA	CHEMICAL	GENE-Y	18	9	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T7	T49	18803986
NA	CHEMICAL	GENE-Y	18	11	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T7	T50	18803986
NA	CHEMICAL	GENE-Y	18	14	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T7	T51	18803986
NA	CHEMICAL	GENE-Y	18	16	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T7	T35	18803986
NA	CHEMICAL	GENE-N	18	19	BACKGROUND : chemical , the first dual inhibitor of gene ( gene ) and gene ( gene ) chemical kinases , was approved by the US Food and Drug Administration ( FDA ) in 2007 .	T7	T37	18803986
NA	CHEMICAL	GENE-Y	5	28	It is indicated for use in combination with chemical for the treatment of patients with advanced breast cancer or metastatic breast cancer ( MBC ) whose tumors overexpress gene ( gene ) and who have received previous treatment that included an chemical , a chemical , and trastuzumab .	T22	T47	18803986
NA	CHEMICAL	GENE-Y	5	30	It is indicated for use in combination with chemical for the treatment of patients with advanced breast cancer or metastatic breast cancer ( MBC ) whose tumors overexpress gene ( gene ) and who have received previous treatment that included an chemical , a chemical , and trastuzumab .	T22	T48	18803986
NA	CHEMICAL	GENE-Y	5	28	It is indicated for use in combination with chemical for the treatment of patients with advanced breast cancer or metastatic breast cancer ( MBC ) whose tumors overexpress gene ( gene ) and who have received previous treatment that included an chemical , a chemical , and trastuzumab .	T27	T47	18803986
NA	CHEMICAL	GENE-Y	5	30	It is indicated for use in combination with chemical for the treatment of patients with advanced breast cancer or metastatic breast cancer ( MBC ) whose tumors overexpress gene ( gene ) and who have received previous treatment that included an chemical , a chemical , and trastuzumab .	T27	T48	18803986
NA	CHEMICAL	GENE-Y	40	28	It is indicated for use in combination with chemical for the treatment of patients with advanced breast cancer or metastatic breast cancer ( MBC ) whose tumors overexpress gene ( gene ) and who have received previous treatment that included an chemical , a chemical , and trastuzumab .	T28	T47	18803986
NA	CHEMICAL	GENE-Y	40	30	It is indicated for use in combination with chemical for the treatment of patients with advanced breast cancer or metastatic breast cancer ( MBC ) whose tumors overexpress gene ( gene ) and who have received previous treatment that included an chemical , a chemical , and trastuzumab .	T28	T48	18803986
NA	CHEMICAL	GENE-Y	3	7	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T1	T32	18803986
NA	CHEMICAL	GENE-Y	3	9	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T1	T33	18803986
NA	CHEMICAL	GENE-N	3	11	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T1	T34	18803986
NA	CHEMICAL	GENE-Y	5	7	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T2	T32	18803986
NA	CHEMICAL	GENE-Y	5	9	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T2	T33	18803986
NA	CHEMICAL	GENE-N	5	11	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T2	T34	18803986
NA	CHEMICAL	GENE-Y	7	7	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T3	T32	18803986
NA	CHEMICAL	GENE-Y	7	9	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T3	T33	18803986
NA	CHEMICAL	GENE-N	7	11	Search terms included chemical , chemical , gene , gene , gene , dual-receptor blockade , adverse events , and clinical trials .	T3	T34	18803986
CPR:9	CHEMICAL	GENE-Y	0	6	chemical is metabolized primarily by the gene isozyme , with 1 metabolite remaining active against gene but not gene .	T6	T36	18803986
NA	CHEMICAL	GENE-Y	0	15	chemical is metabolized primarily by the gene isozyme , with 1 metabolite remaining active against gene but not gene .	T6	T38	18803986
NA	CHEMICAL	GENE-Y	0	18	chemical is metabolized primarily by the gene isozyme , with 1 metabolite remaining active against gene but not gene .	T6	T39	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T9	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T10	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T11	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T12	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T13	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T14	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T15	T40	18803986
NA	CHEMICAL	GENE-Y	1	15	In a Phase III trial comparing chemical and chemical with chemical alone in women with gene-positive , locally advanced breast cancer or MBC that had progressed after treatment with an chemical , a chemical , and trastuzumab , the combination of chemical and chemical was associated with a numeric improvement in response rate compared with chemical alone ( 22 % vs 14 % , respectively ; P = NS ) and a significant increase in time to progression ( 6.2 vs 4.3 months ; hazard ratio = 0.57 ; 95 % CI , 0.43-0.77 ; P < 0.001 ) .	T16	T40	18803986
CPR:4	CHEMICAL	GENE-Y	2	9	CONCLUSIONS : chemical is a dual inhibitor of the gene and gene chemical kinases .	T24	T41	18803986
CPR:4	CHEMICAL	GENE-Y	2	11	CONCLUSIONS : chemical is a dual inhibitor of the gene and gene chemical kinases .	T24	T42	18803986
CPR:4	CHEMICAL	GENE-N	2	4	CONCLUSIONS : chemical is a dual inhibitor of the gene and gene chemical kinases .	T24	T43	18803986
NA	CHEMICAL	GENE-Y	12	9	CONCLUSIONS : chemical is a dual inhibitor of the gene and gene chemical kinases .	T25	T41	18803986
NA	CHEMICAL	GENE-Y	12	11	CONCLUSIONS : chemical is a dual inhibitor of the gene and gene chemical kinases .	T25	T42	18803986
NA	CHEMICAL	GENE-N	12	4	CONCLUSIONS : chemical is a dual inhibitor of the gene and gene chemical kinases .	T25	T43	18803986
NA	CHEMICAL	GENE-Y	8	16	It is approved by the FDA for use in combination with chemical for the treatment of gene-positive MBC that has progressed with standard treatment .	T26	T44	18803986
CPR:4	CHEMICAL	GENE-Y	3	1	As a prodrug chemical is completely converted to its active metabolite chemical ( M1 ) which blocks the chemical dehydrogenase , a key enzyme of the chemical de novo synthesis .	T1	T11	12063741
CPR:4	CHEMICAL	GENE-Y	11	1	As a prodrug chemical is completely converted to its active metabolite chemical ( M1 ) which blocks the chemical dehydrogenase , a key enzyme of the chemical de novo synthesis .	T2	T11	12063741
NA	CHEMICAL	GENE-Y	1	1	As a prodrug chemical is completely converted to its active metabolite chemical ( M1 ) which blocks the chemical dehydrogenase , a key enzyme of the chemical de novo synthesis .	T3	T11	12063741
NA	CHEMICAL	GENE-Y	26	1	As a prodrug chemical is completely converted to its active metabolite chemical ( M1 ) which blocks the chemical dehydrogenase , a key enzyme of the chemical de novo synthesis .	T5	T11	12063741
NA	CHEMICAL	GENE-Y	20	5	Upon differentiation , osteoclasts express gene ( gene ) , which is essential for vesicular storage and subsequent exocytosis of chemical in neurons .	T4	T17	16957773
NA	CHEMICAL	GENE-Y	20	7	Upon differentiation , osteoclasts express gene ( gene ) , which is essential for vesicular storage and subsequent exocytosis of chemical in neurons .	T4	T18	16957773
CPR:9	CHEMICAL	GENE-Y	8	0	gene is localized in transcytotic vesicles and accumulates chemical .	T6	T19	16957773
NA	CHEMICAL	GENE-Y	0	12	chemical- and chemical-dependent secretion of chemical was absent in osteoclasts prepared from gene-/- knockout mice .	T11	T20	16957773
NA	CHEMICAL	GENE-Y	2	12	chemical- and chemical-dependent secretion of chemical was absent in osteoclasts prepared from gene-/- knockout mice .	T12	T20	16957773
NA	CHEMICAL	GENE-Y	5	12	chemical- and chemical-dependent secretion of chemical was absent in osteoclasts prepared from gene-/- knockout mice .	T13	T20	16957773
NA	CHEMICAL	GENE-Y	4	2	Osteoclasts express gene , a gene .	T14	T21	16957773
NA	CHEMICAL	GENE-N	4	5	Osteoclasts express gene , a gene .	T14	T22	16957773
CPR:3	CHEMICAL	GENE-N	0	20	chemical ( chemical ) , a novel drug approved for the treatment of relapsing-remitting multiple sclerosis , activates different chemical receptor ( gene ) subtypes .	T1	T27	23073075
CPR:3	CHEMICAL	GENE-N	0	22	chemical ( chemical ) , a novel drug approved for the treatment of relapsing-remitting multiple sclerosis , activates different chemical receptor ( gene ) subtypes .	T1	T28	23073075
CPR:3	CHEMICAL	GENE-N	2	20	chemical ( chemical ) , a novel drug approved for the treatment of relapsing-remitting multiple sclerosis , activates different chemical receptor ( gene ) subtypes .	T6	T27	23073075
CPR:3	CHEMICAL	GENE-N	2	22	chemical ( chemical ) , a novel drug approved for the treatment of relapsing-remitting multiple sclerosis , activates different chemical receptor ( gene ) subtypes .	T6	T28	23073075
NA	CHEMICAL	GENE-N	5	20	chemical ( chemical ) , a novel drug approved for the treatment of relapsing-remitting multiple sclerosis , activates different chemical receptor ( gene ) subtypes .	T7	T27	23073075
NA	CHEMICAL	GENE-N	5	22	chemical ( chemical ) , a novel drug approved for the treatment of relapsing-remitting multiple sclerosis , activates different chemical receptor ( gene ) subtypes .	T7	T28	23073075
NA	CHEMICAL	GENE-N	9	11	However , recent evidence suggests that the action of chemical involves gene expressed by cells resident in the CNS , including neurons .	T9	T29	23073075
NA	CHEMICAL	GENE-N	11	4	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T2	T30	23073075
CPR:6	CHEMICAL	GENE-Y	11	11	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T2	T21	23073075
CPR:6	CHEMICAL	GENE-Y	11	13	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T2	T22	23073075
NA	CHEMICAL	GENE-N	11	24	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T2	T23	23073075
NA	CHEMICAL	GENE-N	11	26	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T2	T24	23073075
NA	CHEMICAL	GENE-N	11	32	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T2	T26	23073075
NA	CHEMICAL	GENE-N	4	4	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T3	T30	23073075
NA	CHEMICAL	GENE-Y	4	11	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T3	T21	23073075
NA	CHEMICAL	GENE-Y	4	13	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T3	T22	23073075
NA	CHEMICAL	GENE-N	4	24	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T3	T23	23073075
NA	CHEMICAL	GENE-N	4	26	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T3	T24	23073075
NA	CHEMICAL	GENE-N	4	32	Neuroprotection was attenuated by gene , and inhibited by the selective gene ( gene ) antagonist , chemical , and by inhibitors of the gene ( gene ) and the chemical-3-kinase ( gene ) pathways .	T3	T26	23073075
NA	CHEMICAL	GENE-Y	13	15	Diabetic cardiomyopathy is associated with suppression of cardiac autophagy , and activation of chemical-activated protein kinase ( gene ) restores cardiac autophagy and prevents cardiomyopathy in diabetic mice , albeit by an unknown mechanism .	T6	T32	23223177
NA	CHEMICAL	GENE-Y	13	17	Diabetic cardiomyopathy is associated with suppression of cardiac autophagy , and activation of chemical-activated protein kinase ( gene ) restores cardiac autophagy and prevents cardiomyopathy in diabetic mice , albeit by an unknown mechanism .	T6	T11	23223177
NA	CHEMICAL	GENE-N	38	3	We hypothesized that gene-induced autophagy ameliorates diabetic cardiomyopathy by inhibiting cardiomyocyte apoptosis and examined the effects of gene on the interaction between gene and gene , a switch between autophagy and apoptosis , in diabetic mice and high chemical-treated H9c2 cardiac myoblast cells .	T2	T15	23223177
NA	CHEMICAL	GENE-N	38	17	We hypothesized that gene-induced autophagy ameliorates diabetic cardiomyopathy by inhibiting cardiomyocyte apoptosis and examined the effects of gene on the interaction between gene and gene , a switch between autophagy and apoptosis , in diabetic mice and high chemical-treated H9c2 cardiac myoblast cells .	T2	T16	23223177
NA	CHEMICAL	GENE-N	38	22	We hypothesized that gene-induced autophagy ameliorates diabetic cardiomyopathy by inhibiting cardiomyocyte apoptosis and examined the effects of gene on the interaction between gene and gene , a switch between autophagy and apoptosis , in diabetic mice and high chemical-treated H9c2 cardiac myoblast cells .	T2	T17	23223177
NA	CHEMICAL	GENE-N	38	24	We hypothesized that gene-induced autophagy ameliorates diabetic cardiomyopathy by inhibiting cardiomyocyte apoptosis and examined the effects of gene on the interaction between gene and gene , a switch between autophagy and apoptosis , in diabetic mice and high chemical-treated H9c2 cardiac myoblast cells .	T2	T18	23223177
CPR:4	CHEMICAL	GENE-Y	6	8	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T19	23223177
CPR:4	CHEMICAL	GENE-Y	6	12	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T20	23223177
CPR:4	CHEMICAL	GENE-Y	6	14	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T21	23223177
CPR:4	CHEMICAL	GENE-Y	6	16	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T22	23223177
CPR:4	CHEMICAL	GENE-Y	6	18	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T23	23223177
NA	CHEMICAL	GENE-Y	6	24	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T24	23223177
NA	CHEMICAL	GENE-Y	6	27	Exposure of H9c2 cells to high chemical reduced gene activity , inhibited gene ( gene ) -gene ( gene ) signaling , and promoted gene binding to gene .	T3	T25	23223177
NA	CHEMICAL	GENE-Y	11	2	Activation of gene , which normalized cardiac autophagy , attenuated high chemical-induced apoptosis in cultured H9c2 cells .	T5	T31	23223177
CPR:3	CHEMICAL	GENE-Y	5	14	Finally , chronic administration of chemical in diabetic mice restored cardiac autophagy by activating gene-gene pathways and dissociating gene and gene .	T1	T7	23223177
CPR:3	CHEMICAL	GENE-Y	5	14	Finally , chronic administration of chemical in diabetic mice restored cardiac autophagy by activating gene-gene pathways and dissociating gene and gene .	T1	T8	23223177
NA	CHEMICAL	GENE-Y	5	6	Finally , chronic administration of chemical in diabetic mice restored cardiac autophagy by activating gene-gene pathways and dissociating gene and gene .	T1	T9	23223177
NA	CHEMICAL	GENE-Y	5	20	Finally , chronic administration of chemical in diabetic mice restored cardiac autophagy by activating gene-gene pathways and dissociating gene and gene .	T1	T10	23223177
NA	CHEMICAL	GENE-Y	3	8	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T14	T22	12901032
NA	CHEMICAL	GENE-Y	3	11	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T14	T23	12901032
CPR:4	CHEMICAL	GENE-Y	8	8	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T6	T22	12901032
CPR:4	CHEMICAL	GENE-Y	8	11	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T6	T23	12901032
CPR:4	CHEMICAL	GENE-Y	8	8	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T7	T22	12901032
CPR:4	CHEMICAL	GENE-Y	8	11	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T7	T23	12901032
CPR:4	CHEMICAL	GENE-Y	28	8	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T8	T22	12901032
CPR:4	CHEMICAL	GENE-Y	28	11	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T8	T23	12901032
CPR:4	CHEMICAL	GENE-Y	32	8	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T9	T22	12901032
CPR:4	CHEMICAL	GENE-Y	32	11	Patients stable on chemical therapy and concurrently taking a gene ( gene ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , chemical , or chemical ) randomly received chemical 200 mg/day or chemical 25 mg/day for three weeks .	T9	T23	12901032
NA	CHEMICAL	GENE-Y	13	7	Adverse drug reactions were similar for each gene inhibitor , but the rate of edema requiring medical intervention was higher in the chemical group .	T1	T21	12901032
CPR:9	CHEMICAL	GENE-N	5	1	The gene is the predominant chemical degrading enzyme in a variety of inflammatory cells including eosinophils , neutrophils , macrophages , T cells and monocytes .	T5	T15	17352685
CPR:4	CHEMICAL	GENE-N	5	2	Consequently , gene inhibitors including chemical and chemical have been tested in several models of allergic and irritant skin inflammation .	T6	T18	17352685
CPR:4	CHEMICAL	GENE-N	7	2	Consequently , gene inhibitors including chemical and chemical have been tested in several models of allergic and irritant skin inflammation .	T7	T18	17352685
NA	CHEMICAL	GENE-N	18	1	These gene inhibitors displayed strong anti-inflammatory action in models of allergic contact dermatitis in mice , in the chemical induced skin inflammation in mice and in gene sensitised guinea pigs .	T8	T19	17352685
NA	CHEMICAL	GENE-Y	18	7	These gene inhibitors displayed strong anti-inflammatory action in models of allergic contact dermatitis in mice , in the chemical induced skin inflammation in mice and in gene sensitised guinea pigs .	T8	T20	17352685
CPR:4	CHEMICAL	GENE-N	9	19	Results of early clinical trials with both topically ( chemical , chemical ) and systemically ( CC-10004 ) active gene inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004 , also in psoriasis .	T1	T12	17352685
CPR:4	CHEMICAL	GENE-N	10	19	Results of early clinical trials with both topically ( chemical , chemical ) and systemically ( CC-10004 ) active gene inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004 , also in psoriasis .	T2	T12	17352685
CPR:4	CHEMICAL	GENE-Y	9	0	A one-pot domino synthesis and discovery of highly functionalized chemical as gene inhibitors .	T7	T11	23434223
CPR:9	CHEMICAL	GENE-Y	10	29	The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters , chemical and chemical , share the same gene ( gene ) and are both present in neurons during postnatal development .	T6	T19	17554001
CPR:9	CHEMICAL	GENE-Y	10	31	The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters , chemical and chemical , share the same gene ( gene ) and are both present in neurons during postnatal development .	T6	T20	17554001
CPR:9	CHEMICAL	GENE-Y	24	29	The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters , chemical and chemical , share the same gene ( gene ) and are both present in neurons during postnatal development .	T7	T19	17554001
CPR:9	CHEMICAL	GENE-Y	24	31	The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters , chemical and chemical , share the same gene ( gene ) and are both present in neurons during postnatal development .	T7	T20	17554001
CPR:9	CHEMICAL	GENE-Y	8	3	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T9	T21	17554001
CPR:9	CHEMICAL	GENE-N	8	6	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T9	T22	17554001
CPR:9	CHEMICAL	GENE-Y	10	3	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T10	T21	17554001
CPR:9	CHEMICAL	GENE-N	10	6	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T10	T22	17554001
NA	CHEMICAL	GENE-Y	11	3	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T11	T21	17554001
NA	CHEMICAL	GENE-N	11	6	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T11	T22	17554001
NA	CHEMICAL	GENE-Y	24	3	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T12	T21	17554001
NA	CHEMICAL	GENE-N	24	6	We have expressed gene and the gene for chemical and chemical in a neuroendocrine cell line and measured the quantal release of chemical and chemical using a novel double-sniffer patch-clamp technique .	T12	T22	17554001
CPR:9	CHEMICAL	GENE-Y	3	9	We found that chemical is released from vesicles when gene is coexpressed with either the gene gene or the gene gene .	T13	T23	17554001
NA	CHEMICAL	GENE-N	3	15	We found that chemical is released from vesicles when gene is coexpressed with either the gene gene or the gene gene .	T13	T24	17554001
NA	CHEMICAL	GENE-Y	3	16	We found that chemical is released from vesicles when gene is coexpressed with either the gene gene or the gene gene .	T13	T25	17554001
NA	CHEMICAL	GENE-N	3	17	We found that chemical is released from vesicles when gene is coexpressed with either the gene gene or the gene gene .	T13	T26	17554001
NA	CHEMICAL	GENE-Y	3	20	We found that chemical is released from vesicles when gene is coexpressed with either the gene gene or the gene gene .	T13	T27	17554001
NA	CHEMICAL	GENE-Y	16	2	However , gene was more effective than gene , probably because gene is unable to operate in the reverse mode , which gives it an advantage in maintaining the high cytosolic chemical concentration required for efficient vesicular loading by gene .	T14	T28	17554001
NA	CHEMICAL	GENE-Y	16	7	However , gene was more effective than gene , probably because gene is unable to operate in the reverse mode , which gives it an advantage in maintaining the high cytosolic chemical concentration required for efficient vesicular loading by gene .	T14	T29	17554001
NA	CHEMICAL	GENE-Y	16	11	However , gene was more effective than gene , probably because gene is unable to operate in the reverse mode , which gives it an advantage in maintaining the high cytosolic chemical concentration required for efficient vesicular loading by gene .	T14	T30	17554001
CPR:9	CHEMICAL	GENE-Y	16	39	However , gene was more effective than gene , probably because gene is unable to operate in the reverse mode , which gives it an advantage in maintaining the high cytosolic chemical concentration required for efficient vesicular loading by gene .	T14	T31	17554001
CPR:9	CHEMICAL	GENE-Y	10	27	The vesicular inhibitory phenotype was gradually altered from glycinergic to chemicalergic through mixed events when GABA is introduced into the secretory cell and competes for uptake by gene .	T1	T15	17554001
NA	CHEMICAL	GENE-N	15	3	Interestingly , the gene ortholog from Caenorhabditis elegans ( UNC-47 ) , a species lacking chemical transmission , also supports chemical exocytosis in the presence of gene , and a point mutation of UNC-47 that abolishes chemical transmission in the worm confers glycine specificity .	T2	T16	17554001
NA	CHEMICAL	GENE-N	15	26	Interestingly , the gene ortholog from Caenorhabditis elegans ( UNC-47 ) , a species lacking chemical transmission , also supports chemical exocytosis in the presence of gene , and a point mutation of UNC-47 that abolishes chemical transmission in the worm confers glycine specificity .	T2	T17	17554001
NA	CHEMICAL	GENE-N	20	3	Interestingly , the gene ortholog from Caenorhabditis elegans ( UNC-47 ) , a species lacking chemical transmission , also supports chemical exocytosis in the presence of gene , and a point mutation of UNC-47 that abolishes chemical transmission in the worm confers glycine specificity .	T3	T16	17554001
CPR:9	CHEMICAL	GENE-N	20	26	Interestingly , the gene ortholog from Caenorhabditis elegans ( UNC-47 ) , a species lacking chemical transmission , also supports chemical exocytosis in the presence of gene , and a point mutation of UNC-47 that abolishes chemical transmission in the worm confers glycine specificity .	T3	T17	17554001
NA	CHEMICAL	GENE-N	36	3	Interestingly , the gene ortholog from Caenorhabditis elegans ( UNC-47 ) , a species lacking chemical transmission , also supports chemical exocytosis in the presence of gene , and a point mutation of UNC-47 that abolishes chemical transmission in the worm confers glycine specificity .	T4	T16	17554001
NA	CHEMICAL	GENE-N	36	26	Interestingly , the gene ortholog from Caenorhabditis elegans ( UNC-47 ) , a species lacking chemical transmission , also supports chemical exocytosis in the presence of gene , and a point mutation of UNC-47 that abolishes chemical transmission in the worm confers glycine specificity .	T4	T17	17554001
NA	CHEMICAL	GENE-Y	14	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T5	T16	10637238
NA	CHEMICAL	GENE-Y	14	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T5	T17	10637238
NA	CHEMICAL	GENE-Y	14	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T5	T18	10637238
NA	CHEMICAL	GENE-Y	32	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T6	T16	10637238
NA	CHEMICAL	GENE-Y	32	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T6	T17	10637238
NA	CHEMICAL	GENE-Y	32	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T6	T18	10637238
NA	CHEMICAL	GENE-Y	20	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T7	T16	10637238
NA	CHEMICAL	GENE-Y	20	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T7	T17	10637238
NA	CHEMICAL	GENE-Y	20	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T7	T18	10637238
NA	CHEMICAL	GENE-Y	20	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T8	T16	10637238
NA	CHEMICAL	GENE-Y	20	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T8	T17	10637238
NA	CHEMICAL	GENE-Y	20	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T8	T18	10637238
NA	CHEMICAL	GENE-Y	48	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T9	T16	10637238
NA	CHEMICAL	GENE-Y	48	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T9	T17	10637238
NA	CHEMICAL	GENE-Y	48	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T9	T18	10637238
NA	CHEMICAL	GENE-Y	50	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T10	T16	10637238
NA	CHEMICAL	GENE-Y	50	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T10	T17	10637238
NA	CHEMICAL	GENE-Y	50	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T10	T18	10637238
NA	CHEMICAL	GENE-Y	53	15	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T11	T16	10637238
NA	CHEMICAL	GENE-Y	53	17	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T11	T17	10637238
NA	CHEMICAL	GENE-Y	53	21	PATIENTS AND METHODS : Between January 1988 and December 1992 , 231 patients with chemical receptor ( gene ) -positive or gene-unknown metastatic breast cancer were randomized to receive either chemotherapy ( chemical , chemical , and chemical inverted question markCAF ) or chemohormonal therapy ( CAF plus chemical and chemical inverted question markchemical ; Pharmacia-Upjohn , Kalamazoo , MI inverted question markCAFTH ) as front-line therapy for metastatic breast cancer .	T11	T18	10637238
NA	CHEMICAL	GENE-Y	1	2	Nuclear chemical kinase-theta is activated in response to gene .	T9	T31	11309392
NA	CHEMICAL	GENE-Y	1	5	Nuclear chemical kinase-theta is activated in response to gene .	T9	T30	11309392
NA	CHEMICAL	GENE-Y	30	12	Previous work from our laboratory showed that stimulation of quiescent fibroblasts with gene leads to the production of two lipid second messengers in the nucleus : an increase in nuclear chemical mass and an activation of phospholipase D , which catalyzes the hydrolysis of chemical to generate chemical .	T3	T25	11309392
NA	CHEMICAL	GENE-Y	22	12	Previous work from our laboratory showed that stimulation of quiescent fibroblasts with gene leads to the production of two lipid second messengers in the nucleus : an increase in nuclear chemical mass and an activation of phospholipase D , which catalyzes the hydrolysis of chemical to generate chemical .	T4	T25	11309392
NA	CHEMICAL	GENE-Y	47	12	Previous work from our laboratory showed that stimulation of quiescent fibroblasts with gene leads to the production of two lipid second messengers in the nucleus : an increase in nuclear chemical mass and an activation of phospholipase D , which catalyzes the hydrolysis of chemical to generate chemical .	T5	T25	11309392
NA	CHEMICAL	GENE-N	0	1	chemical kinase ( gene ) catalyzes the conversion of chemical to chemical , making it an attractive candidate for a signal transduction component .	T6	T26	11309392
NA	CHEMICAL	GENE-N	0	3	chemical kinase ( gene ) catalyzes the conversion of chemical to chemical , making it an attractive candidate for a signal transduction component .	T6	T27	11309392
CPR:9	CHEMICAL	GENE-N	9	1	chemical kinase ( gene ) catalyzes the conversion of chemical to chemical , making it an attractive candidate for a signal transduction component .	T7	T26	11309392
CPR:9	CHEMICAL	GENE-N	9	3	chemical kinase ( gene ) catalyzes the conversion of chemical to chemical , making it an attractive candidate for a signal transduction component .	T7	T27	11309392
CPR:9	CHEMICAL	GENE-N	11	1	chemical kinase ( gene ) catalyzes the conversion of chemical to chemical , making it an attractive candidate for a signal transduction component .	T8	T26	11309392
CPR:9	CHEMICAL	GENE-N	11	3	chemical kinase ( gene ) catalyzes the conversion of chemical to chemical , making it an attractive candidate for a signal transduction component .	T8	T27	11309392
CPR:4	CHEMICAL	GENE-Y	8	10	We took advantage of the previous observations that chemical inhibits gene ( reviewed by Sakane , F. , Imai , S. , Kai , M. , Wada , I. , and Kanoh , H .	T1	T12	11309392
NA	CHEMICAL	GENE-Y	10	2	Constitutively active gene inhibited the nuclear stimulated activity , whereas chemical did not have an inhibitory effect .	T2	T16	11309392
CPR:4	CHEMICAL	GENE-Y	2	8	We used chemical , a well-known disruptor of gene-gene interaction , to validate the specificity of the assay .	T2	T21	23261524
CPR:4	CHEMICAL	GENE-Y	2	8	We used chemical , a well-known disruptor of gene-gene interaction , to validate the specificity of the assay .	T2	T22	23261524
CPR:3	CHEMICAL	GENE-Y	7	14	The reduction of BiFC signal mediated by chemical was correlated with an increase in gene transactivation , gene cleavage , and cell death .	T1	T4	23261524
CPR:3	CHEMICAL	GENE-N	7	17	The reduction of BiFC signal mediated by chemical was correlated with an increase in gene transactivation , gene cleavage , and cell death .	T1	T5	23261524
CPR:3	CHEMICAL	GENE-Y	1	4	Oral chemical increases active gene ( 7-36 ) chemical secretion and improves glycemic control in chemical-chemical induced diabetic rats .	T40	T58	23466488
NA	CHEMICAL	GENE-Y	8	4	Oral chemical increases active gene ( 7-36 ) chemical secretion and improves glycemic control in chemical-chemical induced diabetic rats .	T39	T58	23466488
NA	CHEMICAL	GENE-Y	14	4	Oral chemical increases active gene ( 7-36 ) chemical secretion and improves glycemic control in chemical-chemical induced diabetic rats .	T41	T58	23466488
NA	CHEMICAL	GENE-Y	14	4	Oral chemical increases active gene ( 7-36 ) chemical secretion and improves glycemic control in chemical-chemical induced diabetic rats .	T38	T58	23466488
NA	CHEMICAL	GENE-N	3	6	It decreased blood chemical , stimulated gene secretion in type 2 diabetic patients .	T30	T57	23466488
CPR:3	CHEMICAL	GENE-Y	9	11	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T18	T54	23466488
CPR:3	CHEMICAL	GENE-Y	9	13	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T18	T55	23466488
NA	CHEMICAL	GENE-Y	18	11	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T22	T54	23466488
NA	CHEMICAL	GENE-Y	18	13	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T22	T55	23466488
NA	CHEMICAL	GENE-Y	7	11	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T23	T54	23466488
NA	CHEMICAL	GENE-Y	7	13	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T23	T55	23466488
NA	CHEMICAL	GENE-Y	20	11	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T24	T54	23466488
NA	CHEMICAL	GENE-Y	20	13	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T24	T55	23466488
NA	CHEMICAL	GENE-Y	23	11	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T25	T54	23466488
NA	CHEMICAL	GENE-Y	23	13	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T25	T55	23466488
NA	CHEMICAL	GENE-Y	23	11	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T26	T54	23466488
NA	CHEMICAL	GENE-Y	23	13	The objective of the present investigation was to evaluate chemical increases gene ( gene ) ( 7-36 ) chemical secretion in chemical-chemical ( chemical-chemical ) induced diabetic Sprague Dawley rats .	T26	T55	23466488
NA	CHEMICAL	GENE-N	16	1	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T42	23466488
NA	CHEMICAL	GENE-Y	16	11	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T43	23466488
NA	CHEMICAL	GENE-Y	16	22	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T44	23466488
NA	CHEMICAL	GENE-N	16	27	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T45	23466488
NA	CHEMICAL	GENE-N	16	38	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T46	23466488
NA	CHEMICAL	GENE-N	16	46	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T47	23466488
NA	CHEMICAL	GENE-N	16	50	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T2	T48	23466488
NA	CHEMICAL	GENE-N	41	1	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T42	23466488
NA	CHEMICAL	GENE-Y	41	11	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T43	23466488
NA	CHEMICAL	GENE-Y	41	22	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T44	23466488
NA	CHEMICAL	GENE-N	41	27	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T45	23466488
NA	CHEMICAL	GENE-N	41	38	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T46	23466488
NA	CHEMICAL	GENE-N	41	46	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T47	23466488
NA	CHEMICAL	GENE-N	41	50	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T3	T48	23466488
NA	CHEMICAL	GENE-N	1	1	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T42	23466488
NA	CHEMICAL	GENE-Y	1	11	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T43	23466488
NA	CHEMICAL	GENE-Y	1	22	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T44	23466488
NA	CHEMICAL	GENE-N	1	27	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T45	23466488
NA	CHEMICAL	GENE-N	1	38	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T46	23466488
NA	CHEMICAL	GENE-N	1	46	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T47	23466488
NA	CHEMICAL	GENE-N	1	50	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T4	T48	23466488
NA	CHEMICAL	GENE-N	45	1	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T42	23466488
NA	CHEMICAL	GENE-Y	45	11	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T43	23466488
NA	CHEMICAL	GENE-Y	45	22	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T44	23466488
NA	CHEMICAL	GENE-N	45	27	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T45	23466488
NA	CHEMICAL	GENE-N	45	38	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T46	23466488
NA	CHEMICAL	GENE-N	45	46	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T47	23466488
NA	CHEMICAL	GENE-N	45	50	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T5	T48	23466488
NA	CHEMICAL	GENE-N	48	1	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T42	23466488
NA	CHEMICAL	GENE-Y	48	11	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T43	23466488
NA	CHEMICAL	GENE-Y	48	22	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T44	23466488
NA	CHEMICAL	GENE-N	48	27	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T45	23466488
NA	CHEMICAL	GENE-N	48	38	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T46	23466488
NA	CHEMICAL	GENE-N	48	46	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T47	23466488
NA	CHEMICAL	GENE-N	48	50	Glycosylated gene , lipid profile , plasma and colonic active ( gene ) ( 7-36 ) chemical , mRNA expression of proglucagon gene , plasma and pancreatic gene , histology of pancreata and biomarkers of oxidative stress ( gene , reduced chemical , chemical , chemical peroxidase , chemical S transferase ) were measured after 8week .	T6	T48	23466488
NA	CHEMICAL	GENE-Y	1	4	Plasma chemical , active gene ( 7-36 ) chemical concentration and gene levels were measured after chemical loading .	T12	T49	23466488
NA	CHEMICAL	GENE-N	1	11	Plasma chemical , active gene ( 7-36 ) chemical concentration and gene levels were measured after chemical loading .	T12	T50	23466488
NA	CHEMICAL	GENE-Y	8	4	Plasma chemical , active gene ( 7-36 ) chemical concentration and gene levels were measured after chemical loading .	T13	T49	23466488
NA	CHEMICAL	GENE-N	8	11	Plasma chemical , active gene ( 7-36 ) chemical concentration and gene levels were measured after chemical loading .	T13	T50	23466488
NA	CHEMICAL	GENE-Y	16	4	Plasma chemical , active gene ( 7-36 ) chemical concentration and gene levels were measured after chemical loading .	T14	T49	23466488
NA	CHEMICAL	GENE-N	16	11	Plasma chemical , active gene ( 7-36 ) chemical concentration and gene levels were measured after chemical loading .	T14	T50	23466488
NA	CHEMICAL	GENE-Y	5	7	The docking data indicated that chemical bind to the gene .	T15	T51	23466488
NA	CHEMICAL	GENE-N	2	3	Effects of chemical oxidase inhibitors on levels of chemical and chemical in striatum and plasma .	T33	T44	2506486
NA	CHEMICAL	GENE-N	8	3	Effects of chemical oxidase inhibitors on levels of chemical and chemical in striatum and plasma .	T34	T44	2506486
NA	CHEMICAL	GENE-N	10	3	Effects of chemical oxidase inhibitors on levels of chemical and chemical in striatum and plasma .	T35	T44	2506486
NA	CHEMICAL	GENE-Y	2	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T2	T37	2506486
NA	CHEMICAL	GENE-Y	2	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T2	T38	2506486
NA	CHEMICAL	GENE-Y	4	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T12	T37	2506486
NA	CHEMICAL	GENE-Y	4	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T12	T38	2506486
NA	CHEMICAL	GENE-Y	7	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T14	T37	2506486
NA	CHEMICAL	GENE-Y	7	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T14	T38	2506486
NA	CHEMICAL	GENE-Y	9	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T21	T37	2506486
NA	CHEMICAL	GENE-Y	9	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T21	T38	2506486
NA	CHEMICAL	GENE-Y	12	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T27	T37	2506486
NA	CHEMICAL	GENE-Y	12	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T27	T38	2506486
NA	CHEMICAL	GENE-Y	14	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T32	T37	2506486
NA	CHEMICAL	GENE-Y	14	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T32	T38	2506486
NA	CHEMICAL	GENE-Y	16	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T8	T37	2506486
NA	CHEMICAL	GENE-Y	16	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T8	T38	2506486
CPR:4	CHEMICAL	GENE-Y	16	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T9	T37	2506486
CPR:4	CHEMICAL	GENE-Y	16	29	Levels of chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) in plasma and the striatium were measured after inhibition of chemical oxidase type A ( gene ) by chemical ( 4 mg/kg i.p .	T9	T38	2506486
CPR:4	CHEMICAL	GENE-Y	0	2	) , gene by chemical ( 1 mg/kg i.p .	T10	T39	2506486
CPR:4	CHEMICAL	GENE-Y	7	3	) , both gene and gene by chemical ( 75 mg/kg i.p . )	T11	T40	2506486
CPR:4	CHEMICAL	GENE-Y	7	5	) , both gene and gene by chemical ( 75 mg/kg i.p . )	T11	T41	2506486
CPR:4	CHEMICAL	GENE-N	5	3	or peripheral neuronal gene by chemical ( 40 mg/kg i.p . ) .	T13	T42	2506486
CPR:9	CHEMICAL	GENE-Y	0	15	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T1	T36	17869551
CPR:9	CHEMICAL	GENE-Y	0	21	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T1	T37	17869551
CPR:9	CHEMICAL	GENE-Y	2	15	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T11	T36	17869551
CPR:9	CHEMICAL	GENE-Y	2	21	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T11	T37	17869551
CPR:9	CHEMICAL	GENE-Y	11	15	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T23	T36	17869551
CPR:9	CHEMICAL	GENE-Y	11	21	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T23	T37	17869551
CPR:9	CHEMICAL	GENE-Y	13	15	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T29	T36	17869551
CPR:9	CHEMICAL	GENE-Y	13	21	chemical ( chemical ) is an important vasorelaxant produced along with chemical from chemical in a reaction catalyzed by gene ( gene ) .	T29	T37	17869551
CPR:4	CHEMICAL	GENE-Y	4	10	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T31	T34	17869551
CPR:4	CHEMICAL	GENE-Y	4	12	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T31	T35	17869551
NA	CHEMICAL	GENE-Y	9	10	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T2	T34	17869551
NA	CHEMICAL	GENE-Y	9	12	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T2	T35	17869551
NA	CHEMICAL	GENE-Y	4	10	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T3	T34	17869551
NA	CHEMICAL	GENE-Y	4	12	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T3	T35	17869551
NA	CHEMICAL	GENE-Y	19	10	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T4	T34	17869551
NA	CHEMICAL	GENE-Y	19	12	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T4	T35	17869551
NA	CHEMICAL	GENE-Y	23	10	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T5	T34	17869551
NA	CHEMICAL	GENE-Y	23	12	As further support , chemical , an inhibitor of chemical synthase ( gene ) , a component of the chemical-chemical cycle , inhibited chemical production in a dose-dependent manner .	T5	T35	17869551
CPR:3	CHEMICAL	GENE-Y	0	14	chemical protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the gene/chemical oxygenase-1 pathway .	T19	T33	23403272
CPR:3	CHEMICAL	GENE-Y	0	15	chemical protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the gene/chemical oxygenase-1 pathway .	T19	T34	23403272
NA	CHEMICAL	GENE-Y	14	14	chemical protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the gene/chemical oxygenase-1 pathway .	T20	T33	23403272
NA	CHEMICAL	GENE-Y	14	15	chemical protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the gene/chemical oxygenase-1 pathway .	T20	T34	23403272
CPR:4	CHEMICAL	GENE-N	6	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T10	T29	23403272
CPR:4	CHEMICAL	GENE-N	6	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T10	T30	23403272
CPR:3	CHEMICAL	GENE-N	6	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T10	T31	23403272
CPR:3	CHEMICAL	GENE-N	6	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T10	T32	23403272
NA	CHEMICAL	GENE-N	14	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T11	T29	23403272
NA	CHEMICAL	GENE-N	14	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T11	T30	23403272
NA	CHEMICAL	GENE-N	14	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T11	T31	23403272
NA	CHEMICAL	GENE-N	14	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T11	T32	23403272
NA	CHEMICAL	GENE-N	23	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T12	T29	23403272
NA	CHEMICAL	GENE-N	23	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T12	T30	23403272
NA	CHEMICAL	GENE-N	23	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T12	T31	23403272
NA	CHEMICAL	GENE-N	23	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T12	T32	23403272
NA	CHEMICAL	GENE-N	25	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T13	T29	23403272
NA	CHEMICAL	GENE-N	25	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T13	T30	23403272
NA	CHEMICAL	GENE-N	25	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T13	T31	23403272
NA	CHEMICAL	GENE-N	25	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T13	T32	23403272
NA	CHEMICAL	GENE-N	28	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T14	T29	23403272
NA	CHEMICAL	GENE-N	28	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T14	T30	23403272
NA	CHEMICAL	GENE-N	28	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T14	T31	23403272
NA	CHEMICAL	GENE-N	28	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T14	T32	23403272
NA	CHEMICAL	GENE-N	43	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T15	T29	23403272
NA	CHEMICAL	GENE-N	43	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T15	T30	23403272
NA	CHEMICAL	GENE-N	43	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T15	T31	23403272
NA	CHEMICAL	GENE-N	43	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T15	T32	23403272
NA	CHEMICAL	GENE-N	45	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T16	T29	23403272
NA	CHEMICAL	GENE-N	45	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T16	T30	23403272
NA	CHEMICAL	GENE-N	45	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T16	T31	23403272
NA	CHEMICAL	GENE-N	45	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T16	T32	23403272
NA	CHEMICAL	GENE-N	48	29	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T17	T29	23403272
NA	CHEMICAL	GENE-N	48	31	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T17	T30	23403272
NA	CHEMICAL	GENE-N	48	49	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T17	T31	23403272
NA	CHEMICAL	GENE-N	48	51	In particular , we showed that chemical significantly reduced the formation of intracellular reactive chemical species ( ROS ) , the level of chemical ( chemical ) and chemical dehydrogenase ( gene ) leakage , and enhanced production of the endogenous antioxidants , chemical ( chemical ) and chemical dismutase ( gene ) in EA.hy926 cells .	T17	T32	23403272
CPR:3	CHEMICAL	GENE-Y	5	8	Treatment of these cells with chemical significantly induced gene expression .	T18	T21	23403272
NA	CHEMICAL	GENE-Y	2	8	Moreover , chemical promoted the nuclear translocation of gene ( gene ) .	T1	T22	23403272
NA	CHEMICAL	GENE-Y	2	10	Moreover , chemical promoted the nuclear translocation of gene ( gene ) .	T1	T23	23403272
CPR:3	CHEMICAL	GENE-Y	1	2	The chemical-induced gene expression was abrogated by gene siRNA .	T2	T24	23403272
NA	CHEMICAL	GENE-Y	1	7	The chemical-induced gene expression was abrogated by gene siRNA .	T2	T25	23403272
CPR:4	CHEMICAL	GENE-Y	6	4	Furthermore , inhibition of gene with chemical ( chemical ) significantly reversed the protective effect of chemical against radiation-induced damage in EA.hy926 cells .	T3	T26	23403272
CPR:4	CHEMICAL	GENE-Y	8	4	Furthermore , inhibition of gene with chemical ( chemical ) significantly reversed the protective effect of chemical against radiation-induced damage in EA.hy926 cells .	T4	T26	23403272
CPR:3	CHEMICAL	GENE-Y	16	4	Furthermore , inhibition of gene with chemical ( chemical ) significantly reversed the protective effect of chemical against radiation-induced damage in EA.hy926 cells .	T5	T26	23403272
NA	CHEMICAL	GENE-Y	7	18	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T6	T33	16988497
NA	CHEMICAL	GENE-Y	7	20	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T6	T20	16988497
NA	CHEMICAL	GENE-Y	7	23	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T6	T23	16988497
NA	CHEMICAL	GENE-Y	7	25	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T6	T28	16988497
NA	CHEMICAL	GENE-Y	9	18	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T8	T33	16988497
NA	CHEMICAL	GENE-Y	9	20	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T8	T20	16988497
NA	CHEMICAL	GENE-Y	9	23	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T8	T23	16988497
NA	CHEMICAL	GENE-Y	9	25	AIM : To compare the composition of chemical ( chemical ) in diet , and the expression of gene ( gene ) and gene ( gene ) genes in peripheral blood mononuclear cells ( PBMCs ) between Chinese and Europeans .	T8	T28	16988497
NA	CHEMICAL	GENE-Y	25	19	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T14	T34	16988497
NA	CHEMICAL	GENE-Y	25	21	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T14	T35	16988497
CPR:4	CHEMICAL	GENE-Y	25	47	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T14	T18	16988497
CPR:4	CHEMICAL	GENE-Y	25	49	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T14	T19	16988497
NA	CHEMICAL	GENE-Y	0	19	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T15	T34	16988497
NA	CHEMICAL	GENE-Y	0	21	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T15	T35	16988497
CPR:4	CHEMICAL	GENE-Y	0	47	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T15	T18	16988497
CPR:4	CHEMICAL	GENE-Y	0	49	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T15	T19	16988497
NA	CHEMICAL	GENE-Y	25	19	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T16	T34	16988497
NA	CHEMICAL	GENE-Y	25	21	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T16	T35	16988497
CPR:4	CHEMICAL	GENE-Y	25	47	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T16	T18	16988497
CPR:4	CHEMICAL	GENE-Y	25	49	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T16	T19	16988497
NA	CHEMICAL	GENE-Y	0	19	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T17	T34	16988497
NA	CHEMICAL	GENE-Y	0	21	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T17	T35	16988497
CPR:4	CHEMICAL	GENE-Y	0	47	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T17	T18	16988497
CPR:4	CHEMICAL	GENE-Y	0	49	A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC gene and gene genes , but a significant negative correlation between dietary intake of chemical ( chemical ) and chemical ( chemical ) and the expression of PBMC gene and gene genes .	T17	T19	16988497
CPR:3	CHEMICAL	GENE-Y	5	14	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T1	T21	16988497
CPR:3	CHEMICAL	GENE-Y	5	16	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T1	T22	16988497
NA	CHEMICAL	GENE-Y	5	29	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T1	T24	16988497
NA	CHEMICAL	GENE-Y	5	31	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T1	T25	16988497
CPR:3	CHEMICAL	GENE-Y	7	14	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T2	T21	16988497
CPR:3	CHEMICAL	GENE-Y	7	16	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T2	T22	16988497
NA	CHEMICAL	GENE-Y	7	29	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T2	T24	16988497
NA	CHEMICAL	GENE-Y	7	31	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T2	T25	16988497
NA	CHEMICAL	GENE-Y	21	14	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T3	T21	16988497
NA	CHEMICAL	GENE-Y	21	16	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T3	T22	16988497
CPR:4	CHEMICAL	GENE-Y	21	29	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T3	T24	16988497
CPR:4	CHEMICAL	GENE-Y	21	31	CONCLUSION : Intake of high chemical and chemical appears to increase expression of PBMC gene and gene genes , whilst high chemical intake appears to decrease expression of PBMC gene and gene genes .	T3	T25	16988497
NA	CHEMICAL	GENE-Y	0	6	chemical is a bimodal modulator of gene channels .	T13	T28	23220749
NA	CHEMICAL	GENE-N	8	6	We wanted to test whether sensory gene are a molecular target for chemical .	T7	T18	23220749
NA	CHEMICAL	GENE-Y	25	5	Here , we show that gene , gene , gene , and gene , as well as gene , and gene , which are expressed in dorsal root ganglion neurons , are insensitive toward chemical treatment .	T9	T19	23220749
NA	CHEMICAL	GENE-Y	25	7	Here , we show that gene , gene , gene , and gene , as well as gene , and gene , which are expressed in dorsal root ganglion neurons , are insensitive toward chemical treatment .	T9	T20	23220749
NA	CHEMICAL	GENE-Y	25	9	Here , we show that gene , gene , gene , and gene , as well as gene , and gene , which are expressed in dorsal root ganglion neurons , are insensitive toward chemical treatment .	T9	T21	23220749
NA	CHEMICAL	GENE-Y	25	12	Here , we show that gene , gene , gene , and gene , as well as gene , and gene , which are expressed in dorsal root ganglion neurons , are insensitive toward chemical treatment .	T9	T22	23220749
NA	CHEMICAL	GENE-Y	25	17	Here , we show that gene , gene , gene , and gene , as well as gene , and gene , which are expressed in dorsal root ganglion neurons , are insensitive toward chemical treatment .	T9	T23	23220749
NA	CHEMICAL	GENE-Y	25	20	Here , we show that gene , gene , gene , and gene , as well as gene , and gene , which are expressed in dorsal root ganglion neurons , are insensitive toward chemical treatment .	T9	T24	23220749
NA	CHEMICAL	GENE-Y	10	4	On the contrary , gene could be concentration-dependently modulated by chemical .	T11	T26	23220749
CPR:4	CHEMICAL	GENE-Y	4	30	Whereas the addition of chemical in the low micromolar range produced an irreversible activation of the channel , application of higher concentrations caused a reversible voltage-dependent inhibition of heterologously expressed gene channels , resulting from a reduction of single-channel open times .	T12	T27	23220749
NA	CHEMICAL	GENE-N	7	12	In addition , we provide evidence that chemical also acts on endogenous gene in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1 , from which chemical is released upon activation of gene .	T2	T14	23220749
CPR:3	CHEMICAL	GENE-Y	7	38	In addition , we provide evidence that chemical also acts on endogenous gene in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1 , from which chemical is released upon activation of gene .	T2	T15	23220749
NA	CHEMICAL	GENE-N	10	12	In addition , we provide evidence that chemical also acts on endogenous gene in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1 , from which chemical is released upon activation of gene .	T3	T14	23220749
NA	CHEMICAL	GENE-Y	10	38	In addition , we provide evidence that chemical also acts on endogenous gene in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1 , from which chemical is released upon activation of gene .	T3	T15	23220749
NA	CHEMICAL	GENE-Y	15	0	gene receptor mutant mice consume more food , which leads to late-onset obesity and impaired chemical tolerance .	T3	T6	16973729
NA	CHEMICAL	GENE-Y	2	13	Administration of chemical and chemical , both of which induce anorexic effects via gene receptors and/or gene receptors , suppressed food intake in 5- and 8-wk-old Ay mice , whereas the anorexic effects were attenuated in food-restricted Ay mice .	T1	T7	16973729
NA	CHEMICAL	GENE-Y	2	16	Administration of chemical and chemical , both of which induce anorexic effects via gene receptors and/or gene receptors , suppressed food intake in 5- and 8-wk-old Ay mice , whereas the anorexic effects were attenuated in food-restricted Ay mice .	T1	T8	16973729
NA	CHEMICAL	GENE-Y	4	13	Administration of chemical and chemical , both of which induce anorexic effects via gene receptors and/or gene receptors , suppressed food intake in 5- and 8-wk-old Ay mice , whereas the anorexic effects were attenuated in food-restricted Ay mice .	T2	T7	16973729
NA	CHEMICAL	GENE-Y	4	16	Administration of chemical and chemical , both of which induce anorexic effects via gene receptors and/or gene receptors , suppressed food intake in 5- and 8-wk-old Ay mice , whereas the anorexic effects were attenuated in food-restricted Ay mice .	T2	T8	16973729
NA	CHEMICAL	GENE-Y	0	2	chemical D2 receptor activation leads to an up-regulation of gene via Gβγ-gene-dependent induction of gene .	T7	T34	23373701
NA	CHEMICAL	GENE-Y	0	5	chemical D2 receptor activation leads to an up-regulation of gene via Gβγ-gene-dependent induction of gene .	T7	T37	23373701
NA	CHEMICAL	GENE-N	0	11	chemical D2 receptor activation leads to an up-regulation of gene via Gβγ-gene-dependent induction of gene .	T7	T35	23373701
NA	CHEMICAL	GENE-Y	0	14	chemical D2 receptor activation leads to an up-regulation of gene via Gβγ-gene-dependent induction of gene .	T7	T36	23373701
NA	CHEMICAL	GENE-N	7	16	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T1	T23	23373701
NA	CHEMICAL	GENE-N	7	18	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T1	T25	23373701
NA	CHEMICAL	GENE-N	7	31	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T1	T26	23373701
NA	CHEMICAL	GENE-N	7	45	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T1	T27	23373701
NA	CHEMICAL	GENE-N	7	45	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T1	T28	23373701
CPR:5	CHEMICAL	GENE-N	16	16	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T2	T23	23373701
CPR:5	CHEMICAL	GENE-N	16	18	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T2	T25	23373701
CPR:3	CHEMICAL	GENE-N	16	31	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T2	T26	23373701
CPR:3	CHEMICAL	GENE-N	16	45	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T2	T27	23373701
CPR:3	CHEMICAL	GENE-N	16	45	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T2	T28	23373701
NA	CHEMICAL	GENE-N	27	16	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T3	T23	23373701
NA	CHEMICAL	GENE-N	27	18	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T3	T25	23373701
NA	CHEMICAL	GENE-N	27	31	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T3	T26	23373701
NA	CHEMICAL	GENE-N	27	45	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T3	T27	23373701
NA	CHEMICAL	GENE-N	27	45	We found that treatment of both differentiated chemicalrgic-like SH-SY5Y cells and rat midbrain slices with the gene ( gene ) agonist , chemical , triggered an increase in the expression of gene that was temporally preceded by an increase in the levels of chemical-finger protein 268 ( gene ) , a DNA-binding transcription factor encoded by an immediate-early gene .	T3	T28	23373701
CPR:4	CHEMICAL	GENE-Y	5	3	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T4	T29	23373701
CPR:4	CHEMICAL	GENE-Y	5	11	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T4	T30	23373701
CPR:4	CHEMICAL	GENE-Y	5	13	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T4	T31	23373701
NA	CHEMICAL	GENE-Y	16	3	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T5	T29	23373701
NA	CHEMICAL	GENE-Y	16	11	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T5	T30	23373701
NA	CHEMICAL	GENE-Y	16	13	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T5	T31	23373701
NA	CHEMICAL	GENE-Y	17	3	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T6	T29	23373701
NA	CHEMICAL	GENE-Y	17	11	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T6	T30	23373701
NA	CHEMICAL	GENE-Y	17	13	Moreover , the gene inhibitor chemical blocked the increase of both gene and gene expression following chemical-evoked chemical release in SH-SY5Y cells .	T6	T31	23373701
CPR:3	CHEMICAL	GENE-Y	0	2	chemical evokes gene activation in bovine aortic endothelial cell cultures .	T22	T44	10460702
NA	CHEMICAL	GENE-Y	11	2	Activation of gene ( gene ) results in the production of chemical ( chemical ) that mediates the vasorelaxing properties of endothelial cells .	T9	T32	10460702
NA	CHEMICAL	GENE-Y	11	4	Activation of gene ( gene ) results in the production of chemical ( chemical ) that mediates the vasorelaxing properties of endothelial cells .	T9	T38	10460702
CPR:9	CHEMICAL	GENE-Y	13	2	Activation of gene ( gene ) results in the production of chemical ( chemical ) that mediates the vasorelaxing properties of endothelial cells .	T20	T32	10460702
CPR:9	CHEMICAL	GENE-Y	13	4	Activation of gene ( gene ) results in the production of chemical ( chemical ) that mediates the vasorelaxing properties of endothelial cells .	T20	T38	10460702
NA	CHEMICAL	GENE-Y	11	16	The goal of this project was to address the possibility that chemical ( chemical ) stimulates gene activity in bovine aortic endothelial cell ( BAEC ) cultures .	T7	T35	10460702
NA	CHEMICAL	GENE-Y	13	16	The goal of this project was to address the possibility that chemical ( chemical ) stimulates gene activity in bovine aortic endothelial cell ( BAEC ) cultures .	T8	T35	10460702
NA	CHEMICAL	GENE-N	7	8	Here , we tested the hypothesis that chemical receptors mediate gene activation by measuring agonist-stimulated chemical ( chemical ) formation in BAEC cultures .	T10	T36	10460702
NA	CHEMICAL	GENE-Y	7	10	Here , we tested the hypothesis that chemical receptors mediate gene activation by measuring agonist-stimulated chemical ( chemical ) formation in BAEC cultures .	T10	T37	10460702
NA	CHEMICAL	GENE-N	15	8	Here , we tested the hypothesis that chemical receptors mediate gene activation by measuring agonist-stimulated chemical ( chemical ) formation in BAEC cultures .	T11	T36	10460702
CPR:9	CHEMICAL	GENE-Y	15	10	Here , we tested the hypothesis that chemical receptors mediate gene activation by measuring agonist-stimulated chemical ( chemical ) formation in BAEC cultures .	T11	T37	10460702
NA	CHEMICAL	GENE-N	17	8	Here , we tested the hypothesis that chemical receptors mediate gene activation by measuring agonist-stimulated chemical ( chemical ) formation in BAEC cultures .	T12	T36	10460702
CPR:9	CHEMICAL	GENE-Y	17	10	Here , we tested the hypothesis that chemical receptors mediate gene activation by measuring agonist-stimulated chemical ( chemical ) formation in BAEC cultures .	T12	T37	10460702
CPR:3	CHEMICAL	GENE-Y	3	16	We found that chemical stimulated the conversion of chemical ( chemical ) to chemical , indicating gene activation .	T13	T39	10460702
CPR:9	CHEMICAL	GENE-Y	8	16	We found that chemical stimulated the conversion of chemical ( chemical ) to chemical , indicating gene activation .	T14	T39	10460702
CPR:9	CHEMICAL	GENE-Y	10	16	We found that chemical stimulated the conversion of chemical ( chemical ) to chemical , indicating gene activation .	T15	T39	10460702
CPR:9	CHEMICAL	GENE-Y	13	16	We found that chemical stimulated the conversion of chemical ( chemical ) to chemical , indicating gene activation .	T16	T39	10460702
CPR:5	CHEMICAL	GENE-Y	7	3	The high affinity gene receptor agonist , chemical ( 5-NOT ) -stimulated chemical turnover responses were concentration- ( 0.01 nM to 100 microM ) and time-dependent .	T17	T40	10460702
NA	CHEMICAL	GENE-Y	12	3	The high affinity gene receptor agonist , chemical ( 5-NOT ) -stimulated chemical turnover responses were concentration- ( 0.01 nM to 100 microM ) and time-dependent .	T18	T40	10460702
NA	CHEMICAL	GENE-Y	6	7	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T21	T41	10460702
CPR:6	CHEMICAL	GENE-Y	6	14	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T21	T42	10460702
CPR:6	CHEMICAL	GENE-N	6	8	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T21	T43	10460702
NA	CHEMICAL	GENE-Y	6	21	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T21	T24	10460702
NA	CHEMICAL	GENE-Y	29	7	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T1	T41	10460702
NA	CHEMICAL	GENE-Y	29	14	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T1	T42	10460702
NA	CHEMICAL	GENE-N	29	8	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T1	T43	10460702
CPR:6	CHEMICAL	GENE-Y	29	21	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T1	T24	10460702
NA	CHEMICAL	GENE-Y	17	7	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T2	T41	10460702
NA	CHEMICAL	GENE-Y	17	14	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T2	T42	10460702
NA	CHEMICAL	GENE-N	17	8	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T2	T43	10460702
CPR:6	CHEMICAL	GENE-Y	17	21	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T2	T24	10460702
NA	CHEMICAL	GENE-Y	34	7	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T3	T41	10460702
NA	CHEMICAL	GENE-Y	34	14	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T3	T42	10460702
NA	CHEMICAL	GENE-N	34	8	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T3	T43	10460702
CPR:6	CHEMICAL	GENE-Y	34	21	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T3	T24	10460702
NA	CHEMICAL	GENE-Y	7	7	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T4	T41	10460702
NA	CHEMICAL	GENE-Y	7	14	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T4	T42	10460702
NA	CHEMICAL	GENE-N	7	8	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T4	T43	10460702
CPR:6	CHEMICAL	GENE-Y	7	21	These responses were effectively blocked by the gene receptor antagonist , isamoltane , the gene/gene antagonist , chemical , and the gene selective antagonists ( 0.01-10 microM ) : chemical ( chemical ) and chemical ( chemical ) .	T4	T24	10460702
NA	CHEMICAL	GENE-Y	19	6	These findings lend evidence of a gene receptor/gene pathway , accounting in part for the activation of gene by chemical .	T5	T29	10460702
NA	CHEMICAL	GENE-Y	19	7	These findings lend evidence of a gene receptor/gene pathway , accounting in part for the activation of gene by chemical .	T5	T30	10460702
CPR:3	CHEMICAL	GENE-Y	19	17	These findings lend evidence of a gene receptor/gene pathway , accounting in part for the activation of gene by chemical .	T5	T31	10460702
NA	CHEMICAL	GENE-N	3	6	Protective Role of chemical Bioactivated with gene in an Experimental Model of Multiple Sclerosis .	T7	T18	23638842
CPR:9	CHEMICAL	GENE-N	18	18	Recent literature shows that Brassica vegetables ( Cruciferae ) possess therapeutic effects particularly ascribed due to their content in chemical , which upon gene hydrolysis release the corresponding chemical .	T3	T14	23638842
CPR:9	CHEMICAL	GENE-N	28	18	Recent literature shows that Brassica vegetables ( Cruciferae ) possess therapeutic effects particularly ascribed due to their content in chemical , which upon gene hydrolysis release the corresponding chemical .	T4	T14	23638842
NA	CHEMICAL	GENE-N	8	5	acephala sabellica ) bioactivated with gene ( bioactive chemical ) ( 10 mg/kg/day intraperitoneally ) , in an experimental autoimmune encephalomyelitis ( EAE ) , a model of multiple sclerosis .	T6	T15	23638842
CPR:4	CHEMICAL	GENE-N	18	21	RESULTS : By Western blot analysis of spinal cord tissues , we have demonstrated that treatment with bioactive chemical significantly decreased gene translocation , pro-inflammatory gene production such as gene ( gene ) , and apoptosis ( gene and gene expression ) .	T1	T8	23638842
CPR:4	CHEMICAL	GENE-N	18	25	RESULTS : By Western blot analysis of spinal cord tissues , we have demonstrated that treatment with bioactive chemical significantly decreased gene translocation , pro-inflammatory gene production such as gene ( gene ) , and apoptosis ( gene and gene expression ) .	T1	T9	23638842
CPR:4	CHEMICAL	GENE-Y	18	29	RESULTS : By Western blot analysis of spinal cord tissues , we have demonstrated that treatment with bioactive chemical significantly decreased gene translocation , pro-inflammatory gene production such as gene ( gene ) , and apoptosis ( gene and gene expression ) .	T1	T10	23638842
CPR:4	CHEMICAL	GENE-Y	18	31	RESULTS : By Western blot analysis of spinal cord tissues , we have demonstrated that treatment with bioactive chemical significantly decreased gene translocation , pro-inflammatory gene production such as gene ( gene ) , and apoptosis ( gene and gene expression ) .	T1	T11	23638842
CPR:4	CHEMICAL	GENE-Y	18	37	RESULTS : By Western blot analysis of spinal cord tissues , we have demonstrated that treatment with bioactive chemical significantly decreased gene translocation , pro-inflammatory gene production such as gene ( gene ) , and apoptosis ( gene and gene expression ) .	T1	T12	23638842
CPR:4	CHEMICAL	GENE-Y	18	39	RESULTS : By Western blot analysis of spinal cord tissues , we have demonstrated that treatment with bioactive chemical significantly decreased gene translocation , pro-inflammatory gene production such as gene ( gene ) , and apoptosis ( gene and gene expression ) .	T1	T13	23638842
NA	CHEMICAL	GENE-N	5	1	The gene gene polymorphism and chemical effects on plasma-gene activity .	T10	T28	16325050
NA	CHEMICAL	GENE-Y	5	2	The gene gene polymorphism and chemical effects on plasma-gene activity .	T10	T27	16325050
NA	CHEMICAL	GENE-Y	5	8	The gene gene polymorphism and chemical effects on plasma-gene activity .	T10	T29	16325050
NA	CHEMICAL	GENE-Y	13	13	OBJECTIVES : The purpose of this research was to find out whether , in humans , chemical-induced hemodynamic effects and increase in plasma-gene activity ( PRA ) might be gene ( gene ) genotype-dependent .	T6	T14	16325050
NA	CHEMICAL	GENE-Y	13	8	OBJECTIVES : The purpose of this research was to find out whether , in humans , chemical-induced hemodynamic effects and increase in plasma-gene activity ( PRA ) might be gene ( gene ) genotype-dependent .	T6	T17	16325050
NA	CHEMICAL	GENE-Y	13	28	OBJECTIVES : The purpose of this research was to find out whether , in humans , chemical-induced hemodynamic effects and increase in plasma-gene activity ( PRA ) might be gene ( gene ) genotype-dependent .	T6	T18	16325050
NA	CHEMICAL	GENE-Y	7	13	RESULTS : With regard to PRA , chemical increased PRA more potently in Arg389-gene versus Gly389-gene subjects .	T5	T24	16325050
NA	CHEMICAL	GENE-Y	7	15	RESULTS : With regard to PRA , chemical increased PRA more potently in Arg389-gene versus Gly389-gene subjects .	T5	T25	16325050
NA	CHEMICAL	GENE-Y	0	13	chemical markedly suppressed the chemical-induced PRA increase in Arg389- but only marginally in Gly389-gene subjects .	T7	T26	16325050
NA	CHEMICAL	GENE-Y	4	13	chemical markedly suppressed the chemical-induced PRA increase in Arg389- but only marginally in Gly389-gene subjects .	T8	T26	16325050
NA	CHEMICAL	GENE-Y	5	21	With regard to hemodynamics , chemical caused larger heart rate and contractility increases and diastolic blood pressure decreases in Arg389- versus Gly389-gene subjects .	T9	T11	16325050
NA	CHEMICAL	GENE-Y	0	18	chemical reduced chemical-induced heart rate and contractility increases and diastolic blood pressure decreases more potently in Arg389- versus Gly389-gene subjects .	T1	T12	16325050
NA	CHEMICAL	GENE-Y	2	18	chemical reduced chemical-induced heart rate and contractility increases and diastolic blood pressure decreases more potently in Arg389- versus Gly389-gene subjects .	T2	T12	16325050
CPR:6	CHEMICAL	GENE-Y	3	0	gene antagonism by chemical lowers heart rate variability and baroreflex gain .	T12	T24	12927226
NA	CHEMICAL	GENE-Y	5	5	INTRODUCTION : Blockade of the gene-chemical system ( RAS ) by gene inhibitors has been demonstrated to reduce total mortality in cardiovascular diseases .	T7	T19	12927226
NA	CHEMICAL	GENE-Y	5	20	INTRODUCTION : Blockade of the gene-chemical system ( RAS ) by gene inhibitors has been demonstrated to reduce total mortality in cardiovascular diseases .	T7	T20	12927226
NA	CHEMICAL	GENE-Y	5	11	INTRODUCTION : Blockade of the gene-chemical system ( RAS ) by gene inhibitors has been demonstrated to reduce total mortality in cardiovascular diseases .	T7	T22	12927226
NA	CHEMICAL	GENE-Y	8	2	We sought to assess the effects of the chemical type 1 ( AT1 ) receptor blocker chemical on HRV and BRG .	T8	T21	12927226
CPR:4	CHEMICAL	GENE-Y	16	2	We sought to assess the effects of the chemical type 1 ( AT1 ) receptor blocker chemical on HRV and BRG .	T9	T21	12927226
CPR:3	CHEMICAL	GENE-Y	2	27	RESULTS : chemical tended to lower mean AP , it slightly increased heart rate ( HR ) ( p < 0.05 ) , and markedly increased circulating gene levels ( p < 0.01 ) .	T11	T13	12927226
NA	CHEMICAL	GENE-Y	2	27	RESULTS : chemical tended to lower mean AP , it slightly increased heart rate ( HR ) ( p < 0.05 ) , and markedly increased circulating gene levels ( p < 0.01 ) .	T1	T13	12927226
CPR:6	CHEMICAL	GENE-Y	5	2	CONCLUSIONS : gene antagonism by chemical lowers heart rate variability and baroreflex gain .	T3	T14	12927226
NA	CHEMICAL	GENE-Y	6	2	Support for gene receptor functional selectivity in vivo utilizing structurally diverse , selective gene receptor ligands and the chemical elicited head-twitch response model .	T24	T49	23353901
NA	CHEMICAL	GENE-Y	6	13	Support for gene receptor functional selectivity in vivo utilizing structurally diverse , selective gene receptor ligands and the chemical elicited head-twitch response model .	T24	T48	23353901
NA	CHEMICAL	GENE-Y	5	16	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T17	T46	23353901
NA	CHEMICAL	GENE-N	5	30	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T17	T32	23353901
NA	CHEMICAL	GENE-Y	14	16	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T20	T46	23353901
NA	CHEMICAL	GENE-N	14	30	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T20	T32	23353901
NA	CHEMICAL	GENE-Y	5	16	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T9	T46	23353901
NA	CHEMICAL	GENE-N	5	30	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T9	T32	23353901
NA	CHEMICAL	GENE-Y	34	16	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T10	T46	23353901
NA	CHEMICAL	GENE-N	34	30	There are seemingly conflicting data in the literature regarding the role of chemical ( chemical ) gene receptors in the mouse head-twitch response ( HTR ) elicited by the hallucinogenic gene agonist chemical ( chemical ) .	T10	T32	23353901
NA	CHEMICAL	GENE-Y	16	10	The present experiments tested the hypothesis that both classes of gene receptor compounds could attenuate the chemical-elicited-HTR in a single strain of mice , C57Bl/6J .	T11	T40	23353901
CPR:5	CHEMICAL	GENE-Y	4	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T12	T41	23353901
NA	CHEMICAL	GENE-Y	4	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T12	T42	23353901
NA	CHEMICAL	GENE-N	4	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T12	T43	23353901
NA	CHEMICAL	GENE-Y	4	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T12	T44	23353901
NA	CHEMICAL	GENE-Y	4	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T12	T45	23353901
NA	CHEMICAL	GENE-N	4	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T12	T47	23353901
CPR:5	CHEMICAL	GENE-Y	6	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T13	T41	23353901
NA	CHEMICAL	GENE-Y	6	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T13	T42	23353901
NA	CHEMICAL	GENE-N	6	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T13	T43	23353901
NA	CHEMICAL	GENE-Y	6	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T13	T44	23353901
NA	CHEMICAL	GENE-Y	6	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T13	T45	23353901
NA	CHEMICAL	GENE-N	6	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T13	T47	23353901
CPR:5	CHEMICAL	GENE-Y	8	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T14	T41	23353901
NA	CHEMICAL	GENE-Y	8	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T14	T42	23353901
NA	CHEMICAL	GENE-N	8	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T14	T43	23353901
NA	CHEMICAL	GENE-Y	8	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T14	T44	23353901
NA	CHEMICAL	GENE-Y	8	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T14	T45	23353901
NA	CHEMICAL	GENE-N	8	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T14	T47	23353901
CPR:5	CHEMICAL	GENE-Y	10	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T15	T41	23353901
NA	CHEMICAL	GENE-Y	10	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T15	T42	23353901
NA	CHEMICAL	GENE-N	10	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T15	T43	23353901
NA	CHEMICAL	GENE-Y	10	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T15	T44	23353901
NA	CHEMICAL	GENE-Y	10	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T15	T45	23353901
NA	CHEMICAL	GENE-N	10	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T15	T47	23353901
CPR:5	CHEMICAL	GENE-Y	13	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T16	T41	23353901
NA	CHEMICAL	GENE-Y	13	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T16	T42	23353901
NA	CHEMICAL	GENE-N	13	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T16	T43	23353901
NA	CHEMICAL	GENE-Y	13	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T16	T44	23353901
NA	CHEMICAL	GENE-Y	13	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T16	T45	23353901
NA	CHEMICAL	GENE-N	13	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T16	T47	23353901
NA	CHEMICAL	GENE-Y	5	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T18	T41	23353901
CPR:5	CHEMICAL	GENE-Y	5	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T18	T42	23353901
NA	CHEMICAL	GENE-N	5	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T18	T43	23353901
NA	CHEMICAL	GENE-Y	5	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T18	T44	23353901
NA	CHEMICAL	GENE-Y	5	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T18	T45	23353901
NA	CHEMICAL	GENE-N	5	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T18	T47	23353901
NA	CHEMICAL	GENE-Y	19	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T19	T41	23353901
CPR:5	CHEMICAL	GENE-Y	19	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T19	T42	23353901
NA	CHEMICAL	GENE-N	19	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T19	T43	23353901
NA	CHEMICAL	GENE-Y	19	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T19	T44	23353901
NA	CHEMICAL	GENE-Y	19	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T19	T45	23353901
NA	CHEMICAL	GENE-N	19	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T19	T47	23353901
NA	CHEMICAL	GENE-Y	37	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T21	T41	23353901
NA	CHEMICAL	GENE-Y	37	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T21	T42	23353901
NA	CHEMICAL	GENE-N	37	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T21	T43	23353901
CPR:6	CHEMICAL	GENE-Y	37	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T21	T44	23353901
NA	CHEMICAL	GENE-Y	37	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T21	T45	23353901
NA	CHEMICAL	GENE-N	37	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T21	T47	23353901
NA	CHEMICAL	GENE-Y	42	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T22	T41	23353901
NA	CHEMICAL	GENE-Y	42	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T22	T42	23353901
NA	CHEMICAL	GENE-N	42	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T22	T43	23353901
NA	CHEMICAL	GENE-Y	42	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T22	T44	23353901
CPR:6	CHEMICAL	GENE-Y	42	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T22	T45	23353901
NA	CHEMICAL	GENE-N	42	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T22	T47	23353901
NA	CHEMICAL	GENE-Y	48	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T23	T41	23353901
NA	CHEMICAL	GENE-Y	48	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T23	T42	23353901
NA	CHEMICAL	GENE-N	48	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T23	T43	23353901
NA	CHEMICAL	GENE-Y	48	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T23	T44	23353901
NA	CHEMICAL	GENE-Y	48	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T23	T45	23353901
NA	CHEMICAL	GENE-N	48	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T23	T47	23353901
NA	CHEMICAL	GENE-Y	4	1	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T1	T41	23353901
NA	CHEMICAL	GENE-Y	4	22	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T1	T42	23353901
NA	CHEMICAL	GENE-N	4	26	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T1	T43	23353901
NA	CHEMICAL	GENE-Y	4	35	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T1	T44	23353901
NA	CHEMICAL	GENE-Y	4	40	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T1	T45	23353901
NA	CHEMICAL	GENE-N	4	46	Commercially-available gene agonists ( chemical , chemical , chemical , chemical , and chemical ) , novel chemical ( chemical ) -type gene agonists ( with gene antagonist activity ) , and antagonists selective for gene ( chemical ) , gene ( chemical ) , and gene ( chemical ) receptors attenuated the chemical-elicited-HTR .	T1	T47	23353901
NA	CHEMICAL	GENE-Y	1	1	The gene agonists and chemical decreased locomotion , chemical increased locomotion , chemical resulted in dose-dependent biphasic effects on locomotion , and the PATs did not alter locomotion .	T2	T25	23353901
NA	CHEMICAL	GENE-Y	8	1	The gene agonists and chemical decreased locomotion , chemical increased locomotion , chemical resulted in dose-dependent biphasic effects on locomotion , and the PATs did not alter locomotion .	T3	T25	23353901
NA	CHEMICAL	GENE-Y	12	1	The gene agonists and chemical decreased locomotion , chemical increased locomotion , chemical resulted in dose-dependent biphasic effects on locomotion , and the PATs did not alter locomotion .	T4	T25	23353901
NA	CHEMICAL	GENE-Y	13	7	In vitro molecular pharmacology studies showed that gene agonists potent for attenuating the chemical-elicited-HTR also reduced the efficacy of chemical to activate gene receptor-mediated gene signaling in HEK cells .	T5	T26	23353901
NA	CHEMICAL	GENE-Y	13	22	In vitro molecular pharmacology studies showed that gene agonists potent for attenuating the chemical-elicited-HTR also reduced the efficacy of chemical to activate gene receptor-mediated gene signaling in HEK cells .	T5	T27	23353901
NA	CHEMICAL	GENE-N	13	24	In vitro molecular pharmacology studies showed that gene agonists potent for attenuating the chemical-elicited-HTR also reduced the efficacy of chemical to activate gene receptor-mediated gene signaling in HEK cells .	T5	T28	23353901
NA	CHEMICAL	GENE-Y	19	7	In vitro molecular pharmacology studies showed that gene agonists potent for attenuating the chemical-elicited-HTR also reduced the efficacy of chemical to activate gene receptor-mediated gene signaling in HEK cells .	T6	T26	23353901
CPR:3	CHEMICAL	GENE-Y	19	22	In vitro molecular pharmacology studies showed that gene agonists potent for attenuating the chemical-elicited-HTR also reduced the efficacy of chemical to activate gene receptor-mediated gene signaling in HEK cells .	T6	T27	23353901
NA	CHEMICAL	GENE-N	19	24	In vitro molecular pharmacology studies showed that gene agonists potent for attenuating the chemical-elicited-HTR also reduced the efficacy of chemical to activate gene receptor-mediated gene signaling in HEK cells .	T6	T28	23353901
NA	CHEMICAL	GENE-Y	5	0	gene mediated hemodynamic profile of chemical .	T5	T7	20496522
CPR:4	CHEMICAL	GENE-Y	12	14	To further investigate this positive correlation and its possible therapeutic implications , a selective gene inhibitor , chemical , was tested on three variants of HT-29 colon cancer cell lines , HT-29/Inv1 , HT-29/Inv2 and HT-29/Inv3 , with graded increases of in vitro Matrigel invasive potential and gene expression levels .	T2	T10	12824918
NA	CHEMICAL	GENE-Y	12	47	To further investigate this positive correlation and its possible therapeutic implications , a selective gene inhibitor , chemical , was tested on three variants of HT-29 colon cancer cell lines , HT-29/Inv1 , HT-29/Inv2 and HT-29/Inv3 , with graded increases of in vitro Matrigel invasive potential and gene expression levels .	T2	T11	12824918
NA	CHEMICAL	GENE-Y	4	6	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T21	17333241
NA	CHEMICAL	GENE-Y	4	8	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T22	17333241
NA	CHEMICAL	GENE-Y	4	10	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T23	17333241
NA	CHEMICAL	GENE-Y	4	12	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T24	17333241
NA	CHEMICAL	GENE-Y	4	14	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T25	17333241
NA	CHEMICAL	GENE-Y	4	18	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T15	17333241
NA	CHEMICAL	GENE-Y	4	20	Genotyping of the single chemical polymorphisms gene-129 , gene-588 , gene-52 , gene-105 and gene-114 and deletions of gene and gene were performed with real-time PCR or ordinary PCR and subsequent agarose electrophoresis .	T11	T16	17333241
NA	CHEMICAL	GENE-Y	14	5	Furthermore , with respect to gene and gene there were statistically significant differences in chemical-levels between genotypes among exposed workers but not among controls .	T2	T17	17333241
NA	CHEMICAL	GENE-Y	14	7	Furthermore , with respect to gene and gene there were statistically significant differences in chemical-levels between genotypes among exposed workers but not among controls .	T2	T18	17333241
NA	CHEMICAL	GENE-Y	5	8	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T6	T16	23537661
NA	CHEMICAL	GENE-Y	5	10	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T6	T17	23537661
NA	CHEMICAL	GENE-Y	5	25	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T6	T9	23537661
CPR:5	CHEMICAL	GENE-Y	14	8	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T7	T16	23537661
NA	CHEMICAL	GENE-Y	14	10	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T7	T17	23537661
NA	CHEMICAL	GENE-Y	14	25	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T7	T9	23537661
CPR:5	CHEMICAL	GENE-Y	16	8	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T8	T16	23537661
NA	CHEMICAL	GENE-Y	16	10	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T8	T17	23537661
NA	CHEMICAL	GENE-Y	16	25	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T8	T9	23537661
CPR:5	CHEMICAL	GENE-Y	4	8	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T1	T16	23537661
NA	CHEMICAL	GENE-Y	4	10	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T1	T17	23537661
NA	CHEMICAL	GENE-Y	4	25	Other dams received 1.8ng/kg/day of a mixture of gene ( gene ) agonists ( chemicals , chemical and chemical ) without or with 0.5M ( 0.5Mgene ) .	T1	T9	23537661
NA	CHEMICAL	GENE-N	12	6	In vitro studies demonstrated that the gene ( gene ) retinoid , chemical , at biologically relevant concentrations of 10 ( -6 ) M to 10 ( -8 ) M , upregulated both the gene and gene subunits of the gene and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox .	T4	T19	15811959
NA	CHEMICAL	GENE-N	12	8	In vitro studies demonstrated that the gene ( gene ) retinoid , chemical , at biologically relevant concentrations of 10 ( -6 ) M to 10 ( -8 ) M , upregulated both the gene and gene subunits of the gene and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox .	T4	T20	15811959
CPR:3	CHEMICAL	GENE-Y	12	34	In vitro studies demonstrated that the gene ( gene ) retinoid , chemical , at biologically relevant concentrations of 10 ( -6 ) M to 10 ( -8 ) M , upregulated both the gene and gene subunits of the gene and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox .	T4	T21	15811959
CPR:3	CHEMICAL	GENE-Y	12	36	In vitro studies demonstrated that the gene ( gene ) retinoid , chemical , at biologically relevant concentrations of 10 ( -6 ) M to 10 ( -8 ) M , upregulated both the gene and gene subunits of the gene and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox .	T4	T22	15811959
CPR:3	CHEMICAL	GENE-N	12	40	In vitro studies demonstrated that the gene ( gene ) retinoid , chemical , at biologically relevant concentrations of 10 ( -6 ) M to 10 ( -8 ) M , upregulated both the gene and gene subunits of the gene and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox .	T4	T23	15811959
NA	CHEMICAL	GENE-N	9	2	Modulation of gene expression was observed at or above a chemical dose of 150 mg/day .	T1	T7	15811959
CPR:9	CHEMICAL	GENE-Y	7	1	Although gene ( gene ) is primarily a hydrolytic enzyme , metabolising the neurotransmitter chemical in cholinergic synapses , it also has some non-catalytic functions in the brain which are far less well characterised .	T1	T36	23047022
CPR:9	CHEMICAL	GENE-Y	7	3	Although gene ( gene ) is primarily a hydrolytic enzyme , metabolising the neurotransmitter chemical in cholinergic synapses , it also has some non-catalytic functions in the brain which are far less well characterised .	T1	T24	23047022
NA	CHEMICAL	GENE-Y	10	1	Since gene does not possess a gene , its anchorage in the membrane is established via the chemical Rich Membrane Anchor ( gene ) , a transmembrane protein .	T11	T27	23047022
NA	CHEMICAL	GENE-N	10	5	Since gene does not possess a gene , its anchorage in the membrane is established via the chemical Rich Membrane Anchor ( gene ) , a transmembrane protein .	T11	T28	23047022
NA	CHEMICAL	GENE-Y	10	20	Since gene does not possess a gene , its anchorage in the membrane is established via the chemical Rich Membrane Anchor ( gene ) , a transmembrane protein .	T11	T29	23047022
NA	CHEMICAL	GENE-Y	10	22	Since gene does not possess a gene , its anchorage in the membrane is established via the chemical Rich Membrane Anchor ( gene ) , a transmembrane protein .	T11	T30	23047022
NA	CHEMICAL	GENE-Y	31	9	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T2	T12	23047022
NA	CHEMICAL	GENE-N	31	37	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T2	T13	23047022
NA	CHEMICAL	GENE-N	31	22	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T2	T14	23047022
NA	CHEMICAL	GENE-Y	33	9	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T3	T12	23047022
NA	CHEMICAL	GENE-N	33	37	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T3	T13	23047022
NA	CHEMICAL	GENE-N	33	22	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T3	T14	23047022
NA	CHEMICAL	GENE-Y	36	9	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T4	T12	23047022
NA	CHEMICAL	GENE-N	36	37	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T4	T13	23047022
NA	CHEMICAL	GENE-N	36	22	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T4	T14	23047022
NA	CHEMICAL	GENE-Y	46	9	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T5	T12	23047022
NA	CHEMICAL	GENE-N	46	37	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T5	T13	23047022
NA	CHEMICAL	GENE-N	46	22	In an effort to understand the shedding process of gene , we have used several pharmacological treatments , which showed that it is likely to be mediated in part by an chemical- and chemical-sensitive , but chemical-insensitive gene , with the possible additional involvement of a chemical isomerase .	T5	T14	23047022
CPR:3	CHEMICAL	GENE-Y	16	3	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T7	T15	23047022
CPR:5	CHEMICAL	GENE-N	16	11	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T7	T16	23047022
CPR:5	CHEMICAL	GENE-N	16	13	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T7	T17	23047022
NA	CHEMICAL	GENE-N	16	28	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T7	T18	23047022
CPR:3	CHEMICAL	GENE-Y	18	3	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T8	T15	23047022
CPR:5	CHEMICAL	GENE-N	18	11	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T8	T16	23047022
CPR:5	CHEMICAL	GENE-N	18	13	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T8	T17	23047022
NA	CHEMICAL	GENE-N	18	28	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T8	T18	23047022
CPR:3	CHEMICAL	GENE-Y	24	3	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T9	T15	23047022
NA	CHEMICAL	GENE-N	24	11	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T9	T16	23047022
NA	CHEMICAL	GENE-N	24	13	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T9	T17	23047022
NA	CHEMICAL	GENE-N	24	28	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T9	T18	23047022
CPR:4	CHEMICAL	GENE-Y	30	3	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T10	T15	23047022
NA	CHEMICAL	GENE-N	30	11	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T10	T16	23047022
NA	CHEMICAL	GENE-N	30	13	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T10	T17	23047022
CPR:6	CHEMICAL	GENE-N	30	28	Cellular release of gene by SH-SY5Y is significantly enhanced by the gene ( gene ) agonists chemical or chemical , with the effect of chemical blocked by the gene antagonist chemical .	T10	T18	23047022
NA	CHEMICAL	GENE-Y	17	19	OBJECTIVE : To assess whether hormonal agents used in the medical treatment of endometriosis , such as chemical and gene agonist , exert direct regulatory action on gene ( gene ) expression by endometrial epithelial cells .	T1	T8	11056242
NA	CHEMICAL	GENE-Y	17	8	OBJECTIVE : To assess whether hormonal agents used in the medical treatment of endometriosis , such as chemical and gene agonist , exert direct regulatory action on gene ( gene ) expression by endometrial epithelial cells .	T1	T10	11056242
NA	CHEMICAL	GENE-Y	17	29	OBJECTIVE : To assess whether hormonal agents used in the medical treatment of endometriosis , such as chemical and gene agonist , exert direct regulatory action on gene ( gene ) expression by endometrial epithelial cells .	T1	T11	11056242
NA	CHEMICAL	GENE-N	19	13	DESIGN : Primary cultures of epithelial cells isolated from human endometrium were exposed to different concentrations of gene and chemical hormone analogs .	T5	T12	11056242
NA	CHEMICAL	GENE-Y	2	0	gene is a well known gene blocker and has been shown to affect presynaptic chemical currents as well postsynaptic potentials .	T4	T5	23523780
NA	CHEMICAL	GENE-N	2	2	gene is a well known gene blocker and has been shown to affect presynaptic chemical currents as well postsynaptic potentials .	T4	T10	23523780
NA	CHEMICAL	GENE-Y	2	0	gene is a well known gene blocker and has been shown to affect presynaptic chemical currents as well postsynaptic potentials .	T1	T5	23523780
NA	CHEMICAL	GENE-N	2	2	gene is a well known gene blocker and has been shown to affect presynaptic chemical currents as well postsynaptic potentials .	T1	T10	23523780
NA	CHEMICAL	GENE-N	2	0	gene play a vital role in presynaptic neurotransmitter release and thus play a role in action potential generation .	T3	T9	23523780
CPR:4	CHEMICAL	GENE-N	2	5	Administration of chemical , a gene inhibitor , isolated a single response to gene , which was characterized by a reduction in network activity .	T2	T6	23523780
CPR:4	CHEMICAL	GENE-N	2	4	Administration of chemical , a gene inhibitor , isolated a single response to gene , which was characterized by a reduction in network activity .	T2	T7	23523780
NA	CHEMICAL	GENE-Y	20	6	There was inconsistent stereological evidence of a loss of DA neurons , as identified by chromogenic or fluorescent-tagged antibodies to chemical hydroxylase in the substantia nigra pars compacta ( SNpc ) .	T14	T22	23523781
NA	CHEMICAL	GENE-Y	28	9	There was no evidence that PQ induced neuronal degeneration in the SNpc or degenerating neuronal processes in the striatum , as indicated by the absence of uptake of chemical stain or reduced immunolabeling of chemical-hydroxylase-positive ( gene ( + ) ) neurons .	T15	T23	23523781
NA	CHEMICAL	GENE-Y	28	36	There was no evidence that PQ induced neuronal degeneration in the SNpc or degenerating neuronal processes in the striatum , as indicated by the absence of uptake of chemical stain or reduced immunolabeling of chemical-hydroxylase-positive ( gene ( + ) ) neurons .	T15	T24	23523781
NA	CHEMICAL	GENE-Y	9	9	There was no evidence that PQ induced neuronal degeneration in the SNpc or degenerating neuronal processes in the striatum , as indicated by the absence of uptake of chemical stain or reduced immunolabeling of chemical-hydroxylase-positive ( gene ( + ) ) neurons .	T16	T23	23523781
NA	CHEMICAL	GENE-Y	9	36	There was no evidence that PQ induced neuronal degeneration in the SNpc or degenerating neuronal processes in the striatum , as indicated by the absence of uptake of chemical stain or reduced immunolabeling of chemical-hydroxylase-positive ( gene ( + ) ) neurons .	T16	T24	23523781
CPR:3	CHEMICAL	GENE-N	0	5	chemical and chemical also increased gene activity by about 150 and 240 % and demonstrated mineralization up to 110 and 200 % respectively as compared to control ( which was considered as 100 % ) .	T15	T24	23570998
CPR:3	CHEMICAL	GENE-N	2	5	chemical and chemical also increased gene activity by about 150 and 240 % and demonstrated mineralization up to 110 and 200 % respectively as compared to control ( which was considered as 100 % ) .	T16	T24	23570998
CPR:3	CHEMICAL	GENE-Y	4	23	Further , both the chemical were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like gene , gene , gene , gene and gene .	T17	T19	23570998
CPR:3	CHEMICAL	GENE-Y	4	25	Further , both the chemical were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like gene , gene , gene , gene and gene .	T17	T20	23570998
CPR:3	CHEMICAL	GENE-Y	4	27	Further , both the chemical were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like gene , gene , gene , gene and gene .	T17	T21	23570998
CPR:3	CHEMICAL	GENE-Y	4	29	Further , both the chemical were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like gene , gene , gene , gene and gene .	T17	T22	23570998
CPR:3	CHEMICAL	GENE-Y	4	31	Further , both the chemical were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like gene , gene , gene , gene and gene .	T17	T23	23570998
NA	CHEMICAL	GENE-Y	12	0	gene regulation , an enzyme-enzyme activity control : identification of residues of chemical carbamoyltransferase and gene responsible for enzyme catalytic and regulatory activities .	T20	T32	12679340
NA	CHEMICAL	GENE-Y	12	3	gene regulation , an enzyme-enzyme activity control : identification of residues of chemical carbamoyltransferase and gene responsible for enzyme catalytic and regulatory activities .	T20	T34	12679340
NA	CHEMICAL	GENE-Y	12	15	gene regulation , an enzyme-enzyme activity control : identification of residues of chemical carbamoyltransferase and gene responsible for enzyme catalytic and regulatory activities .	T20	T33	12679340
NA	CHEMICAL	GENE-Y	4	9	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T3	T25	12679340
NA	CHEMICAL	GENE-Y	4	11	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T3	T29	12679340
NA	CHEMICAL	GENE-Y	4	14	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T3	T30	12679340
NA	CHEMICAL	GENE-Y	4	16	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T3	T23	12679340
NA	CHEMICAL	GENE-Y	4	16	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T3	T24	12679340
NA	CHEMICAL	GENE-Y	6	9	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T4	T25	12679340
NA	CHEMICAL	GENE-Y	6	11	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T4	T29	12679340
NA	CHEMICAL	GENE-Y	6	14	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T4	T30	12679340
NA	CHEMICAL	GENE-Y	6	16	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T4	T23	12679340
NA	CHEMICAL	GENE-Y	6	16	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T4	T24	12679340
NA	CHEMICAL	GENE-Y	8	9	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T5	T25	12679340
NA	CHEMICAL	GENE-Y	8	11	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T5	T29	12679340
NA	CHEMICAL	GENE-Y	8	14	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T5	T30	12679340
NA	CHEMICAL	GENE-Y	8	16	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T5	T23	12679340
NA	CHEMICAL	GENE-Y	8	16	In the presence of chemical and chemical , chemical carbamoyltransferase ( gene ) and gene form a one-to-one enzyme complex in which the activity of gene is inhibited whereas gene remains catalytically active .	T5	T24	12679340
NA	CHEMICAL	GENE-Y	4	1	In gene , two chemical at the chemical terminus of the protein are crucial for its gene function but not for its catalytic activity and trimeric structure .	T6	T26	12679340
NA	CHEMICAL	GENE-Y	4	16	In gene , two chemical at the chemical terminus of the protein are crucial for its gene function but not for its catalytic activity and trimeric structure .	T6	T27	12679340
NA	CHEMICAL	GENE-Y	7	1	In gene , two chemical at the chemical terminus of the protein are crucial for its gene function but not for its catalytic activity and trimeric structure .	T7	T26	12679340
NA	CHEMICAL	GENE-Y	7	16	In gene , two chemical at the chemical terminus of the protein are crucial for its gene function but not for its catalytic activity and trimeric structure .	T7	T27	12679340
NA	CHEMICAL	GENE-Y	6	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T8	T28	12679340
NA	CHEMICAL	GENE-Y	6	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T8	T31	12679340
NA	CHEMICAL	GENE-Y	10	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T9	T28	12679340
NA	CHEMICAL	GENE-Y	10	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T9	T31	12679340
NA	CHEMICAL	GENE-Y	12	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T10	T28	12679340
NA	CHEMICAL	GENE-Y	12	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T10	T31	12679340
NA	CHEMICAL	GENE-Y	14	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T11	T28	12679340
NA	CHEMICAL	GENE-Y	14	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T11	T31	12679340
NA	CHEMICAL	GENE-Y	16	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T12	T28	12679340
NA	CHEMICAL	GENE-Y	16	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T12	T31	12679340
NA	CHEMICAL	GENE-Y	19	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T13	T28	12679340
NA	CHEMICAL	GENE-Y	19	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T13	T31	12679340
NA	CHEMICAL	GENE-Y	25	1	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T14	T28	12679340
NA	CHEMICAL	GENE-Y	25	31	In gene , mutations of putative chemical binding residues , chemical-182 , chemical-184 , chemical-185 , chemical-289 , and chemical-256 greatly reduced the affinity for chemical and impaired the interaction with gene .	T14	T31	12679340
CPR:4	CHEMICAL	GENE-Y	0	8	chemical is known to be an inhibitor of gene , and recent data have shown this drug to antagonize gene as well .	T1	T20	2857786
CPR:6	CHEMICAL	GENE-N	0	3	chemical is known to be an inhibitor of gene , and recent data have shown this drug to antagonize gene as well .	T1	T18	2857786
NA	CHEMICAL	GENE-Y	0	2	chemical was a less potent antagonist of tissue responses to chemical , and the underestimation in the pKB ( as compared to that obtained with chemical ) could be eliminated by prior treatment of tissues with the gene inhibitor chemical .	T11	T21	2857786
NA	CHEMICAL	GENE-Y	2	2	chemical was a less potent antagonist of tissue responses to chemical , and the underestimation in the pKB ( as compared to that obtained with chemical ) could be eliminated by prior treatment of tissues with the gene inhibitor chemical .	T12	T21	2857786
NA	CHEMICAL	GENE-Y	2	2	chemical was a less potent antagonist of tissue responses to chemical , and the underestimation in the pKB ( as compared to that obtained with chemical ) could be eliminated by prior treatment of tissues with the gene inhibitor chemical .	T13	T21	2857786
CPR:4	CHEMICAL	GENE-Y	15	2	chemical was a less potent antagonist of tissue responses to chemical , and the underestimation in the pKB ( as compared to that obtained with chemical ) could be eliminated by prior treatment of tissues with the gene inhibitor chemical .	T14	T21	2857786
CPR:4	CHEMICAL	GENE-Y	4	6	These data suggested that chemical had a dual effect on tissue responses to chemical-producing potentiation by blockade of gene and concomitant antagonism by blockade of gene .	T15	T17	2857786
CPR:6	CHEMICAL	GENE-N	4	12	These data suggested that chemical had a dual effect on tissue responses to chemical-producing potentiation by blockade of gene and concomitant antagonism by blockade of gene .	T15	T19	2857786
CPR:5	CHEMICAL	GENE-Y	6	6	These data suggested that chemical had a dual effect on tissue responses to chemical-producing potentiation by blockade of gene and concomitant antagonism by blockade of gene .	T2	T17	2857786
NA	CHEMICAL	GENE-N	6	12	These data suggested that chemical had a dual effect on tissue responses to chemical-producing potentiation by blockade of gene and concomitant antagonism by blockade of gene .	T2	T19	2857786
NA	CHEMICAL	GENE-N	8	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T9	T24	23384447
NA	CHEMICAL	GENE-N	8	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T9	T25	23384447
NA	CHEMICAL	GENE-N	8	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T10	T24	23384447
NA	CHEMICAL	GENE-N	8	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T10	T25	23384447
NA	CHEMICAL	GENE-N	78	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T11	T24	23384447
NA	CHEMICAL	GENE-N	78	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T11	T25	23384447
NA	CHEMICAL	GENE-N	8	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T12	T24	23384447
NA	CHEMICAL	GENE-N	8	56	To determine if these contaminants may contribute to a cardiovascular health risk , especially when combined with a high fat and chemical diet and chemical exposure , we treated human coronary artery endothelial cells ( HCAEC ) with two mixtures of 4 organic ( NCM1 ) or 22 organic and inorganic ( NCM2 ) chemicals detected in Northerners ' blood during 2004-2005 in the presence or absence of gene ( 1.5mg/ml ) , gene ( 1.0mg/ml ) and chemical ( 10mmol/L ) ( LVG ) , and in the absence or presence of 0.1 % chemical .	T12	T25	23384447
NA	CHEMICAL	GENE-Y	30	30	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T1	T15	23384447
NA	CHEMICAL	GENE-Y	30	32	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T1	T16	23384447
NA	CHEMICAL	GENE-N	30	35	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T1	T17	23384447
NA	CHEMICAL	GENE-N	30	37	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T1	T18	23384447
NA	CHEMICAL	GENE-Y	30	45	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T1	T19	23384447
NA	CHEMICAL	GENE-Y	30	47	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T1	T20	23384447
NA	CHEMICAL	GENE-Y	47	30	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T2	T15	23384447
NA	CHEMICAL	GENE-Y	47	32	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T2	T16	23384447
NA	CHEMICAL	GENE-N	47	35	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T2	T17	23384447
NA	CHEMICAL	GENE-N	47	37	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T2	T18	23384447
NA	CHEMICAL	GENE-Y	47	45	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T2	T19	23384447
NA	CHEMICAL	GENE-Y	47	47	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T2	T20	23384447
NA	CHEMICAL	GENE-Y	54	30	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T3	T15	23384447
NA	CHEMICAL	GENE-Y	54	32	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T3	T16	23384447
NA	CHEMICAL	GENE-N	54	35	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T3	T17	23384447
NA	CHEMICAL	GENE-N	54	37	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T3	T18	23384447
NA	CHEMICAL	GENE-Y	54	45	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T3	T19	23384447
NA	CHEMICAL	GENE-Y	54	47	NCM1 treatment did not affect cell viability , but increased cell size , disrupted cell membrane integrity , and decreased cell density , uptake of small peptides , release of gene ( gene ) and gene ( gene ) , while causing no changes in gene ( gene ) protein expression and chemical ( chemical ) release .	T3	T20	23384447
NA	CHEMICAL	GENE-Y	22	17	In contrast , NCM2 decreased cell viability , total protein yield , uptake of small peptides , gene protein expression , and chemical release and caused membrane damage , but caused no changes in the secretion of gene , chemical and gene .	T4	T21	23384447
NA	CHEMICAL	GENE-Y	22	37	In contrast , NCM2 decreased cell viability , total protein yield , uptake of small peptides , gene protein expression , and chemical release and caused membrane damage , but caused no changes in the secretion of gene , chemical and gene .	T4	T22	23384447
NA	CHEMICAL	GENE-N	22	41	In contrast , NCM2 decreased cell viability , total protein yield , uptake of small peptides , gene protein expression , and chemical release and caused membrane damage , but caused no changes in the secretion of gene , chemical and gene .	T4	T23	23384447
NA	CHEMICAL	GENE-Y	33	17	In contrast , NCM2 decreased cell viability , total protein yield , uptake of small peptides , gene protein expression , and chemical release and caused membrane damage , but caused no changes in the secretion of gene , chemical and gene .	T5	T21	23384447
NA	CHEMICAL	GENE-Y	33	37	In contrast , NCM2 decreased cell viability , total protein yield , uptake of small peptides , gene protein expression , and chemical release and caused membrane damage , but caused no changes in the secretion of gene , chemical and gene .	T5	T22	23384447
NA	CHEMICAL	GENE-N	33	41	In contrast , NCM2 decreased cell viability , total protein yield , uptake of small peptides , gene protein expression , and chemical release and caused membrane damage , but caused no changes in the secretion of gene , chemical and gene .	T5	T23	23384447
NA	CHEMICAL	GENE-Y	10	0	gene regulates opiate activation of gene signaling and relapse of chemical-seeking behavior .	T6	T26	15937104
NA	CHEMICAL	GENE-N	10	5	gene regulates opiate activation of gene signaling and relapse of chemical-seeking behavior .	T6	T27	15937104
NA	CHEMICAL	GENE-N	2	0	gene inhibits chemical production , but betagamma regulates several molecular pathways , including gene ( gene ) .	T1	T8	15937104
NA	CHEMICAL	GENE-N	2	13	gene inhibits chemical production , but betagamma regulates several molecular pathways , including gene ( gene ) .	T1	T9	15937104
NA	CHEMICAL	GENE-N	2	15	gene inhibits chemical production , but betagamma regulates several molecular pathways , including gene ( gene ) .	T1	T10	15937104
NA	CHEMICAL	GENE-Y	3	5	In rats self-administering chemical , gene antisense in the NAc core , but not shell , eliminates reinstatement of chemical-seeking behavior , a model of human relapse .	T3	T20	15937104
NA	CHEMICAL	GENE-Y	7	5	In rats self-administering chemical , gene antisense in the NAc core , but not shell , eliminates reinstatement of chemical-seeking behavior , a model of human relapse .	T4	T20	15937104
NA	CHEMICAL	GENE-Y	13	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T18	8733007
NA	CHEMICAL	GENE-Y	13	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T19	8733007
NA	CHEMICAL	GENE-Y	13	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T20	8733007
NA	CHEMICAL	GENE-Y	13	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T21	8733007
NA	CHEMICAL	GENE-Y	13	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T13	8733007
NA	CHEMICAL	GENE-Y	13	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T14	8733007
NA	CHEMICAL	GENE-N	13	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T6	T15	8733007
NA	CHEMICAL	GENE-Y	47	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T18	8733007
NA	CHEMICAL	GENE-Y	47	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T19	8733007
NA	CHEMICAL	GENE-Y	47	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T20	8733007
NA	CHEMICAL	GENE-Y	47	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T21	8733007
NA	CHEMICAL	GENE-Y	47	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T13	8733007
NA	CHEMICAL	GENE-Y	47	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T14	8733007
NA	CHEMICAL	GENE-N	47	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T7	T15	8733007
NA	CHEMICAL	GENE-Y	13	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T18	8733007
NA	CHEMICAL	GENE-Y	13	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T19	8733007
NA	CHEMICAL	GENE-Y	13	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T20	8733007
NA	CHEMICAL	GENE-Y	13	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T21	8733007
NA	CHEMICAL	GENE-Y	13	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T13	8733007
NA	CHEMICAL	GENE-Y	13	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T14	8733007
NA	CHEMICAL	GENE-N	13	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T8	T15	8733007
NA	CHEMICAL	GENE-Y	13	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T18	8733007
NA	CHEMICAL	GENE-Y	13	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T19	8733007
NA	CHEMICAL	GENE-Y	13	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T20	8733007
NA	CHEMICAL	GENE-Y	13	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T21	8733007
NA	CHEMICAL	GENE-Y	13	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T13	8733007
NA	CHEMICAL	GENE-Y	13	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T14	8733007
NA	CHEMICAL	GENE-N	13	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T10	T15	8733007
NA	CHEMICAL	GENE-Y	107	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T18	8733007
NA	CHEMICAL	GENE-Y	107	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T19	8733007
NA	CHEMICAL	GENE-Y	107	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T20	8733007
NA	CHEMICAL	GENE-Y	107	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T21	8733007
NA	CHEMICAL	GENE-Y	107	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T13	8733007
NA	CHEMICAL	GENE-Y	107	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T14	8733007
NA	CHEMICAL	GENE-N	107	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T11	T15	8733007
NA	CHEMICAL	GENE-Y	117	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T18	8733007
NA	CHEMICAL	GENE-Y	117	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T19	8733007
CPR:6	CHEMICAL	GENE-Y	117	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T20	8733007
CPR:6	CHEMICAL	GENE-Y	117	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T21	8733007
NA	CHEMICAL	GENE-Y	117	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T13	8733007
NA	CHEMICAL	GENE-Y	117	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T14	8733007
NA	CHEMICAL	GENE-N	117	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T12	T15	8733007
NA	CHEMICAL	GENE-Y	35	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T18	8733007
NA	CHEMICAL	GENE-Y	35	13	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T19	8733007
NA	CHEMICAL	GENE-Y	35	29	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T20	8733007
NA	CHEMICAL	GENE-Y	35	114	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T21	8733007
CPR:6	CHEMICAL	GENE-Y	35	125	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T13	8733007
CPR:6	CHEMICAL	GENE-Y	35	137	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T14	8733007
NA	CHEMICAL	GENE-N	35	150	In extending these initial findings , we have shown that cardiac fibrosis ( i ) is not reversed by correction of mineralocorticoid-induced hypokalemia ; ( ii ) appears not to involve the plasma or tissue gene-chemical systems , as fibrosis is largely unaffected by concurrent administration of chemical or chemical ; ( iii ) is independent of cardiac hypertrophy , in that it is equally seen in right and left ventricles , and in rats rendered hypertensive without cardiac hypertrophy by the administration of chemical ; ( iv ) is independent of elevated blood pressure , in that it is found in normotensive animals infused peripherally with chemical and intracerebroventricularly with the gene ( gene ) antagonist chemical ; ( v ) is via classical gene , in that it is blocked by concurrent administration of the gene antagonist chemical ; and ( vi ) may or may not be a direct cardiac effect , inasmuch as data for in vivo effects on gene formation by cardiac fibroblasts are conflicting .	T1	T15	8733007
NA	CHEMICAL	GENE-Y	4	8	A brief history of chemical and its role in modulating psychostimulant effects .	T15	T24	23348754
NA	CHEMICAL	GENE-Y	13	7	Over the past century , the polypeptide gene has played an important role in medicine with major highlights including the identification of its involvement in parturition and the milk let-down reflex .	T8	T19	23348754
NA	CHEMICAL	GENE-Y	4	0	gene is now implicated in an extensive range of psychological phenomena including reward and memory processes and has been investigated as a treatment for several psychiatric disorders including addiction , anxiety , autism , and schizophrenia .	T7	T18	23348754
NA	CHEMICAL	GENE-Y	6	6	We then outline some pharmacological limitations in this field of research before highlighting the role of chemical in a wide range of behavioral and neuronal processes .	T10	T21	23348754
NA	CHEMICAL	GENE-Y	10	13	Finally , we review evidence for a modulatory role of chemical with regard to psychostimulant effects .	T11	T22	23348754
NA	CHEMICAL	GENE-Y	4	19	Key findings suggest that chemical attenuates a broad number of chemical and chemical induced behaviors and associated neuronal activity in rodents .	T12	T23	23348754
NA	CHEMICAL	GENE-Y	6	19	Key findings suggest that chemical attenuates a broad number of chemical and chemical induced behaviors and associated neuronal activity in rodents .	T13	T23	23348754
NA	CHEMICAL	GENE-Y	6	19	Key findings suggest that chemical attenuates a broad number of chemical and chemical induced behaviors and associated neuronal activity in rodents .	T14	T23	23348754
NA	CHEMICAL	GENE-N	6	6	Evidence also outlines a role for gene in the prosocial effects of chemical ( chemical , chemical ) in both rodents and humans .	T1	T16	23348754
NA	CHEMICAL	GENE-N	3	6	Evidence also outlines a role for gene in the prosocial effects of chemical ( chemical , chemical ) in both rodents and humans .	T2	T16	23348754
NA	CHEMICAL	GENE-N	14	6	Evidence also outlines a role for gene in the prosocial effects of chemical ( chemical , chemical ) in both rodents and humans .	T3	T16	23348754
NA	CHEMICAL	GENE-N	3	6	Evidence also outlines a role for gene in the prosocial effects of chemical ( chemical , chemical ) in both rodents and humans .	T4	T16	23348754
CPR:4	CHEMICAL	GENE-Y	2	4	UNLABELLED : chemical is a potent and specific peripheral chemical-chemical-methyltransferase ( gene ) inhibitor .	T5	T26	10439935
CPR:4	CHEMICAL	GENE-Y	2	11	UNLABELLED : chemical is a potent and specific peripheral chemical-chemical-methyltransferase ( gene ) inhibitor .	T5	T28	10439935
NA	CHEMICAL	GENE-Y	4	4	UNLABELLED : chemical is a potent and specific peripheral chemical-chemical-methyltransferase ( gene ) inhibitor .	T15	T26	10439935
NA	CHEMICAL	GENE-Y	4	11	UNLABELLED : chemical is a potent and specific peripheral chemical-chemical-methyltransferase ( gene ) inhibitor .	T15	T28	10439935
NA	CHEMICAL	GENE-Y	9	4	UNLABELLED : chemical is a potent and specific peripheral chemical-chemical-methyltransferase ( gene ) inhibitor .	T17	T26	10439935
NA	CHEMICAL	GENE-Y	9	11	UNLABELLED : chemical is a potent and specific peripheral chemical-chemical-methyltransferase ( gene ) inhibitor .	T17	T28	10439935
NA	CHEMICAL	GENE-Y	10	14	It has been shown to improve the clinical benefits of chemical plus an chemical decarboxylase inhibitor ( gene ) when given to patients with Parkinson 's disease and end-of-dose deterioration in the response to chemical ( the 'wearing off ' phenomenon ) .	T7	T24	10439935
NA	CHEMICAL	GENE-Y	10	17	It has been shown to improve the clinical benefits of chemical plus an chemical decarboxylase inhibitor ( gene ) when given to patients with Parkinson 's disease and end-of-dose deterioration in the response to chemical ( the 'wearing off ' phenomenon ) .	T7	T25	10439935
NA	CHEMICAL	GENE-Y	13	14	It has been shown to improve the clinical benefits of chemical plus an chemical decarboxylase inhibitor ( gene ) when given to patients with Parkinson 's disease and end-of-dose deterioration in the response to chemical ( the 'wearing off ' phenomenon ) .	T9	T24	10439935
NA	CHEMICAL	GENE-Y	13	17	It has been shown to improve the clinical benefits of chemical plus an chemical decarboxylase inhibitor ( gene ) when given to patients with Parkinson 's disease and end-of-dose deterioration in the response to chemical ( the 'wearing off ' phenomenon ) .	T9	T25	10439935
NA	CHEMICAL	GENE-Y	34	14	It has been shown to improve the clinical benefits of chemical plus an chemical decarboxylase inhibitor ( gene ) when given to patients with Parkinson 's disease and end-of-dose deterioration in the response to chemical ( the 'wearing off ' phenomenon ) .	T12	T24	10439935
NA	CHEMICAL	GENE-Y	34	17	It has been shown to improve the clinical benefits of chemical plus an chemical decarboxylase inhibitor ( gene ) when given to patients with Parkinson 's disease and end-of-dose deterioration in the response to chemical ( the 'wearing off ' phenomenon ) .	T12	T25	10439935
NA	CHEMICAL	GENE-Y	18	26	In 2 well conducted trials of 6 months ' duration and smaller short term studies , treatment with chemical ( 200 mg with each dose of chemical/gene inhibitor ) was associated with significant increases in daily 'on ' time and decreases in 'off ' time .	T14	T27	10439935
NA	CHEMICAL	GENE-Y	26	26	In 2 well conducted trials of 6 months ' duration and smaller short term studies , treatment with chemical ( 200 mg with each dose of chemical/gene inhibitor ) was associated with significant increases in daily 'on ' time and decreases in 'off ' time .	T16	T27	10439935
NA	CHEMICAL	GENE-Y	0	10	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T19	T21	10439935
NA	CHEMICAL	GENE-Y	0	15	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T19	T22	10439935
NA	CHEMICAL	GENE-Y	0	10	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T1	T21	10439935
NA	CHEMICAL	GENE-Y	0	15	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T1	T22	10439935
NA	CHEMICAL	GENE-Y	10	10	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T2	T21	10439935
NA	CHEMICAL	GENE-Y	10	15	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T2	T22	10439935
NA	CHEMICAL	GENE-Y	18	10	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T3	T21	10439935
NA	CHEMICAL	GENE-Y	18	15	chemical also provided benefits when given with controlled release chemical/ gene inhibitor or with standard chemical/gene inhibitor and chemical in small trials .	T3	T22	10439935
NA	CHEMICAL	GENE-Y	10	10	CONCLUSIONS : The efficacy and tolerability of entacapone administered with chemical/gene inhibitor have not yet been compared with those of other strategies for the treatment of Parkinson 's disease .	T8	T23	10439935
NA	CHEMICAL	GENE-Y	2	11	Neuroprotection by chemical against chemical-induced chemical neuron death is mediated by gene in primary cultures of mouse mesencephalon .	T21	T36	17320868
NA	CHEMICAL	GENE-Y	4	11	Neuroprotection by chemical against chemical-induced chemical neuron death is mediated by gene in primary cultures of mouse mesencephalon .	T22	T36	17320868
NA	CHEMICAL	GENE-Y	5	11	Neuroprotection by chemical against chemical-induced chemical neuron death is mediated by gene in primary cultures of mouse mesencephalon .	T23	T36	17320868
NA	CHEMICAL	GENE-Y	10	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T11	T26	17320868
NA	CHEMICAL	GENE-Y	10	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T11	T27	17320868
NA	CHEMICAL	GENE-Y	10	19	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T11	T28	17320868
NA	CHEMICAL	GENE-Y	10	19	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T11	T29	17320868
NA	CHEMICAL	GENE-Y	10	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T11	T30	17320868
NA	CHEMICAL	GENE-Y	17	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T12	T26	17320868
NA	CHEMICAL	GENE-Y	17	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T12	T27	17320868
NA	CHEMICAL	GENE-Y	17	19	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T12	T28	17320868
NA	CHEMICAL	GENE-Y	17	19	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T12	T29	17320868
NA	CHEMICAL	GENE-Y	17	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T12	T30	17320868
NA	CHEMICAL	GENE-Y	24	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T13	T26	17320868
NA	CHEMICAL	GENE-Y	24	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T13	T27	17320868
NA	CHEMICAL	GENE-Y	24	19	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T13	T28	17320868
NA	CHEMICAL	GENE-Y	24	19	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T13	T29	17320868
NA	CHEMICAL	GENE-Y	24	12	Utilizing primary mesencephalic neurons , we found expression of both chemical receptor alpha ( gene ) and chemical receptor beta ( gene ) with a predominance of gene on both chemical neurons and astrocytes .	T13	T30	17320868
NA	CHEMICAL	GENE-Y	4	25	We also found that chemical protects chemical neurons from injury induced by the complex I inhibitor , chemical ( chemical ) in a time- and gene-dependent manner .	T14	T31	17320868
NA	CHEMICAL	GENE-Y	6	25	We also found that chemical protects chemical neurons from injury induced by the complex I inhibitor , chemical ( chemical ) in a time- and gene-dependent manner .	T15	T31	17320868
NA	CHEMICAL	GENE-Y	17	25	We also found that chemical protects chemical neurons from injury induced by the complex I inhibitor , chemical ( chemical ) in a time- and gene-dependent manner .	T16	T31	17320868
NA	CHEMICAL	GENE-Y	18	25	We also found that chemical protects chemical neurons from injury induced by the complex I inhibitor , chemical ( chemical ) in a time- and gene-dependent manner .	T17	T31	17320868
NA	CHEMICAL	GENE-Y	5	20	At least 4 h of chemical pre-treatment was required to elicit protection , an effect that was blocked by the gene antagonist , chemical .	T18	T32	17320868
CPR:6	CHEMICAL	GENE-Y	12	20	At least 4 h of chemical pre-treatment was required to elicit protection , an effect that was blocked by the gene antagonist , chemical .	T19	T32	17320868
NA	CHEMICAL	GENE-Y	8	2	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T20	T33	17320868
NA	CHEMICAL	GENE-Y	8	12	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T20	T34	17320868
NA	CHEMICAL	GENE-Y	8	20	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T20	T35	17320868
NA	CHEMICAL	GENE-Y	8	2	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T2	T33	17320868
NA	CHEMICAL	GENE-Y	8	12	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T2	T34	17320868
CPR:5	CHEMICAL	GENE-Y	8	20	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T2	T35	17320868
NA	CHEMICAL	GENE-Y	2	2	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T3	T33	17320868
NA	CHEMICAL	GENE-Y	2	12	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T3	T34	17320868
NA	CHEMICAL	GENE-Y	2	20	Moreover , gene mediated the protection afforded by chemical since only the gene agonist , HPTE , but not the gene agonist , chemical , protected against chemical cell loss .	T3	T35	17320868
NA	CHEMICAL	GENE-Y	19	10	Since glial cells were shown to express significant levels of gene , we investigated a possible indirect mechanism of chemical-mediated neuroprotection through glial cell interaction .	T4	T24	17320868
NA	CHEMICAL	GENE-Y	11	8	Preferentially expressed on presynaptic nerve terminals , the gene negatively modulates chemical and chemical release and is widely distributed in the brain .	T1	T8	23452205
NA	CHEMICAL	GENE-Y	13	8	Preferentially expressed on presynaptic nerve terminals , the gene negatively modulates chemical and chemical release and is widely distributed in the brain .	T2	T8	23452205
NA	CHEMICAL	GENE-Y	18	3	High levels of gene are seen in brain areas such as prefrontal cortex , hippocampus and amygdala where chemical hyperfunction may be implicated in disorders and diseases such as anxiety and schizophrenia .	T3	T9	23452205
CPR:6	CHEMICAL	GENE-Y	0	6	chemical ( SB ) is an gene ( gene ) antagonist that has previously been shown to inhibit gene-based cancer cell invasion , and to possess in vivo anti-inflammatory and anti-nociceptive effects .	T1	T14	23611835
CPR:6	CHEMICAL	GENE-Y	0	8	chemical ( SB ) is an gene ( gene ) antagonist that has previously been shown to inhibit gene-based cancer cell invasion , and to possess in vivo anti-inflammatory and anti-nociceptive effects .	T1	T16	23611835
CPR:4	CHEMICAL	GENE-Y	0	18	chemical ( SB ) is an gene ( gene ) antagonist that has previously been shown to inhibit gene-based cancer cell invasion , and to possess in vivo anti-inflammatory and anti-nociceptive effects .	T1	T22	23611835
NA	CHEMICAL	GENE-Y	7	14	Molecular docking studies suggested that SB has a good affinity towards chemical-binding site on gene subunit .	T2	T20	23611835
CPR:6	CHEMICAL	GENE-Y	3	15	Of note , chemical which is a close structural analogue of chemical with a potent gene antagonistic activity did not exhibit a similar antimitotic activity .	T3	T21	23611835
CPR:6	CHEMICAL	GENE-Y	11	15	Of note , chemical which is a close structural analogue of chemical with a potent gene antagonistic activity did not exhibit a similar antimitotic activity .	T4	T21	23611835
NA	CHEMICAL	GENE-Y	7	5	Blood complete counts , high-sensitive gene , chemical and routine biochemical tests were carried out by routine procedures .	T6	T10	22258629
CPR:6	CHEMICAL	GENE-Y	11	20	The aim of this study was to determine if macaque represents a suitable species for the pre-clinical evaluation of novel gene antagonists , such as chemical ( chemical ) .	T2	T13	16298345
CPR:6	CHEMICAL	GENE-Y	22	20	The aim of this study was to determine if macaque represents a suitable species for the pre-clinical evaluation of novel gene antagonists , such as chemical ( chemical ) .	T3	T13	16298345
NA	CHEMICAL	GENE-Y	18	7	To do this we cloned and expressed gene from rhesus macaque and compared the binding properties of [ chemical ] -MIP-1beta and chemical with gene .	T4	T16	16298345
NA	CHEMICAL	GENE-Y	18	24	To do this we cloned and expressed gene from rhesus macaque and compared the binding properties of [ chemical ] -MIP-1beta and chemical with gene .	T4	T17	16298345
NA	CHEMICAL	GENE-Y	17	7	To do this we cloned and expressed gene from rhesus macaque and compared the binding properties of [ chemical ] -MIP-1beta and chemical with gene .	T5	T16	16298345
NA	CHEMICAL	GENE-Y	17	24	To do this we cloned and expressed gene from rhesus macaque and compared the binding properties of [ chemical ] -MIP-1beta and chemical with gene .	T5	T17	16298345
NA	CHEMICAL	GENE-N	1	10	[ chemical ] -MIP-1beta bound with similar high affinity to gene from macaque ( K ( d ) = 0.24 +/- 0.05 nM ) and human ( K ( d ) = 0.23 +/- 0.05 nM ) and with similar kinetic properties .	T6	T18	16298345
NA	CHEMICAL	GENE-N	0	9	chemical inhibited binding of [ chemical ] -MIP-1beta to gene from macaque and human with similar potency ( IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM , respectively ) and antagonised MIP-1beta induced intracellular chemical release mediated through gene from macaque and human with similar potency ( IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89 , respectively ) .	T7	T21	16298345
CPR:6	CHEMICAL	GENE-N	0	41	chemical inhibited binding of [ chemical ] -MIP-1beta to gene from macaque and human with similar potency ( IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM , respectively ) and antagonised MIP-1beta induced intracellular chemical release mediated through gene from macaque and human with similar potency ( IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89 , respectively ) .	T7	T22	16298345
NA	CHEMICAL	GENE-N	5	9	chemical inhibited binding of [ chemical ] -MIP-1beta to gene from macaque and human with similar potency ( IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM , respectively ) and antagonised MIP-1beta induced intracellular chemical release mediated through gene from macaque and human with similar potency ( IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89 , respectively ) .	T8	T21	16298345
NA	CHEMICAL	GENE-N	5	41	chemical inhibited binding of [ chemical ] -MIP-1beta to gene from macaque and human with similar potency ( IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM , respectively ) and antagonised MIP-1beta induced intracellular chemical release mediated through gene from macaque and human with similar potency ( IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89 , respectively ) .	T8	T22	16298345
NA	CHEMICAL	GENE-N	37	9	chemical inhibited binding of [ chemical ] -MIP-1beta to gene from macaque and human with similar potency ( IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM , respectively ) and antagonised MIP-1beta induced intracellular chemical release mediated through gene from macaque and human with similar potency ( IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89 , respectively ) .	T9	T21	16298345
NA	CHEMICAL	GENE-N	37	41	chemical inhibited binding of [ chemical ] -MIP-1beta to gene from macaque and human with similar potency ( IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM , respectively ) and antagonised MIP-1beta induced intracellular chemical release mediated through gene from macaque and human with similar potency ( IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89 , respectively ) .	T9	T22	16298345
NA	CHEMICAL	GENE-N	0	6	chemical bound with high affinity to gene from macaque ( K ( d ) = 1.36+/-0.07 nM ) and human ( K ( d ) = 0.86 +/- 0.08 nM ) , but was found to dissociate approximately 10-fold more quickly from gene .	T10	T11	16298345
NA	CHEMICAL	GENE-Y	0	42	chemical bound with high affinity to gene from macaque ( K ( d ) = 1.36+/-0.07 nM ) and human ( K ( d ) = 0.86 +/- 0.08 nM ) , but was found to dissociate approximately 10-fold more quickly from gene .	T10	T12	16298345
NA	CHEMICAL	GENE-Y	27	11	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T14	T36	16675639
NA	CHEMICAL	GENE-Y	27	13	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T14	T37	16675639
NA	CHEMICAL	GENE-Y	27	15	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T14	T38	16675639
NA	CHEMICAL	GENE-Y	27	22	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T14	T39	16675639
NA	CHEMICAL	GENE-Y	15	11	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T16	T36	16675639
NA	CHEMICAL	GENE-Y	15	13	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T16	T37	16675639
NA	CHEMICAL	GENE-Y	15	15	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T16	T38	16675639
NA	CHEMICAL	GENE-Y	15	22	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T16	T39	16675639
NA	CHEMICAL	GENE-Y	18	11	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T17	T36	16675639
NA	CHEMICAL	GENE-Y	18	13	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T17	T37	16675639
NA	CHEMICAL	GENE-Y	18	15	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T17	T38	16675639
NA	CHEMICAL	GENE-Y	18	22	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T17	T39	16675639
CPR:4	CHEMICAL	GENE-Y	31	11	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T18	T36	16675639
CPR:4	CHEMICAL	GENE-Y	31	13	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T18	T37	16675639
CPR:4	CHEMICAL	GENE-Y	31	15	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T18	T38	16675639
CPR:4	CHEMICAL	GENE-Y	31	22	Competitive radioligand binding assays were performed using cells expressing either the gene ( gene ) or chemical ( chemical ) transporter ( gene ) with K ( i ) values for chemical of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM , respectively .	T18	T39	16675639
NA	CHEMICAL	GENE-Y	0	15	chemical showed weak binding affinity ( 62 % inhibition at 100 microM ) at the gene .	T19	T40	16675639
CPR:9	CHEMICAL	GENE-Y	2	10	Inhibition of chemical or chemical uptake by chemical for the gene or gene produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM , respectively .	T22	T41	16675639
NA	CHEMICAL	GENE-Y	2	12	Inhibition of chemical or chemical uptake by chemical for the gene or gene produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM , respectively .	T22	T42	16675639
NA	CHEMICAL	GENE-Y	4	10	Inhibition of chemical or chemical uptake by chemical for the gene or gene produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM , respectively .	T23	T41	16675639
CPR:9	CHEMICAL	GENE-Y	4	12	Inhibition of chemical or chemical uptake by chemical for the gene or gene produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM , respectively .	T23	T42	16675639
NA	CHEMICAL	GENE-Y	7	10	Inhibition of chemical or chemical uptake by chemical for the gene or gene produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM , respectively .	T24	T41	16675639
NA	CHEMICAL	GENE-Y	7	12	Inhibition of chemical or chemical uptake by chemical for the gene or gene produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM , respectively .	T24	T42	16675639
NA	CHEMICAL	GENE-Y	4	13	To mimic chronic selective chemical reuptake inhibitor treatment and to block the inhibitory gene autoreceptors , a gene antagonist , chemical ( chemical ) ( 0.3 mg/kg s.c .	T3	T34	16675639
NA	CHEMICAL	GENE-Y	4	17	To mimic chronic selective chemical reuptake inhibitor treatment and to block the inhibitory gene autoreceptors , a gene antagonist , chemical ( chemical ) ( 0.3 mg/kg s.c .	T3	T35	16675639
NA	CHEMICAL	GENE-Y	16	13	To mimic chronic selective chemical reuptake inhibitor treatment and to block the inhibitory gene autoreceptors , a gene antagonist , chemical ( chemical ) ( 0.3 mg/kg s.c .	T4	T34	16675639
CPR:6	CHEMICAL	GENE-Y	16	17	To mimic chronic selective chemical reuptake inhibitor treatment and to block the inhibitory gene autoreceptors , a gene antagonist , chemical ( chemical ) ( 0.3 mg/kg s.c .	T4	T35	16675639
NA	CHEMICAL	GENE-Y	22	13	To mimic chronic selective chemical reuptake inhibitor treatment and to block the inhibitory gene autoreceptors , a gene antagonist , chemical ( chemical ) ( 0.3 mg/kg s.c .	T5	T34	16675639
CPR:6	CHEMICAL	GENE-Y	22	17	To mimic chronic selective chemical reuptake inhibitor treatment and to block the inhibitory gene autoreceptors , a gene antagonist , chemical ( chemical ) ( 0.3 mg/kg s.c .	T5	T35	16675639
NA	CHEMICAL	GENE-Y	8	1	The gene ( gene ) is highly expressed in different regions of the brain and is associated with cognitive function as well as anxiety .	T5	T22	23321689
NA	CHEMICAL	GENE-N	8	3	The gene ( gene ) is highly expressed in different regions of the brain and is associated with cognitive function as well as anxiety .	T5	T21	23321689
NA	CHEMICAL	GENE-N	1	6	Previously chemical , which activates both gene , has been shown to have an anxiogenic effect in behavioral tests .	T6	T20	23321689
NA	CHEMICAL	GENE-Y	0	25	chemical on the other hand displayed an increase in anxiety-like behavior at a higher dose ( 10 mg/kg ) that was significantly reduced by the gene antagonist chemical .	T1	T15	23321689
CPR:6	CHEMICAL	GENE-Y	16	25	chemical on the other hand displayed an increase in anxiety-like behavior at a higher dose ( 10 mg/kg ) that was significantly reduced by the gene antagonist chemical .	T2	T15	23321689
CPR:6	CHEMICAL	GENE-Y	4	2	However the gene antagonist chemical was unable to reverse these anxiety-like effects seen with chemical .	T3	T16	23321689
NA	CHEMICAL	GENE-Y	14	2	However the gene antagonist chemical was unable to reverse these anxiety-like effects seen with chemical .	T4	T16	23321689
CPR:4	CHEMICAL	GENE-Y	6	8	Synthesis and dual biological effects of chemical/chemical derivatives as gene inhibitor and antioxidant .	T23	T28	23305921
CPR:4	CHEMICAL	GENE-Y	6	8	Synthesis and dual biological effects of chemical/chemical derivatives as gene inhibitor and antioxidant .	T24	T28	23305921
CPR:4	CHEMICAL	GENE-Y	4	9	We previously reported that chemical ( chemical ) acted as both a good antioxidant and gene inhibitor , in particular when chemical was conjugated with chemical or chemical having aromatic ring like chemical .	T6	T25	23305921
CPR:4	CHEMICAL	GENE-Y	6	9	We previously reported that chemical ( chemical ) acted as both a good antioxidant and gene inhibitor , in particular when chemical was conjugated with chemical or chemical having aromatic ring like chemical .	T15	T25	23305921
NA	CHEMICAL	GENE-Y	6	9	We previously reported that chemical ( chemical ) acted as both a good antioxidant and gene inhibitor , in particular when chemical was conjugated with chemical or chemical having aromatic ring like chemical .	T1	T25	23305921
NA	CHEMICAL	GENE-Y	15	9	We previously reported that chemical ( chemical ) acted as both a good antioxidant and gene inhibitor , in particular when chemical was conjugated with chemical or chemical having aromatic ring like chemical .	T2	T25	23305921
NA	CHEMICAL	GENE-Y	11	9	We previously reported that chemical ( chemical ) acted as both a good antioxidant and gene inhibitor , in particular when chemical was conjugated with chemical or chemical having aromatic ring like chemical .	T3	T25	23305921
NA	CHEMICAL	GENE-Y	11	9	We previously reported that chemical ( chemical ) acted as both a good antioxidant and gene inhibitor , in particular when chemical was conjugated with chemical or chemical having aromatic ring like chemical .	T4	T25	23305921
NA	CHEMICAL	GENE-Y	3	27	Here , various chemical ( chemical ) derivatives were further conjugated with chemical and chemical ( chemical and chemical ) to study the structure and activity relationship as both antioxidants and gene inhibitors .	T5	T26	23305921
NA	CHEMICAL	GENE-Y	5	27	Here , various chemical ( chemical ) derivatives were further conjugated with chemical and chemical ( chemical and chemical ) to study the structure and activity relationship as both antioxidants and gene inhibitors .	T7	T26	23305921
NA	CHEMICAL	GENE-Y	12	27	Here , various chemical ( chemical ) derivatives were further conjugated with chemical and chemical ( chemical and chemical ) to study the structure and activity relationship as both antioxidants and gene inhibitors .	T8	T26	23305921
NA	CHEMICAL	GENE-Y	14	27	Here , various chemical ( chemical ) derivatives were further conjugated with chemical and chemical ( chemical and chemical ) to study the structure and activity relationship as both antioxidants and gene inhibitors .	T9	T26	23305921
NA	CHEMICAL	GENE-Y	16	27	Here , various chemical ( chemical ) derivatives were further conjugated with chemical and chemical ( chemical and chemical ) to study the structure and activity relationship as both antioxidants and gene inhibitors .	T10	T26	23305921
NA	CHEMICAL	GENE-Y	18	27	Here , various chemical ( chemical ) derivatives were further conjugated with chemical and chemical ( chemical and chemical ) to study the structure and activity relationship as both antioxidants and gene inhibitors .	T11	T26	23305921
NA	CHEMICAL	GENE-Y	12	7	An important effector of the ISR is gene ( gene ) , a transcription factor that regulates genes involved in redox homeostasis and chemical metabolism and transport .	T10	T22	23229510
NA	CHEMICAL	GENE-Y	12	9	An important effector of the ISR is gene ( gene ) , a transcription factor that regulates genes involved in redox homeostasis and chemical metabolism and transport .	T10	T23	23229510
CPR:3	CHEMICAL	GENE-Y	5	17	We identified one compound , chemical chemical , that activated the ISR and dose-dependently increased levels of gene in transformed cells .	T11	T26	23229510
CPR:3	CHEMICAL	GENE-Y	4	17	We identified one compound , chemical chemical , that activated the ISR and dose-dependently increased levels of gene in transformed cells .	T12	T26	23229510
NA	CHEMICAL	GENE-Y	26	0	A dose-dependent decrease in viability was observed in several mouse and human tumor cell lines , and knockdown of gene significantly increased the antiproliferative effects of chemical .	T1	T27	23229510
NA	CHEMICAL	GENE-Y	0	8	chemical-mediated induction of senescence was not dependent on gene or gene ; however , gene conferred protection against the growth inhibitory effects of chemical .	T3	T13	23229510
NA	CHEMICAL	GENE-Y	0	10	chemical-mediated induction of senescence was not dependent on gene or gene ; however , gene conferred protection against the growth inhibitory effects of chemical .	T3	T14	23229510
NA	CHEMICAL	GENE-Y	0	14	chemical-mediated induction of senescence was not dependent on gene or gene ; however , gene conferred protection against the growth inhibitory effects of chemical .	T3	T15	23229510
NA	CHEMICAL	GENE-Y	23	8	chemical-mediated induction of senescence was not dependent on gene or gene ; however , gene conferred protection against the growth inhibitory effects of chemical .	T4	T13	23229510
NA	CHEMICAL	GENE-Y	23	10	chemical-mediated induction of senescence was not dependent on gene or gene ; however , gene conferred protection against the growth inhibitory effects of chemical .	T4	T14	23229510
NA	CHEMICAL	GENE-Y	23	14	chemical-mediated induction of senescence was not dependent on gene or gene ; however , gene conferred protection against the growth inhibitory effects of chemical .	T4	T15	23229510
CPR:3	CHEMICAL	GENE-Y	0	13	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T6	T16	23229510
CPR:3	CHEMICAL	GENE-Y	0	15	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T6	T17	23229510
CPR:3	CHEMICAL	GENE-Y	0	18	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T6	T18	23229510
CPR:3	CHEMICAL	GENE-Y	0	20	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T6	T19	23229510
NA	CHEMICAL	GENE-Y	13	13	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T7	T16	23229510
NA	CHEMICAL	GENE-Y	13	15	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T7	T17	23229510
NA	CHEMICAL	GENE-Y	13	18	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T7	T18	23229510
NA	CHEMICAL	GENE-Y	13	20	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T7	T19	23229510
NA	CHEMICAL	GENE-Y	24	13	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T8	T16	23229510
NA	CHEMICAL	GENE-Y	24	15	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T8	T17	23229510
NA	CHEMICAL	GENE-Y	24	18	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T8	T18	23229510
NA	CHEMICAL	GENE-Y	24	20	chemical also activated DNA damage response signaling , resulting in increased levels of chemical15-gene , gene , and gene ( gene ) , although chemical does not appear to cause physical DNA damage .	T8	T19	23229510
CPR:6	CHEMICAL	GENE-N	0	18	chemical is a second-generation chemical gene antagonist , with a distinct pharmacological profile that differs from first-generation 5-HT3 receptor antagonists .	T1	T25	19852528
CPR:6	CHEMICAL	GENE-N	0	5	chemical is a second-generation chemical gene antagonist , with a distinct pharmacological profile that differs from first-generation 5-HT3 receptor antagonists .	T1	T23	19852528
NA	CHEMICAL	GENE-N	4	18	chemical is a second-generation chemical gene antagonist , with a distinct pharmacological profile that differs from first-generation 5-HT3 receptor antagonists .	T15	T25	19852528
NA	CHEMICAL	GENE-N	4	5	chemical is a second-generation chemical gene antagonist , with a distinct pharmacological profile that differs from first-generation 5-HT3 receptor antagonists .	T15	T23	19852528
CPR:6	CHEMICAL	GENE-N	1	4	Oral chemical is likely to be a useful addition to oral formulations of other gener antagonists in preventing CINV in patients receiving MEC .	T12	T24	19852528
NA	CHEMICAL	GENE-Y	6	8	Contractile tension of the vas deferens in response to chemical was markedly decreased in gene KO mice , and this contraction was completely abolished in gene triple-KO mice .	T1	T6	17603545
NA	CHEMICAL	GENE-N	6	8	Contractile tension of the vas deferens in response to chemical was markedly decreased in gene KO mice , and this contraction was completely abolished in gene triple-KO mice .	T1	T7	17603545
CPR:3	CHEMICAL	GENE-Y	6	0	gene ( gene ) activators , chemical and chemical , increase gene mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes .	T12	T30	10933891
CPR:3	CHEMICAL	GENE-Y	6	2	gene ( gene ) activators , chemical and chemical , increase gene mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes .	T12	T32	10933891
CPR:3	CHEMICAL	GENE-Y	6	11	gene ( gene ) activators , chemical and chemical , increase gene mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes .	T12	T31	10933891
CPR:3	CHEMICAL	GENE-Y	5	0	gene ( gene ) activators , chemical and chemical , increase gene mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes .	T13	T30	10933891
CPR:3	CHEMICAL	GENE-Y	5	2	gene ( gene ) activators , chemical and chemical , increase gene mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes .	T13	T32	10933891
CPR:3	CHEMICAL	GENE-Y	5	11	gene ( gene ) activators , chemical and chemical , increase gene mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes .	T13	T31	10933891
CPR:9	CHEMICAL	GENE-N	1	0	gene ( gene ) are inner mitochondrial membrane transporters which act as pores for chemical ions , dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis .	T10	T14	10933891
CPR:9	CHEMICAL	GENE-N	1	2	gene ( gene ) are inner mitochondrial membrane transporters which act as pores for chemical ions , dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis .	T10	T18	10933891
NA	CHEMICAL	GENE-Y	9	14	We have studied the effects of two fibrates , chemical and chemical , on gene and gene mRNA levels in primary monolayer cultures of rat adipocytes and undifferentiated preadipocytes .	T7	T19	10933891
NA	CHEMICAL	GENE-Y	9	16	We have studied the effects of two fibrates , chemical and chemical , on gene and gene mRNA levels in primary monolayer cultures of rat adipocytes and undifferentiated preadipocytes .	T7	T20	10933891
NA	CHEMICAL	GENE-Y	8	14	We have studied the effects of two fibrates , chemical and chemical , on gene and gene mRNA levels in primary monolayer cultures of rat adipocytes and undifferentiated preadipocytes .	T8	T19	10933891
NA	CHEMICAL	GENE-Y	8	16	We have studied the effects of two fibrates , chemical and chemical , on gene and gene mRNA levels in primary monolayer cultures of rat adipocytes and undifferentiated preadipocytes .	T8	T20	10933891
CPR:3	CHEMICAL	GENE-Y	2	10	Thus , chemical treatment resulted in an 8-fold induction in gene mRNA levels in preadipocytes compared with the 3.5-fold induction observed in adipocytes .	T9	T23	10933891
NA	CHEMICAL	GENE-Y	13	3	In contrast to gene , gene mRNA levels were only slightly modified by chemical in adipocytes .	T11	T28	10933891
NA	CHEMICAL	GENE-Y	13	5	In contrast to gene , gene mRNA levels were only slightly modified by chemical in adipocytes .	T11	T29	10933891
CPR:3	CHEMICAL	GENE-Y	3	3	The induction in gene expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after chemical or chemical treatment .	T1	T15	10933891
CPR:3	CHEMICAL	GENE-Y	22	3	The induction in gene expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after chemical or chemical treatment .	T2	T15	10933891
NA	CHEMICAL	GENE-Y	7	8	The use of a combination of a chemical gene receptor antagonist , chemical and a gene antagonist has significantly improved the control of acute and delayed emesis in single-day chemotherapy .	T3	T10	23404093
NA	CHEMICAL	GENE-Y	7	9	The use of a combination of a chemical gene receptor antagonist , chemical and a gene antagonist has significantly improved the control of acute and delayed emesis in single-day chemotherapy .	T3	T11	23404093
NA	CHEMICAL	GENE-Y	3	8	The use of a combination of a chemical gene receptor antagonist , chemical and a gene antagonist has significantly improved the control of acute and delayed emesis in single-day chemotherapy .	T4	T10	23404093
NA	CHEMICAL	GENE-Y	3	9	The use of a combination of a chemical gene receptor antagonist , chemical and a gene antagonist has significantly improved the control of acute and delayed emesis in single-day chemotherapy .	T4	T11	23404093
CPR:6	CHEMICAL	GENE-Y	0	4	chemical , a second-generation gene receptor antagonist with a different half-life , a different binding capacity and a different mechanism of action than the first-generation gene receptor antagonists appears to be the most effective agent in its class .	T5	T12	23404093
NA	CHEMICAL	GENE-Y	0	25	chemical , a second-generation gene receptor antagonist with a different half-life , a different binding capacity and a different mechanism of action than the first-generation gene receptor antagonists appears to be the most effective agent in its class .	T5	T13	23404093
CPR:6	CHEMICAL	GENE-Y	0	11	chemical , the first and only agent clinically available in the gene antagonist drug class has been used effectively as an additive agent to the gene receptor antagonists and chemical to control CINV .	T6	T14	23404093
NA	CHEMICAL	GENE-Y	0	25	chemical , the first and only agent clinically available in the gene antagonist drug class has been used effectively as an additive agent to the gene receptor antagonists and chemical to control CINV .	T6	T15	23404093
NA	CHEMICAL	GENE-Y	15	11	chemical , the first and only agent clinically available in the gene antagonist drug class has been used effectively as an additive agent to the gene receptor antagonists and chemical to control CINV .	T7	T14	23404093
NA	CHEMICAL	GENE-Y	15	25	chemical , the first and only agent clinically available in the gene antagonist drug class has been used effectively as an additive agent to the gene receptor antagonists and chemical to control CINV .	T7	T15	23404093
CPR:6	CHEMICAL	GENE-Y	0	5	chemical and chemical are other gene antagonists that are currently in phase III clinical trials .	T8	T16	23404093
CPR:6	CHEMICAL	GENE-Y	2	5	chemical and chemical are other gene antagonists that are currently in phase III clinical trials .	T9	T16	23404093
NA	CHEMICAL	GENE-N	11	3	We also examined gene receptor signaling by in vivo measurement of chemical-stimulated chemical hydrolysis .	T3	T14	22709946
NA	CHEMICAL	GENE-N	7	3	We also examined gene receptor signaling by in vivo measurement of chemical-stimulated chemical hydrolysis .	T4	T14	22709946
CPR:3	CHEMICAL	GENE-Y	8	19	However , chronic treatment of cLH rats with chemical did not reverse learned helplessness , indicating that the enhanced gene function is not the only player in the behavioral phenotype of this genetic model of depression .	T1	T9	22709946
NA	CHEMICAL	GENE-N	8	3	Pre-steady-state currents in gene induced by photolysis of a new caged chemical derivative .	T24	T46	17311416
NA	CHEMICAL	GENE-N	2	3	Pre-steady-state currents in gene induced by photolysis of a new caged chemical derivative .	T25	T46	17311416
NA	CHEMICAL	GENE-N	0	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T28	17311416
NA	CHEMICAL	GENE-N	0	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T30	17311416
NA	CHEMICAL	GENE-N	0	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T31	17311416
NA	CHEMICAL	GENE-Y	0	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T32	17311416
NA	CHEMICAL	GENE-Y	0	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T33	17311416
NA	CHEMICAL	GENE-Y	0	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T34	17311416
NA	CHEMICAL	GENE-N	0	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T35	17311416
NA	CHEMICAL	GENE-Y	0	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T36	17311416
NA	CHEMICAL	GENE-Y	0	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T37	17311416
NA	CHEMICAL	GENE-Y	0	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T38	17311416
NA	CHEMICAL	GENE-Y	0	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T1	T39	17311416
CPR:9	CHEMICAL	GENE-N	6	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T28	17311416
CPR:9	CHEMICAL	GENE-N	6	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T30	17311416
CPR:9	CHEMICAL	GENE-N	6	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T31	17311416
CPR:9	CHEMICAL	GENE-Y	6	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T32	17311416
CPR:9	CHEMICAL	GENE-Y	6	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T33	17311416
CPR:9	CHEMICAL	GENE-Y	6	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T34	17311416
CPR:9	CHEMICAL	GENE-N	6	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T35	17311416
CPR:9	CHEMICAL	GENE-Y	6	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T36	17311416
CPR:9	CHEMICAL	GENE-Y	6	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T37	17311416
CPR:9	CHEMICAL	GENE-Y	6	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T38	17311416
CPR:9	CHEMICAL	GENE-Y	6	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T18	T39	17311416
CPR:9	CHEMICAL	GENE-N	10	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T28	17311416
CPR:9	CHEMICAL	GENE-N	10	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T30	17311416
CPR:9	CHEMICAL	GENE-N	10	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T31	17311416
CPR:9	CHEMICAL	GENE-Y	10	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T32	17311416
CPR:9	CHEMICAL	GENE-Y	10	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T33	17311416
CPR:9	CHEMICAL	GENE-Y	10	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T34	17311416
CPR:9	CHEMICAL	GENE-N	10	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T35	17311416
CPR:9	CHEMICAL	GENE-Y	10	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T36	17311416
CPR:9	CHEMICAL	GENE-Y	10	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T37	17311416
CPR:9	CHEMICAL	GENE-Y	10	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T38	17311416
CPR:9	CHEMICAL	GENE-Y	10	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T21	T39	17311416
CPR:9	CHEMICAL	GENE-N	12	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T28	17311416
CPR:9	CHEMICAL	GENE-N	12	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T30	17311416
CPR:9	CHEMICAL	GENE-N	12	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T31	17311416
CPR:9	CHEMICAL	GENE-Y	12	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T32	17311416
CPR:9	CHEMICAL	GENE-Y	12	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T33	17311416
CPR:9	CHEMICAL	GENE-Y	12	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T34	17311416
NA	CHEMICAL	GENE-N	12	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T35	17311416
CPR:9	CHEMICAL	GENE-Y	12	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T36	17311416
CPR:9	CHEMICAL	GENE-Y	12	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T37	17311416
CPR:9	CHEMICAL	GENE-Y	12	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T38	17311416
CPR:9	CHEMICAL	GENE-Y	12	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T23	T39	17311416
NA	CHEMICAL	GENE-N	47	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T28	17311416
NA	CHEMICAL	GENE-N	47	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T30	17311416
NA	CHEMICAL	GENE-N	47	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T31	17311416
NA	CHEMICAL	GENE-Y	47	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T32	17311416
NA	CHEMICAL	GENE-Y	47	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T33	17311416
NA	CHEMICAL	GENE-Y	47	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T34	17311416
NA	CHEMICAL	GENE-N	47	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T35	17311416
NA	CHEMICAL	GENE-Y	47	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T36	17311416
NA	CHEMICAL	GENE-Y	47	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T37	17311416
NA	CHEMICAL	GENE-Y	47	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T38	17311416
NA	CHEMICAL	GENE-Y	47	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T5	T39	17311416
NA	CHEMICAL	GENE-N	29	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T28	17311416
NA	CHEMICAL	GENE-N	29	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T30	17311416
NA	CHEMICAL	GENE-N	29	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T31	17311416
NA	CHEMICAL	GENE-Y	29	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T32	17311416
NA	CHEMICAL	GENE-Y	29	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T33	17311416
NA	CHEMICAL	GENE-Y	29	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T34	17311416
NA	CHEMICAL	GENE-N	29	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T35	17311416
NA	CHEMICAL	GENE-Y	29	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T36	17311416
NA	CHEMICAL	GENE-Y	29	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T37	17311416
NA	CHEMICAL	GENE-Y	29	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T38	17311416
NA	CHEMICAL	GENE-Y	29	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T9	T39	17311416
NA	CHEMICAL	GENE-N	30	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T28	17311416
NA	CHEMICAL	GENE-N	30	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T30	17311416
NA	CHEMICAL	GENE-N	30	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T31	17311416
NA	CHEMICAL	GENE-Y	30	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T32	17311416
NA	CHEMICAL	GENE-Y	30	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T33	17311416
NA	CHEMICAL	GENE-Y	30	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T34	17311416
NA	CHEMICAL	GENE-N	30	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T35	17311416
NA	CHEMICAL	GENE-Y	30	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T36	17311416
NA	CHEMICAL	GENE-Y	30	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T37	17311416
NA	CHEMICAL	GENE-Y	30	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T38	17311416
NA	CHEMICAL	GENE-Y	30	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T10	T39	17311416
NA	CHEMICAL	GENE-N	31	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T28	17311416
NA	CHEMICAL	GENE-N	31	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T30	17311416
NA	CHEMICAL	GENE-N	31	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T31	17311416
NA	CHEMICAL	GENE-Y	31	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T32	17311416
NA	CHEMICAL	GENE-Y	31	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T33	17311416
NA	CHEMICAL	GENE-Y	31	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T34	17311416
NA	CHEMICAL	GENE-N	31	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T35	17311416
NA	CHEMICAL	GENE-Y	31	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T36	17311416
NA	CHEMICAL	GENE-Y	31	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T37	17311416
NA	CHEMICAL	GENE-Y	31	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T38	17311416
NA	CHEMICAL	GENE-Y	31	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T11	T39	17311416
NA	CHEMICAL	GENE-N	45	2	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T28	17311416
NA	CHEMICAL	GENE-N	45	25	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T30	17311416
NA	CHEMICAL	GENE-N	45	27	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T31	17311416
NA	CHEMICAL	GENE-Y	45	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T32	17311416
NA	CHEMICAL	GENE-Y	45	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T33	17311416
NA	CHEMICAL	GENE-Y	45	39	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T34	17311416
NA	CHEMICAL	GENE-N	45	42	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T35	17311416
NA	CHEMICAL	GENE-Y	45	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T36	17311416
NA	CHEMICAL	GENE-Y	45	33	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T37	17311416
NA	CHEMICAL	GENE-Y	45	54	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T38	17311416
NA	CHEMICAL	GENE-Y	45	57	chemical-Dependent transmembrane transport of small neutral chemical , such as chemical and chemical , is mediated , among others , by the gene of the gene [ gene , chemical chemical chemical transporter 1 ( gene ) , and gene ] and gene families [ chemical-coupled neutral chemical transporter 1 ( gene ) , gene , and gene ] .	T12	T39	17311416
CPR:9	CHEMICAL	GENE-Y	4	34	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T15	T40	17311416
CPR:9	CHEMICAL	GENE-Y	4	36	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T15	T41	17311416
CPR:9	CHEMICAL	GENE-Y	4	39	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T15	T42	17311416
CPR:9	CHEMICAL	GENE-Y	4	34	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T16	T40	17311416
CPR:9	CHEMICAL	GENE-Y	4	36	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T16	T41	17311416
CPR:9	CHEMICAL	GENE-Y	4	39	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T16	T42	17311416
CPR:9	CHEMICAL	GENE-Y	16	34	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T17	T40	17311416
CPR:9	CHEMICAL	GENE-Y	16	36	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T17	T41	17311416
CPR:9	CHEMICAL	GENE-Y	16	39	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T17	T42	17311416
CPR:9	CHEMICAL	GENE-Y	18	34	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T19	T40	17311416
CPR:9	CHEMICAL	GENE-Y	18	36	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T19	T41	17311416
CPR:9	CHEMICAL	GENE-Y	18	39	Here , we describe a new photolabile chemical derivative based on protection of chemical with the chemical ( chemical ) caging group , which we use for pre-steady-state kinetic analysis of alanine transport by gene , gene , and gene .	T19	T42	17311416
NA	CHEMICAL	GENE-Y	4	19	Photolytic release of free chemical results in the generation of significant transient current components in HEK293 cells expressing the gene , gene , and gene proteins .	T22	T43	17311416
NA	CHEMICAL	GENE-Y	4	21	Photolytic release of free chemical results in the generation of significant transient current components in HEK293 cells expressing the gene , gene , and gene proteins .	T22	T44	17311416
NA	CHEMICAL	GENE-Y	4	24	Photolytic release of free chemical results in the generation of significant transient current components in HEK293 cells expressing the gene , gene , and gene proteins .	T22	T45	17311416
NA	CHEMICAL	GENE-Y	5	11	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T24	7601910
NA	CHEMICAL	GENE-Y	5	13	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T15	7601910
NA	CHEMICAL	GENE-Y	5	16	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T16	7601910
NA	CHEMICAL	GENE-Y	5	18	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T17	7601910
NA	CHEMICAL	GENE-Y	5	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T18	7601910
NA	CHEMICAL	GENE-Y	5	23	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T19	7601910
NA	CHEMICAL	GENE-Y	5	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T20	7601910
NA	CHEMICAL	GENE-Y	5	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T21	7601910
NA	CHEMICAL	GENE-N	5	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T22	7601910
NA	CHEMICAL	GENE-N	5	40	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T2	T23	7601910
NA	CHEMICAL	GENE-Y	5	11	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T24	7601910
NA	CHEMICAL	GENE-Y	5	13	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T15	7601910
NA	CHEMICAL	GENE-Y	5	16	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T16	7601910
NA	CHEMICAL	GENE-Y	5	18	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T17	7601910
NA	CHEMICAL	GENE-Y	5	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T18	7601910
NA	CHEMICAL	GENE-Y	5	23	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T19	7601910
NA	CHEMICAL	GENE-Y	5	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T20	7601910
NA	CHEMICAL	GENE-Y	5	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T21	7601910
NA	CHEMICAL	GENE-N	5	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T22	7601910
NA	CHEMICAL	GENE-N	5	40	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T3	T23	7601910
NA	CHEMICAL	GENE-Y	26	11	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T24	7601910
NA	CHEMICAL	GENE-Y	26	13	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T15	7601910
NA	CHEMICAL	GENE-Y	26	16	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T16	7601910
NA	CHEMICAL	GENE-Y	26	18	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T17	7601910
NA	CHEMICAL	GENE-Y	26	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T18	7601910
NA	CHEMICAL	GENE-Y	26	23	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T19	7601910
NA	CHEMICAL	GENE-Y	26	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T20	7601910
NA	CHEMICAL	GENE-Y	26	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T21	7601910
NA	CHEMICAL	GENE-N	26	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T22	7601910
NA	CHEMICAL	GENE-N	26	40	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T4	T23	7601910
NA	CHEMICAL	GENE-Y	34	11	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T24	7601910
NA	CHEMICAL	GENE-Y	34	13	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T15	7601910
NA	CHEMICAL	GENE-Y	34	16	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T16	7601910
NA	CHEMICAL	GENE-Y	34	18	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T17	7601910
NA	CHEMICAL	GENE-Y	34	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T18	7601910
NA	CHEMICAL	GENE-Y	34	23	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T19	7601910
NA	CHEMICAL	GENE-Y	34	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T20	7601910
NA	CHEMICAL	GENE-Y	34	28	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T21	7601910
NA	CHEMICAL	GENE-N	34	5	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T22	7601910
NA	CHEMICAL	GENE-N	34	40	This analysis revealed significant differences in the expression level of the gene ( gene ) , gene ( gene ) , gene ( gene ) , chemical receptor gamma ( gene ) , and chemical response element binding protein ( gene ) .	T5	T23	7601910
NA	CHEMICAL	GENE-N	0	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T1	T26	1881457
NA	CHEMICAL	GENE-N	2	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T2	T26	1881457
NA	CHEMICAL	GENE-N	2	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T3	T26	1881457
NA	CHEMICAL	GENE-N	2	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T4	T26	1881457
NA	CHEMICAL	GENE-N	2	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T5	T26	1881457
NA	CHEMICAL	GENE-N	2	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T6	T26	1881457
NA	CHEMICAL	GENE-N	2	10	chemical is a relatively potent inhibitor of chemical oxidase-A and -B and causes increases in whole-brain levels of chemical and chemical , and decreases in chemical , chemical , and chemical after acute i.p .	T8	T26	1881457
CPR:4	CHEMICAL	GENE-N	0	2	chemical is a more potent chemical oxidase inhibitor than is chemical .	T9	T27	1881457
NA	CHEMICAL	GENE-N	2	2	chemical is a more potent chemical oxidase inhibitor than is chemical .	T10	T27	1881457
CPR:4	CHEMICAL	GENE-N	2	2	chemical is a more potent chemical oxidase inhibitor than is chemical .	T11	T27	1881457
CPR:4	CHEMICAL	GENE-N	2	8	Optimization of chemical as dual function inhibitors targeting gene and gene .	T6	T17	23220644
CPR:4	CHEMICAL	GENE-Y	2	3	Optimization of chemical as dual function inhibitors targeting gene and gene .	T6	T18	23220644
CPR:9	CHEMICAL	GENE-N	6	4	Dual function inhibitors targeting gene ( gene ) and gene ( gene ) may balance the chemical ( AA ) metabolic network and be used as new anti-inflammatory drugs .	T1	T8	23220644
CPR:9	CHEMICAL	GENE-N	6	5	Dual function inhibitors targeting gene ( gene ) and gene ( gene ) may balance the chemical ( AA ) metabolic network and be used as new anti-inflammatory drugs .	T1	T12	23220644
CPR:9	CHEMICAL	GENE-Y	6	9	Dual function inhibitors targeting gene ( gene ) and gene ( gene ) may balance the chemical ( AA ) metabolic network and be used as new anti-inflammatory drugs .	T1	T13	23220644
CPR:9	CHEMICAL	GENE-Y	6	5	Dual function inhibitors targeting gene ( gene ) and gene ( gene ) may balance the chemical ( AA ) metabolic network and be used as new anti-inflammatory drugs .	T1	T16	23220644
CPR:4	CHEMICAL	GENE-Y	20	19	In previous study , we discovered multi-target drugs towards the AA metabolic network , among which a dual-target inhibitor ( chemical ) for gene ( gene ) and gene ( gene ) was found .	T2	T7	23220644
CPR:4	CHEMICAL	GENE-Y	20	19	In previous study , we discovered multi-target drugs towards the AA metabolic network , among which a dual-target inhibitor ( chemical ) for gene ( gene ) and gene ( gene ) was found .	T2	T9	23220644
CPR:4	CHEMICAL	GENE-Y	20	16	In previous study , we discovered multi-target drugs towards the AA metabolic network , among which a dual-target inhibitor ( chemical ) for gene ( gene ) and gene ( gene ) was found .	T2	T10	23220644
CPR:4	CHEMICAL	GENE-Y	20	19	In previous study , we discovered multi-target drugs towards the AA metabolic network , among which a dual-target inhibitor ( chemical ) for gene ( gene ) and gene ( gene ) was found .	T2	T11	23220644
NA	CHEMICAL	GENE-Y	0	5	chemical 5-HT ( 2B ) receptor loss of function mutation in a patient with chemical-associated primary pulmonary hypertension .	T8	T14	14659797
NA	CHEMICAL	GENE-Y	10	5	chemical 5-HT ( 2B ) receptor loss of function mutation in a patient with chemical-associated primary pulmonary hypertension .	T9	T14	14659797
NA	CHEMICAL	GENE-Y	5	10	A mouse model incriminates the chemical 5-HT ( 2B ) receptor but contrasts with other models where this receptor has been shown to mediate pulmonary arterial relaxation via chemical production .	T3	T11	14659797
NA	CHEMICAL	GENE-Y	28	10	A mouse model incriminates the chemical 5-HT ( 2B ) receptor but contrasts with other models where this receptor has been shown to mediate pulmonary arterial relaxation via chemical production .	T4	T11	14659797
CPR:9	CHEMICAL	GENE-Y	2	0	gene catalyzes an unusual oxidative decarboxylation of chemical .	T26	T37	3094574
CPR:9	CHEMICAL	GENE-Y	6	0	gene usually catalyzes the conversion of chemical to o-chemical and oxidation of diphenols to the corresponding quinones .	T12	T27	3094574
CPR:9	CHEMICAL	GENE-Y	8	0	gene usually catalyzes the conversion of chemical to o-chemical and oxidation of diphenols to the corresponding quinones .	T23	T27	3094574
NA	CHEMICAL	GENE-N	11	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T13	T29	3094574
NA	CHEMICAL	GENE-Y	11	14	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T13	T30	3094574
NA	CHEMICAL	GENE-N	11	17	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T13	T31	3094574
NA	CHEMICAL	GENE-N	11	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T13	T32	3094574
NA	CHEMICAL	GENE-Y	11	23	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T13	T33	3094574
NA	CHEMICAL	GENE-N	11	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T13	T34	3094574
NA	CHEMICAL	GENE-N	16	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T14	T29	3094574
NA	CHEMICAL	GENE-Y	16	14	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T14	T30	3094574
NA	CHEMICAL	GENE-N	16	17	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T14	T31	3094574
NA	CHEMICAL	GENE-N	16	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T14	T32	3094574
NA	CHEMICAL	GENE-Y	16	23	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T14	T33	3094574
NA	CHEMICAL	GENE-N	16	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T14	T34	3094574
NA	CHEMICAL	GENE-N	19	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T15	T29	3094574
NA	CHEMICAL	GENE-Y	19	14	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T15	T30	3094574
NA	CHEMICAL	GENE-N	19	17	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T15	T31	3094574
NA	CHEMICAL	GENE-N	19	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T15	T32	3094574
NA	CHEMICAL	GENE-Y	19	23	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T15	T33	3094574
NA	CHEMICAL	GENE-N	19	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T15	T34	3094574
NA	CHEMICAL	GENE-N	22	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T16	T29	3094574
NA	CHEMICAL	GENE-Y	22	14	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T16	T30	3094574
NA	CHEMICAL	GENE-N	22	17	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T16	T31	3094574
NA	CHEMICAL	GENE-N	22	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T16	T32	3094574
NA	CHEMICAL	GENE-Y	22	23	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T16	T33	3094574
NA	CHEMICAL	GENE-N	22	12	None of the following enzymes tested catalyzed the new reaction : chemical oxidase , gene , chemical dismutase , chemical oxidase , chemical beta-hydroxylase , and gene .	T16	T34	3094574
NA	CHEMICAL	GENE-N	0	1	chemical oxidase inhibitors such as chemical , chemical , and chemical inhibited the reaction drastically , suggesting the participation of the active site chemical of the enzyme in the catalysis .	T17	T35	3094574
CPR:4	CHEMICAL	GENE-N	5	1	chemical oxidase inhibitors such as chemical , chemical , and chemical inhibited the reaction drastically , suggesting the participation of the active site chemical of the enzyme in the catalysis .	T18	T35	3094574
CPR:4	CHEMICAL	GENE-N	7	1	chemical oxidase inhibitors such as chemical , chemical , and chemical inhibited the reaction drastically , suggesting the participation of the active site chemical of the enzyme in the catalysis .	T19	T35	3094574
CPR:4	CHEMICAL	GENE-N	10	1	chemical oxidase inhibitors such as chemical , chemical , and chemical inhibited the reaction drastically , suggesting the participation of the active site chemical of the enzyme in the catalysis .	T20	T35	3094574
NA	CHEMICAL	GENE-N	23	1	chemical oxidase inhibitors such as chemical , chemical , and chemical inhibited the reaction drastically , suggesting the participation of the active site chemical of the enzyme in the catalysis .	T21	T35	3094574
CPR:4	CHEMICAL	GENE-Y	0	2	chemical , a well-known competitive inhibitor of gene , competitively inhibited the new reaction also .	T22	T36	3094574
NA	CHEMICAL	GENE-N	2	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T7	T31	15198222
NA	CHEMICAL	GENE-Y	2	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T7	T17	15198222
NA	CHEMICAL	GENE-Y	2	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T7	T18	15198222
NA	CHEMICAL	GENE-N	4	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T8	T31	15198222
NA	CHEMICAL	GENE-Y	4	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T8	T17	15198222
NA	CHEMICAL	GENE-Y	4	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T8	T18	15198222
NA	CHEMICAL	GENE-N	6	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T9	T31	15198222
NA	CHEMICAL	GENE-Y	6	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T9	T17	15198222
NA	CHEMICAL	GENE-Y	6	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T9	T18	15198222
NA	CHEMICAL	GENE-N	8	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T10	T31	15198222
NA	CHEMICAL	GENE-Y	8	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T10	T17	15198222
NA	CHEMICAL	GENE-Y	8	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T10	T18	15198222
NA	CHEMICAL	GENE-N	10	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T11	T31	15198222
NA	CHEMICAL	GENE-Y	10	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T11	T17	15198222
NA	CHEMICAL	GENE-Y	10	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T11	T18	15198222
NA	CHEMICAL	GENE-N	13	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T12	T31	15198222
NA	CHEMICAL	GENE-Y	13	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T12	T17	15198222
NA	CHEMICAL	GENE-Y	13	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T12	T18	15198222
NA	CHEMICAL	GENE-N	22	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T13	T31	15198222
CPR:4	CHEMICAL	GENE-Y	22	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T13	T17	15198222
CPR:4	CHEMICAL	GENE-Y	22	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T13	T18	15198222
NA	CHEMICAL	GENE-N	24	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T14	T31	15198222
CPR:4	CHEMICAL	GENE-Y	24	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T14	T17	15198222
CPR:4	CHEMICAL	GENE-Y	24	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T14	T18	15198222
NA	CHEMICAL	GENE-N	26	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T15	T31	15198222
CPR:4	CHEMICAL	GENE-Y	26	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T15	T17	15198222
CPR:4	CHEMICAL	GENE-Y	26	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T15	T18	15198222
NA	CHEMICAL	GENE-N	28	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T16	T31	15198222
CPR:4	CHEMICAL	GENE-Y	28	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T16	T17	15198222
CPR:4	CHEMICAL	GENE-Y	28	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T16	T18	15198222
NA	CHEMICAL	GENE-N	8	18	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T1	T31	15198222
CPR:4	CHEMICAL	GENE-Y	8	41	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T1	T17	15198222
CPR:4	CHEMICAL	GENE-Y	8	43	RESULTS : chemical , chemical , chemical , chemical , chemical , and chemical had little selectivity toward gene isozymes , whereas chemical , chemical , chemical , chemical , and chemical had more than 5 times greater preference for inhibiting gene than gene .	T1	T18	15198222
CPR:4	CHEMICAL	GENE-Y	5	5	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T2	T22	15198222
NA	CHEMICAL	GENE-Y	5	25	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T2	T23	15198222
CPR:4	CHEMICAL	GENE-Y	12	5	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T3	T22	15198222
NA	CHEMICAL	GENE-Y	12	25	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T3	T23	15198222
CPR:4	CHEMICAL	GENE-Y	15	5	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T4	T22	15198222
NA	CHEMICAL	GENE-Y	15	25	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T4	T23	15198222
NA	CHEMICAL	GENE-Y	17	5	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T5	T22	15198222
CPR:4	CHEMICAL	GENE-Y	17	25	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T5	T23	15198222
NA	CHEMICAL	GENE-Y	19	5	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T6	T22	15198222
CPR:4	CHEMICAL	GENE-Y	19	25	CONCLUSIONS AND CLINICAL RELEVANCE : gene was selectively inhibited by chemical , chemical , and chemical ; chemical and chemical also appeared to be preferential gene inhibitors in dogs .	T6	T23	15198222
NA	CHEMICAL	GENE-N	3	14	Increased productivity of chemical in the Str ( r ) mutant ( containing the gene mutation in the gene protein ) may be a result of an aberrant protein synthesis mechanism .	T9	T17	14602594
NA	CHEMICAL	GENE-Y	3	18	Increased productivity of chemical in the Str ( r ) mutant ( containing the gene mutation in the gene protein ) may be a result of an aberrant protein synthesis mechanism .	T9	T18	14602594
NA	CHEMICAL	GENE-N	12	1	The gene mutant ribosome was characterized by increased gene stability in low chemical concentrations .	T2	T10	14602594
NA	CHEMICAL	GENE-N	12	8	The gene mutant ribosome was characterized by increased gene stability in low chemical concentrations .	T2	T11	14602594
NA	CHEMICAL	GENE-N	5	6	Molecular and functional characterization of chemical-containing monooxygenases in cynomolgus macaque .	T11	T50	23623750
NA	CHEMICAL	GENE-N	0	1	chemical-containing monooxygenases ( gene ) , drug-metabolizing enzymes essential for the metabolism of endogenous biochemicals and foreign compounds , have been characterized in human ( including gene and gene ) , but remain to be investigated in cynomolgus macaque .	T1	T12	23623750
NA	CHEMICAL	GENE-N	0	3	chemical-containing monooxygenases ( gene ) , drug-metabolizing enzymes essential for the metabolism of endogenous biochemicals and foreign compounds , have been characterized in human ( including gene and gene ) , but remain to be investigated in cynomolgus macaque .	T1	T32	23623750
NA	CHEMICAL	GENE-N	0	26	chemical-containing monooxygenases ( gene ) , drug-metabolizing enzymes essential for the metabolism of endogenous biochemicals and foreign compounds , have been characterized in human ( including gene and gene ) , but remain to be investigated in cynomolgus macaque .	T1	T28	23623750
NA	CHEMICAL	GENE-Y	0	28	chemical-containing monooxygenases ( gene ) , drug-metabolizing enzymes essential for the metabolism of endogenous biochemicals and foreign compounds , have been characterized in human ( including gene and gene ) , but remain to be investigated in cynomolgus macaque .	T1	T29	23623750
NA	CHEMICAL	GENE-N	0	4	chemical sequences of cynomolgus gene , respectively , shared high sequence identities ( 94-98 % ) and were closely clustered in a phylogenetic tree , with gene .	T9	T33	23623750
NA	CHEMICAL	GENE-N	0	26	chemical sequences of cynomolgus gene , respectively , shared high sequence identities ( 94-98 % ) and were closely clustered in a phylogenetic tree , with gene .	T9	T34	23623750
CPR:9	CHEMICAL	GENE-Y	9	0	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T46	23623750
CPR:9	CHEMICAL	GENE-Y	9	2	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T47	23623750
CPR:9	CHEMICAL	GENE-Y	9	4	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T48	23623750
CPR:9	CHEMICAL	GENE-Y	9	7	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T49	23623750
NA	CHEMICAL	GENE-Y	9	12	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T13	23623750
NA	CHEMICAL	GENE-Y	9	12	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T14	23623750
NA	CHEMICAL	GENE-Y	9	14	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T10	T15	23623750
NA	CHEMICAL	GENE-Y	17	0	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T46	23623750
NA	CHEMICAL	GENE-Y	17	2	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T47	23623750
NA	CHEMICAL	GENE-Y	17	4	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T48	23623750
NA	CHEMICAL	GENE-Y	17	7	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T49	23623750
CPR:9	CHEMICAL	GENE-Y	17	12	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T13	23623750
CPR:9	CHEMICAL	GENE-Y	17	12	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T14	23623750
CPR:9	CHEMICAL	GENE-Y	17	14	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T2	T15	23623750
NA	CHEMICAL	GENE-Y	19	0	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T46	23623750
NA	CHEMICAL	GENE-Y	19	2	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T47	23623750
NA	CHEMICAL	GENE-Y	19	4	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T48	23623750
NA	CHEMICAL	GENE-Y	19	7	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T49	23623750
CPR:9	CHEMICAL	GENE-Y	19	12	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T13	23623750
CPR:9	CHEMICAL	GENE-Y	19	12	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T14	23623750
CPR:9	CHEMICAL	GENE-Y	19	14	gene , gene , gene , and gene metabolized chemical , and gene/gene and gene also metabolized chemical and chemical , respectively .	T3	T15	23623750
CPR:9	CHEMICAL	GENE-Y	33	7	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T4	T16	23623750
NA	CHEMICAL	GENE-Y	33	24	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T4	T17	23623750
NA	CHEMICAL	GENE-Y	33	44	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T4	T18	23623750
NA	CHEMICAL	GENE-Y	33	7	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T6	T16	23623750
NA	CHEMICAL	GENE-Y	33	24	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T6	T17	23623750
CPR:9	CHEMICAL	GENE-Y	33	44	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T6	T18	23623750
NA	CHEMICAL	GENE-Y	2	7	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T7	T16	23623750
NA	CHEMICAL	GENE-Y	2	24	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T7	T17	23623750
CPR:9	CHEMICAL	GENE-Y	2	44	Rates of chemical chemical-oxygenation ( catalyzed by gene ) varied ( approximately 20-fold ) among the 28 cynomolgus livers and were significantly correlated with gene protein expression , indicating that the inter-animal variations in chemical chemical-oxygenation might be partly accounted for by the variable gene expression .	T7	T18	23623750
CPR:9	CHEMICAL	GENE-Y	2	0	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T19	23623750
NA	CHEMICAL	GENE-Y	2	10	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T20	23623750
NA	CHEMICAL	GENE-Y	2	18	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T21	23623750
CPR:9	CHEMICAL	GENE-Y	2	25	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T22	23623750
CPR:9	CHEMICAL	GENE-Y	2	27	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T23	23623750
CPR:9	CHEMICAL	GENE-Y	2	29	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T24	23623750
CPR:9	CHEMICAL	GENE-Y	2	32	gene metabolized chemical only slightly , but minimal expression of gene in all tissue precludes the importance of gene in drug metabolism , unlike cynomolgus gene , gene , gene , and gene which were all functional .	T8	T25	23623750
CPR:4	CHEMICAL	GENE-Y	13	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T5	T21	23008503
NA	CHEMICAL	GENE-Y	13	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T5	T22	23008503
NA	CHEMICAL	GENE-N	13	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T5	T23	23008503
NA	CHEMICAL	GENE-N	13	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T5	T24	23008503
CPR:4	CHEMICAL	GENE-Y	15	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T6	T21	23008503
NA	CHEMICAL	GENE-Y	15	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T6	T22	23008503
NA	CHEMICAL	GENE-N	15	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T6	T23	23008503
NA	CHEMICAL	GENE-N	15	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T6	T24	23008503
NA	CHEMICAL	GENE-Y	20	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T7	T21	23008503
CPR:4	CHEMICAL	GENE-Y	20	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T7	T22	23008503
NA	CHEMICAL	GENE-N	20	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T7	T23	23008503
NA	CHEMICAL	GENE-N	20	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T7	T24	23008503
NA	CHEMICAL	GENE-Y	22	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T8	T21	23008503
CPR:4	CHEMICAL	GENE-Y	22	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T8	T22	23008503
NA	CHEMICAL	GENE-N	22	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T8	T23	23008503
NA	CHEMICAL	GENE-N	22	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T8	T24	23008503
NA	CHEMICAL	GENE-Y	2	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T9	T21	23008503
NA	CHEMICAL	GENE-Y	2	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T9	T22	23008503
NA	CHEMICAL	GENE-N	2	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T9	T23	23008503
NA	CHEMICAL	GENE-N	2	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T9	T24	23008503
NA	CHEMICAL	GENE-Y	6	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T10	T21	23008503
NA	CHEMICAL	GENE-Y	6	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T10	T22	23008503
NA	CHEMICAL	GENE-N	6	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T10	T23	23008503
NA	CHEMICAL	GENE-N	6	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T10	T24	23008503
NA	CHEMICAL	GENE-Y	6	5	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T11	T21	23008503
NA	CHEMICAL	GENE-Y	6	18	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T11	T22	23008503
NA	CHEMICAL	GENE-N	6	41	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T11	T23	23008503
NA	CHEMICAL	GENE-N	6	58	We examined in cats the 1 ) ulcerogenic effects of selective gene ( chemical , chemical ) and gene ( chemical , chemical ) inhibitors on the gastrointestinal mucosa , 2 ) effect of feeding and chemical on the expression of gene isoforms and chemical ( chemical ) level in the duodenum , and 3 ) localization of gene isoforms in the duodenum .	T11	T24	23008503
NA	CHEMICAL	GENE-N	6	4	Localization and expression of gene isoforms ( by immunohistochemistry , Western blot ) and chemical level ( by enzyme immunoassay ) were examined .	T12	T26	23008503
NA	CHEMICAL	GENE-N	11	8	Second , feeding increased both the expression of gene isoforms and chemical level in the duodenum , and the effects were markedly inhibited by pretreatment with chemical .	T3	T14	23008503
CPR:4	CHEMICAL	GENE-N	13	8	Second , feeding increased both the expression of gene isoforms and chemical level in the duodenum , and the effects were markedly inhibited by pretreatment with chemical .	T4	T14	23008503
NA	CHEMICAL	GENE-Y	6	0	gene knockout mice exhibit impaired adipocyte chemical-dependent insulinotropic polypeptide receptor ( gene ) expression .	T7	T64	23002036
NA	CHEMICAL	GENE-Y	6	9	gene knockout mice exhibit impaired adipocyte chemical-dependent insulinotropic polypeptide receptor ( gene ) expression .	T7	T66	23002036
NA	CHEMICAL	GENE-Y	6	11	gene knockout mice exhibit impaired adipocyte chemical-dependent insulinotropic polypeptide receptor ( gene ) expression .	T7	T65	23002036
NA	CHEMICAL	GENE-Y	0	2	chemical-dependent insulinotropic polypeptide ( gene ) is an gene that also plays a regulatory role in fat metabolism .	T1	T8	23002036
NA	CHEMICAL	GENE-Y	0	4	chemical-dependent insulinotropic polypeptide ( gene ) is an gene that also plays a regulatory role in fat metabolism .	T1	T41	23002036
NA	CHEMICAL	GENE-N	0	8	chemical-dependent insulinotropic polypeptide ( gene ) is an gene that also plays a regulatory role in fat metabolism .	T1	T45	23002036
NA	CHEMICAL	GENE-Y	38	4	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T24	23002036
NA	CHEMICAL	GENE-Y	38	13	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T31	23002036
NA	CHEMICAL	GENE-Y	38	9	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T32	23002036
NA	CHEMICAL	GENE-Y	38	18	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T33	23002036
NA	CHEMICAL	GENE-Y	38	25	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T34	23002036
NA	CHEMICAL	GENE-Y	38	27	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T35	23002036
NA	CHEMICAL	GENE-Y	38	33	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T36	23002036
NA	CHEMICAL	GENE-Y	38	35	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T37	23002036
NA	CHEMICAL	GENE-Y	38	9	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T38	23002036
NA	CHEMICAL	GENE-Y	38	42	In 3T3-L1 cells , gene was demonstrated to be a key mediator of gene stimulation of gene ( gene ) activity , involving activation of gene ( gene ) and reduced phosphorylation of gene ( gene ) and chemical-activated protein kinase ( gene ) .	T5	T39	23002036
NA	CHEMICAL	GENE-Y	30	6	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T43	23002036
NA	CHEMICAL	GENE-Y	30	11	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T44	23002036
NA	CHEMICAL	GENE-Y	30	17	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T46	23002036
NA	CHEMICAL	GENE-Y	30	24	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T47	23002036
NA	CHEMICAL	GENE-Y	30	27	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T48	23002036
NA	CHEMICAL	GENE-Y	30	27	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T49	23002036
NA	CHEMICAL	GENE-Y	30	27	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T50	23002036
NA	CHEMICAL	GENE-Y	30	27	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T51	23002036
NA	CHEMICAL	GENE-Y	30	34	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T52	23002036
NA	CHEMICAL	GENE-Y	30	42	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T53	23002036
NA	CHEMICAL	GENE-Y	30	45	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T54	23002036
NA	CHEMICAL	GENE-Y	30	50	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T55	23002036
NA	CHEMICAL	GENE-Y	30	55	Analysis of primary adipocytes isolated from gene ( -/- ) , gene ( +/- ) , and gene ( +/+ ) mice found that gene stimulated the gene/gene/gene/gene pathway and chemical uptake only in gene ( +/+ ) adipocytes , suggesting that gene signaling and/or gene responsiveness were compromised in gene ( +/- ) and gene ( -/- ) adipocytes .	T6	T56	23002036
NA	CHEMICAL	GENE-Y	6	5	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T63	23002036
NA	CHEMICAL	GENE-Y	6	7	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T9	23002036
NA	CHEMICAL	GENE-Y	6	10	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T10	23002036
NA	CHEMICAL	GENE-Y	6	12	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T11	23002036
NA	CHEMICAL	GENE-N	6	19	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T12	23002036
NA	CHEMICAL	GENE-N	6	21	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T13	23002036
NA	CHEMICAL	GENE-N	6	23	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T14	23002036
NA	CHEMICAL	GENE-N	6	25	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T15	23002036
NA	CHEMICAL	GENE-N	6	35	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T16	23002036
NA	CHEMICAL	GENE-N	6	35	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T17	23002036
NA	CHEMICAL	GENE-Y	6	35	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T18	23002036
NA	CHEMICAL	GENE-Y	6	39	In addition , genes encoding gene ( gene ) , gene ( gene ) , and the signaling proteins gene ( gene ) /gene ( gene ) , were downregulated , and phosphorylated levels of gene/gene/gene were decreased in gene ( -/- ) mice .	T2	T19	23002036
NA	CHEMICAL	GENE-N	7	13	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T3	T20	23002036
NA	CHEMICAL	GENE-N	7	15	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T3	T21	23002036
NA	CHEMICAL	GENE-Y	7	19	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T3	T22	23002036
NA	CHEMICAL	GENE-Y	7	23	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T3	T23	23002036
NA	CHEMICAL	GENE-N	10	13	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T4	T20	23002036
NA	CHEMICAL	GENE-N	10	15	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T4	T21	23002036
NA	CHEMICAL	GENE-Y	10	19	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T4	T22	23002036
NA	CHEMICAL	GENE-Y	10	23	Chromatin immunoprecipitation assays were used to identify a chemical ( chemical ) -response element ( gene ) responsible for gene-mediated transcriptional activation of gene .	T4	T23	23002036
CPR:4	CHEMICAL	GENE-N	2	8	UNLABELLED : chemical is an inhibitor of the gene .	T7	T33	11772142
CPR:4	CHEMICAL	GENE-N	2	7	CONCLUSION : chemical is a well tolerated gene inhibitor .	T18	T31	11772142
NA	CHEMICAL	GENE-N	10	10	We aim to `` tilt '' the stability of the gene structure from a noncanonical conformation to a ( humanized ) type 1 canonical conformation by studying the effect of selected mutations to the chemical sequence of the gene , gene , and proximal residues .	T1	T10	23231492
NA	CHEMICAL	GENE-N	10	22	We aim to `` tilt '' the stability of the gene structure from a noncanonical conformation to a ( humanized ) type 1 canonical conformation by studying the effect of selected mutations to the chemical sequence of the gene , gene , and proximal residues .	T1	T11	23231492
NA	CHEMICAL	GENE-N	10	40	We aim to `` tilt '' the stability of the gene structure from a noncanonical conformation to a ( humanized ) type 1 canonical conformation by studying the effect of selected mutations to the chemical sequence of the gene , gene , and proximal residues .	T1	T12	23231492
NA	CHEMICAL	GENE-Y	25	15	Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by gene enzymes via in vivo and in vitro oxidation of chemical and chemical .	T12	T16	23282066
NA	CHEMICAL	GENE-Y	27	15	Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by gene enzymes via in vivo and in vitro oxidation of chemical and chemical .	T13	T16	23282066
CPR:4	CHEMICAL	GENE-N	2	7	Furthermore , chemical caused mechanism-based inactivation of gene-dependent chemical 1'-hydroxylation in mouse , rat and human intestinal microsomes with similar potencies .	T1	T14	23282066
CPR:9	CHEMICAL	GENE-N	8	7	Furthermore , chemical caused mechanism-based inactivation of gene-dependent chemical 1'-hydroxylation in mouse , rat and human intestinal microsomes with similar potencies .	T2	T14	23282066
NA	CHEMICAL	GENE-Y	20	4	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T41	23341458
NA	CHEMICAL	GENE-Y	20	8	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T42	23341458
NA	CHEMICAL	GENE-N	20	12	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T43	23341458
NA	CHEMICAL	GENE-Y	20	18	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T44	23341458
NA	CHEMICAL	GENE-N	20	35	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T45	23341458
NA	CHEMICAL	GENE-Y	20	38	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T46	23341458
NA	CHEMICAL	GENE-Y	20	44	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T7	T11	23341458
NA	CHEMICAL	GENE-Y	24	4	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T41	23341458
NA	CHEMICAL	GENE-Y	24	8	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T42	23341458
NA	CHEMICAL	GENE-N	24	12	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T43	23341458
NA	CHEMICAL	GENE-Y	24	18	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T44	23341458
NA	CHEMICAL	GENE-N	24	35	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T45	23341458
NA	CHEMICAL	GENE-Y	24	38	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T46	23341458
NA	CHEMICAL	GENE-Y	24	44	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T8	T11	23341458
NA	CHEMICAL	GENE-Y	0	4	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T41	23341458
NA	CHEMICAL	GENE-Y	0	8	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T42	23341458
NA	CHEMICAL	GENE-N	0	12	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T43	23341458
NA	CHEMICAL	GENE-Y	0	18	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T44	23341458
NA	CHEMICAL	GENE-N	0	35	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T45	23341458
NA	CHEMICAL	GENE-Y	0	38	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T46	23341458
NA	CHEMICAL	GENE-Y	0	44	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T9	T11	23341458
NA	CHEMICAL	GENE-Y	44	4	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T41	23341458
NA	CHEMICAL	GENE-Y	44	8	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T42	23341458
NA	CHEMICAL	GENE-N	44	12	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T43	23341458
NA	CHEMICAL	GENE-Y	44	18	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T44	23341458
NA	CHEMICAL	GENE-N	44	35	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T45	23341458
NA	CHEMICAL	GENE-Y	44	38	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T46	23341458
NA	CHEMICAL	GENE-Y	44	44	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T1	T11	23341458
NA	CHEMICAL	GENE-Y	51	4	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T41	23341458
NA	CHEMICAL	GENE-Y	51	8	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T42	23341458
NA	CHEMICAL	GENE-N	51	12	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T43	23341458
NA	CHEMICAL	GENE-Y	51	18	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T44	23341458
NA	CHEMICAL	GENE-N	51	35	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T45	23341458
NA	CHEMICAL	GENE-Y	51	38	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T46	23341458
NA	CHEMICAL	GENE-Y	51	44	chemical-terminal sequencing indicated that gene was cleaved by gene at the canonical gene , giving rise to mature gene ( chemical ( 282 ) ↓chemical ( 283 ) ) , as well as in the chemical-terminal heparin binding region of mature gene , generating a truncated mature gene peptide ( chemical ( 289 ) ↓chemical ( 290 ) ) .	T2	T11	23341458
CPR:6	CHEMICAL	GENE-Y	7	5	Functional and bioenergetic consequences of gene antagonist chemical in hearts with postinfarction LV remodeling .	T7	T14	16775509
NA	CHEMICAL	GENE-Y	20	23	The structural left ventricular ( LV ) remodeling and contractile dysfunction of hearts with postinfarction LV remodeling are benefited by chemical type 1 receptor ( gene ) blocker .	T3	T9	16775509
NA	CHEMICAL	GENE-Y	20	22	The structural left ventricular ( LV ) remodeling and contractile dysfunction of hearts with postinfarction LV remodeling are benefited by chemical type 1 receptor ( gene ) blocker .	T3	T12	16775509
NA	CHEMICAL	GENE-N	14	9	Animals with heart failure demonstrated reductions in both mitochondrial gene expression and myocardial high-energy chemical levels .	T4	T10	16775509
NA	CHEMICAL	GENE-N	9	16	Our previous study showed that the stimulatory effect of chemical on VSMC proliferation is inhibited by gene and the gene , a member of the gene family .	T7	T23	19293728
NA	CHEMICAL	GENE-Y	9	19	Our previous study showed that the stimulatory effect of chemical on VSMC proliferation is inhibited by gene and the gene , a member of the gene family .	T7	T24	19293728
NA	CHEMICAL	GENE-N	9	25	Our previous study showed that the stimulatory effect of chemical on VSMC proliferation is inhibited by gene and the gene , a member of the gene family .	T7	T25	19293728
NA	CHEMICAL	GENE-N	21	16	Our previous study showed that the stimulatory effect of chemical on VSMC proliferation is inhibited by gene and the gene , a member of the gene family .	T8	T23	19293728
NA	CHEMICAL	GENE-Y	21	19	Our previous study showed that the stimulatory effect of chemical on VSMC proliferation is inhibited by gene and the gene , a member of the gene family .	T8	T24	19293728
NA	CHEMICAL	GENE-N	21	25	Our previous study showed that the stimulatory effect of chemical on VSMC proliferation is inhibited by gene and the gene , a member of the gene family .	T8	T25	19293728
NA	CHEMICAL	GENE-Y	7	10	METHODS : VSMC proliferation was determined by chemical incorporation ; gene mRNA and protein expressions were determined by RT-PCR , immunoblotting , and immunohistochemistry .	T9	T33	19293728
NA	CHEMICAL	GENE-Y	6	2	RESULTS : gene increased VSMC proliferation in immortalized aortic A10 cells , determined by chemical incorporation .	T1	T34	19293728
NA	CHEMICAL	GENE-N	8	2	Although the gene , by itself , had no effect on VSMC proliferation , stimulation with chemical , a gene agonist , inhibited the stimulatory effect of gene .	T2	T10	19293728
CPR:5	CHEMICAL	GENE-N	8	19	Although the gene , by itself , had no effect on VSMC proliferation , stimulation with chemical , a gene agonist , inhibited the stimulatory effect of gene .	T2	T11	19293728
CPR:4	CHEMICAL	GENE-Y	8	27	Although the gene , by itself , had no effect on VSMC proliferation , stimulation with chemical , a gene agonist , inhibited the stimulatory effect of gene .	T2	T12	19293728
CPR:4	CHEMICAL	GENE-Y	4	6	The inhibitory effect of chemical on gene-mediated VSMC proliferation was receptor specific , because its effect could be blocked by chemical , a gene antagonist .	T3	T13	19293728
NA	CHEMICAL	GENE-N	4	10	The inhibitory effect of chemical on gene-mediated VSMC proliferation was receptor specific , because its effect could be blocked by chemical , a gene antagonist .	T3	T14	19293728
NA	CHEMICAL	GENE-Y	20	6	The inhibitory effect of chemical on gene-mediated VSMC proliferation was receptor specific , because its effect could be blocked by chemical , a gene antagonist .	T4	T13	19293728
CPR:6	CHEMICAL	GENE-N	20	10	The inhibitory effect of chemical on gene-mediated VSMC proliferation was receptor specific , because its effect could be blocked by chemical , a gene antagonist .	T4	T14	19293728
CPR:4	CHEMICAL	GENE-Y	0	3	chemical also inhibited gene mRNA and protein expression , which was time dependent and concentration dependent .	T5	T15	19293728
NA	CHEMICAL	GENE-N	10	1	A gene or gene inhibitor blocked the inhibitory effect of chemical on gene expression , indicating that gene and gene were involved in the signaling pathway .	T6	T16	19293728
NA	CHEMICAL	GENE-N	10	3	A gene or gene inhibitor blocked the inhibitory effect of chemical on gene expression , indicating that gene and gene were involved in the signaling pathway .	T6	T17	19293728
CPR:4	CHEMICAL	GENE-Y	10	2	A gene or gene inhibitor blocked the inhibitory effect of chemical on gene expression , indicating that gene and gene were involved in the signaling pathway .	T6	T18	19293728
NA	CHEMICAL	GENE-N	10	17	A gene or gene inhibitor blocked the inhibitory effect of chemical on gene expression , indicating that gene and gene were involved in the signaling pathway .	T6	T19	19293728
NA	CHEMICAL	GENE-N	10	19	A gene or gene inhibitor blocked the inhibitory effect of chemical on gene expression , indicating that gene and gene were involved in the signaling pathway .	T6	T20	19293728
NA	CHEMICAL	GENE-Y	10	15	This study was designed to investigate the delayed effects of chemical and treadmill exercise on gene activity , lipid peroxidation and histology of peripheral tissues of mice .	T7	T18	10942908
CPR:4	CHEMICAL	GENE-Y	4	9	The group treated with chemical alone showed decreased plasma gene ( gene ) activity ( 87 % of control ) , whereas chemical plus exercise significantly decreased the gene activity ( 79 % of control ) , indicating an interactive effect of the combination .	T12	T19	10942908
CPR:4	CHEMICAL	GENE-Y	4	11	The group treated with chemical alone showed decreased plasma gene ( gene ) activity ( 87 % of control ) , whereas chemical plus exercise significantly decreased the gene activity ( 79 % of control ) , indicating an interactive effect of the combination .	T12	T20	10942908
NA	CHEMICAL	GENE-Y	4	28	The group treated with chemical alone showed decreased plasma gene ( gene ) activity ( 87 % of control ) , whereas chemical plus exercise significantly decreased the gene activity ( 79 % of control ) , indicating an interactive effect of the combination .	T12	T21	10942908
NA	CHEMICAL	GENE-Y	22	9	The group treated with chemical alone showed decreased plasma gene ( gene ) activity ( 87 % of control ) , whereas chemical plus exercise significantly decreased the gene activity ( 79 % of control ) , indicating an interactive effect of the combination .	T13	T19	10942908
NA	CHEMICAL	GENE-Y	22	11	The group treated with chemical alone showed decreased plasma gene ( gene ) activity ( 87 % of control ) , whereas chemical plus exercise significantly decreased the gene activity ( 79 % of control ) , indicating an interactive effect of the combination .	T13	T20	10942908
CPR:4	CHEMICAL	GENE-Y	22	28	The group treated with chemical alone showed decreased plasma gene ( gene ) activity ( 87 % of control ) , whereas chemical plus exercise significantly decreased the gene activity ( 79 % of control ) , indicating an interactive effect of the combination .	T13	T21	10942908
CPR:4	CHEMICAL	GENE-Y	2	2	However , gene activity in triceps muscle decreased significantly ( 78 % of control ) in the group treated with chemical plus exercise .	T1	T16	10942908
NA	CHEMICAL	GENE-N	0	1	chemical phosphokinase activity in plasma increased slightly ( compared to control , chemical or exercise group ) in mice treated with chemical plus exercise , which may be indicative of perturbation in the integrity of the skeletal muscle due to combination .	T2	T17	10942908
CPR:3	CHEMICAL	GENE-N	3	1	chemical phosphokinase activity in plasma increased slightly ( compared to control , chemical or exercise group ) in mice treated with chemical plus exercise , which may be indicative of perturbation in the integrity of the skeletal muscle due to combination .	T3	T17	10942908
CPR:3	CHEMICAL	GENE-N	3	1	chemical phosphokinase activity in plasma increased slightly ( compared to control , chemical or exercise group ) in mice treated with chemical plus exercise , which may be indicative of perturbation in the integrity of the skeletal muscle due to combination .	T4	T17	10942908
CPR:6	CHEMICAL	GENE-Y	5	10	Inhibition of platelet aggregation by chemical , a reversible oral gene receptor antagonist , compared with chemical in patients with acute coronary syndromes .	T28	T30	17980251
CPR:6	CHEMICAL	GENE-Y	16	10	Inhibition of platelet aggregation by chemical , a reversible oral gene receptor antagonist , compared with chemical in patients with acute coronary syndromes .	T27	T30	17980251
CPR:6	CHEMICAL	GENE-Y	0	5	chemical is a reversible oral gene receptor antagonist that has been studied in ACS patients in comparison with chemical ( DISPERSE-2 study ) .	T20	T29	17980251
CPR:6	CHEMICAL	GENE-Y	18	5	chemical is a reversible oral gene receptor antagonist that has been studied in ACS patients in comparison with chemical ( DISPERSE-2 study ) .	T21	T29	17980251
NA	CHEMICAL	GENE-N	22	6	This article summarizes some findings of a research that I have pursued for the past 25 years , whose roots are immersed in the field of inherited metabolic disorders , and deal with different aspects of the vitamin chemical , starting with a patient with multiple gene deficiency ( MCD ) .	T5	T13	16359899
CPR:3	CHEMICAL	GENE-Y	7	1	On the other hand , gene ( gene ) mRNA levels were markedly low in the deficient animals , and increased upon chemical injection .	T1	T9	16359899
CPR:3	CHEMICAL	GENE-Y	7	7	On the other hand , gene ( gene ) mRNA levels were markedly low in the deficient animals , and increased upon chemical injection .	T1	T10	16359899
NA	CHEMICAL	GENE-N	0	12	chemical D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via gene phosphorylation .	T22	T38	18973551
NA	CHEMICAL	GENE-Y	2	15	Clinical improvements in Parkinson 's disease produced by chemical D3 receptor-preferring agonists have been related to their neuroprotective actions and , more recently , to their neuroregenerative properties .	T16	T34	18973551
NA	CHEMICAL	GENE-N	6	23	However , it is unclear whether chemical agonists produce their neurotrophic effects by acting directly on receptors expressed by the mesencephalic dopaminergic neurons or indirectly on receptors expressed by astrocytes , via release of gene .	T12	T32	18973551
NA	CHEMICAL	GENE-Y	10	21	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T13	T35	18973551
NA	CHEMICAL	GENE-Y	10	39	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T13	T36	18973551
NA	CHEMICAL	GENE-Y	14	21	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T14	T35	18973551
NA	CHEMICAL	GENE-Y	14	39	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T14	T36	18973551
NA	CHEMICAL	GENE-Y	3	21	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T15	T35	18973551
NA	CHEMICAL	GENE-Y	3	39	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T15	T36	18973551
NA	CHEMICAL	GENE-Y	18	21	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T17	T35	18973551
NA	CHEMICAL	GENE-Y	18	39	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T17	T36	18973551
NA	CHEMICAL	GENE-Y	28	21	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T18	T35	18973551
NA	CHEMICAL	GENE-Y	28	39	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T18	T36	18973551
NA	CHEMICAL	GENE-Y	35	21	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T19	T35	18973551
NA	CHEMICAL	GENE-Y	35	39	In this study , we investigated the effects of the chemical D3 receptor-preferring agonists chemical and chemical ( chemical ) , as well as of the indirect agonist chemical , on dopaminergic neurons identified by chemical hydroxylase immunoreactivity ( gene-IR ) .	T19	T36	18973551
NA	CHEMICAL	GENE-Y	7	48	After 3 days of incubation , both chemical ( 1-10 microm ) and chemical ( 5-500 nm ) dose-dependently increased the maximal dendrite length ( P < 0.001 ) , number of primary dendrites ( P < 0.01 ) and chemical uptake ( P < 0.01 ) of gene-IR-positive mesencephalic neurons .	T20	T23	18973551
NA	CHEMICAL	GENE-Y	13	48	After 3 days of incubation , both chemical ( 1-10 microm ) and chemical ( 5-500 nm ) dose-dependently increased the maximal dendrite length ( P < 0.001 ) , number of primary dendrites ( P < 0.01 ) and chemical uptake ( P < 0.01 ) of gene-IR-positive mesencephalic neurons .	T21	T23	18973551
NA	CHEMICAL	GENE-Y	1	48	After 3 days of incubation , both chemical ( 1-10 microm ) and chemical ( 5-500 nm ) dose-dependently increased the maximal dendrite length ( P < 0.001 ) , number of primary dendrites ( P < 0.01 ) and chemical uptake ( P < 0.01 ) of gene-IR-positive mesencephalic neurons .	T1	T23	18973551
NA	CHEMICAL	GENE-N	10	8	All neurotrophic effects were blocked by the unselective gene antagonist chemical ( 5 microm ) and by the selective gene antagonist chemical at a low dose ( 50 nm ) .	T3	T24	18973551
NA	CHEMICAL	GENE-Y	10	19	All neurotrophic effects were blocked by the unselective gene antagonist chemical ( 5 microm ) and by the selective gene antagonist chemical at a low dose ( 50 nm ) .	T3	T25	18973551
NA	CHEMICAL	GENE-N	21	8	All neurotrophic effects were blocked by the unselective gene antagonist chemical ( 5 microm ) and by the selective gene antagonist chemical at a low dose ( 50 nm ) .	T4	T24	18973551
CPR:6	CHEMICAL	GENE-Y	21	19	All neurotrophic effects were blocked by the unselective gene antagonist chemical ( 5 microm ) and by the selective gene antagonist chemical at a low dose ( 50 nm ) .	T4	T25	18973551
CPR:3	CHEMICAL	GENE-N	0	8	chemical and chemical also increased the phosphorylation of gene ( gene ) within minutes , an effect blocked by pretreatment with chemical .	T5	T26	18973551
CPR:3	CHEMICAL	GENE-N	0	10	chemical and chemical also increased the phosphorylation of gene ( gene ) within minutes , an effect blocked by pretreatment with chemical .	T5	T27	18973551
CPR:3	CHEMICAL	GENE-N	2	8	chemical and chemical also increased the phosphorylation of gene ( gene ) within minutes , an effect blocked by pretreatment with chemical .	T6	T26	18973551
CPR:3	CHEMICAL	GENE-N	2	10	chemical and chemical also increased the phosphorylation of gene ( gene ) within minutes , an effect blocked by pretreatment with chemical .	T6	T27	18973551
CPR:4	CHEMICAL	GENE-N	21	8	chemical and chemical also increased the phosphorylation of gene ( gene ) within minutes , an effect blocked by pretreatment with chemical .	T7	T26	18973551
CPR:4	CHEMICAL	GENE-N	21	10	chemical and chemical also increased the phosphorylation of gene ( gene ) within minutes , an effect blocked by pretreatment with chemical .	T7	T27	18973551
NA	CHEMICAL	GENE-N	11	3	Inhibition of the gene signalling pathway to gene was obtained with chemical , chemical or chemical , resulting in blockade of neurotrophic effects .	T8	T28	18973551
NA	CHEMICAL	GENE-N	11	7	Inhibition of the gene signalling pathway to gene was obtained with chemical , chemical or chemical , resulting in blockade of neurotrophic effects .	T8	T29	18973551
NA	CHEMICAL	GENE-N	13	3	Inhibition of the gene signalling pathway to gene was obtained with chemical , chemical or chemical , resulting in blockade of neurotrophic effects .	T9	T28	18973551
NA	CHEMICAL	GENE-N	13	7	Inhibition of the gene signalling pathway to gene was obtained with chemical , chemical or chemical , resulting in blockade of neurotrophic effects .	T9	T29	18973551
NA	CHEMICAL	GENE-N	15	3	Inhibition of the gene signalling pathway to gene was obtained with chemical , chemical or chemical , resulting in blockade of neurotrophic effects .	T10	T28	18973551
NA	CHEMICAL	GENE-N	15	7	Inhibition of the gene signalling pathway to gene was obtained with chemical , chemical or chemical , resulting in blockade of neurotrophic effects .	T10	T29	18973551
CPR:4	CHEMICAL	GENE-Y	10	0	gene ( gene ) gene expression is negatively regulated by chemical without direct binding of chemical receptor to the gene promoter .	T9	T33	23221600
CPR:4	CHEMICAL	GENE-Y	10	2	gene ( gene ) gene expression is negatively regulated by chemical without direct binding of chemical receptor to the gene promoter .	T9	T35	23221600
NA	CHEMICAL	GENE-N	10	16	gene ( gene ) gene expression is negatively regulated by chemical without direct binding of chemical receptor to the gene promoter .	T9	T34	23221600
NA	CHEMICAL	GENE-Y	15	0	gene ( gene ) gene expression is negatively regulated by chemical without direct binding of chemical receptor to the gene promoter .	T7	T33	23221600
NA	CHEMICAL	GENE-Y	15	2	gene ( gene ) gene expression is negatively regulated by chemical without direct binding of chemical receptor to the gene promoter .	T7	T35	23221600
NA	CHEMICAL	GENE-N	15	16	gene ( gene ) gene expression is negatively regulated by chemical without direct binding of chemical receptor to the gene promoter .	T7	T34	23221600
NA	CHEMICAL	GENE-Y	0	1	chemical desaturase-1 ( gene ) plays a pivotal role in an increase of chemical by an excess of dietary chemical intake .	T1	T10	23221600
NA	CHEMICAL	GENE-Y	0	3	chemical desaturase-1 ( gene ) plays a pivotal role in an increase of chemical by an excess of dietary chemical intake .	T1	T22	23221600
NA	CHEMICAL	GENE-Y	13	1	chemical desaturase-1 ( gene ) plays a pivotal role in an increase of chemical by an excess of dietary chemical intake .	T6	T10	23221600
NA	CHEMICAL	GENE-Y	13	3	chemical desaturase-1 ( gene ) plays a pivotal role in an increase of chemical by an excess of dietary chemical intake .	T6	T22	23221600
NA	CHEMICAL	GENE-Y	3	1	chemical desaturase-1 ( gene ) plays a pivotal role in an increase of chemical by an excess of dietary chemical intake .	T2	T10	23221600
NA	CHEMICAL	GENE-Y	3	3	chemical desaturase-1 ( gene ) plays a pivotal role in an increase of chemical by an excess of dietary chemical intake .	T2	T22	23221600
CPR:3	CHEMICAL	GENE-Y	1	3	Dietary chemical increase gene gene expression in liver by chemical response element binding protein ( SREBP ) -1c-dependent and gene -independent pathways .	T3	T19	23221600
NA	CHEMICAL	GENE-Y	1	14	Dietary chemical increase gene gene expression in liver by chemical response element binding protein ( SREBP ) -1c-dependent and gene -independent pathways .	T3	T20	23221600
NA	CHEMICAL	GENE-Y	1	15	Dietary chemical increase gene gene expression in liver by chemical response element binding protein ( SREBP ) -1c-dependent and gene -independent pathways .	T3	T21	23221600
NA	CHEMICAL	GENE-Y	9	3	Dietary chemical increase gene gene expression in liver by chemical response element binding protein ( SREBP ) -1c-dependent and gene -independent pathways .	T4	T19	23221600
NA	CHEMICAL	GENE-Y	9	14	Dietary chemical increase gene gene expression in liver by chemical response element binding protein ( SREBP ) -1c-dependent and gene -independent pathways .	T4	T20	23221600
NA	CHEMICAL	GENE-Y	9	15	Dietary chemical increase gene gene expression in liver by chemical response element binding protein ( SREBP ) -1c-dependent and gene -independent pathways .	T4	T21	23221600
CPR:4	CHEMICAL	GENE-N	4	10	Previous report demonstrated that chemical ( TH ) negatively regulates gene before gene was revealed .	T5	T23	23221600
NA	CHEMICAL	GENE-Y	4	12	Previous report demonstrated that chemical ( TH ) negatively regulates gene before gene was revealed .	T5	T24	23221600
NA	CHEMICAL	GENE-Y	0	4	chemical : chemical Oxidoreductase 1 Inducer Activity of Some Saudi Arabian Medicinal Plants .	T13	T19	23512501
NA	CHEMICAL	GENE-Y	2	4	chemical : chemical Oxidoreductase 1 Inducer Activity of Some Saudi Arabian Medicinal Plants .	T14	T19	23512501
NA	CHEMICAL	GENE-N	6	9	One such multifunctional cytoprotective enzyme is chemical : chemical oxidoreductase .	T7	T16	23512501
NA	CHEMICAL	GENE-N	8	9	One such multifunctional cytoprotective enzyme is chemical : chemical oxidoreductase .	T8	T16	23512501
NA	CHEMICAL	GENE-N	26	29	In this study , we prepared extracts of 27 Saudi Arabian medicinal plants which belong to 18 different plant families and tested their ability to induce chemical : chemical oxidoreductase in murine hepatoma cells grown in microtiter plate wells .	T9	T17	23512501
NA	CHEMICAL	GENE-N	28	29	In this study , we prepared extracts of 27 Saudi Arabian medicinal plants which belong to 18 different plant families and tested their ability to induce chemical : chemical oxidoreductase in murine hepatoma cells grown in microtiter plate wells .	T10	T17	23512501
NA	CHEMICAL	GENE-N	10	6	In addition to the Brassicaceae , a known source of chemical : chemical oxidoreductase inducer activity , we found substantial inducer activity in extracts from the Apiaceae , Apocynaceae , and the Asteraceae families .	T11	T18	23512501
NA	CHEMICAL	GENE-N	12	6	In addition to the Brassicaceae , a known source of chemical : chemical oxidoreductase inducer activity , we found substantial inducer activity in extracts from the Apiaceae , Apocynaceae , and the Asteraceae families .	T12	T18	23512501
NA	CHEMICAL	GENE-Y	5	0	gene ( gene/gene ) mediates chemical-induced flushing .	T17	T30	16322797
NA	CHEMICAL	GENE-Y	5	2	gene ( gene/gene ) mediates chemical-induced flushing .	T17	T32	16322797
NA	CHEMICAL	GENE-Y	5	2	gene ( gene/gene ) mediates chemical-induced flushing .	T17	T31	16322797
NA	CHEMICAL	GENE-N	10	10	Its special profile of actions , especially the rise in gene-chemical levels induced by chemical , is unique among the currently available pharmacological tools to treat lipid disorders .	T4	T21	16322797
CPR:3	CHEMICAL	GENE-N	14	10	Its special profile of actions , especially the rise in gene-chemical levels induced by chemical , is unique among the currently available pharmacological tools to treat lipid disorders .	T7	T21	16322797
NA	CHEMICAL	GENE-N	2	3	Recently , a gene , termed gene ( gene in humans , gene in mice ) , was described and shown to mediate the chemical-induced antilipolytic effects in adipocytes .	T9	T22	16322797
NA	CHEMICAL	GENE-Y	2	6	Recently , a gene , termed gene ( gene in humans , gene in mice ) , was described and shown to mediate the chemical-induced antilipolytic effects in adipocytes .	T9	T23	16322797
NA	CHEMICAL	GENE-Y	2	8	Recently , a gene , termed gene ( gene in humans , gene in mice ) , was described and shown to mediate the chemical-induced antilipolytic effects in adipocytes .	T9	T24	16322797
NA	CHEMICAL	GENE-Y	2	12	Recently , a gene , termed gene ( gene in humans , gene in mice ) , was described and shown to mediate the chemical-induced antilipolytic effects in adipocytes .	T9	T25	16322797
NA	CHEMICAL	GENE-Y	14	10	In the present study , we show that mice lacking gene did not show chemical-induced flushing .	T11	T26	16322797
NA	CHEMICAL	GENE-Y	7	15	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T12	T27	16322797
NA	CHEMICAL	GENE-N	7	6	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T12	T28	16322797
NA	CHEMICAL	GENE-Y	20	15	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T13	T27	16322797
NA	CHEMICAL	GENE-N	20	6	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T13	T28	16322797
NA	CHEMICAL	GENE-Y	21	15	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T14	T27	16322797
NA	CHEMICAL	GENE-N	21	6	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T14	T28	16322797
NA	CHEMICAL	GENE-Y	21	15	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T15	T27	16322797
NA	CHEMICAL	GENE-N	21	6	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T15	T28	16322797
NA	CHEMICAL	GENE-Y	21	15	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T16	T27	16322797
NA	CHEMICAL	GENE-N	21	6	In addition , flushing in response to chemical was also abrogated in the absence of gene , and mice lacking chemical ( chemical ) and chemical ( chemical ) receptors had reduced flushing responses .	T16	T28	16322797
NA	CHEMICAL	GENE-Y	4	4	The mouse orthologue of gene , gene , is highly expressed in macrophages and other immune cells , and transplantation of wild-type bone marrow into irradiated gene-deficient mice restored the chemical-induced flushing response .	T2	T29	16322797
NA	CHEMICAL	GENE-Y	4	6	The mouse orthologue of gene , gene , is highly expressed in macrophages and other immune cells , and transplantation of wild-type bone marrow into irradiated gene-deficient mice restored the chemical-induced flushing response .	T2	T18	16322797
NA	CHEMICAL	GENE-Y	4	26	The mouse orthologue of gene , gene , is highly expressed in macrophages and other immune cells , and transplantation of wild-type bone marrow into irradiated gene-deficient mice restored the chemical-induced flushing response .	T2	T19	16322797
NA	CHEMICAL	GENE-Y	16	2	Effect of gene gene polymorphism on gene and gene enzyme activities in Turkish population exposed to chemical .	T4	T30	23625910
NA	CHEMICAL	GENE-N	16	3	Effect of gene gene polymorphism on gene and gene enzyme activities in Turkish population exposed to chemical .	T4	T31	23625910
NA	CHEMICAL	GENE-Y	16	5	Effect of gene gene polymorphism on gene and gene enzyme activities in Turkish population exposed to chemical .	T4	T32	23625910
NA	CHEMICAL	GENE-Y	16	8	Effect of gene gene polymorphism on gene and gene enzyme activities in Turkish population exposed to chemical .	T4	T33	23625910
NA	CHEMICAL	GENE-Y	11	11	The aim of this study was to determine the effects of gene gene polymorphism and its effects on gene and gene enzyme activities in individuals who were exposed to chemical insecticides due to occupational reasons , and to profile the probability of susceptibility to chemical compounds .	T2	T20	23625910
NA	CHEMICAL	GENE-Y	11	18	The aim of this study was to determine the effects of gene gene polymorphism and its effects on gene and gene enzyme activities in individuals who were exposed to chemical insecticides due to occupational reasons , and to profile the probability of susceptibility to chemical compounds .	T2	T21	23625910
NA	CHEMICAL	GENE-Y	11	20	The aim of this study was to determine the effects of gene gene polymorphism and its effects on gene and gene enzyme activities in individuals who were exposed to chemical insecticides due to occupational reasons , and to profile the probability of susceptibility to chemical compounds .	T2	T22	23625910
NA	CHEMICAL	GENE-Y	44	11	The aim of this study was to determine the effects of gene gene polymorphism and its effects on gene and gene enzyme activities in individuals who were exposed to chemical insecticides due to occupational reasons , and to profile the probability of susceptibility to chemical compounds .	T3	T20	23625910
NA	CHEMICAL	GENE-Y	44	18	The aim of this study was to determine the effects of gene gene polymorphism and its effects on gene and gene enzyme activities in individuals who were exposed to chemical insecticides due to occupational reasons , and to profile the probability of susceptibility to chemical compounds .	T3	T21	23625910
NA	CHEMICAL	GENE-Y	44	20	The aim of this study was to determine the effects of gene gene polymorphism and its effects on gene and gene enzyme activities in individuals who were exposed to chemical insecticides due to occupational reasons , and to profile the probability of susceptibility to chemical compounds .	T3	T22	23625910
NA	CHEMICAL	GENE-N	4	5	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T7	T25	15049511
NA	CHEMICAL	GENE-N	4	10	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T7	T26	15049511
NA	CHEMICAL	GENE-Y	4	12	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T7	T22	15049511
NA	CHEMICAL	GENE-Y	4	14	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T7	T23	15049511
NA	CHEMICAL	GENE-Y	4	17	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T7	T24	15049511
CPR:4	CHEMICAL	GENE-N	7	5	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T8	T25	15049511
NA	CHEMICAL	GENE-N	7	10	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T8	T26	15049511
NA	CHEMICAL	GENE-Y	7	12	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T8	T22	15049511
NA	CHEMICAL	GENE-Y	7	14	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T8	T23	15049511
NA	CHEMICAL	GENE-Y	7	17	Inhibitory effects of the chemical oxidase inhibitor chemical on the gene enzymes gene , gene , and gene .	T8	T24	15049511
CPR:4	CHEMICAL	GENE-N	4	6	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T20	15049511
CPR:4	CHEMICAL	GENE-N	4	14	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T9	15049511
NA	CHEMICAL	GENE-N	4	19	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T10	15049511
NA	CHEMICAL	GENE-N	4	21	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T11	15049511
NA	CHEMICAL	GENE-Y	4	26	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T12	15049511
NA	CHEMICAL	GENE-Y	4	28	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T13	15049511
NA	CHEMICAL	GENE-Y	4	31	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T2	T14	15049511
NA	CHEMICAL	GENE-N	6	6	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T20	15049511
NA	CHEMICAL	GENE-N	6	14	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T9	15049511
NA	CHEMICAL	GENE-N	6	19	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T10	15049511
NA	CHEMICAL	GENE-N	6	21	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T11	15049511
NA	CHEMICAL	GENE-Y	6	26	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T12	15049511
NA	CHEMICAL	GENE-Y	6	28	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T13	15049511
NA	CHEMICAL	GENE-Y	6	31	The inhibitory effects of chemical , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , on three gene ( gene ) enzymes , namely gene , gene , and gene , have been evaluated in vitro .	T5	T14	15049511
NA	CHEMICAL	GENE-N	8	20	A range of substrate concentrations was coincubated with a range of chemical concentrations in the presence of each of the gene enzymes at 37 degrees C for a predetermined period of time .	T3	T16	15049511
CPR:4	CHEMICAL	GENE-Y	4	10	The results demonstrated that chemical is a competitive inhibitor of gene ( Ki = 32 microM ) and gene ( Ki = 367 microM ) and a noncompetitive inhibitor of gene ( Ki = 56 microM ) .	T4	T17	15049511
CPR:4	CHEMICAL	GENE-Y	4	18	The results demonstrated that chemical is a competitive inhibitor of gene ( Ki = 32 microM ) and gene ( Ki = 367 microM ) and a noncompetitive inhibitor of gene ( Ki = 56 microM ) .	T4	T18	15049511
CPR:4	CHEMICAL	GENE-Y	4	30	The results demonstrated that chemical is a competitive inhibitor of gene ( Ki = 32 microM ) and gene ( Ki = 367 microM ) and a noncompetitive inhibitor of gene ( Ki = 56 microM ) .	T4	T19	15049511
NA	CHEMICAL	GENE-Y	1	8	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T11	T54	23625915
NA	CHEMICAL	GENE-Y	1	10	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T11	T55	23625915
NA	CHEMICAL	GENE-Y	1	15	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T11	T51	23625915
NA	CHEMICAL	GENE-Y	1	23	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T11	T52	23625915
NA	CHEMICAL	GENE-N	1	15	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T11	T53	23625915
NA	CHEMICAL	GENE-Y	19	8	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T10	T54	23625915
NA	CHEMICAL	GENE-Y	19	10	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T10	T55	23625915
NA	CHEMICAL	GENE-Y	19	15	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T10	T51	23625915
NA	CHEMICAL	GENE-Y	19	23	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T10	T52	23625915
NA	CHEMICAL	GENE-N	19	15	Store-operated chemical Entry ( SOCE ) Induced by gene mediates gene Phosphorylation to inhibit SOCE in Endothelial Cells through chemical-activated Protein Kinase and gene gene .	T10	T53	23625915
NA	CHEMICAL	GENE-Y	1	3	The chemical sensor gene is crucial for activation of store-operated chemical entry ( SOCE ) through gene and gene .	T3	T29	23625915
NA	CHEMICAL	GENE-N	1	16	The chemical sensor gene is crucial for activation of store-operated chemical entry ( SOCE ) through gene and gene .	T3	T47	23625915
NA	CHEMICAL	GENE-N	1	18	The chemical sensor gene is crucial for activation of store-operated chemical entry ( SOCE ) through gene and gene .	T3	T12	23625915
NA	CHEMICAL	GENE-Y	10	3	The chemical sensor gene is crucial for activation of store-operated chemical entry ( SOCE ) through gene and gene .	T8	T29	23625915
NA	CHEMICAL	GENE-N	10	16	The chemical sensor gene is crucial for activation of store-operated chemical entry ( SOCE ) through gene and gene .	T8	T47	23625915
NA	CHEMICAL	GENE-N	10	18	The chemical sensor gene is crucial for activation of store-operated chemical entry ( SOCE ) through gene and gene .	T8	T12	23625915
NA	CHEMICAL	GENE-Y	6	8	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T31	23625915
NA	CHEMICAL	GENE-Y	6	10	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T32	23625915
NA	CHEMICAL	GENE-Y	6	15	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T33	23625915
NA	CHEMICAL	GENE-N	6	8	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T34	23625915
NA	CHEMICAL	GENE-Y	6	18	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T35	23625915
NA	CHEMICAL	GENE-N	6	19	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T36	23625915
NA	CHEMICAL	GENE-Y	6	22	Here we show that SOCE activates chemical-activated protein kinase ( gene ) ; its effector gene gene ( gene gene ) phosphorylates gene , thus inhibiting SOCE in human lung microvascular endothelial cells ( ECs ) .	T2	T37	23625915
CPR:3	CHEMICAL	GENE-Y	4	2	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T4	T38	23625915
CPR:3	CHEMICAL	GENE-Y	4	7	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T4	T39	23625915
CPR:4	CHEMICAL	GENE-Y	4	14	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T4	T40	23625915
NA	CHEMICAL	GENE-Y	6	2	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T5	T38	23625915
NA	CHEMICAL	GENE-Y	6	7	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T5	T39	23625915
NA	CHEMICAL	GENE-Y	6	14	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T5	T40	23625915
NA	CHEMICAL	GENE-Y	15	2	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T6	T38	23625915
NA	CHEMICAL	GENE-Y	15	7	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T6	T39	23625915
NA	CHEMICAL	GENE-Y	15	14	Activation of gene using chemical resulted in gene phosphorylation on chemical residues and prevented gene-induced chemical entry .	T6	T40	23625915
CPR:4	CHEMICAL	GENE-Y	2	5	Further , chemical pretreatment blocked gene-induced increase in permeability of mouse-lung microvessels .	T7	T41	23625915
CPR:4	CHEMICAL	GENE-N	2	8	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T9	T46	23625915
CPR:4	CHEMICAL	GENE-N	2	9	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T9	T48	23625915
CPR:4	CHEMICAL	GENE-Y	2	12	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T9	T49	23625915
NA	CHEMICAL	GENE-Y	2	18	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T9	T50	23625915
NA	CHEMICAL	GENE-N	4	8	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T1	T46	23625915
NA	CHEMICAL	GENE-N	4	9	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T1	T48	23625915
NA	CHEMICAL	GENE-Y	4	12	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T1	T49	23625915
NA	CHEMICAL	GENE-Y	4	18	Interestingly , chemical , a selective inhibitor of gene gene , blocked gene phosphorylation and led to sustained gene-puncta formation and chemical entry .	T1	T50	23625915
NA	CHEMICAL	GENE-Y	36	37	As part of our ongoing search for natural sources of therapeutic and preventive agents for diabetic complications , we evaluated the inhibitory effects of components of the fruit of Xanthium strumarium ( X. strumarium ) on chemical reductase ( gene ) and chemical formation in rat lenses with high levels of chemical .	T4	T12	23604720
NA	CHEMICAL	GENE-Y	36	39	As part of our ongoing search for natural sources of therapeutic and preventive agents for diabetic complications , we evaluated the inhibitory effects of components of the fruit of Xanthium strumarium ( X. strumarium ) on chemical reductase ( gene ) and chemical formation in rat lenses with high levels of chemical .	T4	T13	23604720
NA	CHEMICAL	GENE-Y	42	37	As part of our ongoing search for natural sources of therapeutic and preventive agents for diabetic complications , we evaluated the inhibitory effects of components of the fruit of Xanthium strumarium ( X. strumarium ) on chemical reductase ( gene ) and chemical formation in rat lenses with high levels of chemical .	T5	T12	23604720
NA	CHEMICAL	GENE-Y	42	39	As part of our ongoing search for natural sources of therapeutic and preventive agents for diabetic complications , we evaluated the inhibitory effects of components of the fruit of Xanthium strumarium ( X. strumarium ) on chemical reductase ( gene ) and chemical formation in rat lenses with high levels of chemical .	T5	T13	23604720
NA	CHEMICAL	GENE-Y	51	37	As part of our ongoing search for natural sources of therapeutic and preventive agents for diabetic complications , we evaluated the inhibitory effects of components of the fruit of Xanthium strumarium ( X. strumarium ) on chemical reductase ( gene ) and chemical formation in rat lenses with high levels of chemical .	T6	T12	23604720
NA	CHEMICAL	GENE-Y	51	39	As part of our ongoing search for natural sources of therapeutic and preventive agents for diabetic complications , we evaluated the inhibitory effects of components of the fruit of Xanthium strumarium ( X. strumarium ) on chemical reductase ( gene ) and chemical formation in rat lenses with high levels of chemical .	T6	T13	23604720
CPR:4	CHEMICAL	GENE-Y	5	22	From the 10 isolated compounds , chemical showed the most potent inhibition , with IC50 values of 0.30 and 0.67 μM for gene and gene , respectively .	T9	T18	23604720
CPR:4	CHEMICAL	GENE-Y	5	24	From the 10 isolated compounds , chemical showed the most potent inhibition , with IC50 values of 0.30 and 0.67 μM for gene and gene , respectively .	T9	T19	23604720
CPR:4	CHEMICAL	GENE-Y	11	17	In the kinetic analyses using Lineweaver-Burk plots of 1/velocity and 1/substrate , chemical showed competitive inhibition of gene .	T10	T11	23604720
NA	CHEMICAL	GENE-N	7	28	In addition , there is inhibition of chemical uptake , eventually resulting in changes in chemical levels , dependent on the type of chemical receptors ( A1 or A2 ) .	T7	T21	12180353
NA	CHEMICAL	GENE-N	15	28	In addition , there is inhibition of chemical uptake , eventually resulting in changes in chemical levels , dependent on the type of chemical receptors ( A1 or A2 ) .	T8	T21	12180353
NA	CHEMICAL	GENE-N	12	28	In addition , there is inhibition of chemical uptake , eventually resulting in changes in chemical levels , dependent on the type of chemical receptors ( A1 or A2 ) .	T9	T21	12180353
CPR:3	CHEMICAL	GENE-N	0	11	chemical decreases levels of serum triglycerides and causes some increase in gene-chemical levels .	T15	T22	12180353
NA	CHEMICAL	GENE-N	11	11	chemical decreases levels of serum triglycerides and causes some increase in gene-chemical levels .	T16	T22	12180353
CPR:9	CHEMICAL	GENE-N	0	10	chemical undergoes intensive and finally complete hepatic metabolism via the gene systems .	T3	T18	12180353
CPR:4	CHEMICAL	GENE-Y	3	3	Examination of phosphorylation in gene , we found an inhibitory effect by chemical at 20 and 50 mM .	T8	T19	23128353
CPR:3	CHEMICAL	GENE-N	0	15	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T9	T20	23128353
CPR:3	CHEMICAL	GENE-Y	0	18	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T9	T21	23128353
NA	CHEMICAL	GENE-Y	0	20	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T9	T22	23128353
CPR:4	CHEMICAL	GENE-Y	0	29	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T9	T23	23128353
NA	CHEMICAL	GENE-N	17	15	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T10	T20	23128353
NA	CHEMICAL	GENE-Y	17	18	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T10	T21	23128353
NA	CHEMICAL	GENE-Y	17	20	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T10	T22	23128353
NA	CHEMICAL	GENE-Y	17	29	chemical at 50 mM was demonstrated to elevate both the mRNA and protein expression of gene and chemical oxygenase-1 ( gene ) , but also caused a reduction in gene protein expression .	T10	T23	23128353
CPR:4	CHEMICAL	GENE-Y	3	5	In addition , chemical attenuated gene protein stability via the proteasomal proteolytic pathway , as well as inducing gene nuclear accumulation .	T1	T12	23128353
CPR:3	CHEMICAL	GENE-Y	3	18	In addition , chemical attenuated gene protein stability via the proteasomal proteolytic pathway , as well as inducing gene nuclear accumulation .	T1	T13	23128353
CPR:4	CHEMICAL	GENE-N	8	17	bolus ) ; finally , 8 rabbits received chemical ( chemical ) , an inhibitor of platelet gene/gene interaction ( 10 mg/kg i.v .	T1	T14	8697470
CPR:4	CHEMICAL	GENE-Y	8	17	bolus ) ; finally , 8 rabbits received chemical ( chemical ) , an inhibitor of platelet gene/gene interaction ( 10 mg/kg i.v .	T1	T15	8697470
CPR:4	CHEMICAL	GENE-N	10	17	bolus ) ; finally , 8 rabbits received chemical ( chemical ) , an inhibitor of platelet gene/gene interaction ( 10 mg/kg i.v .	T2	T14	8697470
CPR:4	CHEMICAL	GENE-Y	10	17	bolus ) ; finally , 8 rabbits received chemical ( chemical ) , an inhibitor of platelet gene/gene interaction ( 10 mg/kg i.v .	T2	T15	8697470
NA	CHEMICAL	GENE-Y	10	2	Infusion of gene failed to restore CFVs in ridogrel e chemical treated rabbits ( 1 of 7 and 0 of 8 rabbits , respectively ) , showing that activation of extrinsic coagulation by gene was overcome by inhibition of platelet function .	T4	T29	8697470
NA	CHEMICAL	GENE-Y	10	33	Infusion of gene failed to restore CFVs in ridogrel e chemical treated rabbits ( 1 of 7 and 0 of 8 rabbits , respectively ) , showing that activation of extrinsic coagulation by gene was overcome by inhibition of platelet function .	T4	T30	8697470
NA	CHEMICAL	GENE-Y	13	10	Activated partial thromboplastin time , and ex vivo platelet aggregation in response to chemical and gene , were not different after gene infusion , while prothrombin time was slightly but significantly prolonged as compared to baseline values .	T5	T32	8697470
NA	CHEMICAL	GENE-Y	13	21	Activated partial thromboplastin time , and ex vivo platelet aggregation in response to chemical and gene , were not different after gene infusion , while prothrombin time was slightly but significantly prolonged as compared to baseline values .	T5	T33	8697470
NA	CHEMICAL	GENE-N	9	18	Rescue of this impaired extinction consolidation/retrieval was achieved with chemical ( chemical partial agonist ) or chemical ( gene ( gene ) inhibitor ) , applied after extinction training .	T7	T16	22722028
NA	CHEMICAL	GENE-N	9	20	Rescue of this impaired extinction consolidation/retrieval was achieved with chemical ( chemical partial agonist ) or chemical ( gene ( gene ) inhibitor ) , applied after extinction training .	T7	T17	22722028
NA	CHEMICAL	GENE-N	11	18	Rescue of this impaired extinction consolidation/retrieval was achieved with chemical ( chemical partial agonist ) or chemical ( gene ( gene ) inhibitor ) , applied after extinction training .	T8	T16	22722028
NA	CHEMICAL	GENE-N	11	20	Rescue of this impaired extinction consolidation/retrieval was achieved with chemical ( chemical partial agonist ) or chemical ( gene ( gene ) inhibitor ) , applied after extinction training .	T8	T17	22722028
CPR:4	CHEMICAL	GENE-N	16	18	Rescue of this impaired extinction consolidation/retrieval was achieved with chemical ( chemical partial agonist ) or chemical ( gene ( gene ) inhibitor ) , applied after extinction training .	T9	T16	22722028
CPR:4	CHEMICAL	GENE-N	16	20	Rescue of this impaired extinction consolidation/retrieval was achieved with chemical ( chemical partial agonist ) or chemical ( gene ( gene ) inhibitor ) , applied after extinction training .	T9	T17	22722028
CPR:4	CHEMICAL	GENE-N	18	24	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T1	T10	22722028
NA	CHEMICAL	GENE-Y	18	30	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T1	T11	22722028
NA	CHEMICAL	GENE-Y	18	32	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T1	T12	22722028
NA	CHEMICAL	GENE-N	18	27	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T1	T13	22722028
NA	CHEMICAL	GENE-N	28	24	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T2	T10	22722028
CPR:5	CHEMICAL	GENE-Y	28	30	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T2	T11	22722028
CPR:5	CHEMICAL	GENE-Y	28	32	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T2	T12	22722028
NA	CHEMICAL	GENE-N	28	27	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T2	T13	22722028
NA	CHEMICAL	GENE-N	20	24	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T3	T10	22722028
NA	CHEMICAL	GENE-Y	20	30	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T3	T11	22722028
NA	CHEMICAL	GENE-Y	20	32	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T3	T12	22722028
NA	CHEMICAL	GENE-N	20	27	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T3	T13	22722028
NA	CHEMICAL	GENE-N	38	24	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T4	T10	22722028
NA	CHEMICAL	GENE-Y	38	30	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T4	T11	22722028
NA	CHEMICAL	GENE-Y	38	32	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T4	T12	22722028
CPR:3	CHEMICAL	GENE-N	38	27	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T4	T13	22722028
NA	CHEMICAL	GENE-N	40	24	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T5	T10	22722028
NA	CHEMICAL	GENE-Y	40	30	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T5	T11	22722028
NA	CHEMICAL	GENE-Y	40	32	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T5	T12	22722028
CPR:3	CHEMICAL	GENE-N	40	27	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T5	T13	22722028
NA	CHEMICAL	GENE-N	42	24	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T6	T10	22722028
NA	CHEMICAL	GENE-Y	42	30	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T6	T11	22722028
NA	CHEMICAL	GENE-Y	42	32	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T6	T12	22722028
NA	CHEMICAL	GENE-N	42	27	Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of chemical ( a GABAergic enhancer and gene inhibitor ) or chemical [ gene ( gene ) agonist ] , while chemical or chemical ( chemical receptor potentiator ) failed to affect extinction acquisition in S1 mice .	T6	T13	22722028
CPR:4	CHEMICAL	GENE-Y	0	5	chemical type dual inhibitors of gene/chemical synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks .	T6	T20	23281812
CPR:4	CHEMICAL	GENE-Y	0	6	chemical type dual inhibitors of gene/chemical synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks .	T6	T21	23281812
NA	CHEMICAL	GENE-Y	5	5	chemical type dual inhibitors of gene/chemical synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks .	T7	T20	23281812
NA	CHEMICAL	GENE-Y	5	6	chemical type dual inhibitors of gene/chemical synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks .	T7	T21	23281812
NA	CHEMICAL	GENE-Y	8	3	Dual inhibitors of gene ( gene ) and chemical synthase ( gene ) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients .	T3	T14	23281812
NA	CHEMICAL	GENE-Y	8	5	Dual inhibitors of gene ( gene ) and chemical synthase ( gene ) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients .	T3	T15	23281812
NA	CHEMICAL	GENE-Y	8	9	Dual inhibitors of gene ( gene ) and chemical synthase ( gene ) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients .	T3	T16	23281812
NA	CHEMICAL	GENE-Y	8	11	Dual inhibitors of gene ( gene ) and chemical synthase ( gene ) are therefore proposed as a novel strategy for the adjuvant therapy to reduce the CVD risk for these patients .	T3	T17	23281812
NA	CHEMICAL	GENE-Y	11	6	By combining decisive structural features of gene and gene inhibitors into a common template , a series of chemical were designed and synthesized .	T4	T18	23281812
NA	CHEMICAL	GENE-Y	11	8	By combining decisive structural features of gene and gene inhibitors into a common template , a series of chemical were designed and synthesized .	T4	T19	23281812
NA	CHEMICAL	GENE-N	2	7	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T4	T22	16763553
NA	CHEMICAL	GENE-N	2	16	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T4	T23	16763553
NA	CHEMICAL	GENE-N	7	7	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T6	T22	16763553
NA	CHEMICAL	GENE-N	7	16	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T6	T23	16763553
CPR:9	CHEMICAL	GENE-N	23	7	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T7	T22	16763553
CPR:9	CHEMICAL	GENE-N	23	16	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T7	T23	16763553
CPR:9	CHEMICAL	GENE-N	7	7	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T8	T22	16763553
CPR:9	CHEMICAL	GENE-N	7	16	The tissue chemical level is maintained through a cascade of metabolic reactions where chemical dehydrogenases ( gene ) catalyze the terminal reaction of chemical biosynthesis from chemical , a rate-limiting step .	T8	T23	16763553
NA	CHEMICAL	GENE-N	6	11	We showed that dietary supplement of chemical enhanced the expression of gene genes and the cellular chemical content in vital organs such as brain , kidney , liver and heart .	T9	T24	16763553
NA	CHEMICAL	GENE-N	16	11	We showed that dietary supplement of chemical enhanced the expression of gene genes and the cellular chemical content in vital organs such as brain , kidney , liver and heart .	T10	T24	16763553
NA	CHEMICAL	GENE-N	3	12	Consistently , the chemical-lowering agent ( chemical ) downregulated the expression of gene genes in several organs especially the liver and in cultured liver cells .	T11	T25	16763553
NA	CHEMICAL	GENE-N	6	12	Consistently , the chemical-lowering agent ( chemical ) downregulated the expression of gene genes in several organs especially the liver and in cultured liver cells .	T12	T25	16763553
NA	CHEMICAL	GENE-N	2	13	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T14	T26	16763553
NA	CHEMICAL	GENE-N	2	15	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T14	T27	16763553
CPR:3	CHEMICAL	GENE-Y	2	28	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T14	T28	16763553
CPR:3	CHEMICAL	GENE-Y	2	30	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T14	T29	16763553
NA	CHEMICAL	GENE-N	7	13	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T15	T26	16763553
NA	CHEMICAL	GENE-N	7	15	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T15	T27	16763553
CPR:3	CHEMICAL	GENE-Y	7	28	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T15	T28	16763553
CPR:3	CHEMICAL	GENE-Y	7	30	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T15	T29	16763553
NA	CHEMICAL	GENE-N	24	13	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T16	T26	16763553
NA	CHEMICAL	GENE-N	24	15	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T16	T27	16763553
NA	CHEMICAL	GENE-Y	24	28	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T16	T28	16763553
NA	CHEMICAL	GENE-Y	24	30	Further , chemical metabolites , predominantly the chemical , the natural ligands for gene ( gene ) , induced these genes via upregulation of chemical regulatory element binding protein-1c ( gene ) that bound to the regulatory regions of these genes .	T16	T29	16763553
CPR:4	CHEMICAL	GENE-Y	0	9	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T2	T19	23266270
CPR:4	CHEMICAL	GENE-Y	0	11	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T2	T20	23266270
CPR:4	CHEMICAL	GENE-Y	0	14	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T2	T21	23266270
CPR:4	CHEMICAL	GENE-Y	0	16	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T2	T22	23266270
NA	CHEMICAL	GENE-Y	25	9	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T4	T19	23266270
NA	CHEMICAL	GENE-Y	25	11	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T4	T20	23266270
NA	CHEMICAL	GENE-Y	25	14	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T4	T21	23266270
NA	CHEMICAL	GENE-Y	25	16	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T4	T22	23266270
NA	CHEMICAL	GENE-Y	10	9	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T5	T19	23266270
NA	CHEMICAL	GENE-Y	10	11	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T5	T20	23266270
NA	CHEMICAL	GENE-Y	10	14	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T5	T21	23266270
NA	CHEMICAL	GENE-Y	10	16	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T5	T22	23266270
NA	CHEMICAL	GENE-Y	10	9	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T6	T19	23266270
NA	CHEMICAL	GENE-Y	10	11	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T6	T20	23266270
NA	CHEMICAL	GENE-Y	10	14	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T6	T21	23266270
NA	CHEMICAL	GENE-Y	10	16	chemical induced dose-dependent reduction of the protein levels of gene ( gene ) and gene ( gene ) and concomitant reduction in the production of chemical and chemical ( chemical ) .	T6	T22	23266270
CPR:4	CHEMICAL	GENE-N	2	8	Additionally , chemical suppressed the production of inflammatory gene , including gene ( gene ) , gene , and gene .	T7	T23	23266270
CPR:4	CHEMICAL	GENE-Y	2	11	Additionally , chemical suppressed the production of inflammatory gene , including gene ( gene ) , gene , and gene .	T7	T24	23266270
CPR:4	CHEMICAL	GENE-Y	2	13	Additionally , chemical suppressed the production of inflammatory gene , including gene ( gene ) , gene , and gene .	T7	T25	23266270
CPR:4	CHEMICAL	GENE-Y	2	12	Additionally , chemical suppressed the production of inflammatory gene , including gene ( gene ) , gene , and gene .	T7	T26	23266270
CPR:4	CHEMICAL	GENE-Y	2	19	Additionally , chemical suppressed the production of inflammatory gene , including gene ( gene ) , gene , and gene .	T7	T27	23266270
NA	CHEMICAL	GENE-N	6	16	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T9	T28	23266270
NA	CHEMICAL	GENE-N	6	18	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T9	T29	23266270
NA	CHEMICAL	GENE-N	6	23	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T9	T30	23266270
NA	CHEMICAL	GENE-N	6	25	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T9	T31	23266270
NA	CHEMICAL	GENE-N	8	16	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T10	T28	23266270
NA	CHEMICAL	GENE-N	8	18	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T10	T29	23266270
NA	CHEMICAL	GENE-N	8	23	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T10	T30	23266270
NA	CHEMICAL	GENE-N	8	25	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T10	T31	23266270
NA	CHEMICAL	GENE-N	10	16	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T11	T28	23266270
NA	CHEMICAL	GENE-N	10	18	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T11	T29	23266270
NA	CHEMICAL	GENE-N	10	23	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T11	T30	23266270
NA	CHEMICAL	GENE-N	10	25	We investigated the mechanism by which chemical inhibits chemical and chemical by examining the level of gene ( gene ) activation within the gene ( gene ) pathway , which is an inflammation-induced signaling pathway in RAW 264.7 cells .	T11	T31	23266270
CPR:4	CHEMICAL	GENE-N	0	5	chemical inhibited LPS-induced phosphorylation of gene , gene , and gene .	T12	T32	23266270
CPR:4	CHEMICAL	GENE-N	0	7	chemical inhibited LPS-induced phosphorylation of gene , gene , and gene .	T12	T33	23266270
CPR:4	CHEMICAL	GENE-N	0	10	chemical inhibited LPS-induced phosphorylation of gene , gene , and gene .	T12	T34	23266270
CPR:4	CHEMICAL	GENE-Y	2	8	Furthermore , chemical inhibited the LPS-induced phosphorylation of gene and gene gene .	T13	T35	23266270
CPR:4	CHEMICAL	GENE-N	2	10	Furthermore , chemical inhibited the LPS-induced phosphorylation of gene and gene gene .	T13	T36	23266270
CPR:4	CHEMICAL	GENE-Y	2	11	Furthermore , chemical inhibited the LPS-induced phosphorylation of gene and gene gene .	T13	T16	23266270
NA	CHEMICAL	GENE-N	4	0	gene is rapidly induced in growth-stimulated mouse fibroblasts and releases chemical decarboxylase from gene suppression .	T5	T28	10698696
NA	CHEMICAL	GENE-Y	4	11	gene is rapidly induced in growth-stimulated mouse fibroblasts and releases chemical decarboxylase from gene suppression .	T5	T30	10698696
NA	CHEMICAL	GENE-N	4	13	gene is rapidly induced in growth-stimulated mouse fibroblasts and releases chemical decarboxylase from gene suppression .	T5	T29	10698696
NA	CHEMICAL	GENE-Y	0	1	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T1	T6	10698696
NA	CHEMICAL	GENE-Y	0	3	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T1	T13	10698696
CPR:9	CHEMICAL	GENE-Y	9	1	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T4	T6	10698696
CPR:9	CHEMICAL	GENE-Y	9	3	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T4	T13	10698696
CPR:9	CHEMICAL	GENE-Y	9	1	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T2	T6	10698696
CPR:9	CHEMICAL	GENE-Y	9	3	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T2	T13	10698696
CPR:9	CHEMICAL	GENE-Y	9	1	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T3	T6	10698696
CPR:9	CHEMICAL	GENE-Y	9	3	chemical decarboxylase ( gene ) catalyses the first step in the synthesis of the polyamines chemical , chemical and chemical .	T3	T13	10698696
CPR:5	CHEMICAL	GENE-Y	6	7	Discovery of a novel series of chemical gene agonists .	T6	T10	23414838
NA	CHEMICAL	GENE-Y	2	7	Discovery of a novel series of chemical gene agonists .	T7	T10	23414838
CPR:5	CHEMICAL	GENE-Y	12	4	High throughput screening led to the identification of a novel series of chemical gene ( gene ) agonists .	T4	T9	23414838
CPR:5	CHEMICAL	GENE-N	12	15	High throughput screening led to the identification of a novel series of chemical gene ( gene ) agonists .	T4	T8	23414838
NA	CHEMICAL	GENE-Y	8	4	High throughput screening led to the identification of a novel series of chemical gene ( gene ) agonists .	T5	T9	23414838
NA	CHEMICAL	GENE-N	8	15	High throughput screening led to the identification of a novel series of chemical gene ( gene ) agonists .	T5	T8	23414838
NA	CHEMICAL	GENE-Y	5	2	Suppression of gene expression is a common feature of chemical-resistant and chemical-resistant RBL-2H3 cells .	T23	T31	23598904
NA	CHEMICAL	GENE-Y	5	2	Suppression of gene expression is a common feature of chemical-resistant and chemical-resistant RBL-2H3 cells .	T24	T31	23598904
NA	CHEMICAL	GENE-N	9	5	To clarify the roles of gene in hyperaccumulation of chemical and chemical in RBL-2H3 cells , chemical-resistant and chemical-resistant cells were developed from RBL-2H3 cells by continuous exposure to chemical and chemical , respectively .	T5	T27	23598904
NA	CHEMICAL	GENE-N	11	5	To clarify the roles of gene in hyperaccumulation of chemical and chemical in RBL-2H3 cells , chemical-resistant and chemical-resistant cells were developed from RBL-2H3 cells by continuous exposure to chemical and chemical , respectively .	T6	T27	23598904
NA	CHEMICAL	GENE-N	16	5	To clarify the roles of gene in hyperaccumulation of chemical and chemical in RBL-2H3 cells , chemical-resistant and chemical-resistant cells were developed from RBL-2H3 cells by continuous exposure to chemical and chemical , respectively .	T7	T27	23598904
NA	CHEMICAL	GENE-N	18	5	To clarify the roles of gene in hyperaccumulation of chemical and chemical in RBL-2H3 cells , chemical-resistant and chemical-resistant cells were developed from RBL-2H3 cells by continuous exposure to chemical and chemical , respectively .	T8	T27	23598904
NA	CHEMICAL	GENE-N	29	5	To clarify the roles of gene in hyperaccumulation of chemical and chemical in RBL-2H3 cells , chemical-resistant and chemical-resistant cells were developed from RBL-2H3 cells by continuous exposure to chemical and chemical , respectively .	T9	T27	23598904
NA	CHEMICAL	GENE-N	31	5	To clarify the roles of gene in hyperaccumulation of chemical and chemical in RBL-2H3 cells , chemical-resistant and chemical-resistant cells were developed from RBL-2H3 cells by continuous exposure to chemical and chemical , respectively .	T10	T27	23598904
NA	CHEMICAL	GENE-N	6	15	RBL-Cdr cells also showed cross-resistance to chemical and chemical probably due to enhanced expression of gene .	T18	T28	23598904
NA	CHEMICAL	GENE-N	8	15	RBL-Cdr cells also showed cross-resistance to chemical and chemical probably due to enhanced expression of gene .	T19	T28	23598904
CPR:9	CHEMICAL	GENE-Y	9	16	Among the possible transporters involved in the uptake of chemical and chemical , the expression of gene ( gene ) , encoded by gene , showed a marked suppression in both RBL-Cdr and RBL-Mnr cells .	T21	T29	23598904
CPR:9	CHEMICAL	GENE-Y	9	18	Among the possible transporters involved in the uptake of chemical and chemical , the expression of gene ( gene ) , encoded by gene , showed a marked suppression in both RBL-Cdr and RBL-Mnr cells .	T21	T30	23598904
CPR:9	CHEMICAL	GENE-Y	9	23	Among the possible transporters involved in the uptake of chemical and chemical , the expression of gene ( gene ) , encoded by gene , showed a marked suppression in both RBL-Cdr and RBL-Mnr cells .	T21	T25	23598904
CPR:9	CHEMICAL	GENE-Y	11	16	Among the possible transporters involved in the uptake of chemical and chemical , the expression of gene ( gene ) , encoded by gene , showed a marked suppression in both RBL-Cdr and RBL-Mnr cells .	T22	T29	23598904
CPR:9	CHEMICAL	GENE-Y	11	18	Among the possible transporters involved in the uptake of chemical and chemical , the expression of gene ( gene ) , encoded by gene , showed a marked suppression in both RBL-Cdr and RBL-Mnr cells .	T22	T30	23598904
CPR:9	CHEMICAL	GENE-Y	11	23	Among the possible transporters involved in the uptake of chemical and chemical , the expression of gene ( gene ) , encoded by gene , showed a marked suppression in both RBL-Cdr and RBL-Mnr cells .	T22	T25	23598904
NA	CHEMICAL	GENE-Y	5	9	Identification of binding sites for chemical and chemical on gene . The solution structure of gene ( gene ) ( Sia , S. , Li , M. X. , Spyracopoulos , L. , Gagne , S. M. , Liu , W. , Putkey , J . A .	T16	T26	9525919
NA	CHEMICAL	GENE-Y	5	15	Identification of binding sites for chemical and chemical on gene . The solution structure of gene ( gene ) ( Sia , S. , Li , M. X. , Spyracopoulos , L. , Gagne , S. M. , Liu , W. , Putkey , J . A .	T16	T19	9525919
NA	CHEMICAL	GENE-Y	5	17	Identification of binding sites for chemical and chemical on gene . The solution structure of gene ( gene ) ( Sia , S. , Li , M. X. , Spyracopoulos , L. , Gagne , S. M. , Liu , W. , Putkey , J . A .	T16	T22	9525919
NA	CHEMICAL	GENE-Y	7	9	Identification of binding sites for chemical and chemical on gene . The solution structure of gene ( gene ) ( Sia , S. , Li , M. X. , Spyracopoulos , L. , Gagne , S. M. , Liu , W. , Putkey , J . A .	T17	T26	9525919
NA	CHEMICAL	GENE-Y	7	15	Identification of binding sites for chemical and chemical on gene . The solution structure of gene ( gene ) ( Sia , S. , Li , M. X. , Spyracopoulos , L. , Gagne , S. M. , Liu , W. , Putkey , J . A .	T17	T19	9525919
NA	CHEMICAL	GENE-Y	7	17	Identification of binding sites for chemical and chemical on gene . The solution structure of gene ( gene ) ( Sia , S. , Li , M. X. , Spyracopoulos , L. , Gagne , S. M. , Liu , W. , Putkey , J . A .	T17	T22	9525919
NA	CHEMICAL	GENE-Y	13	17	For example , it is clear that the closed conformation of the regulatory chemical-terminal domain in chemical-bound gene ( gene ) presents a much different binding surface for chemical-sensitizing compounds than previously thought .	T5	T20	9525919
NA	CHEMICAL	GENE-Y	13	19	For example , it is clear that the closed conformation of the regulatory chemical-terminal domain in chemical-bound gene ( gene ) presents a much different binding surface for chemical-sensitizing compounds than previously thought .	T5	T21	9525919
NA	CHEMICAL	GENE-Y	16	17	For example , it is clear that the closed conformation of the regulatory chemical-terminal domain in chemical-bound gene ( gene ) presents a much different binding surface for chemical-sensitizing compounds than previously thought .	T6	T20	9525919
NA	CHEMICAL	GENE-Y	16	19	For example , it is clear that the closed conformation of the regulatory chemical-terminal domain in chemical-bound gene ( gene ) presents a much different binding surface for chemical-sensitizing compounds than previously thought .	T6	T21	9525919
NA	CHEMICAL	GENE-Y	22	17	For example , it is clear that the closed conformation of the regulatory chemical-terminal domain in chemical-bound gene ( gene ) presents a much different binding surface for chemical-sensitizing compounds than previously thought .	T7	T20	9525919
NA	CHEMICAL	GENE-Y	22	19	For example , it is clear that the closed conformation of the regulatory chemical-terminal domain in chemical-bound gene ( gene ) presents a much different binding surface for chemical-sensitizing compounds than previously thought .	T7	T21	9525919
NA	CHEMICAL	GENE-Y	19	23	We report here the use of Met methyl groups as site-specific structural markers to identify drug binding sites for chemical and chemical on gene .	T8	T23	9525919
NA	CHEMICAL	GENE-Y	21	23	We report here the use of Met methyl groups as site-specific structural markers to identify drug binding sites for chemical and chemical on gene .	T9	T23	9525919
NA	CHEMICAL	GENE-Y	12	15	Drug dependent changes in the NMR heteronuclear single-quantum coherence spectra of [ chemical ] Met-labeled gene indicate that chemical and chemical bind to similar sites but only in the presence of chemical .	T10	T24	9525919
NA	CHEMICAL	GENE-Y	18	15	Drug dependent changes in the NMR heteronuclear single-quantum coherence spectra of [ chemical ] Met-labeled gene indicate that chemical and chemical bind to similar sites but only in the presence of chemical .	T11	T24	9525919
NA	CHEMICAL	GENE-Y	3	15	Drug dependent changes in the NMR heteronuclear single-quantum coherence spectra of [ chemical ] Met-labeled gene indicate that chemical and chemical bind to similar sites but only in the presence of chemical .	T12	T24	9525919
NA	CHEMICAL	GENE-Y	31	15	Drug dependent changes in the NMR heteronuclear single-quantum coherence spectra of [ chemical ] Met-labeled gene indicate that chemical and chemical bind to similar sites but only in the presence of chemical .	T13	T24	9525919
NA	CHEMICAL	GENE-Y	8	14	There are 3-4 drug binding sites in the chemical- and chemical-terminal domains of intact gene that exhibit fast exchange on the NMR time scale .	T14	T25	9525919
NA	CHEMICAL	GENE-Y	10	14	There are 3-4 drug binding sites in the chemical- and chemical-terminal domains of intact gene that exhibit fast exchange on the NMR time scale .	T15	T25	9525919
NA	CHEMICAL	GENE-N	5	0	gene , peroxisomal enzymes and chemical cofactors in koala liver .	T11	T17	11246504
NA	CHEMICAL	GENE-N	7	8	We have examined hepatic levels of microsomal chemical hydroxylase activity and cyanide-insensitive palmitoyl coenzyme A oxidative activity in koala ( Phascolarctos cinereus ) and tammar wallaby ( Macropus eugenii ) and compared our results to those determined in rat .	T2	T14	11246504
NA	CHEMICAL	GENE-N	41	21	Reverse transcription of koala liver mRNA , followed by polymerase chain reaction using primers based on highly conserved areas in the gene family led to the cloning of a partial , near full length , cDNA clone with approximately 70 % chemical and deduced chemical sequence identity to gene .	T9	T15	11246504
NA	CHEMICAL	GENE-Y	41	48	Reverse transcription of koala liver mRNA , followed by polymerase chain reaction using primers based on highly conserved areas in the gene family led to the cloning of a partial , near full length , cDNA clone with approximately 70 % chemical and deduced chemical sequence identity to gene .	T9	T16	11246504
NA	CHEMICAL	GENE-N	28	21	Reverse transcription of koala liver mRNA , followed by polymerase chain reaction using primers based on highly conserved areas in the gene family led to the cloning of a partial , near full length , cDNA clone with approximately 70 % chemical and deduced chemical sequence identity to gene .	T10	T15	11246504
NA	CHEMICAL	GENE-Y	28	48	Reverse transcription of koala liver mRNA , followed by polymerase chain reaction using primers based on highly conserved areas in the gene family led to the cloning of a partial , near full length , cDNA clone with approximately 70 % chemical and deduced chemical sequence identity to gene .	T10	T16	11246504
NA	CHEMICAL	GENE-Y	0	9	chemical regulates non-neuronal cholinergic activity in T lymphocytes via gene-mediated pathways .	T11	T30	16828882
NA	CHEMICAL	GENE-N	12	4	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T3	T15	16828882
NA	CHEMICAL	GENE-Y	12	16	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T3	T16	16828882
NA	CHEMICAL	GENE-Y	12	6	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T3	T17	16828882
NA	CHEMICAL	GENE-Y	12	13	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T3	T18	16828882
NA	CHEMICAL	GENE-N	26	4	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T4	T15	16828882
NA	CHEMICAL	GENE-Y	26	16	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T4	T16	16828882
NA	CHEMICAL	GENE-Y	26	6	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T4	T17	16828882
NA	CHEMICAL	GENE-Y	26	13	We previously showed that gene stimulates an independent , non-neuronal cholinergic system in T cells via gene-mediated pathways , as evidenced by increases in chemical ( chemical ) synthesis and gene ( gene ) mRNA expression .	T4	T18	16828882
NA	CHEMICAL	GENE-Y	1	5	The chemical-lowering drug chemical inhibits gene signaling by binding to an allosteric site on gene ( gene ) , which leads to immunomodulation .	T5	T20	16828882
NA	CHEMICAL	GENE-Y	1	14	The chemical-lowering drug chemical inhibits gene signaling by binding to an allosteric site on gene ( gene ) , which leads to immunomodulation .	T5	T22	16828882
NA	CHEMICAL	GENE-Y	1	16	The chemical-lowering drug chemical inhibits gene signaling by binding to an allosteric site on gene ( gene ) , which leads to immunomodulation .	T5	T23	16828882
CPR:4	CHEMICAL	GENE-Y	3	5	The chemical-lowering drug chemical inhibits gene signaling by binding to an allosteric site on gene ( gene ) , which leads to immunomodulation .	T6	T20	16828882
NA	CHEMICAL	GENE-Y	3	14	The chemical-lowering drug chemical inhibits gene signaling by binding to an allosteric site on gene ( gene ) , which leads to immunomodulation .	T6	T22	16828882
NA	CHEMICAL	GENE-Y	3	16	The chemical-lowering drug chemical inhibits gene signaling by binding to an allosteric site on gene ( gene ) , which leads to immunomodulation .	T6	T23	16828882
NA	CHEMICAL	GENE-N	13	3	We found that anti-gene monoclonal antibody ( mAb ) increased gene activity , chemical synthesis and release , and expression of gene and gene mRNA in MOLT-3 cells , a human leukemic T cell line .	T8	T25	16828882
NA	CHEMICAL	GENE-N	13	10	We found that anti-gene monoclonal antibody ( mAb ) increased gene activity , chemical synthesis and release , and expression of gene and gene mRNA in MOLT-3 cells , a human leukemic T cell line .	T8	T26	16828882
NA	CHEMICAL	GENE-Y	13	21	We found that anti-gene monoclonal antibody ( mAb ) increased gene activity , chemical synthesis and release , and expression of gene and gene mRNA in MOLT-3 cells , a human leukemic T cell line .	T8	T27	16828882
NA	CHEMICAL	GENE-Y	13	23	We found that anti-gene monoclonal antibody ( mAb ) increased gene activity , chemical synthesis and release , and expression of gene and gene mRNA in MOLT-3 cells , a human leukemic T cell line .	T8	T28	16828882
CPR:4	CHEMICAL	GENE-Y	0	3	chemical abolished these anti-gene mAb-induced increases in lymphocytic cholinergic activity in a manner independent of its chemical-lowering activity .	T10	T29	16828882
NA	CHEMICAL	GENE-Y	0	3	chemical abolished these anti-gene mAb-induced increases in lymphocytic cholinergic activity in a manner independent of its chemical-lowering activity .	T1	T29	16828882
NA	CHEMICAL	GENE-Y	12	0	gene agonist inhibits biliary growth of BDL rats by downregulation of the chemical-dependent PKA/gene/gene pathway .	T29	T60	17334413
NA	CHEMICAL	GENE-N	12	13	gene agonist inhibits biliary growth of BDL rats by downregulation of the chemical-dependent PKA/gene/gene pathway .	T29	T61	17334413
NA	CHEMICAL	GENE-Y	12	13	gene agonist inhibits biliary growth of BDL rats by downregulation of the chemical-dependent PKA/gene/gene pathway .	T29	T62	17334413
NA	CHEMICAL	GENE-N	0	11	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T1	T49	17334413
NA	CHEMICAL	GENE-Y	0	13	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T1	T57	17334413
NA	CHEMICAL	GENE-Y	0	15	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T1	T59	17334413
NA	CHEMICAL	GENE-Y	0	17	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T1	T30	17334413
NA	CHEMICAL	GENE-Y	0	19	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T1	T31	17334413
NA	CHEMICAL	GENE-N	8	11	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T23	T49	17334413
NA	CHEMICAL	GENE-Y	8	13	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T23	T57	17334413
NA	CHEMICAL	GENE-Y	8	15	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T23	T59	17334413
NA	CHEMICAL	GENE-Y	8	17	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T23	T30	17334413
NA	CHEMICAL	GENE-Y	8	19	chemical regulates many functions by binding to four chemical G-coupled receptor proteins ( gene , gene , gene and gene ) .	T23	T31	17334413
NA	CHEMICAL	GENE-N	11	1	As gene exerts their effects by coupling to gene proteins reducing chemical ( chemical ) levels ( a key player in the modulation of cholangiocyte hyperplasia/damage ) , we evaluated the role of gene in the regulation of biliary growth .	T14	T32	17334413
NA	CHEMICAL	GENE-N	11	8	As gene exerts their effects by coupling to gene proteins reducing chemical ( chemical ) levels ( a key player in the modulation of cholangiocyte hyperplasia/damage ) , we evaluated the role of gene in the regulation of biliary growth .	T14	T38	17334413
NA	CHEMICAL	GENE-Y	11	33	As gene exerts their effects by coupling to gene proteins reducing chemical ( chemical ) levels ( a key player in the modulation of cholangiocyte hyperplasia/damage ) , we evaluated the role of gene in the regulation of biliary growth .	T14	T46	17334413
NA	CHEMICAL	GENE-N	13	1	As gene exerts their effects by coupling to gene proteins reducing chemical ( chemical ) levels ( a key player in the modulation of cholangiocyte hyperplasia/damage ) , we evaluated the role of gene in the regulation of biliary growth .	T19	T32	17334413
NA	CHEMICAL	GENE-N	13	8	As gene exerts their effects by coupling to gene proteins reducing chemical ( chemical ) levels ( a key player in the modulation of cholangiocyte hyperplasia/damage ) , we evaluated the role of gene in the regulation of biliary growth .	T19	T38	17334413
NA	CHEMICAL	GENE-Y	13	33	As gene exerts their effects by coupling to gene proteins reducing chemical ( chemical ) levels ( a key player in the modulation of cholangiocyte hyperplasia/damage ) , we evaluated the role of gene in the regulation of biliary growth .	T19	T46	17334413
CPR:5	CHEMICAL	GENE-Y	8	13	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T20	T48	17334413
NA	CHEMICAL	GENE-Y	8	19	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T20	T50	17334413
CPR:5	CHEMICAL	GENE-Y	10	13	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T21	T48	17334413
NA	CHEMICAL	GENE-Y	10	19	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T21	T50	17334413
NA	CHEMICAL	GENE-Y	17	13	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T22	T48	17334413
CPR:6	CHEMICAL	GENE-Y	17	19	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T22	T50	17334413
NA	CHEMICAL	GENE-Y	4	13	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T24	T48	17334413
NA	CHEMICAL	GENE-Y	4	19	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T24	T50	17334413
NA	CHEMICAL	GENE-Y	29	13	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T25	T48	17334413
NA	CHEMICAL	GENE-Y	29	19	( 2 ) Does in vivo administration of chemical ( chemical ) ( gene agonist ) , chemical ( gene antagonist ) or chemical , in the absence/presence of chemical , to bile duct ligated ( BDL ) rats regulate cholangiocyte proliferation ?	T25	T50	17334413
NA	CHEMICAL	GENE-N	5	15	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T26	T51	17334413
NA	CHEMICAL	GENE-N	5	17	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T26	T52	17334413
NA	CHEMICAL	GENE-N	5	19	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T26	T53	17334413
NA	CHEMICAL	GENE-N	5	21	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T26	T54	17334413
NA	CHEMICAL	GENE-Y	5	23	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T26	T55	17334413
NA	CHEMICAL	GENE-Y	5	25	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T26	T56	17334413
NA	CHEMICAL	GENE-N	12	15	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T27	T51	17334413
NA	CHEMICAL	GENE-N	12	17	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T27	T52	17334413
NA	CHEMICAL	GENE-N	12	19	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T27	T53	17334413
NA	CHEMICAL	GENE-N	12	21	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T27	T54	17334413
NA	CHEMICAL	GENE-Y	12	23	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T27	T55	17334413
NA	CHEMICAL	GENE-Y	12	25	and ( 3 ) Does chemical inhibit cholangiocyte proliferation by downregulation of chemical-dependent phosphorylation of gene ( gene ) /gene ( gene ) /gene ( gene ) ?	T27	T56	17334413
NA	CHEMICAL	GENE-N	8	31	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T6	T33	17334413
NA	CHEMICAL	GENE-N	8	10	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T6	T34	17334413
NA	CHEMICAL	GENE-Y	8	10	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T6	T35	17334413
NA	CHEMICAL	GENE-N	21	31	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T7	T33	17334413
NA	CHEMICAL	GENE-N	21	10	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T7	T34	17334413
NA	CHEMICAL	GENE-Y	21	10	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T7	T35	17334413
NA	CHEMICAL	GENE-N	28	31	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T8	T33	17334413
NA	CHEMICAL	GENE-N	28	10	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T8	T34	17334413
NA	CHEMICAL	GENE-Y	28	10	Following in vivo treatment of BDL rats with chemical for 1 week , and in vitro stimulation of BDL cholangiocytes with chemical , we evaluated cholangiocyte proliferation , chemical levels and gene , gene and gene phosphorylation .	T8	T35	17334413
CPR:4	CHEMICAL	GENE-N	0	12	chemical inhibition of cholangiocyte growth was associated with decreased chemical levels and gene/gene/gene phosphorylation .	T16	T39	17334413
CPR:4	CHEMICAL	GENE-N	0	12	chemical inhibition of cholangiocyte growth was associated with decreased chemical levels and gene/gene/gene phosphorylation .	T16	T40	17334413
CPR:4	CHEMICAL	GENE-Y	0	12	chemical inhibition of cholangiocyte growth was associated with decreased chemical levels and gene/gene/gene phosphorylation .	T16	T41	17334413
NA	CHEMICAL	GENE-N	9	12	chemical inhibition of cholangiocyte growth was associated with decreased chemical levels and gene/gene/gene phosphorylation .	T17	T39	17334413
NA	CHEMICAL	GENE-N	9	12	chemical inhibition of cholangiocyte growth was associated with decreased chemical levels and gene/gene/gene phosphorylation .	T17	T40	17334413
NA	CHEMICAL	GENE-Y	9	12	chemical inhibition of cholangiocyte growth was associated with decreased chemical levels and gene/gene/gene phosphorylation .	T17	T41	17334413
NA	CHEMICAL	GENE-Y	12	4	Reticulated platelets and uninhibited gene and gene decrease the antiplatelet effects of chemical .	T11	T27	17319904
NA	CHEMICAL	GENE-Y	12	6	Reticulated platelets and uninhibited gene and gene decrease the antiplatelet effects of chemical .	T11	T28	17319904
NA	CHEMICAL	GENE-N	11	14	Immature ( reticulated ) platelets may modulate the antiplatelet effects of chemical through uninhibited gene gene and gene .	T2	T19	17319904
NA	CHEMICAL	GENE-Y	11	1	Immature ( reticulated ) platelets may modulate the antiplatelet effects of chemical through uninhibited gene gene and gene .	T2	T20	17319904
NA	CHEMICAL	GENE-Y	11	17	Immature ( reticulated ) platelets may modulate the antiplatelet effects of chemical through uninhibited gene gene and gene .	T2	T21	17319904
NA	CHEMICAL	GENE-Y	14	7	Platelet studies included light transmission aggregometry ; gene and gene expression , and serum chemical ( chemical ) levels .	T7	T22	17319904
NA	CHEMICAL	GENE-N	14	9	Platelet studies included light transmission aggregometry ; gene and gene expression , and serum chemical ( chemical ) levels .	T7	T23	17319904
NA	CHEMICAL	GENE-Y	15	7	Platelet studies included light transmission aggregometry ; gene and gene expression , and serum chemical ( chemical ) levels .	T8	T22	17319904
NA	CHEMICAL	GENE-N	15	9	Platelet studies included light transmission aggregometry ; gene and gene expression , and serum chemical ( chemical ) levels .	T8	T23	17319904
NA	CHEMICAL	GENE-N	21	10	Baseline platelet aggregation to 1 microg mL ( -1 ) gene , and postaspirin aggregations to 5 microm and 20 microm chemical and gene , were greater in the upper than in the lower tertile of reticulated platelets .	T10	T25	17319904
NA	CHEMICAL	GENE-N	21	23	Baseline platelet aggregation to 1 microg mL ( -1 ) gene , and postaspirin aggregations to 5 microm and 20 microm chemical and gene , were greater in the upper than in the lower tertile of reticulated platelets .	T10	T26	17319904
CPR:3	CHEMICAL	GENE-Y	1	1	Stimulated gene and gene expression were also higher in the upper tertile both before and after chemical .	T1	T12	17319904
CPR:3	CHEMICAL	GENE-N	1	3	Stimulated gene and gene expression were also higher in the upper tertile both before and after chemical .	T1	T13	17319904
CPR:4	CHEMICAL	GENE-Y	16	10	The high fat diet significantly increased hepatic mRNA expressions of gene , gene and gene genes in comparison to the control diet , which was subsequently reversed by supplementation with chemical .	T6	T13	23561166
CPR:4	CHEMICAL	GENE-Y	16	12	The high fat diet significantly increased hepatic mRNA expressions of gene , gene and gene genes in comparison to the control diet , which was subsequently reversed by supplementation with chemical .	T6	T14	23561166
CPR:4	CHEMICAL	GENE-Y	16	14	The high fat diet significantly increased hepatic mRNA expressions of gene , gene and gene genes in comparison to the control diet , which was subsequently reversed by supplementation with chemical .	T6	T15	23561166
CPR:4	CHEMICAL	GENE-Y	3	11	In addition , chemical supplementation significantly reduced hepatic mRNA abundance of gene , gene and gene compared to the control group .	T7	T16	23561166
CPR:4	CHEMICAL	GENE-Y	3	13	In addition , chemical supplementation significantly reduced hepatic mRNA abundance of gene , gene and gene compared to the control group .	T7	T17	23561166
CPR:4	CHEMICAL	GENE-Y	3	15	In addition , chemical supplementation significantly reduced hepatic mRNA abundance of gene , gene and gene compared to the control group .	T7	T18	23561166
CPR:3	CHEMICAL	GENE-Y	11	6	Finally , epididymal mRNA abundance of gene was significantly increased by chemical supplementation , compared to levels in the control and HF groups .	T8	T19	23561166
CPR:3	CHEMICAL	GENE-Y	5	2	Enhancement of gene expression by chemical was further confirmed in differentiated 3T3-L1 adipocytes .	T9	T20	23561166
NA	CHEMICAL	GENE-Y	2	10	Inhibition of chemical binding to rat renal brush-border membrane by gene ligands and basic peptides .	T13	T26	16488503
NA	CHEMICAL	GENE-Y	9	7	Our previous studies showed that coadministration of gene and a 20-residue basic peptide , N-WASP181-200 ( gene , pI=10.87 ) inhibits renal accumulation of chemical .	T4	T22	16488503
NA	CHEMICAL	GENE-N	9	16	Our previous studies showed that coadministration of gene and a 20-residue basic peptide , N-WASP181-200 ( gene , pI=10.87 ) inhibits renal accumulation of chemical .	T4	T15	16488503
NA	CHEMICAL	GENE-Y	16	10	In this study , we examined effects of ligands of gene , an endocytic receptor involved in renal uptake of chemical , and basic peptides including N-WASP180-200 and its mutant peptides on chemical binding to isolated rat renal brush-border membrane ( BBM ) .	T5	T19	16488503
NA	CHEMICAL	GENE-Y	16	10	In this study , we examined effects of ligands of gene , an endocytic receptor involved in renal uptake of chemical , and basic peptides including N-WASP180-200 and its mutant peptides on chemical binding to isolated rat renal brush-border membrane ( BBM ) .	T6	T19	16488503
NA	CHEMICAL	GENE-Y	0	7	chemical binding to BBM was inhibited by gene ligands , basic peptide fragments of gene , and N-WASP181-200 in a concentration-dependent manner .	T7	T20	16488503
NA	CHEMICAL	GENE-Y	0	14	chemical binding to BBM was inhibited by gene ligands , basic peptide fragments of gene , and N-WASP181-200 in a concentration-dependent manner .	T7	T21	16488503
NA	CHEMICAL	GENE-N	2	29	By substituting chemical for chemical in N-WASP181-200 at positions 9 and 15 , the inhibitory effect on chemical binding to BBM was reduced , which may be related to a decrease in the gene content in the peptide .	T9	T23	16488503
NA	CHEMICAL	GENE-N	4	29	By substituting chemical for chemical in N-WASP181-200 at positions 9 and 15 , the inhibitory effect on chemical binding to BBM was reduced , which may be related to a decrease in the gene content in the peptide .	T10	T23	16488503
NA	CHEMICAL	GENE-N	5	29	By substituting chemical for chemical in N-WASP181-200 at positions 9 and 15 , the inhibitory effect on chemical binding to BBM was reduced , which may be related to a decrease in the gene content in the peptide .	T11	T23	16488503
NA	CHEMICAL	GENE-N	0	6	chemical binding to BBM treated with gene , in which gene completely disappeared , was significantly but not completely decreased compared with the native BBM .	T12	T24	16488503
NA	CHEMICAL	GENE-Y	0	8	chemical binding to BBM treated with gene , in which gene completely disappeared , was significantly but not completely decreased compared with the native BBM .	T12	T25	16488503
NA	CHEMICAL	GENE-N	7	7	In addition , treatment of BBM with gene led to a decrease in the inhibitory effect of N-WASP181-200 on chemical binding .	T1	T14	16488503
NA	CHEMICAL	GENE-Y	15	4	These observations support that gene ligands and basic peptides including N-WASP181-200 decrease renal accumulation of chemical by inhibiting its binding to BBM of proximal tubule cells , partly interacting with gene .	T2	T16	16488503
NA	CHEMICAL	GENE-Y	15	30	These observations support that gene ligands and basic peptides including N-WASP181-200 decrease renal accumulation of chemical by inhibiting its binding to BBM of proximal tubule cells , partly interacting with gene .	T2	T17	16488503
NA	CHEMICAL	GENE-N	2	6	Activity of chemical against clinically-relevant chemical-resistant gene mutants of gene-ITD .	T18	T38	23430109
NA	CHEMICAL	GENE-Y	2	9	Activity of chemical against clinically-relevant chemical-resistant gene mutants of gene-ITD .	T18	T39	23430109
NA	CHEMICAL	GENE-N	5	6	Activity of chemical against clinically-relevant chemical-resistant gene mutants of gene-ITD .	T19	T38	23430109
NA	CHEMICAL	GENE-Y	5	9	Activity of chemical against clinically-relevant chemical-resistant gene mutants of gene-ITD .	T19	T39	23430109
NA	CHEMICAL	GENE-N	3	3	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T10	T27	23430109
NA	CHEMICAL	GENE-N	3	7	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T10	T35	23430109
NA	CHEMICAL	GENE-Y	3	18	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T10	T24	23430109
NA	CHEMICAL	GENE-N	3	3	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T12	T27	23430109
NA	CHEMICAL	GENE-N	3	7	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T12	T35	23430109
NA	CHEMICAL	GENE-Y	3	18	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T12	T24	23430109
NA	CHEMICAL	GENE-N	7	3	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T3	T27	23430109
NA	CHEMICAL	GENE-N	7	7	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T3	T35	23430109
CPR:4	CHEMICAL	GENE-Y	7	18	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T3	T24	23430109
NA	CHEMICAL	GENE-N	3	3	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T4	T27	23430109
NA	CHEMICAL	GENE-N	3	7	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T4	T35	23430109
CPR:4	CHEMICAL	GENE-Y	3	18	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T4	T24	23430109
NA	CHEMICAL	GENE-N	25	3	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T5	T27	23430109
NA	CHEMICAL	GENE-N	25	7	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T5	T35	23430109
CPR:4	CHEMICAL	GENE-Y	25	18	Secondary point mutations in the gene ( gene ) are common causes of acquired clinical resistance to the gene inhibitors chemical ( chemical ) and chemical .	T5	T24	23430109
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T6	T25	23430109
NA	CHEMICAL	GENE-N	0	5	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T6	T26	23430109
NA	CHEMICAL	GENE-N	0	28	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T6	T28	23430109
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T7	T25	23430109
NA	CHEMICAL	GENE-N	2	5	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T7	T26	23430109
NA	CHEMICAL	GENE-N	2	28	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T7	T28	23430109
NA	CHEMICAL	GENE-N	9	5	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T8	T25	23430109
NA	CHEMICAL	GENE-N	9	5	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T8	T26	23430109
NA	CHEMICAL	GENE-N	9	28	chemical ( chemical ) is a gene inhibitor with in vitro and clinical activity in chemical kinase inhibitor ( TKI ) -resistant chronic myeloid leukemia , irrespective of gene mutation .	T8	T28	23430109
NA	CHEMICAL	GENE-Y	0	24	chemical has demonstrated early clinical efficacy in chemotherapy-resistant acute myeloid leukemia ( AML ) patients with internal tandem duplication ( ITD ) mutations in gene .	T9	T29	23430109
NA	CHEMICAL	GENE-Y	3	11	We assessed the in vitro activity of chemical against clinically relevant gene-ITD mutant isoforms that confer resistance to chemical or chemical .	T11	T30	23430109
NA	CHEMICAL	GENE-Y	18	11	We assessed the in vitro activity of chemical against clinically relevant gene-ITD mutant isoforms that confer resistance to chemical or chemical .	T13	T30	23430109
NA	CHEMICAL	GENE-Y	19	11	We assessed the in vitro activity of chemical against clinically relevant gene-ITD mutant isoforms that confer resistance to chemical or chemical .	T14	T30	23430109
NA	CHEMICAL	GENE-Y	7	3	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T15	T31	23430109
NA	CHEMICAL	GENE-N	7	11	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T15	T32	23430109
NA	CHEMICAL	GENE-N	7	23	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T15	T33	23430109
NA	CHEMICAL	GENE-N	7	25	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T15	T34	23430109
NA	CHEMICAL	GENE-Y	9	3	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T16	T31	23430109
NA	CHEMICAL	GENE-N	9	11	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T16	T32	23430109
NA	CHEMICAL	GENE-N	9	23	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T16	T33	23430109
NA	CHEMICAL	GENE-N	9	25	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T16	T34	23430109
NA	CHEMICAL	GENE-Y	17	3	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T17	T31	23430109
NA	CHEMICAL	GENE-N	17	11	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T17	T32	23430109
NA	CHEMICAL	GENE-N	17	23	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T17	T33	23430109
NA	CHEMICAL	GENE-N	17	25	Substitution of the gene `` gatekeeper '' chemical with chemical ( gene ) conferred mild resistance to chemical , but substitutions at the gene ( gene ) residue D835 conferred a high degree of resistance .	T17	T34	23430109
NA	CHEMICAL	GENE-Y	4	9	The switch control inhibitor chemical was similarly inactive against gene AL mutations .	T1	T20	23430109
NA	CHEMICAL	GENE-Y	5	9	On the basis of its in vitro activity against gene TKI-resistant F691 substitutions , further clinical evaluation of chemical in TKI-naive and select TKI-resistant gene-ITD+ AML patients is warranted .	T2	T21	23430109
NA	CHEMICAL	GENE-Y	5	24	On the basis of its in vitro activity against gene TKI-resistant F691 substitutions , further clinical evaluation of chemical in TKI-naive and select TKI-resistant gene-ITD+ AML patients is warranted .	T2	T22	23430109
NA	CHEMICAL	GENE-Y	4	25	Atypical antipsychotic drugs , chemical , chemical , and chemical , preferentially increase chemical and chemical release in rat medial prefrontal cortex : role of gene receptor agonism .	T51	T64	12445705
NA	CHEMICAL	GENE-Y	6	25	Atypical antipsychotic drugs , chemical , chemical , and chemical , preferentially increase chemical and chemical release in rat medial prefrontal cortex : role of gene receptor agonism .	T52	T64	12445705
NA	CHEMICAL	GENE-Y	9	25	Atypical antipsychotic drugs , chemical , chemical , and chemical , preferentially increase chemical and chemical release in rat medial prefrontal cortex : role of gene receptor agonism .	T53	T64	12445705
NA	CHEMICAL	GENE-Y	13	25	Atypical antipsychotic drugs , chemical , chemical , and chemical , preferentially increase chemical and chemical release in rat medial prefrontal cortex : role of gene receptor agonism .	T54	T64	12445705
NA	CHEMICAL	GENE-Y	15	25	Atypical antipsychotic drugs , chemical , chemical , and chemical , preferentially increase chemical and chemical release in rat medial prefrontal cortex : role of gene receptor agonism .	T50	T64	12445705
CPR:5	CHEMICAL	GENE-Y	2	8	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T27	T57	12445705
NA	CHEMICAL	GENE-Y	2	15	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T27	T58	12445705
CPR:4	CHEMICAL	GENE-Y	2	34	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T27	T59	12445705
CPR:4	CHEMICAL	GENE-Y	2	36	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T27	T60	12445705
CPR:5	CHEMICAL	GENE-Y	4	8	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T28	T57	12445705
NA	CHEMICAL	GENE-Y	4	15	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T28	T58	12445705
CPR:4	CHEMICAL	GENE-Y	4	34	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T28	T59	12445705
CPR:4	CHEMICAL	GENE-Y	4	36	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T28	T60	12445705
NA	CHEMICAL	GENE-Y	11	8	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T29	T57	12445705
CPR:6	CHEMICAL	GENE-Y	11	15	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T29	T58	12445705
CPR:4	CHEMICAL	GENE-Y	11	34	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T29	T59	12445705
CPR:4	CHEMICAL	GENE-Y	11	36	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T29	T60	12445705
NA	CHEMICAL	GENE-Y	26	8	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T31	T57	12445705
NA	CHEMICAL	GENE-Y	26	15	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T31	T58	12445705
NA	CHEMICAL	GENE-Y	26	34	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T31	T59	12445705
NA	CHEMICAL	GENE-Y	26	36	Although only chemical and chemical are directly acting gene agonists , chemical , a selective gene antagonist , partially attenuates these atypical APD-induced increases in cortical chemical release that may be due to combined gene and gene blockade .	T31	T60	12445705
NA	CHEMICAL	GENE-Y	5	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T37	T61	12445705
NA	CHEMICAL	GENE-Y	5	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T37	T62	12445705
NA	CHEMICAL	GENE-Y	5	31	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T37	T63	12445705
NA	CHEMICAL	GENE-Y	7	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T38	T61	12445705
NA	CHEMICAL	GENE-Y	7	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T38	T62	12445705
NA	CHEMICAL	GENE-Y	7	31	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T38	T63	12445705
NA	CHEMICAL	GENE-Y	9	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T39	T61	12445705
NA	CHEMICAL	GENE-Y	9	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T39	T62	12445705
NA	CHEMICAL	GENE-Y	9	31	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T39	T63	12445705
NA	CHEMICAL	GENE-Y	19	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T40	T61	12445705
NA	CHEMICAL	GENE-Y	19	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T40	T62	12445705
NA	CHEMICAL	GENE-Y	19	31	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T40	T63	12445705
NA	CHEMICAL	GENE-Y	21	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T41	T61	12445705
NA	CHEMICAL	GENE-Y	21	11	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T41	T62	12445705
NA	CHEMICAL	GENE-Y	21	31	The present study determined whether chemical , chemical and chemical , gene/gene antagonist atypical APDs , also increase cortical chemical and chemical release , and whether these effects are related to gene agonism .	T41	T63	12445705
NA	CHEMICAL	GENE-Y	4	23	These results indicate that chemical , chemical and chemical preferentially increase chemical release in the mPFC , compared to the NAC via a gene-related mechanism .	T16	T55	12445705
NA	CHEMICAL	GENE-Y	6	23	These results indicate that chemical , chemical and chemical preferentially increase chemical release in the mPFC , compared to the NAC via a gene-related mechanism .	T18	T55	12445705
NA	CHEMICAL	GENE-Y	8	23	These results indicate that chemical , chemical and chemical preferentially increase chemical release in the mPFC , compared to the NAC via a gene-related mechanism .	T19	T55	12445705
NA	CHEMICAL	GENE-Y	11	23	These results indicate that chemical , chemical and chemical preferentially increase chemical release in the mPFC , compared to the NAC via a gene-related mechanism .	T20	T55	12445705
NA	CHEMICAL	GENE-N	0	1	chemical receptor blockade in normotensive subjects : A direct comparison of three gene antagonists .	T21	T33	10082498
NA	CHEMICAL	GENE-Y	0	1	chemical receptor blockade in normotensive subjects : A direct comparison of three gene antagonists .	T21	T34	10082498
NA	CHEMICAL	GENE-Y	2	8	Use of chemical ( chemical ) II AT1 receptor antagonists for treatment of hypertension is rapidly increasing , yet direct comparisons of the relative efficacy of antagonists to block the renin-angiotensin system in humans are lacking .	T14	T28	10082498
NA	CHEMICAL	GENE-Y	4	8	Use of chemical ( chemical ) II AT1 receptor antagonists for treatment of hypertension is rapidly increasing , yet direct comparisons of the relative efficacy of antagonists to block the renin-angiotensin system in humans are lacking .	T8	T28	10082498
NA	CHEMICAL	GENE-N	5	6	In this study , the chemical receptor blockade induced by the recommended starting dose of 3 antagonists was evaluated in normotensive subjects in a double-blind , placebo-controlled , randomized , 4-way crossover study .	T9	T25	10082498
NA	CHEMICAL	GENE-Y	3	3	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T13	T26	10082498
NA	CHEMICAL	GENE-Y	3	34	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T13	T27	10082498
NA	CHEMICAL	GENE-Y	3	36	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T13	T29	10082498
NA	CHEMICAL	GENE-N	3	30	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T13	T30	10082498
NA	CHEMICAL	GENE-Y	32	3	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T15	T26	10082498
NA	CHEMICAL	GENE-Y	32	34	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T15	T27	10082498
NA	CHEMICAL	GENE-Y	32	36	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T15	T29	10082498
NA	CHEMICAL	GENE-N	32	30	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T15	T30	10082498
NA	CHEMICAL	GENE-Y	45	3	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T16	T26	10082498
NA	CHEMICAL	GENE-Y	45	34	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T16	T27	10082498
NA	CHEMICAL	GENE-Y	45	36	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T16	T29	10082498
NA	CHEMICAL	GENE-N	45	30	Blockade of the gene-chemical system was assessed before and 4 , 24 , and 30 hours after drug intake by 3 independent methods : inhibition of the blood pressure response to exogenous chemical , in vitro gene receptor assay , and reactive changes in plasma chemical levels .	T16	T30	10082498
NA	CHEMICAL	GENE-N	5	6	Similar results were obtained when chemical receptor blockade was assessed with an in vitro receptor assay and by the reactive rise in plasma chemical levels .	T2	T22	10082498
NA	CHEMICAL	GENE-N	23	6	Similar results were obtained when chemical receptor blockade was assessed with an in vitro receptor assay and by the reactive rise in plasma chemical levels .	T3	T22	10082498
NA	CHEMICAL	GENE-N	5	2	Downregulation of gene but not chemical loss leads to mitochondrial dysfunction in female mice CNS : implications in excitotoxicity .	T21	T40	17512091
NA	CHEMICAL	GENE-N	11	18	We examined the critical roles played by the antioxidant , non-protein chemical , chemical and related enzyme , gene in maintaining mitochondrial function during excitotoxicity caused by chemical ( chemical ) , the causative factor of neurolathyrism , a motor neuron disease involving the pyramidal system .	T11	T37	17512091
NA	CHEMICAL	GENE-N	13	18	We examined the critical roles played by the antioxidant , non-protein chemical , chemical and related enzyme , gene in maintaining mitochondrial function during excitotoxicity caused by chemical ( chemical ) , the causative factor of neurolathyrism , a motor neuron disease involving the pyramidal system .	T12	T37	17512091
NA	CHEMICAL	GENE-N	19	18	We examined the critical roles played by the antioxidant , non-protein chemical , chemical and related enzyme , gene in maintaining mitochondrial function during excitotoxicity caused by chemical ( chemical ) , the causative factor of neurolathyrism , a motor neuron disease involving the pyramidal system .	T13	T37	17512091
NA	CHEMICAL	GENE-N	29	18	We examined the critical roles played by the antioxidant , non-protein chemical , chemical and related enzyme , gene in maintaining mitochondrial function during excitotoxicity caused by chemical ( chemical ) , the causative factor of neurolathyrism , a motor neuron disease involving the pyramidal system .	T14	T37	17512091
CPR:4	CHEMICAL	GENE-N	0	8	chemical causes loss of chemical and inhibition of gene in lumbosacral cord of male mice through oxidation of chemical groups , while female mice are resistant .	T15	T38	17512091
NA	CHEMICAL	GENE-N	4	8	chemical causes loss of chemical and inhibition of gene in lumbosacral cord of male mice through oxidation of chemical groups , while female mice are resistant .	T16	T38	17512091
NA	CHEMICAL	GENE-N	18	8	chemical causes loss of chemical and inhibition of gene in lumbosacral cord of male mice through oxidation of chemical groups , while female mice are resistant .	T17	T38	17512091
NA	CHEMICAL	GENE-N	1	19	Reducing chemical levels in female mice CNS by pretreatment with chemical or chemical did not result in inhibition of gene activity , unlike male mice .	T18	T39	17512091
NA	CHEMICAL	GENE-N	10	19	Reducing chemical levels in female mice CNS by pretreatment with chemical or chemical did not result in inhibition of gene activity , unlike male mice .	T19	T39	17512091
NA	CHEMICAL	GENE-N	3	19	Reducing chemical levels in female mice CNS by pretreatment with chemical or chemical did not result in inhibition of gene activity , unlike male mice .	T20	T39	17512091
NA	CHEMICAL	GENE-N	8	16	Further , treatment of female mice depleted of chemical with chemical did not induce inhibition of gene indicating that chemical levels were not critical for maintaining gene activity in female mice unlike their male counterpart .	T1	T22	17512091
NA	CHEMICAL	GENE-N	8	26	Further , treatment of female mice depleted of chemical with chemical did not induce inhibition of gene indicating that chemical levels were not critical for maintaining gene activity in female mice unlike their male counterpart .	T1	T23	17512091
NA	CHEMICAL	GENE-N	10	16	Further , treatment of female mice depleted of chemical with chemical did not induce inhibition of gene indicating that chemical levels were not critical for maintaining gene activity in female mice unlike their male counterpart .	T2	T22	17512091
NA	CHEMICAL	GENE-N	10	26	Further , treatment of female mice depleted of chemical with chemical did not induce inhibition of gene indicating that chemical levels were not critical for maintaining gene activity in female mice unlike their male counterpart .	T2	T23	17512091
NA	CHEMICAL	GENE-N	19	16	Further , treatment of female mice depleted of chemical with chemical did not induce inhibition of gene indicating that chemical levels were not critical for maintaining gene activity in female mice unlike their male counterpart .	T3	T22	17512091
NA	CHEMICAL	GENE-N	19	26	Further , treatment of female mice depleted of chemical with chemical did not induce inhibition of gene indicating that chemical levels were not critical for maintaining gene activity in female mice unlike their male counterpart .	T3	T23	17512091
NA	CHEMICAL	GENE-N	21	6	Female mice express higher levels of gene in certain CNS regions and downregulation of gene using antisense oligonucleotides sensitizes them to chemical toxicity seen as gene loss .	T6	T28	17512091
NA	CHEMICAL	GENE-N	21	7	Female mice express higher levels of gene in certain CNS regions and downregulation of gene using antisense oligonucleotides sensitizes them to chemical toxicity seen as gene loss .	T6	T29	17512091
CPR:4	CHEMICAL	GENE-N	21	25	Female mice express higher levels of gene in certain CNS regions and downregulation of gene using antisense oligonucleotides sensitizes them to chemical toxicity seen as gene loss .	T6	T30	17512091
NA	CHEMICAL	GENE-N	9	2	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T7	T31	17512091
CPR:3	CHEMICAL	GENE-Y	9	16	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T7	T32	17512091
CPR:3	CHEMICAL	GENE-N	9	22	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T7	T33	17512091
NA	CHEMICAL	GENE-N	9	29	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T7	T34	17512091
NA	CHEMICAL	GENE-N	20	2	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T8	T31	17512091
NA	CHEMICAL	GENE-Y	20	16	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T8	T32	17512091
NA	CHEMICAL	GENE-N	20	22	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T8	T33	17512091
NA	CHEMICAL	GENE-N	20	29	Ovariectomy downregulates gene and renders female mice vulnerable to chemical toxicity as evidenced by activation of gene , loss of chemical and gene activity indicating the important role of gene in neuroprotection .	T8	T34	17512091
CPR:3	CHEMICAL	GENE-N	0	11	chemical protects against mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of gene in the CNS .	T9	T35	17512091
NA	CHEMICAL	GENE-Y	10	19	In the present work we show that reduction sensitive and chemical-stable heteromers can be reconstituted in vitro by mixing gene with either serglycin , versican or gene isolated from various monocytic cell lines .	T3	T19	23601700
NA	CHEMICAL	GENE-N	10	26	In the present work we show that reduction sensitive and chemical-stable heteromers can be reconstituted in vitro by mixing gene with either serglycin , versican or gene isolated from various monocytic cell lines .	T3	T20	23601700
NA	CHEMICAL	GENE-Y	6	7	In addition , a strong but chemical-soluble gene·gene heteromer was formed .	T4	T21	23601700
NA	CHEMICAL	GENE-N	6	7	In addition , a strong but chemical-soluble gene·gene heteromer was formed .	T4	T22	23601700
NA	CHEMICAL	GENE-Y	13	25	As for the heteromer isolated from THP-1 cells , the in vitro reconstituted chemical-stable and chemical-soluble heteromers had a weaker binding to gelatin than the gene monomer .	T7	T24	23601700
NA	CHEMICAL	GENE-Y	15	25	As for the heteromer isolated from THP-1 cells , the in vitro reconstituted chemical-stable and chemical-soluble heteromers had a weaker binding to gelatin than the gene monomer .	T8	T24	23601700
NA	CHEMICAL	GENE-Y	5	5	However , the presence of gene inhibited the formation of the chemical-soluble heteromer , but not the chemical-stable reduction sensitive heteromer .	T1	T13	23601700
NA	CHEMICAL	GENE-Y	17	5	However , the presence of gene inhibited the formation of the chemical-soluble heteromer , but not the chemical-stable reduction sensitive heteromer .	T2	T13	23601700
CPR:3	CHEMICAL	GENE-Y	0	15	chemical interacts with a common binding site to elicit opposite effects on inactivation gating of gene and gene chemical channels .	T18	T39	23319419
CPR:3	CHEMICAL	GENE-Y	0	17	chemical interacts with a common binding site to elicit opposite effects on inactivation gating of gene and gene chemical channels .	T18	T40	23319419
CPR:3	CHEMICAL	GENE-N	0	3	chemical interacts with a common binding site to elicit opposite effects on inactivation gating of gene and gene chemical channels .	T18	T41	23319419
NA	CHEMICAL	GENE-Y	3	15	chemical interacts with a common binding site to elicit opposite effects on inactivation gating of gene and gene chemical channels .	T19	T39	23319419
NA	CHEMICAL	GENE-Y	3	17	chemical interacts with a common binding site to elicit opposite effects on inactivation gating of gene and gene chemical channels .	T19	T40	23319419
NA	CHEMICAL	GENE-N	3	3	chemical interacts with a common binding site to elicit opposite effects on inactivation gating of gene and gene chemical channels .	T19	T41	23319419
NA	CHEMICAL	GENE-Y	9	10	Rapid and voltage-dependent inactivation greatly attenuates outward currents in chemical-a-go-go-related gene ( gene ) chemical channels .	T15	T38	23319419
NA	CHEMICAL	GENE-Y	9	12	Rapid and voltage-dependent inactivation greatly attenuates outward currents in chemical-a-go-go-related gene ( gene ) chemical channels .	T15	T23	23319419
NA	CHEMICAL	GENE-N	9	15	Rapid and voltage-dependent inactivation greatly attenuates outward currents in chemical-a-go-go-related gene ( gene ) chemical channels .	T15	T24	23319419
NA	CHEMICAL	GENE-Y	9	10	Rapid and voltage-dependent inactivation greatly attenuates outward currents in chemical-a-go-go-related gene ( gene ) chemical channels .	T1	T38	23319419
NA	CHEMICAL	GENE-Y	9	12	Rapid and voltage-dependent inactivation greatly attenuates outward currents in chemical-a-go-go-related gene ( gene ) chemical channels .	T1	T23	23319419
NA	CHEMICAL	GENE-N	9	15	Rapid and voltage-dependent inactivation greatly attenuates outward currents in chemical-a-go-go-related gene ( gene ) chemical channels .	T1	T24	23319419
NA	CHEMICAL	GENE-Y	6	8	In contrast , inactivation of related chemical-a-go-go ( gene ) chemical channels is very slow and minimally reduces outward currents .	T7	T32	23319419
NA	CHEMICAL	GENE-N	6	11	In contrast , inactivation of related chemical-a-go-go ( gene ) chemical channels is very slow and minimally reduces outward currents .	T7	T33	23319419
NA	CHEMICAL	GENE-Y	7	8	In contrast , inactivation of related chemical-a-go-go ( gene ) chemical channels is very slow and minimally reduces outward currents .	T8	T32	23319419
NA	CHEMICAL	GENE-N	7	11	In contrast , inactivation of related chemical-a-go-go ( gene ) chemical channels is very slow and minimally reduces outward currents .	T8	T33	23319419
CPR:3	CHEMICAL	GENE-Y	1	4	Although chemical greatly attenuates gene inactivation by shifting its voltage dependence to more positive potentials , it enhances the rate and extent of gene inactivation without altering its voltage dependence .	T12	T34	23319419
CPR:4	CHEMICAL	GENE-Y	1	23	Although chemical greatly attenuates gene inactivation by shifting its voltage dependence to more positive potentials , it enhances the rate and extent of gene inactivation without altering its voltage dependence .	T12	T35	23319419
NA	CHEMICAL	GENE-Y	10	12	Here , we investigate whether the inverse functional response to chemical in gene and gene channels is related to differences in chemical binding site or to intrinsic mechanisms of inactivation .	T13	T36	23319419
NA	CHEMICAL	GENE-Y	10	14	Here , we investigate whether the inverse functional response to chemical in gene and gene channels is related to differences in chemical binding site or to intrinsic mechanisms of inactivation .	T13	T37	23319419
NA	CHEMICAL	GENE-Y	21	12	Here , we investigate whether the inverse functional response to chemical in gene and gene channels is related to differences in chemical binding site or to intrinsic mechanisms of inactivation .	T14	T36	23319419
NA	CHEMICAL	GENE-Y	21	14	Here , we investigate whether the inverse functional response to chemical in gene and gene channels is related to differences in chemical binding site or to intrinsic mechanisms of inactivation .	T14	T37	23319419
CPR:5	CHEMICAL	GENE-Y	0	7	chemical is a mixed agonist of mutant gene and gene/gene chimera channels that inactivate by a combination of slow and fast mechanisms .	T17	T20	23319419
CPR:5	CHEMICAL	GENE-Y	0	9	chemical is a mixed agonist of mutant gene and gene/gene chimera channels that inactivate by a combination of slow and fast mechanisms .	T17	T21	23319419
CPR:5	CHEMICAL	GENE-Y	0	9	chemical is a mixed agonist of mutant gene and gene/gene chimera channels that inactivate by a combination of slow and fast mechanisms .	T17	T22	23319419
NA	CHEMICAL	GENE-Y	9	19	With the exception of three residues , the specific chemical that form the putative binding pocket for chemical in gene are conserved in gene .	T2	T25	23319419
NA	CHEMICAL	GENE-Y	9	23	With the exception of three residues , the specific chemical that form the putative binding pocket for chemical in gene are conserved in gene .	T2	T26	23319419
NA	CHEMICAL	GENE-Y	17	19	With the exception of three residues , the specific chemical that form the putative binding pocket for chemical in gene are conserved in gene .	T3	T25	23319419
NA	CHEMICAL	GENE-Y	17	23	With the exception of three residues , the specific chemical that form the putative binding pocket for chemical in gene are conserved in gene .	T3	T26	23319419
NA	CHEMICAL	GENE-Y	7	3	Mutations introduced into gene to replicate the chemical binding site in gene did not alter the functional response to chemical .	T4	T27	23319419
NA	CHEMICAL	GENE-Y	7	11	Mutations introduced into gene to replicate the chemical binding site in gene did not alter the functional response to chemical .	T4	T28	23319419
NA	CHEMICAL	GENE-Y	19	3	Mutations introduced into gene to replicate the chemical binding site in gene did not alter the functional response to chemical .	T5	T27	23319419
NA	CHEMICAL	GENE-Y	19	11	Mutations introduced into gene to replicate the chemical binding site in gene did not alter the functional response to chemical .	T5	T28	23319419
NA	CHEMICAL	GENE-N	0	2	chemical D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by chemical , chemical and chemical .	T22	T32	19496999
NA	CHEMICAL	GENE-N	13	2	chemical D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by chemical , chemical and chemical .	T25	T32	19496999
NA	CHEMICAL	GENE-N	7	2	chemical D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by chemical , chemical and chemical .	T23	T32	19496999
NA	CHEMICAL	GENE-N	7	2	chemical D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by chemical , chemical and chemical .	T24	T32	19496999
NA	CHEMICAL	GENE-Y	6	12	Differences between typical and second-generation antipsychotics in chemical D ( 2 ) receptor modulation within various brain areas remain a topic for debate .	T9	T28	19496999
NA	CHEMICAL	GENE-N	10	8	The aim of the present study was therefore to investigate chemical D ( 2/3 ) receptor apparent binding potential ( BP ( app ) ) and occupancy in midbrain and temporal cortex among chemical- , chemical- and chemical-treated schizophrenia patients .	T10	T29	19496999
NA	CHEMICAL	GENE-N	27	8	The aim of the present study was therefore to investigate chemical D ( 2/3 ) receptor apparent binding potential ( BP ( app ) ) and occupancy in midbrain and temporal cortex among chemical- , chemical- and chemical-treated schizophrenia patients .	T11	T29	19496999
NA	CHEMICAL	GENE-N	27	8	The aim of the present study was therefore to investigate chemical D ( 2/3 ) receptor apparent binding potential ( BP ( app ) ) and occupancy in midbrain and temporal cortex among chemical- , chemical- and chemical-treated schizophrenia patients .	T12	T29	19496999
NA	CHEMICAL	GENE-N	37	8	The aim of the present study was therefore to investigate chemical D ( 2/3 ) receptor apparent binding potential ( BP ( app ) ) and occupancy in midbrain and temporal cortex among chemical- , chemical- and chemical-treated schizophrenia patients .	T13	T29	19496999
NA	CHEMICAL	GENE-N	2	3	METHODS : chemical D ( 2/3 ) binding was studied on single-photon emission computed tomography ligand chemical in 13 schizophrenia patients treated with medication ( two with chemical , four with chemical and seven with chemical ) , six drug-naive patients and seven healthy controls .	T14	T30	19496999
NA	CHEMICAL	GENE-N	4	3	METHODS : chemical D ( 2/3 ) binding was studied on single-photon emission computed tomography ligand chemical in 13 schizophrenia patients treated with medication ( two with chemical , four with chemical and seven with chemical ) , six drug-naive patients and seven healthy controls .	T15	T30	19496999
NA	CHEMICAL	GENE-N	27	3	METHODS : chemical D ( 2/3 ) binding was studied on single-photon emission computed tomography ligand chemical in 13 schizophrenia patients treated with medication ( two with chemical , four with chemical and seven with chemical ) , six drug-naive patients and seven healthy controls .	T16	T30	19496999
NA	CHEMICAL	GENE-N	17	3	METHODS : chemical D ( 2/3 ) binding was studied on single-photon emission computed tomography ligand chemical in 13 schizophrenia patients treated with medication ( two with chemical , four with chemical and seven with chemical ) , six drug-naive patients and seven healthy controls .	T17	T30	19496999
NA	CHEMICAL	GENE-N	17	3	METHODS : chemical D ( 2/3 ) binding was studied on single-photon emission computed tomography ligand chemical in 13 schizophrenia patients treated with medication ( two with chemical , four with chemical and seven with chemical ) , six drug-naive patients and seven healthy controls .	T18	T30	19496999
NA	CHEMICAL	GENE-N	5	12	RESULTS : Statistically significant differences in midbrain chemical D ( 2/3 ) receptor BP ( app ) ( P = 0.015 ) and occupancy ( P = 0.016 ) were observed between the chemical , chemical and chemical groups .	T19	T31	19496999
NA	CHEMICAL	GENE-N	5	12	RESULTS : Statistically significant differences in midbrain chemical D ( 2/3 ) receptor BP ( app ) ( P = 0.015 ) and occupancy ( P = 0.016 ) were observed between the chemical , chemical and chemical groups .	T20	T31	19496999
NA	CHEMICAL	GENE-N	5	12	RESULTS : Statistically significant differences in midbrain chemical D ( 2/3 ) receptor BP ( app ) ( P = 0.015 ) and occupancy ( P = 0.016 ) were observed between the chemical , chemical and chemical groups .	T21	T31	19496999
NA	CHEMICAL	GENE-N	7	12	RESULTS : Statistically significant differences in midbrain chemical D ( 2/3 ) receptor BP ( app ) ( P = 0.015 ) and occupancy ( P = 0.016 ) were observed between the chemical , chemical and chemical groups .	T1	T31	19496999
NA	CHEMICAL	GENE-N	9	14	CONCLUSION : Both typical and second-generation antipsychotics occupy cortical chemical D ( 2/3 ) receptors , thus mediating therapeutic efficacy .	T6	T26	19496999
NA	CHEMICAL	GENE-N	8	29	RATIONALE : A recent study suggested that selective chemical reuptake inhibitors were inactive in 40-week-old male mice in the mouse forced swimming test , possibly because of alteration of gene receptors .	T15	T27	11243491
NA	CHEMICAL	GENE-Y	7	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T14	T32	11243491
NA	CHEMICAL	GENE-Y	7	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T14	T33	11243491
NA	CHEMICAL	GENE-Y	7	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T14	T34	11243491
NA	CHEMICAL	GENE-Y	7	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T14	T35	11243491
NA	CHEMICAL	GENE-Y	9	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T16	T32	11243491
NA	CHEMICAL	GENE-Y	9	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T16	T33	11243491
NA	CHEMICAL	GENE-Y	9	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T16	T34	11243491
NA	CHEMICAL	GENE-Y	9	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T16	T35	11243491
NA	CHEMICAL	GENE-Y	12	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T17	T32	11243491
NA	CHEMICAL	GENE-Y	12	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T17	T33	11243491
NA	CHEMICAL	GENE-Y	12	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T17	T34	11243491
NA	CHEMICAL	GENE-Y	12	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T17	T35	11243491
NA	CHEMICAL	GENE-Y	14	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T18	T32	11243491
NA	CHEMICAL	GENE-Y	14	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T18	T33	11243491
NA	CHEMICAL	GENE-Y	14	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T18	T34	11243491
NA	CHEMICAL	GENE-Y	14	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T18	T35	11243491
NA	CHEMICAL	GENE-Y	19	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T19	T32	11243491
NA	CHEMICAL	GENE-Y	19	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T19	T33	11243491
NA	CHEMICAL	GENE-Y	19	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T19	T34	11243491
NA	CHEMICAL	GENE-Y	19	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T19	T35	11243491
NA	CHEMICAL	GENE-Y	22	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T20	T32	11243491
NA	CHEMICAL	GENE-Y	22	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T20	T33	11243491
NA	CHEMICAL	GENE-Y	22	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T20	T34	11243491
NA	CHEMICAL	GENE-Y	22	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T20	T35	11243491
NA	CHEMICAL	GENE-Y	24	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T21	T32	11243491
NA	CHEMICAL	GENE-Y	24	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T21	T33	11243491
NA	CHEMICAL	GENE-Y	24	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T21	T34	11243491
NA	CHEMICAL	GENE-Y	24	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T21	T35	11243491
NA	CHEMICAL	GENE-Y	29	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T22	T32	11243491
NA	CHEMICAL	GENE-Y	29	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T22	T33	11243491
NA	CHEMICAL	GENE-Y	29	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T22	T34	11243491
NA	CHEMICAL	GENE-Y	29	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T22	T35	11243491
NA	CHEMICAL	GENE-Y	31	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T23	T32	11243491
NA	CHEMICAL	GENE-Y	31	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T23	T33	11243491
NA	CHEMICAL	GENE-Y	31	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T23	T34	11243491
NA	CHEMICAL	GENE-Y	31	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T23	T35	11243491
NA	CHEMICAL	GENE-Y	34	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T24	T32	11243491
NA	CHEMICAL	GENE-Y	34	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T24	T33	11243491
NA	CHEMICAL	GENE-Y	34	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T24	T34	11243491
NA	CHEMICAL	GENE-Y	34	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T24	T35	11243491
NA	CHEMICAL	GENE-Y	59	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T25	T32	11243491
NA	CHEMICAL	GENE-Y	59	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T25	T33	11243491
CPR:5	CHEMICAL	GENE-Y	59	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T25	T34	11243491
NA	CHEMICAL	GENE-Y	59	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T25	T35	11243491
NA	CHEMICAL	GENE-Y	41	53	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T26	T32	11243491
NA	CHEMICAL	GENE-Y	41	55	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T26	T33	11243491
NA	CHEMICAL	GENE-Y	41	62	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T26	T34	11243491
CPR:5	CHEMICAL	GENE-Y	41	68	METHODS : Different classes of antidepressants [ chemical ( chemical ) , chemical ( chemical reuptake inhibitor ) , chemical ( mixed chemical and chemical reuptake inhibitors ) , chemical and chemical ( selective chemical reuptake inhibitor ) ] were tested in the same randomised experimental session , alone and in combination with gene and gene receptor agonists [ chemical ( partial gene agonist ) , chemical ( gene agonist ) ] in the mouse forced swimming test .	T26	T35	11243491
NA	CHEMICAL	GENE-Y	3	5	Preclinical properties of chemical : a PET agent for gene plaques in the brain .	T9	T22	19837759
NA	CHEMICAL	GENE-Y	0	18	chemical ( chemical ) is such as an agent currently in phase III clinical studies for PET of gene plaques in the brain .	T3	T16	19837759
NA	CHEMICAL	GENE-Y	1	18	chemical ( chemical ) is such as an agent currently in phase III clinical studies for PET of gene plaques in the brain .	T4	T16	19837759
NA	CHEMICAL	GENE-Y	6	8	METHODS : In vitro binding of chemical to gene plaques in the postmortem AD brain tissue was evaluated by in vitro binding assay and autoradiography .	T5	T17	19837759
NA	CHEMICAL	GENE-Y	4	16	In vivo biodistribution of chemical in mice and ex vivo autoradiography of AD transgenic mice ( gene/gene ) with gene aggregates in the brain were performed .	T6	T18	19837759
NA	CHEMICAL	GENE-Y	4	16	In vivo biodistribution of chemical in mice and ex vivo autoradiography of AD transgenic mice ( gene/gene ) with gene aggregates in the brain were performed .	T6	T19	19837759
NA	CHEMICAL	GENE-Y	4	19	In vivo biodistribution of chemical in mice and ex vivo autoradiography of AD transgenic mice ( gene/gene ) with gene aggregates in the brain were performed .	T6	T20	19837759
NA	CHEMICAL	GENE-Y	2	4	RESULTS : chemical displayed a high binding affinity and specificity to gene plaques ( K ( d ) , 3.72 +/- 0.30 nM ) .	T8	T10	19837759
NA	CHEMICAL	GENE-Y	0	6	chemical displayed excellent binding affinity to gene plaques in the AD brain by ex vivo autoradiography in transgenic AD model mice .	T1	T12	19837759
NA	CHEMICAL	GENE-Y	5	0	gene mutants were hypersensitive to chemical ( chemical ) , chemical , and UV-B light but only mildly sensitive to gamma-radiation .	T2	T13	15075397
NA	CHEMICAL	GENE-Y	7	0	gene mutants were hypersensitive to chemical ( chemical ) , chemical , and UV-B light but only mildly sensitive to gamma-radiation .	T3	T13	15075397
NA	CHEMICAL	GENE-Y	10	0	gene mutants were hypersensitive to chemical ( chemical ) , chemical , and UV-B light but only mildly sensitive to gamma-radiation .	T4	T13	15075397
NA	CHEMICAL	GENE-Y	5	16	G2 arrest also was observed in wild-type plants in response to chemical but was defective in gene mutants , resulting in compaction of nuclei and subsequent cell death .	T5	T16	15075397
CPR:9	CHEMICAL	GENE-N	2	4	Metabolism of chemical by gene Enzymes .	T9	T23	23512537
CPR:9	CHEMICAL	GENE-N	10	6	It is possible that variations in gene enzyme-mediated metabolism of chemical may contribute to this phenomenon .	T4	T14	23512537
NA	CHEMICAL	GENE-N	18	9	This hypothesis was explored by evaluating the contributions of gene , and gene enzymes in the metabolism of chemical in vitro and relating metabolism to changes in gene enzyme mRNA expression via the gene in lung and liver cells .	T5	T15	23512537
CPR:9	CHEMICAL	GENE-N	18	12	This hypothesis was explored by evaluating the contributions of gene , and gene enzymes in the metabolism of chemical in vitro and relating metabolism to changes in gene enzyme mRNA expression via the gene in lung and liver cells .	T5	T16	23512537
NA	CHEMICAL	GENE-N	18	27	This hypothesis was explored by evaluating the contributions of gene , and gene enzymes in the metabolism of chemical in vitro and relating metabolism to changes in gene enzyme mRNA expression via the gene in lung and liver cells .	T5	T17	23512537
NA	CHEMICAL	GENE-Y	18	24	This hypothesis was explored by evaluating the contributions of gene , and gene enzymes in the metabolism of chemical in vitro and relating metabolism to changes in gene enzyme mRNA expression via the gene in lung and liver cells .	T5	T18	23512537
CPR:9	CHEMICAL	GENE-Y	4	0	gene and gene metabolized chemical via hydroxylation ( [ M4 ] and [ M6 ] ) and dehydrogenation ( [ M5 ] ) at similar rates ; gene did not metabolize chemical .	T7	T19	23512537
CPR:9	CHEMICAL	GENE-Y	4	2	gene and gene metabolized chemical via hydroxylation ( [ M4 ] and [ M6 ] ) and dehydrogenation ( [ M5 ] ) at similar rates ; gene did not metabolize chemical .	T7	T20	23512537
NA	CHEMICAL	GENE-Y	4	27	gene and gene metabolized chemical via hydroxylation ( [ M4 ] and [ M6 ] ) and dehydrogenation ( [ M5 ] ) at similar rates ; gene did not metabolize chemical .	T7	T21	23512537
NA	CHEMICAL	GENE-Y	31	0	gene and gene metabolized chemical via hydroxylation ( [ M4 ] and [ M6 ] ) and dehydrogenation ( [ M5 ] ) at similar rates ; gene did not metabolize chemical .	T8	T19	23512537
NA	CHEMICAL	GENE-Y	31	2	gene and gene metabolized chemical via hydroxylation ( [ M4 ] and [ M6 ] ) and dehydrogenation ( [ M5 ] ) at similar rates ; gene did not metabolize chemical .	T8	T20	23512537
NA	CHEMICAL	GENE-Y	31	27	gene and gene metabolized chemical via hydroxylation ( [ M4 ] and [ M6 ] ) and dehydrogenation ( [ M5 ] ) at similar rates ; gene did not metabolize chemical .	T8	T21	23512537
CPR:4	CHEMICAL	GENE-Y	8	3	The earliest known gene inhibitors , namely , chemical and chemical , performed poorly in clinical trials ( e.g. , poor oral activity , brain penetration , and hepatotoxic liability ) .	T1	T7	11893059
CPR:4	CHEMICAL	GENE-Y	10	3	The earliest known gene inhibitors , namely , chemical and chemical , performed poorly in clinical trials ( e.g. , poor oral activity , brain penetration , and hepatotoxic liability ) .	T2	T7	11893059
CPR:3	CHEMICAL	GENE-N	16	4	Increased urinary excretion of gene , gene , gene and gene correlates with chronic sensitization to chemical nephrotoxicity in rats .	T6	T11	23261757
CPR:3	CHEMICAL	GENE-Y	16	6	Increased urinary excretion of gene , gene , gene and gene correlates with chronic sensitization to chemical nephrotoxicity in rats .	T6	T12	23261757
CPR:3	CHEMICAL	GENE-Y	16	8	Increased urinary excretion of gene , gene , gene and gene correlates with chronic sensitization to chemical nephrotoxicity in rats .	T6	T13	23261757
CPR:3	CHEMICAL	GENE-Y	16	10	Increased urinary excretion of gene , gene , gene and gene correlates with chronic sensitization to chemical nephrotoxicity in rats .	T6	T14	23261757
NA	CHEMICAL	GENE-N	10	4	Four proteins , namely gene , gene , gene and chemical binding protein were increased in the urine in temporal association with the appearance of chronic predisposition .	T1	T7	23261757
NA	CHEMICAL	GENE-Y	10	6	Four proteins , namely gene , gene , gene and chemical binding protein were increased in the urine in temporal association with the appearance of chronic predisposition .	T1	T8	23261757
NA	CHEMICAL	GENE-Y	10	8	Four proteins , namely gene , gene , gene and chemical binding protein were increased in the urine in temporal association with the appearance of chronic predisposition .	T1	T9	23261757
NA	CHEMICAL	GENE-Y	10	12	Four proteins , namely gene , gene , gene and chemical binding protein were increased in the urine in temporal association with the appearance of chronic predisposition .	T1	T10	23261757
CPR:4	CHEMICAL	GENE-Y	7	10	Immunofluorescence staining and western blotting demonstrated that chemical treatment reduced gene and gene expression in the retinas of OLETF rats .	T7	T9	23536314
CPR:4	CHEMICAL	GENE-Y	7	12	Immunofluorescence staining and western blotting demonstrated that chemical treatment reduced gene and gene expression in the retinas of OLETF rats .	T7	T10	23536314
CPR:9	CHEMICAL	GENE-Y	14	6	The unique role of the enzyme gene ( gene ) in the production of chemical ( chemical ) makes it a likely target for biochemical manipulation .	T17	T25	1359745
CPR:9	CHEMICAL	GENE-Y	14	8	The unique role of the enzyme gene ( gene ) in the production of chemical ( chemical ) makes it a likely target for biochemical manipulation .	T17	T26	1359745
CPR:9	CHEMICAL	GENE-Y	16	6	The unique role of the enzyme gene ( gene ) in the production of chemical ( chemical ) makes it a likely target for biochemical manipulation .	T21	T25	1359745
CPR:9	CHEMICAL	GENE-Y	16	8	The unique role of the enzyme gene ( gene ) in the production of chemical ( chemical ) makes it a likely target for biochemical manipulation .	T21	T26	1359745
NA	CHEMICAL	GENE-Y	23	4	The rationale for using gene inhibitors for the treatment of inflammatory bowel disease ( IBD ) is based on the increased generation of chemical in the inflamed mucosa , chemical being the most potent chemotactic and chemokinetic metabolite of chemical .	T11	T24	1359745
NA	CHEMICAL	GENE-Y	29	4	The rationale for using gene inhibitors for the treatment of inflammatory bowel disease ( IBD ) is based on the increased generation of chemical in the inflamed mucosa , chemical being the most potent chemotactic and chemokinetic metabolite of chemical .	T12	T24	1359745
NA	CHEMICAL	GENE-Y	39	4	The rationale for using gene inhibitors for the treatment of inflammatory bowel disease ( IBD ) is based on the increased generation of chemical in the inflamed mucosa , chemical being the most potent chemotactic and chemokinetic metabolite of chemical .	T13	T24	1359745
NA	CHEMICAL	GENE-Y	6	19	Furthermore , conventional drugs , such as corticosteroids , chemical , and chemical , inhibit chemical production and specific gene inhibition accelerates healing in animal models of acute colitis .	T14	T27	1359745
NA	CHEMICAL	GENE-Y	12	19	Furthermore , conventional drugs , such as corticosteroids , chemical , and chemical , inhibit chemical production and specific gene inhibition accelerates healing in animal models of acute colitis .	T15	T27	1359745
NA	CHEMICAL	GENE-Y	15	19	Furthermore , conventional drugs , such as corticosteroids , chemical , and chemical , inhibit chemical production and specific gene inhibition accelerates healing in animal models of acute colitis .	T16	T27	1359745
NA	CHEMICAL	GENE-Y	15	4	The compounds identified as gene inhibitors can be divided into antioxidants , substrate-analogous , and a large miscellaneous group of inhibitors , where chemical are potent and more selective inhibitors of gene .	T18	T28	1359745
CPR:4	CHEMICAL	GENE-Y	15	31	The compounds identified as gene inhibitors can be divided into antioxidants , substrate-analogous , and a large miscellaneous group of inhibitors , where chemical are potent and more selective inhibitors of gene .	T18	T29	1359745
CPR:4	CHEMICAL	GENE-Y	1	9	The chemical , chemical , is the first selective gene inhibitor evaluated for the treatment of patients with IBD .	T19	T30	1359745
CPR:4	CHEMICAL	GENE-Y	3	9	The chemical , chemical , is the first selective gene inhibitor evaluated for the treatment of patients with IBD .	T20	T30	1359745
NA	CHEMICAL	GENE-Y	9	5	The proof that any putative gene inhibitor is blocking chemical production is an important stage in assessing any such drug .	T7	T23	1359745
NA	CHEMICAL	GENE-Y	1	4	The chemical-terminal portion of gene shows sequence homology to members of the cartilage link protein family of gene .	T5	T28	7516184
NA	CHEMICAL	GENE-N	1	14	The chemical-terminal portion of gene shows sequence homology to members of the cartilage link protein family of gene .	T5	T13	7516184
NA	CHEMICAL	GENE-Y	1	4	The chemical-terminal half of gene contains a so-called gene , characteristic for developmentally regulated proteins .	T3	T15	7516184
NA	CHEMICAL	GENE-N	1	6	The chemical-terminal half of gene contains a so-called gene , characteristic for developmentally regulated proteins .	T3	T16	7516184
NA	CHEMICAL	GENE-N	4	13	The protein that binds gene was purified from human serum and identified as gene ( gene ) by chemical-terminal microsequencing .	T6	T22	7516184
NA	CHEMICAL	GENE-N	4	15	The protein that binds gene was purified from human serum and identified as gene ( gene ) by chemical-terminal microsequencing .	T6	T23	7516184
CPR:3	CHEMICAL	GENE-Y	4	0	gene were activated by chemical as assessed using a glucocorticoid-responsive reporter plasmid , pTAT3-CAT .	T10	T18	10796070
CPR:6	CHEMICAL	GENE-Y	3	1	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T2	T11	10796070
NA	CHEMICAL	GENE-Y	3	14	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T2	T12	10796070
NA	CHEMICAL	GENE-Y	3	29	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T2	T13	10796070
CPR:6	CHEMICAL	GENE-Y	5	1	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T3	T11	10796070
NA	CHEMICAL	GENE-Y	5	14	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T3	T12	10796070
NA	CHEMICAL	GENE-Y	5	29	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T3	T13	10796070
NA	CHEMICAL	GENE-Y	12	1	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T4	T11	10796070
NA	CHEMICAL	GENE-Y	12	14	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T4	T12	10796070
NA	CHEMICAL	GENE-Y	12	29	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T4	T13	10796070
NA	CHEMICAL	GENE-Y	13	1	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T5	T11	10796070
NA	CHEMICAL	GENE-Y	13	14	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T5	T12	10796070
NA	CHEMICAL	GENE-Y	13	29	The gene antagonist chemical ( chemical ) significantly counteracted the effect of chemical on gene activation , indicating that the chemical effect is specific and is mediated through the gene .	T5	T13	10796070
NA	CHEMICAL	GENE-Y	5	2	Involvement of gene and up-regulated chemical synthases in chemical liposome-induced chemical production by microglia .	T17	T48	16371234
NA	CHEMICAL	GENE-Y	5	6	Involvement of gene and up-regulated chemical synthases in chemical liposome-induced chemical production by microglia .	T17	T49	16371234
NA	CHEMICAL	GENE-Y	7	2	Involvement of gene and up-regulated chemical synthases in chemical liposome-induced chemical production by microglia .	T18	T48	16371234
NA	CHEMICAL	GENE-Y	7	6	Involvement of gene and up-regulated chemical synthases in chemical liposome-induced chemical production by microglia .	T18	T49	16371234
CPR:9	CHEMICAL	GENE-Y	10	2	Involvement of gene and up-regulated chemical synthases in chemical liposome-induced chemical production by microglia .	T16	T48	16371234
CPR:9	CHEMICAL	GENE-Y	10	6	Involvement of gene and up-regulated chemical synthases in chemical liposome-induced chemical production by microglia .	T16	T49	16371234
NA	CHEMICAL	GENE-N	15	4	The specific ligand for gene ( gene ) , gene , significantly suppressed PS liposome-induced chemical production .	T14	T42	16371234
NA	CHEMICAL	GENE-N	15	6	The specific ligand for gene ( gene ) , gene , significantly suppressed PS liposome-induced chemical production .	T14	T43	16371234
NA	CHEMICAL	GENE-N	15	9	The specific ligand for gene ( gene ) , gene , significantly suppressed PS liposome-induced chemical production .	T14	T44	16371234
NA	CHEMICAL	GENE-N	4	0	gene gene and membrane-bound chemical synthase-1 ( gene ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	T15	T45	16371234
NA	CHEMICAL	GENE-Y	4	1	gene gene and membrane-bound chemical synthase-1 ( gene ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	T15	T46	16371234
NA	CHEMICAL	GENE-Y	4	5	gene gene and membrane-bound chemical synthase-1 ( gene ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	T15	T47	16371234
NA	CHEMICAL	GENE-Y	4	7	gene gene and membrane-bound chemical synthase-1 ( gene ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	T15	T19	16371234
NA	CHEMICAL	GENE-Y	4	14	Furthermore , PS liposome-induced chemical production was significantly suppressed by chemical , a preferential gene inhibitor , but not by chemical , a selective gene inhibitor .	T3	T24	16371234
NA	CHEMICAL	GENE-Y	4	24	Furthermore , PS liposome-induced chemical production was significantly suppressed by chemical , a preferential gene inhibitor , but not by chemical , a selective gene inhibitor .	T3	T25	16371234
CPR:4	CHEMICAL	GENE-Y	10	14	Furthermore , PS liposome-induced chemical production was significantly suppressed by chemical , a preferential gene inhibitor , but not by chemical , a selective gene inhibitor .	T4	T24	16371234
NA	CHEMICAL	GENE-Y	10	24	Furthermore , PS liposome-induced chemical production was significantly suppressed by chemical , a preferential gene inhibitor , but not by chemical , a selective gene inhibitor .	T4	T25	16371234
NA	CHEMICAL	GENE-Y	20	14	Furthermore , PS liposome-induced chemical production was significantly suppressed by chemical , a preferential gene inhibitor , but not by chemical , a selective gene inhibitor .	T5	T24	16371234
CPR:4	CHEMICAL	GENE-Y	20	24	Furthermore , PS liposome-induced chemical production was significantly suppressed by chemical , a preferential gene inhibitor , but not by chemical , a selective gene inhibitor .	T5	T25	16371234
CPR:9	CHEMICAL	GENE-Y	27	9	These observations strongly suggest that the up-regulation of terminal gene that are preferentially coupled with gene , especially gene , plays the pivotal role in PS liposome-induced chemical production by microglia .	T6	T33	16371234
CPR:9	CHEMICAL	GENE-Y	27	15	These observations strongly suggest that the up-regulation of terminal gene that are preferentially coupled with gene , especially gene , plays the pivotal role in PS liposome-induced chemical production by microglia .	T6	T34	16371234
CPR:9	CHEMICAL	GENE-Y	27	18	These observations strongly suggest that the up-regulation of terminal gene that are preferentially coupled with gene , especially gene , plays the pivotal role in PS liposome-induced chemical production by microglia .	T6	T35	16371234
CPR:4	CHEMICAL	GENE-Y	0	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T1	T14	11252887
CPR:4	CHEMICAL	GENE-Y	0	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T1	T12	11252887
CPR:4	CHEMICAL	GENE-Y	0	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T1	T13	11252887
CPR:4	CHEMICAL	GENE-Y	2	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T4	T14	11252887
CPR:4	CHEMICAL	GENE-Y	2	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T4	T12	11252887
CPR:4	CHEMICAL	GENE-Y	2	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T4	T13	11252887
CPR:4	CHEMICAL	GENE-Y	4	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T6	T14	11252887
CPR:4	CHEMICAL	GENE-Y	4	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T6	T12	11252887
CPR:4	CHEMICAL	GENE-Y	4	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T6	T13	11252887
NA	CHEMICAL	GENE-Y	7	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T9	T14	11252887
NA	CHEMICAL	GENE-Y	7	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T9	T12	11252887
NA	CHEMICAL	GENE-Y	7	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T9	T13	11252887
NA	CHEMICAL	GENE-Y	7	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T2	T14	11252887
NA	CHEMICAL	GENE-Y	7	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T2	T12	11252887
NA	CHEMICAL	GENE-Y	7	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T2	T13	11252887
NA	CHEMICAL	GENE-Y	21	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T3	T14	11252887
NA	CHEMICAL	GENE-Y	21	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T3	T12	11252887
NA	CHEMICAL	GENE-Y	21	7	chemical ( chemical , chemical ) is a novel , multitargeted antifolate that inhibits chemical synthase , chemical reductase , and chemical transferase .	T3	T13	11252887
CPR:4	CHEMICAL	GENE-Y	0	16	chemical , an opiate agonist of high specificity for mu-receptors , was recently reported to suppress gene and chemical levels in normal subjects , but not in patients with proven gene-dependent Cushing 's disease .	T1	T20	1322429
NA	CHEMICAL	GENE-Y	0	30	chemical , an opiate agonist of high specificity for mu-receptors , was recently reported to suppress gene and chemical levels in normal subjects , but not in patients with proven gene-dependent Cushing 's disease .	T1	T32	1322429
NA	CHEMICAL	GENE-Y	16	16	chemical , an opiate agonist of high specificity for mu-receptors , was recently reported to suppress gene and chemical levels in normal subjects , but not in patients with proven gene-dependent Cushing 's disease .	T2	T20	1322429
NA	CHEMICAL	GENE-Y	16	30	chemical , an opiate agonist of high specificity for mu-receptors , was recently reported to suppress gene and chemical levels in normal subjects , but not in patients with proven gene-dependent Cushing 's disease .	T2	T32	1322429
CPR:4	CHEMICAL	GENE-Y	15	6	In seven normal subjects , basal gene plasma levels were significantly suppressed 3 h after chemical administration ( 16 mg , orally ) from 5 +/- 1 to 2 +/- 0 pmol/L ( P less than 0.0001 ) .	T14	T33	1322429
NA	CHEMICAL	GENE-Y	13	9	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T15	T34	1322429
NA	CHEMICAL	GENE-Y	13	77	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T15	T36	1322429
NA	CHEMICAL	GENE-Y	13	26	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T15	T38	1322429
NA	CHEMICAL	GENE-Y	13	62	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T15	T39	1322429
NA	CHEMICAL	GENE-Y	17	9	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T16	T34	1322429
NA	CHEMICAL	GENE-Y	17	77	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T16	T36	1322429
NA	CHEMICAL	GENE-Y	17	26	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T16	T38	1322429
NA	CHEMICAL	GENE-Y	17	62	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T16	T39	1322429
NA	CHEMICAL	GENE-Y	22	9	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T17	T34	1322429
NA	CHEMICAL	GENE-Y	22	77	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T17	T36	1322429
NA	CHEMICAL	GENE-Y	22	26	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T17	T38	1322429
NA	CHEMICAL	GENE-Y	22	62	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T17	T39	1322429
CPR:4	CHEMICAL	GENE-Y	39	9	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T18	T34	1322429
CPR:4	CHEMICAL	GENE-Y	39	77	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T18	T36	1322429
CPR:4	CHEMICAL	GENE-Y	39	26	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T18	T38	1322429
CPR:4	CHEMICAL	GENE-Y	39	62	After the combined pituitary stimulation test ( 100 micrograms gene , 100 micrograms chemical , 100 micrograms chemical , and 200 micrograms chemical ) , the gene peak ( maximum increase at 30 min ) was significantly blunted by chemical from 9 +/- 1 to 4 +/- 1 pmol/L ( P less than 0.001 ) and the area under the curve of gene from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h ( P less than 0.05 ) .	T18	T39	1322429
NA	CHEMICAL	GENE-Y	25	2	In the gene-hypoglycemia test ( 0.15 IU/kg BW ) , neither the gene peak nor the area under the curve of gene was affected by chemical .	T3	T21	1322429
NA	CHEMICAL	GENE-Y	25	12	In the gene-hypoglycemia test ( 0.15 IU/kg BW ) , neither the gene peak nor the area under the curve of gene was affected by chemical .	T3	T22	1322429
NA	CHEMICAL	GENE-Y	25	21	In the gene-hypoglycemia test ( 0.15 IU/kg BW ) , neither the gene peak nor the area under the curve of gene was affected by chemical .	T3	T23	1322429
NA	CHEMICAL	GENE-Y	23	21	In six patients with Cushing 's disease and one patient with secondary adrenal insufficiency due to hypothalamic failure , neither basal gene and chemical levels nor gene-stimulated levels were influenced by chemical .	T4	T24	1322429
NA	CHEMICAL	GENE-Y	23	26	In six patients with Cushing 's disease and one patient with secondary adrenal insufficiency due to hypothalamic failure , neither basal gene and chemical levels nor gene-stimulated levels were influenced by chemical .	T4	T25	1322429
NA	CHEMICAL	GENE-Y	31	21	In six patients with Cushing 's disease and one patient with secondary adrenal insufficiency due to hypothalamic failure , neither basal gene and chemical levels nor gene-stimulated levels were influenced by chemical .	T5	T24	1322429
NA	CHEMICAL	GENE-Y	31	26	In six patients with Cushing 's disease and one patient with secondary adrenal insufficiency due to hypothalamic failure , neither basal gene and chemical levels nor gene-stimulated levels were influenced by chemical .	T5	T25	1322429
NA	CHEMICAL	GENE-Y	7	15	In four cultured human corticotropic adenomas , chemical was not able to reduce basal and gene-induced gene secretion .	T6	T26	1322429
NA	CHEMICAL	GENE-Y	7	16	In four cultured human corticotropic adenomas , chemical was not able to reduce basal and gene-induced gene secretion .	T6	T27	1322429
CPR:4	CHEMICAL	GENE-Y	3	10	In summary , chemical is able to reduce basal and gene-induced gene and chemical levels in normal subjects , but not in patients with Cushing 's disease or secondary adrenal failure of hypothalamic origin .	T7	T28	1322429
CPR:4	CHEMICAL	GENE-Y	3	11	In summary , chemical is able to reduce basal and gene-induced gene and chemical levels in normal subjects , but not in patients with Cushing 's disease or secondary adrenal failure of hypothalamic origin .	T7	T29	1322429
NA	CHEMICAL	GENE-Y	4	10	In summary , chemical is able to reduce basal and gene-induced gene and chemical levels in normal subjects , but not in patients with Cushing 's disease or secondary adrenal failure of hypothalamic origin .	T8	T28	1322429
NA	CHEMICAL	GENE-Y	4	11	In summary , chemical is able to reduce basal and gene-induced gene and chemical levels in normal subjects , but not in patients with Cushing 's disease or secondary adrenal failure of hypothalamic origin .	T8	T29	1322429
NA	CHEMICAL	GENE-Y	0	6	chemical has no significant effect on gene-hypoglycemia-induced gene and chemical levels and , therefore , no effect on stress-induced elevation of cortisol levels .	T9	T30	1322429
NA	CHEMICAL	GENE-Y	0	7	chemical has no significant effect on gene-hypoglycemia-induced gene and chemical levels and , therefore , no effect on stress-induced elevation of cortisol levels .	T9	T31	1322429
NA	CHEMICAL	GENE-Y	9	6	chemical has no significant effect on gene-hypoglycemia-induced gene and chemical levels and , therefore , no effect on stress-induced elevation of cortisol levels .	T10	T30	1322429
NA	CHEMICAL	GENE-Y	9	7	chemical has no significant effect on gene-hypoglycemia-induced gene and chemical levels and , therefore , no effect on stress-induced elevation of cortisol levels .	T10	T31	1322429
NA	CHEMICAL	GENE-N	1	4	The chemical-dependent drug efflux pump gene ( gene ) affects the absorption and disposition of many compounds .	T1	T10	12699389
NA	CHEMICAL	GENE-N	1	5	The chemical-dependent drug efflux pump gene ( gene ) affects the absorption and disposition of many compounds .	T1	T8	12699389
NA	CHEMICAL	GENE-N	1	7	The chemical-dependent drug efflux pump gene ( gene ) affects the absorption and disposition of many compounds .	T1	T13	12699389
NA	CHEMICAL	GENE-N	4	24	The assays included in chemical predictions , inhibition assays ( based on cellular uptake of chemical or chemical ) , and functional assays ( gene activity assay and transcellular transport assay , the latter for a subset of compounds ) .	T2	T14	12699389
NA	CHEMICAL	GENE-N	3	24	The assays included in chemical predictions , inhibition assays ( based on cellular uptake of chemical or chemical ) , and functional assays ( gene activity assay and transcellular transport assay , the latter for a subset of compounds ) .	T3	T14	12699389
NA	CHEMICAL	GENE-N	17	24	The assays included in chemical predictions , inhibition assays ( based on cellular uptake of chemical or chemical ) , and functional assays ( gene activity assay and transcellular transport assay , the latter for a subset of compounds ) .	T4	T14	12699389
NA	CHEMICAL	GENE-N	35	17	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T4	T17	15557593
NA	CHEMICAL	GENE-Y	35	28	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T4	T18	15557593
NA	CHEMICAL	GENE-N	35	47	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T4	T19	15557593
CPR:4	CHEMICAL	GENE-N	20	17	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T5	T17	15557593
CPR:4	CHEMICAL	GENE-Y	20	28	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T5	T18	15557593
CPR:4	CHEMICAL	GENE-N	20	47	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T5	T19	15557593
CPR:4	CHEMICAL	GENE-N	22	17	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T6	T17	15557593
CPR:4	CHEMICAL	GENE-Y	22	28	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T6	T18	15557593
CPR:4	CHEMICAL	GENE-N	22	47	MATERIALS AND METHODS : Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors , two gene inhibitors , chemical and chemical , were used to disrupt gene-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose ( MTD ) or metronomic chemotherapy and/or gene inhibition .	T6	T19	15557593
CPR:4	CHEMICAL	GENE-N	2	25	RESULTS : chemical , despite equivocal efficacy as monotherapy , reduced pericyte coverage of tumor vessels and enhanced efficacy in combination with metronomic chemotherapy or gene inhibition .	T7	T8	15557593
CPR:4	CHEMICAL	GENE-Y	0	2	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T1	T11	23397032
NA	CHEMICAL	GENE-Y	0	7	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T1	T12	23397032
NA	CHEMICAL	GENE-Y	0	10	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T1	T13	23397032
NA	CHEMICAL	GENE-Y	0	12	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T1	T14	23397032
NA	CHEMICAL	GENE-Y	0	22	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T1	T15	23397032
NA	CHEMICAL	GENE-Y	0	28	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T1	T16	23397032
NA	CHEMICAL	GENE-Y	17	2	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T2	T11	23397032
NA	CHEMICAL	GENE-Y	17	7	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T2	T12	23397032
NA	CHEMICAL	GENE-Y	17	10	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T2	T13	23397032
NA	CHEMICAL	GENE-Y	17	12	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T2	T14	23397032
NA	CHEMICAL	GENE-Y	17	22	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T2	T15	23397032
NA	CHEMICAL	GENE-Y	17	28	chemical suppressed gene gene transcription enhanced by gene without affecting gene expression or Smad1 phosphorylation , and chemical-gene complex was bound to gene , which forms heterodimers with gene .	T2	T16	23397032
NA	CHEMICAL	GENE-Y	8	3	High doses of gene counteracted the effect of chemical on apoptosis of mPOBs , which was blunted by neutralizing anti-gene antibody or gene small interfering RNA .	T3	T17	23397032
NA	CHEMICAL	GENE-Y	8	19	High doses of gene counteracted the effect of chemical on apoptosis of mPOBs , which was blunted by neutralizing anti-gene antibody or gene small interfering RNA .	T3	T18	23397032
NA	CHEMICAL	GENE-Y	8	22	High doses of gene counteracted the effect of chemical on apoptosis of mPOBs , which was blunted by neutralizing anti-gene antibody or gene small interfering RNA .	T3	T19	23397032
CPR:4	CHEMICAL	GENE-Y	2	14	Cellular responses to DNA damage induced by chemical or chemical include down-regulation of endogenous gene coincident with increases in gene .	T2	T28	23382381
CPR:3	CHEMICAL	GENE-Y	2	19	Cellular responses to DNA damage induced by chemical or chemical include down-regulation of endogenous gene coincident with increases in gene .	T2	T29	23382381
CPR:4	CHEMICAL	GENE-Y	8	14	Cellular responses to DNA damage induced by chemical or chemical include down-regulation of endogenous gene coincident with increases in gene .	T3	T28	23382381
CPR:3	CHEMICAL	GENE-Y	8	19	Cellular responses to DNA damage induced by chemical or chemical include down-regulation of endogenous gene coincident with increases in gene .	T3	T29	23382381
NA	CHEMICAL	GENE-Y	0	5	gene binds directly to the gene chemical terminus and can deubiquitinate and stabilize gene .	T1	T13	23382381
NA	CHEMICAL	GENE-Y	0	13	gene binds directly to the gene chemical terminus and can deubiquitinate and stabilize gene .	T1	T14	23382381
NA	CHEMICAL	GENE-Y	7	0	gene regulates transcription of the ion uptake chemical/chemical cotransporter ( gene ) gene in zebrafish gill .	T7	T40	23395804
NA	CHEMICAL	GENE-Y	7	8	gene regulates transcription of the ion uptake chemical/chemical cotransporter ( gene ) gene in zebrafish gill .	T7	T41	23395804
NA	CHEMICAL	GENE-Y	7	10	gene regulates transcription of the ion uptake chemical/chemical cotransporter ( gene ) gene in zebrafish gill .	T7	T42	23395804
NA	CHEMICAL	GENE-Y	7	0	gene regulates transcription of the ion uptake chemical/chemical cotransporter ( gene ) gene in zebrafish gill .	T8	T40	23395804
NA	CHEMICAL	GENE-Y	7	8	gene regulates transcription of the ion uptake chemical/chemical cotransporter ( gene ) gene in zebrafish gill .	T8	T41	23395804
NA	CHEMICAL	GENE-Y	7	10	gene regulates transcription of the ion uptake chemical/chemical cotransporter ( gene ) gene in zebrafish gill .	T8	T42	23395804
NA	CHEMICAL	GENE-N	10	3	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T15	23395804
NA	CHEMICAL	GENE-Y	10	11	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T16	23395804
NA	CHEMICAL	GENE-Y	10	15	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T17	23395804
NA	CHEMICAL	GENE-Y	10	17	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T18	23395804
NA	CHEMICAL	GENE-Y	10	19	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T19	23395804
NA	CHEMICAL	GENE-Y	10	23	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T20	23395804
NA	CHEMICAL	GENE-Y	10	25	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T21	23395804
NA	CHEMICAL	GENE-Y	10	27	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T22	23395804
NA	CHEMICAL	GENE-Y	10	31	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T23	23395804
NA	CHEMICAL	GENE-Y	10	33	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T24	23395804
NA	CHEMICAL	GENE-Y	10	35	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T2	T25	23395804
NA	CHEMICAL	GENE-N	10	3	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T15	23395804
NA	CHEMICAL	GENE-Y	10	11	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T16	23395804
NA	CHEMICAL	GENE-Y	10	15	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T17	23395804
NA	CHEMICAL	GENE-Y	10	17	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T18	23395804
NA	CHEMICAL	GENE-Y	10	19	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T19	23395804
NA	CHEMICAL	GENE-Y	10	23	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T20	23395804
NA	CHEMICAL	GENE-Y	10	25	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T21	23395804
NA	CHEMICAL	GENE-Y	10	27	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T22	23395804
NA	CHEMICAL	GENE-Y	10	31	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T23	23395804
NA	CHEMICAL	GENE-Y	10	33	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T24	23395804
NA	CHEMICAL	GENE-Y	10	35	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T3	T25	23395804
NA	CHEMICAL	GENE-N	10	3	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T15	23395804
NA	CHEMICAL	GENE-Y	10	11	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T16	23395804
NA	CHEMICAL	GENE-Y	10	15	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T17	23395804
NA	CHEMICAL	GENE-Y	10	17	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T18	23395804
NA	CHEMICAL	GENE-Y	10	19	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T19	23395804
NA	CHEMICAL	GENE-Y	10	23	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T20	23395804
NA	CHEMICAL	GENE-Y	10	25	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T21	23395804
NA	CHEMICAL	GENE-Y	10	27	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T22	23395804
NA	CHEMICAL	GENE-Y	10	31	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T23	23395804
NA	CHEMICAL	GENE-Y	10	33	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T24	23395804
NA	CHEMICAL	GENE-Y	10	35	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T4	T25	23395804
NA	CHEMICAL	GENE-N	10	3	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T15	23395804
NA	CHEMICAL	GENE-Y	10	11	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T16	23395804
NA	CHEMICAL	GENE-Y	10	15	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T17	23395804
NA	CHEMICAL	GENE-Y	10	17	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T18	23395804
NA	CHEMICAL	GENE-Y	10	19	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T19	23395804
NA	CHEMICAL	GENE-Y	10	23	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T20	23395804
NA	CHEMICAL	GENE-Y	10	25	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T21	23395804
NA	CHEMICAL	GENE-Y	10	27	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T22	23395804
NA	CHEMICAL	GENE-Y	10	31	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T23	23395804
NA	CHEMICAL	GENE-Y	10	33	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T24	23395804
NA	CHEMICAL	GENE-Y	10	35	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T5	T25	23395804
NA	CHEMICAL	GENE-N	10	3	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T15	23395804
NA	CHEMICAL	GENE-Y	10	11	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T16	23395804
NA	CHEMICAL	GENE-Y	10	15	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T17	23395804
NA	CHEMICAL	GENE-Y	10	17	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T18	23395804
NA	CHEMICAL	GENE-Y	10	19	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T19	23395804
NA	CHEMICAL	GENE-Y	10	23	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T20	23395804
NA	CHEMICAL	GENE-Y	10	25	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T21	23395804
NA	CHEMICAL	GENE-Y	10	27	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T22	23395804
NA	CHEMICAL	GENE-Y	10	31	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T23	23395804
NA	CHEMICAL	GENE-Y	10	33	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T24	23395804
NA	CHEMICAL	GENE-Y	10	35	Ion-poor conditions led to increases in the expression of gene ( gene ) , chemical/chemical cotransporter ( gene ; gene ) , chemical/chemical exchanger ( gene ; gene ) , and gene ( gene ; gene ) transcripts within the gill .	T6	T25	23395804
NA	CHEMICAL	GENE-Y	2	0	gene and chemical enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala .	T11	T26	23470280
NA	CHEMICAL	GENE-Y	12	7	While these behaviors can be modulated by gene ( gene ) and chemical signaling , the mechanism ( s ) by which these signals modify CeA glutamatergic neurotransmission remains unclear .	T5	T18	23470280
NA	CHEMICAL	GENE-Y	12	9	While these behaviors can be modulated by gene ( gene ) and chemical signaling , the mechanism ( s ) by which these signals modify CeA glutamatergic neurotransmission remains unclear .	T5	T19	23470280
NA	CHEMICAL	GENE-Y	7	21	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T6	T20	23470280
NA	CHEMICAL	GENE-N	7	30	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T6	T21	23470280
NA	CHEMICAL	GENE-Y	32	21	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T7	T20	23470280
NA	CHEMICAL	GENE-N	32	30	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T7	T21	23470280
NA	CHEMICAL	GENE-Y	34	21	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T8	T20	23470280
NA	CHEMICAL	GENE-N	34	30	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T8	T21	23470280
NA	CHEMICAL	GENE-Y	57	21	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T9	T20	23470280
NA	CHEMICAL	GENE-N	57	30	Utilizing whole-cell patch-clamp electrophysiology recordings from neurons in the lateral subdivision of the CeA ( CeAL ) , we show that gene , chemical ( DA ) and the β-adrenergic receptor agonist chemical ( chemical ) all enhance the frequency of spontaneous excitatory postsynaptic currents ( sEPSC ) without altering sEPSC kinetics , suggesting they increase presynaptic chemical release .	T9	T21	23470280
NA	CHEMICAL	GENE-N	13	8	While previous work from our lab suggests that gene mediate the effect of chemical on excitatory transmission in other subregions of the extended amygdala , blockade of gene in the CeAL failed to significantly alter effects of DA and chemical on glutamatergic transmission .	T10	T25	23470280
NA	CHEMICAL	GENE-N	13	27	While previous work from our lab suggests that gene mediate the effect of chemical on excitatory transmission in other subregions of the extended amygdala , blockade of gene in the CeAL failed to significantly alter effects of DA and chemical on glutamatergic transmission .	T10	T12	23470280
NA	CHEMICAL	GENE-N	13	8	While previous work from our lab suggests that gene mediate the effect of chemical on excitatory transmission in other subregions of the extended amygdala , blockade of gene in the CeAL failed to significantly alter effects of DA and chemical on glutamatergic transmission .	T1	T25	23470280
NA	CHEMICAL	GENE-N	13	27	While previous work from our lab suggests that gene mediate the effect of chemical on excitatory transmission in other subregions of the extended amygdala , blockade of gene in the CeAL failed to significantly alter effects of DA and chemical on glutamatergic transmission .	T1	T12	23470280
NA	CHEMICAL	GENE-Y	4	6	These findings suggest that chemical and gene enhancement of glutamatergic transmission onto CeAL neurons occurs via distinct mechanisms .	T2	T13	23470280
NA	CHEMICAL	GENE-Y	4	1	While gene increased spontaneous chemical release in the CeAL , gene caused no significant changes to optogenetically evoked chemical release in this region .	T3	T14	23470280
NA	CHEMICAL	GENE-Y	4	10	While gene increased spontaneous chemical release in the CeAL , gene caused no significant changes to optogenetically evoked chemical release in this region .	T3	T15	23470280
NA	CHEMICAL	GENE-Y	18	1	While gene increased spontaneous chemical release in the CeAL , gene caused no significant changes to optogenetically evoked chemical release in this region .	T4	T14	23470280
NA	CHEMICAL	GENE-Y	18	10	While gene increased spontaneous chemical release in the CeAL , gene caused no significant changes to optogenetically evoked chemical release in this region .	T4	T15	23470280
NA	CHEMICAL	GENE-Y	19	5	When treatment is started , gene agonists initially stimulate the release of gene , causing a surge in serum chemical that can precipitate a `` flare '' phenomenon or worsening of disease , particularly in patients with bone metastatic disease .	T1	T5	16985933
NA	CHEMICAL	GENE-N	19	12	When treatment is started , gene agonists initially stimulate the release of gene , causing a surge in serum chemical that can precipitate a `` flare '' phenomenon or worsening of disease , particularly in patients with bone metastatic disease .	T1	T6	16985933
NA	CHEMICAL	GENE-Y	22	28	Results from 1 phase II and 3 phase III clinical trials demonstrate that abarelix produces medical castration more quickly and without causing chemical surge , as compared with gene agonists with or without a nonsteroidal antagonist .	T2	T11	16985933
NA	CHEMICAL	GENE-Y	0	9	chemical ( chemical ) , a selective chemical D4 receptor antagonist .	T27	T39	15992586
NA	CHEMICAL	GENE-Y	2	9	chemical ( chemical ) , a selective chemical D4 receptor antagonist .	T28	T39	15992586
NA	CHEMICAL	GENE-Y	5	9	chemical ( chemical ) , a selective chemical D4 receptor antagonist .	T29	T39	15992586
NA	CHEMICAL	GENE-Y	0	11	chemical ( chemical ) was identified as a potent chemical D4 receptor antagonist with excellent receptor selectivity .	T1	T30	15992586
NA	CHEMICAL	GENE-Y	2	11	chemical ( chemical ) was identified as a potent chemical D4 receptor antagonist with excellent receptor selectivity .	T21	T30	15992586
NA	CHEMICAL	GENE-Y	7	11	chemical ( chemical ) was identified as a potent chemical D4 receptor antagonist with excellent receptor selectivity .	T3	T30	15992586
NA	CHEMICAL	GENE-N	0	9	chemical competition binding assays showed that chemical potently bound to membrane from cells expressing recombinant gene ( Ki=1.5 nM ) , which was 20-fold higher than that of chemical ( Ki=30.4 nM ) .	T11	T33	15992586
NA	CHEMICAL	GENE-N	6	9	chemical competition binding assays showed that chemical potently bound to membrane from cells expressing recombinant gene ( Ki=1.5 nM ) , which was 20-fold higher than that of chemical ( Ki=30.4 nM ) .	T12	T33	15992586
NA	CHEMICAL	GENE-N	28	9	chemical competition binding assays showed that chemical potently bound to membrane from cells expressing recombinant gene ( Ki=1.5 nM ) , which was 20-fold higher than that of chemical ( Ki=30.4 nM ) .	T14	T33	15992586
NA	CHEMICAL	GENE-N	0	9	chemical exhibited highly selective binding for the chemical D4.4 receptor ( > 2700-fold ) when compared to gene .	T15	T34	15992586
NA	CHEMICAL	GENE-N	0	9	chemical exhibited highly selective binding for the chemical D4.4 receptor ( > 2700-fold ) when compared to gene .	T15	T35	15992586
NA	CHEMICAL	GENE-N	7	9	chemical exhibited highly selective binding for the chemical D4.4 receptor ( > 2700-fold ) when compared to gene .	T16	T34	15992586
NA	CHEMICAL	GENE-N	7	9	chemical exhibited highly selective binding for the chemical D4.4 receptor ( > 2700-fold ) when compared to gene .	T16	T35	15992586
NA	CHEMICAL	GENE-Y	2	40	Furthermore , in comparison to chemical and chemical , chemical exhibits better receptor selectivity , showing no affinity up to 10 microM for a panel of more than 70 receptors and channels , with the exception of moderate affinity for gene ( Ki=370 nM ) .	T18	T36	15992586
NA	CHEMICAL	GENE-Y	7	40	Furthermore , in comparison to chemical and chemical , chemical exhibits better receptor selectivity , showing no affinity up to 10 microM for a panel of more than 70 receptors and channels , with the exception of moderate affinity for gene ( Ki=370 nM ) .	T19	T36	15992586
NA	CHEMICAL	GENE-Y	9	40	Furthermore , in comparison to chemical and chemical , chemical exhibits better receptor selectivity , showing no affinity up to 10 microM for a panel of more than 70 receptors and channels , with the exception of moderate affinity for gene ( Ki=370 nM ) .	T20	T36	15992586
NA	CHEMICAL	GENE-N	0	18	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T22	T37	15992586
NA	CHEMICAL	GENE-N	0	28	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T22	T38	15992586
NA	CHEMICAL	GENE-N	8	18	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T23	T37	15992586
NA	CHEMICAL	GENE-N	8	28	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T23	T38	15992586
NA	CHEMICAL	GENE-N	14	18	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T24	T37	15992586
NA	CHEMICAL	GENE-N	14	28	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T24	T38	15992586
NA	CHEMICAL	GENE-N	15	18	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T25	T37	15992586
NA	CHEMICAL	GENE-N	15	28	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T25	T38	15992586
NA	CHEMICAL	GENE-N	17	18	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T26	T37	15992586
NA	CHEMICAL	GENE-N	17	28	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T26	T38	15992586
NA	CHEMICAL	GENE-N	0	18	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T2	T37	15992586
NA	CHEMICAL	GENE-N	0	28	chemical potently inhibited the functional activity of agonist-induced chemical-gamma-S binding assay and 1 microM chemical induced-chemical flux in gene expressing cells , but not in human chemical D2L or D3 receptor cells .	T2	T38	15992586
NA	CHEMICAL	GENE-N	3	2	In contrast to chemical , chemical did not exhibit any significant intrinsic activity in a gene .	T4	T31	15992586
NA	CHEMICAL	GENE-N	5	2	In contrast to chemical , chemical did not exhibit any significant intrinsic activity in a gene .	T5	T31	15992586
CPR:9	CHEMICAL	GENE-Y	9	2	Contributions of gene to the uptake and toxicity of chemical and chemical anticancer drugs in dorsal root ganglion neurons .	T28	T43	23123662
CPR:9	CHEMICAL	GENE-Y	11	2	Contributions of gene to the uptake and toxicity of chemical and chemical anticancer drugs in dorsal root ganglion neurons .	T29	T43	23123662
NA	CHEMICAL	GENE-Y	8	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T14	T35	23123662
NA	CHEMICAL	GENE-Y	8	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T14	T36	23123662
NA	CHEMICAL	GENE-Y	8	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T14	T37	23123662
NA	CHEMICAL	GENE-Y	8	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T14	T38	23123662
NA	CHEMICAL	GENE-Y	20	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T15	T35	23123662
NA	CHEMICAL	GENE-Y	20	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T15	T36	23123662
NA	CHEMICAL	GENE-Y	20	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T15	T37	23123662
NA	CHEMICAL	GENE-Y	20	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T15	T38	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T16	T35	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T16	T36	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T16	T37	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T16	T38	23123662
NA	CHEMICAL	GENE-Y	44	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T17	T35	23123662
NA	CHEMICAL	GENE-Y	44	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T17	T36	23123662
NA	CHEMICAL	GENE-Y	44	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T17	T37	23123662
NA	CHEMICAL	GENE-Y	44	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T17	T38	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T18	T35	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T18	T36	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T18	T37	23123662
NA	CHEMICAL	GENE-Y	14	10	This study aimed to understand the role of chemical transporter 1 ( gene ) in the uptake and toxicity of chemical and chemical drugs in cultured rat DRG neurons , and the functional activities of gene ( gene ) as a membrane transporter of chemical and chemical drugs .	T18	T38	23123662
CPR:9	CHEMICAL	GENE-Y	17	3	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T20	T39	23123662
CPR:9	CHEMICAL	GENE-Y	17	8	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T20	T40	23123662
CPR:9	CHEMICAL	GENE-Y	4	3	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T21	T39	23123662
CPR:9	CHEMICAL	GENE-Y	4	8	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T21	T40	23123662
CPR:9	CHEMICAL	GENE-Y	4	3	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T22	T39	23123662
CPR:9	CHEMICAL	GENE-Y	4	8	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T22	T40	23123662
CPR:9	CHEMICAL	GENE-Y	4	3	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T23	T39	23123662
CPR:9	CHEMICAL	GENE-Y	4	8	Heterologous expression of gene in HEK293 cells ( HEK/gene cells ) increased the uptake and cytotoxicity of chemical , chemical , chemical and chemical , in comparison to isogenic vector-transfected control cells .	T23	T40	23123662
CPR:9	CHEMICAL	GENE-Y	25	6	Cultured rat DRG neurons endogenously expressed gene protein on their neuronal cell body plasma membranes and cytoplasm , and displayed substantial capacity for taking up chemical , but were resistant to chemical toxicity .	T24	T41	23123662
NA	CHEMICAL	GENE-Y	31	6	Cultured rat DRG neurons endogenously expressed gene protein on their neuronal cell body plasma membranes and cytoplasm , and displayed substantial capacity for taking up chemical , but were resistant to chemical toxicity .	T25	T41	23123662
CPR:9	CHEMICAL	GENE-Y	3	11	The uptake of chemical by both cultured rat DRG neurons and HEK/gene cells was saturable and inhibited by cold temperature , chemical and chemical , consistent with it being mediated by gene .	T26	T42	23123662
NA	CHEMICAL	GENE-Y	3	31	The uptake of chemical by both cultured rat DRG neurons and HEK/gene cells was saturable and inhibited by cold temperature , chemical and chemical , consistent with it being mediated by gene .	T26	T30	23123662
NA	CHEMICAL	GENE-Y	21	11	The uptake of chemical by both cultured rat DRG neurons and HEK/gene cells was saturable and inhibited by cold temperature , chemical and chemical , consistent with it being mediated by gene .	T27	T42	23123662
NA	CHEMICAL	GENE-Y	21	31	The uptake of chemical by both cultured rat DRG neurons and HEK/gene cells was saturable and inhibited by cold temperature , chemical and chemical , consistent with it being mediated by gene .	T27	T30	23123662
NA	CHEMICAL	GENE-Y	23	11	The uptake of chemical by both cultured rat DRG neurons and HEK/gene cells was saturable and inhibited by cold temperature , chemical and chemical , consistent with it being mediated by gene .	T1	T42	23123662
NA	CHEMICAL	GENE-Y	23	31	The uptake of chemical by both cultured rat DRG neurons and HEK/gene cells was saturable and inhibited by cold temperature , chemical and chemical , consistent with it being mediated by gene .	T1	T30	23123662
NA	CHEMICAL	GENE-Y	3	11	The accumulation of chemical by both cultured rat DRG neurons and HEK/gene cells , during chemical exposure , was saturable and temperature dependent , but was inhibited by chemical only in HEK/gene cells .	T5	T31	23123662
NA	CHEMICAL	GENE-Y	3	31	The accumulation of chemical by both cultured rat DRG neurons and HEK/gene cells , during chemical exposure , was saturable and temperature dependent , but was inhibited by chemical only in HEK/gene cells .	T5	T32	23123662
NA	CHEMICAL	GENE-Y	15	11	The accumulation of chemical by both cultured rat DRG neurons and HEK/gene cells , during chemical exposure , was saturable and temperature dependent , but was inhibited by chemical only in HEK/gene cells .	T6	T31	23123662
NA	CHEMICAL	GENE-Y	15	31	The accumulation of chemical by both cultured rat DRG neurons and HEK/gene cells , during chemical exposure , was saturable and temperature dependent , but was inhibited by chemical only in HEK/gene cells .	T6	T32	23123662
NA	CHEMICAL	GENE-Y	28	11	The accumulation of chemical by both cultured rat DRG neurons and HEK/gene cells , during chemical exposure , was saturable and temperature dependent , but was inhibited by chemical only in HEK/gene cells .	T7	T31	23123662
NA	CHEMICAL	GENE-Y	28	31	The accumulation of chemical by both cultured rat DRG neurons and HEK/gene cells , during chemical exposure , was saturable and temperature dependent , but was inhibited by chemical only in HEK/gene cells .	T7	T32	23123662
CPR:9	CHEMICAL	GENE-Y	6	3	In conclusion , gene can transport chemical and chemical drugs , and sensitizes cells to their cytotoxicities .	T9	T33	23123662
CPR:9	CHEMICAL	GENE-Y	8	3	In conclusion , gene can transport chemical and chemical drugs , and sensitizes cells to their cytotoxicities .	T10	T33	23123662
NA	CHEMICAL	GENE-Y	1	13	Elevated chemical AUC in virtual rheumatoid arthritis patients , following 100 pg/mL of gene was comparable to observed clinical data ( 59 % versus 58 % ) .	T1	T7	23588308
NA	CHEMICAL	GENE-Y	15	13	In virtual bone marrow transplant ( BMT ) patients , 500 pg/ml of gene resulted in increase in chemical AUC that was in good agreement with the observed data ( 45 % versus 39 % ) .	T2	T9	23588308
CPR:4	CHEMICAL	GENE-Y	0	2	chemical inhibits gene-mediated Cl- secretion .	T25	T35	9710435
NA	CHEMICAL	GENE-Y	5	13	To determine whether this inhibition of ICl was due to the inhibition of gene , the effects of chemical and chemical on gene gene in excised , inside-out patches from L-cells were evaluated .	T1	T26	9710435
NA	CHEMICAL	GENE-Y	5	22	To determine whether this inhibition of ICl was due to the inhibition of gene , the effects of chemical and chemical on gene gene in excised , inside-out patches from L-cells were evaluated .	T1	T27	9710435
NA	CHEMICAL	GENE-N	5	23	To determine whether this inhibition of ICl was due to the inhibition of gene , the effects of chemical and chemical on gene gene in excised , inside-out patches from L-cells were evaluated .	T1	T28	9710435
NA	CHEMICAL	GENE-Y	13	13	To determine whether this inhibition of ICl was due to the inhibition of gene , the effects of chemical and chemical on gene gene in excised , inside-out patches from L-cells were evaluated .	T2	T26	9710435
NA	CHEMICAL	GENE-Y	13	22	To determine whether this inhibition of ICl was due to the inhibition of gene , the effects of chemical and chemical on gene gene in excised , inside-out patches from L-cells were evaluated .	T2	T27	9710435
NA	CHEMICAL	GENE-N	13	23	To determine whether this inhibition of ICl was due to the inhibition of gene , the effects of chemical and chemical on gene gene in excised , inside-out patches from L-cells were evaluated .	T2	T28	9710435
CPR:4	CHEMICAL	GENE-Y	0	6	chemical ( 300 microM ) reduced gene Cl- current by 60+/-16 % and this was explained by a short-lived block ( approximately 1.2 ms ) which causes an apparent reduction in single channel amplitude from 1.07+/-0.04 pA to 0.59+/-0.04 pA ( n = 3 ) .	T3	T29	9710435
CPR:4	CHEMICAL	GENE-Y	2	8	Similarly , chemical ( 3 mM ) reduced gene Cl- current by 50+/-8 % with an apparent reduction in single channel amplitude from 1.08+/-0.03 pA to 0.48+/-0.06 pA ( n = 4 ) .	T4	T30	9710435
CPR:4	CHEMICAL	GENE-Y	10	28	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T6	T31	9710435
CPR:4	CHEMICAL	GENE-N	10	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T6	T32	9710435
CPR:4	CHEMICAL	GENE-N	10	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T6	T33	9710435
CPR:4	CHEMICAL	GENE-Y	12	28	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T7	T31	9710435
CPR:4	CHEMICAL	GENE-N	12	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T7	T32	9710435
CPR:4	CHEMICAL	GENE-N	12	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T7	T33	9710435
NA	CHEMICAL	GENE-Y	14	28	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T8	T31	9710435
NA	CHEMICAL	GENE-N	14	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T8	T32	9710435
NA	CHEMICAL	GENE-N	14	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T8	T33	9710435
NA	CHEMICAL	GENE-Y	35	28	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T10	T31	9710435
NA	CHEMICAL	GENE-N	35	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T10	T32	9710435
NA	CHEMICAL	GENE-N	35	24	Based on these results , we conclude that the NSAIDs chemical and chemical inhibit chemical-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of gene gene as well as basolateral membrane chemical channels .	T10	T33	9710435
NA	CHEMICAL	GENE-Y	0	7	chemical does not prevent chemical-induced desensitization of gene-mediated cardiovascular in vivo functions in human volunteers .	T17	T31	10226872
NA	CHEMICAL	GENE-Y	4	7	chemical does not prevent chemical-induced desensitization of gene-mediated cardiovascular in vivo functions in human volunteers .	T18	T31	10226872
CPR:5	CHEMICAL	GENE-Y	9	7	In humans , prolonged administration of the gene agonist chemical leads to a desensitization of gene-mediated cardiovascular responses , which can be blunted by concomitant administration of the antianaphylactic drug chemical .	T15	T27	10226872
NA	CHEMICAL	GENE-Y	9	11	In humans , prolonged administration of the gene agonist chemical leads to a desensitization of gene-mediated cardiovascular responses , which can be blunted by concomitant administration of the antianaphylactic drug chemical .	T15	T20	10226872
NA	CHEMICAL	GENE-Y	11	7	In humans , prolonged administration of the gene agonist chemical leads to a desensitization of gene-mediated cardiovascular responses , which can be blunted by concomitant administration of the antianaphylactic drug chemical .	T10	T27	10226872
NA	CHEMICAL	GENE-Y	11	11	In humans , prolonged administration of the gene agonist chemical leads to a desensitization of gene-mediated cardiovascular responses , which can be blunted by concomitant administration of the antianaphylactic drug chemical .	T10	T20	10226872
NA	CHEMICAL	GENE-N	6	16	This study investigated the effect of chemical , another antiallergic drug , on chemical-induced desensitization of gene-mediated cardiovascular and noncardiovascular responses .	T11	T26	10226872
NA	CHEMICAL	GENE-N	13	16	This study investigated the effect of chemical , another antiallergic drug , on chemical-induced desensitization of gene-mediated cardiovascular and noncardiovascular responses .	T12	T26	10226872
NA	CHEMICAL	GENE-Y	8	0	gene cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective gene agonist chemical ; gene cardiovascular function was assessed by exercise-induced tachycardia .	T16	T28	10226872
CPR:5	CHEMICAL	GENE-N	8	26	gene cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective gene agonist chemical ; gene cardiovascular function was assessed by exercise-induced tachycardia .	T16	T29	10226872
NA	CHEMICAL	GENE-Y	8	30	gene cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective gene agonist chemical ; gene cardiovascular function was assessed by exercise-induced tachycardia .	T16	T30	10226872
NA	CHEMICAL	GENE-Y	0	7	chemical affected neither the rightward shift of gene-mediated responses nor the small rightward shift in gene-mediated exercise tachycardia after 2 weeks ' administration of chemical .	T4	T21	10226872
NA	CHEMICAL	GENE-Y	0	15	chemical affected neither the rightward shift of gene-mediated responses nor the small rightward shift in gene-mediated exercise tachycardia after 2 weeks ' administration of chemical .	T4	T22	10226872
NA	CHEMICAL	GENE-Y	14	7	chemical affected neither the rightward shift of gene-mediated responses nor the small rightward shift in gene-mediated exercise tachycardia after 2 weeks ' administration of chemical .	T5	T21	10226872
NA	CHEMICAL	GENE-Y	14	15	chemical affected neither the rightward shift of gene-mediated responses nor the small rightward shift in gene-mediated exercise tachycardia after 2 weeks ' administration of chemical .	T5	T22	10226872
NA	CHEMICAL	GENE-Y	8	13	Tremulousness observed during the first few days of chemical administration disappeared after 4 to 8 days , indicating development of desensitization of gene-mediated noncardiovascular responses .	T6	T23	10226872
NA	CHEMICAL	GENE-N	12	10	Diabetic rats showed significant ( p < 0.05 ) increased in plasma chemical , gene and significant ( p < 0.05 ) decreased in circulating gene and gene .	T10	T26	23102509
NA	CHEMICAL	GENE-N	12	10	Diabetic rats showed significant ( p < 0.05 ) increased in plasma chemical , gene and significant ( p < 0.05 ) decreased in circulating gene and gene .	T10	T27	23102509
NA	CHEMICAL	GENE-N	12	10	Diabetic rats showed significant ( p < 0.05 ) increased in plasma chemical , gene and significant ( p < 0.05 ) decreased in circulating gene and gene .	T10	T28	23102509
NA	CHEMICAL	GENE-Y	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T29	23102509
NA	CHEMICAL	GENE-Y	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T30	23102509
NA	CHEMICAL	GENE-N	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T31	23102509
NA	CHEMICAL	GENE-N	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T32	23102509
NA	CHEMICAL	GENE-Y	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T33	23102509
NA	CHEMICAL	GENE-N	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T34	23102509
NA	CHEMICAL	GENE-N	8	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T21	23102509
NA	CHEMICAL	GENE-N	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T22	23102509
NA	CHEMICAL	GENE-N	8	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T23	23102509
NA	CHEMICAL	GENE-N	8	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T24	23102509
NA	CHEMICAL	GENE-N	8	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T11	T25	23102509
NA	CHEMICAL	GENE-Y	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T29	23102509
NA	CHEMICAL	GENE-Y	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T30	23102509
NA	CHEMICAL	GENE-N	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T31	23102509
NA	CHEMICAL	GENE-N	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T32	23102509
NA	CHEMICAL	GENE-Y	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T33	23102509
NA	CHEMICAL	GENE-N	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T34	23102509
NA	CHEMICAL	GENE-N	10	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T21	23102509
NA	CHEMICAL	GENE-N	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T22	23102509
NA	CHEMICAL	GENE-N	10	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T23	23102509
NA	CHEMICAL	GENE-N	10	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T24	23102509
NA	CHEMICAL	GENE-N	10	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T12	T25	23102509
CPR:9	CHEMICAL	GENE-Y	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T29	23102509
CPR:9	CHEMICAL	GENE-Y	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T30	23102509
NA	CHEMICAL	GENE-N	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T31	23102509
NA	CHEMICAL	GENE-N	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T32	23102509
NA	CHEMICAL	GENE-Y	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T33	23102509
NA	CHEMICAL	GENE-N	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T34	23102509
NA	CHEMICAL	GENE-N	12	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T21	23102509
NA	CHEMICAL	GENE-N	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T22	23102509
NA	CHEMICAL	GENE-N	12	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T23	23102509
NA	CHEMICAL	GENE-N	12	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T24	23102509
NA	CHEMICAL	GENE-N	12	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T13	T25	23102509
NA	CHEMICAL	GENE-Y	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T29	23102509
NA	CHEMICAL	GENE-Y	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T30	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T31	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T32	23102509
NA	CHEMICAL	GENE-Y	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T33	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T34	23102509
NA	CHEMICAL	GENE-N	16	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T21	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T22	23102509
NA	CHEMICAL	GENE-N	16	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T23	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T24	23102509
NA	CHEMICAL	GENE-N	16	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T14	T25	23102509
NA	CHEMICAL	GENE-Y	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T29	23102509
NA	CHEMICAL	GENE-Y	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T30	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T31	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T32	23102509
NA	CHEMICAL	GENE-Y	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T33	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T34	23102509
NA	CHEMICAL	GENE-N	16	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T21	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T22	23102509
NA	CHEMICAL	GENE-N	16	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T23	23102509
NA	CHEMICAL	GENE-N	16	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T24	23102509
NA	CHEMICAL	GENE-N	16	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T15	T25	23102509
NA	CHEMICAL	GENE-Y	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T29	23102509
NA	CHEMICAL	GENE-Y	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T30	23102509
NA	CHEMICAL	GENE-N	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T31	23102509
NA	CHEMICAL	GENE-N	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T32	23102509
NA	CHEMICAL	GENE-Y	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T33	23102509
NA	CHEMICAL	GENE-N	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T34	23102509
NA	CHEMICAL	GENE-N	7	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T21	23102509
NA	CHEMICAL	GENE-N	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T22	23102509
NA	CHEMICAL	GENE-N	7	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T23	23102509
NA	CHEMICAL	GENE-N	7	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T24	23102509
NA	CHEMICAL	GENE-N	7	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T16	T25	23102509
NA	CHEMICAL	GENE-Y	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T29	23102509
NA	CHEMICAL	GENE-Y	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T30	23102509
NA	CHEMICAL	GENE-N	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T31	23102509
NA	CHEMICAL	GENE-N	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T32	23102509
NA	CHEMICAL	GENE-Y	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T33	23102509
NA	CHEMICAL	GENE-N	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T34	23102509
NA	CHEMICAL	GENE-N	39	53	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T21	23102509
NA	CHEMICAL	GENE-N	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T22	23102509
NA	CHEMICAL	GENE-N	39	59	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T23	23102509
NA	CHEMICAL	GENE-N	39	7	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T24	23102509
NA	CHEMICAL	GENE-N	39	64	The altered activities of key enzymes such as chemical-6-phosphatase and chemical-1,6-bisphosphatase of chemical metabolism significantly ( p < 0.05 ) increased whereas gene , chemical kinase , chemical dehydrogenase and glycogen content significantly ( p < 0.05 ) decreased in the liver of diabetic rats and also increased activities of chemical transaminase ( gene ) , chemical transaminase ( gene ) and gene ( gene ) .	T2	T25	23102509
NA	CHEMICAL	GENE-Y	2	3	Overexpression of chemical oxidase induces chemical-dependent and mitochondria-mediated apoptosis .	T10	T26	16874462
CPR:9	CHEMICAL	GENE-Y	5	3	Overexpression of chemical oxidase induces chemical-dependent and mitochondria-mediated apoptosis .	T11	T26	16874462
NA	CHEMICAL	GENE-Y	0	1	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T1	T12	16874462
NA	CHEMICAL	GENE-Y	0	3	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T1	T14	16874462
CPR:9	CHEMICAL	GENE-Y	16	1	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T3	T12	16874462
CPR:9	CHEMICAL	GENE-Y	16	3	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T3	T14	16874462
CPR:9	CHEMICAL	GENE-Y	6	1	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T4	T12	16874462
CPR:9	CHEMICAL	GENE-Y	6	3	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T4	T14	16874462
CPR:9	CHEMICAL	GENE-Y	20	1	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T5	T12	16874462
CPR:9	CHEMICAL	GENE-Y	20	3	chemical oxidase ( gene ) , a mitochondrial inner-membrane protein , catalyzes the rate-limiting oxidation of chemical to chemical ( chemical ) .	T5	T14	16874462
NA	CHEMICAL	GENE-Y	13	6	Previously we showed that overexpression of gene is associated with generation of reactive chemical species ( ROS ) and apoptosis in gene-inducible colorectal cancer cells , DLD-1.gene .	T6	T15	16874462
NA	CHEMICAL	GENE-Y	13	21	Previously we showed that overexpression of gene is associated with generation of reactive chemical species ( ROS ) and apoptosis in gene-inducible colorectal cancer cells , DLD-1.gene .	T6	T16	16874462
NA	CHEMICAL	GENE-Y	13	26	Previously we showed that overexpression of gene is associated with generation of reactive chemical species ( ROS ) and apoptosis in gene-inducible colorectal cancer cells , DLD-1.gene .	T6	T17	16874462
NA	CHEMICAL	GENE-Y	23	7	To further investigate the molecular basis of gene-induced apoptosis , we utilized the DLD-1.gene cells to show that cells overproducing gene exhibit an chemical-dependent apoptotic response .	T7	T20	16874462
NA	CHEMICAL	GENE-Y	23	13	To further investigate the molecular basis of gene-induced apoptosis , we utilized the DLD-1.gene cells to show that cells overproducing gene exhibit an chemical-dependent apoptotic response .	T7	T21	16874462
CPR:9	CHEMICAL	GENE-Y	23	20	To further investigate the molecular basis of gene-induced apoptosis , we utilized the DLD-1.gene cells to show that cells overproducing gene exhibit an chemical-dependent apoptotic response .	T7	T22	16874462
NA	CHEMICAL	GENE-Y	6	33	The apoptotic effect is specific for chemical , detectable at 0.2 mM , maximal at 1 mM , and occurs during 48-72 h following the addition of chemical to cells with maximally induced gene .	T8	T23	16874462
CPR:9	CHEMICAL	GENE-Y	27	33	The apoptotic effect is specific for chemical , detectable at 0.2 mM , maximal at 1 mM , and occurs during 48-72 h following the addition of chemical to cells with maximally induced gene .	T9	T23	16874462
NA	CHEMICAL	GENE-Y	8	17	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T3	T25	1280065
NA	CHEMICAL	GENE-Y	8	26	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T3	T26	1280065
NA	CHEMICAL	GENE-Y	10	17	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T4	T25	1280065
NA	CHEMICAL	GENE-Y	10	26	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T4	T26	1280065
NA	CHEMICAL	GENE-Y	12	17	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T5	T25	1280065
NA	CHEMICAL	GENE-Y	12	26	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T5	T26	1280065
NA	CHEMICAL	GENE-Y	23	17	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T6	T25	1280065
NA	CHEMICAL	GENE-Y	23	26	This binding was not significantly inhibited by the chemical analogue chemical ( chemical ) , indicating that gene binding was not just through chemical binding sites as suggested for other gene binding sites .	T6	T26	1280065
CPR:4	CHEMICAL	GENE-Y	5	5	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T14	1280065
CPR:4	CHEMICAL	GENE-Y	5	7	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T15	1280065
NA	CHEMICAL	GENE-Y	5	9	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T16	1280065
NA	CHEMICAL	GENE-Y	5	21	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T17	1280065
NA	CHEMICAL	GENE-Y	5	23	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T18	1280065
NA	CHEMICAL	GENE-Y	5	30	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T19	1280065
NA	CHEMICAL	GENE-Y	5	32	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T1	T20	1280065
NA	CHEMICAL	GENE-Y	16	5	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T14	1280065
NA	CHEMICAL	GENE-Y	16	7	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T15	1280065
NA	CHEMICAL	GENE-Y	16	9	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T16	1280065
CPR:4	CHEMICAL	GENE-Y	16	21	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T17	1280065
NA	CHEMICAL	GENE-Y	16	23	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T18	1280065
CPR:4	CHEMICAL	GENE-Y	16	30	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T19	1280065
NA	CHEMICAL	GENE-Y	16	32	Inhibition of binding of both gene and gene to gene by chemical was similar , although chemical inhibited the binding of gene to gene slightly more than the binding of gene to gene .	T2	T20	1280065
NA	CHEMICAL	GENE-Y	2	3	Synthesis , chemical reductase inhibition , antitumor testing , and molecular modeling study of some new chemical analogs .	T5	T12	16971132
CPR:4	CHEMICAL	GENE-Y	16	3	Synthesis , chemical reductase inhibition , antitumor testing , and molecular modeling study of some new chemical analogs .	T4	T12	16971132
CPR:4	CHEMICAL	GENE-N	11	39	In order to produce potent new leads for anticancer drugs , a new series of chemical analogs was designed to resemble chemical ( chemical , 1 ) structure features and fitted with functional groups believed to enhance inhibition of gene activity .	T3	T7	16971132
CPR:4	CHEMICAL	GENE-N	11	39	In order to produce potent new leads for anticancer drugs , a new series of chemical analogs was designed to resemble chemical ( chemical , 1 ) structure features and fitted with functional groups believed to enhance inhibition of gene activity .	T1	T7	16971132
CPR:4	CHEMICAL	GENE-N	23	39	In order to produce potent new leads for anticancer drugs , a new series of chemical analogs was designed to resemble chemical ( chemical , 1 ) structure features and fitted with functional groups believed to enhance inhibition of gene activity .	T2	T7	16971132
NA	CHEMICAL	GENE-Y	3	18	Cellular effects of chemical on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated gene mutations .	T13	T27	16782438
NA	CHEMICAL	GENE-Y	4	6	BACKGROUND : Activating mutations in the gene gene , which encodes a chemical kinase receptor , often cause medullary thyroid carcinoma ( MTC ) .	T8	T20	16782438
NA	CHEMICAL	GENE-N	4	14	BACKGROUND : Activating mutations in the gene gene , which encodes a chemical kinase receptor , often cause medullary thyroid carcinoma ( MTC ) .	T8	T24	16782438
CPR:4	CHEMICAL	GENE-N	2	4	We evaluated chemical , a chemical kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors , as a potential drug for systemic treatment of MTC , in 2 MTC-derived cell lines expressing multiple endocrine neoplasia-associated mutant gene .	T6	T19	16782438
NA	CHEMICAL	GENE-N	2	10	We evaluated chemical , a chemical kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors , as a potential drug for systemic treatment of MTC , in 2 MTC-derived cell lines expressing multiple endocrine neoplasia-associated mutant gene .	T6	T21	16782438
NA	CHEMICAL	GENE-N	5	4	We evaluated chemical , a chemical kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors , as a potential drug for systemic treatment of MTC , in 2 MTC-derived cell lines expressing multiple endocrine neoplasia-associated mutant gene .	T7	T19	16782438
NA	CHEMICAL	GENE-N	5	10	We evaluated chemical , a chemical kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors , as a potential drug for systemic treatment of MTC , in 2 MTC-derived cell lines expressing multiple endocrine neoplasia-associated mutant gene .	T7	T21	16782438
CPR:4	CHEMICAL	GENE-Y	2	4	RESULTS : chemical inhibited gene gene phosphorylation in a dose-dependent manner after 1.5 hours of exposure .	T12	T25	16782438
CPR:4	CHEMICAL	GENE-N	2	5	RESULTS : chemical inhibited gene gene phosphorylation in a dose-dependent manner after 1.5 hours of exposure .	T12	T26	16782438
CPR:4	CHEMICAL	GENE-Y	2	4	CONCLUSIONS : chemical inhibits gene-mediated MTC cell growth affecting gene protein levels in vitro in a dose-dependent manner .	T3	T16	16782438
CPR:4	CHEMICAL	GENE-Y	2	9	CONCLUSIONS : chemical inhibits gene-mediated MTC cell growth affecting gene protein levels in vitro in a dose-dependent manner .	T3	T17	16782438
NA	CHEMICAL	GENE-N	7	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T9	T24	23602986
NA	CHEMICAL	GENE-N	7	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T9	T25	23602986
NA	CHEMICAL	GENE-N	9	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T10	T24	23602986
NA	CHEMICAL	GENE-N	9	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T10	T25	23602986
NA	CHEMICAL	GENE-N	12	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T11	T24	23602986
NA	CHEMICAL	GENE-N	12	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T11	T25	23602986
NA	CHEMICAL	GENE-N	14	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T15	T24	23602986
NA	CHEMICAL	GENE-N	14	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T15	T25	23602986
NA	CHEMICAL	GENE-N	17	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T16	T24	23602986
NA	CHEMICAL	GENE-N	17	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T16	T25	23602986
NA	CHEMICAL	GENE-N	19	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T19	T24	23602986
NA	CHEMICAL	GENE-N	19	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T19	T25	23602986
NA	CHEMICAL	GENE-N	22	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T20	T24	23602986
NA	CHEMICAL	GENE-N	22	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T20	T25	23602986
NA	CHEMICAL	GENE-N	22	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T2	T24	23602986
NA	CHEMICAL	GENE-N	22	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T2	T25	23602986
NA	CHEMICAL	GENE-N	27	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T4	T24	23602986
NA	CHEMICAL	GENE-N	27	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T4	T25	23602986
NA	CHEMICAL	GENE-N	29	58	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T8	T24	23602986
NA	CHEMICAL	GENE-N	29	60	The present work evaluated the effects of chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) , chemical ( chemical ) and chemical ( chemical ) on memory extinction and the following biochemical parameters of the hippocampus : lipid peroxidation ( LPO ) , antioxidant capacity ( AC ) and the phosphorylation of gene ( gene ) .	T8	T25	23602986
NA	CHEMICAL	GENE-N	0	6	chemical also increased the phosphorylation of gene in a similar fashion as chemical .	T21	T23	23602986
NA	CHEMICAL	GENE-N	7	6	chemical also increased the phosphorylation of gene in a similar fashion as chemical .	T1	T23	23602986
NA	CHEMICAL	GENE-Y	6	23	A positron emission tomography study of chemical in schizophrenia : a preliminary finding of an antipsychotic effect with only transiently high chemical D2 receptor occupancy .	T9	T21	10839333
NA	CHEMICAL	GENE-Y	7	23	A positron emission tomography study of chemical in schizophrenia : a preliminary finding of an antipsychotic effect with only transiently high chemical D2 receptor occupancy .	T8	T21	10839333
NA	CHEMICAL	GENE-Y	10	17	As such , relatively little has been published regarding its in vivo effects at the chemical type 2 ( gene ) and chemical type 2a ( 5-HT2a ) receptor systems .	T4	T14	10839333
NA	CHEMICAL	GENE-Y	10	17	As such , relatively little has been published regarding its in vivo effects at the chemical type 2 ( gene ) and chemical type 2a ( 5-HT2a ) receptor systems .	T4	T16	10839333
NA	CHEMICAL	GENE-Y	10	28	As such , relatively little has been published regarding its in vivo effects at the chemical type 2 ( gene ) and chemical type 2a ( 5-HT2a ) receptor systems .	T4	T17	10839333
NA	CHEMICAL	GENE-Y	10	17	As such , relatively little has been published regarding its in vivo effects at the chemical type 2 ( gene ) and chemical type 2a ( 5-HT2a ) receptor systems .	T5	T14	10839333
NA	CHEMICAL	GENE-Y	10	17	As such , relatively little has been published regarding its in vivo effects at the chemical type 2 ( gene ) and chemical type 2a ( 5-HT2a ) receptor systems .	T5	T16	10839333
NA	CHEMICAL	GENE-Y	10	28	As such , relatively little has been published regarding its in vivo effects at the chemical type 2 ( gene ) and chemical type 2a ( 5-HT2a ) receptor systems .	T5	T17	10839333
CPR:3	CHEMICAL	GENE-Y	2	13	RESULTS : chemical was an effective antipsychotic and improved the extrapyramidal symptoms and gene level elevation noted at baseline .	T7	T20	10839333
NA	CHEMICAL	GENE-Y	7	20	Study of the additional subjects revealed that chemical does give rise to transiently high ( 58 % -64 % ) gene occupancy 2 to 3 hours after a single dose that then decreases to minimal levels in 12 hours .	T1	T11	10839333
NA	CHEMICAL	GENE-Y	2	7	CONCLUSIONS : chemical shows a transiently high gene occupancy , which decreases to very low levels by the end of the dosing interval .	T3	T12	10839333
NA	CHEMICAL	GENE-Y	2	3	Oncogenic mutations in gene , which encodes the chemical-3-kinase ( PI3K ) catalytic subunit p110α , occur in ∼25 % of human breast cancers .	T1	T4	22370636
NA	CHEMICAL	GENE-Y	2	14	Oncogenic mutations in gene , which encodes the chemical-3-kinase ( PI3K ) catalytic subunit p110α , occur in ∼25 % of human breast cancers .	T1	T12	22370636
NA	CHEMICAL	GENE-Y	16	4	Whole-exome analysis of the gene ( gene ) -driven mammary tumors identified multiple mutations , including chemical53 mutations that appeared spontaneously during the development of adenocarinoma and spindle cell tumors .	T2	T13	22370636
NA	CHEMICAL	GENE-N	16	6	Whole-exome analysis of the gene ( gene ) -driven mammary tumors identified multiple mutations , including chemical53 mutations that appeared spontaneously during the development of adenocarinoma and spindle cell tumors .	T2	T14	22370636
NA	CHEMICAL	GENE-Y	0	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T24	T36	15671155
NA	CHEMICAL	GENE-Y	0	2	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T24	T26	15671155
NA	CHEMICAL	GENE-Y	0	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T24	T29	15671155
NA	CHEMICAL	GENE-Y	0	7	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T24	T30	15671155
NA	CHEMICAL	GENE-Y	5	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T5	T36	15671155
NA	CHEMICAL	GENE-Y	5	2	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T5	T26	15671155
NA	CHEMICAL	GENE-Y	5	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T5	T29	15671155
NA	CHEMICAL	GENE-Y	5	7	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T5	T30	15671155
CPR:9	CHEMICAL	GENE-Y	10	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T10	T36	15671155
CPR:9	CHEMICAL	GENE-Y	10	2	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T10	T26	15671155
CPR:9	CHEMICAL	GENE-Y	10	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T10	T29	15671155
CPR:9	CHEMICAL	GENE-Y	10	7	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T10	T30	15671155
CPR:9	CHEMICAL	GENE-Y	15	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T16	T36	15671155
CPR:9	CHEMICAL	GENE-Y	15	2	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T16	T26	15671155
CPR:9	CHEMICAL	GENE-Y	15	11	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T16	T29	15671155
CPR:9	CHEMICAL	GENE-Y	15	7	chemical-gamma-lyase ( gene ) and chemical-beta-synthase ( gene ) utilize chemical as substrate to form chemical .	T16	T30	15671155
NA	CHEMICAL	GENE-Y	5	19	Of these two enzymes , chemical-gamma-lyase ( gene ) is believed to be the key enzyme that forms chemical in the cardiovascular system .	T17	T32	15671155
NA	CHEMICAL	GENE-Y	5	7	Of these two enzymes , chemical-gamma-lyase ( gene ) is believed to be the key enzyme that forms chemical in the cardiovascular system .	T17	T33	15671155
CPR:9	CHEMICAL	GENE-Y	18	19	Of these two enzymes , chemical-gamma-lyase ( gene ) is believed to be the key enzyme that forms chemical in the cardiovascular system .	T18	T32	15671155
CPR:9	CHEMICAL	GENE-Y	18	7	Of these two enzymes , chemical-gamma-lyase ( gene ) is believed to be the key enzyme that forms chemical in the cardiovascular system .	T18	T33	15671155
NA	CHEMICAL	GENE-Y	9	14	In this paper , we report the presence of chemical synthesizing enzyme activity and gene ( as determined by mRNA signal ) in the pancreas .	T20	T34	15671155
CPR:4	CHEMICAL	GENE-Y	15	12	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T21	T35	15671155
NA	CHEMICAL	GENE-N	15	4	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T21	T37	15671155
CPR:4	CHEMICAL	GENE-Y	17	12	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T22	T35	15671155
NA	CHEMICAL	GENE-N	17	4	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T22	T37	15671155
NA	CHEMICAL	GENE-Y	25	12	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T23	T35	15671155
NA	CHEMICAL	GENE-N	25	4	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T23	T37	15671155
NA	CHEMICAL	GENE-Y	15	12	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T2	T35	15671155
NA	CHEMICAL	GENE-N	15	4	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T2	T37	15671155
NA	CHEMICAL	GENE-Y	12	12	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T3	T35	15671155
NA	CHEMICAL	GENE-N	12	4	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T3	T37	15671155
NA	CHEMICAL	GENE-Y	72	12	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T4	T35	15671155
NA	CHEMICAL	GENE-N	72	4	Also , prophylactic , as well as therapeutic , treatment with the gene inhibitor , chemical ( chemical ) , significantly reduced the severity of chemical-induced pancreatitis and associated lung injury , as determined by 1 ) hypergenemia [ plasma amylase ( U/L ) ( control , 1204+/-59 ) ; prophylactic treatment : placebo , 10635+/-305 ; chemical , 7904+/-495 ; therapeutic treatment : placebo , 10427+/-470 ; chemical , 7811+/-428 ; P < 0.05 chemical c.f .	T4	T37	15671155
CPR:3	CHEMICAL	GENE-Y	37	18	placebo ; n=24 animals in each group ] ; 2 ) neutrophil sequestration in the pancreas [ pancreatic gene ( gene ) activity ( fold increase over control ) ( prophylactic treatment : placebo , 5.78+/-0.63 ; chemical , 2.97+/-0.39 ; therapeutic treatment : placebo , 5.48+/-0.52 ; chemical , 3.03+/-0.47 ; P < 0.05 chemical c.f .	T6	T27	15671155
CPR:3	CHEMICAL	GENE-Y	37	20	placebo ; n=24 animals in each group ] ; 2 ) neutrophil sequestration in the pancreas [ pancreatic gene ( gene ) activity ( fold increase over control ) ( prophylactic treatment : placebo , 5.78+/-0.63 ; chemical , 2.97+/-0.39 ; therapeutic treatment : placebo , 5.48+/-0.52 ; chemical , 3.03+/-0.47 ; P < 0.05 chemical c.f .	T6	T28	15671155
NA	CHEMICAL	GENE-Y	48	18	placebo ; n=24 animals in each group ] ; 2 ) neutrophil sequestration in the pancreas [ pancreatic gene ( gene ) activity ( fold increase over control ) ( prophylactic treatment : placebo , 5.78+/-0.63 ; chemical , 2.97+/-0.39 ; therapeutic treatment : placebo , 5.48+/-0.52 ; chemical , 3.03+/-0.47 ; P < 0.05 chemical c.f .	T7	T27	15671155
NA	CHEMICAL	GENE-Y	48	20	placebo ; n=24 animals in each group ] ; 2 ) neutrophil sequestration in the pancreas [ pancreatic gene ( gene ) activity ( fold increase over control ) ( prophylactic treatment : placebo , 5.78+/-0.63 ; chemical , 2.97+/-0.39 ; therapeutic treatment : placebo , 5.48+/-0.52 ; chemical , 3.03+/-0.47 ; P < 0.05 chemical c.f .	T7	T28	15671155
NA	CHEMICAL	GENE-Y	52	18	placebo ; n=24 animals in each group ] ; 2 ) neutrophil sequestration in the pancreas [ pancreatic gene ( gene ) activity ( fold increase over control ) ( prophylactic treatment : placebo , 5.78+/-0.63 ; chemical , 2.97+/-0.39 ; therapeutic treatment : placebo , 5.48+/-0.52 ; chemical , 3.03+/-0.47 ; P < 0.05 chemical c.f .	T8	T27	15671155
NA	CHEMICAL	GENE-Y	52	20	placebo ; n=24 animals in each group ] ; 2 ) neutrophil sequestration in the pancreas [ pancreatic gene ( gene ) activity ( fold increase over control ) ( prophylactic treatment : placebo , 5.78+/-0.63 ; chemical , 2.97+/-0.39 ; therapeutic treatment : placebo , 5.48+/-0.52 ; chemical , 3.03+/-0.47 ; P < 0.05 chemical c.f .	T8	T28	15671155
NA	CHEMICAL	GENE-Y	2	3	Binding of chemical to gene and its anticonvulsant and locomotor effects in mice , compared with chemical and chemical .	T50	T56	10064839
NA	CHEMICAL	GENE-Y	16	3	Binding of chemical to gene and its anticonvulsant and locomotor effects in mice , compared with chemical and chemical .	T49	T56	10064839
NA	CHEMICAL	GENE-Y	18	3	Binding of chemical to gene and its anticonvulsant and locomotor effects in mice , compared with chemical and chemical .	T51	T56	10064839
NA	CHEMICAL	GENE-N	0	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T35	T54	10064839
NA	CHEMICAL	GENE-Y	0	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T35	T55	10064839
NA	CHEMICAL	GENE-N	0	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T35	T52	10064839
NA	CHEMICAL	GENE-N	1	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T36	T54	10064839
NA	CHEMICAL	GENE-Y	1	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T36	T55	10064839
NA	CHEMICAL	GENE-N	1	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T36	T52	10064839
NA	CHEMICAL	GENE-N	4	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T37	T54	10064839
NA	CHEMICAL	GENE-Y	4	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T37	T55	10064839
NA	CHEMICAL	GENE-N	4	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T37	T52	10064839
NA	CHEMICAL	GENE-N	10	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T38	T54	10064839
NA	CHEMICAL	GENE-Y	10	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T38	T55	10064839
NA	CHEMICAL	GENE-N	10	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T38	T52	10064839
NA	CHEMICAL	GENE-N	32	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T39	T54	10064839
NA	CHEMICAL	GENE-Y	32	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T39	T55	10064839
NA	CHEMICAL	GENE-N	32	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T39	T52	10064839
NA	CHEMICAL	GENE-N	41	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T40	T54	10064839
NA	CHEMICAL	GENE-Y	41	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T40	T55	10064839
NA	CHEMICAL	GENE-N	41	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T40	T52	10064839
NA	CHEMICAL	GENE-N	46	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T41	T54	10064839
NA	CHEMICAL	GENE-Y	46	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T41	T55	10064839
NA	CHEMICAL	GENE-N	46	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T41	T52	10064839
NA	CHEMICAL	GENE-N	47	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T42	T54	10064839
NA	CHEMICAL	GENE-Y	47	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T42	T55	10064839
NA	CHEMICAL	GENE-N	47	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T42	T52	10064839
NA	CHEMICAL	GENE-N	59	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T43	T54	10064839
NA	CHEMICAL	GENE-Y	59	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T43	T55	10064839
NA	CHEMICAL	GENE-N	59	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T43	T52	10064839
NA	CHEMICAL	GENE-N	67	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T44	T54	10064839
NA	CHEMICAL	GENE-Y	67	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T44	T55	10064839
NA	CHEMICAL	GENE-N	67	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T44	T52	10064839
NA	CHEMICAL	GENE-N	69	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T45	T54	10064839
NA	CHEMICAL	GENE-Y	69	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T45	T55	10064839
NA	CHEMICAL	GENE-N	69	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T45	T52	10064839
NA	CHEMICAL	GENE-N	74	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T46	T54	10064839
NA	CHEMICAL	GENE-Y	74	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T46	T55	10064839
NA	CHEMICAL	GENE-N	74	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T46	T52	10064839
NA	CHEMICAL	GENE-N	76	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T47	T54	10064839
NA	CHEMICAL	GENE-Y	76	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T47	T55	10064839
NA	CHEMICAL	GENE-N	76	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T47	T52	10064839
NA	CHEMICAL	GENE-N	79	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T48	T54	10064839
NA	CHEMICAL	GENE-Y	79	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T48	T55	10064839
NA	CHEMICAL	GENE-N	79	30	chemical ( chemical , chemical ) , an analog of chemical , which has been safely used as an antitussive for more than 20 years , is also known not to form chemical . This study therefore characterized the binding of chemical to the gene and chemical-linked chemical sites and examined the anticonvulsant as well as locomotor effects of chemical in mice in comparison with those of chemical and chemical . We found that chemical , chemical , and chemical were relative high-affinity ligands at gene ( Ki=151 , 205 , 144 nM , respectively ) while all of them were with low affinity at gene ( Ki=4-11 microM ) .	T48	T52	10064839
NA	CHEMICAL	GENE-Y	20	12	Furthermore , since they have equipotent anticonvulsant effects and similar binding affinities to gene , the very low affinity of chemical at chemical sites may suggest that acting on the chemical sites may not be the requisite for mediating the anticonvulsant activity of these chemical analogs .	T18	T53	10064839
NA	CHEMICAL	GENE-Y	22	12	Furthermore , since they have equipotent anticonvulsant effects and similar binding affinities to gene , the very low affinity of chemical at chemical sites may suggest that acting on the chemical sites may not be the requisite for mediating the anticonvulsant activity of these chemical analogs .	T19	T53	10064839
NA	CHEMICAL	GENE-Y	30	12	Furthermore , since they have equipotent anticonvulsant effects and similar binding affinities to gene , the very low affinity of chemical at chemical sites may suggest that acting on the chemical sites may not be the requisite for mediating the anticonvulsant activity of these chemical analogs .	T20	T53	10064839
NA	CHEMICAL	GENE-Y	44	12	Furthermore , since they have equipotent anticonvulsant effects and similar binding affinities to gene , the very low affinity of chemical at chemical sites may suggest that acting on the chemical sites may not be the requisite for mediating the anticonvulsant activity of these chemical analogs .	T21	T53	10064839
CPR:4	CHEMICAL	GENE-Y	0	2	chemical downregulates gene through activation of gene .	T11	T37	16938288
CPR:3	CHEMICAL	GENE-Y	0	6	chemical downregulates gene through activation of gene .	T11	T38	16938288
CPR:6	CHEMICAL	GENE-Y	2	5	OBJECTIVE : chemical , an gene ( gene ) antagonist , was found to have a unique property : it is a partial agonist of gene ( gene ) .	T3	T28	16938288
CPR:6	CHEMICAL	GENE-Y	2	7	OBJECTIVE : chemical , an gene ( gene ) antagonist , was found to have a unique property : it is a partial agonist of gene ( gene ) .	T3	T32	16938288
CPR:5	CHEMICAL	GENE-Y	2	15	OBJECTIVE : chemical , an gene ( gene ) antagonist , was found to have a unique property : it is a partial agonist of gene ( gene ) .	T3	T19	16938288
CPR:5	CHEMICAL	GENE-Y	2	15	OBJECTIVE : chemical , an gene ( gene ) antagonist , was found to have a unique property : it is a partial agonist of gene ( gene ) .	T3	T26	16938288
NA	CHEMICAL	GENE-Y	15	6	Since previous studies have demonstrated that gene activators suppressed gene expression , we examined whether chemical affects gene expression in vascular smooth muscle cells .	T8	T27	16938288
NA	CHEMICAL	GENE-Y	15	9	Since previous studies have demonstrated that gene activators suppressed gene expression , we examined whether chemical affects gene expression in vascular smooth muscle cells .	T8	T29	16938288
NA	CHEMICAL	GENE-Y	15	17	Since previous studies have demonstrated that gene activators suppressed gene expression , we examined whether chemical affects gene expression in vascular smooth muscle cells .	T8	T30	16938288
CPR:4	CHEMICAL	GENE-Y	2	7	RESULTS : chemical decreased the expression of gene at the mRNA and protein levels in a dose- and time-dependent manner .	T9	T34	16938288
NA	CHEMICAL	GENE-N	9	1	Decreased gene activity with unchanged mRNA stability suggested that chemical suppressed gene gene expression at the transcriptional level .	T10	T35	16938288
CPR:4	CHEMICAL	GENE-Y	9	11	Decreased gene activity with unchanged mRNA stability suggested that chemical suppressed gene gene expression at the transcriptional level .	T10	T36	16938288
NA	CHEMICAL	GENE-Y	5	5	However , the expression of gene was not suppressed by other gene antagonists such as chemical or chemical .	T1	T12	16938288
CPR:6	CHEMICAL	GENE-Y	5	11	However , the expression of gene was not suppressed by other gene antagonists such as chemical or chemical .	T1	T13	16938288
NA	CHEMICAL	GENE-Y	17	5	However , the expression of gene was not suppressed by other gene antagonists such as chemical or chemical .	T2	T12	16938288
CPR:6	CHEMICAL	GENE-Y	17	11	However , the expression of gene was not suppressed by other gene antagonists such as chemical or chemical .	T2	T13	16938288
CPR:3	CHEMICAL	GENE-Y	11	4	Since the suppression of gene expression was prevented by pretreatment with chemical , a gene antagonist , gene should have participated in the process .	T4	T14	16938288
CPR:6	CHEMICAL	GENE-Y	11	13	Since the suppression of gene expression was prevented by pretreatment with chemical , a gene antagonist , gene should have participated in the process .	T4	T15	16938288
NA	CHEMICAL	GENE-Y	11	13	Since the suppression of gene expression was prevented by pretreatment with chemical , a gene antagonist , gene should have participated in the process .	T4	T16	16938288
CPR:4	CHEMICAL	GENE-Y	12	7	The deletion and mutation analysis of the gene gene promoter indicated that a gene located in the proximal promoter region is responsible for the chemical-induced downregulation .	T5	T17	16938288
CPR:4	CHEMICAL	GENE-N	12	13	The deletion and mutation analysis of the gene gene promoter indicated that a gene located in the proximal promoter region is responsible for the chemical-induced downregulation .	T5	T18	16938288
NA	CHEMICAL	GENE-Y	5	16	CONCLUSION : Our data provides a novel insight into an effect of chemical : chemical inhibits gene gene expression through gene activation .	T6	T20	16938288
NA	CHEMICAL	GENE-Y	5	5	CONCLUSION : Our data provides a novel insight into an effect of chemical : chemical inhibits gene gene expression through gene activation .	T6	T21	16938288
CPR:4	CHEMICAL	GENE-Y	5	16	CONCLUSION : Our data provides a novel insight into an effect of chemical : chemical inhibits gene gene expression through gene activation .	T7	T20	16938288
CPR:3	CHEMICAL	GENE-Y	5	5	CONCLUSION : Our data provides a novel insight into an effect of chemical : chemical inhibits gene gene expression through gene activation .	T7	T21	16938288
NA	CHEMICAL	GENE-Y	7	7	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T20	10866053
NA	CHEMICAL	GENE-Y	7	9	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T21	10866053
NA	CHEMICAL	GENE-Y	7	18	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T22	10866053
NA	CHEMICAL	GENE-Y	7	22	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T23	10866053
NA	CHEMICAL	GENE-Y	7	25	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T24	10866053
NA	CHEMICAL	GENE-Y	7	31	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T25	10866053
NA	CHEMICAL	GENE-Y	7	34	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T26	10866053
NA	CHEMICAL	GENE-Y	7	42	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T27	10866053
NA	CHEMICAL	GENE-Y	7	45	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T28	10866053
NA	CHEMICAL	GENE-Y	7	58	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T29	10866053
NA	CHEMICAL	GENE-Y	7	63	In this study , we compared the gene and gene binding properties and metabolic and mitogenic potencies of gene aspart ( B28Asp gene ) , gene lispro ( B28Lys , B29Pro gene ) , gene glargine ( A21Gly , B31Arg , B32Arg gene ) , gene detemir ( NN304 ) [ B29Lys ( chemical ) , desB30 human gene ] , and reference gene analogs .	T2	T30	10866053
NA	CHEMICAL	GENE-Y	3	9	The attachment of a chemical chain to LysB29 provided gene detemir with reduced receptor affinities and metabolic and mitogenic potencies but did not change the balance between mitogenic and metabolic potencies .	T1	T14	10866053
NA	CHEMICAL	GENE-N	15	9	Only strains of P. aeruginosa producing large amounts of gene may be resistant to both chemical and chemical .	T5	T20	8150771
NA	CHEMICAL	GENE-N	17	9	Only strains of P. aeruginosa producing large amounts of gene may be resistant to both chemical and chemical .	T6	T20	8150771
CPR:3	CHEMICAL	GENE-N	9	9	To mechanistically evaluate this regional selectivity , we assessed gene ( gene ) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and chemical-treated rats .	T1	T17	11304699
CPR:3	CHEMICAL	GENE-N	9	11	To mechanistically evaluate this regional selectivity , we assessed gene ( gene ) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and chemical-treated rats .	T1	T18	11304699
NA	CHEMICAL	GENE-Y	5	5	We therefore sought to establish a role for gene in malignant glioma cell motility , migration , and invasion and determine the effects of chemical on these cell movement-related processes .	T5	T13	18593927
NA	CHEMICAL	GENE-Y	35	25	Scratch wound-healing recovery , Boyden chamber migration , Matrigel invasion , and organotypic slice invasion assays were performed before and after the down-regulation of cellular gene levels and in the absence and presence of sublethal chemical ( chemical ; chemical ) concentrations .	T6	T14	18593927
NA	CHEMICAL	GENE-Y	36	25	Scratch wound-healing recovery , Boyden chamber migration , Matrigel invasion , and organotypic slice invasion assays were performed before and after the down-regulation of cellular gene levels and in the absence and presence of sublethal chemical ( chemical ; chemical ) concentrations .	T7	T14	18593927
NA	CHEMICAL	GENE-Y	25	25	Scratch wound-healing recovery , Boyden chamber migration , Matrigel invasion , and organotypic slice invasion assays were performed before and after the down-regulation of cellular gene levels and in the absence and presence of sublethal chemical ( chemical ; chemical ) concentrations .	T1	T14	18593927
CPR:4	CHEMICAL	GENE-Y	6	4	The direct inhibition of gene by chemical is likely a contributing factor .	T3	T9	18593927
NA	CHEMICAL	GENE-Y	3	0	gene is expressed in numerous tissues , whereas expression of gene , which encodes the chemical transporter gene/gene , is most abundant in kidney and muscle .	T3	T8	15058382
NA	CHEMICAL	GENE-Y	3	10	gene is expressed in numerous tissues , whereas expression of gene , which encodes the chemical transporter gene/gene , is most abundant in kidney and muscle .	T3	T9	15058382
NA	CHEMICAL	GENE-N	3	16	gene is expressed in numerous tissues , whereas expression of gene , which encodes the chemical transporter gene/gene , is most abundant in kidney and muscle .	T3	T10	15058382
NA	CHEMICAL	GENE-Y	3	3	gene is expressed in numerous tissues , whereas expression of gene , which encodes the chemical transporter gene/gene , is most abundant in kidney and muscle .	T3	T11	15058382
NA	CHEMICAL	GENE-Y	3	17	gene is expressed in numerous tissues , whereas expression of gene , which encodes the chemical transporter gene/gene , is most abundant in kidney and muscle .	T3	T12	15058382
CPR:4	CHEMICAL	GENE-N	0	13	chemical causes an increase in brain ornithine that is prevented by prior chemical oxidase inhibition .	T34	T44	17768678
NA	CHEMICAL	GENE-N	4	13	chemical causes an increase in brain ornithine that is prevented by prior chemical oxidase inhibition .	T35	T44	17768678
CPR:4	CHEMICAL	GENE-N	0	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T1	T39	17768678
CPR:4	CHEMICAL	GENE-N	0	13	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T1	T40	17768678
CPR:4	CHEMICAL	GENE-Y	0	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T1	T43	17768678
CPR:4	CHEMICAL	GENE-N	2	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T6	T39	17768678
CPR:4	CHEMICAL	GENE-N	2	13	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T6	T40	17768678
CPR:4	CHEMICAL	GENE-Y	2	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T6	T43	17768678
NA	CHEMICAL	GENE-N	5	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T27	T39	17768678
NA	CHEMICAL	GENE-N	5	13	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T27	T40	17768678
NA	CHEMICAL	GENE-Y	5	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T27	T43	17768678
NA	CHEMICAL	GENE-N	18	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T33	T39	17768678
NA	CHEMICAL	GENE-N	18	13	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T33	T40	17768678
NA	CHEMICAL	GENE-Y	18	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T33	T43	17768678
NA	CHEMICAL	GENE-N	20	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T5	T39	17768678
NA	CHEMICAL	GENE-N	20	13	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T5	T40	17768678
NA	CHEMICAL	GENE-Y	20	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T5	T43	17768678
NA	CHEMICAL	GENE-N	26	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T14	T39	17768678
NA	CHEMICAL	GENE-N	26	13	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T14	T40	17768678
NA	CHEMICAL	GENE-Y	26	5	chemical ( chemical ) , a nonselective irreversible inhibitor of chemical oxidase ( gene ) , also inhibits chemical-transaminase ( chemical-T ) , markedly increasing brain chemical levels .	T14	T43	17768678
CPR:9	CHEMICAL	GENE-N	0	6	chemical is also a substrate for gene , and studies suggest that a metabolite formed by the action of this enzyme on chemical may be responsible for the increase in chemical observed .	T16	T38	17768678
NA	CHEMICAL	GENE-N	22	6	chemical is also a substrate for gene , and studies suggest that a metabolite formed by the action of this enzyme on chemical may be responsible for the increase in chemical observed .	T17	T38	17768678
NA	CHEMICAL	GENE-N	30	6	chemical is also a substrate for gene , and studies suggest that a metabolite formed by the action of this enzyme on chemical may be responsible for the increase in chemical observed .	T18	T38	17768678
NA	CHEMICAL	GENE-N	12	10	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T29	T41	17768678
NA	CHEMICAL	GENE-N	12	31	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T29	T42	17768678
NA	CHEMICAL	GENE-N	21	10	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T30	T41	17768678
NA	CHEMICAL	GENE-N	21	31	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T30	T42	17768678
NA	CHEMICAL	GENE-N	3	10	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T31	T41	17768678
CPR:4	CHEMICAL	GENE-N	3	31	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T31	T42	17768678
NA	CHEMICAL	GENE-N	35	10	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T32	T41	17768678
CPR:4	CHEMICAL	GENE-N	35	31	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T32	T42	17768678
NA	CHEMICAL	GENE-N	12	10	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T2	T41	17768678
NA	CHEMICAL	GENE-N	12	31	To determine whether a metabolite formed by the action of gene on chemical may be responsible for the elevation in brain chemical observed , animals were pretreated with vehicle or the gene inhibitor chemical ( chemical ) before vehicle or chemical ( 15 mg/kg ) , and brains collected 3 h later .	T2	T42	17768678
NA	CHEMICAL	GENE-N	0	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T3	T37	17768678
NA	CHEMICAL	GENE-N	15	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T4	T37	17768678
NA	CHEMICAL	GENE-N	33	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T7	T37	17768678
NA	CHEMICAL	GENE-N	37	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T8	T37	17768678
NA	CHEMICAL	GENE-N	41	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T9	T37	17768678
NA	CHEMICAL	GENE-N	47	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T10	T37	17768678
CPR:9	CHEMICAL	GENE-N	53	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T11	T37	17768678
NA	CHEMICAL	GENE-N	67	59	chemical levels ( measured by an HPLC procedure ) were dose- and time-dependently increased in chemical-treated animals , with levels reaching approximately 650 % of control at 6 and 12 h. Pretreatment with chemical completely abolished the chemical-induced increase in brain chemical , suggesting , as with chemical , that a metabolite of chemical formed by the action of gene is responsible for the elevation of brain chemical observed .	T12	T37	17768678
NA	CHEMICAL	GENE-Y	18	3	We demonstrated by in vitro gel-shift assays that binding interactions of the gene ( gene ) were disrupted on chemical ( chemical ) -substituted gene .	T8	T21	14722255
NA	CHEMICAL	GENE-Y	18	14	We demonstrated by in vitro gel-shift assays that binding interactions of the gene ( gene ) were disrupted on chemical ( chemical ) -substituted gene .	T8	T22	14722255
NA	CHEMICAL	GENE-N	18	24	We demonstrated by in vitro gel-shift assays that binding interactions of the gene ( gene ) were disrupted on chemical ( chemical ) -substituted gene .	T8	T23	14722255
NA	CHEMICAL	GENE-Y	21	3	We demonstrated by in vitro gel-shift assays that binding interactions of the gene ( gene ) were disrupted on chemical ( chemical ) -substituted gene .	T9	T21	14722255
NA	CHEMICAL	GENE-Y	21	14	We demonstrated by in vitro gel-shift assays that binding interactions of the gene ( gene ) were disrupted on chemical ( chemical ) -substituted gene .	T9	T22	14722255
NA	CHEMICAL	GENE-N	21	24	We demonstrated by in vitro gel-shift assays that binding interactions of the gene ( gene ) were disrupted on chemical ( chemical ) -substituted gene .	T9	T23	14722255
NA	CHEMICAL	GENE-N	14	3	We hypothesized that gene ( gene ) transcriptional processes would therefore be affected by chemical ( chemical ) incorporation into a promoter gene .	T12	T24	14722255
NA	CHEMICAL	GENE-N	14	5	We hypothesized that gene ( gene ) transcriptional processes would therefore be affected by chemical ( chemical ) incorporation into a promoter gene .	T12	T25	14722255
NA	CHEMICAL	GENE-N	14	22	We hypothesized that gene ( gene ) transcriptional processes would therefore be affected by chemical ( chemical ) incorporation into a promoter gene .	T12	T26	14722255
NA	CHEMICAL	GENE-N	16	3	We hypothesized that gene ( gene ) transcriptional processes would therefore be affected by chemical ( chemical ) incorporation into a promoter gene .	T13	T24	14722255
NA	CHEMICAL	GENE-N	16	5	We hypothesized that gene ( gene ) transcriptional processes would therefore be affected by chemical ( chemical ) incorporation into a promoter gene .	T13	T25	14722255
NA	CHEMICAL	GENE-N	16	22	We hypothesized that gene ( gene ) transcriptional processes would therefore be affected by chemical ( chemical ) incorporation into a promoter gene .	T13	T26	14722255
NA	CHEMICAL	GENE-N	7	13	With increasing amounts of HeLa extract , chemical substitution for chemical within the gene decreased in vitro gene transcription by approximately 35 % compared with control substrates .	T15	T17	14722255
NA	CHEMICAL	GENE-N	7	17	With increasing amounts of HeLa extract , chemical substitution for chemical within the gene decreased in vitro gene transcription by approximately 35 % compared with control substrates .	T15	T18	14722255
NA	CHEMICAL	GENE-N	7	13	With increasing amounts of HeLa extract , chemical substitution for chemical within the gene decreased in vitro gene transcription by approximately 35 % compared with control substrates .	T1	T17	14722255
NA	CHEMICAL	GENE-N	7	17	With increasing amounts of HeLa extract , chemical substitution for chemical within the gene decreased in vitro gene transcription by approximately 35 % compared with control substrates .	T1	T18	14722255
NA	CHEMICAL	GENE-N	5	6	In contrast , transcription on chemical-substituted gene reached a plateau after 20 min .	T2	T19	14722255
NA	CHEMICAL	GENE-N	2	20	Furthermore , chemical-substituted promoter sequences trapped or sequestered TBP , preventing its dissociation from DNA and subsequent binding to additional gene to reinitiate transcription .	T3	T20	14722255
CPR:3	CHEMICAL	GENE-Y	5	9	Novel mechanism of action for chemical : induction of gene , gene , and angiogenesis by inhibition of chemical hydroxylases .	T14	T38	15192023
CPR:3	CHEMICAL	GENE-Y	5	11	Novel mechanism of action for chemical : induction of gene , gene , and angiogenesis by inhibition of chemical hydroxylases .	T14	T39	15192023
CPR:4	CHEMICAL	GENE-N	5	19	Novel mechanism of action for chemical : induction of gene , gene , and angiogenesis by inhibition of chemical hydroxylases .	T14	T37	15192023
NA	CHEMICAL	GENE-Y	18	9	Novel mechanism of action for chemical : induction of gene , gene , and angiogenesis by inhibition of chemical hydroxylases .	T13	T38	15192023
NA	CHEMICAL	GENE-Y	18	11	Novel mechanism of action for chemical : induction of gene , gene , and angiogenesis by inhibition of chemical hydroxylases .	T13	T39	15192023
NA	CHEMICAL	GENE-N	18	19	Novel mechanism of action for chemical : induction of gene , gene , and angiogenesis by inhibition of chemical hydroxylases .	T13	T37	15192023
NA	CHEMICAL	GENE-N	2	0	gene is a known target of chemical .	T7	T19	15192023
NA	CHEMICAL	GENE-N	20	15	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T8	T20	15192023
NA	CHEMICAL	GENE-N	20	17	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T8	T21	15192023
NA	CHEMICAL	GENE-N	20	23	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T8	T22	15192023
NA	CHEMICAL	GENE-N	20	25	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T8	T23	15192023
NA	CHEMICAL	GENE-N	21	15	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T9	T20	15192023
NA	CHEMICAL	GENE-N	21	17	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T9	T21	15192023
NA	CHEMICAL	GENE-N	21	23	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T9	T22	15192023
NA	CHEMICAL	GENE-N	21	25	We therefore investigated whether inhibition of other members of this enzyme family , namely the gene ( gene ) -regulating chemical-dependent chemical hydroxylase domain ( gene ) enzymes , could represent a novel mechanism of action .	T9	T23	15192023
CPR:3	CHEMICAL	GENE-Y	0	7	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T24	15192023
CPR:3	CHEMICAL	GENE-N	0	12	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T25	15192023
CPR:3	CHEMICAL	GENE-Y	0	14	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T26	15192023
CPR:3	CHEMICAL	GENE-Y	0	16	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T27	15192023
CPR:3	CHEMICAL	GENE-Y	0	18	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T28	15192023
CPR:3	CHEMICAL	GENE-Y	0	21	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T29	15192023
CPR:3	CHEMICAL	GENE-Y	0	23	chemical induced rapid and transient expression of gene and downstream targets of gene ( gene , gene , gene , and gene [ gene ] ) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation .	T10	T30	15192023
CPR:4	CHEMICAL	GENE-N	0	3	chemical dose-dependently inhibited gene activity and induced nonhydroxylated gene , evidence for gene stabilization specifically by inhibition of gene enzyme activity .	T11	T31	15192023
CPR:3	CHEMICAL	GENE-Y	0	8	chemical dose-dependently inhibited gene activity and induced nonhydroxylated gene , evidence for gene stabilization specifically by inhibition of gene enzyme activity .	T11	T32	15192023
NA	CHEMICAL	GENE-N	0	12	chemical dose-dependently inhibited gene activity and induced nonhydroxylated gene , evidence for gene stabilization specifically by inhibition of gene enzyme activity .	T11	T33	15192023
CPR:4	CHEMICAL	GENE-N	0	18	chemical dose-dependently inhibited gene activity and induced nonhydroxylated gene , evidence for gene stabilization specifically by inhibition of gene enzyme activity .	T11	T34	15192023
CPR:3	CHEMICAL	GENE-Y	3	5	In vivo , chemical induced gene and gene protein in tissue extracts and elevated plasma gene levels .	T12	T35	15192023
CPR:3	CHEMICAL	GENE-Y	3	7	In vivo , chemical induced gene and gene protein in tissue extracts and elevated plasma gene levels .	T12	T36	15192023
CPR:3	CHEMICAL	GENE-Y	3	15	In vivo , chemical induced gene and gene protein in tissue extracts and elevated plasma gene levels .	T12	T15	15192023
CPR:3	CHEMICAL	GENE-N	2	5	Thus , chemical activates the gene pathway through inhibition of gene activity and initiates a pro-angiogenic phenotype .	T2	T16	15192023
CPR:4	CHEMICAL	GENE-N	2	10	Thus , chemical activates the gene pathway through inhibition of gene activity and initiates a pro-angiogenic phenotype .	T2	T17	15192023
CPR:3	CHEMICAL	GENE-Y	32	9	A reporter construct driven by 4 kb of the gene 5'-flanking region , containing six putative gene and two potential gene , was highly activated in embryonic pituitary cells and up-regulated by chemical .	T1	T3	23161868
CPR:3	CHEMICAL	GENE-N	32	16	A reporter construct driven by 4 kb of the gene 5'-flanking region , containing six putative gene and two potential gene , was highly activated in embryonic pituitary cells and up-regulated by chemical .	T1	T4	23161868
CPR:3	CHEMICAL	GENE-N	32	20	A reporter construct driven by 4 kb of the gene 5'-flanking region , containing six putative gene and two potential gene , was highly activated in embryonic pituitary cells and up-regulated by chemical .	T1	T5	23161868
CPR:3	CHEMICAL	GENE-N	14	4	However , mutating putative gene did not substantially reduce induction of gene activity by chemical , suggesting additional gene within the 5'-flanking region are responsible for glucocorticoid regulation .	T2	T10	23161868
CPR:3	CHEMICAL	GENE-N	14	11	However , mutating putative gene did not substantially reduce induction of gene activity by chemical , suggesting additional gene within the 5'-flanking region are responsible for glucocorticoid regulation .	T2	T11	23161868
NA	CHEMICAL	GENE-N	14	18	However , mutating putative gene did not substantially reduce induction of gene activity by chemical , suggesting additional gene within the 5'-flanking region are responsible for glucocorticoid regulation .	T2	T12	23161868
NA	CHEMICAL	GENE-N	10	9	The present study investigated the effect of neonatal exposure to chemical on hippocampus-dependent novel object recognition test performance and the expression of the chemical ( chemical ) receptor and its signal transduction pathway-related genes in the hippocampi of young adult and adult mice .	T9	T22	23212306
NA	CHEMICAL	GENE-N	23	9	The present study investigated the effect of neonatal exposure to chemical on hippocampus-dependent novel object recognition test performance and the expression of the chemical ( chemical ) receptor and its signal transduction pathway-related genes in the hippocampi of young adult and adult mice .	T10	T22	23212306
NA	CHEMICAL	GENE-N	25	9	The present study investigated the effect of neonatal exposure to chemical on hippocampus-dependent novel object recognition test performance and the expression of the chemical ( chemical ) receptor and its signal transduction pathway-related genes in the hippocampi of young adult and adult mice .	T11	T22	23212306
NA	CHEMICAL	GENE-N	28	25	The hippocampi were collected on PND 50 or PND 85 after the completion of the novel object recognition test , and the expression levels of gene and the chemical receptor and its signal transduction pathway-related genes were examined using real-time RT-PCR .	T13	T23	23212306
NA	CHEMICAL	GENE-N	28	7	The hippocampi were collected on PND 50 or PND 85 after the completion of the novel object recognition test , and the expression levels of gene and the chemical receptor and its signal transduction pathway-related genes were examined using real-time RT-PCR .	T13	T24	23212306
NA	CHEMICAL	GENE-N	1	6	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T2	T16	23212306
NA	CHEMICAL	GENE-N	1	11	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T2	T17	23212306
NA	CHEMICAL	GENE-Y	1	15	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T2	T18	23212306
NA	CHEMICAL	GENE-Y	1	15	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T2	T19	23212306
NA	CHEMICAL	GENE-N	12	6	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T3	T16	23212306
NA	CHEMICAL	GENE-N	12	11	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T3	T17	23212306
NA	CHEMICAL	GENE-Y	12	15	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T3	T18	23212306
NA	CHEMICAL	GENE-Y	12	15	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T3	T19	23212306
NA	CHEMICAL	GENE-N	23	6	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T4	T16	23212306
NA	CHEMICAL	GENE-N	23	11	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T4	T17	23212306
NA	CHEMICAL	GENE-Y	23	15	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T4	T18	23212306
NA	CHEMICAL	GENE-Y	23	15	The chemical receptor subunits NR1 and NR2B and the related protein gene chemical/calmodulin-dependent protein kinase ( CaMK ) -IV and the transcription factor chemical responsive element binding protein ( CREB ) -1 mRNA levels were reduced in the PND 50 mice .	T4	T19	23212306
NA	CHEMICAL	GENE-Y	1	26	A chemical tolerance test with 75 g chemical load was performed before and after treatment , collecting blood at 0 , 1 and 2 h for gene , chemical , FFA and chemical .	T5	T20	23461841
NA	CHEMICAL	GENE-Y	6	26	A chemical tolerance test with 75 g chemical load was performed before and after treatment , collecting blood at 0 , 1 and 2 h for gene , chemical , FFA and chemical .	T6	T20	23461841
NA	CHEMICAL	GENE-Y	6	26	A chemical tolerance test with 75 g chemical load was performed before and after treatment , collecting blood at 0 , 1 and 2 h for gene , chemical , FFA and chemical .	T8	T20	23461841
NA	CHEMICAL	GENE-Y	32	26	A chemical tolerance test with 75 g chemical load was performed before and after treatment , collecting blood at 0 , 1 and 2 h for gene , chemical , FFA and chemical .	T9	T20	23461841
NA	CHEMICAL	GENE-Y	3	4	[ Change of chemical transporter activity ( gene ) during the action of chemical ( in depression ) ] .	T6	T12	15787205
NA	CHEMICAL	GENE-Y	3	7	[ Change of chemical transporter activity ( gene ) during the action of chemical ( in depression ) ] .	T6	T13	15787205
NA	CHEMICAL	GENE-Y	13	4	[ Change of chemical transporter activity ( gene ) during the action of chemical ( in depression ) ] .	T7	T12	15787205
NA	CHEMICAL	GENE-Y	13	7	[ Change of chemical transporter activity ( gene ) during the action of chemical ( in depression ) ] .	T7	T13	15787205
CPR:4	CHEMICAL	GENE-Y	0	2	chemical has an antidepressant effect through blocking the chemical transporter .	T1	T11	15787205
NA	CHEMICAL	GENE-Y	8	2	chemical has an antidepressant effect through blocking the chemical transporter .	T5	T11	15787205
NA	CHEMICAL	GENE-Y	4	11	After 3 weeks ' chemical treatment we studied the change in gene activity , which corresponds to the occupancy of chemical .	T2	T9	15787205
NA	CHEMICAL	GENE-Y	20	11	After 3 weeks ' chemical treatment we studied the change in gene activity , which corresponds to the occupancy of chemical .	T3	T9	15787205
NA	CHEMICAL	GENE-Y	0	8	chemical mediates lipolysis in adipose tissue through its gene .	T6	T16	16018973
NA	CHEMICAL	GENE-N	3	1	A gene to chemical ( chemical ) was identified recently but the physiological/pharmacological role of the receptor remains poorly defined .	T2	T9	16018973
NA	CHEMICAL	GENE-N	5	1	A gene to chemical ( chemical ) was identified recently but the physiological/pharmacological role of the receptor remains poorly defined .	T3	T9	16018973
NA	CHEMICAL	GENE-N	14	7	We present our studies to demonstrate that gene , but not gene , binds chemical at high affinities and effectively mediates gene signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing gene .	T1	T7	16018973
NA	CHEMICAL	GENE-N	14	11	We present our studies to demonstrate that gene , but not gene , binds chemical at high affinities and effectively mediates gene signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing gene .	T1	T8	16018973
CPR:3	CHEMICAL	GENE-N	14	21	We present our studies to demonstrate that gene , but not gene , binds chemical at high affinities and effectively mediates gene signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing gene .	T1	T10	16018973
NA	CHEMICAL	GENE-N	14	37	We present our studies to demonstrate that gene , but not gene , binds chemical at high affinities and effectively mediates gene signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing gene .	T1	T11	16018973
NA	CHEMICAL	GENE-Y	9	2	Furthermore , gene , but not gene , expressed in differentiated 3T3L1 adipocytes effectively mediated inhibition of lipolysis by chemical .	T4	T12	16018973
NA	CHEMICAL	GENE-Y	9	6	Furthermore , gene , but not gene , expressed in differentiated 3T3L1 adipocytes effectively mediated inhibition of lipolysis by chemical .	T4	T13	16018973
CPR:3	CHEMICAL	GENE-N	3	18	Distinct roles of chemical in modulating spatial memory consolidation , retrieval , reconsolidation and the accompanying changes of gene and gene activation in hippocampus and prefrontal cortex .	T11	T24	23159329
CPR:3	CHEMICAL	GENE-N	3	20	Distinct roles of chemical in modulating spatial memory consolidation , retrieval , reconsolidation and the accompanying changes of gene and gene activation in hippocampus and prefrontal cortex .	T11	T25	23159329
NA	CHEMICAL	GENE-N	9	1	The gene ( gene ) and the transcription factor chemical response element-binding protein ( gene ) were involved in neuroplastic changes associated with learning and memory .	T5	T12	23159329
NA	CHEMICAL	GENE-N	9	3	The gene ( gene ) and the transcription factor chemical response element-binding protein ( gene ) were involved in neuroplastic changes associated with learning and memory .	T5	T17	23159329
NA	CHEMICAL	GENE-N	9	12	The gene ( gene ) and the transcription factor chemical response element-binding protein ( gene ) were involved in neuroplastic changes associated with learning and memory .	T5	T18	23159329
NA	CHEMICAL	GENE-N	9	14	The gene ( gene ) and the transcription factor chemical response element-binding protein ( gene ) were involved in neuroplastic changes associated with learning and memory .	T5	T19	23159329
NA	CHEMICAL	GENE-N	21	3	Activation of both gene and gene in the hippocampus was found following memory consolidation but not after retrieval or reconsolidation in chemical-treated mouse groups .	T1	T22	23159329
NA	CHEMICAL	GENE-N	21	5	Activation of both gene and gene in the hippocampus was found following memory consolidation but not after retrieval or reconsolidation in chemical-treated mouse groups .	T1	T23	23159329
CPR:3	CHEMICAL	GENE-N	22	6	In contrast , activation of both gene and gene in the PFC was found following memory retrieval but not other processes in chemical-treated mouse groups .	T2	T13	23159329
CPR:3	CHEMICAL	GENE-N	22	8	In contrast , activation of both gene and gene in the PFC was found following memory retrieval but not other processes in chemical-treated mouse groups .	T2	T14	23159329
NA	CHEMICAL	GENE-Y	0	3	chemical receptor gene gene modulates early event-related potentials in auditory and visual oddball target detection tasks .	T3	T8	17590520
NA	CHEMICAL	GENE-N	3	6	The same sense chemical-to-chemical polymorphism ( c.gene ; gene ) was shown to preferentially modulate early components in both modalities .	T1	T4	17590520
NA	CHEMICAL	GENE-N	3	8	The same sense chemical-to-chemical polymorphism ( c.gene ; gene ) was shown to preferentially modulate early components in both modalities .	T1	T5	17590520
NA	CHEMICAL	GENE-N	3	6	The same sense chemical-to-chemical polymorphism ( c.gene ; gene ) was shown to preferentially modulate early components in both modalities .	T2	T4	17590520
NA	CHEMICAL	GENE-N	3	8	The same sense chemical-to-chemical polymorphism ( c.gene ; gene ) was shown to preferentially modulate early components in both modalities .	T2	T5	17590520
NA	CHEMICAL	GENE-N	2	6	Autoradiography of chemical gels of cross-linked gene showed only three protein bands specifically binding salmon calcitonin .	T5	T8	3004987
NA	CHEMICAL	GENE-Y	0	1	chemical synthase expression pattern , expression level and single chemical polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with chemical .	T6	T13	16596248
NA	CHEMICAL	GENE-Y	9	1	chemical synthase expression pattern , expression level and single chemical polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with chemical .	T8	T13	16596248
NA	CHEMICAL	GENE-Y	23	1	chemical synthase expression pattern , expression level and single chemical polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with chemical .	T7	T13	16596248
NA	CHEMICAL	GENE-Y	4	5	Several variables associated to chemical synthase ( gene ) , the biological target of chemical ( chemical ) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer ( CRC ) patients .	T3	T10	16596248
NA	CHEMICAL	GENE-Y	4	7	Several variables associated to chemical synthase ( gene ) , the biological target of chemical ( chemical ) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer ( CRC ) patients .	T3	T11	16596248
NA	CHEMICAL	GENE-Y	14	5	Several variables associated to chemical synthase ( gene ) , the biological target of chemical ( chemical ) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer ( CRC ) patients .	T5	T10	16596248
NA	CHEMICAL	GENE-Y	14	7	Several variables associated to chemical synthase ( gene ) , the biological target of chemical ( chemical ) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer ( CRC ) patients .	T5	T11	16596248
NA	CHEMICAL	GENE-Y	7	5	Several variables associated to chemical synthase ( gene ) , the biological target of chemical ( chemical ) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer ( CRC ) patients .	T1	T10	16596248
NA	CHEMICAL	GENE-Y	7	7	Several variables associated to chemical synthase ( gene ) , the biological target of chemical ( chemical ) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer ( CRC ) patients .	T1	T11	16596248
NA	CHEMICAL	GENE-Y	3	12	Phα1β toxin prevents chemical-induced nociceptive behavior and mechanical hypersensitivity without acting on gene channels .	T17	T23	23597507
NA	CHEMICAL	GENE-Y	8	24	We also investigated the effect of Phα1β on chemical transients in cultured dorsal root ganglia ( DRG ) neurons and HEK293 cells expressing the gene receptor .	T10	T20	23597507
NA	CHEMICAL	GENE-Y	14	24	Intraplantar or intrathecal administered Phα1β reduced both nocifensive behavior and mechanical hypersensitivity induced by chemical similarly to that observed with chemical , a specific gene antagonist .	T11	T21	23597507
CPR:6	CHEMICAL	GENE-Y	20	24	Intraplantar or intrathecal administered Phα1β reduced both nocifensive behavior and mechanical hypersensitivity induced by chemical similarly to that observed with chemical , a specific gene antagonist .	T12	T21	23597507
NA	CHEMICAL	GENE-N	5	6	In contrast , ω-conotoxin MVIIA ( a selective gene blocker ) was effective only when administered intrathecally .	T16	T22	23597507
NA	CHEMICAL	GENE-Y	6	16	Moreover , Phα1β did not inhibit chemical-activated currents in patch-clamp recordings of HEK293 cells that expressed gene receptors .	T7	T18	23597507
CPR:4	CHEMICAL	GENE-N	9	10	BACKGROUND : The active metabolite of the anti-inflammatory drug chemical has been characterized as a selective inhibitor of the inducible chemical H synthase ( gene ) .	T17	T25	7554708
CPR:4	CHEMICAL	GENE-N	9	21	BACKGROUND : The active metabolite of the anti-inflammatory drug chemical has been characterized as a selective inhibitor of the inducible chemical H synthase ( gene ) .	T17	T28	7554708
NA	CHEMICAL	GENE-N	14	10	BACKGROUND : The active metabolite of the anti-inflammatory drug chemical has been characterized as a selective inhibitor of the inducible chemical H synthase ( gene ) .	T6	T25	7554708
NA	CHEMICAL	GENE-N	14	21	BACKGROUND : The active metabolite of the anti-inflammatory drug chemical has been characterized as a selective inhibitor of the inducible chemical H synthase ( gene ) .	T6	T28	7554708
NA	CHEMICAL	GENE-Y	12	34	METHODS : We measured the urinary excretion of products of platelet ( chemical [ chemical ] ) and renal ( chemical [ chemical ] ) chemical metabolism as in vivo indexes of the constitutive gene pathway .	T11	T30	7554708
NA	CHEMICAL	GENE-Y	14	34	METHODS : We measured the urinary excretion of products of platelet ( chemical [ chemical ] ) and renal ( chemical [ chemical ] ) chemical metabolism as in vivo indexes of the constitutive gene pathway .	T12	T30	7554708
NA	CHEMICAL	GENE-Y	20	34	METHODS : We measured the urinary excretion of products of platelet ( chemical [ chemical ] ) and renal ( chemical [ chemical ] ) chemical metabolism as in vivo indexes of the constitutive gene pathway .	T13	T30	7554708
NA	CHEMICAL	GENE-Y	22	34	METHODS : We measured the urinary excretion of products of platelet ( chemical [ chemical ] ) and renal ( chemical [ chemical ] ) chemical metabolism as in vivo indexes of the constitutive gene pathway .	T14	T30	7554708
NA	CHEMICAL	GENE-Y	25	34	METHODS : We measured the urinary excretion of products of platelet ( chemical [ chemical ] ) and renal ( chemical [ chemical ] ) chemical metabolism as in vivo indexes of the constitutive gene pathway .	T15	T30	7554708
CPR:9	CHEMICAL	GENE-N	5	12	Moreover , the production of chemical during whole blood clotting was assessed as an index of the gene activity of platelet gene ex vivo .	T16	T31	7554708
CPR:9	CHEMICAL	GENE-Y	5	21	Moreover , the production of chemical during whole blood clotting was assessed as an index of the gene activity of platelet gene ex vivo .	T16	T32	7554708
CPR:4	CHEMICAL	GENE-Y	5	16	The daily administration of low-dose chemical ( 40 mg ) , a selective inhibitor of platelet gene , caused a cumulative inhibition of urinary chemical and whole blood chemical production that recovered with a timecourse consistent with platelet turnover .	T4	T24	7554708
CPR:9	CHEMICAL	GENE-Y	24	16	The daily administration of low-dose chemical ( 40 mg ) , a selective inhibitor of platelet gene , caused a cumulative inhibition of urinary chemical and whole blood chemical production that recovered with a timecourse consistent with platelet turnover .	T5	T24	7554708
CPR:9	CHEMICAL	GENE-Y	28	16	The daily administration of low-dose chemical ( 40 mg ) , a selective inhibitor of platelet gene , caused a cumulative inhibition of urinary chemical and whole blood chemical production that recovered with a timecourse consistent with platelet turnover .	T7	T24	7554708
CPR:4	CHEMICAL	GENE-N	2	7	CONCLUSIONS : chemical does dose-dependently inhibit the gene activity of platelet gene of healthy subjects both in vivo and ex vivo .	T8	T26	7554708
CPR:4	CHEMICAL	GENE-Y	2	11	CONCLUSIONS : chemical does dose-dependently inhibit the gene activity of platelet gene of healthy subjects both in vivo and ex vivo .	T8	T27	7554708
NA	CHEMICAL	GENE-Y	8	12	Quantification and regulation of the subcellular distribution of chemical chemical : chemical N-acyltransferase activity in rat liver .	T11	T26	17379925
NA	CHEMICAL	GENE-Y	9	12	Quantification and regulation of the subcellular distribution of chemical chemical : chemical N-acyltransferase activity in rat liver .	T12	T26	17379925
NA	CHEMICAL	GENE-Y	11	12	Quantification and regulation of the subcellular distribution of chemical chemical : chemical N-acyltransferase activity in rat liver .	T13	T26	17379925
NA	CHEMICAL	GENE-Y	0	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T1	T14	17379925
NA	CHEMICAL	GENE-Y	0	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T1	T20	17379925
NA	CHEMICAL	GENE-Y	1	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T2	T14	17379925
NA	CHEMICAL	GENE-Y	1	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T2	T20	17379925
NA	CHEMICAL	GENE-Y	3	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T7	T14	17379925
NA	CHEMICAL	GENE-Y	3	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T7	T20	17379925
CPR:9	CHEMICAL	GENE-Y	14	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T10	T14	17379925
CPR:9	CHEMICAL	GENE-Y	14	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T10	T20	17379925
NA	CHEMICAL	GENE-Y	17	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T4	T14	17379925
NA	CHEMICAL	GENE-Y	17	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T4	T20	17379925
NA	CHEMICAL	GENE-Y	18	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T5	T14	17379925
NA	CHEMICAL	GENE-Y	18	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T5	T20	17379925
NA	CHEMICAL	GENE-Y	20	4	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T6	T14	17379925
NA	CHEMICAL	GENE-Y	20	6	chemical chemical : chemical N-acyltransferase ( gene ) is responsible for the amidation of chemical with the chemical chemical and chemical .	T6	T20	17379925
NA	CHEMICAL	GENE-Y	2	9	Treatment with chemical or chemical had no effect on gene activity in any subcellular compartment .	T8	T24	17379925
NA	CHEMICAL	GENE-Y	4	9	Treatment with chemical or chemical had no effect on gene activity in any subcellular compartment .	T9	T24	17379925
NA	CHEMICAL	GENE-Y	5	36	The solubility-driven structural modification of chemical is described , which resulted in the development of a new series of chemical analogues with high antibacterial activity against Gram-positive pathogens , including that against chemical-resistant strains and low gene inhibition .	T5	T10	23428155
CPR:4	CHEMICAL	GENE-Y	11	36	The solubility-driven structural modification of chemical is described , which resulted in the development of a new series of chemical analogues with high antibacterial activity against Gram-positive pathogens , including that against chemical-resistant strains and low gene inhibition .	T2	T10	23428155
NA	CHEMICAL	GENE-Y	11	36	The solubility-driven structural modification of chemical is described , which resulted in the development of a new series of chemical analogues with high antibacterial activity against Gram-positive pathogens , including that against chemical-resistant strains and low gene inhibition .	T3	T10	23428155
NA	CHEMICAL	GENE-N	7	12	In human kidney , we found unique chemical-binding sites that were insensitive to chemical and were thus unlikely to be gene .	T25	T42	12827214
NA	CHEMICAL	GENE-N	12	12	In human kidney , we found unique chemical-binding sites that were insensitive to chemical and were thus unlikely to be gene .	T32	T42	12827214
NA	CHEMICAL	GENE-N	0	2	chemical bound to the chemical-insensitive sites monophasically with a high affinity ( pK ( d ) ; 9.1+/-0.08 , n=8 ) , and the B ( max ) value ( 814+/-204 fmol mg ( -1 ) protein , n=8 ) was more than ten times that of the chemical-sensitive gene ( pK ( d ) =9.9+/-0.13 , B ( max ) =66+/-23 fmol mg ( -1 ) protein , n=7 ) .	T28	T45	12827214
NA	CHEMICAL	GENE-N	2	2	chemical bound to the chemical-insensitive sites monophasically with a high affinity ( pK ( d ) ; 9.1+/-0.08 , n=8 ) , and the B ( max ) value ( 814+/-204 fmol mg ( -1 ) protein , n=8 ) was more than ten times that of the chemical-sensitive gene ( pK ( d ) =9.9+/-0.13 , B ( max ) =66+/-23 fmol mg ( -1 ) protein , n=7 ) .	T29	T45	12827214
NA	CHEMICAL	GENE-N	2	2	chemical bound to the chemical-insensitive sites monophasically with a high affinity ( pK ( d ) ; 9.1+/-0.08 , n=8 ) , and the B ( max ) value ( 814+/-204 fmol mg ( -1 ) protein , n=8 ) was more than ten times that of the chemical-sensitive gene ( pK ( d ) =9.9+/-0.13 , B ( max ) =66+/-23 fmol mg ( -1 ) protein , n=7 ) .	T30	T45	12827214
CPR:6	CHEMICAL	GENE-N	6	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T36	T46	12827214
NA	CHEMICAL	GENE-N	6	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T36	T40	12827214
CPR:6	CHEMICAL	GENE-N	8	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T37	T46	12827214
NA	CHEMICAL	GENE-N	8	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T37	T40	12827214
CPR:6	CHEMICAL	GENE-N	10	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T38	T46	12827214
NA	CHEMICAL	GENE-N	10	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T38	T40	12827214
NA	CHEMICAL	GENE-N	18	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T1	T46	12827214
NA	CHEMICAL	GENE-N	18	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T1	T40	12827214
NA	CHEMICAL	GENE-N	18	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T2	T46	12827214
NA	CHEMICAL	GENE-N	18	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T2	T40	12827214
NA	CHEMICAL	GENE-N	6	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T3	T46	12827214
NA	CHEMICAL	GENE-N	6	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T3	T40	12827214
NA	CHEMICAL	GENE-N	3	3	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T4	T46	12827214
NA	CHEMICAL	GENE-N	3	5	However , other gene antagonists ( chemical , chemical and chemical ) did not inhibit the binding at a range of concentrations that generally exhibit gene antagonism , and chemical , chemical and chemical were without effect on the chemical binding .	T4	T40	12827214
NA	CHEMICAL	GENE-N	9	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T5	T41	12827214
NA	CHEMICAL	GENE-N	11	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T6	T41	12827214
NA	CHEMICAL	GENE-N	13	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T7	T41	12827214
NA	CHEMICAL	GENE-N	17	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T8	T41	12827214
NA	CHEMICAL	GENE-N	21	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T9	T41	12827214
NA	CHEMICAL	GENE-N	23	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T10	T41	12827214
NA	CHEMICAL	GENE-N	25	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T11	T41	12827214
NA	CHEMICAL	GENE-N	10	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T12	T41	12827214
NA	CHEMICAL	GENE-N	32	10	On the other hand , ligands for the renal chemical-transporter ( chemical and chemical ) and for chemical recognition sites ( chemical , chemical and chemical ) displaced the binding of chemical to chemical-insensitive sites at micromolar concentrations .	T13	T41	12827214
NA	CHEMICAL	GENE-N	3	12	Photoaffinity labeling with chemical showed chemical-insensitive labeling at around 100 kDa , a molecular size larger than that of gene expressed in 293 cells ( 50-60 and 70-80 kDa , respectively ) on electrophoresis .	T14	T43	12827214
NA	CHEMICAL	GENE-N	5	12	Photoaffinity labeling with chemical showed chemical-insensitive labeling at around 100 kDa , a molecular size larger than that of gene expressed in 293 cells ( 50-60 and 70-80 kDa , respectively ) on electrophoresis .	T15	T43	12827214
NA	CHEMICAL	GENE-N	7	5	In contrast , there was no detectable chemical-insensitive binding site but were chemical-sensitive gene in human liver ( pK ( d ) =10.0+/-0.06 , B ( max ) =44+/-6 fmol mg ( -1 ) protein , n=3 ) .	T17	T44	12827214
NA	CHEMICAL	GENE-N	12	5	In contrast , there was no detectable chemical-insensitive binding site but were chemical-sensitive gene in human liver ( pK ( d ) =10.0+/-0.06 , B ( max ) =44+/-6 fmol mg ( -1 ) protein , n=3 ) .	T18	T44	12827214
NA	CHEMICAL	GENE-N	4	1	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T8	23299080
NA	CHEMICAL	GENE-Y	4	2	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T5	23299080
NA	CHEMICAL	GENE-Y	4	4	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T12	23299080
NA	CHEMICAL	GENE-Y	4	9	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T13	23299080
NA	CHEMICAL	GENE-Y	4	8	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T18	23299080
NA	CHEMICAL	GENE-Y	4	9	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T19	23299080
NA	CHEMICAL	GENE-Y	4	17	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T1	T4	23299080
NA	CHEMICAL	GENE-N	7	1	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T8	23299080
NA	CHEMICAL	GENE-Y	7	2	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T5	23299080
NA	CHEMICAL	GENE-Y	7	4	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T12	23299080
NA	CHEMICAL	GENE-Y	7	9	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T13	23299080
NA	CHEMICAL	GENE-Y	7	8	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T18	23299080
NA	CHEMICAL	GENE-Y	7	9	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T19	23299080
NA	CHEMICAL	GENE-Y	7	17	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T2	T4	23299080
NA	CHEMICAL	GENE-N	14	1	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T8	23299080
NA	CHEMICAL	GENE-Y	14	2	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T5	23299080
NA	CHEMICAL	GENE-Y	14	4	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T12	23299080
NA	CHEMICAL	GENE-Y	14	9	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T13	23299080
NA	CHEMICAL	GENE-Y	14	8	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T18	23299080
NA	CHEMICAL	GENE-Y	14	9	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T19	23299080
NA	CHEMICAL	GENE-Y	14	17	The gene gene ( gene ) , chemical X receptor ( gene ) and chemical receptor ( gene ) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters .	T3	T4	23299080
NA	CHEMICAL	GENE-Y	2	4	Effects of chemical on gene-mediated fulminant hepatitis in mice .	T12	T23	15665864
NA	CHEMICAL	GENE-Y	5	19	We investigated the effects of chemical on fulminant hepatitis in C57BL/6J mice induced by lethal challenge of the activating anti-gene antibody , Jo2 .	T5	T20	15665864
NA	CHEMICAL	GENE-N	15	15	Intraperitoneal injection of Jo2 ( 0.6 microg g ( -1 ) ) to mice resulted in fulminant hepatitis , as evidenced by increase of gene activities and histopathological alterations in liver sections , as well as animal death .	T7	T21	15665864
NA	CHEMICAL	GENE-N	19	15	Intraperitoneal injection of Jo2 ( 0.6 microg g ( -1 ) ) to mice resulted in fulminant hepatitis , as evidenced by increase of gene activities and histopathological alterations in liver sections , as well as animal death .	T8	T21	15665864
NA	CHEMICAL	GENE-N	4	3	Jo2-induced activation of gene in liver tissues was inhibited by chemical pretreatment , and yet the direct addition of chemical to liver extracts from Jo2-challenged mice failed to block gene activation in vitro .	T11	T22	15665864
NA	CHEMICAL	GENE-N	4	29	Jo2-induced activation of gene in liver tissues was inhibited by chemical pretreatment , and yet the direct addition of chemical to liver extracts from Jo2-challenged mice failed to block gene activation in vitro .	T11	T13	15665864
NA	CHEMICAL	GENE-N	4	3	Jo2-induced activation of gene in liver tissues was inhibited by chemical pretreatment , and yet the direct addition of chemical to liver extracts from Jo2-challenged mice failed to block gene activation in vitro .	T1	T22	15665864
NA	CHEMICAL	GENE-N	4	29	Jo2-induced activation of gene in liver tissues was inhibited by chemical pretreatment , and yet the direct addition of chemical to liver extracts from Jo2-challenged mice failed to block gene activation in vitro .	T1	T13	15665864
CPR:4	CHEMICAL	GENE-Y	2	8	Moreover , chemical efficiently suppressed the release of gene from mitochondria of the liver tissues from Jo2-challenged mice .	T2	T14	15665864
NA	CHEMICAL	GENE-Y	15	3	In contrast , gene activation and gene truncation triggered by Jo2 were not diminished by chemical pretreatment in mouse livers .	T3	T15	15665864
NA	CHEMICAL	GENE-Y	15	6	In contrast , gene activation and gene truncation triggered by Jo2 were not diminished by chemical pretreatment in mouse livers .	T3	T16	15665864
NA	CHEMICAL	GENE-Y	2	5	Stoichiometry of chemical binding to gene measured by the disassembly of gene : gene microtubules .	T6	T16	2125244
NA	CHEMICAL	GENE-Y	2	11	Stoichiometry of chemical binding to gene measured by the disassembly of gene : gene microtubules .	T6	T17	2125244
NA	CHEMICAL	GENE-N	2	13	Stoichiometry of chemical binding to gene measured by the disassembly of gene : gene microtubules .	T6	T15	2125244
CPR:4	CHEMICAL	GENE-Y	3	15	The concentration of chemical required to inhibit the assembly or to induce the disassembly of gene : gene microtubules is markedly dependent upon the microtubule protein concentration .	T1	T7	2125244
CPR:4	CHEMICAL	GENE-N	3	17	The concentration of chemical required to inhibit the assembly or to induce the disassembly of gene : gene microtubules is markedly dependent upon the microtubule protein concentration .	T1	T8	2125244
NA	CHEMICAL	GENE-N	6	8	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T2	T9	2125244
NA	CHEMICAL	GENE-Y	6	12	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T2	T10	2125244
NA	CHEMICAL	GENE-Y	6	16	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T2	T11	2125244
NA	CHEMICAL	GENE-N	21	8	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T3	T9	2125244
NA	CHEMICAL	GENE-Y	21	12	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T3	T10	2125244
NA	CHEMICAL	GENE-Y	21	16	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T3	T11	2125244
NA	CHEMICAL	GENE-N	35	8	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T4	T9	2125244
NA	CHEMICAL	GENE-Y	35	12	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T4	T10	2125244
NA	CHEMICAL	GENE-Y	35	16	Analysis of this relationship shows that chemical and gene compete for common gene sites , that gene can bind 5-6 moles.mole-1 chemical , and that the Kd of these sites is congruent to 20 microM chemical .	T4	T11	2125244
NA	CHEMICAL	GENE-N	3	4	The activities of chemical dismutase , gene and chemical peroxidase were found significantly higher in combined treated than untreated rats .	T7	T24	22287617
NA	CHEMICAL	GENE-Y	3	6	The activities of chemical dismutase , gene and chemical peroxidase were found significantly higher in combined treated than untreated rats .	T7	T25	22287617
NA	CHEMICAL	GENE-N	3	9	The activities of chemical dismutase , gene and chemical peroxidase were found significantly higher in combined treated than untreated rats .	T7	T26	22287617
NA	CHEMICAL	GENE-N	8	4	The activities of chemical dismutase , gene and chemical peroxidase were found significantly higher in combined treated than untreated rats .	T8	T24	22287617
NA	CHEMICAL	GENE-Y	8	6	The activities of chemical dismutase , gene and chemical peroxidase were found significantly higher in combined treated than untreated rats .	T8	T25	22287617
NA	CHEMICAL	GENE-N	8	9	The activities of chemical dismutase , gene and chemical peroxidase were found significantly higher in combined treated than untreated rats .	T8	T26	22287617
NA	CHEMICAL	GENE-N	7	16	In vitro binding studies showed that both chemical and chemical interact in the nanomolar range with gene receptors labelled by chemical in cortical membranes .	T5	T23	1666997
NA	CHEMICAL	GENE-N	9	16	In vitro binding studies showed that both chemical and chemical interact in the nanomolar range with gene receptors labelled by chemical in cortical membranes .	T6	T23	1666997
NA	CHEMICAL	GENE-N	11	16	In vitro binding studies showed that both chemical and chemical interact in the nanomolar range with gene receptors labelled by chemical in cortical membranes .	T7	T23	1666997
NA	CHEMICAL	GENE-Y	4	14	By contrast , neither chemical nor chemical can be considered as possible ligands of gene and gene receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	T9	T24	1666997
NA	CHEMICAL	GENE-Y	4	16	By contrast , neither chemical nor chemical can be considered as possible ligands of gene and gene receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	T9	T25	1666997
NA	CHEMICAL	GENE-Y	6	14	By contrast , neither chemical nor chemical can be considered as possible ligands of gene and gene receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	T10	T24	1666997
NA	CHEMICAL	GENE-Y	6	16	By contrast , neither chemical nor chemical can be considered as possible ligands of gene and gene receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	T10	T25	1666997
NA	CHEMICAL	GENE-N	2	15	Interestingly , chemical binds with a good affinity ( IC50 = 0.30 microM ) to gene receptors labelled by chemical in cortical membranes .	T12	T26	1666997
NA	CHEMICAL	GENE-N	5	15	Interestingly , chemical binds with a good affinity ( IC50 = 0.30 microM ) to gene receptors labelled by chemical in cortical membranes .	T13	T26	1666997
NA	CHEMICAL	GENE-N	9	4	Complementary experiments using the gene-dependent Bezold-Jarisch reflex confirmed that chemical really acts in vivo as a gene antagonist ( IC50 = 50 micrograms/kg i.v .	T14	T27	1666997
CPR:6	CHEMICAL	GENE-N	9	16	Complementary experiments using the gene-dependent Bezold-Jarisch reflex confirmed that chemical really acts in vivo as a gene antagonist ( IC50 = 50 micrograms/kg i.v .	T14	T28	1666997
NA	CHEMICAL	GENE-N	3	8	) , whereas chemical is essentially inactive on gene receptors .	T15	T29	1666997
NA	CHEMICAL	GENE-N	12	14	The second part of this study consisted of looking for possible changes in central gene 24 h after either a single or a repeated ( for 14 days ) treatment with chemical ( 10 mg/kg i.p .	T1	T18	1666997
NA	CHEMICAL	GENE-N	4	0	gene phosphorylates gene at chemical-26 ( chemical26 ) and primes it for inactivation .	T1	T23	23332762
NA	CHEMICAL	GENE-Y	4	2	gene phosphorylates gene at chemical-26 ( chemical26 ) and primes it for inactivation .	T1	T24	23332762
NA	CHEMICAL	GENE-N	0	0	gene phosphorylates gene at chemical-26 ( chemical26 ) and primes it for inactivation .	T2	T23	23332762
NA	CHEMICAL	GENE-Y	0	2	gene phosphorylates gene at chemical-26 ( chemical26 ) and primes it for inactivation .	T2	T24	23332762
NA	CHEMICAL	GENE-Y	2	5	Elimination of chemical26 phosphorylation promotes gene proapoptotic activity , thereby accelerating gene-induced apoptosis in cultured cells and increasing mortality in animals .	T3	T25	23332762
NA	CHEMICAL	GENE-Y	2	11	Elimination of chemical26 phosphorylation promotes gene proapoptotic activity , thereby accelerating gene-induced apoptosis in cultured cells and increasing mortality in animals .	T3	T26	23332762
NA	CHEMICAL	GENE-N	0	4	chemical induced apoptotic changes in neural stem cells : amelioration by gene support .	T15	T32	23261589
NA	CHEMICAL	GENE-N	8	17	In this study we explored the toxicity of chemical toward NSCs focusing on apoptosis and status of gene survival signaling .	T14	T31	23261589
CPR:4	CHEMICAL	GENE-N	0	5	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T19	23261589
CPR:4	CHEMICAL	GENE-N	0	12	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T20	23261589
CPR:4	CHEMICAL	GENE-Y	0	14	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T21	23261589
CPR:4	CHEMICAL	GENE-Y	0	16	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T22	23261589
CPR:4	CHEMICAL	GENE-N	0	18	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T23	23261589
CPR:4	CHEMICAL	GENE-Y	0	19	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T24	23261589
CPR:4	CHEMICAL	GENE-Y	0	21	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T25	23261589
CPR:4	CHEMICAL	GENE-N	0	24	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T26	23261589
CPR:4	CHEMICAL	GENE-N	0	24	chemical toxicity coincided with reduced gene level and its downstream effectors : gene , gene , gene and gene gene , gene suggesting repressed gene/gene signaling .	T5	T27	23261589
NA	CHEMICAL	GENE-N	22	25	Multiple neurotrophic factor support in the form of Olfactory Ensheathing Cell 's Conditioned Media ( OEC CM ) potentially protected NSCs against chemical through activating gene/gene pathway .	T7	T28	23261589
NA	CHEMICAL	GENE-N	22	25	Multiple neurotrophic factor support in the form of Olfactory Ensheathing Cell 's Conditioned Media ( OEC CM ) potentially protected NSCs against chemical through activating gene/gene pathway .	T7	T29	23261589
CPR:4	CHEMICAL	GENE-N	5	7	This was confirmed on adding chemical the gene inhibitor which abolished the protection .	T8	T30	23261589
NA	CHEMICAL	GENE-Y	0	2	chemical suppression in humans by the orally active gene inhibitor chemical ( chemical ) : comparison with chemical .	T27	T48	11799102
CPR:4	CHEMICAL	GENE-Y	10	2	chemical suppression in humans by the orally active gene inhibitor chemical ( chemical ) : comparison with chemical .	T29	T48	11799102
CPR:4	CHEMICAL	GENE-Y	12	2	chemical suppression in humans by the orally active gene inhibitor chemical ( chemical ) : comparison with chemical .	T30	T48	11799102
NA	CHEMICAL	GENE-Y	17	2	chemical suppression in humans by the orally active gene inhibitor chemical ( chemical ) : comparison with chemical .	T28	T48	11799102
NA	CHEMICAL	GENE-Y	6	0	gene is the main determinant of chemical levels .	T19	T31	11799102
CPR:4	CHEMICAL	GENE-Y	9	7	We tested the new orally active nonpeptidic gene inhibitor chemical ( chemical , an chemical with a 50 % inhibitory concentration [ IC50 ] in the low nanomolar range ) in 18 healthy volunteers on a constant 100 mmol/d chemical diet using a double-blind , 3-way crossover protocol .	T16	T42	11799102
CPR:4	CHEMICAL	GENE-Y	11	7	We tested the new orally active nonpeptidic gene inhibitor chemical ( chemical , an chemical with a 50 % inhibitory concentration [ IC50 ] in the low nanomolar range ) in 18 healthy volunteers on a constant 100 mmol/d chemical diet using a double-blind , 3-way crossover protocol .	T17	T42	11799102
CPR:4	CHEMICAL	GENE-Y	13	7	We tested the new orally active nonpeptidic gene inhibitor chemical ( chemical , an chemical with a 50 % inhibitory concentration [ IC50 ] in the low nanomolar range ) in 18 healthy volunteers on a constant 100 mmol/d chemical diet using a double-blind , 3-way crossover protocol .	T18	T42	11799102
NA	CHEMICAL	GENE-Y	39	7	We tested the new orally active nonpeptidic gene inhibitor chemical ( chemical , an chemical with a 50 % inhibitory concentration [ IC50 ] in the low nanomolar range ) in 18 healthy volunteers on a constant 100 mmol/d chemical diet using a double-blind , 3-way crossover protocol .	T20	T42	11799102
NA	CHEMICAL	GENE-Y	10	5	There was a dose-dependent decrease in plasma gene activity , chemical , and geneI following single doses of chemical starting with 40 mg .	T24	T44	11799102
NA	CHEMICAL	GENE-Y	10	13	There was a dose-dependent decrease in plasma gene activity , chemical , and geneI following single doses of chemical starting with 40 mg .	T24	T45	11799102
CPR:4	CHEMICAL	GENE-Y	18	5	There was a dose-dependent decrease in plasma gene activity , chemical , and geneI following single doses of chemical starting with 40 mg .	T26	T44	11799102
CPR:4	CHEMICAL	GENE-Y	18	13	There was a dose-dependent decrease in plasma gene activity , chemical , and geneI following single doses of chemical starting with 40 mg .	T26	T45	11799102
CPR:4	CHEMICAL	GENE-Y	13	13	Inhibition was still marked and significant after repeated dosing with maximal decreases in gene levels by 89 % and 75 % on Days 1 and 8 , respectively , when the highest dose of chemical was compared with placebo .	T3	T32	11799102
CPR:3	CHEMICAL	GENE-Y	19	8	At the same time , mean plasma active gene was increased 16- and 34-fold at the highest dose of chemical .	T4	T34	11799102
CPR:4	CHEMICAL	GENE-Y	6	4	In conclusion , the gene inhibitor chemical dose-dependently decreases gene levels in humans following oral administration .	T11	T37	11799102
CPR:4	CHEMICAL	GENE-Y	6	9	In conclusion , the gene inhibitor chemical dose-dependently decreases gene levels in humans following oral administration .	T11	T38	11799102
NA	CHEMICAL	GENE-N	5	7	Effect of the Potent Antiviral chemical on gene Production by Murine Macrophages Stimulated with HSV-2 .	T12	T21	23512754
NA	CHEMICAL	GENE-N	4	21	The antiherpetic action of chemical was measured by plaque reduction assay , and the immunomodulatory effect was determined by measuring the gene production using a bioassay and ELISA method .	T8	T16	23512754
CPR:3	CHEMICAL	GENE-Y	17	5	In macrophages , levels of gene , gene , NO , gene and gene were increased by chemical used alone or in combination with HSV-2 .	T11	T17	23512754
CPR:3	CHEMICAL	GENE-Y	17	7	In macrophages , levels of gene , gene , NO , gene and gene were increased by chemical used alone or in combination with HSV-2 .	T11	T18	23512754
CPR:3	CHEMICAL	GENE-Y	17	11	In macrophages , levels of gene , gene , NO , gene and gene were increased by chemical used alone or in combination with HSV-2 .	T11	T19	23512754
CPR:3	CHEMICAL	GENE-Y	17	13	In macrophages , levels of gene , gene , NO , gene and gene were increased by chemical used alone or in combination with HSV-2 .	T11	T20	23512754
CPR:3	CHEMICAL	GENE-Y	2	6	Besides , chemical not only synergized gene production combined with gene , but also prolonged its expression in time .	T1	T13	23512754
CPR:3	CHEMICAL	GENE-Y	2	10	Besides , chemical not only synergized gene production combined with gene , but also prolonged its expression in time .	T1	T14	23512754
NA	CHEMICAL	GENE-N	20	11	The accuracy of DNA synthesis depends on the accuracy of the gene as well as the quality and concentration ( s ) of the available chemical DNA precursors ( chemical ) .	T3	T23	23218950
NA	CHEMICAL	GENE-N	20	11	The accuracy of DNA synthesis depends on the accuracy of the gene as well as the quality and concentration ( s ) of the available chemical DNA precursors ( chemical ) .	T7	T23	23218950
NA	CHEMICAL	GENE-Y	5	4	These strains , defective in chemical deaminase and chemical kinase , respectively , are characterized by both disturbances of chemical pools and a mutator phenotype .	T9	T21	23218950
NA	CHEMICAL	GENE-Y	5	4	These strains , defective in chemical deaminase and chemical kinase , respectively , are characterized by both disturbances of chemical pools and a mutator phenotype .	T9	T22	23218950
NA	CHEMICAL	GENE-Y	8	4	These strains , defective in chemical deaminase and chemical kinase , respectively , are characterized by both disturbances of chemical pools and a mutator phenotype .	T10	T21	23218950
NA	CHEMICAL	GENE-Y	8	4	These strains , defective in chemical deaminase and chemical kinase , respectively , are characterized by both disturbances of chemical pools and a mutator phenotype .	T10	T22	23218950
NA	CHEMICAL	GENE-Y	19	4	These strains , defective in chemical deaminase and chemical kinase , respectively , are characterized by both disturbances of chemical pools and a mutator phenotype .	T11	T21	23218950
NA	CHEMICAL	GENE-Y	19	4	These strains , defective in chemical deaminase and chemical kinase , respectively , are characterized by both disturbances of chemical pools and a mutator phenotype .	T11	T22	23218950
NA	CHEMICAL	GENE-Y	11	3	We show that gene strains suffer from increased intracellular levels of chemical ( 4-fold ) and reduced levels of chemical ( 2-fold ) , while displaying , as measured using a set of lacZ reversion markers in a mismatch-repair defective ( mutL ) background , a strong mutator effect for gene and gene transversions ( 27- and 42-fold enhancement , respectively ) .	T12	T25	23218950
NA	CHEMICAL	GENE-N	11	50	We show that gene strains suffer from increased intracellular levels of chemical ( 4-fold ) and reduced levels of chemical ( 2-fold ) , while displaying , as measured using a set of lacZ reversion markers in a mismatch-repair defective ( mutL ) background , a strong mutator effect for gene and gene transversions ( 27- and 42-fold enhancement , respectively ) .	T12	T14	23218950
NA	CHEMICAL	GENE-N	11	52	We show that gene strains suffer from increased intracellular levels of chemical ( 4-fold ) and reduced levels of chemical ( 2-fold ) , while displaying , as measured using a set of lacZ reversion markers in a mismatch-repair defective ( mutL ) background , a strong mutator effect for gene and gene transversions ( 27- and 42-fold enhancement , respectively ) .	T12	T15	23218950
NA	CHEMICAL	GENE-Y	19	3	We show that gene strains suffer from increased intracellular levels of chemical ( 4-fold ) and reduced levels of chemical ( 2-fold ) , while displaying , as measured using a set of lacZ reversion markers in a mismatch-repair defective ( mutL ) background , a strong mutator effect for gene and gene transversions ( 27- and 42-fold enhancement , respectively ) .	T13	T25	23218950
NA	CHEMICAL	GENE-N	19	50	We show that gene strains suffer from increased intracellular levels of chemical ( 4-fold ) and reduced levels of chemical ( 2-fold ) , while displaying , as measured using a set of lacZ reversion markers in a mismatch-repair defective ( mutL ) background , a strong mutator effect for gene and gene transversions ( 27- and 42-fold enhancement , respectively ) .	T13	T14	23218950
NA	CHEMICAL	GENE-N	19	52	We show that gene strains suffer from increased intracellular levels of chemical ( 4-fold ) and reduced levels of chemical ( 2-fold ) , while displaying , as measured using a set of lacZ reversion markers in a mismatch-repair defective ( mutL ) background , a strong mutator effect for gene and gene transversions ( 27- and 42-fold enhancement , respectively ) .	T13	T15	23218950
NA	CHEMICAL	GENE-Y	3	3	In contrast , gene strains possess a lowered chemical level ( 4-fold ) and modestly enhanced chemical level ( 2-fold ) , while its mutator effect is specific for just the gene transversions .	T1	T16	23218950
NA	CHEMICAL	GENE-N	3	31	In contrast , gene strains possess a lowered chemical level ( 4-fold ) and modestly enhanced chemical level ( 2-fold ) , while its mutator effect is specific for just the gene transversions .	T1	T17	23218950
NA	CHEMICAL	GENE-Y	16	3	In contrast , gene strains possess a lowered chemical level ( 4-fold ) and modestly enhanced chemical level ( 2-fold ) , while its mutator effect is specific for just the gene transversions .	T2	T16	23218950
NA	CHEMICAL	GENE-N	16	31	In contrast , gene strains possess a lowered chemical level ( 4-fold ) and modestly enhanced chemical level ( 2-fold ) , while its mutator effect is specific for just the gene transversions .	T2	T17	23218950
CPR:3	CHEMICAL	GENE-Y	0	7	chemical stimulates Th17 differentiation enhancing phosphorylation of gene and gene to worsen experimental autoimmune encephalomyelitis .	T14	T29	23639249
CPR:3	CHEMICAL	GENE-Y	0	9	chemical stimulates Th17 differentiation enhancing phosphorylation of gene and gene to worsen experimental autoimmune encephalomyelitis .	T14	T30	23639249
CPR:3	CHEMICAL	GENE-Y	19	16	In the present study , using in vitro Th17 differentiation model , we examined effects of gene activation by chemical ( chemical ) , a uremic toxin , on Th17 differentiation and investigated underlying mechanisms .	T4	T18	23639249
CPR:3	CHEMICAL	GENE-Y	21	16	In the present study , using in vitro Th17 differentiation model , we examined effects of gene activation by chemical ( chemical ) , a uremic toxin , on Th17 differentiation and investigated underlying mechanisms .	T5	T18	23639249
CPR:3	CHEMICAL	GENE-Y	0	4	chemical increased expression of gene , the master transcription factor for Th17 differentiation , and stimulated Th17 differentiation , in a comparative manner as chemical ( chemical ) , a prototypical gene ligand .	T6	T19	23639249
NA	CHEMICAL	GENE-Y	0	31	chemical increased expression of gene , the master transcription factor for Th17 differentiation , and stimulated Th17 differentiation , in a comparative manner as chemical ( chemical ) , a prototypical gene ligand .	T6	T20	23639249
NA	CHEMICAL	GENE-Y	5	4	chemical increased expression of gene , the master transcription factor for Th17 differentiation , and stimulated Th17 differentiation , in a comparative manner as chemical ( chemical ) , a prototypical gene ligand .	T7	T19	23639249
NA	CHEMICAL	GENE-Y	5	31	chemical increased expression of gene , the master transcription factor for Th17 differentiation , and stimulated Th17 differentiation , in a comparative manner as chemical ( chemical ) , a prototypical gene ligand .	T7	T20	23639249
NA	CHEMICAL	GENE-Y	26	4	chemical increased expression of gene , the master transcription factor for Th17 differentiation , and stimulated Th17 differentiation , in a comparative manner as chemical ( chemical ) , a prototypical gene ligand .	T8	T19	23639249
NA	CHEMICAL	GENE-Y	26	31	chemical increased expression of gene , the master transcription factor for Th17 differentiation , and stimulated Th17 differentiation , in a comparative manner as chemical ( chemical ) , a prototypical gene ligand .	T8	T20	23639249
CPR:3	CHEMICAL	GENE-Y	24	2	Activation of gene , which is phosphorylated by the gene signaling pathways and thus is necessary for Th17 differentiation , was strongly stimulated by chemical and chemical .	T9	T21	23639249
CPR:3	CHEMICAL	GENE-Y	24	9	Activation of gene , which is phosphorylated by the gene signaling pathways and thus is necessary for Th17 differentiation , was strongly stimulated by chemical and chemical .	T9	T22	23639249
CPR:3	CHEMICAL	GENE-Y	26	2	Activation of gene , which is phosphorylated by the gene signaling pathways and thus is necessary for Th17 differentiation , was strongly stimulated by chemical and chemical .	T10	T21	23639249
CPR:3	CHEMICAL	GENE-Y	26	9	Activation of gene , which is phosphorylated by the gene signaling pathways and thus is necessary for Th17 differentiation , was strongly stimulated by chemical and chemical .	T10	T22	23639249
CPR:3	CHEMICAL	GENE-Y	18	2	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T23	23639249
NA	CHEMICAL	GENE-Y	18	11	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T24	23639249
NA	CHEMICAL	GENE-Y	18	25	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T25	23639249
NA	CHEMICAL	GENE-Y	18	36	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T27	23639249
NA	CHEMICAL	GENE-Y	18	38	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T28	23639249
NA	CHEMICAL	GENE-Y	18	60	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T15	23639249
NA	CHEMICAL	GENE-Y	18	66	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T11	T16	23639249
CPR:3	CHEMICAL	GENE-Y	20	2	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T23	23639249
NA	CHEMICAL	GENE-Y	20	11	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T24	23639249
NA	CHEMICAL	GENE-Y	20	25	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T25	23639249
NA	CHEMICAL	GENE-Y	20	36	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T27	23639249
NA	CHEMICAL	GENE-Y	20	38	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T28	23639249
NA	CHEMICAL	GENE-Y	20	60	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T15	23639249
NA	CHEMICAL	GENE-Y	20	66	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T12	T16	23639249
NA	CHEMICAL	GENE-Y	3	2	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T23	23639249
NA	CHEMICAL	GENE-Y	3	11	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T24	23639249
CPR:4	CHEMICAL	GENE-Y	3	25	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T25	23639249
CPR:4	CHEMICAL	GENE-Y	3	36	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T27	23639249
CPR:4	CHEMICAL	GENE-Y	3	38	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T28	23639249
NA	CHEMICAL	GENE-Y	3	60	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T15	23639249
NA	CHEMICAL	GENE-Y	3	66	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T13	T16	23639249
NA	CHEMICAL	GENE-Y	18	2	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T23	23639249
NA	CHEMICAL	GENE-Y	18	11	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T24	23639249
NA	CHEMICAL	GENE-Y	18	25	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T25	23639249
NA	CHEMICAL	GENE-Y	18	36	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T27	23639249
NA	CHEMICAL	GENE-Y	18	38	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T28	23639249
CPR:3	CHEMICAL	GENE-Y	18	60	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T15	23639249
CPR:3	CHEMICAL	GENE-Y	18	66	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T1	T16	23639249
NA	CHEMICAL	GENE-Y	2	2	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T23	23639249
NA	CHEMICAL	GENE-Y	2	11	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T24	23639249
NA	CHEMICAL	GENE-Y	2	25	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T25	23639249
NA	CHEMICAL	GENE-Y	2	36	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T27	23639249
NA	CHEMICAL	GENE-Y	2	38	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T28	23639249
CPR:3	CHEMICAL	GENE-Y	2	60	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T15	23639249
CPR:3	CHEMICAL	GENE-Y	2	66	Phosphorylation of gene , which was shown to be activated by gene ligands , was also increased by chemical and chemical , and blocking of gene activity by chemical ( PP2 ) inhibited phosphorylation of both gene and gene , raising a possibility that stimulatory activities of chemical and chemical on Th17 differentiation could be exerted via increased phosphorylation of gene , which in turn stimulates gene activation .	T2	T16	23639249
CPR:6	CHEMICAL	GENE-Y	6	9	We also examined the effects of chemical , a gene antagonist , in parallel .	T5	T18	1329582
NA	CHEMICAL	GENE-Y	22	1	The in vivo blood level and tissue distribution studies in albino rats also demonstrated potential of dual targeted system towards gene and chemical receptors .	T3	T23	23298577
NA	CHEMICAL	GENE-N	22	23	The in vivo blood level and tissue distribution studies in albino rats also demonstrated potential of dual targeted system towards gene and chemical receptors .	T3	T24	23298577
NA	CHEMICAL	GENE-N	13	11	RESULTS : We first showed that expression of the genes encoding gene and gene decreased between E13.5 and E17.5 .	T1	T27	17221210
NA	CHEMICAL	GENE-Y	13	13	RESULTS : We first showed that expression of the genes encoding gene and gene decreased between E13.5 and E17.5 .	T1	T10	17221210
NA	CHEMICAL	GENE-N	8	0	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T11	17221210
NA	CHEMICAL	GENE-Y	8	25	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T12	17221210
NA	CHEMICAL	GENE-Y	8	27	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T13	17221210
NA	CHEMICAL	GENE-Y	8	30	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T14	17221210
NA	CHEMICAL	GENE-Y	8	32	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T15	17221210
NA	CHEMICAL	GENE-Y	8	37	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T16	17221210
NA	CHEMICAL	GENE-Y	8	40	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T17	17221210
NA	CHEMICAL	GENE-Y	8	42	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T18	17221210
NA	CHEMICAL	GENE-Y	8	47	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T19	17221210
NA	CHEMICAL	GENE-Y	8	50	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T20	17221210
NA	CHEMICAL	GENE-Y	8	10	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T21	17221210
NA	CHEMICAL	GENE-Y	8	59	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T5	T22	17221210
NA	CHEMICAL	GENE-N	57	0	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T11	17221210
NA	CHEMICAL	GENE-Y	57	25	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T12	17221210
NA	CHEMICAL	GENE-Y	57	27	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T13	17221210
NA	CHEMICAL	GENE-Y	57	30	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T14	17221210
NA	CHEMICAL	GENE-Y	57	32	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T15	17221210
NA	CHEMICAL	GENE-Y	57	37	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T16	17221210
NA	CHEMICAL	GENE-Y	57	40	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T17	17221210
NA	CHEMICAL	GENE-Y	57	42	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T18	17221210
NA	CHEMICAL	GENE-Y	57	47	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T19	17221210
NA	CHEMICAL	GENE-Y	57	50	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T20	17221210
NA	CHEMICAL	GENE-Y	57	10	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T21	17221210
NA	CHEMICAL	GENE-Y	57	59	gene-positive cells that developed in the presence of chemical exhibited a phenotype of mature cells with regard to the expression of the following genes : gene ( gene ) , gene ( gene ; previously known as gene ) , gene ( gene ; previously known as gene ) and gene ( gene ; previously known as chemical transporter 2 ) .	T6	T22	17221210
CPR:3	CHEMICAL	GENE-Y	0	10	chemical , popularly known for its cooling effect , activates gene -- a cold-activated gene .	T1	T10	16829128
CPR:3	CHEMICAL	GENE-N	0	12	chemical , popularly known for its cooling effect , activates gene -- a cold-activated gene .	T1	T11	16829128
NA	CHEMICAL	GENE-Y	10	27	However , human physiological studies demonstrate a paradoxical role of chemical in modulation of warm sensation , and here , we show that chemical also activates heat-activated gene .	T2	T12	16829128
CPR:3	CHEMICAL	GENE-Y	23	27	However , human physiological studies demonstrate a paradoxical role of chemical in modulation of warm sensation , and here , we show that chemical also activates heat-activated gene .	T3	T12	16829128
CPR:4	CHEMICAL	GENE-Y	4	6	We further show that chemical inhibits gene , potentially explaining the use of chemical as an analgesic .	T4	T13	16829128
NA	CHEMICAL	GENE-Y	13	6	We further show that chemical inhibits gene , potentially explaining the use of chemical as an analgesic .	T5	T13	16829128
CPR:3	CHEMICAL	GENE-Y	2	16	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T6	T14	16829128
CPR:3	CHEMICAL	GENE-Y	2	18	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T6	T15	16829128
NA	CHEMICAL	GENE-N	2	25	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T6	T16	16829128
CPR:3	CHEMICAL	GENE-Y	5	16	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T7	T14	16829128
CPR:3	CHEMICAL	GENE-Y	5	18	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T7	T15	16829128
NA	CHEMICAL	GENE-N	5	25	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T7	T16	16829128
CPR:3	CHEMICAL	GENE-Y	7	16	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T8	T14	16829128
CPR:3	CHEMICAL	GENE-Y	7	18	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T8	T15	16829128
NA	CHEMICAL	GENE-N	7	25	Similar to chemical , both chemical and chemical ( initially reported to be specific activators of gene and gene , respectively ) also modulate other gene .	T8	T16	16829128
NA	CHEMICAL	GENE-N	12	9	BMMs are the major source of inflammatory factors and gene , including chemical protease gene ( gene ) .	T1	T2	22614014
NA	CHEMICAL	GENE-N	12	13	BMMs are the major source of inflammatory factors and gene , including chemical protease gene ( gene ) .	T1	T3	22614014
NA	CHEMICAL	GENE-Y	12	14	BMMs are the major source of inflammatory factors and gene , including chemical protease gene ( gene ) .	T1	T4	22614014
NA	CHEMICAL	GENE-Y	12	16	BMMs are the major source of inflammatory factors and gene , including chemical protease gene ( gene ) .	T1	T5	22614014
NA	CHEMICAL	GENE-Y	2	4	Neuroparalysis and chemical efficacy in chemical poisoning : a study of gene .	T9	T19	11393267
NA	CHEMICAL	GENE-Y	5	4	Neuroparalysis and chemical efficacy in chemical poisoning : a study of gene .	T10	T19	11393267
NA	CHEMICAL	GENE-Y	11	4	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T6	T14	11393267
NA	CHEMICAL	GENE-Y	11	6	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T6	T16	11393267
CPR:3	CHEMICAL	GENE-Y	11	12	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T6	T18	11393267
NA	CHEMICAL	GENE-Y	16	4	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T2	T14	11393267
NA	CHEMICAL	GENE-Y	16	6	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T2	T16	11393267
NA	CHEMICAL	GENE-Y	16	12	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T2	T18	11393267
NA	CHEMICAL	GENE-Y	41	4	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T5	T14	11393267
NA	CHEMICAL	GENE-Y	41	6	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T5	T16	11393267
NA	CHEMICAL	GENE-Y	41	12	The temporal profile of gene ( gene ) and in vitro chemical-reactivated gene was studied in a cohort of 25 chemical-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of chemical treatment .	T5	T18	11393267
CPR:3	CHEMICAL	GENE-Y	8	3	Reactivation potentials of gene ( the difference between chemical-reactivated and -unreactivated enzyme activity ) declined significantly with time after chemical ingestion .	T7	T17	11393267
CPR:4	CHEMICAL	GENE-Y	19	3	Reactivation potentials of gene ( the difference between chemical-reactivated and -unreactivated enzyme activity ) declined significantly with time after chemical ingestion .	T8	T17	11393267
CPR:4	CHEMICAL	GENE-Y	3	18	Patients who received chemical prior to hospitalization had a higher rate of intermediate syndrome and lower levels of gene at admission than those who had not .	T1	T11	11393267
CPR:6	CHEMICAL	GENE-N	6	4	Toxicity profile of small-molecule gene antagonist chemical is linked to gene pharmacology .	T5	T24	22956632
NA	CHEMICAL	GENE-Y	6	10	Toxicity profile of small-molecule gene antagonist chemical is linked to gene pharmacology .	T5	T25	22956632
CPR:6	CHEMICAL	GENE-N	0	13	chemical is a small-molecule drug that triggers tumor cell apoptosis by selectively antagonizing gene .	T2	T13	22956632
CPR:3	CHEMICAL	GENE-N	0	2	chemical induces gene transcriptional activity leading to expression of several gene and gene , of which gene ( gene ) is the most important for single-agent tumor activity .	T3	T14	22956632
NA	CHEMICAL	GENE-N	0	10	chemical induces gene transcriptional activity leading to expression of several gene and gene , of which gene ( gene ) is the most important for single-agent tumor activity .	T3	T15	22956632
NA	CHEMICAL	GENE-N	0	6	chemical induces gene transcriptional activity leading to expression of several gene and gene , of which gene ( gene ) is the most important for single-agent tumor activity .	T3	T16	22956632
NA	CHEMICAL	GENE-Y	0	16	chemical induces gene transcriptional activity leading to expression of several gene and gene , of which gene ( gene ) is the most important for single-agent tumor activity .	T3	T17	22956632
NA	CHEMICAL	GENE-Y	0	18	chemical induces gene transcriptional activity leading to expression of several gene and gene , of which gene ( gene ) is the most important for single-agent tumor activity .	T3	T18	22956632
NA	CHEMICAL	GENE-Y	10	22	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T9	16449956
NA	CHEMICAL	GENE-Y	10	24	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T11	16449956
NA	CHEMICAL	GENE-Y	10	39	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T12	16449956
NA	CHEMICAL	GENE-Y	10	36	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T13	16449956
NA	CHEMICAL	GENE-Y	10	57	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T14	16449956
NA	CHEMICAL	GENE-N	10	63	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T16	16449956
NA	CHEMICAL	GENE-N	10	65	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T1	T17	16449956
NA	CHEMICAL	GENE-Y	36	22	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T9	16449956
NA	CHEMICAL	GENE-Y	36	24	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T11	16449956
NA	CHEMICAL	GENE-Y	36	39	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T12	16449956
NA	CHEMICAL	GENE-Y	36	36	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T13	16449956
NA	CHEMICAL	GENE-Y	36	57	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T14	16449956
NA	CHEMICAL	GENE-N	36	63	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T16	16449956
NA	CHEMICAL	GENE-N	36	65	The diagnosis of CTLN2 was confirmed by elevations of plasma chemical level ( 384.3 nmol/mL ; normal 17-43 nmol/mL ) and serum gene ( gene ) ( 110 ng/mL ; normal 4.6-12.2 ng/mL ) , decrease in hepatic chemical synthetase activity ( 5.5 % of control ) , lack of hepatic gene protein expression and mutations in gene gene ( compound heterozygote with gene and gene ) .	T2	T17	16449956
NA	CHEMICAL	GENE-N	0	23	chemical , thought to be responsible for the chemopreventive properties of this food group , are conjugated to chemical by chemical chemical-transferases ( gene ) before urinary excretion .	T1	T11	17617661
NA	CHEMICAL	GENE-N	18	23	chemical , thought to be responsible for the chemopreventive properties of this food group , are conjugated to chemical by chemical chemical-transferases ( gene ) before urinary excretion .	T2	T11	17617661
NA	CHEMICAL	GENE-N	20	23	chemical , thought to be responsible for the chemopreventive properties of this food group , are conjugated to chemical by chemical chemical-transferases ( gene ) before urinary excretion .	T3	T11	17617661
NA	CHEMICAL	GENE-N	21	23	chemical , thought to be responsible for the chemopreventive properties of this food group , are conjugated to chemical by chemical chemical-transferases ( gene ) before urinary excretion .	T4	T11	17617661
NA	CHEMICAL	GENE-Y	2	13	Control of hyperchemicalemia and atherosclerosis using the cholesterol recognition/interaction chemical sequence of the gene .	T13	T21	23182766
NA	CHEMICAL	GENE-Y	9	13	Control of hyperchemicalemia and atherosclerosis using the cholesterol recognition/interaction chemical sequence of the gene .	T14	T21	23182766
NA	CHEMICAL	GENE-Y	7	1	The gene is an ubiquitous high affinity chemical-binding protein reported to be present in the endothelial and smooth muscle cells of the blood vessels ; its expression dramatically increased in macrophages found in atherosclerotic plaques .	T9	T18	23182766
NA	CHEMICAL	GENE-Y	4	6	A domain in the chemical-terminus of gene was identified and characterized as the chemical recognition/interaction chemical consensus ( CRAC ) .	T5	T17	23182766
NA	CHEMICAL	GENE-Y	13	6	A domain in the chemical-terminus of gene was identified and characterized as the chemical recognition/interaction chemical consensus ( CRAC ) .	T6	T17	23182766
NA	CHEMICAL	GENE-Y	15	6	A domain in the chemical-terminus of gene was identified and characterized as the chemical recognition/interaction chemical consensus ( CRAC ) .	T7	T17	23182766
NA	CHEMICAL	GENE-Y	24	27	We report herein the therapeutic benefit that resulted for the administration of the VLNYYVWR human CRAC sequence to guinea pigs fed with a high chemical diet and gene knock-out B6.129P2-Apoetm1Unc/J mice .	T10	T19	23182766
NA	CHEMICAL	GENE-Y	16	29	CRAC treatment ( 3 and 30mg/kg once daily for 6 weeks ) resulted in reduced circulating chemical levels in guinea pigs fed with 2 % high chemical diet and gene knock-out B6.129P2-Apoetm1Unc/J mice .	T11	T20	23182766
NA	CHEMICAL	GENE-Y	26	29	CRAC treatment ( 3 and 30mg/kg once daily for 6 weeks ) resulted in reduced circulating chemical levels in guinea pigs fed with 2 % high chemical diet and gene knock-out B6.129P2-Apoetm1Unc/J mice .	T12	T20	23182766
CPR:3	CHEMICAL	GENE-N	6	9	The treatment also prevented the high chemical diet-induced increase in serum chemical kinase , total and isoforms , markers of neurological , cardiac and muscular damage .	T3	T15	23182766
NA	CHEMICAL	GENE-N	9	9	The treatment also prevented the high chemical diet-induced increase in serum chemical kinase , total and isoforms , markers of neurological , cardiac and muscular damage .	T4	T15	23182766
NA	CHEMICAL	GENE-Y	1	2	The chemical hydroxylase inhibitor chemical ( 300µM , 24h ) completely abolished chemical-induced DA release .	T2	T27	23425605
CPR:4	CHEMICAL	GENE-Y	4	2	The chemical hydroxylase inhibitor chemical ( 300µM , 24h ) completely abolished chemical-induced DA release .	T3	T27	23425605
NA	CHEMICAL	GENE-Y	12	2	The chemical hydroxylase inhibitor chemical ( 300µM , 24h ) completely abolished chemical-induced DA release .	T4	T27	23425605
NA	CHEMICAL	GENE-Y	0	20	chemical significantly increased DA precursor accumulation in cells treated with chemical ( 10µM ) , revealing that chemical increases chemical hydroxylase activity .	T5	T28	23425605
NA	CHEMICAL	GENE-Y	6	20	chemical significantly increased DA precursor accumulation in cells treated with chemical ( 10µM ) , revealing that chemical increases chemical hydroxylase activity .	T6	T28	23425605
CPR:3	CHEMICAL	GENE-Y	17	20	chemical significantly increased DA precursor accumulation in cells treated with chemical ( 10µM ) , revealing that chemical increases chemical hydroxylase activity .	T7	T28	23425605
NA	CHEMICAL	GENE-Y	6	20	chemical significantly increased DA precursor accumulation in cells treated with chemical ( 10µM ) , revealing that chemical increases chemical hydroxylase activity .	T8	T28	23425605
